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Propositions 
 
1. Many breakthroughs in genetic engineering and molecular biology were based on 
bacterial-phage interaction mechanisms.  
(this thesis) 
 
2. The use of temperature for regulating molecular mechanisms and microbial production 
profiles holds great potential.  
(this thesis)  
 
3. Enzymatic promiscuity hinders the development of accurate metabolic models. 
 
4. Laboratory cultured meat is not a realistic replacement of real meat from a social, 
financial and scientific perspective. 
 
5. Vaccine refusal has revived previously eradicated diseases, mostly affecting the 
offspring of those who refuse to vaccinate. 
 
6. The EU regulatory policy on genetically modified organisms (GMOs) is an act of 
reality denial. 
 
7. Hard work increases one’s chances to get lucky. 
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Chapter 1
GENERAL INTRODUCTION
SHORT HISTORY OF MICROBIOLOGY & MICROBIAL BIOTECHNOLOGY
The founding stone of microbiology as a scientific discipline was set in the 1670s (Fig. 
1). This was the decade that Antonie van Leeuwenhoek and Robert Hooke, the
first acknowledged microscopists and the “Fathers of Microbiology”, started 
corresponding their microscopic observations on “animalcules” (“tiny animals”) to the
Royal Society1. Two centuries later, Louis Pasteur experimentally connected the spoilage
of milk and wine with bacterial activity, also postulating that bacteria could be the
causative agents of human diseases2. This hypothesis was confirmed by Robert Koch, 
the founder of modern bacteriology, towards the end of the 19th century; Koch identified 
the bacteria that cause anthrax (Bacillus anthracis) , tuberculosis (Mycobacterium
tuberculosis) and cholera (Vibrio cholerae), introduced the concept of infectious
diseases, and established the first pure bacterial culturing methods, which are still used 
today2. Except for infection agents it was later shown that bacteria are an important
contributor to the human microbiome and numerous studies have demonstrated the
close relation between the human microbiome composition and human health3.  
Microbes have been extensively used throughout the thousands of years of
human history for basic biotechnological applications (Fig. 1), such as the production 
of foods (e.g. bread and cheese) and beverages (e.g. wine and beer)2,4. Nonetheless, the
conscious and controlled biotechnological exploitation of microbes began only 
upon the identification of bacteria, yeasts and fungi as entities and of microbial
fermentation as a process. The use of pure yeast cultures as a practice for beer brewing, 
aiming to keep the quality and the taste of a beer constant, started only towards the end 
of the 19th century. Additionally, during World War I chemicals, such as acetone and 
glycerol that were used for the production of explosives2, respectively, were overconsumed 
and found to be in short supply. The replenishment of these products was achieved via
bacterial fermentations, and it was then that the “biotechnology” definition was coined as
the conversion of raw material to valuable products by biological systems. Since then, 
many additional useful products, such as chemicals and health related molecules, have
been produced via microbial based biotechnological processes. Moreover, many ancient
biotechnological production processes, such as food and beverage fermentations, have
been improved and protocols have been established for performing them in a more
controlled manner2,4.  
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Figure 1. Timeline of the summarised history of microbial biotechnology, molecular biology and genome 
engineering.
MOLECULAR BIOLOGY AND GENOME ENGINEERING
In the forty-year long period right after World War II, a series of milestones in the field of 
molecular biology extended the abilities to modify the production pattern and capacities of 
microbes in a targeted manner, providing the foundation of the microbial genome engineering 
field (Fig. 1). These milestones include the discovery of DNA as the molecule of life5, the 
elucidation of the DNA structure6, the discovery of the restriction enzymes7, the 
transformation and propagation of DNA plasmid material into E. coli8 and the development of 
the polymerase chain reaction9 (Fig. 1). In the middle of the twentieth century it was shown 
that radiation10 and certain chemical agents11 can increase the natural rate with which the 
genome of an organism is mutated, while a  later it was demonstrated that transposition 
genetic elements can be randomly inserted in genomes, disrupting genes and hence their 
function12. These approaches, as well as laboratory evolution, were extensively used for 
decades in industry and academia, aiming to develop randomly mutated microbial strains with 
desired traits and enhanced production capacities13. The random nature of  these tools resulted 
in strain development processes with low efficiencies and high screening requirements, 
making clear the need for the construction of efficient and targeted genome engineering tools.   
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The targeted microbial genome engineering era opened up in the late 1970s with the
targeted introduction of heterologous DNA fragments into the Saccharomyces cerevisiae
genome via transformation and homologous recombination (HR)14. As for the first bacterial
targeted genome editing applications, these came slightly later and were also relying on the
native bacterial HR systems and provided HR templates carrying the desired modifications15. 
In the cases of tools that employed replicating DNA vectors, an extensive screening process
was required upon transformation of the vector to the cells, aiming at the identification of the
clones where a single cross over event (SCO) had occurred. Subsequently, the use of a
plasmid-borne counter-selection system, such as the pyrF-system, the lacZ-system and the
tdk-hpt system16, was used for the selection of clones that lost the editing plasmid. This kind 
of tools commonly resulted in wild type revertant clones, especially for genes that code for
important functions. For the tools that were based on suicide DNA vectors, an antibiotic
resistance marker gene was introduced to the HR template for selection purposes, restricting 
the execution of sequential editing rounds for a species to the number of available marker
genes16. Moreover, an extensive screening process was required for identification of the
clones where a double cross-over (DCO) event occurred resulting in the elimination of the
suicide plasmid from the genome together the wild type targeted gene. Further employment
of recombinase-based systems (Cre-lox system, FLP-FRT system)16 allowed for marker
gene recycling. Nonetheless, genome editing using these methods was proved to be time
consuming, laborious, frequently resulted in chromosomal scars and could induce
undesirable chromosomal rearrangements. As an alternative, group II intron 
retrotransposition systems (ClosTron system, TargeTron system, ThermoTargeTron 
system)17-20 have been developed and successfully employed for a limited number of
bacterial species, nonetheless they often resulted in unstable insertions and polar effects, 
making their usefulness even more restricted. Additionally, the developed recombineering-
based methods (phage λ-Red system, Rac prophage-RecETsystem)21,22 that rely on the
heterologous expression of viral recombination systems and immediate transformation of the
targeted strain with ssDNA or dsDNA linear fragments, are easy-to-apply and time-efficient;
however, this system only provides relatively low engineering efficienciesfor just a handful
of model bacteria23-26. In sum, all the previously described tools were proved to be generally 
inefficient for editing the genome of non-modelbacteria with restricted genetic toolbox, low
transformation and recombination efficiencies. 
Worth mentioning is that, starting from the last couple of years of the 20th 
century, the eukaryotic genome engineering field met a new era  with the development of the
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nc-finger nucleases) and the transcription activator-like effector nucleases (TALENs)27,28, 
giving great hope that these tools could be adapted for prokaryotic genome engineering too. 
These chimeric nucleases are constructed as a “chain” of ZF and TALE DNA-binding 
domains fused to the non-specific DNA cleavage domain of the FokI restriction enzyme. The 
ability of FokI-dimers to introduce double stranded DNA breaks (DSDBs) in a sequence 
specific and programmable manner was exploited for stimulation of the error-prone non-
homologous end-joining (NHEJ) or homology directed repair mechanisms mostly in 
eukaryotic cells, resulting in targeted mutations in their genomes27,28. Nonetheless, the 
complexity in the designing and construction process of these tools discouraged their 
extensive use for bacterial genome engineering purposes. Hence, the need for user-friendly, 
efficient  and generally applicable bacterial genome editing tools remained. 
MICROBIAL METABOLIC ENGINEERING: THE CRISPR-CAS ERA
Microbial metabolic engineering is a practice dedicated to the exploration of the metabolism 
and the exploitation of the production capacities of industrially relevant microorganisms. 
Over the last decades, extensive microbial metabolic engineering studies have been conducted 
both for fundamental purposes and for biotechnological applications. These studies have 
resulted in the impressive gain of insight in the metabolism of -mostly- model  
microorganisms, such as E. coli, B. subtilis and S. cerevisiae, and in the development of 
strains that produce a wide range of compounds at high titers. Hence, it seems like a safe bet 
to hypothesize that thorough investigation of the metabolism of additional, non-model 
microorganisms holds great promise on the extension of the products range and the further 
improvement of the production processes.
All the past and current metabolic engineering studies rely on at least one of the 
following approaches: 1) episomal- or chromosomal-based overexpression of the native rate-
limiting enzyme(s) of the desired production pathway, 2) episomal- or chromosomal-based 
overexpression of the heterologous enzyme(s) of the desired production pathway, 3) 
downregulation of competing pathways either via deletion or via down regulation of the 
corresponding pathway gene(s), 4) enzyme engineering. All these approaches depend on 
synthetic biology and genome engineering applications, which are organism-specific and 
rarely applicable to a wide range of   microorganisms. Hence, the development of highly 
effective general genome engineering tools, is very important for further metabolic 
engineering studies.
wide range of microorganisms. Hence, the development of highly effective
general genome engineering tools,is very imp ortant for further metabolic engineering studies.  
In 2007 it was discovered that bacterial and archaeal genomes carry adaptive
immune systems against viruses and mobile genetic elemen ts in the form of
clustered regularlyinterspaced short palindromic repeats (CRISPR) and CRISPR-
associated (Cas) proteins29. The importance of these systems was underlined by the
observation that approximately half of the currently sequenced bacterial and archaeal
genomes contain at least one CRISPR-Cas system30. Moreover, the specificity of the
CRISPR-Cas targeting mechanisms was proved to be adaptable ina very simple way, 
especially when compared to ZFNs and TALENs; small RNA molecules could lead the
single or multi-subunit effectors of the CRISPR-Cas systems to their DNA or RNA
cleavage targets. Not surprisingly, at the beginning of the 2010s, the first Cas
endonuclease was employed for the development of eukaryotic and prokaryotic
genome editing and silencing tools31-34; it was the Cas9 RNA-guided DNA
endonuclease from Streptococcus pyogenes, denoted as SpCas9. The first generation 
of the CRISPR-Cas-based tools for bacterial genome editing, which are reviewed 
in chapter 2 of this thesis, almost exclusively relied on the introduction of desired 
modifications to a bacterial genome via HR templates while the SpCas9-targeted 
DSDBs act as moderate inducers of the HR cellular mechanism and as strict
counter selection system in favor of the modified genomes. Moreover, the
first CRISPR-Cas-based tool for bacterial transcriptional silencing was based 
on the targeting of the catalytically inactive (“dead”) SpdCas9 variant to the promoter
region of the gene of interest, or within the gene sequence for lower silencing effect. 
Chapter 8 presents the metabolic engineering studies on model and non-model
bacteria that relied on these tools for improvement of their production profiles
in green chemicals. The remarkable simplicity and efficiency of the SpCas9-based 
engineering tools lead to the further development of a number of genome engineering 
related applications, such as base editing35, EvolvR systems36 and the use of
antiCRISPR systems for improving thecontrol over Cas9-based tools and their
editing efficiencies, as described in chapter 6 of this thesis. Additionally, it is
anticipated that the evaluation of a rapidly increasing number of Cas effectors
with improved characteristics compared to SpCas9, as described in chapter 5 
of this thesis for a thermoactive Cas9 homologue, will result in a collection of CRISPR-
Cas tools that will further facilitate metabolic engineering studies.  
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TRANSITIONING TO THE GREEN-CHEMICALS AND BIOFUELS ERA
Fossil resources are currently extensively exploited for covering the exponentially 
growing global demand for fuels and chemicals. The environmental impacts caused 
by this exploitation are already visible and impose serious threats on the inhabitability 
of our planet in the near future. The use of renewable resources for the microbial-
based production of chemicals and fuels in a biorefinery is an attractive and 
environmentally friendly (“green”) approach.The complete transition from the 
fossil-based to the microbial-based production of chemicals and fuels requires 
the development of financially competitive biotechnological processes. The total 
cost of each process is determined by the cost of: 
1. the fermentation process, including:
a. the cost of the employed carbon and electron sources, as well as additional
nutritional requirements of the microbial workhorse
b. the cost of the required oxygen, carbon dioxide and energy inputs etc.
c. the cost of the equipment and related operational costs
2. The products separation and purification process, i.e. the downstream processing
Both cost categories heavily rely on the characteristics, requirements and possible 
byproducts of the employed microbial production platform, especially when the selling price 
of the targeted product  is low, as is the case for bulk chemicals and fuels. Hence, the careful 
selection of an appropriate microbial workhorse, according to the requirements of an a priori 
designed production process, is mandatory in order to secure the financial success of a green 
chemicals or biofuels production process. Additionally, it is required that the selected 
microbes can be subjected to targeted genetic modifications for metabolic engineering 
purposes, aiming to achieve the production of heterologous products or to enhance the 
production of native products, at least up to financially viable levels. Nonetheless, not all the 
commonly employed model microbial platforms, such as E. coli, S. cerevisiae and B. subtilis, 
can withstand production conditions (such as high temperatures, low pH, etc.) that in some 
cases would enable the financial viability of a production process. Moreover, the vast majority 
of the remaining, non-model microbes are usually not genetically accessible, while if they are, 
they have limited -if any- genetic and genome engineering toolboxes, a fact that hinders the 
efficient engineering of their metabolism towards the desired products. Hence, the genetic 
“taming” of biotechnologically relevant microbes is gaining increasing attention the last years, 
in parallel with the efforts to transition to a sustainable economic and environmental model.
NON-MODEL BACTERIA WITH BIOTECHNOLOGICAL PERSPECTIVE:
BACILLUS SMITHII, PSEUDOMONAS PUTIDA AND RHODOBACTER SPHAEROIDES
The main focus of this thesis, as presented in Chapters 3, 4 and 5, was the development
of Cas9-based efficient genome engineering tools for three biotechnologically 
interesting non-model bacteria: the moderately thermophilic bacteriumBacillus
smithii and the mesophilic bacteriaRhodobacter sphaeroides  and Pseudomonas putida .  
The biotechnological relevance of B. smithii resides in its abilities to utilize both C5
and C6 sugars, to grow in a wide temperature range withstanding wide
temperature fluctuations, to tolerate low pH conditions for an extended period of
time and to be genetically accessible37. These characteristics render B. smithii a
strain with great potential to become a production platform in a Simultaneous
Saccharification and Fermentation (SSF) set-up that employs lignocellulosic biomass as
carbon source. Chapter 8 presents further work on the employment of the developed Cas9-
based tools towards the exploration and exploitation of its metabolism. 
P. putida has attracted a lot of attention for its innate biotechnological potential
towards bioremediation38,39 and biocontrol40,41 that emanates from its adaptability 
to harsh physicochemical conditions (such as in the presence of solvents) and its diverse
metab olism. Moreover, its ability to consume a wide range of substrates only 
enhanced this interest42. Metabolically engineered P. putida strains have already been 
constructed and used towards the production of bioplastics39 as well as agricultural and 
pharmaceutical compounds42. Hence, the development of tools that enhance the
genome engineering throughput forP. putida, like the tool described in this thesis in 
Chapter 5, will only accelerate the biotechnological exploitation of this bacterium. 
The highly adaptable metabolism of R. sphaeroides has been 
extensively investigated in diverse studies with fundamental and biotechnological
interests43. R. sphaeroides is a facultative phototrophic microorganism, grows on a wide
range of carbon sources and can use many different electron acceptors for respiration 
purposes44,45. The studies that emplo yed R. sphaeroides for bioremediation, 
photoheterotrophic hydrogen production and heterotrophic terpene biosynthesis have
underlined its biotechnological versatility and relevance46,47. It is anticipated that
the development of efficient engineering tools for R. sphaeroides , like the one
described in Chapter 4, will contribute to the elucidation of its comp lex metabolism as well
as to the construction of readily applicable hydrogen or terpene production strains.
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TRANSITIONING TO THE GREEN-CHEMICALS AND BIOFUELS ERA
Fossil resources are currently extensively exploited for covering the
exponentially growing global demand for fuels and chemicals. The
environmental impacts caused by this exploitationare already visible and impose
serious threats on the inhabitability of our planet in the near future. The use
of renewable resources for the microbial-based production of chemicals and fuels
in a biorefinery is an attractive and environmentally friendly (“green”)
approach.The complete transition from the fossil-based to the microbial-based 
production of chemicals and fuels requires the development of financially competitive
biotechnological processes. The total cost of each process is determined by the cost of:
1. The fermentation process, including:
a. the cost of the employed carbon and electron sources, as well as additional
nutritional requirements of the microbial workhorse
b. the cost of the required oxygen, carbon dioxide and energy inputs etc.
c. the cost of the equipment and related operational costs
2. The products separation and purification process, i.e. the downstream processing
Both cost categories heavily rely on the characteristics, requirements and 
possible byproducts of the employed microbial production platform, especially when 
the selling price of the targeted product is low, as is the case for bulk 
chemicals and fuels. Hence, the careful selection of an appropriate microbial
workhorse, according to the requirements of an a priori designed production process, 
is mandatory in order to secure the financial success of a green chemicals or biofuels
production process. Additionally, it is required that the selected microbes can be
subjected to targeted genetic modifications for metabolic engineering purposes, aimin g 
to achieve the production of heterologous products or to enhance the production of
native products, at least up to financially viable levels. Nonetheless, not all the
commonly employed model microbial platforms, such asE. coli, S. cerevisiae and 
B. subtilis, can withstand production conditions (such as high temperatures, low
pH, etc.) that in some cases would enable the financial viability of a production
process. Moreover, the vast majority of the remaining, non-mode lmicrobes are usually
not genetically accessible, while if they are, they have limited -if any- genetic and
genome engineering toolboxes, a fact that hinders the efficient engineering of
their metabolism towards the desired products. Hence, the genetic
“taming” of biotechnologically relevant microbes is gaining increasing attention
the last years, in parallel with the efforts to transition to a sustainable economic and
environmental model.
NON-MODEL BACTERIA WITH BIOTECHNOLOGICAL PERSPECTIVE: 
BACILLUS SMITHII, PSEUDOMONAS PUTIDA AND RHODOBACTER SPHAEROIDES
The main focus of this thesis, as presented in Chapters 3, 4 and 5, was the development of 
Cas9-based efficient genome engineering tools for three biotechnologically interesting non-
model bacteria: the moderately thermophilic bacterium Bacillus smithii and the mesophilic 
bacteria Rhodobacter sphaeroides and Pseudomonas putida.  
The biotechnological relevance of B. smithii resides in its abilities to utilize both C5 
and C6 sugars, to grow in a wide temperature range withstanding wide temperature 
fluctuations, to tolerate low pH conditions for an extended period of time and to be 
genetically accessible37. These characteristics render B. smithii a strain with great potential to 
become a production platform in a Simultaneous Saccharification and Fermentation (SSF) 
set-up that employs lignocellulosic biomass as carbon source. Chapter 8 presents further work 
on the employment of the developed Cas9-based tools towards the exploration and 
exploitation of its metabolism. 
P. putida has attracted a lot of attention for its innate biotechnological potential
towards bioremediation38,39 and biocontrol40,41 that emanates from its adaptability to harsh 
physicochemical conditions (such as in the presence of solvents) and its diverse metabolism. 
Moreover, its ability to consume a wide range of substrates only enhanced this interest42. 
Metabolically engineered P. putida strains have already been constructed and used towards 
the production of bioplastics39 as well as agricultural and pharmaceutical compounds42. 
Hence, the development of tools that enhance the genome engineering throughput for P. 
putida, like the tool described in this thesis in Chapter 5, will only accelerate the 
biotechnological exploitation of this bacterium. 
The highly adaptable metabolism of R. sphaeroides has been extensively 
investigated in diverse studies with fundamental and biotechnological interests43. R. 
sphaeroides is a facultative phototrophic microorganism, grows on a wide range of carbon 
sources and can use many different electron acceptors for respiration purposes44,45. The 
studies that employed R. sphaeroides for bioremediation, photoheterotrophic hydrogen 
production and heterotrophic terpene biosynthesis have underlined its biotechnological 
versatility and relevance46,47. It is anticipated that the development of efficient engineering 
tools for R. sphaeroides, like the one described in Chapter 4, will contribute to the elucidation 
of its complex metabolism as well as to the construction of readily applicable hydrogen or 
terpene production strains.
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up to 70 °C, motivating its further use for the development of uniquely versatile and 
robust Cas9-based genome engineering tools, applied on B. smithii at 55 °C and on P. 
putida at 37 °C.  
Chapter 6 studies the potential to harness the activity of an antiCRISPR protein for
genome engineering purposes. The AcrIIC1Nme antiCRISPR protein from Neisseria 
meningitidis is proven to capture two thermo-active Cas9 orthologues (ThermoCas9 and 
GeoCas9) in a DNA-bound, but catalytically inactive form in vivo in E. coli at 37°C. 
The Cas9/AcrIIC1Nme complexes have a transcriptional silencing effect with efficiency 
comparable to thecatalytically "dead" Thermo-dCas9 and Geo-dCas9 variants. Finally, this
chapter describes the controllable and efficient Cas9/AcrIIC1Nme-based tool for coupled 
silencing and targeting in bacteria. 
Chapter 7 reviews recent metabolic engineering studies that aimed to improve the
production capacities of model and non-model prokaryotes and that were executed 
employing CRISPR-Cas-based DNA/RNA engineering technologies. Additionally, this
chapter analyses how novel CRISPR-Cas systems from diverse environments will
amplify the number of CRISPR-Cas-based engineering applications and extend the variety 
of organisms on which these applications can be employed for metabolic engineering 
purposes. 
Chapter 8 presents the work performed on studying the metabolism ofB. smithii via
the employment of the developed Cas9-based genome editing tools. The described work 
aimed to either relieve the NAD+ deficiency of the B. smithii ΔldhL strain under
oxygen limited conditions or to study the non-canonical acetate production pathway ofB. 
smithii. Moreover, B. smithii was cultured under at different temperatures aiming to 
discover differences in growth, production and protein content. Finally, a B. smithii strain 
was engineered to produce higher amounts of dicarboxylic acids and lower amounts of
acetate.
Chapter 9 summarizes the work presented in this thesis, discusses its general scope and puts
the presented results in perspective. Moreover, further work towards the development
of additional genetic tools for B. smithii and genome editing tools for thermophilic and 
mesophilic bacteria is also discussed together with the encountered bottlenecks and future
perspectives. Finally, additional work aiming the identification of the B. smithii acetate
production pathway and the enhancement of its dicarboxylic acids production levels is
presented and future engineering avenues are discussed. 
THESIS OUTLINE
As briefly introduced above in Chapter 1, microbes have been extensively exploited 
throughout the reported human history for biotechnological applications, especially in the 
field of food biotechnology. Nowadays, the microbial production of green chemicals and 
fuels gains increasing attention, especially due to the ease in the construction of metabolically 
engineered microorganisms with high production capacities. This ease was achieved due to 
the development of efficient genome engineering tools. This thesis describes the development 
of genetic tools as well as novel CRISPR-Cas9-based and antiCRISPR-based prokaryotic 
genome engineering tools, for mesophilic and thermophilic bacteria, and the use of these 
tools for the metabolic exploration and exploitation of the moderate thermophilic bacterium 
B. smithii.
Chapter 2 discusses the currently established and extensively used CRISPR-Cas-based tools 
for engineering the genomes of model and non-model prokaryotes. Additionally, it analyses 
the possibilities to improve and expand these tools for further enhancement of their 
throughput.
Chapter 3 describes the first application of Streptococcus pyogenes Cas9 (spCas9)-based 
genome editing on a moder ate thermophilic bacterium, B. smithii . Plasmid-borne editing 
templates introduce the desired modifications to the B. smithii genome at higher culturing 
temperatures via homologous recombination (HR), while consequent culturing at lower 
temperatures allows for spCas9-based introduction of lethal double-stranded DNA breaks to 
the genomes of the non-edited cells, acting as a counter-selection mechanism. 
Chapter 4 describes the development of the first SpCas9-based genome editing tool for the 
α-proteobacterium Rhodobacter sphaeroides. Plasmid-borne HR editing templates introduce 
the desired modifications to the R. sphaeroides genome and the SpCas9-based introduction of 
lethal genomic DNA breaks allows the survival and easy selection of the edited cells. 
Additionally, this chapter shows that the native R. sphaeroides non-homologous end joining 
(NHEJ) mechanism can repair the SpCas9-induced genomic DNA breaks and is based on the 
LigD and not on the predicted Ku homologs, strongly suggesting the existence of an 
unprecedented bacterial NHEJ system.
Chapter 5 focuses on the characterization of ThermoCas9, a Cas9 orthologue from the type 
II-C CRISPR-Cas system of the thermophilic bacterium Geobacillus thermodenitrificans. 
Amongst others, it is demonstrated that ThermoCas9 is in vitro active up to 70 °C, 
motivating its further use for the development of uniquely versatile and robust Cas9-based 
genome engineering tools, applied on B. smithii at 55 °C and on P. putida at 37 °C.
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Thesis outline
As briefly introduced above in Chapter 1, microbes have been extensively 
exploited throughout the reported human history for biotechnological applications, 
especially in the field of food biotechnology. Nowadays, the microbial production of green 
chemicals and fuels gainsincreasing attention, especially due to the ease in the construction 
of metabolically engineered microorganisms with high production capacities. This ease
was achieved due to the development of efficient genome engineering tools. This thesis
describes the development of genetic tools as well as novel CRISPR-Cas9-based and 
antiCRISPR-based prokaryotic genome engineering tools, for mesophilic and thermophilic
bacteria, and the use of these tools for the metab olic exploration and exploitation of the
moderate thermophilic bacterium B. smithii. 
Chapter 2 discusses the currently established and extensively used CRISPR-Cas-based 
tools for engineering the genomes of model and non-model prokaryotes. Additionally, it
analyses the possibilities to improve and expand these tools for further enhancement of their
throughput. 
Chapter 3 describes the first application of Streptococcus pyogenes Cas9 (spCas9)-
based genome editing on a moderate thermophilic bacterium, B. smithii . Plasmid-borne
editing templates introduce the desired modifications to theB. smithii genome at higher
culturing temperatures via homologous recombination (HR), while consequent
culturing at lower temperatures alows for spCas9-based introduction of lethal double-
stranded DNA breaks to the genomes of the non-edited cells, acting as a counter-selection 
mechanism.  
Chapter 4 describes the development of the first SpCas9-based genome editing tool for the
α-proteobacterium Rhodobacter sphaeroides . Plasmid-borne HR editing templates introduce
the desired modifications to theR. sphaeroides genome and the SpCas9-based introduction of
lethal genomic DNA breaks allows the survival and easy selection of the edited cells. 
Additionally, this chapter shows that the native R. sphaeroides non-homologous end 
joining (NHEJ) mechanism can repair the SpCas9-induced genomic DNA breaks and is
based on the LigD and not on the predicted Ku homologs, strongly suggesting the
existence of an unprecedented bacterial NHEJ system.  
Chapter 5 focuses on the characterization of ThermoCas9, a Cas9 orthologue from the type
II-C CRISPR-Cas system of the thermophilic bacterium Geobacillus
thermodenitrificans. Amongst others, it is demonstrated that ThermoCas9 is in vitro active
Chapter 6 studies the potential to harness the activity of an antiCRISPR protein for 
genome engineering purposes. The AcrIIC1Nme antiCRISPR protein from Neisseria 
meningitidis is proven to capture two thermo-active Cas9 orthologues (ThermoCas9 and 
GeoCas9) in a DNA-bound, but catalytically inactive form in vivo in E. coli at 37°C. The 
Cas9/AcrIIC1Nme complexes have a transcriptional silencing effect with efficiency 
comparable to the catalytically "dead" Thermo-dCas9 and Geo-dCas9 variants. Finally, this 
chapter describes the controllable and efficient Cas9/AcrIIC1Nme-based tool for coupled 
silencing and targeting in bacteria.
Chapter 7 reviews recent metabolic engineering studies that aimed to improve the 
production capacities of model and non-model prokaryotes and that were executed 
employing CRISPR-Cas-based DNA/RNA engineering technologies. Additionally, this 
chapter analyses how  novel CRISPR-Cas systems from diverse environments will amplify 
the number of CRISPR-Cas-based engineering applications and extend the variety of 
organisms on which these applications can be employed for metabolic engineering 
purposes. 
Chapter 8 presents the work performed on studying the metabolism of B. smithii via the 
employment of the developed Cas9-based genome editing tools. The described work aimed 
to either relieve the NAD+ deficiency of the B. smithii ΔldhL strain under oxygen limited 
conditions or to study the non-canonical acetate production pathway of B. smithii. Moreover, 
B. smithii was cultured under at different temperatures aiming to discover differences in 
growth, production and protein content. Finally, a B. smithii strain was engineered to produce 
higher amounts of dicarboxylic acids and lower amounts of acetate.
Chapter 9 summarises the work presented in this thesis, discusses its general scope and puts 
the presented results in perspective. Moreover, further work towards the development of 
additional genetic tools for B. smithii and genome editing tools for thermophilic and 
mesophilic bacteria is also discussed together with the encountered bottlenecks and future 
perspectives. Finally, additional work aiming the identification of the B. smithii acetate 
production pathway and the enhancement of its dicarboxylic acids production levels is 
presented and future engineering avenues are discussed.
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Chapter 2
• What is the efficiency of bacterial genome editing by CRISPR-Cas variants such as Cpf1
or C2C1, as compared to Cas9? In particular, could such systems enhance
recombination-mediated genome editing?
• Can endogenous CRISPR-Cas systems substitute SpCas9 for genome editing purposes
in non-model bacteria that do not support SpCas9 activity?
• How to rapidly characterize novel CRISPR-Cas-systems, including PAM-identification,
so they can be applied for genome editing?
• Can CRISPR-Cas-systems be exploited for purposes beyond genome editing?
• Whereas gene silencing seems highly effective in prokaryotes, gene activation needs further
improvement – how can this be achieved?
• Can NHEJ in bacteria be established heterologously, so it can be used as general means for
CRISPR-Cas-based gene disruption?
KEYWORDS 
CRISPR-Cas, bacteria, recombineering, genome editing, Cas9
GLOSS ARY
• Clustered regularly interspaced short palindromic repeats (CRISPR): a bacterial
or archaeal DNA array constituted of small (30-45 nt long) sequences, usually of
foreign origin, which are separated by (almost) identical repeat sequences of similar size.
• CRISPR-associated (Cas) enzymes: enzymes encoded bycas genes that generally reside
in close proximity to a CRISPR array, taking part in any of the three stages of the
CRISPR–Cas based immunity.
• CRISPR locus: a bacterial or archaeal DNA locus constituted of a CRISPR array,
its corresponding Cas genes and possible ancillary modules.
• CRISPR RNA (crRNA): an RNA molecule that guides the targeting of CRISPR-
Cas systems. It originates from the CRISPR locus and is comprised of the processed
transcript of a spacer and a CRISPR array repeat.
• Double-Stranded DNA Break (DSDB): damage of the DNA such that the backbones
of both strands are cleaved simultaneously.
• Non-Homologous End Joining (NHEJ): An error-prone DSDB-repair mechanism,
based on the concerted activities of DNA-binding protein Ku and ligase LigD.
• Protospacer: a DNA-sequence, targeted for cleavage by a CRISPR-Cas system, that
is identical to a spacer sequence of the corresponding CRISPR-array.
• Protospacer adjacent motif (PAM): the short (2-8 nt) conserved sequence adjacent to
a protospacer, mandatory for recognition and targeting by CRISPR-Cas systems (except
Type III), as a means to discriminate self (CRISPR spacer) from non-self (invader
protospacer).
• Recombineering (recombination-mediated genetic engineering): genetic engineering
tool mediated by phage-derived recombination systems, such as λ-Red or RecET, that
facilitate the homologous recombination between ssDNA or dsDNA fragments with
complementary genome sequences.
• Seed: the first 8-12 bp of a protospacer immediately adjacent to the PAM-
sequence; required together with the PAM for successful targeting.
• Single-Stranded DNA Break (SSDB): cleavage of the DNA such that the backbone of
one of the strands is nicked while the other one remains intact.
• Single guide RNA (sgRNA): a synthetic chimera combining the crRNA and tracrRNA
into a single CRISPR guide.
• Spacer: short (30-45 nt) DNA sequences derived from target genetic elements; located
in the CRISPR array and flanked by repeat sequences.
• Trans-activating CRISPR RNA (tracrRNA): an RNA molecule encoded by Type
II CRISPR loci, that hybridizes to the repeat parts of crRNAs. The crRNA:tracrRNA
hybrid is required for Cas9 activation.
ABSTRACT
The increasing demand for environmentally friendly production processes of green chemicals 
and fuels has stimulated research in microbial metabolic engineering. CRISPR-Cas-based 
tools for genome editing and expression control have enabled fast, easy and accurate strain 
development for established production platform organisms, such as Escherichia coli 
and Saccharomyces cerevisiae. However, the growing interest in alternative production 
hosts for which genome editing options are generally limited, requires further 
development of such engineering tools. In this review we discuss established and 
emerging CRISPR-Cas-based tools for genome editing and transcription control of model 
and non-model bacteria, and we analyse the possibilities for further improvement and 
expansion of these tools for next generation bacterial engineering.
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• What is the efficiency of bacterial genome editing by CRISPR-Cas variants such as Cpf1
or C2C1, as compared to Cas9? In particular, could such systems enhance 
recombination-mediated genome editing?
• Can endogenous CRISPR-Cas systems substituteSpCas9 for genome editing purposes 
in non-model bacteria that do not support SpCas9 activity?
• How to rapidly characterize novel CRISPR-Cas-systems, including PAM-identification, 
so they can be applied for genome editing?
• Can CRISPR-Cas-systems be exploited for purposes beyond genome editing?
• Whereas gene silencing seems highly effective in prokaryotes, gene activation needs further
improvement – how can this be achieved?
• Can NHEJ in bacteria be established heterologously, so it can be used as general means for
CRISPR-Cas-based gene disruption?
K EYWO RDS
CRISPR-Cas, bacteria, recom bineering, genom e editing, Cas9
G LO SSARY 
• Clustered regularly interspaced short palindromic repeats (CRISPR): a bacterial
or archaeal DNA array constituted of small (30-45 nt long) sequences, usually of
foreign origin, which are separated by (almost) identical repeat sequences of similar size.
• CRISPR-associated (Cas) enzymes: enzymes encoded by cas genes that generally reside
in close proximity to a CRISPR array, taking part in any of the three stages of the
CRISPR–Cas based immunity.
• CRISPR locus: a bacterial or archaeal DNA locus constituted of a CRISPR array,
its corresponding Cas genes and possible ancillary modules.
• CRISPR RNA (crRNA): an RNA molecule that guides the targeting of CRISPR-
Cas systems. It originates from the CRISPR locus and is comprised of the processed
transcript of a spacer and a CRISPR array repeat.
• Double-Stranded DNA Break (DSDB): damage of the DNA such that the backbones
of both strands are cleaved simultaneously.
• Non-Homologous End Joining (NHEJ): An error-prone DSDB-repair mechanism,
based on the concerted activities of DNA-binding protein Ku and ligase LigD.
• Protospacer: a DNA-sequence, targeted for cleavage by a CRISPR-Cas system, that
is identical to a spacer sequence of the corresponding CRISPR-array.
• Protospacer adjacent motif (PAM): the short (2-8 nt) conserved sequence adjacent to
a protospacer, mandatory for recognition and targeting by CRISPR-C as systems (except
Type III), as a means to discriminate self (CRISPR spacer) from non-self (invader
protospacer).
• Recombineering (recombination-mediated genetic engineering): genetic engineering
tool mediated by phage-derived recombination systems, such as λ-Red or RecET, that
facilitate the homologous recombination between ssDNA or dsDNA fragments with
complementary genome sequences.
• Seed: the first 8-12 bp of a protospacer immediately adjacent to the PAM-
sequence; required together with the PAM for successful targeting.
• Single-Stranded DNA Break (SSDB): cleavage of the DNA such that the backbone of
one of the strands is nicked while the other one remains intact.
• Single guide RNA (sgRNA): a synthetic chimera combining the crRNA and tracrRNA
into a single CRISPR guide.
• Spacer: short (30-45 nt) DNA sequences derived from target genetic elements; located
in the CRISPR array and flanked by repeat sequences.
• Trans-activating CRISPR RNA (tracrRNA): an RNA molecule encoded by Type
II CRISPR loci, that hybridizes to the repeat parts of crRNAs. The crRNA:tracrRNA
hybrid is required for Cas9 activation.
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activating CRISPR RNA (crRNA:tracrRNA) duplex. The spacer part of the crRNA m olecule
is responsible for the specificity of the Cas9 activity, due to its com plem entarity to one of the
strands of the targeted protospacer (Fig. box 1). A short and conserved protospacer adjacent
motif (PAM), flanking the 3’-end of the protospacer, is required for Cas9-mediated cleavage 
activity7, 8. This is crucial for avoiding autoimmunity: the absence of a PAM motif flanki ng
the spacers of the CRISPR array on the host’s chrom osom e prevents lethal self-targeting events. 
Table 1. Classification of Cas proteins in CRISPR-Cas systems according to their 
mode of action. Based on5. The components that are not present in all the subtypes of the
corresponding type are indicated by brackets. a Abbreviations: LS: large subunit protein; SS: small
subunit protein. In some type I systems SS is fused to LS (Cas8). b The Cas proteins that are 
responsible for the target binding in Type I, III, and probably type IV systems form Cascade-like 
complexes. c The Cas proteins that are responsible for the target binding in Type III-A and D 
systems form the Csm-complex. d The Cas proteins that are responsible for the target binding in 
Type III-B and C systems form the Cmr-complex. 
Class Type Subtypes Acquisition Expression Interference
Processing of the
pre-crRNA 
transcript
Target
bindinga,b
Target
cleavage
Type of
nuclease 
activity
1 I A-F,U Cas1, Cas2,
Cas4
Cas6 Cas7, Cas5,
Cas8 (LS),
SS
Cas3 3’-5’ 
exonuclea
se (SSDB)
[55]
III A-D (Cas1, Cas2) (Cas6) c,d Cas7,
Cas5,
Cas10 (LS),
SS
Cas7
Cas10
RNase/D
Nase 
[56, 57]
IV - Unknown unknown Cas7, Cas5,
Csf1, (SS)
unknown unknown
2 II A-C Cas1, Cas2,
(Cas4), Cas9
RNase III (Cas9) Cas9 Cas9 Blunt-end
DSDB
inside seed
[58]
V A-C (Cas1),
(Cas2),
(Cas4)
unknown Cas12a,
C2C1,
C2C3
Cpf1,
C2C1,
C2C3
Cpf1:
sticky-end
DSDB
outside
seed [59]
VI - Cas1, Cas2 unknown C2C2 C2C2 unknown 
(RNase?)
FROM EXPLORATION TO EXPLOITATION 
The circular economy requires sustainable and biobased alternatives for generating 
fuels and chemicals that are produced via microbial fermentation. High-throughput genome 
editing tools are essential for the development of economically viable production organisms. 
Therefore, ample research focuses on adapting the efficient use of CRISPR -Cas9-based 
genome editing in eukaryotes for applications in prokaryotes. The main bottleneck of this 
adaptation process is the limitations of the bacterial DNA -repair systems. 
Less than 10 years ago it was discovered that the bacterial and archaeal Clustered 
regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated (Cas) (see 
glossary) systems are in fact RNA-guided adaptive immune systems, conferring sequence-
specific resistance against invasive mobile genetic elements (MGEs)1,2. Since then, 
considerable insight in the molecular events has been acquired and the CRISPR-Cas based 
microbial immunity is now divided into the 3 distinct molecular stages of acquisition, 
expression and interference3 (Table 1). During the acquisition stage the Cas1 and Cas2 
proteins recognize and digest invasive MGEs to sample short DNA sequences from them and 
introduce these into the CRISPR array as spacers. The spacers constitute the memory of the 
system and efficiently vaccinate the microbe against the corresponding MGEs. The 
transcription of the  array as one large premature transcript occurs during the expression stage 
and starts from the leader sequence. Cas enzymes recognize and bind to the premature 
transcript, which is then processed into smaller mature CRISPR RNAs (crRNAs) either by 
specific Cas nucleases or by the cellular RNase III. These mature crRNAs are comprised of 
two parts: the transcript of a spacer followed or preceded by the transcript of a repeat. During 
the interference stage the crRNAs guide the Cas nucleases to target and cleave protospacer 
sequences in invading MGEs.
To date, 6 (I-VI) types of CRISPR-Cas systems have been identified and divided into 
two major classes, class 1 and class 2,  according to the complexity of their interference 
machinery4-6 (Table 1). The CRISPR-Cas class 1 comprises types I, III and the putative type 
IV, all of which confer immunity to their hosts, based on multi-subunit, Cascade-like effector-
complexes (Table 1). The CRISPR-Cas class 2 encompasses types II, V and VI, which base 
their functionality on a large, single protein, multi-domain nuclease (Cas9, Cpf1, C2C1, C2C3 
and C2C2) (Table 1). The type II CRISPR-Cas systems confer immunity to their hosts through 
the Cas9-mediated introduction of sequence-specific, blunt, Double-Stranded DNA Breaks 
(DSDBs) to the targeted MGE protospacers. The Cas9 endonuclease has two nickase domains, 
an HNH and a RuvC, and is active when loaded with a small guide CRISPR-RNA:trans-acti-
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FROM E XPLOR ATION TO E XPLO ITATION
The circular econom y requires sustainable and biobased alternatives for generating fuels
and chem icals that are produced via m icrobial ferm entation. High-throughput genom e editing 
tools are essential for the developm ent of econom ically viable production organism s. Therefore,
am ple research focuses on adapting the efficient use of CRISPR-Cas9-based genom e editing in 
eukaryotes for applications in prokaryotes. The m ain bottleneck of this adaptation process is
the limita tions of thebacterial DNA-repair system s. 
Less than 10 years ago it was discovered that the bacterial and archaeal Clustered
regularly interspaced short palindrom ic repeats (CRISPR)-CRISPR-associated (Cas) (see
glossary) systems are in fact RNA-guided adaptive immune systems, conferring sequence-
specific resistance against invasive mobile genetic elements (MGEs)1,2. Since then, 
considerable insight in the m olecular events has been acquired and the CRISPR-Cas based 
microbial immunity is now divided into the 3 distinct molecular stages of
acquisition, expression and interference3 (Table 1). During the acquisition stage the Cas1 
and Cas2 proteins recognize and digest invasive MGEs to sample short DNA sequences
from them and introduce these into theCRISPR array as spacers. The spacers constitute the
memory of the system and efficiently vaccinate the microbe against the
corresponding MGEs. The transcription of the array as one large premature transcript
occurs during the expression stage and starts from the leader sequence. Cas enzymes
recognize and bind to the premature transcript, which is then processed into smaller
mature CRISPR RNAs (crRNAs) either by specific Cas nucleases or by the cellular RNase
III. These mature crRNAs are comprised of two parts: the transcript of a spacer followed or
preceded by the transcript of a repeat. During the interference stage the crRNAs guide the
Cas nucleases to target and cleave protospacer sequences in invading MGEs.
To date, 6 (I-VI) types of CRISPR-Cas system s have been identified and divided into
two major classes, class 1 and class 2, according to the complexity of their interference
machinery4-6 (Table 1). The CRISPR-Cas class 1 comprises types I, III and the putative type
IV, all of which confer im m unity to their hosts, based on m ulti-subunit, Cascade-like effector-
com plexes (Table 1). The CRISPR-Cas class 2 encom passes types II, V and VI, which base
their functionality on a large, single protein, m ulti-dom ain nuclease (Cas9, Cpf1, C2C1, C2C3
and C2C2) (Table 1). The type II CRISPR-Cas systems confer immuni ty to their hosts through 
the Cas9-m ediated introduction of sequence-specific, blunt, Double-Stranded DNA Breaks
(DSDBs) to the targeted MGE protospacers. The Cas9 endonuclease has two nickase dom ains, 
an HNH and a RuvC, and is active when loaded with a sm all guide CRISPR-RNA:trans-
vating CRISPR RNA (crRNA:tracrRNA) duplex. The spacer part of the crRNA 
molecule is responsible for the specificity of the Cas9 activity, due to its complementarity to 
one of  the strands of the targeted protospacer (Fig. box 1). A short and conserved 
protospacer adjacent motif (PAM), flanking the 3’-end of the protospacer, is required for 
Cas9-mediated cleavage activity7, 8. This is crucial for avoiding autoimmunity: the  absence 
of a PAM motif flanking the spacers of the CRISPR array on the host’s chromosome 
prevents lethal self-targeting events.
Table 1. Classification of Cas proteins in CRISPR-Cas systems according to their mode 
of action. Based on5. The components that are not present in all the subtypes of the corresponding 
type are indicated by brackets. a Abbreviations: LS: large subunit protein; SS: small subunit protein. In 
some type I systems SS is fused to LS (Cas8). b The Cas proteins that are responsible for the target 
binding in Type I, III, and probably type IV systems form Cascade-like complexes. c The Cas proteins 
that are responsible for the target binding in Type III-A and D systems form the Csm-complex. d The 
Cas proteins that are responsible for the target binding in Type III-B and C systems form the Cmr-
complex. 
Class Type Subtypes Acquisition Expression Interference 
Processing of the 
pre-crRNA 
transcript 
Target 
bindinga,b 
Target 
cleavage 
Type of 
nuclease 
activity 
1 I A-F,U Cas1, Cas2, 
Cas4 
Cas6 Cas7, Cas5, 
Cas8 (LS), 
SS 
Cas3 3’-5’ 
exonuclea
se (SSDB) 
[55] 
III A-D (Cas1, Cas2) (Cas6) c,d Cas7, 
Cas5, 
Cas10 (LS), 
SS 
Cas7 
Cas10 
RNase/D
Nase 
[56, 57] 
IV - Unknown unknown Cas7, Cas5, 
Csf1, (SS) 
unknown unknown 
2 II A-C Cas1, Cas2, 
(Cas4), Cas9 
RNase III (Cas9) Cas9 Cas9 Blunt-end 
DSDB 
inside seed 
[58] 
V A-C (Cas1), 
(Cas2), 
(Cas4) 
unknown Cas12a, 
C2C1, 
C2C3 
Cpf1, 
C2C1, 
C2C3 
Cpf1: 
sticky-end 
DSDB 
outside 
seed [59] 
VI - Cas1, Cas2 unknown C2C2 C2C2 unknown 
(RNase?) 
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BO X 1. IN SILICO PREDICTION O F CRISPR-CAS ELEMENTS AND PAM
(continuation)
Fig. box 1. Overview of CRISPR-Cas9 locus components and their structures.  
The figure depicts all the required and optional genomic components for Type II CRISPR-Cas
systems, with all the possible locations and orientations of the tracrRNA-expressing module
and leader sequence14. The CRISPR array consists of interspaced repeats and leads to the
expression of the crRNA-modules of the system. The transcription of the CRISPR array into a
pre-crRNA transcript and the transcription of the tracrRNA expressing module are followed by 
the formation of RNA duplexes by these two elements. The tracrRNA consists of a 3’-end 3D
structure of two or three loops and a 5’-part which is complementary to the repeats ofthe
CRISPR array. The 5’-half of the crRNA in the duplex is comprised of the transcript of a spacer, 
while the 3’-half of the crRNA is formed by the transcript of the CRISPR array repeat. The pre-
crRNA:tracrRNA duplexes are loaded into Cas9s, leading to the drastic conformational change
of the enzymes and their activation. Finally, cellular RNase III enzymes processes the pre-
mature complexes into mature crRNA:tracrRNA:Cas9-complexes. The designing 
and construction of an sgRNA molecule involves the rational truncation of the crRNA
and tracrRNA modules, the addition of a linker sequence (mostly GAAA) between these
two modules and possibly the truncation of the last tracrRNA hairpin.  
The first programmable genome editing tool for bacteria dates from 2013 and it was
based on the Cas9 endonuclease from the Streptococcus pyogenes type II-A CRISPR-Cas
system, denoted as SpCas917-20. Around the sam e time, SpCas9 has also been extensively 
exploited for genome editing purposes of a wide range of eukaryotes18-21. In bacteria, the
CRISPR-Cas9-mediated genome editing tools are based on the heterologous c o-expression of
csn2/cas4cas9 cas1 cas2
Legend:
repeats
spacers
leader (all possible locations indicated)
tracrRNA-expressing module
(all possible locations indicated)
gene present only in Type II-A and B
CRISPR array
Hybridization of tracrRNA and crRNA, and loading into Cas9
CRISPR array
transcription
tracrRNA
transcription
3’5’
sgRNA
variants
Cas9
hairpins5’
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5’
5’ 3’
processing 
by RNaseIII5’
5’ 3’
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BOX 1. IN SILICO PREDICTION OF CRISPR-CAS ELEMENTS AND PAM 
In order to perform in vitro or in vivo PAM-determination studies (Box 2) for Type II systems, it 
is necessary to in silico predict the CRISPR array of the system, the tracrRNA-expressing 
module and the Cas9 gene. The CRISPR array is used for the identification of the crRNA 
module. The tracrRNA-expressing sequence is located either  within a 500 bp-window flanking 
Cas9 or between the Cas genes and the CRISPR locus14. The tracrRNA should consist of a 
5’-sequence with high level of complementarity to the direct repeats of the CRISPR array, 
followed by a predicted structure of no less than two stem-loop structures and a Rho-
independent transcriptional termination signal15 (Fig. box 1). The crRNA and tracrRNA 
molecule can then be used to design a chimeric sgRNA module. The 5’-end of the sgRNA 
consists of a truncated 20 nt long spacer followed by the 16-20 nt long truncated repeat of the 
CRISPR array. The repeat is followed by the corresponding truncated anti-repeat and the stem 
loop of the tracrRNA module. The repeat and anti-repeat parts of the sgRNA are generally 
connected by a GAAA linker16 (Fig. box 1).
IN SILICO PREDICTION OF THE PAM
In some cases, it is possible to predict the PAM in silico by bioinformatic s analyses. The in 
silico predictions are only possible if enough protospacer sequences are available in the 
databases. The in silico process starts with finding hits of spacers from the CRISPR array in 
the genome of the organism under study against databases such as GenBank. A useful tool to 
identify the CRISPR loci is “CRISPR finder” (http://crispr.u-psud.fr/Server/). The identified 
CRISPR loci output can then be loaded into “CRISPR target” (http://
bioanalysis.otago.ac.nz/CRISPRTarget/crispr_analysis.html), which will search selected 
databases and provide an output with matching protospacers. These protospacer sequences 
should then be checked for unique hits and for complementarity to spacers – for example, 
mismatches in the seed sequence are likely to be false positive hits and might be excluded from 
further analysis. Especially hits with prophages and (integrated) plasmids provide confidence 
that the obtained hits are true positives. Subsequently, the flanking regions (3’ for Type II and 
5’for Type I) of the remaining, unique protospacer hits can be aligned a nd compared for 
consensus sequences using tool such as Web Logo (http://weblogo.berkeley.edu/logo.cgi). 
Resulting consensus sequences can then be verified via in vivo or in vitro processes (Box 2).
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IN SILICO PREDICTIO N O F TYPE II CRISPR-CAS ELEMENTS
In order to perform in vitro or in vivo PAM-determ ination studies (Box 2) for Type II system s,
it is necessary to in silico predict the CRISPR array of the system , the tracrRNA-expressing 
m odule and the Cas9 gene. The CRISPR array is used for the identification of the crRNA
module. The tracrRNA-expressing sequence is located either within a 500 bp-window flanking 
Cas9 or between the Cas genes and the CRISPR locus14. The tracrRNA should consist of a 
5’-sequence with high level of com plem entarity to the direct repeats of the CRISPR array, 
followed by a predicted structure of no less than two stem-loop structures and a
Rho-independent transcriptional termination signal15 (Fig. box 1). The crRNA and 
tracrRNA molecule can then be used to design a chimeric sgRNA module. The 5’-end of 
the sgRNA consists of a truncated 20 nt long spacer followed by the 16-20 nt long truncated 
repeat of the CRISPR array. The repeat is followed by the corresponding truncated anti-repeat 
and the stem loop of the tracrRNA module. The repeat and anti-repeat parts of the sgRNA 
are generally connected by a GAAA linker16 (Fig. box 1). 
IN SILICO PREDICTIO N O F TH E PAM
In som e cases, it is possible to predict the PAM in silico by bioinformatic s analyses. The in
silico predictions are only possible if enough protospacer sequences are available in the
databases. The in silico process starts with finding hits of spacers from the CRISPR array in the
genom e of the organism under study against databases such as GenBank. A useful tool to
identify the CRISPR loci is “CRISPR finder” (http://crispr.u-psud.fr/Server/). The identified 
CRISPR loci output can then be loaded into “CRISPR target”
(http://bioanalysis.otago.ac.nz/CRISPRTarget/crispr_analysis.htm l), which will search
selected databases and provide an output with m atching protospacers. These protospacer
sequences should then be checked for unique hits and for com plem entarity to spacers – for
exam ple, m ism atches in the seed sequence are likely to be false positive hits and m ight be
excluded from further analysis. Especially hits with prophages and (integrated) plasmids
provide confidence that the obtained hits are true positives. Subsequently, the flanking regions
(3’ for Type II and 5’for Type I) of the rem aining, unique protospacer hits can be aligned and
com pared for consensus sequences using tool such as WebLogo 
(http://weblogo.berkeley.edu/logo.cgi). Resulting consensus sequences can then be verified via
in vivo or in vitro processes (Box 2). 
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Fig. box 1. Overview of CRISPR-Cas9 locus components and their structures.  
The figure depicts all the required and optional genomic components for Type II 
CRISPR-Cas systems, with all the possible locations and orientations of the tracrRNA-
expressing module and leader sequence14. The CRISPR array consists of interspaced 
repeats and leads to the expression of the crRNA-modules of the system. The transcription of 
the CRISPR array into a pre-crRNA transcript and the transcription of the tracrRNA 
expressing module are followed by the formation of RNA duplexes by these two elements. 
The tracrRNA consists of a 3’-end 3D structure of two or three loops and a 5’-part which is 
complementary to the repeats of the CRISPR array. The 5’-half of the crRNA in the duplex 
is comprised of the transcript of a spacer, while the 3’-half of the crRNA is formed by the 
transcript of the CRISPR array repeat. The pre-crRNA:tracrRNA duplexes are loaded 
into Cas9s, leading to the drastic conformational change of the enzymes and their 
activation. Finally, cellular RNase III enzymes processes the pre-mature complexes 
into mature crRNA:tracrRNA:Cas9-complexes. The designing and construction of an 
sgRNA molecule involves the rational truncation of the crRNA and tracrRNA modules, 
the addition of a linker sequence (mostly GAAA) between these two modules and possibly 
the truncation of the last tracrRNA hairpin.  
The first programmable genome editing tool for bacteria dates from 2013 and it was based 
on the Cas9 endonuclease from the Streptococcus pyogenes type II-A CRISPR-Cas 
system, denoted as SpCas917-20. Around the same time, SpCas9 has also been 
extensively exploited for genome editing purposes of a wide range of eukaryotes18-21. In 
bacteria, the CRISPR-Cas9-mediated genome editing tools are based on the heterologous co-
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Figure 1. (K ey figure) O verview of different systems for Cas9-mediated genome editing and 
counter-selection or repair mechanisms. Note that in all cases, Cas9 might be replaced by any endogenous 
system as well. Also, the nickase variant of Cas9 might be used to create single strand DNA breaks 
instead of double strand DNA breaks. In the figure, only the introduction of mutations in the seed region 
of the protospacer is shown, but also mutations in the PAM-sequence will prevent Cas9-targeting.
BO X 2. PAM-DETERMINATIO N METH O DS
IN VITRO
This approach has been mainly used for PAM-characterization of type II CRISPR-Cas 
systems 15,16. Initially, the in silico identification of three elements is required: the Cas9
gene, the CRISPR array and the tracrRNA (Box 1). The process proceeds with in vitro
transcription and purification of either the crRNA and tracrRNA modules or the sgRNA 
module, and the design and construction of a targeted PAM-containing vector library16. 
Each library member contains a constant 20 bp target protospacer, flanked by a 3’ 5-7 bp 
degenerate sequence, which serves as the PAM. The members of the library that contain the 
right PAM are cleaved by the crRNA: tracrRNA-loaded (or the sgRNA-loaded) Cas9 during 
an in vitro cleavage assay. The cleaved vectors are purified and specific sequencing adaptors 
are added to the blunt end created approximately 3 bp away from the PAM in the 
protospacer seed sequence. The PAM of the cleaved vectors compared to the uncleaved 
library as negative control. 
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expression of two components: the SpCas9 and a crRNA:tracrRNA duplex that directs the 
nuclease to the targeted protospacer. Rationally designed chimeric single guide RNA 
(sgRNA) molecules form a convenient and effective alternative to the crRNA:tracrRNA 
duplex12. The SpCas9-crRNA:tracrRNA (or SpCas9-sgRNA) complex introduces DSDBs to 
the target sites. Cells that carry mutations at these sites can avoid the Cas9-induced DSDBs 
and survive (Figure 1, Key Figure). In eukaryotes, the Non-Homologous End Joining 
(NHEJ) mechanism can repair DSDBs in an error-prone manner, introducing insertion/
deletion (indel) mutations in the targeted site that frequently lead to frame shifts and gene 
disruption. However, in contrast to the eukaryotic genomes that all encode NHEJ-like 
systems, the enzymes that are responsible for the bacterial NHEJ mechanism (Ku/LigD) are 
not encoded by all the bacterial genomes22. This fact explains the small number of CRISPR-
Cas9-based cases of gene knockouts in bacteria compared to the large number of eukaryotic 
knockouts using Cas9. In bacterial CRISPR-Cas9-based genome editing, the DSDBs are 
repaired either by the cellular homologous recombination (HR) system in combination with 
chromosome/plasmid-borne templates, or by an heterologous recombineering system and 
linear single or double stranded DNA templates. Moreover, it is possible that, at least to some 
extent, the introduction of DSDBs in the bacterial genomes triggers the recombination 
mechanisms17. In case of genetic engineering, the rescuing templates are designed to 
introduce chromosomal deletions varying from a single to thousands of nucleotides or 
deliver genetic sequences of variable size. Recombination occurs at a specific chromosomal 
site, depending on the Cas9-associated guide; the only limitation with respect to the selected 
target sequence relates to the requirement for a PAM sequence at the right position. The 
clones with the desired mutations are easily selected through a negative selection process, 
due to the CRISPR-Cas9-based elimination of all the wild type clones. This tandem 
Recombination-CRISPR-Cas9-based counter-selection process has been applied to almost all 
the CRISPR-Cas9-based genome editing examples published to date. 
In this review, we summarize the advances in the CRISPR-Cas-based bacterial 
genome editing and gene expression-modulation technologies, with an emphasis on the Cas9-
based technologies and their application in biotechnologically-relevant bacteria. In addition, 
we discuss the limitations of bacterial genome editing using these technologies and propose 
solutions to overcome them for application in next generation bacterial engineering. 
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two components: the SpCas9 and a crRNA:tracrRNA duplex that directs the nuclease to the
targeted protospacer. Rationally designed chimeric single guide RNA (sgRNA)
molecules form a convenient and effective alternative to the crRNA:tracrRNA duplex12. 
The SpCas9-crRNA:tracrRNA (or SpCas9-sgRNA) complex introduces DSDBs to the target
sites. Cells that carry mutations at these sites can avoid the Cas9-induced DSDBs and survive
(Figure 1, Key Figure). In eukaryotes, the Non-Homologous End Joining (NHEJ)
mechanism can repairDSDBs in an error-prone manner, introducing insertion/deletion 
(indel) mutations in the targeted site that frequently lead to frame shifts and gene
disruption. However, in contrast to the eukaryotic genomes that all encode NHEJ-like
systems, the enzymes that are responsible for the bacterial NHEJ mechanism (Ku/LigD)
are not encoded by all the bacterial genomes22. This fact explains the small number
of CRISPR-Cas9-based cases of gene knockouts in bacteria compared to the large
number of eukaryotic knockouts using Cas9. In bacterial CRISPR-Cas9-based 
genome editing, the DSDBs are repaired either by the cellular homologous
recombination (HR) system in combination with chromosome/plasmid-borne templates, 
or by an heterologous recombineering system and linear single or double stranded DNA
templates. Moreover, it is possible that, at least to some extent, the introduction of DSDBs
in the bacterial genomes triggers the recombination mechanisms17. In case of
genetic engineering, the rescuing templates are designed to introduce chromosomal
deletions varying from a single to thousands of nucleotides or deliver genetic
sequences of variable size. Recombination occurs at a specific chromosomal site, 
depending on the Cas9-associated guide; the only limitation with respect to the selected 
target sequence relates to the requirement for a PAM sequence at the right position. 
The clones with the desired mutations are easily selected through a negative selection 
process, due to the CRISPR-Cas9-based elimination of all the wild type clones. This tandem
Recombination-CRISPR-Cas9-based counter-selection process has been applied to almo st
all the CRISPR-Cas9-based genome editing examples published to date. 
In this review, we summarize the advances in the CRISPR-Cas-based bacterial
genome editing and gene expression-modulation technologies, with an emphasis on the
Cas9-based technologies and their application in biotechnologically-relevant bacteria. In 
addition, we discuss the limitations of bacterial genome editing using these technologies
and propose solutions to overcome them for application in next generation bacterial
engineering. 
Figure 1. (Key figure) Overview of different systems for Cas9-mediated genome editing and 
counter-selection or repair mechanisms. Note that in all cases, Cas9 might be replaced by any endogenous 
system as well. Also, the nickase variant of Cas9 might be used to create single strand DNA breaks 
instead of double strand DNA breaks. In the figure, only the introduction of mutations in the seed region 
of the protospacer is shown, but also mutations in the PAM-sequence will prevent Cas9-targeting.
BOX 2. PAM-DETERMINATION METHODS
IN VITRO
This approach has been mainly used for PAM-characterization of type II CRISPR-Cas 
systems 15,16. Initially, the in silico identification of three elements is required: the cas9 gene, 
the CRISPR array and the tracrRNA (Box 1). The process proceeds with in vitro transcription 
and purification of either the crRNA and tracrRNA modules or the sgRNA module, and the 
design and construction of a targeted PAM-containing vector library16. Each library member 
contains a constant 20 bp target protospacer, flanked by a 3’ 5-7 bp degenerate sequence, 
which serves as the PAM. The members of the library that contain the right PAM are cleaved 
by the crRNA: tracrRNA-loaded (or the sgRNA-loaded) Cas9 during an in vitro cleavage 
assay. The cleaved vectors are purified and specific sequencing adaptors are added to the 
blunt end created approximately 3 bp away from the PAM in the protospacer seed sequence. 
The PAM of the cleaved vectors compared to the uncleaved library as negative control. 
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BOX 2. PAM DETERMINATION METHODS
IN VIVO
The in vivo PAM characterization of a type II CRISPR-Cas system is 
based on the heterologous expression of the Cas9 endonuclease and a negative selection 
process17,23. The first step of the in vivo process is the same as for the in vitro, i.e. the 
identification of the different elements (Box 1). The second step is the plasmid-based   
expression of the Cas9 and tracrRNA module in a selected host. A second plasmid 
encoding the crRNA module is transformed into the same host. The crRNA 
module guides Cas9 to target the members of a PAM-containing vector library. The 
members of the library contain a constant 20 bp target protospacer followed by a 3’ 
5-7 bp degenerate PAM-sequence. After transformation, the vectors from surviving 
colonies on selective medium are sequenced. The PAM is then extracted as a 
consensus from the sequences that are not present in the sequencing results as compared 
to the library prior to transformation (or in a control transformed with a non-
targeted plasmid). In case that the organism harboring the studied CRISPR-Cas 
system is transformable, it is possible to immediately transform the crRNA-expressing 
vector and the PAM-containing vector-library into that strain. This method eliminates 
the requirement for heterologous expression of Cas9 and tracrRNA. Similarly, 
the in vivo approach can be followed for the PAM characterization of native 
type I CRISPR-Cas systems present in the genome of transformable strains.
CRISPR-CAS MEDIATED ENGINEERING OF BACTERIAL GENOMES 
SINGLE-STRANDED DNA RECOMBINEERING (SSDR) 
Jiang et al. were the first to exploit the heterologous expression of SpCas9 to 
introduce defined mutations or to delete genes in bacterial genomes17. During this study, 
the recombineering strain E. coli HME63 and the highly recombinogenic 
Streptococcuspneumoniae crR6Rk were transformed with a pCas9 vector. The vector was 
responsible for the heterologous expression of the SpCas9 and the tracrRNA molecule in 
the cells. The next step in both processes was the simultaneous transformation with 
one or two linear single stranded DNA oligonucleotides for single-stranded DNA 
recombineering (SSDR) and with the pCRISPR vector. The SSDR templates were 
designed either to introduce point mutations to the targeted genes, or to delete 
them. The pCRISPR vector carried and expressed a minimal CRISPR array with one 
or two spacers that targeted the gene or genes of interes leading to a CRISPR-Cas9 ba- 
applied for additional gene disruptions and large chromosomal insertions and deletions in 
E. coli, relying on co-expression either of a crRNA:tracrRNA pair24 or of a chimeric
sgRNA25,26 (Table S1). Remarkably, high levels of editing efficiency were achieved
when the editing ssDNA oligonucleotides were designed to be identical to the
lagging strand of the protospacers; this suggests that the editing oligonucleotides
may be recognized as Okazaki fragments by the cellular replication
mech anism or may prime the Okazaki fragments synthesis27.
Soon after the first SSDR- CRISPR-Cas9-based genome editing tool for E. coli 
was published, a similar tool was developed for Lactobacillus reuteri , a lactic acid bacterium 
used as a probiotic28. The tool was based on a SpCas9 and tracrRNA expressing vector, a 
single or dual step procedure and the RecT expressing Lactobacillus reuteri 6475. During 
the single step procedure the SpCas9 and tracrRNA expressing L. reuteri 6475 was 
simultaneously transformed with a CRISPR-array expressing vector and ssDNA 
recombineering fragments, while during the dual step procedure L. reuteri 6475 was 
transformed with the same ssDNA recombineering fragments prior to the 
transformation with the CRISPR-array expressing vector. Whereas both processes 
yielded almost only recombinant clones, the dual step approach allowed for more 
replication cycles before the CRISPR-Cas9-based counter selection, leading to more 
efficient incorporation of the recombineering fragments and elevated number of 
surviving recombined clones. The same dual step SSDR-CRISPR-Cas9 counter-
selection-based editing tool was used for time-efficient L. reuteri 6475 
chromosomal deletions of up to 1 kb and codon saturation mutage nesis28. 
DO UBLE-STRANDED DNA RECO MBINEERING (DSDR) 
A double-stranded DNA recombineering (DSDR)-CRISPR-Cas9-based 
counter-selection editing system (Fig. 1) was recently developed for E. coli29. The editing 
templates for this system were either cloned into an sgRNA-expressing plasmid or 
introduced into the cells as dsDNA linear fragments. When dsDNA fragments were used 
as HR templates, the single gene deletion efficiency was high and comparable to the 
efficiency observed before17, but the gene insertion efficiency was low and immediately 
proportional to the length of the homologous regions in the HR template fragments.  
The two-plasmid based DSDR- CRISPR-Cas9 counter-selection editing tool was 
employed for E. coli genome editing in many occasions. It was used as an editing tool to 
introduce and express the Shewanella frigidimarina fatty acids production pathway into the 
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BO X 2. PAM-DETERMINATIO N METH O DS
IN VIVO 
The in vivo PAM characterization of a type II CRISPR-Cas system is based on the 
heterologous expression of the Cas9 endonuclease and a negative selection process17,23. The 
first step of the in vivo process is the same as for the in vitro, i.e. the identification of the 
different elements (Box 1). The second step is the plasmid-based expression of the Cas9 and 
tracrRNA module in a selected host. A second plasmid encoding the crRNA module is 
transformed into the same host. The crRNA module guides Cas9 to target the members 
of a PAM-containing vector library. The members of the library contain a constant 20 bp 
target protospacer followed by a 3’ 5-7 bp degenerate PAM-sequence. After transformation, 
the vectors from surviving colonies on selective medium are sequenced. The PAM is then 
extracted as a consensus from the sequences that are not present in the sequencing results 
as compared to the library prior to transformation (or in a control transformed with a 
non-targeted plasmid). In case that the organism harboring the studied CRISPR-Cas 
system is transformable, it is possible to immediately transform the crRNA-expressing 
vector and the PAM-containing vector-library into that strain. This method eliminates the 
requirement for heterologous expression of Cas9 and tracrRNA. Similarly, the in vivo 
approach can be followed for the PAM characterization of native type I CRISPR-Cas systems
present in the genome of transformable strains. 
CRISPR-CAS MEDIATED ENG INEERING  O F BACTERIAL G ENO MES 
SING LE-STRANDED DNA RECO MBINEERING (SSDR) 
Jiang et al. were the first to exploit the heterologous expression of SpCas9 to 
introduce defined mutations or to delete genes in bacterial genomes17. During this 
study, the recombineering strain E. coli HME63 and the highly recombinogenic
Streptococcus pneumoniae crR6Rk were transformed with a pCas9 vector. The vector was
responsible for the heterologous expression of the SpCas9 and the tracrRNA molecu le in the
cells. The next step in both processes was the simultaneous transformation with one or two 
linear single-stranded DNA oligonucleotides for single-stranded DNA recombineeri ng
(SSDR) and with the pCRISPR vector. The SSDR templates were designed either to 
introduce point mutations to the targeted genes, or to delete them. The pCRISPR vector 
carried and expressed a minimal CRISPR array with one or two spacers that targeted the 
gene or genes of interest leading to a CRISPR-Cas9 based counter-selection against the wild 
type genes. This tandem use of an SSDR system followed by CRISPR-Cas9-based counter-
selection led to a highly efficient genome editing tool (Fig. 1). The tool was successfully
sed counter-selection against the wild type genes. This tandem use of an SSDR system 
followed by CRISPR-Cas9-based counter-selection led to a highly efficient genome 
editing tool (Fig. 1). The tool was successfully applied for additional gene disruptions 
and large chromosomal insertions and deletions in E. coli, relying on co-
expression either of a crRNA:tracrRNA pair24 or of a chimeric 
sgRNA25,26 (Table S1). Remarkably, high levels of editing efficiency were 
achieved when the editing ssDNA oligonucleotides were designed to be identical 
to the lagging strand of the protospacers; this suggests that the editing 
oligonucleotides may be recognized as Okazaki fragments by the cellular 
replication mechanism or may prime the Okazaki fragments synthesis27.
Soon after the first SSDR- CRISPR-Cas9-based genome editing tool for E. coli 
was published, a similar tool was developed for Lactobacillus reuteri, a lactic acid 
bacterium used as a probiotic28. The tool was based on a SpCas9 and tracrRNA 
expressing vector, a single or dual step procedure and the RecT expressing L. reuteri 
6475. During the single step procedure the SpCas9 and tracrRNA expressing L. 
reuteri 6475 was simultaneously transformed with a CRISPR-array expressing 
vector and ssDNA recombineering fragments, while during the dual step procedure 
L. reuteri 6475 was transformed with the same ssDNA recombineering fragments prior
to the transformation with the CRISPR-array expressing vector. Whereas both
processes yielded almost only recombinant clones, the dual step approach allowed
for more replication cycles before the CRISPR-Cas9-based counter selection,
leading to more efficient incorporation of the recombineering fragments and
elevated number of surviving recombined clones. The same dual step SSDR-
CRISPR-Cas9 counter-selection-based editing tool was used for time-efficient L.
reuteri 6475 chromosomal deletions of up to 1 kb and codon saturation mutagenesis28.
DOUBLE-STRANDED DNA RECOMBINEERING (DSDR)
A double-stranded DNA recombineering (DSDR)-CRISPR-Cas9-based counter-selection
editing system (Fig. 1) was recently developed for E. coli29. The editing templates
for this system were either cloned into an sgRNA-expressing plasmid or introduced
into the cells as dsDNA linear fragments. When dsDNA fragments were used as HR
templates, the single gene deletion efficiency was high and comparable to the efficiency
observed before17, but the gene insertion efficiency was low and immediately proportional
to the length of the homologous regions in the HR template fragments.
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The two-plasmid based DSDR-CRISPR-Cas9 counter-selection editing tool was 
employed for E. coli genome editing in many occasions. It was used as an editing tool to 
introduce and express the Shewanella frigidimarina fatty acids production pathway into the E. 
coli MG1655 strain30, to perform targeted codon substitution in the chromosome of E. coli 
BW25113 ΔmutS31, and to delete genes from the chromosome of another member of the 
Enterobacteriaceae , the biotechnologically interesting Tatumella citrea DSM 13699 strain29, 
suggesting the broader applicability of the system.
In a recent study,a highly efficient DSDR-CRISPR-Cas9 counter-selection editing 
tool was used to quickly and efficiently engineer the E. coli metabolism25 (Table S1). 
The promoters and the RBSs of several genes encoding enzymes 
involved in the beta-carotene pathway and in the methyl-erythritol-
phosphate (MEP) pathway were sequentially substituted by variant 
expression-controlling elements. The genetic variants with the highest 
enhancement in beta-carotene production were selected after each editing 
cycle for further editing, rendering this study an example of Cas9-
based E. coli metabolic engineering. Interestingly, it was noticed that 
the mismatch repair mechanism of E. coli could efficiently correct point 
mutations introduced by the SSDR- CRISPR-Cas9 counter-selection editing tool. This 
revertant issue was solved either by introducing a ssDNA template carrying 9 consecutive 
mismatch mutations or by using dsDNA editing templates with long homology arms and the 
DSDR- CRISPR-Cas9 counter-selection editing tool25.    
HOMOLOGOUS RECOMBINATION (HR)
Very recently, plasmid-borne homologous recombination (HR) templates and CRISPR-Cas9-
based counter-selection were used a for the simultaneous insertion of 2 or deletion of 3 genes 
with high efficiency29. A non-recombineering HR- CRISPR-Cas9-based counter selection 
editing tool (Fig. 1), which targets insertion sequences (IS) naturally present in the genome of 
E. coli, was used for large chromosomal deletions of up to 133 kb32. In the latter study, a
Cas9 nickase variant (SpCas9D10A that encompasses a non-functional RuvC nuclease
domain) was employed to introduce targeted Single Stranded DNA Breaks (SSDB)12,33.
These breaks, when introduced in pairs, in the correct orientation and position around the IS
elements, led to 5’ overhangs that induce direct recombination between the neighboring and
identical IS elements. This editing approach solves the problem of CRISPR-Cas9-induced
lethal DSDBs, and may be applied for genome editing of prokaryotes that lack well-
developed recombineering systems.
approach in which the spcas9 gene was cloned into the same vector as the sgRNA expressing 
module and the editing template. The CRISPR-Cas9-based counter selection of cells with the 
desired markerless deletion was highly efficient and the multiplex genome editing 
potential of this tool is currently under examination34. The same one-step tool was 
employed for the editing of the Clostridium cellulolyticum H10 (ATCC 35319) 
chromosome35, recently renamed as Ruminiclostridium cellulolyticum, an important 
cellulose-degrading anaerobe used for solvent production36. However, the approach 
contained an important variation: the wild-type SpCas9 was replaced by the SpCas9D10A
mutant, which introduced SSDBs instead of DSDBs in the targeted regions. The 
editing efficiency of the system was affected by the length of the editing template’s 
homologous arms, and the profusion of edited genomes was enhanced with serial, post-
transformatio n recovery transfers35. This single-nick-induced HR- CRISPR-Cas9-based 
counter-selection approach allowed for efficient genome editing of a prokaryote sensitive to 
DSDBs, paving the way for the editing of other prokaryotes with inefficient NHEJ and 
HR mechanisms. It is striking though that the nativeC. cellulolyticum type II CRISPR-Cas 
system was not employed for the development of the editing tool, due to limited 
understanding of this system35. This facts underlines the requirement for solid in silico
sgRNA designing tools and in vitro or in vivo high-throughput PAM determination tools 
(Box 1 & 2).   
A dedicated system has recently been developed for efficient genome editing 
of Streptomyces lividans, Streptomyces viridochromogenes DSM 40736 and Streptomyces 
albus J1074 (Table S1)37, all relevant antibiotic producers, by using an approach that 
resembles the aforementioned approach for Clostridia . The system was based on 
two types of vectors, both with a temperature-sensitive replicon, a codon-optimized spcas9
gene and an HR template. The first vector type additionally carried a crRNA:tracrRNA-
expressing module and the other an sgRNA-expressing module37. This one-plasmid based 
system was employed for efficient single and double gene deletions and for large-size 
chromosomal deletions of up to 30 kb. Interestingly, the sgRNA expressing vectors 
showed higher editing efficiencies compared to the corresponding crRNA:tracrRNA 
expressing vectors. This could be due either to reduced pre-crRNA:tracrRNA processing 
by the host’s RNase III37, or to deletion of the spacer parts by spontaneous homologous 
recombination of the CRISPR repeats.  
Three independent studies describe the development of HR- CRISPR-
Cas9-based counter-selection editing systems for the antibiotic-producing model 
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E. coli MG1655 strain30, to perform targeted codon substitution in the chromosome of E. coli
BW25113 ΔmutS31, and to delete genes from the chromosome of another memb er of the
Enterobacteriaceae , the biotechnologically interesting Tatumella citrea DSM 13699 strain29,
suggesting the broader applicability of the system.
In a recent study, a highly efficient DSDR- CRISPR-Cas9 counter-selection editing 
tool was used to quickly and efficiently engineer the E. coli metabolism25 (Table 
S1). The promoters and the RBSs of several genes encoding enzymes involved in the 
beta-carotene pathway and in the methyl-erythritol-phosphate (MEP) pathway were 
sequentially substituted by variant expression-controlling elements. The genetic variants with 
the highest enhancement in beta-carotene production were selected after each editing cycle 
for further editing, rendering this study an example of Cas9-based E. coli metab olic 
engineering. Interestingly, it was noticed that the mismatch repair mechanism ofE. coli
could efficiently correct point mutations introduced by the SSDR- CRISPR-Cas9 counter-
selection editing tool. This revertant issue was solved either by introducing a ssDNA 
template carrying 9 consecutive mismatch mutatio ns orby using dsDNA editing templates 
with long homology arms and the DSDR- CRISPR-Cas9 counter-selection editing tool25.
H O MO LO G O US RECO MBINATIO N (H R) 
Very recently, plasmid-borne homologous recombination (HR) templates and 
CRISPR-Cas9-based counter-selection were used a for the simultaneous insertion of 2 or 
deletion of 3 genes with high efficiency29. A non-recombineering HR- CRISPR-Cas9-
based counter selection editing tool (Fig. 1), which targets insertion sequences (IS) 
naturally present in the genome of E. coli, was used for large chromosomal deletions of 
up to 133 kb32. In the latter study, a Cas9 nickase variant (SpCas9D10A that encompasses 
a non-functional RuvC nuclease domain) was employed to introduce targeted Single 
Stranded DNA Breaks (SSDB)12,33. These breaks, when introduced in pairs, in the 
correct orientation and position around the IS elements, led to 5’ overhangs that induce 
direct recombination between the neighboring and identical IS elements. This editing 
approach solves the problem of CRISPR-Cas9-induced lethal DSDBs, and may be 
applied for genome editing of prokaryotes that lack well-devel oped recombineering systems.    
A CRISPR-Cas9-based genome editing tool was recently developed for the 
solvent-producing Clostridium beijerinkii NCIMB 8052 (Table S1)34. The low 
natural recombination efficiency of the latter species together with the lack of a 
functional recombineering system led toa single-step HR- CRISPR-Cas9-based editing 
A CRISPR-Cas9-based genome editing tool was recently developed for the solvent-
producing Clostridium beijerinkii NCIMB 8052 (Table S1)34. The low natural recombination 
efficiency of the latter species together with the lack of a functional recombineering system 
led to a single-step HR- CRISPR-Cas9-based editing approach in which the spcas9 gene 
was cloned into the same vector as the sgRNA expressing module and the 
editing template. The CRISPR-Cas9-based counter selection of cells with the desired 
markerless deletion was highly efficient and the multiplex genome editing potential of this 
tool is currently under examination34. The same one-step tool was employed for the editing 
of the Clostridium cellulolyticum H10 (ATCC 35319) chromosome35, recently 
renamed as Ruminiclostridium cellulolyticum, an important cellulose-degrading 
anaerobe used for solvent production36. However, the approach contained an important 
variation: the wild-type SpCas9 was replaced by the SpCas9D10A mutant, which introduced 
SSDBs instead of DSDBs in the targeted regions. The editing efficiency of the system was 
affected by the length of the editing template’s homologous arms, and the profusion of edited 
genomes was enhanced with serial, post-transformation recovery transfers35. This single-nick-
induced HR-CRISPR-Cas9-based counter-selection approach allowed for efficient genome 
editing of a prokaryote sensitive to DSDBs, paving the way for the editing of other 
prokaryotes with inefficient NHEJ and HR mechanisms. It is striking though that the native 
C. cellulolyticum type II CRISPR-Cas system was not employed for the
development of the editing tool, due to limited understanding of this system35.
This facts underlines the requirement for solid in silico sgRNA designing tools and
in vitro or in vivo high-throughput PAM determination tools (Box 1 & 2).
A dedicated system has recently been developed for efficient genome editing 
of Streptomyces lividans, Streptomyces viridochromogenes DSM 40736 and 
Streptomyces albus J1074 (Table S1)37, all relevant antibiotic producers, by using an 
approach that resembles the aforementioned approach for Clostridia. The system 
was based on two types of vectors, both with a temperature-sensitive replicon, a 
codon-optimized spcas9 gene and an HR template. The first vector type additionally carried a 
crRNA:tracrRNA-expressing module and the other an sgRNA-expressing module37. This 
one-plasmid based system was employed for efficient single and double gene 
deletions and for large-size chromosomal deletions of up to 30 kb. Interestingly, 
the sgRNA expressing vectors showed higher editing efficiencies compared to the 
corresponding crRNA:tracrRNA expressing vectors. This could be due either to reduced 
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promising method especially for hard to engineer prokaryotes. Additionally, CRISPRi can be 
an important tool for studying the phenotypic effect of essential genes silencing and for 
targeting specific genes or genotypes in mixed populations or undefined cultures. In all cases 
so far, repression by CRISPRi was shown to be highly specific, reversible after removal of 
the inducer compound and finely tuneable (Box 3).  
The principle of using dCas9 was shown in E. coli by sgRNA-guided silencing 
of reporter genes such as gfp41 or gfp and rfp simultaneously42. The possibility of using 
the system for hard-to-en gineer organisms in a mixed culture was shown shortly after40,43,44
(Table S2). Mimee et al. showed rapid and efficient dCas9-based gene silencing in 
the gut commensal Bacteroides thetaiotaomicron during in vivo colonization of the mouse 
gut. In E. coli, conjugation was used for horizontal transfer of a plasmid containing dCas9 
and an sgRNA directed against an rfp reporter gene from a donor strain into an rfp-expressing 
E. coli acceptor strain. The acceptor strain was part of a mixed E. coli culture and its
RFP expression was successfully silenced43. A similar application of using CRISPR-
Cas-systems as highly specific antimicrobial in a complex environment was also
shown for the wild-type Cas9 variant which was used as highly specific antimicrobial45.
Figure 2. O verview of different systems for CRISPR-Cas-mediated gene expression modulation. a) Gene 
silencing using catalytically inactive Cas9 (dCas9, indicated with two stars in the nuclease dom ains), showing
transcription block by directly binding the prom oter, or blocking transcription elongation when the ORF is
targeted. b) Gene activation via the RNA Polym erase ω-subunit fused to dCas9 in a strain that lacks the ω-subunit
gene (ΔrpoZ). C. Gene silencing using Cascade in a cas3-knockout background.
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pre-crRNA:tracrRNA processing by the host’s RNase III37, or to deletion of the spacer parts 
by spontaneous homologous recombination of the CRISPR repeats.  Three independent 
studies describe the development of HR-CRISPR-Cas9-based counter-selection editing 
systems for the antibiotic-producing model organism Streptomyces coelicolor: 
two systems were developed for S. coelicolor M14538,39 and one for S. 
coelicolor A3(2)40 (Table S1). Zeng et al. and Tong et al. based the editing 
systems on the above described one-step HR-CRISPR-Cas9-based counter-
selection genome editing approach. Both systems yielded efficient single40 and double 
gene deletions, large-size chromosomal deletions and the simultaneous introduction 
of three point mutations in one gene38. Zeng et al. based their editing system on 
the introduction of the codA(sm) mutant cytosine deamidase gene  into the vector of the 
one-step HR-CRISPR-Cas9-based counter-selection genome editing system. The CodA(sm) 
serves as a counter-selection marking by converting 5-fluorocytocine into toxic 5-
fluorouracil. This CRISPR-Cas/CodA(sm)-based editing approach resulted in a 
double counter-selection system that selects for edited and plasmid-free clones in one 
step and it was successfully used for rapid and efficient in-frame gene deletion39.
NON-HOMOLOGOUS END JOINING (NHEJ) 
The only existing example of targeted DSDB introduced by Cas9 combined 
with repair via the NHEJ mechanism in a bacterium (Fig. 1) is presented in one of 
the mentioned S. coelicolor studies40. The incomplete NHEJ mechanism of the S. 
coelicolor A3(2) repaired the Cas9-targeted sites, introducing deletions of variable 
sizes. The efficiency of the CRISPR-Cas9-induced DSDBs– NHEJ editing tool was 
increased by the heterologous expression of a ligase D into the S. coelicolor A3(2) cells.
CRISPR-CAS-BASED EXPRESSION CONTROL IN BACTERIA
GENE REPRESSION 
In some cases, it may be of interest to silence genes rather than knock them out. 
Whereas RNAi is available for this purpose in eukaryotic systems, these knock down 
tools are not yet available for prokaryotes. In 2013, however, two studies reported gene 
silencing in bacteria using catalytically inactive S. pyogenes Cas9D10A, H840D, 
so-called dead Cas9 (dCas9), in which the two nuclease domains are mutated (D10A and 
H840D) and inactivated (Table S2, Fig. 2)41,42. Contrary to RNAi, dCas9 does not act on 
the mRNA but rather on the DNA level, by directly blocking transcription initiation or 
elongation (CRISPRi) depending on whether the promoter region or open reading 
frame is targeted (Box 3).  
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organism Streptomyces coelicolor: two systems were developed for S. coelicolor M14538,39
and one for S. coelicolor A3(2)40 (Table S1). Zeng et al. and Tong et al. based the editing 
systems on the above described one-step HR-CRISPR-Cas9-based counter-selection genome 
editing approach. Both systems yielded efficient single40 and double gene deletions, large-
size chromosomal deletions and the simultaneous introduction of three point mutations in 
one gene38. Zeng et al. based their editing system on the introduction of the 
codA(sm) mutant cytosine deamidase gene into the vector of the one-step HR-
CRISPR-Cas9-based counter-selection genome editing system. The CodA(sm) serves 
as a counter-selection marking by converting 5-fluorocytocine into toxic 5-
fluorouracil. This CRISPR-Cas/CodA(sm)-based editing approach resulted in a 
double counter-selection system that selects for edited and plasmid-free clones in 
one step and it was successfully used for rapid and efficient in-fram e gene deletion39.
NO N-H O MOLO G O US END JO INING (NH EJ) 
The only existing example of targeted DSDB introduced by Cas9 combined 
with repair via the NHEJ mechanism in a bacterium (Fig. 1) is presented in one 
of the mentioned S. coelicolor studies40. The incomplete NHEJ mechanism of theS. 
coelicolor A3(2) repaired the Cas9-targeted sites, introducing deletions of variable sizes. 
The efficiency of the CRISPR-Cas9-induced DSDBs– NHEJ editing tool was increased 
by the heterologous expression of a ligase D into the S. coelicolor A3(2) cells. 
CRISPR-CAS-BASED EXPRESSIO N CO NTRO L IN BACTERIA 
G ENE REPRESSIO N 
In some cases, it may be of interest to silence genes rather than knock them out. 
Whereas RNAi is available for this purpose in eukaryotic systems, these knock down tools 
are not yet available for prokaryotes. In 2013, however, two studies reported gene 
silencing in bacteria using catalytically inactiveS. pyogenes Cas9D10A, H840D, so-called dead 
Cas9 (dCas9), in which the two nuclease domains are mutated (D10A and H840D) and 
inactivated (Table S2, Fig. 2a)41,42. Contrary to RNAi, dCas9 does not act on the mRNA 
but rather on the DNA level, by directly blocking transcription initiation or elongation 
(CRISPRi) depending on whether the promoter region or open reading frame is targeted 
(Box 3).  
An advantage of dCas9-based silencing over Cas9-based editing is that no 
repair pathway is required. CRISPRi can be readily applied in cells lacking the NHEJ 
pathway or for which no fast and efficient HR method is available, making it a 
An advantage of dCas9-based silencing over Cas9-based editing is that no repair 
pathway is required. CRISPRi can be readily applied in cells lacking the NHEJ pathway orfor 
which no fast and efficient HR method is available, making it a promising method 
especially for hard to engineer prokaryotes. Additionally, CRISPRi can be an important tool 
for studying the phenotypic effect of essential genes silencing and for targeting specific genes 
or genotypes in mixed populations or undefined cultures. In all cases so far, repression 
by CRISPRi was shown to be highly specific, reversible after removal of the inducer 
compound and finely tuneable (Box 3).  
The principle of using dCas9 was shown in E. coli by sgRNA-guided 
silencing of reporter genes such as gfp41 or gfp and rfp simultaneously42. The possibility 
of using the system for hard-to-engineer organisms in a mixed culture was shown 
shortly after40,43,44 (Table S2). Mimee et al. showed rapid and efficient dCas9-based 
gene silencing in the gut commensal Bacteroides thetaiotaomicron during in vivo 
colonization of the mouse gut. In E. coli, conjugation was used for horizontal transfer 
of a plasmid containing dCas9 and an sgRNA directed against an rfp reporter gene from a 
Figure 2. O verview of different systems for CRISPR-Cas-mediated gene expression modulation. a) Gene 
silencing using catalytically inactive Cas9 (dCas9, indicated with two stars in the nuclease dom ains), showing 
transcription block by directly binding the prom oter, or blocking transcription elongation when the ORF is 
targeted. b) Gene activation via the RNA Polym erase ω-subunit fused to dCas9 in a strain that lacks the ω-
subunit gene (ΔrpoZ). C. Gene silencing using Cascade in a cas3-knockout background. 
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BO X 3. TUNING  CRISPRi (continuation)
STRAND BIAS
When targeting the promoter, no difference was observed between targeting the template or 
non-template strand. However, when dCas9 was used to target a region within the ORF, 
targeting the non-template (or coding) strand was consistently shown to be highly efficient, 
while targeting the template strand gave less or no repression40-42,46. It was hypothesized that 
this is due to the ability of the RNAP to ‘unzip’ dCas9 from the template strand via its 
helicase activity42,46. Remarkably, when using Type I-E Δcas3 systems this strand bias for 
ORF-targets was found to be inversed48,50. 
SPACER MISMATCH ES
dCas9 binds steadily to the DNA target only if the 12 nt long protospacer seed sequence is 
fully complimentary to the corresponding part of the spacer sequence41,42. The more
mismatches afterthe 12 nt seed sequence, the less efficient the binding and repression. 
Interestingly, when there are only 12 complementary nucleotides when using wild-type Cas9, 
the active protein can bind but not cleave, hence functioning as a dCas9 without the active 
site mutations41. This hold promise for future engineering purposes especially for those
using endogenous systems, which can in this way also be used as repressor without making 
genomic mutations in cas9. 
MULTIPLEXING
The use of multiple sgRNAs targeting different regions of the same gene (either 
promoter and/or ORF region) can further enhance repression42,46.
INDUCTIO N
If an inducible promoter is used for dCas9, Cascade or guide RNA expression, in most 
cases the amount of repression was shown to increase with increasing inducer 
concentration or time42,48. On the other hand, in Mycobacteria using dCas9 it was found 
that longer induction time did not increase left-over protein levels, but increasing the 
length of hybridizing spacer part did, indicating differences per organism, and the need
for optimization of the system for each new host46.  
G ENO ME EDITING AND REPRESSIO N USING ENDO G ENO US CRISPR-
CAS SYSTEMS 
The dCas9 system is easily transferable to different hosts as it requires only a 
single plasmid containing dCas9 and the targeting spacer(s). However, it might not be
readily applicable in thermophilic hosts, as SpCas9 is derived from a mesophilic organism, or
in poorly genetically accessible organisms due to the large size of cas9. In such cases, an 
alternative may be to use the host’s endogenous CRISPR system for silencing. As the 
number of available plasmids and inducible promoters for non-model organisms is oft en
donor strain into an rfp-expressing E. coli acceptor strain. The acceptor strain was part of a 
mixed E. coli culture and its RFP expression was successfully silenced43. A similar 
application of using CRISPR-Cas-system as highly specific antimicrobial in a complex 
environment was also shown for the wild-type Cas9 variant which was used as highly 
specific antimicrobial45.
Another important application of CRISPRi is the targeting of essential 
genes46,47 (Table S2). Previously, laborious methods were required in order to study 
or silence essential genes, for example by establishing conditional knockouts. Using 
CRISPRi, the amount of silencing can be appropriately fine-tuned (Box 3), and 
repression can be induced in a simple and fast way, also in hard-to-
engineer organisms. This has allowed for the identification of essential genes in the 
pathogen Mycobacterium tuberculosis, which could be possible new drug targets46. A 
first successful example of using CRISPRi for metabolic engineering 
aimed at the production of PHA in E. coli and used dCas9-based 
downregulation of several essential TCA cycle genes47.  
GENE ACTIVATION
The properties of dCas9 as a non-cleaving DNA-binding protein can be further exploited by 
attaching other functional molecules to it. This was shown in bacteria in which dCas9 was 
fused to the RNA Polymerase ω-subunit (dCas9::ω) in an E. coli ΔrpoZ strain that lacks the 
ω-subunit gene41 (Fig. 2b). The dCas9::ω chimera was programmed to target a promoter 
driving lacZ expression. A maximum of 23-fold induction in lacZ expression was observed, 
which might be further optimized by adjusting the linker or by using a different activator 
domain41.  
BOX 3. TUNING CRISPRi
Whereas in some cases maximal repression via CRISPRi is desired, in other cases (e.g. 
when genes are essential) it is necessary to fine-tune repression levels. Below, several 
determinants of the strength of CRISPRi are listed that can be used when tuning 
repression and designing targets and sp spacers.
TARGET REGION
Repression strength changes when targeting different regions of the promoter or open reading 
frame (ORF) relative to the transcription start site (TSS). The most efficient repression using 
dCas9 can be obtained by targeting the -35 box41,42,47, which was found to be similar when 
using Type I-E Δcas3 systems48. The further away the target is from the TSS, then the less
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Another important application of CRISPRi is the targeting of essential 
genes46,47 (Table S2). Previously, laborious methods were required in order to study or 
silence essential genes, for example by establishing conditional knockouts. Using 
CRISPRi, the amount of silencing can be appropriately fine-tuned (Box 3), and repression 
can be induced in a simple and fast way, also in hard-to-engineer organisms. This has 
allowed for the identification of essential genes in the pathogen Mycobacterium
tuberculosis, which could be possible new drug targets46. A first successful example of 
using CRISPRi for metab olic engineering aimed at the production of PHA in E. coli and 
used dCas9-based downregulation of several essential TCA cycle genes47.  
G ENE ACTIVATIO N 
The properties of dCas9 as a non-cleaving DNA-binding protein can be further 
exploited by attaching other functional molecules to it. This was shown in bacteria in which 
dCas9 was fused to the RNA Polymerase ω-subunit (dCas9::ω) in an E. coli ΔrpoZ strain that 
lacks the ω-subunit gene41 (Fig. 2b). The dCas9::ω chimera was programmed to target a 
promoter driving lacZ expression. A maximum of 23-fold induction in lacZ expression was 
observed, which might be further optimized by adjusting the linker or by using a different 
activator domain41.  
BO X 3. TUNING  CRISPRi
Whereas in some cases maximal repression via CRISPRi is desired, in other cases (e.g.
when 
genes are essential) it is necessary to fine-tune repression levels. Below, several determinants 
of the strength of CRISPRi are listed that can be used when tuning repression and 
designing targets and spacers.  
TARG ET REG IO N 
Repression strength changes when targeting different regions of the promoter or open 
reading 
frame (ORF) relative to the transcription start site (TSS). The most efficient repression using 
dCas9 can be obtained by targeting the -35 box41,42,47, which was found to be similar when 
using Type I-E Δcas3 systems48. The further away the target is from the TSS, the less 
efficient the silencing – this holds true for targets in both the promoter and the ORF41,42,46,47. 
Moreover, it should be taken into account that many bacterial genes are in an operon and 
therefore silencing might have an undesired down stream effect49.  
BO X 3. TUNING CRISPRi (continuation)
efficient the silencing – this holds true for targets in both the promoter and the ORF41,42,46,47. 
Moreover, it should be taken into account that many bacterial genes are in an operon and 
therefore silencing might have an undesired downstream effect49.   
STRAND BIAS
When targeting the promoter, no difference was observed between targeting the template or 
non-template strand. However, when dCas9 was used to target a region within the ORF, 
targeting the non-template (or coding) strand was consistently shown to be highly efficient, 
while targeting the template strand gave less or no repression40-42,46. It was hypothesized that 
this is due to the ability of the RNAP to ‘unzip’ dCas9 from the template strand via its 
helicase activity42,46. Remarkably, when using Type I-E Δcas3 systems this strand bias for 
ORF-targets was found to be inversed48,50.
SPACER MISMATCHES
dCas9 binds steadily to the DNA target only if the 12 nt long protospacer seed sequence 
is fully complimentary to the corresponding part of the spacer sequence41,42. The 
more mismatches after the 12 nt seed sequence, the less efficient the binding and 
repression. Interestingly, when there are only 12 complementary nucleotides when using 
wild-type Cas9, the active protein can bind but not cleave, hence functioning as a dCas9 
without the active site mutations41. This hold promise for future engineering purposes 
especially for those using endogenous systems, which can in this way also be used as 
repressor without making genomic mutations in cas9.
MULTIPLEXING 
The use of multiple sgRNAs targeting different regions of the same gene 
(either promoter and/or ORF region) can further enhance repression42,46. 
INDUCTION
If an inducible promoter is used for dCas9, Cascade or guide RNA expression, in 
most cases the amount of repression was shown to increase with increasing 
inducer concentration or time42,48. On the other hand, in Mycobacteria using dCas9 
it was found that longer induction time did not increase left-over protein levels, 
but increasing the length of hybridizing spacer part did, indicating differences 
per organism, and the need for optimization of the system for each new host46.  
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CO NCLUDING REMARK S AND FUTURE DIRECTIO NS 
Whereas CRISPR-Cas9-mediated engineering has moved extremely fast in 
eukaryotes, prokaryotic genome editing using this system is taking off more slowly. This is 
mainly due to the lack or the conditional expression of an efficient NHEJ repair 
pathway in most prokaryotes54,55. The Ku and LigD proteins constitute a minimal, 
error-prone bacterial NHEJ system56 and their heterologous expression in the host of 
interest may lead to the construction of a CRISPR-Cas-based high-throughput tool for gene 
knock-outs in the host.
The absence of an effective repair system in prokaryotes might be highly useful 
for applications other than genome editing. Examples of this are the CRISPR-Cas-
mediated vaccination of biotechnologically interesting strains against bacteriophages by 
natural spacer acquisition1 or by CRISPR design2 as well as the targeted killing of 
specific bacterial strains in complex environments45,52. At the moment, the delivery 
of a CRISPR-Cas-mediated targeted killing or delivery system in undefined mixed 
cultures is still a challenge, but conjugation systems43 or virus-based systems45,57 are 
possible strategies to allow for lateral transfer. In addition, targeting a genome either 
randomly or via IS elements32,53 and selecting for survivors might be a useful tool when 
creating and studying minimal genomes. For other functional genomic studies, the 
possibility of adding functional molecules to dCas9 holds promise for applications 
such as the attachment of fluorescent groups to direct these to specific genomic loci 
and study subcellular localization linked to gene expression. 
It is clear that high transformation and recombination efficiencies of the target 
organism are required for high-throughput genome editing. As already discussed, the 
nickase-Cas9 holds potential for enhancing editing efficiencies. Additional Class2 
effectors, such as Cpf1 and the recently discovered C2C1 and C2C36, are currently 
under evaluation for their editing potential. Cpf1 is an endonuclease that serves as 
the interference machine of the recently identified type V CRISPR-Cas system13. It 
was shown that Cpf1 introduces staggered DSDBs at the PAM distal end of a 
protospacer, which might enhance the efficiency of both HR and directional insertion of 
dsDNA fragments into eukaryotic and prokaryotic genomes13. Moreover, the fact that 
the seed sequence of a protospacer is not affected by the Cpf1 activity leaves also space for 
additional rounds of editing using the same protospacer. Additionally, Cpf1 does not 
require a tracrRNA, simplifying the design process of a Cpf1-based counter-selection tool.  
The use of native CRISPR-Cas systems for editing purposes could overcome 
GENOME EDITING AND REPRESSION USING ENDOGENOUS CRISPR-CAS 
SYSTEMS
The dCas9 system is easily transferable to different hosts as it requires only a single 
plasmid containing dCas9 and the targeting spacer(s). However, it might not be readily 
applicable in thermophilic hosts, as SpCas9 is derived from a mesophilic organism, or in 
poorly genetically accessible organisms due to the large size of cas9. In such cases, an 
alternative may be to use the host’s endogenous CRISPR system for silencing. As the number 
of available plasmids and inducible promoters for non-model organisms is often limited, a 
major advantage of using an endogenous CRISPR-Cas system for editing or silencing is that 
only one, small plasmid containing a spacer (crRNA) and -if necessary- an HR-template, is 
required and no inducible promoters are needed. The only prerequisites are that the CRISPR-
Cas system is functionally expressed, and that (in case of Type I, II and V systems) the PAM 
sequence is known (Box 2). The genome of the thermophilic archaeon Sulfolobus islandicus 
has recently been engineered using its endogenous Type I-A and Type III-B CRISPR-Cas 
systems, including gene deletion, insertion and site-directed mutagenesis51. More specifically, 
for gene deletions using the Type I system, the authors used a single plasmid which included a 
template for HR and a module expressing a crRNA against the target gene51. As the Type I 
system is most wide-spread in bacteria5, promising proofs of principle were provided in two 
parallel studies in which after knockout of the nuclease cas3 in the E. coli Type I-E CRISPR-
Cas system, this system functioned as a guide-directed endogenous silencing system (Fig. 
2c)48,50. The Type I-E Cascade complex consisting of Cas proteins and crRNA is able to bind 
target DNA without cleaving it (due to the absence of Cas3), and as such Cascade can be used 
as a transcriptional road block. Furthermore it was demonstrated that the E. coli Type I-E 
Cascade complex can be successfully used for gene silencing when introduced into 
Salmonella typhimurium48. In E. coli, expression of the Cascade operon is normally repressed 
under laboratory conditions, requiring promoter replacement or induction of the Cascade-
genes even for endogenous use in this species48,50. However, in many other organisms the 
CRISPR-Cas-system appears to be constitutively expressed and can readily be used, such as 
shown for Sulfolobus51.
Next to genome editing and silencing, endogenous CRISPR-Cas-systems have also 
been shown to be effective for self-targeting or targeted killing of specific strains. As 
described earlier, the introduction of DSDBs in bacterial genomes is lethal in the absence of 
either a template for HR or a functional NHEJ system, which is the case in most bacteria. This 
feature can be exploited to specifically kill bacteria with certain genotypes in a mixed popula-
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limited, a major advantage of using an endogenous CRISPR-Cas system for editing or 
silencing is that only one, small plasmid containing a spacer (crRNA) and -if necessary- 
an HR-template, is required and no inducible promoters are needed. The only 
prerequisites are that the CRISPR-Cas system is functionally expressed, and that (in case 
of Type I, II and V systems) the PAM sequence is known (Box 2). The genome of the 
thermophilic archaeon Sulfolobus islandicus has recently been engineered using its 
endogenous Type I-A and Type III-B CRISPR-Cas systems, including gene 
deletion, insertion and site-directed mutagenesis51. More specifically, for gene 
deletions using the Type I system, the authors used a single plasmid which included a 
template for HR and a module expressing a crRNA against the target gene51. As the 
Type I system is most wide-spread in bacteria5, promising proofs of principle were 
provided in two parallel studies in which after knockout of the nuclease cas3 in the E. 
coli Type I-E CRISPR-Cas system, this system functioned as a guide-directed 
endogenous silencing system (Fig. 2c)48,50. The Type I-E Cascade complex consisting of 
Cas proteins and crRNA is able to bind target DNA without cleaving it (due to the 
absence of Cas3), and as such Cascade can be used as a transcriptional road block. 
Furthermore it was demonstrated that the E. coli Type I-E Cascade complex can be 
successfully used for gene silencing when introduced into Salmonella typhimurium48. In E. 
coli, expression of the Cascade operon is normally repressed under laboratory 
conditions, requiring promoter replacement or induction of the Cascade-genes even for 
endogenous use in this species48,50. However, in many other organisms the CRISPR-Cas-
system appears to be constitutively expressed and can readily be used, such as shown for 
Sulfolobus51.  
Next to genome editing and silencing, endogenous CRISPR-Cas-systems have also 
been shown to be effective for self-targeting or targeted killing of specific strains. As 
described earlier, the introduction of DSDBs in bacterial genomes is lethal in the absence 
of either a template for HR or a functional NHEJ system, which is the case in most 
bacteria. This feature can be exploited to specifically kill bacteria with certain genotypes in 
a mixed population. Cas9-mediated killing of cells in the human gut was successfully 
shown45, but also native systems have been evaluated for this purpose using the E. coli
Type I-E52 and the Pectobacterium atrosepticum Type I-F system53 (Table S2). The 
endogenous E. coli CRISPR Type I-E system was used for highly selective targeting 
and removal of E. coli strains from a mixed culture52. In P. atrosepticum, targeting a 
genomic pathogenicity island using its endogenous CRISPR-Cas-system led to excision of 
the island53.  
tion. Cas9-mediated killing of cells in the human gut was successfully shown45, but also 
native systems have been evaluated for this purpose using the E. coli Type I-E52 and the 
Pectobacterium atrosepticum Type I-F system53 (Table S2). The endogenous E. 
coli CRISPR Type I-E system was used for highly selective targeting and removal of E. 
coli strains from a mixed culture52. In P. atrosepticum, targeting a genomic pathogenicity 
island using its endogenous CRISPR-Cas-system led to excision of the island53.  
CONCLUDING REMARKS AND FUTURE DIRECTIONS
Whereas CRISPR-Cas9-mediated engineering has moved extremely fast in eukaryotes, 
prokaryotic genome editing using this system is taking off more slowly. This is mainly due to 
the lack or the conditional expression of an efficient NHEJ repair pathway in most 
prokaryotes54,55. The Ku and LigD proteins constitute a minimal, error-prone bacterial NHEJ 
system56 and their heterologous expression in the host of interest may lead to the construction 
of a CRISPR-Cas-based high-throughput tool for gene knock-outs in the host.
The absence of an effective repair system in prokaryotes might be highly useful for 
applications other than genome editing. Examples of this are the CRISPR-Cas-mediated 
vaccination of biotechnologically interesting strains against bacteriophages by natural spacer 
acquisition1 or by CRISPR design2 as well as the targeted killing of specific bacterial strains 
in complex environments45,52. At the moment, the delivery of a CRISPR-Cas-mediated 
targeted killing or delivery system in undefined mixed cultures is still a challenge, but 
conjugation systems43 or virus-based systems45,57 are possible strategies to allow for lateral 
transfer. In addition, targeting a genome either randomly or via IS elements32,53 and selecting 
for survivors might be a useful tool when creating and studying minimal genomes. For other 
functional genomic studies, the possibility of adding functional molecules to dCas9 holds 
promise for applications such as the attachment of fluorescent groups to direct these to 
specific genomic loci and study subcellular localization linked to gene expression. 
It is clear that high transformation and recombination efficiencies of the target 
organism are required for high-throughput genome editing. As already discussed, the nickase-
Cas9 holds potential for enhancing editing efficiencies. Additional Class 2 effectors, such as 
Cpf1 and the recently discovered C2C1 and C2C36, are currently under evaluation for their 
editing potential. Cpf1 is an endonuclease that serves as the interference machine of the 
recently identified type V CRISPR-Cas system13. It was shown that Cpf1 introduces 
staggered DSDBs at the PAM distal end of a protospacer, which might enhance the efficiency 
of both HR and directional insertion of dsDNA fragments into eukaryotic and prokaryotic ge-
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nomes13. Moreover, the fact that the seed sequence of a protospacer is not affected by the 
Cpf1 activity leaves also space for additional rounds of editing using the same protospacer. 
Additionally, Cpf1 does not require a tracrRNA, simplifying the design process of a Cpf1-
based counter-selection tool.  
The use of native CRISPR-Cas systems for editing purposes could overcome the 
challenges in efficient heterologous expression of a Cas9/Cpf1 system in non-model 
organisms (see Outstanding Questions). This underlines the requirement for rapid 
characterization methods of the host’s CRISPR systems and especially identification of 
the PAM sequenc that these systems recognise. The use of CRISPR-Cas-systems other 
than Cas9 will be an important future research direction, as it will broaden the range 
of biotechnologically relevant micro-organisms in which it can be used. 
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the challenges in efficient heterologous expression of a Cas9/Cpf1 system in non-model 
organisms (see Outstanding Questions). This underlines the requirement for rapid 
characterization methods of the host’s CRISPR systems and especially identification of the 
PAM sequences that these systems recognise. The use of CRISPR-Cas-systems other than 
Cas9 will be an important future research direction, as it will broaden the range of 
biotechnologically relevant micro-organisms in which it can be used. 
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Chapter 3
ABSTRACT 
Well-developed genetic tools for thermophilic microorganisms are scarce, despite 
their industrial and scientific relevance. Whereas highly efficient CRISPR/Cas9-based 
genome editing is on the rise in prokaryotes, it has never been employed in a thermophile. 
Here, we apply Streptococcus pyogenes Cas9 (spCas9)-based genome editingto a moderate 
thermophile, i.e. Bacillus smithii, including a gene deletion, gene knock-out via insertion of 
premature stop codons, and gene insertion. We show that spCas9 is inactive in vivo 
above 42°C and we employ the wide temperature growth range of B. smithii as an 
induction system for spCas9 expression. Homologous recombination with plasmid-born 
editing templates is performed at 45-55°C, when spCas9 is inactive. Subsequent transfer to 
37°C allows for counter-selection through production of active spCas9 that introduces lethal 
double-stranded DNA breaks to the non-edited cells. The developed method takes 4 days with 
90, 100 and 20% efficiency for gene deletion, knockout and insertion, respectively. The 
major advantage of our system is the limited requirement for genetic parts: only one 
plasmid, one selectable marker and a promoter, which does not need to be inducible or well-
characterized. Hence, it can be easily applied for genome editing purposes in both 
mesophilic and thermophilic non-model organisms with limited genetic toolbox and ability 
to grow at temperatures between 37 and above 42°C.
KEYWORDS  
CRISPR/Cas9, bacteria, Bacillus smithii, thermophiles, genome editing, homologous 
recombination 
INTRO DUCTIO N 
Microbial fermentation of renewable resources into green fuels and chemicals is 
playing a major part in the development of the bio-based economy. The 
production costs of these environmentally friendly processes have to be reduced before 
they become competitive with the traditional fossil fuel-based industries. To this end, 
microbes other than the widely-used model organisms, such as Escherichia coli and 
Saccharomyces cerevisiae, are being evaluated for their perspective abilities to act as 
production hosts. Thermophilic organisms are of particular interest due to their 
multiple advantages over mesophilic organisms when being used as production 
hosts1-3. For example, their ability to grow and ferment at thermophilic temperatures reduces 
the contamination risk with mesophiles4-6 and there are examples of using thermophiles for 
non-sterilized fermentations, which would reduce sterilization costs7,8, it reduces the cooling 
costs9,10, increases substrate and product solubility11, and the fermentation process runs at the 
optimum temperature for enzymatic lignocellulose degradation, allowing for efficient 
simultaneous saccharification and fermentation12,13. However, the use of non-model 
thermophiles as production hosts is generally hampered by the lack of well-developed 
genome editing tools compared to the currently used mesophilic  model organisms1,14.
Previous work has established basic genome editing tools for the thermophilic strain 
Bacillus smithii ET 138 (referred to as ET 138 herein), allowing for the introduction of scar-
free markerless gene deletions using homologous recombination15. B. smithii grows between 
37°C and 65°C and efficiently utilizes both C5 and C6 sugars16,17. Its main product isL-lactate 
and in order to use ET 138 as a versatile platform host for the production of other chemicals 
and fuels, its ldhL gene was deleted. No counter-selection tool was used in this process, 
resulting in a very laborious screening process to obtain clean mutants15. Subsequently, a 
lacZ-based counter-selection was developed relying on the toxicity of high concentrations of 
5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal)15,18. Using this system, the
sporulation gene sigF and the pyruvate dehydrogenase complex subunit gene pdhA were
consecutively deleted in the ldhL mutant. The resulting triple mutant strain was sporulation-
deficient, which is desired in industrial fermentations forsafety reasons, and did not produce
L-lactate and acetate. Since the pdhA mutant was also acetate-auxotroph, the double mutant
ET 138 ΔldhL ΔsigF was selected as a basic platform strain forfuture studies15. Although the
lacZ-based counter-selection system significantly decreased the time needed for mutant
selection, the developed process is still time-consuming, with the fastest possible route to gene
deletion taking approximately 2 to 3 weeks from transformation to generation of
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ABSTRACT
Well-developed genetic tools for thermophilic microorganisms are scarce, despite 
their industrial and scientific relevance. Whereas highly efficient CRISPR/Cas9-based 
genome editing is on the rise in prokaryotes, it has never been employed in a thermophile. 
Here, we apply Streptococcus pyogenes Cas9 (spCas9)-based genome editing to a moderate 
thermophile, i.e. Bacillus smithii, including a gene deletion, gene knock-out via insertion of 
premature stop codons, and gene insertion. We show that spCas9 is inactive in vivo above 
42°C and we employ the wide temperature growth range of B. smithii as an induction system
for spCas9 expression. Homologous recombination with plasmid-borne editing templates is 
performed at 45-55°C, when spCas9 is inactive. Subsequent transfer to 37°C allows for
counter-selection through production of active spCas9 that introduces lethal double-
stranded DNA breaks to the non-edited cells. The developed method takes 4 days wit h
90, 100 and 20% efficiency for gene deletion, knockout and insertion, respectively. The 
major advantage of our system is the limitedrequirement for genetic parts: only one plasmid , 
one selectable marker and a promoter, which does not need to be inducible or well-
characterized. Hence, it can be easily applied for genome editing purposes in both 
mesophilic and thermophilic non-model organisms with limited genetic toolbox and 
ability to grow at temperatures between 37 and above 42°C.
K EYWO RDS  
CRISPR/Cas9, bacteria, Bacillus smithii, thermophiles, genome editing, homologous
recombination 
INTRODUCTION 
Microbial fermentation of renewable resources into green fuels and chemicals is 
playing a major part in the development of the bio-based economy. The production costs of 
these environmentally friendly processes have to be reduced before they become competitive 
with the traditional fossil fuel-based industries. To this end, microbes other than the widely-
used model organisms, such as Escherichia coli and Saccharomyces cerevisiae, are being 
evaluated for their perspective abilities to act as production hosts. Thermophilic organisms are 
of particular interest due to their multiple advantages over mesophilic organisms when being 
used as production hosts1-3. For example, their ability to grow and ferment at thermophilic 
temperatures reduces the contamination risk with mesophiles4-6 and there are examples of 
using thermophiles for non-sterilized fermentations, which would reduce sterilization costs7,8, 
it reduces the cooling costs9,10, increases substrate and product solubility11, and the 
fermentation process runs at the optimum temperature for enzymatic lignocellulose 
degradation, allowing for efficient simultaneous saccharification and fermentation12,13. 
However, the use of non-model thermophiles as production hosts is generally hampered by 
the lack of well-developed genome editing tools compared to the currently used mesophilic 
model organisms1,14.
Previous work has established basic genome editing tools for the thermophilic strain 
Bacillus smithii ET 138 (referred to as ET 138 herein), allowing for the introduction of scar-
free markerless gene deletions using homologous recombination15. B. smithii grows between 
37°C and 65°C and efficiently utilizes both C5 and C6 sugars16,17. Its main product is L-lactate 
and in order to use ET 138 as a versatile platform host for the production of other chemicals 
and fuels, its ldhL gene was deleted. No counter-selection tool was used in this process, 
resulting in a very laborious screening process to obtain clean  mutants15. Subsequently, a 
lacZ-based counter-selection was developed relying on the toxicity of high concentrations of 
5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal)15,18. Using this system, the
sporulation gene sigF and the pyruvate dehydrogenase complex subunit gene pdhA were
consecutively deleted in the ldhL mutant. The resulting triple mutant strain was sporulation-
deficient, which is desired in industrial fermentations for safety reasons, and did not produce
L-lactate and acetate. Since the pdhA mutant was also acetate -auxotroph, the double mutant
ET 138 ΔldhL ΔsigF was selected as a basic platform strain for future studies15. Although the
lacZ-based counter-selection system significantly decreased the time needed for
mutant selection, the developed process is still time-consuming, with the fastest possible route
52
Chapter 3
avoided subsequent spCas9 targeting events, but in many studies the number of 
surviving/edited colonies was low with high percentage of mixed (both wild type and mutant) 
or escape mutant genotypes38-40. The number of surviving colonies as well as the 
percentage of successfully edited cells was higher in studies that allowed 
homologous recombination of the editing templates to take place prior to the 
spCas9 targeting. This way spCas9 was employed for stringent counter-selection 
of the unedited genomes. For this approach either homologous 
recombination was faster than spCas9-targeting or cas9sp expression was 
induced after homologous recombination41-43. Moreover, the vast 
majority of the studies required either a multip le-plasmi d system or 
very tightly controlled promoters42,44. Currently, only one plasmid, one selection 
marker and no inducible promoters are available for ET 138, limiting the options 
for such systems. Many of the well-known and widely applied genome editing 
tools, including CRISPR-Cas9 editing, are not amenable to thermophiles. The 
enzymatic machineries of these tools have not proven stable at temperatures 
higher than 37°C. Whereas the native CRISPR-Cas type I system of a 
thermophilic archaeon has been employed for genome editing45 as well as 
chromosome-based genetic manipulations have been reported for a few 
naturally competent thermophiles46, no reports are available on using Cas9-based 
editing in thermophilic organisms. 
In this study, we show that spCas9 is inactive in ET 138 at temperatures above 42°
C and we tightly control its activity by altering the cultivation temperature rather 
than using an inducible promoter. We create a clean gene deletion, a gene disruption 
and a gene insertion by employing a plasmid-borne homologous recombination 
template for introduction of the desired modifications to the genome at 45°C, while 
the non-edited cells are subsequently eliminated by spCas9 counter-selection at 37°C. 
To the best of our knowledge, this is the first time that a temperature-controlled 
recombination/counter-selection tool is employed for genome editing purposes, as 
well as the first time that a Cas9-based editing tool is used for engineering 
the genome and the metabolism of a moderate thermophile. 
RESULTS AND DISCUSSIO N  
IN VIVO EXPRESSIO N VALIDATIO N O F SpCAS9 AT DIFFERENT TEMPERATURES
In a parallel study, we demonstrated that the in vitro sgRNA-loading to spCas9 
requires temperatures below 42°C and is the limiting step towards the in vitro formation of
to gene deletion taking approximately 2 to 3 weeks from transformation to generation ofa 
scar-free markerless knockout15. Moreover, the counter-selection step is not stringent enough 
for removal of genes that are essential for the fitness and the metabolism of the strain. For the 
successfully engineered genes, only 12.5-33% of the colonies had the mutant genotype, 
whereas for other genes only wild-type revertants and false positives were obtained, 
generating mostly (66-88%) or in some cases only wild-type revertants or false positives15. 
The large number of wild-type revertants due to the absence or inefficiency of counter-
selection is a general issue in several non-model organisms19,20. This creates the need for 
laborious PCR-based screening and strongly decreases throughput of the engineering process, 
limiting the study of these organisms and their development into industrial production hosts.  
One of the fastest and most efficient methods currently available for genome editing 
is a system based on the Streptococcus pyogenes Cas9 (spCas9) RNA-guided DNA 
endonuclease of the type II CRISPR-Cas defence system21. Jinek et al. showed that a short 
single guide RNA (sgRNA) molecule can direct the spCas9 endonuclease to a desired 
complementary target , called protospacer22. In the presence of the short 5’-NGG-3’ DNA 
motif right downstream of the 3’-end of the protospacer, called protospacer adjacent motif 
(PAM), spCas9 introduces a lethal chromosomal double stranded DNA break (DSDB)22. The 
system was applied for genome editing of human23-26 and mice cells25, paving the road for 
genome editing of a wide range of eukaryotic cells27-29. In these eukaryotes, the Non-
Homologous End Joining (NHEJ) system repairs spCas9-induced DSDBs in an error-prone 
manner, creating insertion/deletion (indel) mutations23-26. These mutations usually render the 
gene inactive through frameshifting and simultaneously prevent further spCas9-recognition 
and subsequent cleavage due to the alteration of the target site. Whilst for most prokaryotes 
the NHEJ system is generally not present or not active30, the ET 138 genome contains the 
genes for the basic prokaryotic NHEJ-like system, consisting of DNA ligase LigD and DNA-
end-binding protein Ku31,32. However, the functionality of the NHEJ-like system in ET 138 is 
unknown.
The combination of the spCas9 activity with editing templates, such as 
recombineering oligonucleotides or plasmid-borne sequences for homologous recombination, 
has been recently exploited for prokaryotic genome editing33-35. spCas9 was employed to 
introduce DSDBs in prokaryotic genomes. These breaks  modestly induced the recombination 
of a provided rescuing/editing template into the targeted chromosome, resulting in genetically 
modified cells33,36,37.The edited cells avoided subsequent  spCas9 targeting events, but in 
many studies the number of surviving/edited colonies was low with high percentage of mixed 
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a scar-free markerless knockout15. Moreover, the counter-selection step is not stringent 
enough for removal of genes that are essential for the fitness and the metabolism of the 
strain. For the successfully engineered genes, only 12.5-33% of the colonies had the 
mutant genotype, whereas for other genes only wild-type revertants and false positives 
were obtained, generating mostly (66-88%) or in some cases only wild-type 
revertants or false positives15. The large number of wild-type revertants due to the 
absence or inefficiency of counter-selection is a general issue in several non-
model organisms19,20. This creates the need for laborious PCR-based screening and 
strongly decreases throughput of the engineering process, limiting the study of these 
organisms and their development into industrial production host s.  
One of the fastest and most efficient methods currently available for genome editing is 
a system based on the Streptococcus pyogenes Cas9 (spCas9) RNA-guided 
DNA endonuclease of the type II CRISPR-Cas defence system21. Jinek et al. showed that 
a short single guide RNA (sgRNA) molecule can direct the spCas9 endonuclease to 
a desired complementary target, called protospacer22. In the presence of the short 5’-
NGG-3’ DNA motif right downstream of the 3’-end of the protospacer, called 
protospacer adjacent motif (PAM), spCas9 introduces a lethal chromosomal double 
stranded DNA break (DSDB)22. The system was applied for genome editing of 
human[3-26] and mice cells25, paving the road for genome editing of a wide range of 
eukaryotic cells27-29. In these eukaryotes, the Non-Homologous End Joining (NHEJ) 
system repairs spCas9-induced DSDBs in an error-prone manner, creating insertion/
deletion (indel) mutations23-26. These mutations usually render the gene inactive 
through frameshifting and simultaneously prevent further spCas9-recognition and 
subsequent cleavage due to the alteration of the target site. Whilst for most 
prokaryotes the NHEJ system is generally not present or not active30, the ET 138 
genome contains the genes for the basic prokaryotic NHEJ-like system, consisting 
of DNA ligase LigD and DNA-end-binding protein Ku31,32. However, 
the functionality of the NHEJ-like system in  ET 138 is unknown.
The combination of the spCas9 activity with editing templates, such 
as recombineering oligonucleotides or plasmid-borne sequences for homologous 
recombination, has been recently exploited for prokaryotic genome editing33-35. spCas9 
was employed to introduce DSDBs in prokaryotic genomes. These breaks 
modestly induced the recombination of a provided rescuing/editing template into 
the targeted chromosome, resulting in genetically modified cells33,36,37.The edited cells 
(both wild type and mutant) or escape mutant genotypes38-40. The number of surviving 
colonies as well as the percentage of successfully edited cells  was higher in studies that 
allowed homologous recombination of the editing templates to take place prior to the spCas9 
targeting. This way spCas9 was employed for stringent counter-selection of the unedited 
genomes. For this approach either homologous recombination was faster than spCas9-
targeting or cas9sp expression was induced  after homologous recombination41-43. 
Moreover, the vast majority of the studies required either a multiple-plasmid system or 
very tightly controlled promoters42,44. Currently, only one plasmid, one selection 
marker and no inducible promoters are available for ET 138, limiting the options for such 
systems. Many of the well-known and widely applied genome editing tools, including 
CRISPR-Cas9 editing, are not amenable to thermophiles. The enzymatic machineries of 
these tools have not proven stable at temperatures higher than 37°C. Whereas the native 
CRISPR-Cas type I system of a thermophilic archaeon has been employed for genome 
editing45 as well as chromosome-based genetic manipulations have been reported for a 
few naturally competent thermophiles46, no reports are available on using Cas9-based 
editing in thermophilic organisms.
In this study, we show that spCas9 is inactive in ET 138 at temperatures above 42°C 
and we tightly control its activity by altering the cultivation temperature rather than using an 
inducible promoter. We create a clean gene deletion, a gene disruption and a gene insertion 
by employing a plasmid-borne homologous recombination template for introduction of the 
desired modifications to the genome at 45°C, while the non-edited cells are subsequently 
eliminated by spCas9 counter-selection at 37°C. To the best of our knowledge, this is the first 
time that a temperature-controlled recombination/counter-selection tool is employed for 
genome editing purposes, as well as the first time that a Cas9-based editing tool is used for 
engineering the genome and the metabolism of a moderate thermophile. 
RESULTS AND DISCUSSION  
IN VIVO EXPRESSION VALIDATION OF SpCAS9 AT DIFFERENT TEMPERATURES 
In a parallel study, we demonstrated that the in vitro sgRNA-loading to spCas9 
requires temperatures below 42°C and is the limiting step towards the in vitro formation 
of the active gRNA-spCas9-complex (to be published). This result motivated us to evaluate 
the in vivo activity of spCas9 in ET 138 at different temperatures. We designed and 
constructed the modular pWUR_Cas9nt construct, that encompasses the cas9 gene of S. 
pyogenes (referred to as cas9sp herein) and an sgRNA-expressing module for which the 
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generally stressed that the transcriptional start site (TSS) of the promoter driving the sgRNA 
expression must be characterized. However, the TSS of the Ppta we use for the same purpose 
in our study is not characterized and since we remove only the predicted RBS we expect that 
a few nucleotides are still added to the 5’-end of the sgRNA molecules. Even so, we 
hypothesized hat this extended sgRNA module will be efficiently loaded to the spCas9 and 
it will not influence the Cas9 targeting efficiency and specificity, since it is located at the 
PAM distal end. By practically verifying our hypothesis we would facilitate the 
application of our system to other non-model organisms with promoters that do not have 
their transcription start determined. 
Figure 1. Schematic overview of the basic pWUR_Cas9nt construct. A. The non-codon optimized cas9sp gene 
was employed for the construction of the pWUR_Cas9nt vector, since the S. pyogenes and B. smithii GC-
content and codon usage are highly similar. In the pNW33n-based basic construct the spCas9 was placed under 
the control of PxynA. A Rho-independent terminator from B. subtilis59 was introduced after the stop codon of 
the gene. The spCas9 module is followed by an sgRNA-e xpressing module that encompasses a spacer which 
does not target the genome of ET 138. The sgRNA module was placed under the transcriptional control of Ppta
from B. coagulans -without its RBS-[15,49]] and it is followed by a second Rho-independent terminator from B. 
subtilis. The spCas9 and sgRNA modules were synthesized as one fragment, which was subsequently 
cloned into the pNW33n through the BspHI and HindIII restriction sites. B. To prevent double restriction 
sites and create a modular system, 5 point silent mutations (C192A, T387C, T1011A, C3126A, G354A) 
were introduced to the gene (depicted as *). The depicted restriction sites are unique in the construct 
and introduced to facilitate the exchange of genetic parts. The spacer was easily exchanged to targeting 
spacers via BsmBI restriction digestion or Gibson assembly. The basicconstruct did not contain any HR-
templates, but in the cases that these were added they were always inserted right upstream the spCas9-module 
and downstream the origin of replication.C. Total RNA was isolated from ET 138 wild-type cells transformed 
with pWUR_Cas9nt or pNW33n and grown at 55, 45 and 37°C. 6 cDNA libraries were produced with rt-
PCR and used as templates for PCR with cas9sp-specific primers that amplify a 255 bp long region. The 
PCR results are depicted in this agarose gel electrophoresis: Lane 1 corresponds to the marker (1kb+ 
DNA ladder, ThermoFisher), Lanes 2 to 4 correspond to ET 138 wild type cultures transformed 
with the pWUR_Cas9nt and grown at 55, 42, 37°C respectively, Lanes 5 to 7 correspond to ET 138 wild 
type cultures transformed with the pNW33n and grown at 55, 42 and 37°C respectively, Lanes 7, 8, 9, 11, 
12 correspond to different negative controls and Lane 10 corresponds to the positive control, for which 
pWUR_Cas9nt was used as the PCR template. 
is predicted not to target any site of the B. smithii genome, (i.e. nt, for non-targeting). 
The backbone of the pWUR_Cas9nt is the pNW33n vector, which was the only available 
vector for B. smithii (Figure 1A)15,16. The first basic requirement for the design of 
the pWUR_Cas9nt was the development of promoters that will drive the 
expression of the two components of the system: the cas9sp effector and its 
sgRNA guide module. For many non-model organisms, the number of available 
promoters and plasmids is very limited. ET 138 is no exception: only two 
promoters have been evaluated for expression in B. smithii: the heterologous Ppta 
from B. coagulans,  and the native PldhL15. The latter is undesired, as integration 
of pNW33n-based HR-plasmids into the ET 138 genome is possible15 and we 
want to prevent crossover events between the pWUR_Cas9nt construct and the B. smithii 
genome over the promoter region. Additionally, an inducible system 
would be desirable. For these purposes we tested the xynA promoter 
(PxynA) from Thermoanaerobacterium saccharolyticum47. On the genome of its native 
host this promoter is induced by xylose and repressed by glucose. To test expression in ET 
138, we constructed the pWUR_lacZ vector; we used pNW33n as cloning and expression 
vector and we introduced PxynA in front of the B. coagulans-derived lacZ gene, previously 
shown to be functional in ET 13815. Low expression was observed after overnight 
culturing in LB2 liquid medium without added carbon source, and strong 
expression was observed with both xylose and glucose (Figure S1). It is probable 
that the catabolite repression mechanism of ET 138 does not recognize the cre 
(catabolite repression element) sequence present on PxynA, resulting in lack of 
transcriptional repression by glucose in B. smithii ET 138. Although PxynA is not tightly 
controllable in B. smithii we still selected it to drive the expression of cas9 from the 
pWUR_Cas9nt, maintaining the possibility to explore the effects of different cas9sp 
expression levels. During all further experiments in this study, xylose and glucose were both 
added to the media at all the culturing temperatures, to ensure constant induction of SpCas9 
expression at all times from PxynA. Additionally, we placed the sgRNA-module under the 
control of the B. coagulans phosphotransacetylase (pta) promoter Ppta5,49 without its RBS. It 
is generally stressed that the transcriptional start site (TSS) of the promoter driving the 
sgRNA expression must be characterized. However, the TSS of the Ppta we use for the 
same purpose in our study is not characterized and since we remove only the 
predicted RBS we expect that a few nucleotides are added to the 5’-end of the sgRNA molecu-
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the active gRNA-spCas9-complex (to be published). This result motivated us to evaluate the 
in vivo activity of spCas9 in ET 138 at different temperatures. We designed and constructed 
the modular pWUR_Cas9nt construct, that encompasses the cas9 gene of S. pyogenes 
(referred to as cas9sp herein) and an sgRNA-expressing module for which the spacer is 
predicted not to target any site of the B. smithii genome, (i.e. nt, for non-targeting). 
The backbone of the pWUR_Cas9nt is the pNW33n vector, which was the only 
available vector for B. smithii (Figure 1A)15,16. The first basic requirement for the 
design of the pWUR_Cas9nt was the development of promoters that will drive the 
expression of the two components of the system: the cas9sp effector and its sgRNA 
guide module. For many non-model organisms, the number of available 
promoters and plasmids is very limited. ET 138 is no exception: only two promoters 
have been evaluated for expression in B. smithii: the heterologous Ppta from B. 
coagulans , and the native PldhL15. The latter is undesired, as integration of 
pNW33n-based HR-plasmids into the ET 138 genome is possible15 and we 
want to prevent crossover events between the pWUR_Cas9nt construct and the 
B. smithii genome over the promoter region. Additionally, an inducible system would be
desirable. For these purposes we tested the xynA promoter (PxynA) from
Thermoanaerobacterium saccharolyticum47. On the genome of its native host
this promoter is induced by xylose and repressed by glucose. To test expression in
ET 138, we constructed the pWUR_lacZ vector; we used pNW33n as cloning and
expression vector and we introduced PxynA in front of the B. coagulans-derived
lacZ gene, previously shown to be functional in ET 13815. Low expression was
observed after overnight culturing in LB2 liquid medium without added carbon
source, and strong expression was observed with both xylose and glucose (Figure S1).
It is probable that the catabolite repression mechanism of ET 138 does not
recognize the cre (catabolite repression element) sequence present on PxynA,
resulting in lack of transcriptional repression by glucose in B. smithii.ET 138.
Although PxynA is not tightly controllable in B. smithii we still selected it to drive the
expression of cas9 from the pWUR_Cas9nt, maintaining the possibility to explore
the effects of different cas9sp expression levels. During all further experiments in
this study, xylose and glucose were both added to the media at all the culturing
temperatures, to ensure constant induction of cas9sp expression at all times from
PxynA. Additionally, we placed the sgRNA-module under the control of the B.
coagulans phosphotransacetylase (pta) promoter Ppta15,49 without its RBS. It is
Figure 1. Schematic overview of the basic pWUR_Cas9nt construct.  A. The non-codon optimized cas9sp gene 
was employed for the construction of the pWUR_Cas9nt vector, since the S. pyogenes and B. smithii GC-
content and codon usage are highly similar. In the pNW33n-based basic construct the spCas9 was placed under 
the control of PxynA. A Rho-independent terminator from B. subtilis59 was introduced after the stop codon of 
the gene. The spCas9 module is followed by an sgRNA-expressing module that encompasses a spacer which 
does not target the genome of ET 138. The sgRNA module was placed under the transcriptional control of Ppta 
from  B. coagulans -without its RBS-[15,49] and it is followed by a second Rho-independent terminator from B. 
subtilis. The spCas9 and sgRNA modules were synthesized as one fragment, which was subsequently 
cloned into the pNW33n through the BspHI and HindIII restriction sites. B. To prevent double restriction 
sites and create a modular system, 5 point silent mutations (C192A, T387C, T1011A, C3126A, G354A) 
were introduced to the gene (depicted as *). The depicted restriction sites are unique in the construct 
and introduced to facilitate the exchange of genetic parts. The spacer was easily exchanged to targeting 
spacers via BsmBI restriction digestion or Gibson assembly. The basic construct did not contain any HR-
templates, but in the cases that these were added they were always inserted right upstream the spCas9-module 
and downstream the origin of replication. C. Total RNA was isolated from ET 138 wild-type cells transformed 
with pWUR_Cas9nt or pNW33n and grown at 55, 45 and 37°C. 6 cDNA libraries were produced with rt-
PCR and used as templates for PCR with cas9sp-specific primers that amplify a 255 bp long region. The 
PCR results are depicted in this agarose gel electrophoresis: Lane 1 corresponds to the marker (1kb+ 
DNA ladder, ThermoFisher), Lanes 2 to 4 correspond to ET 138 wild type cultures transformed 
with the pWUR_Cas9nt and grown at 55, 42, 37°C respectively, Lanes 5 to 7 correspond to ET 138 wild 
type cultures transformed with the pNW33n and grown at 55, 42 and 37°C respectively, Lanes 7, 8, 9, 11, 
12 correspond to different negative controls and Lane 10 corresponds to the positive control, for which 
pWUR_Cas9nt was used as the PCR template.  
les. Even so, we hypothesized hat this extended sgRNA module will be efficiently loaded to 
the spCas9 and it will not influence the Cas9 targeting efficiency and specificity, since it 
is located at the PAM distal end. By practically verifying our hypothesis we would facilitate 
the application of our system to other non-model organisms with promoters that do not have 
their transcription start determined. 
We evaluated spCas9-expression and toxicity levels in ET 138 by transforming 
a single batch of competent cells, with the non-targeting pWUR_Cas9nt vector and with 
the empty pNW33n control vector. The transformed cells were plated on LB2 
plates supplemented with chloramphenicol. We incubated the plates overnight only at 55°C, 
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the pWUR_Cas9nt sequence, designated pWUR_Cas9sp1, pWUR_Cas9sp2, and 
pWUR_Cas9sp3, each containing a different pyrF-targeting spacer (sp1-3). We transformed 
a single batch of wild type ET 138 competent cells with the 3 targeting vectors, the non-
targeting control pWUR_Cas9nt and the empty vector control pNW33n. After initial 
outgrowth at 55°C on LB2 plates without sugar, one confirmed transformant for each 
construct was subjected to a sequential plating and culturing process in which the 
temperature was stepwise lowered from 55°C to 37°C to induce spCas9-expression (Figure 
2A). Normal growth was observed for all cultures at 55°C, 45°C and 42°C, as well as for the 
control cultures at 37°C. No growth was observed for any of the cultures with pyrF-
targeting sgRNA-modules at 37°C (Figure 2B). We repeated the transformation and 
culturing process using the double mutant B. smithii ET138 ΔldhL ΔsigF strain15. This strain 
is sporulation-deficient, it cannot produce L-lactate and it was constructed as the basic 
platform strain for further metabolic engineering work. We obtained similar results as for the 
wild type B. smithii ET138 strain (Figure S3) and we continued our study using the double 
mutant strain. 
Figure 2. A. Sequential transfer schem e of wild-type ET 138 cultures to evaluate spCas9 expression and targeting 
efficiency at different tem peratures. ET 138 cells were transform ed with the pWUR_Cas9sp1, pWUR_Cas9sp2,
pWUR_Cas9sp3, pWUR_Cas9nt and pNW33n vectors and plated on LB2 agar plates with chloram phenicol (Day
1). After overnight (ON) incubation at 55°C, single colonies were restreaked on LB2 agar plates with
chloram phenicol and incubated ON at 55°C and 45°C (Day 2). Colonies from the 45°C plates were transferred to
LB2 agar plates with chloram phenicol for ON incubation at 37°C (Day 3). The plates from days 2 and 3 were then 
used for inoculation of liquid m edium (Day 4); 1 colony per 55°C, 45°C and 37°C plate was transferred to LB2 
m ediumwith xylose, glucose and chloram phenicol for ON incubation at 55°C, 45°C and 37°C respectively, while
1 extra colony per 45°C plate was transferred to the sam e m edium forovernight incubation at 42°C. B. Results of
the targeting experim ent showing OD600 m easurem ents from cultures of wild-type ET 138 transform ed with the 3 
different pyrF targeting cas9sp constructs, the non-targeting cas9sp construct and pNW33n. The growth of the cells
with the pyrF targeting constructs is greatly affected at 37°C, which is not observed for cells containing the non-
targeting constructs.
In line with the in vitro assay data, the aforem entioned results indicate thatthe designed
spCas9 system is active at 37°C, but is inactive and does not introduce lethal DSDBs to the ET 
138 genome at temperatures above 42°C. It also indicates that the NHEJ system in ET 138 is 
inactive at 37°C or not active enough to counteract the spCas9 activity. In addition, the
as previous incubation attempts at 37 and 42°C were not successful (data not shown). 
One single colony per transformation was  used for sequential transfers in LB2xg 
broth, transferring the cultures from 55°C to 37°C, with two intermediate steps at 45°C and 
42°C. We isolated total RNA from each pWUR_Cas9nt culture after 18 hours of incubation at 
55°C, 42°C and 37°C and performed semi-quantitative reverse transcription (rt)-PCR using 
specific primers for the cas9sp gene. Transcription of cas9sp was observed for 
all tested temperatures (Figure 1C). The growth of the cas9sp-expressing cultures was 
similar to the pNW33n control cultures at all temperatures (Figure 2B), indicating that the 
expression of cas9sp is not toxic for the ET 138 cells at any of the tested temperatures.  
IN VIVO VALIDATION OF SPCAS9 ACTIVITY AT DIFFERENT TEMPERATURES 
As B. smithii genome encompasses the genes for the basic prokaryotic NHEJ-like 
system31,32 our first approach to construct a spCas9-based genome editing tool focused on 
determining the in vivo temperature limits of spCas9 and the capacity of the ET 138 NHEJ-
like mechanism to repair the spCas9-induced DSDBs. We chose to target pyrF as a first proof 
of principle. The pyrF gene encodes the orotidine 5′-phosphate decarboxylase and is part of 
the operon for pyrimidine biosynthesis. Removal of the gene causes uracil-auxotrophy and 
resistance to the toxic uracil-analogue 5-fluorootic acid (5-FOA). It is a frequently used 
selection and counter-selection system in many organisms including thermophiles50-52, and to 
this end we had initially made a clean pyrF deletion mutant ET 138 ΔldhL ΔsigF ΔpyrF by 
adding the fused 1-kb up- and downstream pyrF flanks to pNW33n and applying 5-FOA 
pressure to select for double cross-over mutants. A total of 9 rounds of subculturing on 
selective media containing uracil and 5-FOA was required before pure knockouts were 
obtained with a knockout efficiency of around 50% (data not shown), making the process 
rather time-consuming. Whereas integration of pNW33-based HR-plasmids in ET 138 strains 
occurs15, likely due to the rolling circle-based replication of pNW33n53,54, subsequent 
excision of the plasmid and identification of clean mutant strains is difficult15. The speed and 
ease of this process could be significantly increased by using a strong counter-selection 
system, such as spCas9.
We continued our study by constructing 3 vectors based on the pWUR_Cas9nt 
sequence, designated pWUR_Cas9sp1, pWUR_Cas9sp2, and pWUR_Cas9sp3, each 
containing a different pyrF-targeting spacer (sp1-3). We transformed a single batch of wild 
type ET 138 competent cells with the 3 targeting vectors, the non-targeting control 
pWUR_Cas9nt and the empty vector control pNW33n. After initial outgrowth at 55°C on 
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We evaluated spCas9-expression and toxicity levels in ET 138 by transforming a 
single batch of competent cells, with the non-targeting pWUR_Cas9nt vector and with the 
empty pNW33n control vector. The transformed cells were plated on LB2 plates 
supplemented with chloramphenicol. We incubated the plates overnight only at 55°C, as 
previous incubation attempts at 37 and 42°C were not successful (data not shown). 
One single colony per transformation was used for sequential transfers in LB2xg broth, 
transferring the cultures from 55°C to 37°C, with two intermediate steps at 45°C and 42°C. 
We isolated total RNA from each pWUR_Cas9nt culture after 18 hours of incubation at 
55°C, 42°C and 37°C and performed semi-quantitative reverse transcription (rt)-PCR 
using specific primers for the cas9sp gene. Transcription of cas9sp was observed for all 
tested temperatures (Figure 1C). The growth of the cas9sp-expressing cultures was similar 
to the pNW33n control cultures at all temperatures (Figure 2B), indicating that the 
expression of cas9sp is not toxic for the ET 138 cells at any of the tested temperatures.
IN VIVO VALIDATIO N O F SPCAS9 ACTIVITY AT DIFFERENT TEMPERATURES 
As B. smithii genome encompasses the genes for the basic prokaryotic NHEJ-like system31,32
our first approach to construct a spCas9-based genome editing tool focused on determining 
the in vivo temperature limits of spCas9 and the capacity of the ET 138 NHEJ-like 
mechanism to repair the spCas9-induced DSDBs. We chose to target pyrF as a first proof of 
principle. The pyrF gene encodes the orotidine 5′-phosphate decarboxylase and is part of the 
operon for pyrimidine biosynthesis. Removal of the gene causes uracil-auxotrophy and 
resistance to the toxic uracil-analogue 5-fluorootic acid (5-FOA). It is a frequently used 
selection and counter-selection system in many organisms including thermophiles50-52, and 
to this end we had initially made a clean pyrF deletion mutant ET 138 ΔldhL ΔsigF ΔpyrF by 
adding the fused 1-kb up- and downstream pyrF flanks to pNW33n and applying 5-FOA 
pressure to select for double cross-over mutants. A total of 9 rounds of subculturing on 
selective media containing uracil and 5-FOA was required before pure knockouts were 
obtained with a knockout efficiency of around 50% (data not shown), making the process 
rather time-consuming. Whereas integration of pNW33-basedHR-plasmids in ET 138 strains 
occurs15, likely due to the rolling circle-based replication of pNW33n53,54, subsequent 
excision of the plasmid and identification of clean mutant strains is difficult15. The speed and 
ease of this process could be significantly increased by using a strong counter-selection 
system, suchas spCas9.
We continued our study by constructing 3 vectors based on 
LB2 without sugar, one confirmed transformant for each construct was subjected to a 
sequential plating and culturing process in which the temperature was stepwise lowered from 
55°C to 37°C to induce spCas9-expression (Figure 2A). Normal growth was observed for all 
cultures at 55°C, 45°C and 42°C, as well as for the control cultures at 37°C. No growth was 
observed for any of the cultures with pyrF-targeting sgRNA-modules at 37°C (Figure 2B). We 
repeated the transformation and culturing process using the double mutant B. smithii ET138 
ΔldhL ΔsigF strain15. This strain is sporulation-deficient, it cannot produce L-lactate and it 
was constructed as the basic platform strain for further metabolic engineering work We 
obtained similar results as for the wild type B. smithii ET138 strain (Figure S3) and we 
continued our study using the double mutant strain. 
Figure 2. A. Sequential transfer scheme of wild-type ET 138 cultures to evaluate spCas9 expression and 
targeting efficiency at different temperatures. ET 138 cells were transformed with the pWUR_Cas9sp1, 
pWUR_Cas9sp2, pWUR_Cas9sp3, pWUR_Cas9nt and pNW33n vectors and plated on LB2 agar plates with 
chloramphenicol (Day 1). After overnight (ON) incubation at 55°C, single colonies were restreaked on 
LB2 agar plates with chloramphenicol and incubated ON at 55°C and 45°C (Day 2). Colonies from the 45°C 
plates were transferred to LB2 agar plates with chloramphenicol for ON incubation at 37°C (Day 3). The plates 
from days 2 and 3 were then used for inoculation of liquid medium (Day 4); 1 colony per 55°C, 45°C and 37°
plate was transferred to LB2 medium with xylose, glucose and chloramphenicol for ON incubation at 55°C, 45°C 
and 37°C respectively, while 1 extra colony per 45°C plate was transferred to the same medium for overnight 
incubation at 42°C. B. Results of the targeting experiment showing OD600 measurements from cultures of wild -
type ET 138 transformed with the 3 different pyrF targeting cas9sp constructs, the non-targeting cas9sp construct 
and pNW33n. The growth of the cells with the pyrF targeting constructs is greatly affected at 37°C, which is not 
observed for cells containing the non-targeting constructs. 
In line with the in vitro assay data, the aforementioned results indicate that the 
designed spCas9 system  is active at 37°C, but is inactive and does not introduce lethal SDBs 
to the ET 138 genome at temperatures above 42°C. It also indicates that the NHEJ system in 
ET 138 is inactive at 37°C or not active enough to counteract the spCas9 activity. In 
addition, the sequencing results of the pWUR_Cas9sp2 construct revealed the deletion of 7 
nucleotides near the 3’ end of the Ppta (Figure S2). Nonetheless, the results of the targeting ex-
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periment support our hypothesis that the uncharacterized nature of the Ppta, and possibly 
the extra nucleotides at the 5’ end of the sgRNA module, do not hinder the targeting 
efficiency of spCas9. Moreover, the truncated Ppta of the pWUR_Cas9sp2 construct 
clearly expresses enough sgRNA molecules and the observed 7-nucleotides long deletion has 
no impact to the targeting efficiency of the corresponding spCas9/sgRNA complex. 
The latter two observations reveal that our system tolerates a certain level of flexibility in 
the 5`-extension of the sgRNA molecule.
EFFICIENT GENE DELETION USING A HR-CRISPR-CAS9 COUNTER-SELECTION 
SYSTEM
Taking into account the results described so far, we decided to develop a Cas9-based editing 
system for ET 138 exploiting its efficient homologous recombination mechanism15 and the 
temperature-induced spCas9 activity at 37°C. The new experimental setup consists of a single 
plasmid that combines the recombination template and the spCas9- and sgRNA-expressing 
modules. Providing the cells with the appropriate plasmid-borne editing template at 55°C and 
then inducing the expression of active spCas9 at 37°C through a sequential culturing process, 
is expected to form a powerful homologous recombination and counter-selection system.  
To generate a pyrF deletion mutant, pWUR_Cas9sp1 was selected as the pyrF-
targeting vector for further experiments, which was always compared to the non-tar geting 
control pWUR_Cas9nt. To both vectors, we added a fusion of the two pyrF-flanks (each 1kb), 
creating the pWUR_Cas9nt_hr and pWUR_Cas9sp1_hr vectors (i.e. hr, for homologous 
recombination) (Figure 3A). After transforming the 4 constructs (2 with flanks and 2 withou 
flanks) into ET 138 ΔldhL ΔsigF at 55°C, one verified transformant per construct was 
inoculated into TVMY selection medium containing xylose, glucose and supplemented with 
uracil (TVMYxgu) to complement the auxotrophy in case of successful pyrF deletion. After 
growth at 55°C for 24 hours, cells were sequentially transferred every 24 hours to fresh media 
while gradually lowering the culturing temperature from 55°C to 37°C, with an intermediate 
transfer at 45°C. After 3 more transfers at 37°C to allow for efficient spCas9-counter-
selection, cells were transferred back to 55°C with an intermediate transfer at 45°C, allowing 
for gradual adjustment of their metabolism. As expected, PCR on genomic DNA from the 
pWUR_Cas9nt and pWURCas9_sp1 cultures showed no pyrF knockout bands at any 
culturing temperature due to the lack of homologous recombination template in the constructs. 
In line with the initial in vivo tests, pWURCas9_sp1 cultures at 37°C showed almost no 
growth, while the pWUR_Cas9nt cultures at all the temperatures showed the expected growth
Figure 3. Schem atic representation of the different hom ologous recombination andspCas9-m ediated m utations
described in this study. The first single cross over event (SCO) can occur by insertion of the editing plasm id into
the chrom osom e either through the upstream hom ologous region (UHR)-as depicted here- or through the
downstream hom ologous region (DHR). A. Gene deletion. A scar-less, m arkerless pyrF gene deletion was
established after insertion of the editing vector into the chrom osom e via hom ologous recom bination with the
plasm id-borne editing tem plate (2 × 1 kb flanks,im m ediately flanking the pyrF gene and thus rem oving it from
start to stop codon), after which a second SCO event results in either wildtype revertants or edited cells. The
spCas9 targeting of the wild-type cells acts as counterselection for the pyrF mu tants. (B) Gene knockout via
insertion of stop codons and a restriction site. The followed process was sim ilar to the gene deletion described
above. The hsdR restriction gene was inactivated by inserting stop codons and a restriction site between codons
212 and 221 that were contained in a 2 kb HR fragm ent that expands 289 bp upstream and 1.65 kb downstream
from  the start codon of thehsdR gene on the genom e of the ET 138. Between the two stop codons, an EcoRV
restriction site was added, generating a fram e shift and facilitating the screening process. The spacer was designed
to target the original sequence without stop codons and restriction site. (C) Gene knock-in. The followed process
was sim ilar to the gene deletion and gene knockout processes described above. The ldhL gene was reinserted into
m utant strain ET 138 ΔldhL ΔsigF. This was achieved by adding the original ldhL gene sequence between 2 × 1
kb HR flanks. The spacer was designed to target the area between the ldhL stop codon and the beginning of the
adjacent rhoindependent transcriptional term inator. On the HR flanks, the region between the ldhL stop codon and
its rho-independent transcriptional term inator was inverted, avoiding the spCas9 targeting of edited cells. 
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sequencing results of the pWUR_Cas9sp2 construct revealed the deletion of 7 nucleotides 
near the 3’ end of the Ppta (Figure S2). The results of the targeting experiment though support 
our hypothesis that the uncharacterized nature of the Ppta, and possibly the extra nucleotides 
at the 5’ end of the sgRNA module, do not hinder the targeting efficiency of spCas9. 
Moreover, thetruncated Ppta of the pWUR_Cas9sp2 construct clearly expresses enough 
sgRNA molecules and the observed 7-nucleotides long deletion has no impact to the 
targeting efficiency of the corresponding spCas9/sgRNA complex. The latter two 
observations reveal that our system tolerates a certain level of flexibility in the 5`-
extension of the sgRNA molecule.    
EFFICIENT G ENE DELETIO N USING A H R-CRISPR-CAS9 CO UNTER-SELECTIO N 
SYSTEM 
Taking into account the results described so far, we decided to develop a Cas9-
based editing system for ET 138 exploiting its efficient homologous recombination 
mechanism15 and the temperature-induced spCas9 activity at 37°C. The new experimental 
setup consists of a single plasmid that combines the recombination template and the 
spCas9- and sgRNA-expressing modules. Providing the cells with the appropriate 
plasmid-borne editing template at 55°C and then inducing the expression of active 
spCas9 at 37°C through a sequential culturing process, is expected to form a powerful 
homologous recombination and counter-selection system.  
To generate a pyrF deletion mutant, pWUR_Cas9sp1 was selected as the pyrF-
targeting vector for further experiments, which was always compared to the non-targeting 
control pWUR_Cas9nt. To both vectors, we added a fusion of the two pyrF-flanks (each 
1kb), creating the pWUR_Cas9nt_hr and pWUR_Cas9sp1_hr vectors (i.e. hr, for 
homologous recombination) (Figure 3A). After transforming the 4 constructs (2 with flanks 
and 2 without flanks) into ET 138 ΔldhL ΔsigF at 55°C, one verified transformant per 
construct was inoculated into TVMY selection medium containing xylose, glucose and 
supplemented with uracil (TVMYxgu) to complement the auxotrophy in case of successful 
pyrF deletion. After growth at 55°C for 24 hours, cells were sequentially transferred every 
24 hours to fresh media while gradually lowering the culturing temperature from 55°C to 37°
C, with an intermediate transfer at 45°C. After 3 more transfers at 37°C to allow for efficient 
spCas9-counter-selection, cells were transferred back to 55°C with an intermediate transfer 
at 45°C, allowing for gradual adjustment of their metabolism. As expected, PCR on 
genomic DNA from the pWUR_Cas9nt and pWURCas9_sp1 cultures showed no pyrF 
Figure 3. Schematic representation of the different hom logous recombination andspCas9-mediated mutation s 
described in this study. The first single cross over event (SCO) can occur by insertion of the editing plasmid into the 
chromosome either through the upstream homologous region (UHR) -as depicted here- or through the downstream 
homologous region (DHR). A. Gene deletion. A scarless, markerless pyrF gene deletion was established after 
insertion of the editing vector into the chromosome via homologous recombination with the plasmid-borne editing 
template (2 × 1 kb flanks, immediately flanking the pyrF gene and thus removing it from start to stop codon), after 
which a second SCO event results in either wild-type revertants or edited cells. The spCas9 targeting of the wild-
type cells acts as counter-selection for the pyrF mutants. (B) Gene knockout via insertion of stop codons and a 
restriction site. The followed process was similar to the gene deletion described above. The hsdR restriction gene 
was inactivated by inserting stop codons and a restriction site between codons 212 and 221 that were contained in a 
2 kb HR fragment that expands 289 bp upstream and 1.65 kb downstream from the start codon of the hsdR gene on 
the genome of the ET 138. Between the two stop codons, an EcoRV restriction site was added, generating a frame 
shift and facilitating the screening process. The spacer was designed to target the original sequence without stop 
codons and restriction site. (C) Gene knock-in. The followed process was similar to the gene deletion and gene 
knockout processes described above. The ldhL gene was reinserted into mutant strain ET 138 ΔldhL ΔsigF. This 
was achieved by adding the original ldhL gene sequence between 2 × 1 kb HR flanks. The spacer was designed to 
target the area between the ldhL stop codon and the beginning of the adjacent rho-independent transcriptional 
terminator. On the HR flanks, the region between the ldhL stop codon and its rho-independent transcriptional 
terminator was inverted, avoiding the spCas9 targeting of edited cells. 
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for ET 138 culture. PCR on genomic DNA from the  liquid cultures containing the vectors 
with pyrF flanks showed the absence of  k, but very strong pyrF knockout bands for 
the pWUR_Cas9sp1_hr cultures for the same culturing steps mentioned above (Figure 
4A). The striking difference in the density of the knockout bands between the 
targeting pWUR_Cas9sp1_hr and the non-targeting pWUR_Cas9nt_hr cultures 
indicates successful spCas9 activity and pyrF-targeting by the 
pWUR_Cas9sp1_hr construct. It furthermore indicates that the counter-selection 
activity of spCas9 is already efficient from the first culturing step at 
37°C. Growth of the pWUR_Cas9nt_hr cultures was similar to the control at 
all temperatures, while the pWUR_Cas9sp1_hr cultures showed poor growth in the first 
2 culturing steps at 37°C, but the growth was reconstituted from the 3rd culturing step at 37°
C onwards to control levels (Figure S4). After temperature up shift, colony PCR of the 
55°C colonies showed that 5 out of 10 tested pWUR_Cas9sp1_hr colonies were pure 
pyrF deletion mutants, i.e. an editing efficiency of 50% for our system (data not 
shown). The correct mutations were also verified by sequencing. None of 
the 10 tested pWUR_Cas9nt_hr colonies (non-targeting control) were pyrF deletion 
mutants demonstrating functional spCas9-targeting. 
To improve the efficiency and speed of the system, we repeated the process for the 
pWUR_Cas9sp1_hr-containing strain and reduced the number of culturing steps at 37°C from 
4 to 1 while keeping the culturing time of each step in a window between 8 and 16 hours. 
Moreover, we used 3 different media in order to observe possible medium-dependent 
variations in the efficiency of the system: TVMY selection medium supplemented with 
xylose, glucose and uracil (TVMYxgu), TVMY selection medium supplemented with xylose, 
glucose but not with uracil (TVMYxg) and LB2 medium supplemented with xylose and 
glucose (LB2xg). After the final culturing step at 55°C, cells were plated on selective agar of 
the corresponding medium, supplemented with uracil. Colony PCR on 10 randomly selected 
colonies for each medium and construct showed that from the culturing process on 
TVMYxgu medium 9 out of 10 colonies were pure pyrF deletion mutants colonies (Figure 
4B). From the process with TVMYxg medium, 4 of the checked colonies were pure pyrF 
deletion mutants, proving the efficiency of the counter-selection tool even in the presence of 
an auxotrophy barrier (Figure 4B). The process with the LB2xg medium was repeated twice, 
with 2 different pWUR_Cas9sp1_hr containing ET 138 clones. Surprisingly, all the checked 
colonies from the LB2 medium process (40 in total) contained the wild type pyrF gene (data 
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knockout bands at any culturing temperature due to the lack of homologous recombination 
template in the constructs. In line with the initial in vivo tests, pWURCas9_sp1 cultures at 
37°C showed almost no growth while the pWUR_Cas9nt cultures at all the temperatures 
showed the expected growth for ET 138 culture. PCR on genomic DNA from the liquid 
cultures containing the vectors with pyrF flanks showed the absence of knockout bands for 
the pWUR_Cas9nt_hr cultures from the first culturing step at 37°C onwards, but very 
strong pyrF knockout bands for the pWUR_Cas9sp1_hr cultures for the same 
culturing steps mentioned above (Figure 4A). The striking difference in the density 
of the knockout bands between the targeting pWUR_Cas9sp1_hr and 
the non-targeting pWUR_Cas9nt_hr cultures indicates successful spCas9 
activity and pyrF-targeting by the pWUR_Cas9sp1_hr construct. It 
furthermore indicates that the counter-selection activity of spCas9 is already 
efficient from the first culturing step at 37°C. Growth of the 
pWUR_Cas9nt_hr cultures was similar to the control at all temperatures, 
while the pWUR_Cas9sp1_hr cultures showed poor growth in the first 2 culturing 
steps at 37°C, but the growth was reconstituted from the 3rd culturing step at 37°C 
onwards to control levels (Figure S4). After temperature-upshift, colony PCR of the 55°C 
colonies showed that 5 out of 10 tested pWUR_Cas9sp1_hr colonies were pure pyrF 
deletion mutants, i.e. an editing efficiency of 50% for our system (data not shown). The 
correct mutations were also verified by sequencing. None of the 10 tested 
pWUR_Cas9nt_hr colonies (non-targeting control) were pyrF deletion 
mutants demonstrating functional spCas9-t argeting. 
To improve the efficiency and speed of the system, we repeated the process for 
the pWUR_Cas9sp1_hr-containing strain and reduced the number of culturing steps at 37°C 
from 4 to 1 while keeping the culturing time of each step in a window between 8 and 16 
hours. Moreover, we used 3 different media in order to observe possible medium-dependent 
variations in the efficiency of the system: TVMY selection mediu m 
supplemented with xylose, glucose and uracil (TVMYxgu), TVMY selection 
medium supplemented with xylose, glucose but not with uracil (TVMYxg) and 
LB2 medium supplemented with xylose and glucose (LB2xg). After the final 
culturing step at 55°C, cells were plated on selective agar of the corresponding 
medium, supplemented with uracil. Colony PCR on 10 randomly selected colonies 
for each medium and construct showed that from the culturing process on 
TVMYxgu medium 9 out of 10 colonies were pure pyrF deletion mutants 
Figure 4. A. Agarose gel electrophoresis showing the results from PCR on the genomic DNA of a ET 138 ΔldhL 
ΔsigF culture transformed with pWUR_Cas9sp1_hr and sequentially transferred to different temperatures 
(following the depicted temperature sequence) for detection of pyrF deletion mutants in the culture mixture. The 
pyrF deletion mutant band appears at the 1 st 37°C culturing step (Lane 3) onwards. The last 2 lanes are the 
negative (wild-type) and positive (ΔpyrF) controls, that correspond to 2.9 kb and 2.1 kb long DNA fragments 
respectively. B. Agarose gel electrophoresis showing the resulting products from colony PCR on colonies 
transformed with pWUR_Cas9sp1_hr for the detection of deletion mutants. 9 out of the 10 tested colonies 
(S.C.#1 to S.C.#10) that resulted from the 3-day long editing process in TVMYxgu (TVMY supplemented with 
xylose, glucose and uracil) medium were deletion mutants. 4 out of the 10 tested colonies (S.C.#11 to S.C.#20) 
that resulted from the 3-day long editing process in TVMYxg (TVMY supplemented with xylose and glucose) 
medium were deletion mutants. The last 2 lanes are the negative (wild-type) and positive (ΔpyrF) controls, 
respectively.
not shown). At this moment it is unclear what causes this difference between the LB2xg 
medium  and the 2 types of TVMY media and this will be addressed in future research. To 
retain spCas9-activity, antibiotics were added in all steps.  To allow for subsequent metabolic 
engineering steps, however, plasmid curing is required. After transferring a sequence-verified 
pyrF deletion mutant twice in TVMY medium without antibiotics cells were plated on 
TVMY plates without antibiotics.  Colony PCR with plasmid-specific primers showed that all 
tested colonies had lost the plasmid. Finally, we verified the 5-FOA sensitivity and the uracil 
auxotrophy of 2 ET 138 ΔldhL ΔsigF ΔpyrF cultures that originated from 2 of the tested 
colonies ET 138 (Figure S5).  
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B. smithii ET138 ΔldhL ΔsigF cells were transformed with the new vector and sequentially 
cultured as before, gradually lowering the temperature from 55°C to 37°C, with an 
intermediate transfer at 45°C, and then back up to 55°C. The duration of each culturing step 
was within a window of 8 to 16 hours. Moreover, we used 2 types of selection media, LB2xg 
and TVMYxg. Five transformants per medium were subjected to colony PCR, after which 
the PCR fragments were digested with EcoRV. All colonies from the LB2-culturing process 
were successfully modified (Figure 5A) giving 100% editing efficiency, whereas only 2 of 
the colonies from the TVMY process were modified giving 40% editing efficiency (Figure 
5B). This is in contrast with the result from the pyrF deletion process, where there were no 
modified colonies resulting from the LB2-culturing process. This suggests that the selection 
of culturing medium influences the efficiency of our editing system in a variable and gene-
specific manner. Plasmid curing was performed as before and the correct mutations were 
verified by sequencing. 
Figure 5. A. Agarose gel electrophoresis showing the resulting products from colony PCR on ET 138 
colonies transformed with pWUR_Cas9spR_hr for the detection of hsdR knock-out mutants from the 3-day 
long editing process in LB2xg med ium. The 2.75 kb PCR fragments resulting after using genome-specific 
primers (Lanes 1, 3, 5, 7, 9) were digested with the EcoRV restriction enzyme. Each digestion mixture 
was loaded next to its corresponding undigested PCR-fragment (Lanes 2, 4, 6, 8, 10). All the checked 
colonies were shown to be knock-out mutant cells as the restriction digestion gave the expected bands of 
1.1, 1.05 and 0.6 kb. B. Agarose gel electrophoresis showing the resulting products from colony PCR 
on ET 138 colonies transformed with pWUR_Cas9spR_hr for the detection of hsdR knock-out mutants 
from the 3-d ay long editing process in TVMYxg medium. The 2.75 kb PCR-fragments resulting after using 
genome-specific primers (Lanes 1, 3, 5, 7, 9) were digested with the EcoRV restriction enzyme. Each 
digestion mixture was loaded next to its corresponding undigested PCR-fragment (Lanes 2, 4, 6, 8, 10). For 
the 2 colonies comprised of knock-o ut mutant cells (Lanes 1-2 and 3-4) the restriction digestion gives the 
expected bands of 1.1, 1.05 and 0.6 kb. For the 3 non-edited colonies comprised of wild-type cells (Lanes 5-6, 
7-8, 9-10), the restriction digestion gives the expected bands of 2.15 kb and 0.6 kb. 
We confirmed the lack of a functional R-M system in the newl y developed ET 138 ΔldhL
ΔsigF ΔhsdR strain by successfully transforming the plasmid-cured cells wi th vector pG2K 
(Table S2).[154] In previous attempts we did not succeed in transforming this vector 
into other (hsdR+) ET 138 strains as it contains the aforementioned methylation 
EXPANDING THE TOOLBOX: KNOCKING OUT THE TYPE-I RM SYSTEM  
To increase the potential of ET 138 as platform organism for the production of green 
chemicals we aimed to improve its transformation efficiency. ET 138 has a type I Restriction-
Modification (R-M) system. Methylation analysis of the PacBio genome sequencing data 
showed the existence of the single motif “Cm6AGNNNNNNTGT/ACm6ANNNNNNCTG” 
with N6-methyladenine (m6A) modifications (unpublished data). Our attempts to transform 
different pNW33n-based constructs containing one or multiple copies of this motif were 
unsuccessful or gave 3-orders of magnitude lower transformation efficiencies compared to the 
constructs of the same size that do not contain the aforementioned motif. We decided to 
knock out the hsdR restriction gene of the B. smithii ET138 type I R-M system, expecting to 
overcome the transformation obstacle and further expand its genetic accessibility.
For knocking out the hsdR gene, we followed a different approach compared to the 
pyrF deletion process in order to be able to evaluate the efficiency of the Cas9-based counter-
selection editing method in the introduction of limited-sized modifications to the genome. 
Between the origin of replication (ori) and the cas9sp gene of the pWUR_Cas9nt vector, we 
introduced a 1,920 bp long HR-fragment that resulted from the fusion of 2 separate 
fragments; one that is comprised of the 924 bp upstream of codon 212 of the hsdR gene 
(including the 2 first nucleotides of the codon) and one that is comprise d of the 986 bp 
downstream of codon 221 of the hsdR gene. In this HR-fragment we replaced the 25 nt long 
part between codons 212 and 221 of the hsdR gene, including the last nucleotide of codon 
212, with an 8 nt long sequence comprised of 2 stop codons and the EcoRV restriction site, 
generating a frame shift and facilitating the screening process (Figure 3B). Since the hsdR 
gene is 2952 nucleotides (984 codons) long, only a fifth of it will be translated due the 
introduction of the stop codons. We also introduced a spacer in the sgRNA module for spCas9 
targeting of the unmodified genomes, completing the B. smithii ET138 ΔldhL ΔsigF cells 
were transformed with the new vector and sequentially cultured as before, gradually lowering 
the temperature from 55°C to 37°C, with an intermediate transfer at 45°C, and then back up to 
55°C. The duration of each culturing step was within a window of 8 to 16 hours. Moreover, 
we used 2 types of selection media, LB2xg and TVMYxg. Five transformants  per medium 
were subjected to colony PCR, after which the PCR fragments were digested with  EcoRV. 
All colonies from the LB2-culturing process were successfully modified   (Figure 5A) giving 
100% editing efficiency, whereas only 2 of the colonies from the TVMY process were 
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added in all steps. To allow for subsequent metabolic engineering steps, however, plasmid 
curing is required. After transferring a sequence-verified pyrF deletion mutant twice i n
TVMY medium without antibiotics cells were plated on TVMY plates without antibiotics. 
Colony PCR with plasmid-specific primers showed that all 8 tested colonies had lost the 
plasmid. Finally, we verified the 5-FOA sensitivity and the uracil auxotrophy of 2 ET 138 
ΔldhL ΔsigF ΔpyrF cultures that originated from 2 of the teste d colonies ET 138 (Figure S5).  
EXPANDING TH E TO O LBO X: K NO CK ING O UT TH E TYPE-I RM SYSTEM  
To increase the potential of ET 138 as platform organism for the production of green chemicals
we aimed to improve its transformation efficiency. ET 138 has a type I Restriction-Modification 
(R-M) system. Methylation analysis of the PacBio genome sequencing data 
showed the existence of the single motif “Cm6AGNNNNNNTGT/
ACm6ANNNNNNCTG” with N6-methyladenine (m6A) modifications (unpublished 
data). Our attempts to transform different pNW33n-based constructs containing one or 
multiple copies of this motif were unsuccessful or gave 3-orders of magnitude lower 
transformation efficiencies compared to the constructs of the same size that do not contain 
the aforementioned motif. We decided to knock out the hsdR restriction gene of the 
B. smithii ET138 type I R-M system, expecting to overcome the transformation
obstacle and further expand its genetic accessibility.
For knocking out the hsdR gene, we followed a different approach compared to the
pyrF deletion process in order to be able to evaluate the efficiency of the Cas9-based 
counter-selection editing metho d in the introduction of limited-sized modifications to 
the genome. Between the origin of replication (ori) and the cas9sp gene of the 
pWUR_Cas9nt vector, we introduced a 1,920 bp long HR-fragment that resulted from the 
fusion of 2 separate fragments; one that is comprised of the 924 bp upstream of codon 212 
of the hsdR gene (including the 2 first nucleotides of the codon) and one that is comprise d
of the 986 bp downstream of codon 221 of the hsdR gene. In this HR-fragment we replaced
the 25 nt long part between codons 212 and 221 of the hsdR gene, including the last 
nucleotide of codon 212, with an 8 nt long sequence comprised of 2 stop codons a nd
the EcoRV restriction site, generating a frame shift and facilitating the screening 
process (Figure 3B). Since the hsdR gene is 2952 nucleotides (984 codons) long, 
only a fifth of it will be translated due the introduction of the stop codons. We also 
introduced a spacer in the sgRNA module for spCas9 targeting of the unmodified 
genomes, completing the construction of the pWUR_Cas9spR_hr editing vector.  
modified giving 40% editing efficiency (Figure 5B). This is in contrast with the result from 
the pyrF deletion process, where there were no modified colonies resulting from the 
LB2-culturing process. This suggests that the selection of culturing medium 
influences the efficiency of our editing system in a variable and gene-specific manner. 
Plasmid curing was performed as before and the correct mutations were verified by 
sequencing.
Figure 5. A. Agarose gel electrophoresis showing the resulting products from colony PCR on ET 
138 colonies transformed with pWUR_Cas9spR_hr for the detection of hsdR knock-out mutants from the 
3-day long editing process in LB2xg medium. The 2.75 kb PCR fragments resulting after using genome-
specific primers (Lanes 1, 3, 5, 7, 9) were digested with the EcoRV restriction enzyme. Each
digestion mixture was loaded next to its corresponding undigested PCR-fragment (Lanes 2, 4, 6, 8,
10). All the checked colonies were shown to be knock-out mutant cells as the restriction digestion gave
the expected bands of 1.1, 1.05 and 0.6 kb. B. Agarose gel electrophoresis showing the resulting
products from colony PCR on ET 138 colonies transformed with pWUR_Cas9spR_hr for the detection of
hsdR knock-out mutants from the 3-d ay long editing process in TVMYxg mediu .m. The 2.75 kb
PCR-fragments resulting after using genome-specific primers (Lanes 1, 3, 5, 7, 9) were digested with
the EcoRV restriction enzyme. Each digestion mixture was loaded next to its corresponding undigested PCR-
fragment (Lanes 2, 4, 6, 8, 10). For the 2 colonies comprised of knock-o ut mutant cells
(Lanes 1-2 and 3-4) the restriction digestion gives the expected bands of 1.1, 1.05 and 0.6 kb. For the 3
non-edited colonies comprised of wild-type cells (Lanes 5-6, 7-8, 9-10), the restriction digestion gives the
expected bands of 2.15 kb and 0.6 kb.
We confirmed the lack of a functional R-M system in the newly developed ET 138 
ΔldhL ΔsigF ΔhsdR strain by successfully transforming the plasmid-cured cells with vector 
pG2K (Table S2)51. In previous attempts we did not succeed in transforming this vector into 
other (hsdR+) ET 138 strains as it contains the aforementioned methylation  motif in its 
antibiotic resistance marker gene, the kanamycin nucleotidyltransferase (aadA) gene derived 
from Geobacillus stearothemophilus. This way we added a new antibiotic resistance marker 
to the toolbox of ET 138, and we confirmed that the ET 138 ΔldhL ΔsigF ΔhsdR strain can be 
utilized for the expansion of the genetic parts toolbox. 
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Figure 6. Agarose gel electrophoresis showing the resulting products from colony PCR on the colonies from the 
3-day long ldhL knock-in culturing processes in LB2 medium, using ET 138 ΔldhL ΔsigF ΔhsdR cells 
transformed with the pWUR_Cas9spKI_hr1 vector. For the colony PCR genome-specific primers BG8145 and 
BG8146 were used with the expected size of the PCR fragment for the knock-in mutations being 3.2 kb (equal to 
the size of the PCR fragment for the wild type cells). The expected size of the PCR fragment for the knock-out 
(non-edited) mutants was 2.3 kb. A. When the 45°C culturing step was performed, the process resulted in 4 out of 
the 20 tested colonies having the knock-in genotype (20% editing efficiency), 15 colonies with mixed knock-in 
and wild-type genotype and only 1 colony with wild-type genotype. B. When the 45°C culturing step was omitted, 
the process resulted in only 1 out of the 20 tested colonies having the knock-in genotype, 11 colonies with mixed 
genotype and 8 colonies with the wild-type genotype.
Two versions were constructed of a pWUR_Cas9-based vector that target the ET 138 
ΔldhL ΔsigF ΔhsdR genome at the same position between the ldhL stop codon and the 
beginning of the adjacent rho-independent transcriptional terminator. HR was facilitated with 
1kb flanks (pWUR_Cas9spKI_hr1) or 0.75kb flanks (pWUR_Cas9spKI_hr2). For both 
versions, the region between the ldhL stop codon and its rho-independent transcriptional 
terminator was inverted, avoiding spCas9 targeting (Figure 3C). The region between the start 
and stop codon was provided with the wild-type ldhL sequence to allow its knocking in. 
ET138 ΔldhL ΔsigF ΔhsdR was transformed with the 2 pWUR_Cas9spKI_hr versions and the 
transformants were sequentially cultured as described before, gradually lowering the 
temperature from 55 to 37°C, with or without an intermediate transfer at 45°C, an then back 
up to 55°C. Each culturing step was within a window of 8 to 16 hours. Again, we used 2 types 
of selection media, LB2xg and TVMYxg. The colony PCR results of the TVMY culturing pro
the temperature from 55 to 37°C, with or without an intermediate transfer at 45°C, and 
then back up to 55°C. Each culturing step was within a window of 8 to 16 hours. Again, we 
used 2 types of selection media, LB2xg and TVMYxg. The colony PCR results of the 
TVMY culturing processes showed that none out of the tested colonies had the knock-in 
genotype. The colony PCR results of the LB2 culturing processes with the 
pWUR_Cas9spKI_hr1 transformant showed that with the additional culturing step at 45°
C, 4 out of the 20 tested colonies had the knock-in genotype (20% editing efficiency), 
15 colonies had a mixed knock-in/wild type genotype and only 1 colony had the 
wild-type genotype (Figure 6A). When the culturing step at 45°C was omitted, only 1 
out of the 20 tested colonies had the knock-in genotype, 11 colonies had the mixed 
genotype and 8 colonies had the wild-type genotype(Figure 6B). The colony PCR 
results of the LB2 culturing processes with the pWUR_Cas9spKI_hr2 transformant 
showed that with the additional culturing step at 45°C, 1 out of the 20 tested 
colonies had the knock-in genotype (5% editing efficiency), 7 colonies had the 
mixed knock-in and wild-type genotype, and only 1 colony had the wild-type genotype 
(Figure 6C). When the culturing step at 45°C was omitted none of the 20 tested colonies 
had the knock-in genotype, only 6 colonies had the mixed genotype while the remaining 
14 colonies had the wild-type genotype (Figure 6D). This was the first time that we 
observed colonies with mixed genotypes using our editing approach. The appearance 
of such colonies could be explained by relatively inefficient Cas9 targeting when 
the enzyme is loaded with a suboptimal sgRNA module, as has been described for 
E. coli[155] although the molecular basis for this phenomenon remains elusive.
Alternative sgRNAs may lead to a more stringent counter-selection, thereby
improving the editing efficiency. Additionally, the difference in
recombination efficiency at specific chromosomal sites might influence the editing
efficiency of the tool.[134] In a recent study, that combined dsDNA recombineering
with Cas9-counter-selection, the efficiency of the employed system for insertions
was lower than the efficiency for deletions, while longer homologous regions
lead to higher editing efficiencies.[143] Our results confirm the influence of the HR-
template length, as well as the importance of the culturing period before the induction of
the counter-selection. The editing efficiency of the tool was higher when we emplo yed the
editing construct with the 1 kb HR flanks compared to the editing construct with the
0.75 kb HR flanks (20% vs. 5% efficiency, respectively, Figure 6). Furthermore, we
observed that a culturing period with an additional intermed iate step at 45°C allows for
METABOLIC ENGINEERING USING SPCAS9: KNOCK-IN OF THE LDHL GENE 
Next, we evaluated the applicability of our Cas9-based system in markerless gene 
chromosomal integrations by  knocking into the genome of ET 138 ΔldhL ΔsigF ΔhsdR  the 
942 bp long genomic fragment between the start and the stop codons of the lactate 
dehydrogenase (ldhL) gene. The reconstitution of the lactate production in the resulting ET 
138 ΔsigF ΔhsdR strain would allow for efficient growth under anaerobic conditions, while 
retaining the advantages of a sporulation- and R-M-deficient strain.  
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motif in its antibiotic resistance marker gene, the kanamycin nucleotidyltransferase (aadA) 
gene derived from Geobacillus stearothemophilus. This way we added a new antibiotic 
resistance marker to the toolbox of ET 138, and we confirmed that the ET 138 ΔldhL ΔsigF 
ΔhsdR strain can be utilized for the expansion of the genetic parts toolbox. 
METABO LIC ENG INEERING USING SPCAS9: K NO CK-IN O F TH ELDHL G ENE  
Next, we evaluated the applicability of our Cas9-based system in markerless gene 
chromosomal integrations by knocking into the genome of ET 138 ΔldhL ΔsigF ΔhsdR the 
942 bp long genomic fragment between the start and the stop codons of the lactate 
dehydrogenase (ldhL) gene. The reconstitution of the lactate production in the resulting ET 
138 ΔsigF ΔhsdR strain would allow for efficient growth under anaerobic conditions, while 
retaining the advantages of a sporulation- and R-M-deficient strain.  
Two versions were constructed of a pWUR_Cas9-based vector that target the ET 138 
ΔldhL ΔsigF ΔhsdR genome at the same position between the ldhL stop codon and the 
beginning of the adjacent rho-independent transcriptional terminator . HR was facilitated 
with 1kb flanks (pWUR_Cas9spKI_hr1) or 0.75kb flanks (pWUR_Cas9spKI_hr2). For both 
versions, the region between the ldhL stop codon and its rho-independent transcriptional 
terminator was inverted, avoiding spCas9 targeting (Figure 3C). The region between the 
start and stop codon was provided with the wild-type ldhL sequence to allow its knocking in. 
ET138 ΔldhL ΔsigF ΔhsdR was transformed with the 2 pWUR_Cas9spKI_hr versions 
and the transformants were sequentially cultured as described before, gradually lowering 
Figure 6. Agarose gel electrophoresis showing the resulting products from colony PCR on the colonies from 
the 3-day long ldhL knock-in culturing processes in LB2 medium, using ET 138 ΔldhL ΔsigF ΔhsdR cells 
transformed with the pWUR_Cas9spKI_hr1 vector. For the colony PCR genome-specific primers BG8145 and 
BG8146 were used with the expected size of the PCR fragment for the knock-in mutations being 3.2 kb (equal 
to the size of the PCR fragment for the wild type cells). The expected size of the PCR fragment for the 
knock-out (non-edited) mutants was 2.3 kb. A. When the 45°C culturing step was performed, the process 
resulted in 4 out of the 20 tested colonies having the knock-in genotype (20% editing efficiency), 15 colonies 
with mixed knock-in and wild-type genotype and only 1 colony with wild-type genotype. B. When the 45°C 
culturing step was omitted, the process resulted in only 1 out of the 20 tested colonies having the knock-in 
genotype, 11 colonies with mixed g enotype and 8 colonies with the wild-type genotype.
cesses showed that none out of the tested colonies had the knock-in genotype. The colony 
PCR results of the LB2 culturing processes with the pWUR_Cas9spKI_hr1 transformant 
showed that with the additional culturing step at 45°C, 4 out of the 20 tested colonies had the 
knock-in genotype (20% editing efficiency), 15 colonies had a mixed knock-in/wild type 
genotype and only 1 colony had the wild-type genotype (Figure 6A). When the culturing step 
at 45°C was omitted, only 1 out of the 20 tested colonies had the knock-in genotype, 11 
colonies had the mixed genotype and 8 colonies had the wild-type genotype (Figure 6B). The 
colony PCR results of the LB2 culturing processes with the pWUR_Cas9spKI_hr2 
transformant showed that with the additional culturing step at 45°C, 1 out of the 20 tested 
colonies had the knock-in genotype (5% editing efficiency), 7 colonies had the mixed knock-
in and wild-type genotype, and only 1 colony had the wild-type genotype (Figure 6C). When 
the culturing step at 45°C was omitted none of the 20 tested colonies had the knock-in 
genotype, only 6 colonies had the mixed genotype while the remaining 14 colonies had the 
wild-type genotype (Figure 6D). This was the first time that we observed colonies with mixed 
genotypes using our editing approach. The appearance of such colonies could be explained by 
relatively inefficient Cas9 targeting when the enzyme is loaded with a suboptimal 
sgRNA module, as has been described for E. coli53 although the molecular basis 
for this phenomenon remains elusive. Alternative sgRNAs may lead to a more stringent 
counter-selection, thereby improving the editing efficiency. Additionally, the 
difference in recombination efficiency at specific chromosomal sites might influence the 
editing efficiency of the tool34. In a recent study, that combined dsDNA recombineering with 
Cas9-counter-selection, the efficiency of the employed system for insertions was lower than 
the efficiency  for deletions, while longer homologous regions lead to higher editing 
efficiencies41. Our results confirm the influence of the HR-template length, as well as the 
importance of the culturing period before the induction of the counter-selection. The 
editing efficiency of the tool was higher when we employed the editing construct with the 1 
kb HR flanks compared to the editing construct with the 0.75 kb HR flanks (20% vs. 5% 
efficiency, respectively, Figure 6). Furthermore, we observed that a culturing period with 
an additional intermediate step at 45°C allows for efficient homologous recombination and 
double cross over events to occur, leading to the appearance of the mutants that Cas9 will 
select for. This is in line with the observations in L. reuterii54 and supports that the efficiency 
of our approach to use spCas9 as a counter-selection tool is higher compared to using the 
spCas9 as a tool for induction of the cellular HR mechanism after introduction of targeted DS-
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In the course of our study we showed that spCas9 is not active in vivo above 42°C. This 
observation allowed us to develop an editing system where mutants are constructed via 
homologous recombination events at higher temperatures (>42°C) before Cas9-induced 
counter-selection takes place at 37°C.Crucial factors for obtaining high editing efficiencies is 
to allow for sufficient time for HR at elevated temperatures before starting the spCas9-
based counter-selection, and the length of the HR flanks. Moreover, we 
hypothesize that testing different sgRNA modules may improve the editing efficiency of 
the tool. During our study we observed gene-dependent differences in numbers 
of obtained mutants when repeating the same process using different media. There 
is no obvious link between the editing of a specific gene and the medium used for the 
editing process and this will be subject of further studies. 
The results of the editing approach we developed make our system 
potentially applicable for many interesting model or non-model organisms with an 
active HR mechanism and a growth temperature range covering 37°C to over 
42°C. It is anticipated that the approaches reported here will expand the range 
of organisms for which the powerful Cas9-counter-selection tool can be used, 
thereby greatly increasing engineering throughput for these organisms and 
allowing for both their fundamental study and biotechnological exploitation.  
MATERIALS AND METH O DS 
BACTERIAL STRAINS AND G ROWTH CO NDITIO NS
Strains used in this study are listed in Table S1. All B. smithii strains were routinely cultured 
at 55°C unless stated otherwise. TVMY medium and LB2 medium were used as described 
previously.[117] TVMYxgu is TVMY supplemented with 0.5 g/l xylose, 0.5 g/l glucose and 
50 mg/L uracil. TVMYxg is TVMY supplemented with 0.5 g/l xylose and 0.5 g/l glucose. 
LB2xg is LB2 supplemented with 0.5 g/l xylose and 0.5 g/l glucose. Substrates were added 
separately as 50% autoclaved solutions after autoclavation of the medium. Uracil was added 
as 50 mg/ml filter sterilized solution in 1M NaOH after autoclavation of the medium and 
addition of the substrates. E. coli strains were grown in LB medium at 37°C. For plates, 30 g 
of agar (Difco) per liter of medium was used for B. smithii in all experiments; 15g of agar 
(Difco) per liter of LB was used for E. coli. If required, chloramphenicol was added in 
concentrations of 25 µg/ml for E. coli DH5α, 15 µg/ml for E. coli TG90, and 7 µg/ml for B. 
smithii.  
DBs. In addition, it may be that the stress of the temperature drop increases the efficiency of 
the homologous recombination mechanism.
Next, we attempted to cure the constructed B. smithii ET138 ΔsigF ΔhsdR strain from the 
pWUR_Cas9spKI_hr1 plasmid using the sequential transferring approach in LB2 medium 
without antibiotic at 55°C. However, after the usual 2 transfers none of the tested colonies 
had lost the plasmid. We repeated the same sequential transferring process but raised the 
culturing temperature to 65°C, as the pNW33n replicon might be less stable at elevated 
temperatures. After 2 transfers at 65°C, 1 out of 8 tested colonies was confirmed to be 
plasmid-free by PCR and antibiotic sensitivity and the correct mutations were verified by 
sequencing. Plasmid curing might be simplified in the future by adding to the system an 
sgRNA expressing module with a spacer against the editing plasmid41,55; the module will 
have to either be under the control of a tightly inducible promoter or cloned into a second 
expression vector and transformed into the edited cells in a second transformation round. 
 Finally, evaluation of lactate production in the resulting B. smithii ET138 ΔsigF ΔhsdR strain 
under aerobic, microaerobic and anaerobic conditions showed a complete restoration of 
lactate production to wild-type levels (Table S4).  
 CONCLUSIONS 
In this study, spCas9-based genome editing was applied for the first time to a 
moderate thermophile, establishing a gene deletion, a gene knockout and a gene insertion. 
Major advantage of this system is the requirement of only one plasmid and no inducible or 
highly characterized promoters to drive the spCas9 and sgRNA expression. Additionally, the 
speed and efficiency of the genome editing process of ET 138 has been substantially 
improved compared to the previous lacZ-based counter-selection system. For the three cases 
presented in the present study, it took on average 1 week from transformation to clean 
deletion, knock out or knock in –including the plasmid curing step- with an editing efficiency 
of 90% for the gene deletion, 100% for the gene knock out and 20% for the gene insertion. 
In the course of our study we showed that spCas9 is not active in vivo above 42°C. 
This observation allowed us to develop an editing system where mutants are constructed via 
homologous recombination events at higher temperatures (>42°C) before Cas9-induced 
counter-selection takes place at 37°C. Crucial factors for obtaining high editing efficiencies is 
to allow for sufficient time for HR at elevated temperatures before starting the spCas9-based 
counter-selection, and the length of the HR flanks. Moreover, we hypothesize that testing 
different sgRNA modules may improve the editing efficiency of the tool. During our study we
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efficient homologous recombination and double cross over events to occur, leading to 
the appearance of the mutants that Cas9 will select for. This is in line with the 
observations in L. reuterii 54 and supports that the efficiency of our approach to use 
spCas9 as a counter-selection tool is higher compared to using the spCas9 as a 
tool for induction of the cellular HR mechanism after introduction of targeted 
DSDBs. In addition, it may be that the stress of the temperature drop increases 
the efficiency of the homologous recombination mechanism.  
Next, we attempted to cure the constructedB. smithii ET138 ΔsigF ΔhsdR strain from 
the pWUR_Cas9spKI_hr1 plasmid using the sequential transferring approach in LB2 
medium without antibiotic at 55°C. However, after the usual 2 transfers none of the tested 
colonies had lost the plasmid. We repeated the same sequential transferring process but 
raised the culturing temperature to 65°C, as the pNW33n replicon might be less stable at 
elevated temperatures.[117] After 2 transfers at 65°C, 1 out of 8 tested colonies was 
confirmed to be plasmid-free by PCR and antibiotic sensitivity and the correct mutations 
were verified by sequencing. Plasmid curing might be simplified in the future by adding to 
the system an sgRNA expressing module with a spacer against the editing plasmid;[143, 
157] the module will have to either be under the control of a tightly inducible promoter or 
cloned into a second expression vector and transformed into the edited cells in a second 
transformation round.
Finally, evaluation of lactate production in the resulting B. smithii ET138 ΔsigF
ΔhsdR strain under aerobic, microaerobic and anaerobic conditions showed a complete 
restoration of lactate production to wild-type levels (Table S4).  
 CO NCLUSIO NS 
In this study, spCas9-based genome editing was applied for the first time 
to a moderate thermophile, establishing a gene deletion, a gene knockout and 
a gene insertion. Major advantage of this system is the requirement of only one 
plasmid and no inducible or highly characterized promoters to drive the spCas9 and 
sgRNA expression. Additionally, the speed and efficiency of the genome editing 
process of ET 138 has been substantially improved compared to the previous lacZ-
based counter-selection system. For the three cases presented in the present study, it 
took on average 1 week from transformation to clean deletion, knock out or knock 
in –including the plasmid curing step- with an editing efficiency of 90% for the gene 
deletion, 100% for the gene knock out and 20% for the gene insertion. 
we observed gene-dependent differences in numbers of obtained mutants when repeating the 
same process using different media. There is no obvious link between the editing of a specific 
gene and the medium used for the editing process and this will be subject of further studies. 
The results of the editing approach we developed make our system potentially 
applicable for many interesting model or non-model organisms with an active HR mechanism 
and a growth temperature range covering 37°C to over 42°C. It is anticipated that the 
approaches reported here will expand the range of organisms for which the powerful Cas9-
counter-selection tool can be used, thereby greatly increasing engineering throughput for 
these organisms and allowing for both their fundamental study and biotechnological 
exploitation.  
MATERIALS AND METHODS
BACTERIAL STRAINS AND GROWTH CONDITIONS
Strains used in this study are listed in Table S1. All B. smithii strains were routinely cultured 
at 55°C unless stated otherwise. TVMY medium and LB2 medium were used as described 
previously. TVMYxgu is TVMY supplemented with 0.5 g/l xylose, 0.5 g/l glucose and 50 mg/
L uracil. TVMYxg is TVMY supplemented with 0.5 g/l xylose and 0.5 g/l glucose. LB2xg is 
LB2 supplemented with 0.5 g/l xylose and 0.5 g/l glucose.  Substrates were added separately 
as 50% autoclaved solutions after autoclavation of the medium. Uracil was added as 50 mg/
ml filter sterilized solution in 1M NaOH after autoclavation of the medium and addition of 
the substrates. E. coli strains were grown in LB medium at 37°C. For plates, 30 g of agar 
(Difco) per liter of medium was used for B. smithii in all experiments; 15 g of agar (Difco) 
per liter of LB was used for E. coli. If required, chloramphenicol was added in concentrations 
of 25 µg/ml for E. coli DH5α, 15 µg/ml for E. coli TG90, and 7 µg/ml for B. smithii.  
GENOMIC DNA ISOLATION, TRANSFORMATIONS, COLONY PCR, SEQUENCE 
AND PHENOTYPIC VERIFICATION
Genomic DNA from B. smithii strains was isolated using the MasterPure™ Gram Positive 
DNA Purification Kit (Epicentre). Heat shock transformation of E. coli strains was performed 
according to the NEB supplier’s protocol. Transformation of B. smithii strains was performed 
as described previously15. Plasmids for transforming B. smithii were extracted from E. coli via 
maxiprep isolation (Genomed Jetstar 2.0). For transformation of B. smithii strains, 1 μg DNA 
was used unless stated otherwise in the plasmid construction sections.   
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obtained from NEB. Purification of PCR products was performed after running them on a 
0.8% agarose gel using the Zymoclean™ Gel DNA Recovery Kit. To test the PxynA 
promoter, a DNA fragment comprised of the PxynA and the lacZ gene was synthesized by 
GeneArt and inserted into pNW33n using digestion with BspHI and KpnI and subsequent 
ligation and cloning into E. coli DH5α, creating plasmid pWUR_lacZ. The PxynA sequence 
was used exactly as originally described,[146] using the sequence until the start codon of the 
corresponding gene in the original host.  
For the construction of the basic, modular pWUR_Cas9nt construct, a synthetic gene 
string was synthesized by GeneArt containing the elements depicted in Figure 1B except the 
PxynA promoter. PxynA was amplified from pWUR_lacZ using primers BG6538 and BG6541. 
Primer BG6541 replaces the final 6 bp of PxynA by an XbaI site, changing the final -1 to -6 
sequence from GTAAGA to TCTAGA and keeping the total length the same as in the 
original promoter. Primer BG6538 adds a BspHI site on the start of the PxynA. The entire 
synthesized spCas9 module without promoter for spCas9 was amplified using primers 
BG6542 and BG6543, keeping the XbaI and HindIII sites already present in the module. 
Subsequently, vector pNW33n was digested with BspHI and HindIII, the PxynA PCR-product 
with XbaI and BspHI and the spCas9 module PCR-product with XbaI and HindIII. The three 
elements were ligated in a 3-point ligation and cloned into E. coli TG90. Plasmid was 
extracted and the correct sequence was verified by sequencing, creating plasmid 
pWUR_Cas9nt (Figure 2B). For transformation of this construct to B. smithii strains, 0.1 μg 
DNA was used rather than the standard 1 μg in order to more precisely determine the 
transformation efficiencies together with the targeting constructs described in the next 
section. The resulting CFUs were around 3,000 and 200 per μg DNA for the ΔldhL ΔsigF
and wild-type strain, respectively. Control transformations with empty vector pNW33n 
yielded CFUs of 10,000 and 1,800, respectively.  
To insert the 3 different targeting spacers into pWUR_Cas9nt (which contains a non-
targeting spacer), 3 sets of oligos were annealed to create the 3 spacers, after which the 
annealed spacers were inserted into the construct as follows. Oligo sets were BG6017 and 
BG6021 for spacer 1, BG6018 and BG6022 for spacer 2, BG6019 and BG6023 for spacer 3. 
Each set was annealed by adding 5 μl 10 mM oligo sets together with 10 μl NEB buffer 2.1 
and 74 μL MQ water. Mixtures were heated to 94°C for 5 min and gradually cooled down to 
37°C at 0.03°C/sec using a PCR machine. Annealed oligos and plasmid pWUR_Cas9nt were 
digested with BspEI and BsmBI (NEB). First, BspEI digestion was performed at 37°C 
for 15 min, after which BsmBI was added and the mixture was further incubated at
Potential B. smithii ET138 ΔldhL ΔsigF ΔpyrF colonies were randomly selected and 
subjected to colony PCR using the InstaGene™ Matrix (BIORAD), Taq DNA Polymerase 
(NEB) and the genome specific primers BG6420 and BG6421. Potential B. smithii ET138 
ΔldhL ΔsigF ΔhsdR and B. smithii ET138 ΔsigF ΔhsdR ldhL knock-in colonies were 
randomly selected and subjected to colony PCR using the Phire Plant Direct PCR kit 
(ThermoFisher Scientific) and the genome specific primers BG7881, BG7882 and BG8142, 
BG8143 respectively. Purification of PCR products was performed using the Zymoclean™ 
Gel DNA Recovery Kit, after running them on 0.8% agarose gels. The DNA fragments were 
subsequently sent for sequencing to GATC Biotech. The DNA fragments from the potential B. 
smithii ET138 ΔldhL ΔsigF ΔhsdR colonies were subjected to EcoRV (NEB) restriction 
digestion. To evaluate the 5-FOA sensitivity and uracil auxotrophy of B. smithii ET138 ΔldhL 
ΔsigF ΔpyrF sequence confirmed strains, cells were plated on TVMY medium with 30 g/l 
agar and the following additions: a) 2 g/l 5-FOA and 50 mg/l uracil, b) 2 g/l 5-FOA and no 
uracil, d) no 5-FOA and no uracil. To evaluate lactate production from B. smithii ET138 ΔsigF 
ΔhsdR ldhL knock-in cultures, sequence verified cells were grown overnight in TVMY 
medium containing 10 g/l glucose and subsequently transferred to the same medium and 
grown for 24 h, after which L-lactate specific measurements were performed using MegaZyme 
kit K-LATE.
PLASMID CONSTRUCTION
Plasmids and primers used in this study are shown in Table S2 and S3. Q5 polymerase (NEB) 
was used for all PCR reactions for cloning purposes. NEB T4 ligase was used for assembling 
vectors pWUR_lacZ, pWUR_Cas9nt, pWUR_Cas9nt_hr, pWUR_Cas9sp1, 
pWUR_Cas9sp1_hr, pWUR_Cas9sp2 and pWUR_Cas9sp3. The NEBuilder® HiFi DNA 
Assembly Master Mix was used for assembling the pWUR_Cas9spR_hr, 
pWUR_Cas9spKI_hr1 and pWUR_Cas9spKI_hr2 constructs. All the used restriction enzymes 
were obtained from NEB. Purification of PCR products was performed after running them on 
a 0.8% agarose gel using the Zymoclean™ Gel DNA Recovery Kit. To test the PxynA 
promoter, a DNA fragment comprised of the PxynA and the lacZ gene was synthesized by 
GeneArt and inserted into pNW33n using digestion with BspHI and KpnI and subsequent 
ligation and cloning into E. coli DH5α, creating plasmid pWUR_lacZ. The PxynA  sequence 
was used exactly as originally described, using the sequence until the start codon of the 
corresponding gene in the original host.
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G ENO MIC DNA ISO LATIO N, TRANSFO RMATIO NS, CO LO NY PCR, SEQ UENCE 
AND PH ENO TYPIC VERIFICATIO N
Genomic DNA fromB. smithii strains was isolated using the MasterPure™ Gram Positive 
DNA Purification Kit (Epicentre). Heat shock transformation of E. coli strains was performed 
according to the NEB supplier’s protocol. Transformation ofB. smithii strains was performed 
as described previously15. Plasmids for transforming B. smithii were extracted from E. 
coli via ma xiprep isolation (Genome d Jetstar 2.0). For transforma tion ofB. smithii
strains, 1 μg DNA was used unless stated otherwise in the plasm id construction sections.
Potential B. smithii ET138 ΔldhL ΔsigF ΔpyrF colonies were randomly selected and 
subjected to colony PCR using the InstaGene™ Matrix (BIORAD), Taq DNA Polymerase 
(NEB) and the genome specific primers BG6420 and BG6421. PotentialB. smithii ET138 
ΔldhL ΔsigF ΔhsdR and B. smithii ET138 ΔsigF ΔhsdR ldhL knock-in colonies were 
randomly selected and subjected to colony PCR using the Phire Plant Direct PCR kit 
(ThermoFisher Scientific) and the genome specific primers BG7881, BG7882 and BG8142, 
BG8143 respectively. Purification of PCR products was performed using the Zymo clean™ Gel 
DNA Recovery Kit, after running them on 0.8% agarose gels. The DNA fragments were 
subsequently sent for sequencing to GATC Biotech. The DNA fragments from the potentialB. 
smithii ET138 ΔldhL ΔsigF ΔhsdR colonies were subjected to EcoRV (NEB) restriction 
digestion. To evaluate the 5-FOA sensitivity and uracil auxotrophy of B. smithii ET138 
ΔldhL ΔsigF ΔpyrF sequence confirme d strains, cells were plated on TVMY medium
with 30 g/l agar and the following additions: a) 2 g/l 5-FOA and 50 m g/l uracil, b) 2 g/l5-
FOA and no uracil, d) no 5-FOA and no uracil. To evaluate lactate production from B. smithii
ET138 ΔsigF ΔhsdR ldhL knock-in cultures, sequence verified cells were grown overnight in 
TVMY medium containing 10 g/l glucose and subsequently transferred to the same medium 
and grown for 24 h, after which L-lactate specific measurements were performed using 
MegaZyme kit K-LATE.
PLASMID CO NSTRUCTIO N
Plasmids and primers used in this study are shown in Table S2 and S3. Q5 
polymerase (NEB) was used for all PCR reactions for cloning purposes. NEB T4 ligase was 
used for assembling vectors pWUR_lacZ, pWUR_Cas9nt, 
pWUR_Cas9nt_hr, pWUR_Cas9sp1, pWUR_Cas9sp1_hr, pWUR_Cas9sp2 and 
pWUR_Cas9sp3 . The NEBuilder® HiFi DNA Assembly Master Mix 
was used for assembling the pWUR_Cas9spR_hr, pWUR_Cas9spKI_hr1 
and pWUR_Cas9spKI_hr2 constructs. All the used restriction enzymes were 
For the construction of the basic, modular pWUR_Cas9nt construct, a synthetic gene 
string was synthesized by GeneArt containing the elements depicted in Figure 1B except the 
PxynA promoter. PxynA was amplified from pWUR_lacZ using primers BG6538 and BG6541. 
Primer BG6541 replaces the final 6 bp of PxynA by an XbaI site, changing the final -1 to -6 
sequence from GTAAGA to TCTAGA and keeping the total length the same as in the 
original promoter. Primer BG6538 adds a BspHI site on the start of the PxynA. The entire 
synthesized spCas9 module without promoter for spCas9 was amplified using primers 
BG6542 and BG6543, keeping the XbaI and HindIII sites already present in the module. 
Subsequently, vector pNW33n was digested with BspHI and HindIII, the PxynA PCR-product 
with XbaI and BspHI and the spCas9 module PCR-product with XbaI and HindIII. The three 
elements were ligated in a 3-point ligation and cloned into E. coli TG90. Plasmid was 
extracted and the correct sequence was verified by sequencing, creating plasmid 
pWUR_Cas9nt (Figure 2B). For transformation of this construct to B. smithii strains, 0.1 μg 
DNA was used rather than the standard 1 μg in order to more precisely determine the 
transformation efficiencies together with the targeting constructs described in the next 
section. The resulting CFUs were around 3,000 and 200 per μg DNA for the ΔldhL ΔsigF and 
wild-type strain, respectively. Control transformations with empty vector pNW33n yielded 
CFUs of 10,000 and 1,800, respectively.
To insert the 3 different targeting spacers into pWUR_Cas9nt (which contains a non-
targeting spacer), 3 sets of oligos were annealed to create the 3 spacers, after which the 
annealed spacers were inserted into the construct as follows. Oligo sets were BG6017 and 
BG6021 for spacer 1, BG6018 and BG6022 for spacer 2, BG6019 and BG6023 for spacer 3. 
Each set was annealed by adding 5 μl 10 mM oligo sets together with 10 μl NEB buffer 2.1 
and 74 μL MQ water. Mixtures were heated to 94°C for 5 min and gradually cooled down to 
37°C at 0.03°C/sec using a PCR machine. Annealed oligos and plasmid pWUR_Cas9nt were 
digested with BspEI and BsmBI (NEB). First, BspEI digestion was performed at 37°C for 15 
min, after which BsmBI was added and the mixture was further incubated at 55°C for 15min. 
After gel purification of the digested products, ligation was performed using NEB T4 ligase 
and mixtures were transformed to E. coli TG90. All constructs were verified by sequencing 
spacer 2, which is missing 7 nt from the Ppta that is driving spacer expression (Figure S2). 
Constructs were named pWUR_Cas9sp1 until pWUR_Cas9sp3 according to their 
corresponding spacer. For transformation of this construct to B. smithii strains, 0.1 μg DNA 
was used rather than the standard 1 μg in order to more precisely determine the 
transformation efficiencies. The resulting CFUs were 700-3,300 and 9-300 per μg DNA for 
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from the B. smithii ET 138 genome using primers BG7838 and BG7839. The HR fragment 
downstream of the targeted site in the hsdR gene was PCR amplified from the B. smithii ET 
138 genome using primers BG7840 and BG7841. The cas9sp and sgRNA containing 
fragment was PCR amplified from the pWUR_Cas9sp1 vector using primers BG7842 and 
BG7843.   
Two 4-fragment NEBuilder® HiFi DNA Assemblies were designed and executed 
for the construction of the ldhL-restoration plasmids pWUR_Cas9spKI_hr1 
and pWUR_Cas9spKI_hr2. The backbone of both vectors was PCR amplified 
from the pWUR_Cas9sp1 vector using primers BG8134 and BG7837. The HR fragment 
upstream of and including the ldhL gene was PCR amplified from the B. smithii ET 138 
genome using primers BG8135 and BG8137 for the pWUR_Cas9spKI_hr1 vector 
and primers BG8135 and BG8136 for the pWUR_Cas9spKI_hr2 vector. The HR 
fragment downstream of the ldhL gene was PCR amplified from the B. smithii ET 
138 genome using primers BG8138 and BG8139 for the pWUR_Cas9spKI_hr1 vector 
and primers BG8138 and BG8140 for the pWUR_Cas9spKI_hr2 vector. The cas9sp and 
sgRNA containing fragment of both vectors was PCR amplified from the pWUR_Cas9sp1 
vector using primers BG8141 and BG7842.
RNA ISO LATIO N AND RT-PCR
RNA isolation was performed by the phenol extraction based on Van Hijum et al., 200556.
Overnight 10 ml cultures were centrifuged at 4°C and 4816 x g for 15 min and immediately 
used for RNA isolation. After removal of the medium, cells were resuspended in 0.5 ml ice 
cold TE buffer (pH 8.0) and kept on ice. All samples were divided into two 2 ml screw-
capped tubes containing 0.5 g zirconium beads, 30 μl 10% SDS, 30 μl 3 M sodium acetate 
(pH 5.2), and 500 µl Roti-Phenol (pH 4.5-5.0, Carl Roth GmbH). Cells were disrupted using 
a FastPrep-24 apparatus (MP Biomedicals) at speed 5500 rpm for 45 sec and centrifuged at 4°
C and 10,000 rpm for 5 min. 400 µl of the water phase from each tube was transferred to a 
new tube, to which 400 µl chloroform-isoamyl alcohol (Carl Roth GmbH) was added, after 
which samples were centrifuged at 4°C and 18,400 x g for 3 min. 300 µl of the aqueous phase 
was transferred to a new tube and mixed with 300 µl of the Lysis buffer from the High Pure 
RNA Isolation Kit (Roche). Subsequently, the rest of the procedure from this kit was 
performed according to the manufacturer’s protocol, except for the DNAse incubation step, 
which was performed for 45 min. Integrity and concentration of the isolated RNA was 
checked on Nanodrop-1000.
Reverse Transcriptase PCR was performed using SuperScript III Reverse 
the ΔldhL ΔsigF and wild-type strain, respectively. Control transformations with empty 
vector pNW33n yielded CFUs of 10,000 and 1,800, respectively.  
To insert the pyrF-flanks into the pWUR_Cas9nt and pWUR_Cas9sp1 constructs, 
the already fused pyrF-flanks were amplified from a previous plasmid in which the flanks 
were added as follows: flanks were cloned from genomic DNA of ET 138 using primers BG 
5798, BG5799 (upstream, 958 bp) and BG580, BG5801 (downstream, 979 bp), introducing 
SalI and XbaI restriction sites. The flanks were fused in an overlap extension PCR using 
primers BG5798 and BG5801 making use of the complementary overhangs in primers 
BG5799 and BG5800. Subsequently, the flanks and pNW33n were digested with SalI and 
XbaI, ligated and transformed into E. coli DH5α. To amplify the flanks for insertion into 
spCas9-editing plasmids, primers BG6850 and BG6849 were used, which both introduce a 
BspHI site. The pWUR_Cas9nt and pWUR_Cas9sp1 plasmids, and the amplified pyrF-flanks 
were digested with BspHI, followed by alkaline phosphatase treatment of the vectors 
(Thermo Scientific), ligated and transformed in E. coli TG90. Since only one restriction site 
was used, the flanks could have been inserted in both orientations. For both constructs 
multiple colonies were verified by sequencing and for all constructs the same flank-
orientation was selected and used for future experiments, namely with the downstream flank 
on the PxynA side. The resulting plasmids were named pWUR_Cas9nt_hr and 
pWUR_Cas9sp1_hr. Transformation of these constructs to B. smithii ΔldhL ΔsigF using 0.1 
μg DNA like for the non-flanked versions did not yield any colonies, most likely because 
there is a RM-recognition site present in the flanking regions (data not shown). 
Transformations performed using 5-8 μg DNA resulted in CFUs of around 10 per μg DNA 
(compared to around 700-3,300 for the non-flanked versions and 10,000 for control 
transformations with empty vector pNW33n).  
A 4-fragment NEBuilder® HiFi DNA Assembly was designed and executed for the 
construction of the hsdR–modifying plasmid pWUR_Cas9spR_hr. The backbone of the 
vector was PCR amplified from pWUR_Cas9sp1 using primers BG7836 and BG7837. The 
HR fragment upstream of the targeted site in the hsdR gene was PCR amplified from the B. 
smithii ET 138 genome using primers BG7838 and BG7839. The HR fragment downstream 
of the targeted site in the hsdR gene was PCR amplified from the ET 138 genome using 
primers BG7840 and BG7841. The cas9sp and sgRNA containing fragment was PCR 
amplified from the pWUR_Cas9sp1 vector using primers BG7842 and BG7843.
Two 4-fragment NEBuilder® HiFi DNA Assemblies were designed and executed 
for the construction of the ldhL-restoration plasmids pWUR_Cas9spKI_hr1 and pWUR_Cas9
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55°C for 15min. After gel purification of the digested products, ligation was performed using 
NEB T4 ligase and mixtures were transformed to E. coli TG90. All constructs were verified 
by sequencing spacer 2, which is missing 7 nt from the Ppta that is driving spacer expression 
(Figure S2). Constructs were named pWUR_Cas9sp1 until pWUR_Cas9sp3 according to 
their corresponding spacer. For transformation of this construct to B. smithii strains, 0.1 μg 
DNA was used rather than the standard 1 μg in order to more precisely determine the 
transformation efficiencies. The resulting CFUs were 700-3,300 and 9-300 per μg DNA for 
the ΔldhL ΔsigF and wild-type strain, respectively. Control transformations with empty 
vector pNW33n yielded CFUs of 10,000 and 1,800, respectively.  
To insert the pyrF-flanks into the pWUR_Cas9nt and pWUR_Cas9sp1constructs, the 
already fused pyrF-flanks were amplified from a previous plasmid in which the flanks were 
added as follows: flanks were cloned from genomic DNA of ET 138 using primers BG 5798, 
BG5799 (upstream, 958 bp) and BG580, BG5801 (downstream, 979 bp), introducing SalI 
and XbaI restriction sites. The flanks were fused in an overlap extension PCR using primers 
BG5798 and BG5801 making use of the complementary overhangs in primers BG5799 and 
BG5800. Subsequently, the flanks and pNW33n were digested with SalI and XbaI, ligated 
and transformed into E. coli DH5α. To amplify the flanks for insertion into spCas9-editing 
plasmids, primers BG6850 and BG6849 were used, which both introduce a BspHI site. The 
pWUR_Cas9nt and pWUR_Cas9sp1 plasmids, and the amplified pyrF-flanks were digested 
with BspHI, followed by alkaline phosphatase treatment of the vectors (Thermo Scientific), 
ligated and transformed in E. coli TG90. Since only one restriction site was used, the flanks 
could have been inserted in both orientations. For both constructs multiple colonies were 
verified by sequencing and for all constructs the same flank-orientation was selected and 
used for future experiments, namely with the downstream flank on the PxynA side. The 
resulting plasmids were named pWUR_Cas9nt_hr and pWUR_Cas9sp1_hr. Transformation 
of these constructs to B. smithii ΔldhL ΔsigF using 0.1 μg DNA like for the non-flanked 
versions did not yield any colonies, most likely because there is a RM-recognition site 
present in the flanking regions (data not shown). Transformations performed using 5-8 μg 
DNA resulted in CFUs of around 10 per μg DNA (compared to around 700-3,300 for the 
non-flanked versions and 10,000 for control transformations wit h empty vector pNW33n).  
A 4-fragment NEBuilder® HiFi DNA Assembly was designed and executed for 
the construction of the hsdR–modifying plasmid pWUR_Cas9spR_hr. The backbone of the 
vector was PCR amplified from pWUR_Cas9sp1 using primers BG7836 and BG7837. 
The HR fragment upstream of the targeted site in the hsdR gene was PCR amplified 
spKI_hr2. The backbone of both vectors was PCR amplified from the pWUR_Cas9sp1 vector 
using primers BG8134 and BG7837. The HR fragment upstream of and including the ldhL 
gene was PCR amplified from the B. smithii ET 138 genome using primers BG8135 and 
BG8137 for the pWUR_Cas9spKI_hr1 vector and primers BG8135 and BG8136 for the 
pWUR_Cas9spKI_hr2 vector. The HR fragment downstream of the ldhL gene was PCR 
amplified from the B. smithii ET 138 genome using primers BG8138 and BG8139 for the 
pWUR_Cas9spKI_hr1 vector and primers BG8138 and BG8140 for the 
pWUR_Cas9spKI_hr2 vector. The cas9sp and sgRNA containing fragment of both vectors 
was PCR amplified from the pWUR_Cas9sp1 vector using primers BG8141 and BG7842.
RNA ISOLATION AND RT-PCR
RNA isolation was performed by the phenol extraction based on Van Hijum et al.. Overnight 
10 ml cultures were centrifuged at 4°C and 4816 x g for 15 min and immediately used for 
RNA isolation. After removal of the medium, cells were resuspended in 0.5 ml ice cold TE 
buffer (pH 8.0) and kept on ice. All samples were divided into two 2 ml screw-capped tubes 
containing 0.5 g zirconium beads, 30 μl 10% SDS, 30 μl 3 M sodium acetate (pH 5.2), and 
500 µl Roti-Phenol (pH 4.5-5.0, Carl Roth GmbH). Cells were disrupted using a FastPrep-24 
apparatus (MP Biomedicals) at speed 5500 rpm for 45 sec and centrifuged at 4°C and 10,000 
rpm for 5 min. 400 µl of the water phase from each tube was transferred to a new tube, to 
which 400 µl chloroform-isoamyl alcohol (Carl Roth GmbH) was added, after which samples 
were centrifuged at 4°C and 18,400 x g for 3 min. 300 µl of the aqueous phase was 
transferred to a new tube and mixed with 300 µl of the Lysis buffer from the High Pure RNA 
Isolation Kit (Roche). Subsequently, the rest of the procedure from this kit was performed 
according to the manufacturer’s protocol, except for the DNAse incubation step, which was 
performed for 45 min. Integrity and concentration of the isolated RNA was checked on 
Nanodrop-1000.
Reverse Transcriptase PCR was performed using SuperScript III Reverse 
Transcriptase kit (Invitrogen) according to the manufacturer´s protocol. For synthesis of the 
first-strand cDNA, 2 μg of RNA and 200 ng of random primers were used. After cDNA 
synhesis, the products were used as a template for PCR using spCas9-specific forward and 
reverse primers BG6237 and BG6232, resulting in a 255 bp product. Products were 
visualized on a 2% agarose gel ran for 20 min.  
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Table S1. Strains used in this study
Strain Description Reference/origin 
E. coli DH5α Cloning host NEB 
E. coli TG90 Cloning host [1] 
B. smithii
strains: ET 138 Wild-type, natural isolate [2] 
ET 138 ΔldhL ΔsigF
ET 138 with ldhL and sigF-deletions 
[3] 
ET 138 ΔldhL ΔsigF
ΔpyrF
ET 138 ΔldhL ΔsigF with pyrF-deletion 
This study 
ET 138 ΔldhL ΔsigF ΔhsdR
ET 138 ΔldhL ΔsigF with stop codons and 
frame shiftinserted in the hsdR gene 
This study 
ET 138 ΔsigF ΔhsdR
ET 138 ΔldhL ΔsigF ΔhsdR with the ldhL 
gene re-inserted to restore its original 
sequence 
This study 
Table S2. Plasmids used in this study
Plasmid Description Reference/origin 
pNW33n E. coli-Bacillus shuttle vector, cloning vector, CmR. BGSC 
pWUR_lacZ pNW33n with B. coagulans  lacZ gene under T. 
saccharolyticum PxynA promoter. 
This study; [4,5] 
pWUR_Cas9nt 
pNW33n with spCas9-module1 containing non-targeting 
spacer. 
This study 
pWUR_Cas9sp1 
pNW33n with spCas9-module1 containing spacer targeting 
the pyrF gene at bp nr 124 
This study 
pWUR_Cas9sp2
pNW33n with spCas9-module1 containing spacer targeting 
the pyrF gene at bp nr 267 
This study 
pWUR_Cas9sp3
pNW33n with spCas9-module1 containing spacer targeting 
the pyrF gene at bp nr 583 
This study 
pWUR_Cas9nt_hr 
pNW33n with spCas9-module1 containing non-targeting 
spacer and the fused us+ds pyrF-flanks. 
This study 
pWUR_Cas9sp1_hr 
pNW33n with spCas9-module1 containing spacer targeting 
the pyrF gene at bp nr … and the fused us+ds pyrF-flanks. 
This study 
pWUR_Cas9spR_hr 
pNW33n with spCas9-module1 containing spacer targeting 
the hsdR gene and the fused us+ds hsdR-flanks containing 
mutations as described in M&M. 
This study 
pG2K Modular shuttle vector for Geobacillus and E. coli
Reeve et al, 
2016[6] 
pWUR_Cas9spKI_hr1 
pNW33n with spCas9-module1 containing spacer targeting 
directly downstream of the ldhL gene and the fused us+ds 
ldhL-flanks (~1000 bp each), in which the area between the 
ldhL stop codon and its terminator is inverted. 
This study 
pWUR_Cas9spKI_hr2 
pNW33n with spCas9-module1 containing spacer targeting 
directly downstream of the ldhL gene and the fused us+ds 
ldhL-flanks (~750 bp each), in which the area between the 
ldhL stop codon and its terminator is inverted. 
This study 
1 The spCas9 m odule containsS. pyogenes cas9 under the T. saccharolyticum PxynA prom oter followed by a B. 
subtilis-derived Rho-independent term inator, followed by a spacer underthe B. coagulans Ppta prom oter followed 
by another B. subtilis-derived Rho-independent term inator (Figure 1).
Abbreviations: CmR: chloram phenicol resistance gene (chloram phenicol acetyltransferase); BGSC: Bacillus
Genetic Stock Centre, USA; us: upstream ; ds: downstream ; bp: base pairs.
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re-inserted to restore its original 
sequence 
This study 
Table S2. Plasmids used in this study 
Plasmid Description Reference/origin 
pNW33n E. coli-Bacillus shuttle vector, cloning vector, CmR. BGSC 
pWUR_lacZ pNW33n with B. coagulans lacZ gene under 
T. saccharolyticum PxynA promoter.
This study;  [4,5] 
pWUR_Cas9nt 
pNW33n with spCas9-module1 containing 
non-targeting spacer. 
This study 
pWUR_Cas9sp1 
pNW33n with spCas9-module1 containing 
spacer targeting the pyrF gene at bp nr 124 
This study 
pWUR_Cas9sp2 
pNW33n with spCas9-module1 containing 
spacer targeting the pyrF gene at bp nr 267 
This study 
pWUR_Cas9sp3 
pNW33n with spCas9-module1 containing 
spacer targeting the pyrF gene at bp nr 583 
This study 
pWUR_Cas9nt_hr 
pNW33n with spCas9-module1 containing non-
targeting spacer and the fused us+ds pyrF-flanks. 
This study 
pWUR_Cas9sp1_hr 
pNW33n with spCas9-module1 containing spacer 
targeting the pyrF gene and the fused us+ds pyrF-flanks. 
This study 
pWUR_Cas9spR_hr 
pNW33n with spCas9-module1 containing spacer 
targeting the hsdR gene and the fused us+ds hsdR-
flanks containing mutations  as described in M&M. 
This study 
pG2K Modular shuttle vector for Geobacillus and E. coli 
Reeve et al, 
2016[6] 
pWUR_Cas9spKI_hr1 
pNW33n with spCas9-module1 containing spacer targeting 
directly downstream of the ldhL gene and the fused us+ds 
ldhL-flanks (~1000 bp each), in which the area between the 
ldhL stop codon and its terminator is inverted. 
This study 
pWUR_Cas9spKI_hr2 
pNW33n with spCas9-module1 containing spacer targeting 
directly downstream of the ldhL gene and the fused us+ds 
ldhL-flanks (~750 bp each), in which the area between the 
ldhL stop codon and its terminator is inverted. 
This study 
1 The spCas9 module contains S. pyogenes cas9 under the T. saccharolyticum PxynA promoter followed by a B. 
subtilis-derived Rho-independent term inator, followed by a spacer under the B. coagulans Ppta promoter followed 
by another B. subtilis-derived Rho-independent term inator (Figure 1).
Abbreviations: CmR: chloramphenicol resistance gene (chloramphenicol acetyltransferase); BGSC: Bacillus 
Genetic Stock Centre, USA; us: upstream ; ds: downstream ; bp: base pairs. 
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Table S3. Primers used in this study 
BG  nr Sequence 5’-3’1 Target/purpose 
5798 GCCTCTAGATAGGGATAACAGGGTAATATGCAGCGAT 
GGTCCGGTGTTC 
pyrF-us-Fw, XbaI 
5799 TTTCAGATCTGCTGGTTTACACGCACTTTCCAGCTCCTT C pyrF-us-Rv, overhang 
with BG5800 
5800 GAAGGAGCTGGAAAGTGCGTGTAAACCAGCAGATCTG 
AAA 
pyrF-ds-Fw, overhang 
with BG5799 
5801 GCCGTCGACTAGGGATAACAGGGTAATGTTCCCATGTT 
GTGATTC 
pyrF-ds-Rv, SalI 
6017 CCGGAAAAATGGATTATTCTTAAAATGGATACCGTTAT 
ACACTTTATTTTCAGAATGGAC 
Fw oligo spacer 1 
6018 CCGGAAAAATGGATTATTCTTAAAATGGATACCGTTAT 
ACTCAACGTGCATGCAGCAGGC 
Fw oligo spacer 2 
6019 CCGGAAAAATGGATTATTCTTAAAATGGATACCGTTAT 
ACGCAAAAGCGGCTGGTTGCAA  
Fw oligo spacer 3 
6021 AAACGTCCATTCTGAAAATAAAGTGTATAACGGTATCC 
ATTTTAAGAATAATCCATTTTT 
Rv oligo spacer 1 
6022 AAACGCCTGCTGCATGCACGTTGAGTATAACGGTATCC 
ATTTTAAGAATAATCCATTTTT 
Rv oligo spacer 2 
6023 AAACTTGCAACCAGCCGCTTTTGCGTATAACGGTATCC 
ATTTTAAGAATAATCCATTTTT  
Rv oligo spacer 3 
6850 GCCTCATGAATGCAGCGATGGTCCGGTGTTC pyrF-us-Fw, BspHI site 
6849 GCCTCATGAGTTCCCATGTTGTGATTC pyrF-ds-Rv, BspHI site 
6237 ATTGTGATCCCTAGTAACTC spCas9-specific-Fw, 
to evaluate expression 
6232 GCGCAAAGTATTGTCCATGCC spCas9-specific-Rv, to 
evaluate expression 
6420 TCGGGGGTTCGTTTCCCTTG pyrF KO check Fw 
6421 CTTACACAGCCAGTGACGGAAC pyrF KO check Rv 
7836 gaaagacccgtatccaagaaGTTTTAGAGCTAGAAATAGCAAG FW_pWUR_ori_SpacerR 
7837 TCATGACCAAAATCCCTTAAC RV_pWUR_ori 
7838 tcacgttaagggattttggtcatgaGATATAAGCAATACTGTTTTTCTA 
ATC 
FW_hsdR_USflank1_ori 
7839 ggaaccgttaggatatcTAATGTTGTACTTTTGCACC RV_ hsdR _USflank1 
7840 aagtacaacattagatatcctaaCGGTTCCTGAACTCGGTGAC FW_ hsdR _Dsflank1 
7841 attatcctcagctcactagcgccatGGCCGCTGCTTCACGAGT RV_ hsdR _DSflank1_Cas9 
7842 ATGGCGCTAGTGAGCTG FW_pWUR_cas9 
7843 ctaaaacttcttggatacgggtctttcGTATAACGGTATCCATTTTAAG 
AATAATCC 
RV_pWUR_cas9_SpacerR 
7881 AATACCAAACACGCCCTATAGC FW_ hsdR _check 
7882 CTTGCCCTGTTGAAATAATTAATGC RV_ hsdR _check 
8134 ttatgtaaacgaccatacaaGTTTTAGAGCTAGAAATAGCAAG FW_pNW_ori_SpacerL 
8135 tcacgttaagggattttggtcatgaTAAAGCTGGAAGGATGCC FW_LDH_DS1_ori 
8136 tcacgttaagggattttggtcatgaACATCAAAAGGATAGAGACAAA 
ATC 
FW_LDH_DS2_ori 
8137 ctttcttaatgctggtatgAAAGGGAGCGTTTTAAGTTAAATG RV_LDH_DS 
8138 aaacgctccctttcataccagcaTTAAGAAAGTACTTTATTCATCGT 
TTC 
FW_LDH+US 
8139 attatcctcagctcactagcgccatATGATGAAATACGCTGGC RV_LDH+US1 
8140 attatcctcagctcactagcgccatTTTGGATTTTTGGCAGTATTC RV_LDH+US2 
8141 ctaaaacttgtatggtcgtttacataaGTATAACGGTATCCATTTTAAG 
AATAATCC 
RV_pNW_spCas9_SpacerL 
8142 GCCAACGCTTCATTGTTTCC FW_LDH_Check 
8143 TCAGCCCATTGACTAGGAAG RV_LDH_Check 
1 Nucleotides in lowercase letters correspond to primer overhangs for HiFi DNA Assembly. 
Table S4. Results of the enzym atic assays for L-lactate production, averages of technical
duplos. 
DK O
10ml 
DK O
25ml 
DK O
50ml 
WT 
10ml 
WT 
25ml 
WT 
50ml 
DK O _ki 
10ml 
DK O _ki 
25ml 
DK O _ki 
50ml 
Lactate 
g/L 
0.01 0.05 0.02 1.08 1.48 1.46 1.06 1.39 1.54 
Lactate 
mM 
0.09 0.60 0.24 12.04 16.47 16.21 11.76 15.40 17.07 
O D600 1.28 0.66 0.16 1.10 0.74 0.64 1.18 0.86 0.74 
Prod. 0.07 0.91 1.51 10.94 22.26 25.34 9.97 17.91 23.06 
Abbreviations: DKO: double knockout ET 138 ΔldhL ΔsigF; WT: wild-type ET 138; DKO_ki: ldhL knock-in 
strain ET 138 ΔldhL ΔsigF +ldhL. The results prove the insertion and expression of the ldhL gene in the 
DKO_ki strain; the lactate production and the growth under anaerobic conditions are reconstituted to the wild- 
type levels.
SUPPLEMENTARY FIG URES 
Figure S1. lacZ-expression controlled by PxynA in ET 138 ΔldhL ΔsigF grown in TVMY medium 
containing different carbon sources. Cells were grown overnight (‘ON’, top row) in TVMY medium either 
without carbon source, with xylose or with glucose. Each preculture was used to inoculate 3 different 
TVMY cultures either without carbon source, with xylose or with glucose. The cultures were grown for 8 h (2nd
row and tubes shown). 
Higher LacZ expression leads to darker blue culture colour. 
Figure S2. Sequencing results of the Ppta from pWUR_Cas9sp2. A 7 bp-long deletion is located right downstream
of the predicted -10 region of the prom oter and expands until 8bp upstream of the spacer 2 sequence.
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Figure S3. OD600 measurements from the wild type ET 138 spCas9 targeting experiment. The growth of the 
cells with the spCas9 targeting constructs is greatly affected at 37°C, which is not the case for the cells with the 
negative control constructs. 
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Table S3. Prim ers used in this study
BG nr Sequence 5’-3’1 Target/purpose
5798 GCCTCTAGATAGGGATAACAGGGTAATATGCAGCGAT
GGTCCGGTGTTC 
pyrF-us-Fw, XbaI 
5799 TTTCAGATCTGCTGGTTTACACGCACTTTCCAGCTCCTT C pyrF-us-Rv, overhang with 
BG5800 
5800 GAAGGAGCTGGAAAGTGCGTGTAAACCAGCAGATCTG
AAA 
pyrF-ds-Fw, overhang with 
BG5799 
5801 GCCGTCGACTAGGGATAACAGGGTAATGTTCCCATGTT
GTGATTC 
pyrF-ds-Rv, SalI 
6017 CCGGAAAAATGGATTATTCTTAAAATGGATACCGTTAT
ACACTTTATTTTCAGAATGGAC 
Fw oligo spacer 1 
6018 CCGGAAAAATGGATTATTCTTAAAATGGATACCGTTAT
ACTCAACGTGCATGCAGCAGGC 
Fw oligo spacer 2 
6019 CCGGAAAAATGGATTATTCTTAAAATGGATACCGTTAT
ACGCAAAAGCGGCTGGTTGCAA 
Fw oligo spacer 3 
6021 AAACGTCCATTCTGAAAATAAAGTGTATAACGGTATCC
ATTTTAAGAATAATCCATTTTT 
Rv oligo spacer 1 
6022 AAACGCCTGCTGCATGCACGTTGAGTATAACGGTATCC
ATTTTAAGAATAATCCATTTTT 
Rv oligo spacer 2 
6023 AAACTTGCAACCAGCCGCTTTTGCGTATAACGGTATCC 
ATTTTAAGAATAATCCATTTTT 
Rv oligo spacer 3 
6850 GCCTCATGAATGCAGCGATGGTCCGGTGTTC pyrF-us-Fw, BspHI site 
6849 GCCTCATGAGTTCCCATGTTGTGATTC pyrF-ds-Rv, BspHI site 
6237 ATTGTGATCCCTAGTAACTC spCas9-specific-Fw, to 
evaluate expression 
6232 GCGCAAAGTATTGTCCATGCC spCas9-specific-Rv, to 
evaluate expression 
6420 TCGGGGGTTCGTTTCCCTTG pyrF KO check Fw 
6421 CTTACACAGCCAGTGACGGAAC pyrF KO check Rv 
7836 gaaagacccgtatccaagaaGTTTTAGAGCTAGAAATAGCAAG FW_pWUR_ori_SpacerR 
7837 TCATGACCAAAATCCCTTAAC RV_pWUR_ori 
7838 tcacgttaagggattttggtcatgaGATATAAGCAATACTGTTTTTCTA
ATC 
FW_hsdR_USflank1_ori 
7839 ggaaccgttaggatatcTAATGTTGTACTTTTGCACC RV_ hsdR _USflank1 
7840 aagtacaacattagatatcctaaCGGTTCCTGAACTCGGTGAC FW_ hsdR _Dsflank1 
7841 attatcctcagctcactagcgccatGGCCGCTGCTTCACGAGT RV_ hsdR _DSflank1_Cas9 
7842 ATGGCGCTAGTGAGCTG FW_pWUR_cas9 
7843 ctaaaacttcttggatacgggtctttcGTATAACGGTATCCATTTTAAG
AATAATCC 
RV_pWUR_cas9_SpacerR 
7881 AATACCAAACACGCCCTATAGC FW_ hsdR _check 
7882 CTTGCCCTGTTGAAATAATTAATGC RV_ hsdR _check 
8134 ttatgtaaacgaccatacaaGTTTTAGAGCTAGAAATAGCAAG FW_pNW_ori_SpacerL 
8135 tcacgttaagggattttggtcatgaTAAAGCTGGAAGGATGCC FW_LDH_DS1_ori 
8136 tcacgttaagggattttggtcatgaACATCAAAAGGATAGAGACAAA
ATC 
FW_LDH_DS2_ori 
8137 ctttcttaatgctggtatgAAAGGGAGCGTTTTAAGTTAAATG RV_LDH_DS 
8138 aaacgctccctttcataccagcaTTAAGAAAGTACTTTATTCATCGT
TTC 
FW_LDH+US 
8139 attatcctcagctcactagcgccatATGATGAAATACGCTGGC RV_LDH+US1 
8140 attatcctcagctcactagcgccatTTTGGATTTTTGGCAGTATTC RV_LDH+US2 
8141 ctaaaacttgtatggtcgtttacataaGTATAACGGTATCCATTTTAAG
AATAATCC 
RV_pNW_spCas9_SpacerL 
8142 GCCAACGCTTCATTGTTTCC FW_LDH_Check 
8143 TCAGCCCATTGACTAGGAAG RV_LDH_Check 
1 Nucleotides in lowercase letters correspond to primer overhangs for HiFi DNA Assembly. 
Table S4. Results of the enzymatic assays for L-lactate production, averages of technical 
duplos. 
DKO 
10ml 
DKO 
25ml 
DKO 
50ml 
WT 
10ml 
WT 
25ml 
WT 
50ml 
DKO_ki 
10ml 
DKO_ki 
25ml 
DKO_ki 
50ml 
Lactate 
g/L 
0.01 0.05 0.02 1.08 1.48 1.46 1.06 1.39 1.54 
Lactate 
mM 
0.09 0.60 0.24 12.04 16.47 16.21 11.76 15.40 17.07 
O D600 1.28 0.66 0.16 1.10 0.74 0.64 1.18 0.86 0.74 
Prod. 0.07 0.91 1.51 10.94 22.26 25.34 9.97 17.91 23.06 
Abbreviations: DKO: double knockout ET 138 ΔldhL ΔsigF; WT: wild-type ET 138; DKO_ki: ldhL knock-in 
strain ET 138 ΔldhL ΔsigF +ldhL. The results prove the insertion and expression of the ldhL gene in the 
DKO_ki strain; the lactate production and the growth under anaerobic conditions are reconstituted to the wild- 
type levels.
SUPPLEMENTARY FIGURES 
Figure S1. lacZ-expression controlled by PxynA in ET 138 ΔldhL ΔsigF grown in TVMY medium containing 
different carbon sources. Cells were grown overnight (‘ON’, top row) in TVMY medium either without carbon 
source, with xylose or with glucose. Each preculture was used to inoculate 3 different TVMY cultures either 
without carbon source, with xylose or with glucose. The cultures were grown for 8 h (2nd row and tubes shown). 
Higher LacZ expression leads to darker blue culture colour. 
Figure S2. Sequencing results of the Ppta from pWUR_Cas9sp2. A 7 bp-long deletion is located right 
downstream of the predicted -10 region of the prom oter and expands until 8bp upstream of the spacer 2 
sequence .
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Figure S4.  OD600 measurements from the 7-days long pyrF deletion culturing process. ET 138 ΔldhL ΔsigF 
cells transformed with pWUR_Cas9sp1, pWUR_Cas9sp1_hr, pWUR_Cas9nt or pWUR_Cas9nt_hr were cultured 
in TVMYxgu medium. After growth at 55°C for 24 hours, the cultures were sequentially transferred every 24 
hours to fresh media while gradually lowering the culturing temperature from 55°C to 37°C, with an intermediate 
transfer at 45°C. After 3 more transfers at 37°C cells were transferred back to 55°C with an intermediate transfer 
at 45°C. The pWURCas9_sp1 cultures at 37°C showed almost no growth, indicating efficient spCas9 targeting, 
while the pWUR_Cas9nt and pWUR_Cas9nt_hr control cultures grew at all the temperatures as expected for ET 
138 cultures. The pWUR_Cas9_sp1hr cultures showed poor growth in the first 2 culturing steps at 37°C, but the 
growth was reconstituted from the 3rd culturing step at 37°C onwards to control levels, indicating the 
development of either sgRNA and spCas9 escape mutants, or ΔpyrF deletion mutants that can avoid the spCas9 
targeting.   
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Figure S5. Phenotypic evaluation of 5-FOA sensitivity and uracil auxotrophy of ET 138 pyrF wild-types and 
mutant. Cells were grown overnight on TVMY medium with the following additions: Plates annotated as “Ta” 
contained: 2 g/L 5-FOA and 50 mg/L uracil; Plates annotated as “Tb” contained: 2 g/L 5-FOA and no uracil; 
Plates annotated as “Td” contained: no 5-FOA and no uracil. A. ET 138 wild-type. B. ET 138 ΔldhL ΔsigF. 
C. ET 138 ΔldhL ΔsigF ΔpyrF.
Figure S6. Agarose gel electrophoresis showing the resulting products from colony PCR on the colonies from the
3-day long ldhL knock-in culturing processes in LB2 m edium , using ET 138 ΔldhL ΔsigF ΔhsdR cells transform ed
with the pWUR_Cas9spKI_hr2 vector. For the colony PCR genom e-specific prim ers BG8145 and BG8146 were
used with the expected size of the PCR fragm ent for the knock-in m utations being 3.2 kb (equal to the size of the
PCR fragm ent for the wild type cells). The expected size of the PCR fragm ent for the knock-out (non-edited)
m utants was 2.3 kb.A. When the 45°C culturing step was perform ed, the process resulted in1 out of the 20 tested
colonies having the knock-in genotype, 7 colonies with m ixed knock-in and wild-type genotype, and only 1 colony
with the wild-type genotype. B. When the culturing step at 45°C was om itted none of the 20 tested colonies had
the knock-in genotype, only 6 colonies had the m ixed genotype while the rem aining 14colonies had the wild-type
genotype.
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Figure S3. OD600 measurements from the wild type ET 138 spCas9 targeting experiment. The growth of the 
cells with the spCas9 targeting constructs is greatly affected at 37°C, which is not the case for the cells with the 
negative control constructs. 
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Figure S4. OD600 measurements from the7-days long pyrF deletion culturing process. ET 138 ΔldhL
ΔsigF cells transformed with pWUR_Cas9sp1, pWUR_Cas9sp1_hr, pWUR_Cas9nt or pWUR_Cas9nt_hr 
were cultured in TVMYxgu medium. After growth at 55°C for 24 hours, the cultures were sequentially 
transferred every 24 hours to fresh media while gradually lowering the culturing temperature from 55°C to 37°C, 
with an intermediate transferat 45°C. After 3 more transfers at 37°C cells were transferred back to 55°C with an 
intermediate transfer at 45°C. The pWURCas9_sp1 cultures at 37°C showed almost no growth, indicating 
efficient spCas9 targeting, while the pWUR_Cas9nt and pWUR_Cas9nt_hr control cultures grew at all the 
temperatures as expected for ET 138 cultures. The pWUR_Cas9_sp1hr cultures showed poor growth in the 
first 2 culturing steps at 37°C, but the growth was reconstituted from the 3rd culturing step at 37°C onwards to 
control levels, indicating the development of either sgRNA and spCas9 escape mutants, or ΔpyrF deletion 
mutants that can avoid the spCas9 targetin g.   
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Figure S5. Phenotypic evaluation of 5-FOA sensitivity and uracil auxotrophy of ET 138 pyrF wild-types and 
mutant. Cells were grown overn ight on TVMY medium with the following additions: Plates annotated as “Ta” 
contained: 2 g/L 5-FOA and 50 mg/L uracil; Plates annotated as “Tb” contained:2 g/L 5-FOA and no uracil; 
Plates annotated as “Td” contained: no 5-FOA and no uracil. A. ET 138 wild-type. B. ET 138 ΔldhL ΔsigF. 
C. ET 138 ΔldhL ΔsigF ΔpyrF.
Figure S6. Agarose gel electrophoresis showing the resulting products from colony PCR on the colonies from the 
3-day long ldhL knock-in culturing processes in LB2 medium , using ET 138 ΔldhL ΔsigF ΔhsdR cells transform
ed with the pWUR_Cas9spKI_hr2 vector. For the colony PCR genome specific primers BG8145 and BG8146
were used with the expected size of the PCR fragment for the knock-in mutations being 3.2 kb (equal to the size
of the PCR fragment for the wild type cells). The expected size of the PCR fragment for the knock-out (non-
edited) mutants was 2.3 kb. A. When the 45°C culturing step was performed, the process resulted in 1 out of the
20 tested colonies having the knock-in genotype, 7 colonies with mixed knock-in and wild-type genotype, and 12
colonies with the wild-type genotype. B. When the culturing step at 45°C was omitted none of the 20 tested
colonies had the knock-in genotype, only 6 colonies had the mixed genotype while the remaining 14 colonies had
the wild-type genotype.
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ABSTRACT 
Rhodobacter sphaeroides is a metabolically versatile bacterium that serves as a model 
for analysis of photosynthesis, hydrogen production and terpene biosynthesis. However, 
the lack of efficient tools for R. sphaeroides genome editing is a bottleneck for both 
fundamental studies and biotechnological exploitation. Here we describe the 
development of a highly efficient spCas9-based targeting system for R. sphaeroides. 
We combined the targeting system with plasmid-borne homologous recombination 
(HR) templates for knocking-out and knocking-in different genes, and for single 
nucleotide substitution with efficiencies of up to 100%. The R. sphaeroides 
genome encompasses genes encoding LigD and Ku, the canonical components of the 
non-homologous end joining (NHEJ) system. A unique feature of R. sphaeroides 
strains appears to be the presence of a cluster of two predicted Ku homologs that share 
low sequence similarity. We succeeded in combining spCas9 targeting with the native 
bacterial NHEJ system of R. sphaeroides. The tool resulted in survival through indel 
formation, and subsequent gene inactivation with efficiencies of up to 20%. 
Surprisingly, the NHEJ activity of R. sphaeroides is demonstrated to be based on the 
LigD but not on the predicted Ku homologs, strongly suggesting the existence of an 
unprecedented variant of the NHEJ system. Overall, we anticipate that the presented 
work will facilitate molecular research on R. sphaeroides and will be the starting point for 
further characterization of a non-canonical NHEJ system. 
SIGNIFICANCE 
Bacterial and archaeal genomes encompass arrays of clustered regularly interspaced short 
palindromic repeats (CRISPR) along with CRISPR-associated (Cas) proteins and it was 
recently shown that these systems constitute adaptive immune systems against viruses and 
mobile genetic elements. The Cas9 RNA-guided DNA-endonuclease from the type II 
CRISPR-Cas system of Streptococcus pyogenes (spCas9) has been extensively employed for 
the development of effective and time-efficient genome engineering tools for prokaryotes and 
eukaryotes. In this study, we combine the spCas9 targeting activity with the native 
homologous recombination (HR) and non-homologous end joining (NHEJ) mechanisms of 
the biotechnologically interesting bacterium Rhodobacter sphaeroides for the development of 
genome editing tools. Moreover, we used these tools to delete the NHEJ genes of R. 
sphaeroides and reveal an unprecedented NHEJ mechanism. 
INTRO DUCTIO N
The purple non-sulphur bacterium Rhodobacter sphaeroides is a microorganism with 
an extremely adaptable metabolism1: it is a facultative phototroph that can grow on 
many different carbon substrates and can respire aerobically and anaerobically with different 
electron acceptors2,3. This versatility is reflected in a number of different studies, which 
range from fundamental understanding of photosynthesis and quorum sensing to more
applied fields like bioremediation and photoheterotrophic hydrogen or heterotrophic terpene 
biosynthesis4–8. Still, a lot of work is required to further increase our knowledge on R. 
sphaeroides metabolism and exploit its biotechnological potential.   
The high-throughput exploration of R. sphaeroides metabolism requires 
the development of highly effective and time-efficient genome engineering tools9. 
Currently, the introduction of genomic mutations in R. sphaeroides is based on 
suicide-plasmid driven homologous recombination (HR)10,11. This approach allows 
for markerless modifications, but it is laborious and inefficient12; the lack of a strict 
counter-selection method usually leads to high rates of wild-type revertants during the
curation of the suicide plasmid, especially for essential genes. Therefore, screening of
mutants can be time consuming and is frequently unsuccessful12. 
A wide range of CRISPR-Cas (Clustered Regularly Interspaced Short 
Palindromic Repeats-CRISPR associated proteins) bacterial and archaeal adaptive
immune systems have been repurposed as tools for eukaryotic, prokaryotic and archaeal 
genome engineering13–21. Most of these tools exploit the RNA-guided DNA endonuclease 
from the type II CRISPR-Cas system of Streptococcus pyogenes, denoted as spCas9. As any 
Cas9 orthologue, spCas9 can be easily programmed to precisely introduce double stranded 
DNA breaks (DSB) to a selected DNA sequence, denoted as protospacer. A single, 
customizable guide RNA (sgRNA) molecule directs Cas9 to the protospacer via 
complementarity between its exchangeable 5’-end sequence, denoted as spacer, and the 
protospacer sequence. The only additional requirement for Cas9-based targeting is the
presence of a specific, 3-8nt long motif right after the 3’-end of the selected
protospacer, denoted as protospacer adjacent motif (PAM)14,22. All in all, the 
simplicity in the design and construction of a Cas9-based DNA targeting system has made 
it popular as the basis for numerous genome manipulation applic ations.   
A plethora of Cas9-based tools have been developed the last 5 years for prokaryotes. Cas9 
can serve as an efficient counter selection tool, when combined with plasmid-based 
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with an extremely adaptable metabolism1: it is a facultative phototroph that can 
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with different electron acceptors2,3. This versatility is reflected in a number of different 
studies, which range from fundamental understanding of photosynthesis and quorum 
sensing to more applied fields like bioremediation and photoheterotrophic hydrogen or 
heterotrophic terpene biosynthesis4–8. Still, a lot of work is required to further increase 
our knowledge on R. sphaeroides metabolism and exploit its biotechnological potential.pot
The high-throughput exploration of R. sphaeroides  metabolism requires 
the development of highly effective and time-efficient genome engineering tools9. 
Currently, the introduction of genomic mutations in R. sphaeroides  is based on 
suicide-plasmid driven homologous recombination (HR)10,11. This approach allows 
for markerless modifications, but it is laborious and inefficient12; the lack of a strict 
counter-selection method usually leads to high rates of wild-type revertants during the 
curation of the suicide plasmid, especially for essential genes. Therefore, screening of 
mutants can be time consuming and is frequently unsuccessful12. 
A wide range of CRISPR-Cas (Clustered Regularly Interspaced 
Short Palindromic Repeats-CRISPR associated proteins) bacterial and archaeal 
adaptive immune systems have been repurposed as tools for eukaryotic, prokaryotic and 
archaeal genome engineering13–21. Most of these tools exploit the RNA-guided DNA 
endonuclease from the type II CRISPR-Cas system of Streptococcus pyogenes, denoted as 
spCas9. As any Cas9 orthologue, spCas9 can be easily programmed to precisely introduce 
double stranded DNA breaks (DSB) to a selected DNA sequence, denoted as 
protospacer. A single, customizable guide RNA (sgRNA) molecule directs Cas9 to 
the protospacer via complementarity between its exchangeable 5’-end sequence, 
denoted as spacer, and the protospacer sequence. The only additional requirement for 
Cas9-based targeting is the presence of a specific, 3-8nt long motif right after the 
3’-end of the selected protospacer, denoted as protospacer adjacent motif (PAM)14,22. 
All in all, the simplicity in the design and construction of a Cas9-based DNA 
targeting system has made it popular as the basis for numerous 
genome manipulation applications.   A plethora of Cas9-based tools have been 
developed the last 5 years for prokaryotes. Cas9 can serve as an efficient counter selection
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tool, when combined with plasmid-based ho-mologous recombination (HR) or 
recombineering; Alternative DSB repairing mechanisms (like the template independent non-
homologous end joining, NHEJ) are lacking in most prokaryotes23. Therefore, Cas9-based 
DSBs after HR are lethal if introduced to the wild type genomes: unmodified cells will be 
eliminated from the treated population, allowing survival only for the recombined ones23. 
Additionally, substituting catalytic residues from either one or both of the Cas9 active sites 
leads to the construction of nickase (nCas9) and catalytically inactive (dCas9) variants which 
have been extensively employed for bacterial genome editing and silencing experiments19,24. 
Finally, the construction of dCas9 fusions with transcriptional activation domains25,26, or with 
cytidine deaminase -for single nucleotide base editing-27,28 have further expanded the Cas9-
based bacterial genome engineering toolbox25. 
An alternative approach for introduction of knock-out mutations in bacterial 
genomes with Cas9 targeting relies on the exploitation of the template-independent non-
homologous end joining (NHEJ) repairing mechanism; however, as indicated before, only 
few bacteria have been reported to encompass a functional NHEJ system29,30. Upon the 
formation of a DSB within a genome, an active NHEJ system would allow for repairing the 
break in an error-prone manner, randomly introducing small insertions or deletions (indel) 
that can inactivate a gene via open reading frame shift or premature stop codon formation31–33. 
A Cas9-NHEJ knock-out system has several advantages when compared to other systems, 
including reduced cloning complexity and the potential to create a library of knock-out 
mutants in a high throughput and cost effective manner. 
In this study, we develop a highly efficient HR-Cas9 counter selection tool for R. 
sphaeroides and we implement it for generating gene deletions (knock-outs), 
insertions (knock-ins) and single nucleotide substitutions. Moreover, we 
demonstrate that R. sphaeroides has a functional, non-canonical NHEJ mechanism that can 
repair spCas9-induced DSBs.
RESULTS 
SpCAS9 TARG ETING  IN R. SPHAEROIDES
The first aim of this study was to assess potential toxic effects of spCas9 expression 
in R. sphaeroides cells, as previously reported for other microbial species37–39. For this 
purpose we constructed the pBBR_Cas9_NT control vector by cloning the 
spCas9 gene, codon optimized for R. sphaeroides , and a sgRNA expressing module 
with a non-targeting (NT) spacer in the E. coli-Rhodobacter shuttle vector 
pBBR1MCS2. The expression of the spCas9 gene was under control of the Plac promoter 
that due to the absence of the lacIq repressor gene in the R. sphaeroides genome, has 
constitutive transcription activity. Moreover the sgRNA expressing module was under 
the control of the synthetic constitutive PBBa_J95023 promoter. The pBBR_Cas9_NT 
vector in parallel with the pBBR1MCS2 control vector were conjugated in R. 
sphaeroides cells (Figure 1A). Even though the conjugation efficiency for the 
pBBR_Cas9_NT vector was reduced compared to the pBBR1MC2 (Figure 1B), it 
remained high and the drop in efficiency can most likely be attributed to the almost 
double size of the former vector (9566 bp) compared to the latter (5144bp). 
Moreover, we confirmed the transcription of the spCas9 gene in R. sphaeroides by RT-
PCR (Figure S1).
We further developed a spCas9-based system for efficient introduction of 
lethal double stranded DNA breaks (DSBs) in R. sphaeroides . The pBBR_Cas9_NT 
vector was employed for the construction of three targeting plasmids 
(pBBR_Cas9_sp1-3) each containing a unique spacer that corresponds to a different 
target sequence (protospacer) within the upp (uracil phosphoribosyl transferase) gene 
of the R. sphaeroides genome. It is expected that if the constructed spCas9 system is 
efficiently expressed in R. sphaeroides , the number of obtained colonies upon 
conjugation with the targeting plasmids is going to be substantially lower compared 
to the number of obtained colonies upon conjugation with the control plasmid.  
The pBBR_Cas9 series of plasmids was conjugated in R. sphaeroides 
(Figure 1C). Remarkably, the conjugation efficiency for the 
pBBR_Cas9_sp1 and pBBR_Cas9_sp2 constructs dropped more than 3 orders of 
magnitude compared to the pBBR_Cas9_NT control, while for the pBBR_Cas9_sp3 
the conjugation efficiency dropped only by 50% (Figure 1C). This result shows that 
the constructed spCas9 system is highly active in R. sphaeroides . 
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purpose we constructed the pBBR_Cas9_NT control vector by cloning the 
spCas9 gene, codon optimized for R. sphaeroides, and a sgRNA expressing module 
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pBBR1MCS2. The expression of the spCas9 gene was under control of the Plac promoter 
that due to the absence of the lacIq repressor gene in the R. sphaeroides genome, has 
constitutive transcription activity. Moreover the sgRNA expressing module was under 
the control of the synthetic constitutive PBBa_J95023 promoter. The pBBR_Cas9_NT 
vector in parallel with the pBBR1MCS2 control vector were conjugated in R. 
sphaeroides cells (Figure 1A). Even though the conjugation efficiency for the 
pBBR_Cas9_NT vector was reduced compared to the pBBR1MC2 (Figure 1B), it 
remained high and the drop in efficiency can most likely be attributed to the almost 
double size of the former vector (9566 bp) compared to the latter (5144bp). 
Moreover, we confirmed the transcription of the spCas9 gene in R. sphaeroides by RT-
PCR (Figure S1).
We further developed a spCas9-based system for efficient introduction of lethal 
double stranded DNA breaks (DSBs) in R. sphaeroides. The pBBR_Cas9_NT vector was 
employed for the construction of three targeting plasmids (pBBR_Cas9_sp1-3) 
each containing a unique spacer that corresponds to a different target sequence 
(protospacer) within the upp (uracil phosphoribosyl transferase) gene of the R. sphaeroides 
genome. It is expected that if the constructed spCas9 system is efficiently expressed in R. 
sphaeroides, the number of obtained colonies upon conjugation with the targeting 
plasmids is going to be substantially lower compared to the number of obtained colonies 
upon conjugation with the control plasmid.  
The pBBR_Cas9 series of plasmids was conjugated in R. sphaeroides (Figure 1C). 
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constructs dropped more than 3 orders of magnitude compared to the pBBR_Cas9_NT 
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REPAIR O F SpCAS9 INDUCED DSBS BY TH E NATIVE R. 
SPHAEROIDES NH EJ
The majority of the prokaryotic NHEJ mechanisms consist of one ATP-dependent DNA 
ligase ligD gene and one ku gene, which are typically adjacent within a genome41,42. 
Surprisingly, the genome of all sequenced R. sphaeroides strains, including R. sphaeroides 
2.6.5 (data not shown), encompasses a NHEJ system consisting of 1 ligD and 2 ku 
homologs. The latter are located next to each other within the 1st chromosome of R. 
sphaeroides , in opposing directions with their stop codons being in proximity, while the 
ligD is located within the same chromosome but approximately 1Mb upstream of the 2 ku
homologs. Additionally, phylogenetic analysis of the R. sphaeroides NHEJ genes not only 
shows that they only cluster together with other α-proteobacteria NHEJ genes but also that 
the 2 ku homologs are phylogenetically distant (Figure 1D). The latter is also apparent by 
the great sequence dissimilarity of the 2 ku homologs (no apparent similarity on nucleotide 
level when aligned with BLASTn), which suggests that they cannot be the result of a 
duplication event. 
The existence of NHEJ genes within the genome of R. sphaeroides motivated to 
further study the genomic content of the colonies that escaped the spCas9 targeting of the 
upp gene. Previous studies reported that the toxicity of 5-fluorouracil (5-FU) in bacterial 
species can be circumvented by the deactivation of the uracyl-phosphoribosytransferase 
(upp) gene43. 5-Fluorouracil (5-FU) toxicity on R. sphaeroides was studied by growing the 
bacteria on RÄ agar media with and without 5-FU (100 μg/mL). No colonies were observed 
on the 5-FU containing plates, indicating that, under the used conditions, the spontaneous 
formation of 5-FU resistant R. sphaeroides Δupp mutants occurs in frequency less than 1 per 
105 CFU.
The pBBR_Cas9_sp1 and pBBR_Cas9_sp2 vectors showed the highest 
targeting efficiency in our previous experiment and were selected for further 
conjugation experiments. Surviving colonies were randomly selected and streaked on 
RÄ_5-FU agar plates and only 7% of them were able to grow on the selection plates 
(Table S5). We genotyped all the colonies that survived spCas9 targeting and 5-FU 
selection, through colony PCR and sequencing. The results showed that all the 5-FU 
resistant colonies included mutations within the corresponding protospacer regions 
(Figure 1E). We additionally genotyped all the colonies that survived spCas9 
targeting but not 5-FU selection, through colony PCR and sequencing. The results 
showed that all the non 5-FU resistant colonies did not encompass mutations within 
GGCCATCGATCTCCCGAAGGAGAAGGGGGC 
GGCCATCGATCTCCTGAAGTAGAAGGGGGC
GGCCATCGATCTCCCGAAGGAGAAGGGGGC
    Protospacer (sp2) 
WT
PAM
Fig. 1. Conjugation of upp targeting plasmids. (A) Schematic overview of the di-parental conjugation protocol 
description of the protocol can be found in the Material and Methods section. (B) Colony forming used:
units
 detailed 
 (CFUs) obtained after conjugation of pBBR_Cas9_NT in R. sphaeroides. The efficiency was compared to
an empty pBBR1MCS2 plasmid. (C) CFU obtained after conjugation of the plasmid pBBR_Cas9 harbouring 
different spacers for upp (pBBR_Cas9_sp1-sp3); the plasmid with the non-targeting spacer (pBBR_Cas9_NT) was 
used as control. (D) Phylogenetic comparison of Ku (left) and LigD (right) orthologues. Colours in the background
are used to cluster taxa from the same phylogenetic class: Alphaproteobacteria (blue), Gammaproteobacteria 
(green), Bacilli (grey) and Actinobacteria (red). The evolutionary history was inferred using the Neighbor-Joining 
method51. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test 
(1000 replicates) are shown next to the most important nodes. Evolutionary analyses were conducted in 
MEGA735. Abbreviations: Rsp – Rhodobacter sphaeroides, Rjo – Rhodobacter jorhii, Raz – Rhodobacter 
azotoformans, Cch – Cereibacter changlensis, Sme - Sinorhizobium meliloti, Ama - Aurantimonas 
manganoxydans, Rtr - Rhizobium tropici, Rlu - Rhizobium lusitanum, Nam - Nitrospirillum 
amazonense, Rle - Rhizobium leguminosarum, Pae - Pseudomonas aeruginosa, Ppu - Pseudomonas putida, 
Bce - Bacillus cereus, Bsu - Bacillus subtilis, Mtu - Mycobacterium tuberculosis, Msm - Mycobacterium 
smegmatis, Mha – Mycobacterium haemophilum, Sco – Streptomyces coelicolor, Bth – Bacillus thuringensis, 
Spn – Streptococcus pneumoniae, Mlo – Mesorhizobium loti, Atu – Agrobacterium tumefaciens. (E) Examples 
of insertions or deletions (indel, red) in the protospacer loci detected by the spacers sp1 and sp2 (underlined) in 
the upp gene. The protospacer adjacent motifs (PAM) are shown in light blue.
Moreover, the observed fluctuation of targeting efficiency of different spacers is in 
agreement with previous reports that the targeting efficiency of spCas9 system relies heavily 
on the selected spacer and can substantially differentiate amongst different targets, even 
within the same gene40. 
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Moreover, the observed fluctuation of targeting efficiency of different spacers is in 
agreement with previous reports that the targeting efficiency of spCas9 system relies heavily 
on the selected spacer and can substantially differentiate amongst different targets, even 
within the same gene40. 
Efficient Cas9-based genome editing of Rhodobacter sphaeroides
REPAIR OF SpCAS9 INDUCED DSBS BY THE NATIVE R. SPHAEROIDES 
NHEJ
The majority of the prokaryotic NHEJ mechanisms consist of one ATP-dependent DNA 
ligase ligD gene and one ku gene, which are typically adjacent within a genome41,42. 
Surprisingly, the genome of all sequenced R. sphaeroides strains, including R. sphaeroides 
2.6.5 (data not shown), encompasses a NHEJ system consisting of 1 ligD and 2 ku homologs. 
The latter are located next to each other within the 1st chromosome of R. sphaeroides, in 
opposing directions with their stop codons being in proximity, while the ligD is located within 
the same chromosome but approximately 1Mb upstream of the 2 ku homologs. Additionally, 
phylogenetic analysis of the R. sphaeroides  NHEJ genes not only shows that they only cluster 
together with other α-proteobacteria NHEJ genes but also that the 2 ku homologs are 
phylogenetically distant (Figure 1D). The latter is also apparent by the great sequence 
dissimilarity of the 2 ku homologs (no apparent similarity on nucleotide level when aligned 
with BLASTn), which suggests that they cannot be the result of a duplication event. 
The existence of NHEJ genes within the genome of R. sphaeroides motivated to 
further study the genomic content of the colonies that escaped the spCas9 targeting of the upp 
gene. Previous studies reported that the toxicity of 5-fluorouracil (5-FU) in bacterial species 
can be circumvented by the deactivation of the uracyl-phosphoribosytransferase (upp) gene43. 
5-Fluorouracil (5-FU) toxicity on R. sphaeroides was studied by growing the bacteria on RÄ
agar media with and without 5-FU (100 μg/mL). No colonies were observed on the 5-FU
containing plates, indicating that, under the used conditions,  the spontaneous formation of 5-
FU resistant R. sphaeroides Δupp mutants occurs in frequency less than 1 per 105 CFU.
The pBBR_Cas9_sp1 and pBBR_Cas9_sp2 vectors showed the highest targeting 
efficiency in our previous experiment and were selected for further conjugation 
experiments. Surviving colonies were randomly selected and streaked on RÄ_5-FU agar 
plates and only 7% of them were able to grow on the selection plates (Table S5). We 
genotyped all the colonies that survived spCas9 targeting and 5-FU selection, through 
colony PCR and sequencing. The results showed that all the 5-FU resistant colonies included 
mutations within the corresponding protospacer regions (Figure 1E). We additionally 
genotyped all the colonies that survived spCas9 targeting but not 5-FU selection, through 
colony PCR and sequencing. The results showed that all the non 5-FU resistant colonies did 
not encompass mutations within he upp gene and promoter regions. We further cultured and 
isolated plasmid from 25% of the non-mutant escape colonies; surprisingly the sequencing re-
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sults showed intact spCas9 and sgRNA sequences for all of the examined plasmids, 
suggesting that still a small number of  R. sphaeroides  cells can survive spCas9 targeting. 
As bacteria often have more than a single copy of their chromosome, these survivors 
can result from the RecA-dependent HR repair of the formed DSB, with the 
use of an intact chromosomal copy of the targeted gene as template40.
The obtained results suggested that the R. sphaeroides  native non-homologous end 
joining (NHEJ) mechanism is active, repairing spCas9-induced DSBs through error prone 
correction. Alternatively, the spCas9 targeting mechanism acts as a selection tool in favor of 
cells containing random-naturally occurring mutations within the targeted protospacer 
regions. The second option though is considered unlikely, given the low natural rate of 
spontaneous Δupp mutants formation under 5-FU pressure as well as the relatively high rate 
of Δupp mutants formed upon spCas9 targeting, with mutations within the targeted 
protospacer regions. Nonetheless, we decided to proceed with the construction of several 
NHEJ mutant strains by repeating the targeting assays.  
HOMOLOGOUS RECOMBINATION-SpCAS9 COUNTER SELECTION 
FOR GENE DELETIONS
There are multiple studies on bacterial genome editing employing i) homologous 
recombination (HR) via plasmid-borne templates that carry the desired modifications, and ii) 
Cas9-induced DSBs for the induction of the cellular HR machinery and as a counter-selection 
system for the unedited cells19,23. Previous studies reported HR activity in R. sphaeroides 12 
and here we developed a spCas9 targeting system. Hence, we set out to develop a HR-spCas9 
counter selection system for efficient genome editing in R. sphaeroides . As a proof of 
principle, we programmed the designed HR-spCas9 system to knock out the upp gene of R. 
sphaeroides , excluding the start codon and the last 12 nucleotides of the gene in order to 
avoid potential polar effects for neighboring genes. Two editing plasmids were constructed 
and tested, both containing the previously described spacer 2 for efficient upp targeting and 
HR templates consisted of either 500bp (pBBR_Cas9_Δupp500HR_sp2) or 1kb 
(pBBR_Cas9_Δupp1000HR_sp2) upstream and downstream genomic regions flanking the 
selected for deletion upp fragment. Two control plasmids (pBBR_Cas9_Δupp500HR_NT and 
pBBR_Cas9_Δupp1000HR_NT), containing the same HR templates as the editing plasmids 
but a non-targeting spacer, were also taken along for assessing the contribution of spCas9 to 
the efficiency of the tool. 
A  B 
Fig. 2. Deletion of upp gene from Rhodobacter sphaeroides genome. (A) Number of colonies obtained on RÄ 
agar plates plated with 10-3 dilutions of R. sphaeroides conjugation mixtures with the HR control vectors 
pBBR_Cas9_Δupp500HR_NT and pBBR_Cas9_Δupp1000HR_NT, and HR editing vectors 
pBBR_Cas9_Δupp500HR_sp2 and pBBR_Cas9_Δupp1000HR_sp2. The error bars represent standard 
deviations from three replicate experiments. (B) Restreaks of randomly selected colonies from the above 
mentioned conjugations on RÄ agar plates supplemented with 5-FU. Only Δupp mutants can grow on 5-FU 
plates. (C) Genome specific colony PCR amplification of the upp locus in cells conjugated with the 
pBBR_Cas9_Δupp500HR_NT, pBBR_Cas9_Δupp1000HR_NT, pBBR_Cas9_Δupp500HR_sp2 and 
pBBR_Cas9_Δupp1000HR_sp2 vectors. Amplification yields a 2992 bp product for the wild type upp gene and 
a 2374 bp product for the deleted upp gene. (D) Sequence verification of the desired upp deletion by sanger 
sequencing. 
Upon conjugation of the above described constructs in R. sphaeroides , a drop was 
observed of at least 3 orders of magnitude in the number of surviving colonies upon 
conjugation with the editing constructs compared to the non-targeting control construct 
(Figure 2A). 14 colonies were randomly picked from each plate and streaked on RÄ agar 
plates supplemented with 5-FU. All selected colonies from the conjugation plates with editing 
constructs -regardless the size of the employed HR template- grew on the 5-FU selection 
plates (Figure 2B). We genotyped all the selected colonies through colony PCR and 
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the upp gene and promoter regions. We further cultured and isolated plasmid from 25% of 
the non-mutant escape colonies; surprisingly the sequencing results showed intact spCas9 
and sgRNA sequences for all of the examined plasmids, suggesting that still a 
small number of R. sphaeroides cells can survive spCas9 targeting. As bacteria often 
have more than a single copy of their chromosome, these survivors can result from the 
RecA-dependent HR repair of the formed DSB, with the use of an intact chromosomal 
copy of the targeted gene as template40.
The obtained results suggested that the R. sphaeroides native non-homologous end 
joining (NHEJ) mechanism is active, repairing spCas9-induced DSBs through error prone 
correction. Alternatively, the spCas9 targeting mechanism acts as a selection tool in favor of 
cells containing random-naturally occurring mutations within the targeted protospacer 
regions. The second option though is considered unlikely, given the low natural rate of 
spontaneous Δupp mutants formation under 5-FU pressure as well as the relatively high rate 
of Δupp mutants formed upon spCas9 targeting, with mutations within the targeted 
protospacer regions. Nonetheless, we decided to proceed with the construction of several 
NHEJ mutant strains by repeating the targeting assays.  
H O MO LO G O US RECO MBINATIO N- SPCAS9 CO UNTER SELECTIO N 
FO R G ENE DELETIO NS
There are multiple studies on bacterial genome editing employing i) homologous 
recombination (HR) via plasmid-borne templates that carry the desired modifications, and ii) 
Cas9-induced DSBs for the induction of the cellular HR machinery and as a counter-
selection system for the unedited cells19,23. Previous studies reported HR activity in R. 
sphaeroides 12 and here we developed a spCas9 targeting system. Hence, we set out to 
develop a HR-spCas9 counter selection system for efficient genome editing in R. 
sphaeroides . As a proof of principle, we programmed the designed HR-spCas9 system to 
knock out the upp gene of R. sphaeroides , excluding the start codon and the last 12 
nucleotides of the gene in order to avoid potential polar effects for neighboring genes. Two 
editing plasmids were constructed and tested, both containing the previously described 
spacer 2 for efficient upp targeting and HR templates consisted of either 500bp 
(pBBR_Cas9_Δupp500HR_sp2) or 1kb (pBBR_Cas9_Δupp1000HR_sp2) upstream and 
downstream genomic regions flanking the selected for deletion upp fragment. Two control 
plasmids (pBBR_Cas9_Δupp500HR_NT and pBBR_Cas9_Δupp1000HR_NT), containing 
the same HR templates as the editing plasmids but a non-targeting spacer, were also taken 
along for assessing the contribution of spCas9 to the efficiency of the tool. 
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Fig. 2.  Deletion of upp gene from Rhodobacter sphaeroides genome. (A) Number of colonies obtained on RÄ 
agar plates plated with 10-3 dilutions of R. sphaeroides conjugation mixtures with the HR control vectors 
pBBR_Cas9_Δupp500HR_NT and pBBR_Cas9_Δupp1000HR_NT, and HR editing vectors 
pBBR_Cas9_Δupp500HR_sp2 and pBBR_Cas9_Δupp1000HR_sp2. The error bars represent standard deviations 
from three replicate experiments. (B) Restreaks of randomly selected colonies from the above mentioned 
conjugations on RÄ agar plates supplemented with 5-FU. Only Δupp mutants can grow on 5-FU plates. (C) 
Genome specific colony PCR amplification of the upp locus in cells conjugated with the 
pBBR_Cas9_Δupp500HR_NT, pBBR_Cas9_Δupp1000HR_NT, pBBR_Cas9_Δupp500HR_sp2 and 
pBBR_Cas9_Δupp1000HR_sp2 vectors. Amplification yields a 2992 bp product for the wild type upp gene and 
a 2374 bp product for the deleted upp gene. (D) Sequence verification of the desired upp deletion by sanger 
sequencing. 
Upon conjugation of the above described constructs in R. sphaeroides, a 
drop was observed of at least 3 orders of magnitude in the number of surviving 
colonies upon  conjugation with the editing constructs compared to the non-targeting 
control construct (Figure 2A). 14 colonies were randomly picked from each plate and 
streaked on RÄ agar plates supplemented with 5-FU. All selected colonies from the 
conjugation plates with editing constructs -regardless the size of the employed HR 
template- grew on the 5-FU selection plates (Figure 2B). We genotyped all the selected co-
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The four editing plasmids and the pBBR_Cas9_NT control plasmid were conjugated 
in the plasmid-cured R. sphaeroides Δupp mutant. As expected, a great decrease in the 
number of surviving conjugants was observed for all the editing plasmids compared to the 
non-targeting control plasmid (Figure 3B). The upp genomic region from several colonies 
was amplified by colony PCR with genome specific primers. The editing constructs with 
500bp HR-flanking sites resulted in editing efficiencies of 5% and 10% for spacers 4 and 5 
respectively (Figure S3A, S3B). Increasing the size of the HR-flanking sites increased the 
editing efficiency to 15% for spacer 4 and to 95% for spacer 5 (Figure S3C, S3D). All 
the mutants were subsequently sequence verified for the existence of the “GTG” start 
codon (Figure 3C). This result shows that, unlike the upp deletion process, the efficiency of 
the upp knock-in process is influenced by the size of the HR-template; HR-templates with 
longer flanking regions lead to higher editing efficiencies.  
Fig. 3. Insertion of the gene upp in a Δupp locus with single point m utation. (A) Representation of theΔupp locus
before (left) and after (right) knock-in of the upp gene. The protospacers recognized by spacers sp4 and sp5 are
underlined and their PAM is in bold; spacers sp4 and sp5 were used for counter selection against Δupp. The 
flanking sites surrounding Δupp are in grey and blue, while the inserted upp sequence is in green; after introduction 
of the upp sequence, the protospacers sequences are disrupted, and the starting codon ATG is replaced by GTG
via a 1 bp substitution (red). (B) Colony form ing units (CFU) obtained after conjugation with pBBR_Cas9 
plasm ids (pBBR_Cas9_KIupp500HR_sp4, pBBR_Cas9_KIupp500HR_sp5, pBBR_Cas9_KIupp1000HR_sp4 
and pBBR_Cas9_KIupp1000HR) harbouring different Δupp targeting spacers (sp4 and sp5) and different size HR
tem plates (500 bp and 1000 bp) for the knock-in of the upp gene accom panied by single nucleotidesubstitution; 
the plasm id with the non-targeting spacer (pBBR_Cas9_NT) was used as control. (C) Sequence verification of the 
desired upp insertion and single nucleotide substitution, by sanger sequencing.
5’-GCCCGACCATGCTTGACCATTAAGGGAAACCCCGCTTTACAGAG-3’
3’-CGGGCTGGTACGAACTGGTAATTCCCTTTGGGGCGAAATGTCTC-5’
5’-GCCCGACCGTGCTTGACCATCTGACCGTCGTGACCCACCCGCTC-3’
3’-CGGGCTGGCACGAACTGGTAGACTGGCAGCACTGGGTGGGCGAG-5’
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lonies through colony PCR and sequencing, and we confirmed the desired clean 
deletions (Figure 2C, 2D). Meanwhile none of the selected colonies from the conjugation 
plates with control constructs grew on 5-FU selection plates (Figure 2B), underlining 
the significant contribution of spCas9 targeting to the high efficiency of the 
developed HR-spCas9 counter selection tool in R. sphaeroides.  
Prerequisite for extensive metabolic engineering studies with the HR-spCas9 tool in 
R. sphaeroides is the performance of rapid iterative genome editing cycles. This demands the 
curing of constructed mutants from the spCas9-harbouring editing plasmids via an easy and 
time-effective way. For this purpose, one of the previously constructed Δupp mutants was 
grown in LB broth medium without antibiotic for two iterative inoculation cycles of 24 hours 
each. After plating and incubating the final culture on LB agar plates without antibiotic for 
two days, 5 colonies were selected and re-streaked on LB agar plates with and without 
antibiotic (kanamycin). Colonies that grew only on the agar plate without antibiotic were 
subjected to colony PCR with plasmid specific primers and the plasmid loss was verified 
(Figure S2). The cured R. sphaeroides Δupp strain was further employed for the expansion of 
the spCas9-based toolbox.
HOMOLOGOUS RECOMBINATION- SpCAS9 COUNTER-SELECTION FOR 
GENE INSERTIONS AND SINGLE NUCLEOTIDE SUBSTITUTIONS 
To further expand the genome editing toolbox of R. sphaeroides , we proceeded with the 
development of a plasmid-based HR-spCas9 counter selection knock-in (KI) system. As a 
proof of principle, we designed a system for reinsertion of the upp gene in the genome of the 
previously constructed Δupp mutant strain. We selected two spacers (sp4 and sp5, Table S3) 
for the editing plasmids, aiming to target the remaining fraction of the upp gene in the genome 
of the Δupp mutant (Figure 3A). Moreover, we constructed HR templates containing the upp 
gene - with the “ATG” start codon substituted by the “GTG” as sequence verification marker - 
flanked by either the 500bp (pBBR_Cas9_KIupp500HR_sp4 and 
pBBR_Cas9_KIupp500HR_sp5) or the 1kb (pBBR_Cas9_KIupp1000HR_sp4 and 
pBBR_Cas9_KIupp1000HR_sp5) upstream and downstream genomic regions. Upon 
reinsertion of the upp gene into the Δupp genome the corresponding protospacers would be 
disrupted, providing resistance from the spCas9 targeting.  
The four editing plasmids and the pBBR_Cas9_NT control plasmid were conjugated 
in the plasmid-cured R. sphaeroides Δupp mutant. As expected, a great decrease in the 
number of surviving conjugants was observed for all the editing plasmids compared to the 
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sequencing, and we confirmed the desired clean deletions (Figure 2C, 2D). Meanwhile 
none of the selected colonies from the conjugation plates with control constructs grew 
on 5-FU selection plates (Figure 2B), underlining the significant contribution of 
spCas9 targeting to the high efficiency of the developed HR-spCas9 counter selection 
tool in R. sphaeroides.  
Prerequisite for extensive metabolic engineering studies with the HR-spCas9 tool in 
R. sphaeroides is the performance of rapid iterative genome editing cycles. This deman ds the 
curing of constructed mutants from the spCas9-harbouring editing plasmids via an easy and 
time-effective way. For this purpose, one of the previously constructed Δupp mutants was 
grown in LB broth medium without antibiotic for two iterative inoculation cycles of 24 
hours each. After plating and incubating the final culture on LB agar plates without 
antibiotic for two days, 5 colonies were selected and re-streaked on LB agar plates with and 
without antibiotic (kanamycin). Colonies that grew only on the agar plate without antibiotic 
were subjected to colony PCR with plasmid specific primers and the plasmid loss was 
verified (Figure S2). The cured R. sphaeroides Δupp strain was further employed for the 
expansion of the spCas9-based toolbox.
H O MO LO G O US RECO MBINATIO N- SpCAS9 CO UNTER SELECTIO N 
FO R G ENE INSERTIO NS AND SING LE NUCLEO TIDE SUBSTITUTIO NS 
To further expand the genome editing toolbox of R. sphaeroides , we proceeded with the 
development of a plasmid-based HR-spCas9 counter selection knock-in (KI) system. As a 
proof of principle, we designed a system for reinsertion of the upp gene in the genome of the 
previously constructed Δupp mutant strain. We selected two spacers (sp4 and sp5, Table S3) 
for the editing plasmids, aiming to target the remaining fraction of theupp gene in the 
genome of the Δupp mutant (Figure 3A). Moreover, we constructed HR templates containing 
the upp gene - with the “ATG” start codon substituted by the “GTG” as sequence verification 
marker - flanked by either the 500bp (pBBR_Cas9_KIupp500HR_sp4 and 
pBBR_Cas9_KIupp500HR_sp5) or the 1kb (pBBR_Cas9_KIupp1000HR_sp4 and 
pBBR_Cas9_KIupp1000HR_sp5) upstream and downstream genomic regions. Upon 
reinsertion of the upp gene into the Δupp genome the corresponding protospacers would be 
disrupted, providing resistance from the spCas9 targeting.  
non-targeting control plasmid (Figure 3B). The upp genomic region from 
several colonies was amplified by colony PCR with genome specific primers. The 
editing constructs with 500bp HR-flanking sites resulted in editing efficiencies of 
5% and 10% for spacers 4 and 5 respectively (Figure S3A, S3B). Increasing the 
size of the HR-flanking sites increased the editing efficiency to 15% for spacer 4 
and to 95% for spacer 5 (Figure S3C, S3D). All the mutants were 
subsequently sequence verified for the existence of the “GTG” start codon (Figure 
3C). This result shows that, unlike the upp deletion process, the efficiency of the 
upp knock-in process is influenced by the size of the HR-template; HR-templates 
with longer flanking regions lead to higher editing efficiencies.  
5’-GCCCGACCATGCTTGACCATTAAGGGAAACCCCGCTTTACAGAG-3’
3’-CGGGCTGGTACGAACTGGTAATTCCCTTTGGGGCGAAATGTCTC-5’
5’-GCCCGACCGTGCTTGACCATCTGACCGTCGTGACCCACCCGCTC-3’
3’-CGGGCTGGCACGAACTGGTAGACTGGCAGCACTGGGTGGGCGAG-5’
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Fig. 3. Insertion of the gene upp in a Δupp locus with single point mutation. (A) Representation of the Δupp locus 
before (left) and after (right) knock-in of the upp gene. The protospacers recognized by spacers sp4 and sp5 are 
underlined and their PAM is in bold; spacers sp4 and sp5 were used for counter selection against Δupp. The 
flanking sites surrounding Δupp are in grey and blue, while the inserted upp sequence is in green; after introduction 
of the upp sequence, the protospacers sequences are disrupted, and the starting codon ATG is replaced by GTG 
via a 1 bp substitution (red). (B) Colony forming units (CFU) obtained after conjugation with pBBR_Cas9 
plasmids (pBBR_Cas9_KIupp500HR_sp4, pBBR_Cas9_KIupp500HR_sp5, pBBR_Cas9_KIupp1000HR_sp4 
and pBBR_Cas9_KIupp1000HR) harbouring different Δupp targeting spacers (sp4 and sp5) and different size HR 
templates (500 bp and 1000 bp) for the knock-in of the upp gene accompanied by single nucleotide substitution; 
the plasmid with the non-targeting spacer (pBBR_Cas9_NT) was used as control. (C) Sequence verification of the 
desired upp insertion and single nucleotide substitution, by sanger sequencing. 
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NHEJ GENES DELETIONS VIA HR-CAS9 COUNTER SELECTION TOOL 
The majority of the prokaryotic NHEJ mechanisms consist of an ATP-dependent DNA ligase 
(LigD) and a DNA-end-binding protein (Ku), encoded by the ligD and ku genes that are 
typically clustered41,42. Surprisingly, the R. sphaeroides genome encompasses a NHEJ 
system consisted of one ligD and two ku homologs. The latter are adjacent on the 
large chromosome of R. sphaeroides , in opposing directions with their stop codons 
being in proximity. The sequence difference of the two ku homologs renders it 
unlikely that they are the result of a recent duplication event. The ligD gene, on 
the other hand, is located separately at a distance of approximately 1Mb of the ku genes.  
The aforementioned spCas9 targeting assays results suggested that the native NHEJ 
system of R. sphaeroides  can repair spCas9-induced DSBs. To analyze the involvement of 
LigD and the Ku proteins in the NHEJ process, single and combinatorial deletion of the 
corresponding genes were generated and the resulting mutants were subjected and to  the 
spCas9 targeting assays. The knockout of the ligD, ku1 and ku2 genes was carried out using 
the here established HR-spCas9 counter selection tool. Τhe pBBR_Cas9_Δku1, 
pBBR_Cas9_Δku2 and pBBR_Cas9_ΔligD vectors were employed for the substitution of 
150bp long DNA fragments, roughly located 100bp downstream the start codon of each gene, 
with a “stop-sequence” containing three stop codons in a row and a BamHI restriction site 
(5’-TGATGATGAGGATCC-3’). The double Δku1_Δku2 mutant strain was constructed via 
a sequential process, that started with the knock out of the ku1 gene followed by the knock 
out of the ku2 gene. The employed spacers are listed in Table S3. The efficiencies of the 
knock out processes were lower than the efficiency of the upp deletion process, although still 
11 to 30% of the screened colonies were sequence verified as clean mutants (Table S6). At 
least two verified mutant colonies per strain were cultured, then cured from the 
corresponding editing plasmids and finally employed for the following targeting experiment. 
TARGETING  ASSAYS WITH NHEJ MUTANTS
We aimed to evaluate the efficiency of the native NHEJ mechanism of R. sphaeroides to 
repair spCas9 induced DSBs. For this purpose we conjugated each constructed NHEJ mutant 
strain (Δku1, Δku2, Δku1_Δku2, ΔligD) and the wild type R. sphaeroides with the non-
targeting vector pBBR_Cas9_NT and the previously tested upp targeting vectors 
pBBR_Cas9_sp1 and pBBR_Cas9_sp2. As expected, there was a drop of at least 3 orders of 
magnitude in the number of surviving colonies upon conjugation with the targeting 
constructs compared to the control construct, for all the strains (Figure 4a). Surviving were fu
RÄ_5-FU agar plates. None of the ΔligD streaked colonies survived the 5-FU selection, 
confirming the significance of this gene for the NHEJ activity in R. sphaeroides (Table S7). 
On the contrary, 5% to 20% of the wild type, Δku1, Δku2 and Δku1_ Δku2 streaked colonies 
survived the 5-FU selection and their upp genomic region was PCR amplified and sequenced 
(Table S7). The wild type colonies were shown to contain stop codon forming SNPs within 
the selected protospacer regions. Surprisingly, SNPs and indel mutations were observed in 
the protospacer regions within the genomes of most Δku1, Δku2 and Δku1_ Δku2 mutant 
strains (Table S8). Hence, the vast majority of the screenedcolonies that survived the 5-FU 
selection and contained an intact ligD gene copy in their genome were proven to be Δupp 
mutants with mutations within the targeted protospacer region. Meanwhile, the spCas9 
targeting system based on spacer 2 exhibited the highest efficiency (Table S7). This finding, 
in combination with the corresponding result from the ΔligD mutants, suggests either that the 
Ku activity is not essential for the R. sphaeroides NHEJ system, or that R. sphaeroides uses 
an alternative NHEJ mechanism in which the LigD activity requires assistance of one or 
more elusive proteins.
Fig. 4. Assessment of NHEJ activity in R. sphaeroides ΔligD, Δku1, Δku2 and Δku1-2 mutant strains. (A) 
CFUs obtained after conjugation of the mutant strains with the pBBR_Cas9_sp1 and pBBR_Cas9_sp2 upp
targeting plasmids. The plasmid with the non-targeting spacer (pBBR_Cas9_NT) was used as control. Average 
values of three replicates are shown, with error bars representing standard deviations. (B) Examples of Sanger 
sequencing results on the upp loci corresponding to the protospacers (underlined) recognized by spacers sp1 
ans sp2; the prosotspacer adjacent motifs (PAM) are in light blue. Above the line is shown the protospacer in 
the wild-type genome while, below the continuous dark line, are shown examples of mutations detected in the 
mutant strains Δku1, Δku2 and Δku1-2, in bold. The insertions or deletions (indels) detected in the protospacer 
regions are shown in red. The selected colonies had previously survived the 5FU selection (no survival 
detected in ΔligD strain).
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NH EJ G ENES DELETIO NS VIA H R-CAS9 CO UNTER SELECTIO N TO O L 
The majority of the prokaryotic NHEJ mechanisms consist of an ATP-dependent DNA
ligase (LigD) and a DNA-end-binding protein (Ku) , encoded by the ligD and ku genes
that are typically clustered (41, 42). Surprisingly, the R. sphaeroides genome encompasses
a NHEJ system consisted of one ligD and two ku homologs. The latter are adjacent on 
the large chromosome of R. sphaeroides , in opposing directions with their stop 
codons being in proximity. The sequence difference of the two ku homologs renders it
unlikely that they are the result of a recent duplication event. The ligD gene, on the other
hand, is located separately at a distance of approximately 1Mb of theku genes.  
The aforementioned spCas9 targeting assays results suggested that the native
NHEJ system ofR. sphaeroides can repair spCas9-induced DSBs. To analyze the involvement
of LigD and the Ku proteins in the NHEJ process, single and combinatorial
deletion of the corresponding genes were generated and the resulting mutants were
subjected and to the spCas9 targeting assays. The knockout of the ligD, ku1 and ku2 genes
was carried out using the here established HR-spCas9 counter selection tool. Τhe
pBBR_Cas9_Δku1, pBBR_Cas9_Δku2 and pBBR_Cas9_ΔligD vectors were employed 
for the substitution of 150bp long DNA fragments, roughly located 100bp downstream
the start codon of each gene, with a “stop-sequence” containing three stop codons in 
a row and a BamHI restriction site (5’-TGATGATGAGGATCC-3’). The double
Δku1_Δku2 mutant strain was constructed via a sequential process, that started with the
knock out of the ku1 gene followed by the knock out of the ku2 gene. The employed spacers
are listed in Table S3. The efficiencies of the knock out processes were lower than the
efficiency of the upp deletion process, although still 11 to 30% of the screened colonies
were sequence verified as clean mutants (Table S6). At least two verified mutant colonies
per strain were cultured, then cured from the corresponding editing plasmids and finally 
employed for the following targeting experiment. 
TARG ETING ASSAYS WITH  NH EJ MUTANTS
We aimed to evaluate the efficiency of the native NHEJ mechanism ofR. sphaeroides to 
repair spCas9 induced DSBs. For this purpose we conjugated each constructed NHEJ mutant
strain (Δku1, Δku2, Δku1_Δku2, ΔligD) and the wild type R. sphaeroides with the non-
targeting vector pBBR_Cas9_NT and the previously tested upp targeting vectors
pBBR_Cas9_sp1 and pBBR_Cas9_sp2. As expected, there was a drop of at least 3 orders of
magnitude in the number of surviving colonies upon conjugation with the targeting 
constructs compared to the control construct, for all the strains (Figure 4a). Surviving 
colonies were further streaked on solid 
rther streaked on solid RÄ_5-FU agar plates. None of the ΔligD streaked colonies survived 
the 5-FU selection, confirming the significance of this gene for the NHEJ activity in R. 
sphaeroides (Table S7). On the contrary, 5% to 20% of the wild type, Δku1, Δku2 and Δku1_ 
Δku2 streaked colonies survived the 5-FU selection and their upp genomic region was PCR 
amplified and sequenced (Table S7). The wild type colonies were shown to contain stop 
codon forming SNPs within the selected protospacer regions. Surprisingly, SNPs and indel 
mutations were observed in the protospacer regions within the genomes of most Δku1, Δku2 
and Δku1_ Δku2 mutant strains (Table S8). Hence, the vast majority of the screened colonies 
that survived the 5-FU selection and contained an intact ligD gene copy in their genome were 
proven to be Δupp mutants with mutations within the targeted protospacer region. 
Meanwhile, the spCas9 targeting system based on spacer 2 exhibited the highest efficiency
(Table S7). This finding, in combination with the corresponding result from the ΔligD 
mutants, suggests either that the Ku activity is not essential for the R. sphaeroides NHEJ 
system, or that R. sphaeroides uses an alternative NHEJ mechanism in which the LigD
activity requires assistance of one or more elusive proteins.
1.E+00
1.E+01
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1.E+04
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1.E+06
1.E+07
wt
ΔligD
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Δku2
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FU
CACCTTCGC-ATAATA-TTGCACGG
CACCTTCGCAATAATA-TTGCACGG 
CACCTTCGC-ATAATATTTGCACGG
ATCGATCTCCCGAAGGAGAA------GGGGGCGAAGAA
Protospacer(sp2) PAM
WT
Protospacer(sp1) PAM
ATCGATCTCCCGAAGTAGAA------GGGGGCGAAGAA
ATCGATCTCCCGAAG-AGAA------GGGGGCGAAGAA
ATCGATCTCCCGAAGGAGAAGGAGAAGGGGGCGAAGAA
ATCGATCTCCCGAAGGAGAA--------------AAGA
WT
Δku1, Δku2
Δku1
Δku1-2
Δku2
Δku2
Δku2
Efficient Cas9-based genome editing of Rhodobacter sphaeroides
Fig. 4. Assessment of NHEJ activity in R. sphaeroides ΔligD, Δku1, Δku2 and Δku1-2 mutant strains. (A) 
CFUs obtained after conjugation of the mutant strains with the pBBR_Cas9_sp1 and pBBR_Cas9_sp2 upp 
targeting plasmids. The plasmid with the non-targeting spacer (pBBR_Cas9_NT) was used as control. Average 
values of three replicates are shown, with error bars representing standard deviations. (B) Examples of Sanger 
sequencing results on the upp loci corresponding to the protospacers (underlined) recognized by spacers sp1 
ans sp2; the prosotspacer adjacent motifs (PAM) are in light blue. Above the line is shown the protospacer in 
the wild-type genome while, below the continuous dark line, are shown examples of mutations detected in the 
mutant strains Δku1, Δku2 and Δku1-2, in bold. The insertions or deletions (indels) detected in the protospacer 
regions are shown in red. The selected colonies had previously  survived the 5FU selection (no survival 
detected in ΔligD strain). 
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DISCUSSION
A number of studies have reported the efficient manipulation of native CRISPR-Cas systems 
in bacteria and archaea for genome engineering purposes44,45. R. sphaeroides encompasses a
type I-E CRISPR-Cas system within its genome. We reasoned not to characterize and employ 
it for genome editing purposes, as we wanted to create a tool adaptable to other Rhodobacter 
species and R. sphaeroides  strains that do not encompass the same CRISPR-Cas system
as the here employed strain. Moreover, recent studies have reported the existence of a
wide range of anti-CRISPR systems within bacterial genomes that deactivate native 
CRISPR-Cas systems46. The existence of such a system in the genome of R. sphaeroides 
has not been identified and reported yet, but possible existence could render the 
development of a native CRISPR-Cas based tool difficult. 
In this study we developed a spCas9-based genome editing toolbox for
R. sphaeroides . We demonstrated that it is possible to construct knock-out and knock-in
strains, as well as strains with single nucleotide substitutions, with high efficiency and in a
reduced time-frame, by employing an HR-spCas9 counter selection approach. This
potential will accelerate fundamental studies, amongst others, on membrane and
photosynthetic reaction centre proteins, as well as metabolic engineering studies for
improved hydrogen production and terpene synthesis.
The use of NHEJ-based error prone repair of Cas9-induced DSBs is a 
common approach for gene knock-outs in eukaryotes47. In prokaryotes this is a rather rarely 
employed approach40,48,49, since most bacteria appear to lack a native NHEJ system. That 
explains why the few available examples of successful knock-outs through the Cas9-
NHEJ combination rely on the expression of heterologous NHEJ systems40,49. Here, we 
demonstrated that the native NHEJ system of R. sphaeroides  can repair spCas9-induced 
breaks at easy-to-screen rates. This tool is based on a low complexity cloning approach, 
allowing for the simultaneous and cost-efficient construction of multiple spCas9-based 
targeting constructs at once. Hence, the development of an efficient Cas9-NHEJ tool
in R. sphaeroides  allows for rapid construction of an extensive library of knock-out 
strains. Potentially, the efficiency of the here developed tool could be further improved by
the deletion of the recA gene from the R. sphaeroides  genome. This approach was
previously reported to enhance the spCas9 targeting efficiency in E. coli, regardless the 
employed spacer, and to eliminate non-mutated surviving colonies rescued by unedited 
genome templates via RecA-dependent HR40.
The α-proteobacteria are unique amongst bacteria because they possess two genes
encoding distantly related Ku variants. Since Ku is a component of the canonical NHEJ
system(Figure 1D), we decided to analyse the potential role of these Ku homologs in the
NHEJ system of R. sphaeroides . After performing multiple spCas9 targeting experiments
with a series of the NHEJ mutants, weunexpectedly demonstrated that deletion of the two 
Ku homologs did not affect the efficiency of the R. sphaeroides NHEJ. A possible
explanation could recite in the expression of a protein with Ku characteristics (DNA-end 
binding), such as the host-nuclease inhibitor protein Gam from the Mu phage, but a gene
encoding such protein was not identified in the R. sphaeroides genome50. On the other hand,
the LigD ligase was proven to be indispensable for NHEJ activity. This conclusion comes in 
complete contrast to what it waspreviously demonstrated when the only other Cas9-native
NHEJ tool was reported for bacteria48. In that study, Streptomyces coelicolor was
demonstrated to contain an active butincomplete NHEJsystem, lacking aligD homolog. It
was hypothesized that the LigD function was substituted by other ligases. This explanation 
was supported by the random size of thecreated indel mutations from the emplo yed spCas9-
targeting system, that could extent up to 30kb deletions. In comparison, the targeted indel
mutations generated by our system within the R. sphaeroides genome were restricted in 
length and the longest observed deletion was only 55bp long. Heterologous expression of
the Mycobacterium tuberculosis ligD in S. coelicolor raised the efficiency of the system and 
resulted in shorter indel mutations of 1 to 3 nucleotides.All in all, these results indicate the
existence of an unprecedented prokaryotic NHEJ in R. sphaeroides , and probably in all α-
proteobacteria, that contains either an additional not identified distantly related ku 
homolog, or one or more elusive enzymes with an analogous function, i.e. to protect loose
DNA ends and recruit the LigD.
In our work we demonstrated that the spCas9 endonuclease is active in 
the biotechnologically interesting bacterium R. sphaeroides . We further combined the
spCas9 targeting activity with the native homologous recombination (HR) and non-
homologous end joining (NHEJ) mechanisms ofR. sphaeroides for the development of
efficient genome editing tools. These tools can substantially accelerate fundamental and 
metabolic engineering studies on R. sphaeroides, as already have been achieved for
other microorganisms with developed spCas9 toolbox. Finally, we used the tools for the
deletion of the NHEJ genes of R. sphaeroides and we demonstrated the existence of an 
unprecedented NHEJ mechan ism. 
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A number of studies have reported the efficient manipulation of native CRISPR-Cas systems
in bacteria and archaea for genome engineering purposes44,45. R. sphaeroides encompasses a
type I-E CRISPR-Cas system within its genome. We reasoned not to characterize and 
employ it for genome editing purposes, as we wanted to create a tool adaptable to other
Rhodobacter species and R. sphaeroides strains that do not encompass the same CRISPR-
Cas system as the here employed strain. Moreover, recent studies have reported the existence
of a wide range of anti-CRISPR systems within bacterial genomes that deactivate
native CRISPR-Cas systems46. The existence of such a system in the genome of R. 
sphaeroides has not been identified and reported yet, but possible existence could render
the development of a native CRISPR-Cas based tool difficult. 
In this study we developed a spCas9-based genome editing toolbox for R. 
sphaeroides. We demonstrated that it is possible to construct knock-out and knock-i n
strains, as well as strains with single nucleotide substitutions, with high efficiency and in a
reduced time-frame, by employing an HR-spCas9 counter selection approach. This
potential will accelerate fundamental studies, amongst others, on membrane and 
photosynthetic reaction centre proteins, as well as metabolic engineering studies for
improved hydrogen production and terpene synthesis.  
The use of NHEJ-based error prone repair of Cas9-induced DSBs is a common 
approach for gene knock-outs in eukaryotes47. In prokaryotes this is a rather rarely 
employed approach40,48,49, since most bacteria appear to lack a native NHEJ system. That
explains why the few available examples of successful knock-outs through the Cas9-
NHEJ combination rely on the expression of heterologous NHEJ systems40,49. Here, we
demonstrated that the native NHEJ system ofR. sphaeroides can repair spCas9-induced 
breaks at easy-to-screen rates. This tool is based on a low complexity cloni ng
approach, allowing for the simultaneous and cost-efficient construction of
multiple spCas9-based targeting constructs at once. Hence, the development of
an efficient Cas9-NHEJ tool in R. sphaeroides allows for rapid construction of an 
extensive library of knock-out strains. Potentially, the efficiency of the here
developed tool could be further improved by the deletion of the recA gene from the
R. sphaeroides genome. This approach was previously reported to enhance the spCas9
targeting efficiency in E. coli, regardless the employed spacer, and to eliminate non-
mutated surviving colonies rescued by unedited genome templates via RecA-dependent
HR40.
The α-proteobacteria are unique amongst bacteria because they possess two genes 
encoding distantly related Ku variants. Since Ku is a component of the canonical NHEJ 
system(Figure 1D), we decided to analyse the potential role of these Ku homologs in the 
NHEJ system of R. sphaeroides . After performing multiple spCas9 targeting experiments 
with a series of the NHEJ mutants, we unexpectedly demonstrated that deletion of the two Ku 
homologs did not affect the efficiency of the R. sphaeroides  NHEJ. A possible explanation 
could recite in the expression of a protein with Ku characteristics (DNA-end binding), such 
as the host-nuclease inhibitor protein Gam from the Mu phage, but a gene encoding such 
protein was not identified in the R. sphaeroides  genome50. On the other hand, the LigD ligase 
was proven to be indispensable for NHEJ activity. This conclusion comes in complete
contrast to what it was previously demonstrated when the only other Cas9-native NHEJ tool
was reported for bacteria48. In that study, Streptomyces coelicolor was demonstrated to
contain an active but incomplete NHEJ system, lacking a ligD homolog. It was hypothesized
that the LigD function was substituted by other ligases. This explanation was supported by 
the random size of the created indel mutations from the employed spCas9-targeting system, 
that could extent up to 30kb deletions. In comparison, the targeted indel mutations generated 
by our system within the R. sphaeroides  genome were restricted in length and the longest
observed deletion was only 55bp long. Heterologous expression of the Mycobacterium 
tuberculosis ligD in S. coelicolor raised the efficiency of the system and resulted in shorter
indel mutations of 1 to 3 nucleotides. All in all, these results indicate the existence of an
unprecedented prokaryotic NHEJ in R. sphaeroides , and probably in all α-proteobacteria, that 
contains either an additional not identified distantly related  ku homolog, or one or more 
elusive enzymes with an analogous function, i.e. to protect loose DNA ends and recruit the 
LigD.
In our work we demonstrated that the spCas9 endonuclease is active in
the biotechnologically interesting bacterium R. sphaeroides . We further combined the
spCas9 targeting activity with the native homologous recombination (HR) and non-
homologous end joining (NHEJ) mechanisms of  R. sphaeroides for the development
of efficient genome editing tools. These tools can substantially
accelerate fundamental and metabolic engineering studies on R. sphaeroides, 
as already have been achieved for other microorganisms with developed 
spCas9 toolbox. Finally, we used the tools for the deletion of the NHEJ genes of R. 
sphaeroides and we demonstrated the existence of an unprecedented NHEJ
mechanism. 
Efficient Cas9-based genome editing of Rhodobacter sphaeroides
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MATERIALS AND METHODS
BACTERIAL STRAINS, MEDIA AND GROWTH CONDITIONS
The strains used in this study are listed in Table 1. E. coli DH5a was used for cloning 
and routine amplification. E. coli S17-1 was used as vector donor for R. sphaeroides 
in diparental conjugation.  
Culturing of R. sphaeroides was performed in RÄ minimal or LB (Luria-
Bertani) medium at 250 rpm, 30ºC. Growth on solid medium was performed on  
Ä R supplemented with 15% w/v agar. Culturing of E. coli strains was performed
in LB medium at 250 rpm, 37ºC. Growth on solid medium was performed on 
LB supplemented with 15% w/v agar. When required, kanamycin (50 µg/mL) was
added for all the mentioned growing conditions. 
Table 1. List of strains used in this study 
Strain Description Reference 
E. coli
DH5α 
. fhuA2 Δ(argF-lacZ)U169 phoA glnV44 
Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 
endA1 thi-1 hsdR17 . Strain for assembly 
and plasmid amplification 
Laboratory stock 
S17-1 
Host strain for transconjugation, thi pro 
recA hsdR [RP4-2Tc::Mu-Km ::Tn7] 
Tpr Smr 
Laboratory stock 
R. sphaeroides
265-9c Wild type ATCC 35053 
derivative (52, 53) 
Δupp 265-9cΔupp This study 
Δku1 265-9cΔku1 This study 
Δku2 265-9cΔku2 This study 
ΔligD 265-9cΔligD This study 
Δku1-2 265-9cΔku1_Δku2 This study 
uppKI 265-9cΔupp, KI(ATG->GTG)upp This study 
Δku1Δupp 265-9cΔku1Δupp This study 
Δku2Δupp 265-9cΔku2Δupp This study 
Δku1-2Δupp 265-9cΔku1-2Δupp This study 
PLASMIDS CO NSTRUCTIO N
The plasmids constructed and the primers used for cloning and sequencing are listed 
in Supplementary Tables S1 and S2, respectively. All primers for PCR were prepared 
by Integrated DNA Technologies (IDT) and all the PCR amplifications were performed 
using Q5 High-Fidelity DNA polymerase Master Mix 2x from New England Biolabs (NEB)
according to the manufacturer’s protocol. Due to the high GC content of R. sphaeroides
genome, all PCR reactions using its genomic DNA as template were supplemented with 
DMSO 3% v/v. PCR fragment assemblies were performed emplo ying the HiFi
Assembly kit (NEB). Prior to plasmids assemblies, all PCR products were purified via
gel extraction using the Zymoclean Gel DNA Recovery Kit (Zymo Research). Plasmid 
extractions were performed using the GeneJET Plasmid Miniprep kit (Thermo Fisher
Scientific) and R. sphaeroides genome extractions were performed using the GeneJET
Genomic DNA Purification Kit (Thermo FisherScientific). 
G ENERATIO N OF TH E NO N-TARG ETING CAS9 PLASMID
A synthetic construct containing the sgRNA construct (promoter BBa_J95023, sgRNA
scaffold and BBa_J95029 terminator ) was ordered as gBlock from Integrated DNA
Technologies (Leuven, Belgium). After restriction digestion with SmaI and SalI (Thermo 
Fisher Scientific), the sgRNA construct was ligated into the pUC19 vector and transformed 
into E. coli TOP10 cells for storage and amplification. Subsequently, the pUC19 containing 
the sgRNA construct and the pBBR1MCS2 E. coli-R. sphaeroides shuttle vector were
digested with the same restriction enzymes. After digestion, the sgRNA construct and 
the pBBR1MCS2 backbone were ligated with T4 ligase (Thermo Fisher Scientific) yielding 
the pBBR1MCS2-sgRNA. The spCas9 gene, was codon-harmonized according to R. 
sphaeroides codon-usage using the Galaxy / Codon harmonizer on-line tool (34). The
codon-harmonized spCas9 was synthetically constructed by Baseclear (the Netherlands)
with a 6xHis-tag fused at its C-terminus, and delivered inserted in a pUC57 vector
backbone. The spCas9 gene was PCR amplified using thepUC57hspCas9 vector as template
and primers BG10937/BG10938. The pBBR-sgRNA vector was linearized using primers
BG10939/BG10941. The construction of the non-targeting plasmid pBBR_Cas9_NT
vector was done via HiFi assembly of the two aforementioned PCR amplicons and the
spCas9 amplicon was inserted downstream of the lac promoter site of the pBBR-sgRNA. 
The lack of lacIq repressor gene or its homolog in R. sphaeroides genome allowed 
constitutive transcription of the harmonized spCas9 gene.  
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BACTERIAL STRAINS, MEDIA AND G RO WTH CO NDITIO NS
The strains used in this study are listed in Table 1. E. coli DH5a was used for cloning 
and routine amplification. E. coli S17-1 was used as vector donor for R. sphaeroides in 
diparental conjugation.  
Culturing of R. sphaeroides was performed in RÄ minimal or LB (Luria-
Bertani) medium at 250 rpm, 30 ºC. Growth on solid medium was performed on RÄ
supplemented with 15% w/v agar. Culturing of E. coli strains was performed in LB
medium at 250 rpm, 37 ºC. Growth on solid medium was performed on LB
supplemented with 15% w/v agar. When required, kanamycin (50 µg/mL) was added for
all the mentioned growing conditions. 
Table 1. List of strains used in this study
Strain Description Reference
E. coli
DH5α
. fhuA2 Δ(argF-lacZ)U169 phoA glnV44 
Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 
endA1 thi-1 hsdR17Strain for assem bly
and plasm id am plification
Laboratory stock
S17-1
Host strain for transconjugation, thi pro 
recA hsdR [RP4-2Tc::Mu-Km ::Tn7]
Tpr Smr
Laboratory stock
R. sphaeroides
265-9c Wild type ATCC 35053 
derivative (52, 53)
Δupp 265-9cΔupp This study
Δku1 265-9cΔku1 This study
Δku2 265-9cΔku2 This study
ΔligD 265-9cΔligD This study
Δku1-2 265-9cΔku1_Δku2 This study
uppKI 265-9cΔupp, KI(ATG->GTG)upp This study
Δku1Δupp 265-9cΔku1Δupp This study
Δku2Δupp 265-9cΔku2Δupp This study
Δku1-2Δupp 265-9cΔku1-2Δupp This study
PLASMIDS CONSTRUCTION
The plasmids constructed and the primers used for cloning and sequencing are listed 
in Supplementary Tables S1 and S2, respectively. All primers for PCR were prepared 
by Integrated DNA Technologies (IDT) and all the PCR amplifications were performed
using Q5 High-Fidelity DNA polymerase Master Mix 2x from New England Biolabs 
(NEB) according to the manufacturer’s protocol. Due to the high GC content of R. 
sphaeroides genome, all PCR reactions using its genomic DNA as template
were supplemented with DMSO 3% v/v. PCR fragment assemblies were performed
employing the HiFi Assembly kit (NEB). Prior to plasmids assemblies, all PCR products 
were purified via gel extraction using the Zymoclean Gel DNA Recovery Kit 
(Zymo Research). Plasmid extractions were performed using the GeneJET 
Plasmid Miniprep kit (Thermo Fisher Scientific) and R. sphaeroides genome
extractions were performed using the GeneJET Genomic DNA Purification 
Kit (Thermo Fisher Scientific). 
GENERATION OF THE NON-TARGETING CAS9 PLASMID
A synthetic construct containing the sgRNA construct (promoter BBa_J95023, 
sgRNA scaffold and BBa_J95029 terminator) was ordered as gBlock from
Integrated DNA Technologies (Leuven, Belgium). After restriction digestion with SmaI
and SalI (Thermo Fisher Scientific), the sgRNA construct was ligated into the pUC19 
vector and transformed into E. coli TOP10 cells for storage and amplification. 
Subsequently, the pUC19 containing the sgRNA construct and the pBBR1MCS2 E. 
coli-R. sphaeroides shuttle vector were digested with the same restriction enzymes. 
After digestion, the sgRNA construct and the pBBR1MCS2 backbone were ligated with 
T4 ligase (Thermo Fisher Scientific) yielding the pBBR1MCS2-sgRNA. The spCas9 gene, 
was codon-harmonized according to R. sphaeroides codon-usage using the Galaxy/Codon 
harmonizer on-line tool34. The codon-harmonized spCas9 was synthetically constructed by 
Baseclear (the Netherlands) with a 6xHis-tag fused at its C-terminus, and delivered inserted 
in a pUC57 vector backbone. The spCas9 gene was PCR amplified using the 
pUC57hspCas9 vector as template and primers BG10937/BG10938. The pBBR-sgRNA 
vector was linearized using primers BG10939/BG10941. The construction of the non-
targeting plasmid pBBR_Cas9_NT vector was done via HiFi assembly of the two 
aforementioned PCR amplicons and the spCas9 amplicon was inserted downstream of the 
lac promoter site of the pBBR-sgRNA. The lack of lacIq repressor or its homolog in R. 
sphaeroides genome allowed constitutive transcription of the harmonized spCas9 gene.  
Efficient Cas9-based genome editing of Rhodobacter sphaeroides
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GENERATION OF THE UPP TARGETING PLASMIDS
The spacers introduced in the sgRNA construct of the pBBR_Cas9 vectors are listed in the 
Supplementary Table S3. Using the plasmid pBBR_Cas9_NT as template, it was possible to 
substitute the non-targeting spacer contained in the sgRNA construct with three different 
targeting spacers for the gene uracyl-phosphoribosytransferase upp (sp1-sp3). The 
pBBR_Cas9_NT was used as template for PCR amplification of the backbone, the start 
codon and part of the spCas9 gene, employing primers BG11415/BG11416. The remaining
spCas9 sequence and the promoter of the sgRNA construct were PCR amplified employing
primer BG11412 in combination with primers BG11486, BG11487 and BG11411, which also 
contained the spacer 1, 2 and 3 sequences respectively as overhangs. The remaining part of 
the backbone and the constant part of the sgRNA construct were PCR amplified employing
primer BG11413 in combination with primers BG11488, BG11489 and BG11414 which also 
contained the spacer 1, 2 and 3 sequences respectively as overhangs. 3 fragments assemblies
were performed and the reaction mixtures were transformed in DH5α E. coli competent cells 
(NEB) via heat shock, for storage and plasmid amplification. Upon sequence verification, 
the pBBR_Cas9_NT plasmid was transformed to E. coli S17-1 cells.
GENERATION OF VECTORS FOR GENE KNOCK -OUTs (KO) AND 
GENE KNOCK -INs (KI)
Homologous recombination (HR) followed by Cas9-based counter selection was 
used for the KO of the upp, ligD, ku1 and ku2 genes, as well as the KI of the upp 
gene back to its original place in the R. sphaeroides  genome combined with single 
nucleotide substitution.
Plasmids for upp K O
We started by constructing the HR control, non-targeting plasmids 
pBBR_Cas9_Δupp500HR_NT and pBBR_Cas9_Δupp1000HR_NT. The pBBR_Cas9_NT 
backbone was PCR linearized into two fragments via two PCR reactions using the primers 
sets BG11886/BG11182 and BG11887/BG11888. For HR purposes, the 500bp or 1kb long 
upstream and downstream flanking sites of the upp gene from the R. sphaeroides genome
were PCR amplified employing the primer sets BG11866/BG11867 and BG11869/BG11871 
for the 500bp sizes and the primer sets BG11866/BG11868 and BG11870/BG11871 for the 
1kb sizes. All 4 fragments contained overhangs suitable for HiFi assembly reactions. The two 
pBBR_Cas9_NT fragments and  the two combinations of the HR fragments were assembled
generating the non-targeting, HR control plasmids pBBR_Cas9_Δupp500HR_NT and
in R. sphaeroides. Upon sequence verification in DH5α E. coli, both plasmids were
transformed to E. coli S17-1 cells.
We proceeded with the construction of the HR-editing, targeting plasmid s
pBBR_Cas9_Δupp500HR_sp2 and pBBR_Cas9_Δupp1000HR_sp2. The
previously mentioned couples of primer sets were used for the generation of the 500bp 
and 1kb HR flanking sites. The pBBR_Cas9_NT vector was employed as template
for the PCR amplification of the conserved backbone region included within the
amplification with the BG11887/BG11888 primer set. In addition, the spacer sp2 was
included in the corresponding position employing the primer sets BG11182/BG11487 
and BG11489/BG11886 for the amplification of the spCas9 gene and the sgRNA module
respectively. Then, 5 fragments were assembled to generate pBBR_Cas9_Δupp500HR_sp2 
and pBBR_Cas9_Δupp1000HR_sp2. Upon sequence verification in DH5α E. coli, both 
plasmids were transformed to E. coli S17-1 cells. 
Plasmids for NH EJ genes K O
For the selective deletion of ku1, ku2 and ligD, targeting plasmids were generated with a
similar approach used for assembling theupp targeting plasmids. The primers set BG11887/
BG11888 was used for amplifying the conserved backbone sequence of pBBR_Cas9_NT. 
The 1000 bp flanking sites (with overhangs) for ligD, ku1 and ku2 were obtained with the
primers sets BG12363/BG12366 and BG12365/BG12364 (ligD), BG12360/BG12359 and 
BG12361/BG12362 (ku1), BG12357/BG12356 and BG12355/BG12358 (ku2). The
backbone interspace included between the sgRNA (listed in Supplementary Table 3) and the
flanking sites of the target genes was amplified from pBBR_Cas9_NT using the primer sets
BG11886/BG12340 (ligD), BG11886/BG12336 (ku1) and BG11886/BG12339 (ku2). 
Similarly, from thesame pBBR_Cas9_NT template, thespCas9 sequences including the
sgRNA with the spacer of interest were obtained combining primers BG11182/BG12325 
(ligD), BG11182/BG12333 (ku1) and BG11182/BG12330 (ku2). The 5 fragments assembly 
in E. coli DH5α, generated the plasmids pBBR_Cas9_Δku1, pBBR_Cas9_Δku2 and 
pBBR_Cas9_ΔligD. Upon sequence verification, the plasmids were transformed in E. coli
S17.
Plasmids for upp K I
Also here we employed the aforementioned strategy as for generating the upp KO
plasmids. The pBBR_Cas9_NT plasmid was used as template for the amplification of
the fragments containing the backbone (primer set BG11887/BG11888), spCas9 and the
targeting sgRNAs. 
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G ENERATIO N OF TH E UPP TARG ETING PLASMIDS
The spacers introduced in the sgRNA construct of the pBBR_Cas9 vectors are listed in the
Supplementary Table S3. Using the plasmid pBBR_Cas9_NT as template, it was possible to 
substitute the non-targeting spacer contained in the sgRNA construct with three different
targeting spacers for the gene uracyl-phosphoribosytransferase upp (sp1-sp3). The
pBBR_Cas9_NT was used as template for PCR amplification of the backbone, the start
codon and part of the spCas9 gene, employing primers BG11415/BG11416. The remaining 
spCas9 sequence and the promoter of the sgRNAconstruct were PCR amplified employing 
primer BG11412 in combination with primers BG11486, BG11487 and BG11411, which 
also contained the spacer 1, 2 and 3 sequences respectively as overhangs. The remaining part
of the backbone and the constant part of the sgRNA construct were PCR amplified 
employing primerBG11413 in combination with primers BG11488, BG11489 and BG11414 
which also contained the spacer 1, 2 and 3 sequences respectively as overhangs. 3 fragments
assemblies were performed and the reaction mixtures were transformed in DH5αE. coli
competent cells(NEB) via heat shock, for storage and plasmid amplification. Upon sequence
verification, the pBBR_Cas9_NT plasmid was transformed to E. coli S17-1 cells. 
G ENERATIO N O F VECTO RS FO R G ENE K NO CK-OUTS (K O ) AND G ENE
K NO CK-IN (K I)
Homologous recombination (HR) followed by Cas9-based counter selection was used for
the KO of the upp, ligD, ku1 and ku2 genes, as well as the KI of the upp gene back to its
original place in the R. sphaeroides  genome combined with single nucleotide substitution.  
Plasmids for upp K O
We started by constructing the HR control, non-targeting plasmid s
pBBR_Cas9_Δupp500HR_NT and pBBR_Cas9_Δupp1000HR_NT. The pBBR_Cas9_NT
backbone was PCR linearized into two fragments via two PCR reactionsusing the primers
sets BG11886/BG11182 and BG11887/BG11888. For HR purposes, the 500bp or 1kb long 
upstream and downstream flanking sites of theupp gene from the R. sphaeroides genome
were PCR amplified employing the primer sets BG11866/BG11867 and BG11869/BG11871 
for the 500bp sizes and the primer sets BG11866/BG11868 and BG11870/BG11871 for the
1kb sizes. All 4 fragments contained overhangs suitable for HiFi assembly reactions. The
two pBBR_Cas9_NT fragments and the two combinations of the HR fragmentswere
assembled generating the non-targeting, HR control plasmids pBBR_Cas9_Δupp500HR_NT
and pBBR_Cas9_Δupp1000HR_NT, which were employed as controls f or the HR efficiency 
pBBR_Cas9_Δupp1000HR_NT, which were employed as controls for the HR efficiency in R. 
sphaeroides . Upon sequence verification in DH5α E. coli, both plasmids were transformed to 
E. coli S17-1 cells.
We proceeded with the construction of the HR-editing, targeting plasmids
pBBR_Cas9_Δupp500HR_sp2 and pBBR_Cas9_Δupp1000HR_sp2. The previously 
mentioned  couples of primer sets were used for the generation of the 500bp and 1kb HR
flanking sites. The pBBR_Cas9_NT vector was employed as template for the PCR
amplification of the conserved backbone region included within the amplification with the 
BG11887/BG11888 primer set. In addition, the spacer sp2 was included in the corresponding
position employing the primer sets BG11182/BG11487 and BG11489/BG11886 for the 
amplification of the spCas9 gene and the sgRNA module  respectively. Then, 5 fragments
were assembled to generate pBBR_Cas9_Δupp500HR_sp2 and 
pBBR_Cas9_Δupp1000HR_sp2. Upon sequence verification in E. coli DH5α, both plasmids
were transformed to E. coli S17-1 cells.
Plasmids for NHEJ genes KO
For the selective deletion of ku1, ku2 and ligD, targeting plasmids were generated with a
similar approach used for assembling the upp targeting plasmids. The primers set BG11887/
BG11888 was used for amplifying the conserved backbone sequence of pBBR_Cas9_NT. The
1000 bp flanking sites (with overhangs) for ligD, ku1 and ku2 were obtained with the primers
sets BG12363/BG12366 and BG12365/BG12364 (ligD), BG12360/BG12359 and BG12361/
BG12362 (ku1), BG12357/BG12356 and BG12355/BG12358 (ku2). The backbone interspace 
included between the sgRNA (listed in Supplementary Table 3) and the flanking sites of the
target genes was amplified from pBBR_Cas9_NT using the primer sets BG11886/BG12340 
(ligD), BG11886/BG12336 (ku1) and BG11886/BG12339 (ku2). Similarly, from the same 
pBBR_Cas9_NT template, the spCas9 sequences including the sgRNA with the spacer of
interest were obtained combining primers BG11182/BG12325 (ligD), BG11182/BG12333 
(ku1) and BG11182/BG12330 (ku2). The 5 fragments assembly in E. coli DH5α, generated the 
plasmids pBBR_Cas9_Δku1, pBBR_Cas9_Δku2 and pBBR_Cas9_ΔligD. Upon sequence
verification, the plasmids were transformed in E. coli S17.
Plasmids for upp K I
Also here we employed the aforementioned strategy as for generating the 
upp KO plasmids. The pBBR_Cas9_NT plasmid was used as template for the 
amplification of the fragments containing the backbone (primer set BG11887/BG11888), 
spCas9 and the targeting sgRNAs. 
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For the spacer sp4, the fragments including spCas9 and the sgRNA were generated 
via the amplification with primers sets BG11182/BG12907 and BG11186/BG12908, 
respectively. The spacer sp5 was included in the fragments for spCas9 and sgRNA 
amplifications using primers set BG11182/BG12909 and BG11186/BG12910, respectively. 
Additionally, the templates used for upp insertion included within two flanking sites of 500 
bp or 1000 bp around upp, both amplified from R. sphaeroides genome. For the 500 bp 
flanking sites, genomic amplification was performed using the primers pairs BG12347/
BG11867 and BG11869/BG12348; for the 1000 bp ones, primers sets BG12347/BG11868 
and BG11870/BG12348 were employed. The primers BG12347 and BG12348 introduced the 
single point mutation in the start codon, which changed from ATG to GTG. Assembly with 5 
fragments per plasmid allowed the generation and replication in E. coli DH5α of four 
plasmids:pBBR_Cas9_KIupp500HR_sp4,pBBR_Cas9_KIupp500HR_sp5,pBBR_Cas9_KIup 
p1000HR _sp4 and pBBR_Cas9_KIupp1000HR_sp5. Once their sequence 
was verified, the plasmids were transformed to E.coli S17.
Diparental conjugation and plasmid curation
R. sphaeroides was inoculated from glycerol stock in 10 mL RÄ medium and incubated for 2
days at 30°C and 200 rpm prior to conjugation. After 48 hours, 50 μL of culture were
transferred to fresh 10 mL RÄ medium, incubated for 24 h under the same conditions, and
harvested when the OD at 600nm was approximately 3. E. coli S17-1 harbouring the desired
plasmid was grown overnight in LB supplemented with kanamycin at 37°C and 200 RPM.
Then, the overnight culture was transferred to fresh 2xYT media with antibiotic and grown
for 2 h until the OD at 600nm was approximately 1. The cell suspension was harvested and
washed twice with 1 mL of RÄ medium, mixed with R. sphaeroides culture at a 1:1 ratio (1
mL each) and centrifuged for 1 minute (maximum speed). The pellet was concentrated by
suspension in 100 μL of RÄ medium, which was transferred to a sterile 0.22 µm 47 mm
diameter nitrocellulose filter disc (Sigma-Aldrich) on a PY agar plate and incubated for 6
hours at 28°C. The conjugation mixture was harvested and re-suspended in 2 mL of RÄ
medium. 100 μL of diluted culture was spread on RÄ agar plates containing kanamycin and
incubated at 30°C for 3 days until colonies appeared. Purification of R. sphaeroides
conjugants from E. coli S17-1 donors was performed by subsequent transfer of R.
sphaeroides colonies to LB agar medium supplemented with kanamycin until no E. coli
colonies appeared. Finally, a colony PCR was performed using primer set P3/P4 to verify that
E. coli was not present in the culture.
Plasmid curing from positiveR. sphaeroides mutants was carried out by cultivating the
mutants in 5 mL of RÄ medium without antibiotic for 24 h, twice. The cells from the second 
cultivation were then diluted and spread on RÄ agar plates. The individual colonies were
streaked onto LB agar with and without kanamycin. Those cells that grew on LB without
antibiotic but were unable to grow in the presence of antibiotic were considered to have
lost the plasmid. Final verification of plasmid curing was conducted by 
performing PCR with primers BG10937/BG10938, which are specific for the Cas9 
gene. 
RNA EXTRACTIO N AND REVERSE TRANSCRIPTASEPCR (RT-PCR)
To check expression of the spCas9 gene under the lac promoter, total RNA of R. 
sphaeroides conjugated with the pBBR_Cas9_NT plasmid was extracted employing the
RNAeasy mini kit(Qiagen, Germany) according to the manufacturer’s iprotocol and treated 
with DNAse I (NEB) to remove genomic DNA contamination in the sample. The
SuperScript III Reverse Transcriptase kit (Invitrogen) was used for RT-PCR. When the
first strand of cDNA was synthesized, the primers BG11112 and BG11115 were used to 
verify transcription activity of Cas9 gene using standard PCR. 
5-FU SCREENING
For the 5-fluorouracil (5-FU) screening process we prepared RÄ agar plates supplemented 
with 5-FU up to 100 μg/ml final concentration, usinga 50 mg/mL stock solution prepared in 
dimethyl sulfoxide (DMSO). Colonies obtained from conjugation were picked and streaked 
on RÄ_5-FU plates with kanamycin. Survival colonies were isolated and theirupp locus was
then PCR amplified and sequenced.
PH YLO G ENETICANALYSIS O F TH E AMINO ACID SEQ UENCES O F
K U1, K U2 AND LIG D
From the sequenced genome ofR. sphaeroides 265-9c, the amino acid sequences of the
NHEJ proteins Ku1, Ku2 and LigD were compared to the protein sequences deposited on 
NCBI using the protein BLAST tool (https://blast.ncbi.nlm.nih.gov/Blast.cgi ). The top hits
from each alignment were used to build phylogenetic trees for the two Ku homologs and 
LigD, respectively. For each tree, the sequences were aligned with already characterized 
prokaryotic orthologous belonging to other bacterial classes. The trees were built using 
MEGA7 (35) employing the multip le sequence alignmen t program CulstalW(36) and 
confirmed for their robustness using a bootstrapping value of 1000 repetitions. Table S4 
contains the species names and the deposited accession numbers of the proteins used to build 
the trees.  
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For the spacer sp4, the fragments including spCas9 and the sgRNA were generated via
the amplification with primers sets BG11182/BG12907 and BG11186/BG12908, 
respectively. The spacer sp5 was included in the fragments for spCas9 and sgRNA
amplifications using primersset BG11182/BG12909 and BG11186/BG12910, respectively. 
Additionally, the templates used for upp insertion included within two flanking sites of
500 bp or 1000 bp around upp, both amplified from R. sphaeroides genome. For the 500 
bp flanking sites, genomic amplification was performed using the primers pairs BG12347/
BG11867 and BG11869/BG12348; for the 1000 bp ones, primers sets BG12347/BG11868 
and BG11870/BG12348 were employed. The primers BG12347 and BG12348 introduced 
the single point mutation in the start codon, which changed from ATG to GTG. Assembly 
with 5 fragments per plasmid allowed the generation and replication in E. coli DH5α
of four plasmids: pBBR_Cas9_KIupp500HR_sp4, pBBR_Cas9_KIupp500HR_sp5, 
pBBR_Cas9_KIupp1000HR_sp4 and pBBR_Cas9_KIupp1000HR_sp5. Once
their sequence was verified, the plasmids were transformed to E.coli S17. 
Diparental conjugation and plasmid curation
R. sphaeroides was inoculated from glycerol stock in 10 mL RÄ medium and incubated for
2 days at 30°C and 200 rpm prior to conjugation. After 48 hours, 50 μL of culture were
transferred to fresh 10 mL RÄ medium, incubated for 24 h under the same conditions, and
harvested when the OD at 600nm was approximately 3. E. coli S17-1 harbouring the desired
plasmid was grown overnight in LB supplemented with kanamycin at 37°C and 200 RPM.
Then, the overnight culture was transferred to fresh 2xYT media with antibiotic and grown
for 2 h until the OD at 600nm was approximately 1. The cell suspension was harvested and
washed twice with 1 mL of RÄ medium, mixed withR. sphaeroides culture at a 1:1 ratio (1
mL each) and centrifuged for 1 minute (maximum speed). Thepellet was concentrated by
suspension in 100 μL of RÄ medium, which was transferred toa sterile 0.22 µm 47 mm
diameter nitrocellulose filter disc (Sigma-Aldrich) on a PY agar plate and incubated for 6
hours at 28°C. The conjugation mixture was harvested and re-suspended in 2 mL of RÄ
medium. 100 μL of diluted culture was spread on RÄ agar plates containing kanamycin and
incubated at 30°C for 3 days until colonies appeared. Purification of R. sphaeroides
conjugants from E. coli S17-1 donors was performed by subsequent transfer of R.
sphaeroides colonies to LB agar medium supplemented with kanamycin until no E. coli
colonies appeared. Finally, a colony PCR was performed using primer set P3/P4 to verify
that E. coli was not present in the culture.
Plasmid curing from positive R. sphaeroides mutants was carried out by 
cultivating the mutants in 5 mL of RÄ medium without antibiotic for 24 h, twice. The 
cells from the second cultivation were then diluted and spread on RÄ agar plates. 
The individual colonies were streaked onto LB agar with and without kanamycin. 
Those cells that grew on LB without antibiotic but were unable to grow in the 
presence of antibiotic were considered to have lost the plasmid. Final verification of 
plasmid curing was conducted by performing PCR with primers BG10937/BG10938, 
which are specific for the Cas9 gene. 
RNA EXTRACTIO N AND REVERSE TRANSCRIPTASE PCR (RT-PCR)
To check expression of the spCas9 gene under the lac promoter, total RNA of R. 
sphaeroides conjugated with the pBBR_Cas9_NT plasmid was extracted employing
the RNAeasy mini kit (Qiagen, Germany) according to the manufacturer’s protocol and 
treated with DNAseI (NEB) to remove genomic DNA contamination in the sample. The 
SuperScript III Reverse Transcriptase kit (Invitrogen) was used for RT-PCR. When 
the first strand of cDNA was synthesized, the primers BG11112 and BG11115 
were used to verify transcription activity of Cas9 gene using standard PCR. 
5-FU SCREENING
For the 5-fluorouracil (5-FU) screening process we prepared RÄ agar plates supplemented
with 5-FU up to 100 μg/ml final concentration, using a 50 mg/mL stock solution prepared  in
dimethyl sulfoxide (DMSO). Colonies obtained from conjugation were picked and streaked
on RÄ_5-FU plates with kanamycin. Survival colonies were isolated and their  upp locus was
then PCR amplified and sequenced.
PHYLOGENETC ANALYSIS OF THE AMINO ACID SEQUENCES
OF KU1, KU2 AND LIGD
From the sequenced genome of R. sphaeroides 265-9c, the amino acid sequences of
the NHEJ proteins Ku1, Ku2 and LigD were compared to the protein sequences
deposited on NCBI using the protein BLAST tool (https://blast.ncbi.nlm.nih.gov/
Blast.cgi ). The top hits from each alignment were used to build phylogenetic trees for
the two Ku homologs and LigD, respectively. For each tree, the sequences were aligned
with already characterized prokaryotic orthologous belonging to other bacterial
classes. The trees were built using MEGA735 employing the multiple sequence
alignment program CulstalW36 and confirmed for their robustness using a
bootstrapping value of 1000 repetitions. Table S4 contains the species names and the
deposited accession numbers of the proteins used to build the trees.
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SUPPLEMENTARY FIG URES 
Fig. S1. Reverse Transcriptase PCR (RT-PCR) to assess transcription of Cas9 under the constitutive lac 
prom oter. The expected size of the cDNA am plicon for Cas9 is of 307bp, and it was obtained b y sonication of R. 
sphaeroides cells suspension conjugated with pBBR1MCS2 harbouring: no additional features (well 1), non-
targeting sgRNA (pBBR_NT, well 2), harmonized Cas9 (pBBR_Cas9, well 3) and harmonized Cas9 plus NT -
sgRNA (pBBR_Cas9_NT, well 4). The primers set used was BG11112/BG11115.
Figure S2. Curing from the plasm id after successful conjugation. A) Schematic overview of the workflow: 
mutants from R. sphaeroides were transferred twice to liquid medium without antibiotic and incubated 
over-night. Subsequently, the liquid culture was spread on LB plates. Once colonies form ed, they were 
transferred to LB plates with and without antibiotic. B) The colonies that grew only on the plate without 
antibiotic were PCR amplified with primers annealing to the Cas9 gene in the vector backbone using 
primers set BG10937/BG10938 (P: plasmid control, 1 and 2: curated  R. sphaeroides mutants). 
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Figure S3. Figure S4. 1% agarose electrophoresis showing the colony PCRs after the conjugation of the Δupp 
strain of R. sphaeroides with the plasm ids for upp integration. A) pBBR_Cas9_KIupp500HR_sp4. B)
pBBR_Cas9_KIupp500HR_sp5. C) pBBR_Cas9_KIupp1000HR_sp4. D) pBBR_Cas9_KIupp1000HR_sp5. E)
Schem atic representation of the am plicons generated via colony PCR: theΔupp gene leads to an am plicon size
of 2053bp (left), while a restored upp gene (green) generates an am plicon of the size of 2903bp. The hom ology
regions (500bp and 1000bp) are highlighted in yellow and in yellow with diagonal red bars, respectively.
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Fig. S1. Reverse Transcriptase PCR (RT-PCR) to assess transcription of Cas9 under the constitutive lac
prom oter. The expected size of the cDNA am plicon for Cas9 is of 307bp, and it was obtained by sonication of R. 
sphaeroides cells suspension conjugated with pBBR1MCS2 harbouring: no additional features (well 1), non-
targeting sgRNA (pBBR_NT, well 2), harm onized Cas9 (pBBR_Cas9, well 3) and harm onized Cas9 plus NT-
sgRNA (pBBR_Cas9_NT, well 4). The prim ers set used was BG11112/BG11115.
Figure S2. Curing from theplasm id after successful conjugation. A) Schem atic overview of the workflow: 
mu tants from R. sphaeroides were transferred twice to liquid m edium without antibiotic and incubated over-
night. Subsequently, the liquid culture was spread on LB plates. Once colonies form ed, they were transferred to
LB plates with and without antibiotic. B) The colonies that grew only on the plate without antibiotic were PCR
am plified with prim ers annealing to the Cas9 gene in the vector backbone using prim ers set BG10937/BG10938
(P: plasm id control, 1 and 2: curated R. sphaeroides m utants).
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Figure S3. Figure S4. 1% agarose electrophoresis showing the colony PCRs after the conjugation of the Δupp 
strain of R. sphaeroides with the plasmids for upp integration. A) pBBR_Cas9_KIupp500HR_sp4. B) 
pBBR_Cas9_KIupp500HR_sp5. C) pBBR_Cas9_KIupp1000HR_sp4. D) pBBR_Cas9_KIupp1000HR_sp5. E) 
Schematic representation of the amplicons generated via colony PCR: the Δupp gene leads to an amplicon size of 
2053bp (left), while a restored upp gene (green) generates an amplicon of the size of 2903bp. The homology 
regions (500bp and 1000bp) are highlighted in yellow and in yellow with diagonal red bars, respectively. 
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each for conter selection of hom ologous
recom bination in theupp gene
pBBR_Cas9_KIupp500HR_sp4
derivative of pBBR1MCS2_Cas9_NT with 500 bp 
flanking sites for knock-in of upp in a Δupp strain. It 
also contains sgRNA with spacer 4 for targeting the
genom ic locus of the Δupp previously obtained via
precise HR-CRISPR-Cas.
this study
pBBR_Cas9_KIupp500HR_sp5
derivative of pBBR1MCS2_Cas9_NT with 500 bp 
flanking sites for knock-in of upp in a Δupp strain. It 
also contains sgRNA with spacer 5 for targeting the
genom ic locus of the Δupp previously obtained via
precise HR-CRISPR-Cas.
this study
pBBR_Cas9_KIupp1000HR_sp4 
derivative of pBBR1MCS2_Cas9_NT with 1000 bp
flanking sites for knock-in of upp in a Δupp strain. It 
also contains sgRNA with spacer 4 for targeting the
genom ic locus of the Δupp previously obtained via
precise HR-CRISPR-Cas.
this study
Plasmid Description Source
pBBR_Cas9_KIupp1000HR_sp5
derivative of pBBR1MCS2_Cas9_NT with 1000 bp
flanking sites for knock-in of upp in a Δupp strain. It 
also contains sgRNA with spacer 5 for targeting the 
genom ic locus of the Δupp previously obtained via
precise HR-CRISPR-Cas.
this study
pBBR_Cas9_Δku1
derivative of pBBR1MCS2_Cas9_NT containing
sgRNA with spacer targeting ku1 and 2 flanking sites
of 1000 bp each for counter selection of hom ologous
recom bination of the ku1 gene
this study
pBBR_Cas9_Δku2
derivative of pBBR1MCS2_Cas9_NT containing
sgRNA with spacer targeting ku2 and 2 flanking sites
of 1000 bp each for counter selection of hom ologous
recom bination of the ku2 gene
this study
pBBR_Cas9_ΔligD
derivative of pBBR1MCS2_Cas9_NT containing
sgRNA with spacer targeting ligD and 2 flanking sites
of 1000 bp each for counter selection of hom ologous
recom bination of the ligD gene
this study
SUPPLEMENTARY TABLES 
Table S1. List of plasmids used in this study
Plasmid Description Source 
pUC57hCas9 
pUC57 vector containing DNA encoding the Cas9 
gene harmonized for expression in Rhodobacter 
sphaeroides (hCas9) 
Baseclear 
pBBR1MCS2-sgRNA 
Includes a synthetic construction between the SmaI 
and the SalI restriction sites. This synthetic 
construction contains the promoter BBa_J95023, two 
BsaI restriction sites, the sgRNA the terminator 
BBa_J95029 
Baseclear, 
Huo et. al, 
2011, this 
study 
pBBR1MCS2_Cas9_NT 
Derivative of  pBBR1MCS2-sgRNA. Broad host 
range plasmid (KanR) containing hCas9 under 
constitutive lac promoter and non-targeting sgRNA 
under the promoter BBa_J95023 and the terminator 
BBa_J95029 
this study 
pBBR1MCS2_Cas9_sp1 
derivative of pBBR1MCS2_Cas9_NT containing 
sgRNA with spacer 1 for targeting the gene upp 
this study 
pBBR1MCS2_Cas9_sp2 
derivative of pBBR1MCS2_Cas9_NT containing 
sgRNA with spacer 2 for targeting the gene upp 
this study 
pBBR1MCS2_Cas9_sp3 
derivative of pBBR1MCS2_Cas9_NT containing 
sgRNA with spacer 3 for targeting the gene upp 
this study 
pBBR_Cas9_Δupp500HR_NT 
derivative of pBBR1MCS2_Cas9_NT containing non-
targeting sgRNA and 2 flanking sites of 500 bp each 
for homologous recombination of the upp gene 
this study 
Plasmid Description Source 
pBBR_Cas9_Δupp1000HR_NT 
derivative of pBBR1MCS2_Cas9_NT containing non-
targeting sgRNA and 2 flanking sites of 1000 bp each 
for homologous recombination of the upp gene 
this study 
pBBR_Cas9_Δupp500HR_sp2 
derivative of pBBR1MCS2_Cas9_NT containing 
sgRNA with spacer 2 and 2 flanking sites of 500 bp 
each for counter selection of homologous 
recombination of the upp gene 
this study 
pBBR_Cas9_Δupp1000HR_sp2 
derivative of pBBR1MCS2_Cas9_NT containing 
sgRNA with spacer 2 and 2 flanking sites of 1000 bp 
this study 
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Table S1. List of plasm ids used in this study
Plasmid Description Source
pUC57hCas9
pUC57 vector containing DNA encoding the Cas9 
gene harm onized for expression in Rhodobacter
sphaeroides (hCas9)
Baseclear
pBBR1MCS2-sgRNA
Includes a synthetic construction between the Sm aI
and the SalI restriction sites. This synthetic
construction contains the prom oter BBa_J95023, two 
BsaI restriction sites, the sgRNA the term inator
BBa_J95029
Baseclear,
Huo et. al, 
2011, this
study
pBBR1MCS2_Cas9_NT
Derivative of pBBR1MCS2-sgRNA. Broad host
range plasm id (KanR) containing hCas9 under
constitutive lac prom oter and non-targeting sgRNA
under the prom oter BBa_J95023 and the term inator
BBa_J95029
this study
pBBR1MCS2_Cas9_sp1
derivative of pBBR1MCS2_Cas9_NT containing
sgRNA with spacer 1 for targeting the gene upp
this study
pBBR1MCS2_Cas9_sp2
derivative of pBBR1MCS2_Cas9_NT containing
sgRNA with spacer 2 for targeting the gene upp
this study
pBBR1MCS2_Cas9_sp3
derivative of pBBR1MCS2_Cas9_NT containing
sgRNA with spacer 3 for targeting the gene upp
this study
pBBR_Cas9_Δupp500HR_NT
derivative of pBBR1MCS2_Cas9_NT containing non-
targeting sgRNA and 2 flanking sites of 500 bp each 
for hom ologous recom bination of theupp gene
this study
Plasmid Description Source
pBBR_Cas9_Δupp1000HR_NT
derivative of pBBR1MCS2_Cas9_NT containing non-
targeting sgRNA and 2 flanking sites of 1000 bp each 
for hom ologous recom bination of theupp gene
this study
pBBR_Cas9_Δupp500HR_sp2
derivative of pBBR1MCS2_Cas9_NT containing
sgRNA with spacer 2 and 2 flanking sites of 500 bp 
each for counter selection of hom ologous
recom bination of the upp gene
this study
pBBR_Cas9_Δupp1000HR_sp2
derivative of pBBR1MCS2_Cas9_NT containing
sgRNA with spacer 2 and 2 flanking sites of 1000 bp 
this study
each for conter selection of homologous 
recombination in the upp gene 
pBBR_Cas9_KIupp500HR_sp4 
derivative of pBBR1MCS2_Cas9_NT with 500 bp 
flanking sites for knock-in of upp in a Δupp strain. It 
also contains sgRNA with spacer 4 for targeting the 
genomic locus of the Δupp previously obtained via 
precise HR-CRISPR-Cas. 
this study 
pBBR_Cas9_KIupp500HR_sp5 
derivative of pBBR1MCS2_Cas9_NT with 500 bp 
flanking sites for knock-in of upp in a Δupp strain. It 
also contains sgRNA with spacer 5 for targeting the 
genomic locus of the Δupp previously obtained via 
precise HR-CRISPR-Cas. 
this study 
pBBR_Cas9_KIupp1000HR_sp4 
derivative of pBBR1MCS2_Cas9_NT with 1000 bp 
flanking sites for knock-in of upp in a Δupp strain. It 
also contains sgRNA with spacer 4 for targeting the 
genomic locus of the Δupp previously obtained via 
precise HR-CRISPR-Cas. 
this study 
Plasmid Description Source 
pBBR_Cas9_KIupp1000HR_sp5 
derivative of pBBR1MCS2_Cas9_NT with 1000 bp 
flanking sites for knock-in of upp in a Δupp strain. It 
also contains sgRNA with spacer 5 for targeting the 
genomic locus of the Δupp previously obtained via 
precise HR-CRISPR-Cas. 
this study 
pBBR_Cas9_Δku1 
derivative of pBBR1MCS2_Cas9_NT containing 
sgRNA with spacer targeting ku1 and 2 flanking sites 
of 1000 bp each for counter selection of homologous 
recombination of the ku1 gene 
this study 
pBBR_Cas9_Δku2 
derivative of pBBR1MCS2_Cas9_NT containing 
sgRNA with spacer targeting ku2 and 2 flanking sites 
of 1000 bp each for counter selection of homologous 
recombination of the ku2 gene 
this study 
pBBR_Cas9_ΔligD 
derivative of pBBR1MCS2_Cas9_NT containing 
sgRNA with spacer targeting ligD and 2 flanking sites 
of 1000 bp each for counter selection of homologous 
recombination of the ligD gene 
this study 
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including the spacer 3 for upp
and part of hCas9 gene
BG11486
CACCTTCGCATAATATTGCAGTTTTAGAGCTAGAAATAGCAAGTTA
AAATAAGGCTAGTC
FW to com bine with BG11412
for am plifying the sgRNA
including the spacer 1 for upp
and part of hCas9 gene
BG11487
ATCGATCTCCTGAAGGAGAAGTTTTAGAGCTAGAAATAGCAAGTTA
AAATAAGGCTAGTC
FW to com bine with BG11412
for am plifying the sgRNA
including the spacer 2 for upp
and part of hCas9 gene
BG11413 GCGTTTTCCCTTGTCCAGATAGC
FW conserved for am plifying
the conserved part of the
backbone and include the spacer
of interest for upp in the sgRNA
(provided by RV)
BG11414 CGACGACGATCCAGACGCCGAACCAGCGATCCCGTCCG
RV to com bine with BG11413 
for am plifying the sgRNA
including the spacer 3 for upp
and part of pBBR1MCS2-sgRNA 
backbone
BG11488 TGCAATATTATGCGAAGGTGAACCAGCGATCCCGTCCG
RV to com bine with BG11413 
for am plifying the sgRNA
including the spacer 1 for upp
and part of pBBR1MCS2-sgRNA 
backbone
BG11489 TTCTCCTTCAGGAGATCGATAACCAGCGATCCCGTCCG
RV to com bine with BG11413 
for am plifying the sgRNA
including the spacer 2 for upp
and part of pBBR1MCS2-sgRNA 
backbone
H
R
 p
la
sm
id
s 
fo
ru
pp
kn
oc
k-
ou
t
BG11886 gtgcgggcctcttcgctatta
FW to am plify pBBR_Cas9NT
including the sgRNA with non-
targeting spacer and the hCas9
gene
BG11182 CCATGTCGGCAGAATGCTTAATG
RV to am plify pBBR_Cas9NT
including the sgRNA with non-
targeting spacer and the hCas9
gene
BG11887 CATTAAGCATTCTGCCGACATGG
FW to am plify pBBR_Cas9NT
including the backbone
BG11888 gcctgaatggcgaatggaaattgtaa
RV to am plify pBBR_Cas9NT
including the backbone
BG11866 CTCTGTAAAGCGGGGTTTCCCTTAATGGTCAAGCATGGTCGGGC
FW for 500/1000 bp
am plification of the first
hom ology region ofupp. It
contains overhangs with
BG11871
BG11867 taatagcgaagaggcccgcacCGACGAGACGGTGGGCAA
RV for 500 bp am plification of
the hom ology region ofupp.
Table S2. List of primers used in this study 
Oligo Sequence Description 
U
bi
qu
iti
n 
PC
R
 
P3-
Ec_ubi1  
GATAGCGTCCTAACGGCGTT 
FW for ubiquitin PCR to check 
post-conjugational E. coli 
contamination. Anneals to E 
.coli genome 
P4-
Ec_ubi2  
GGGTTTGTCGAGCAGAATGA 
RV for ubiquitin PCR to check 
post-conjugational E. coli 
contamination. Anneals to E. 
coli genome 
P5-
Rs_ubi10
5F 
GAACCCCTGCCGGCTGGATTACA 
FW for ubiquitin PCR to check 
post-conjugational E. coli 
contamination. Anneals to R. 
sphaeroides genome 
P6-
Rs_ubi50
1R 
CATGGCGAAGCTCTTGGGATTG 
RV for ubiquitin PCR to check 
post-conjugational E. coli 
contamination. Anneals to R. 
sphaeroides genome 
R
T
-P
C
R
 C
as
9 
BG11112 GCCCGTTCTCGAGTTCG 
FW to check Cas9 transcription 
in pBBR_Cas9_NT 
BG11115 GAATCGATCCTCCCCAAGAG 
RV to check Cas9 transcription 
in pBBR_Cas9_NT 
N
on
-t
ar
ge
tin
g:
 p
B
B
R
_C
as
9_
N
T
 
BG10937 GACAAAAAGTACTCGATTGGGC 
FW for amplifying hCas9 from 
pUC57 
BG10938 CTAATGGTGATGGTGATGGTGATC 
RV for amplifying hCas9 from 
pUC57 
BG10939 GCCCAATCGAGTACTTTTTGTCCATAGCTGTTTCCTGTGTGAAATTG 
FW for linearizing 
pBBR1MCS2-sgRNA with 
homologous overhang for 
Gibson assembly with hCas9 
BG10941 TCACCATCACCATCACCATTAGGAGGTCGACGGTGATTGATTGAG 
RV for linearizing 
pBBR1MCS2-sgRNA with 
homologous overhang for 
Gibson assembly with hCas9 
T
ar
ge
tin
g 
up
p:
 p
B
B
R
_C
as
9_
sp
1-
3 
BG11415 ACCTTAACAAGCTCGTCGACGAC  
FW for linearizing the conserved 
parts of hCas9 and backbone of 
pBBR_Cas9_NT 
BG11416 GCTATCTGGACAAGGGAAAACGC  
RV for linearizing the conserved 
parts of hCas9 and backbone of 
pBBR_Cas9_NT 
BG11412 GTCGTCGACGAGCTTGTTAAGGT  
RV conserved for amplifying 
part of the hCas9 gene and 
include the spacer of interest for 
upp in the sgRNA (provided by 
FW) 
BG11411 
CGGCGTCTGGATCGTCGTCGGTTTTAGAGCTAGAAATAGCAAGTTA
AAATAAGGCTAGTC 
FW to combine with BG11412 
for amplifying the sgRNA 
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FW for ubiquitin PCR to check
post-conjugational E. coli
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.coli genom e
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RV for ubiquitin PCR to check
post-conjugational E. coli
contam ination. Anneals toE. 
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GAACCCCTGCCGGCTGGATTACA
FW for ubiquitin PCR to check
post-conjugational E. coli
contam ination. Anneals toR. 
sphaeroides genom e
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CATGGCGAAGCTCTTGGGATTG
RV for ubiquitin PCR to check
post-conjugational E. coli
contam ination. Anneals toR. 
sphaeroides genom e
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FW to check Cas9 transcription
in pBBR_Cas9_NT
BG11115 GAATCGATCCTCCCCAAGAG
RV to check Cas9 transcription
in pBBR_Cas9_NT
N
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BG10937 GACAAAAAGTACTCGATTGGGC
FW for am plifying hCas9 from
pUC57
BG10938 CTAATGGTGATGGTGATGGTGATC
RV for am plifying hCas9 from
pUC57
BG10939 GCCCAATCGAGTACTTTTTGTCCATAGCTGTTTCCTGTGTGAAATTG
FW for linearizing
pBBR1MCS2-sgRNA with
hom ologous overhang for
Gibson assem bly with hCas9
BG10941 TCACCATCACCATCACCATTAGGAGGTCGACGGTGATTGATTGAG
RV for linearizing
pBBR1MCS2-sgRNA with
hom ologous overhang for 
Gibson assem bly with hCas9
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BG11415 ACCTTAACAAGCTCGTCGACGAC
FW for linearizing the conserved
parts of hCas9 and backbone of
pBBR_Cas9_NT
BG11416 GCTATCTGGACAAGGGAAAACGC
RV for linearizing the conserved
parts of hCas9 and backbone of
pBBR_Cas9_NT
BG11412 GTCGTCGACGAGCTTGTTAAGGT
RV conserved for am plifying 
part of the hCas9 gene and
include the spacer of interest for
upp in the sgRNA (provided by
FW)
BG11411
CGGCGTCTGGATCGTCGTCGGTTTTAGAGCTAGAAATAGCAAGTTA
AAATAAGGCTAGTC
FW to com bine with BG11412
for am plifying the sgRNA
Efficient Cas9-based genome editing of Rhodobacter sphaeroides
including the spacer 3 for upp 
and part of hCas9 gene 
BG11486 
CACCTTCGCATAATATTGCAGTTTTAGAGCTAGAAATAGCAAGTTA
AAATAAGGCTAGTC  
FW to combine with BG11412 
for amplifying the sgRNA 
including the spacer 1 for upp 
and part of hCas9 gene 
BG11487 
ATCGATCTCCTGAAGGAGAAGTTTTAGAGCTAGAAATAGCAAGTTA
AAATAAGGCTAGTC  
FW to combine with BG11412 
for amplifying the sgRNA 
including the spacer 2 for upp 
and part of hCas9 gene 
BG11413 GCGTTTTCCCTTGTCCAGATAGC 
FW conserved for amplifying 
the conserved part of the 
backbone and include the spacer 
of interest for upp in the sgRNA 
(provided by RV) 
BG11414 CGACGACGATCCAGACGCCGAACCAGCGATCCCGTCCG  
RV to combine with BG11413 
for amplifying the sgRNA 
including the spacer 3 for upp 
and part of pBBR1MCS2-sgRNA 
backbone 
BG11488 TGCAATATTATGCGAAGGTGAACCAGCGATCCCGTCCG 
RV to combine with BG11413 
for amplifying the sgRNA 
including the spacer 1 for upp 
and part of pBBR1MCS2-sgRNA 
backbone 
BG11489 TTCTCCTTCAGGAGATCGATAACCAGCGATCCCGTCCG 
RV to combine with BG11413 
for amplifying the sgRNA 
including the spacer 2 for upp 
and part of pBBR1MCS2-sgRNA 
backbone 
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BG11886 gtgcgggcctcttcgctatta 
FW to amplify pBBR_Cas9NT 
including the sgRNA with non-
targeting spacer and the hCas9 
gene 
BG11182 CCATGTCGGCAGAATGCTTAATG 
RV to amplify pBBR_Cas9NT 
including the sgRNA with non-
targeting spacer and the hCas9 
gene 
BG11887 CATTAAGCATTCTGCCGACATGG 
FW to amplify pBBR_Cas9NT 
including the backbone 
BG11888 gcctgaatggcgaatggaaattgtaa 
RV to amplify pBBR_Cas9NT 
including the backbone 
BG11866 CTCTGTAAAGCGGGGTTTCCCTTAATGGTCAAGCATGGTCGGGC 
FW for 500/1000 bp 
amplification of the first 
homology region of upp. It 
contains overhangs with 
BG11871 
BG11867 taatagcgaagaggcccgcacCGACGAGACGGTGGGCAA 
RV for 500 bp amplification of 
the homology region of upp.  
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BG12336 G G TG AAG G G CTATCCCCG CAAACCAGCGATCCCGTCCG 
RV to com bine with BG11886 
for am plifying the sgRNA
including the spacer for ku1 and
part of pBBR1MCS2-sgRNA 
backbone
BG12333
TG CG G G G ATAG CCCTTCACCGTTTTAGAGCTAGAAATAGCAAGTT
A AAATAAGGCTAGTC 
FW to com bine with BG11182
for am plifying thesgRNA 
including the spacer for ku1 and
part of hCas9 gene
BG12357 tgatgatgaGGATCCGTTCCCGACAGCGACAAGTG
FW for ku2 flanking site 2
am plification, including
overhangs with flanking site 1
BG12356 taatagcgaagaggcccgcacATGAGATCGGACGGCTCCCG
RV for ku2 flankins site 2
am plification, with overhang for
the backbone
BG12355 ttacaatttccattcgccattcaggcGATGGCGGAATGATCGAGGC
FW for ku2 flanking site 2
am plification, including
overhangs with the plasm id
backbone
BG12358 G G AACG G ATCCtcatcatcaGAAACTCACCCGGTCCGAGG 
RV for ku2 flanking site 2
am plification, including
overhangs with the flanking site
1 
BG12339 CTCACCG CATCG ACG AATTCAACCAGCGATCCCGTCCG 
RV to com bine with BG11886 
for am plifying the sgRNA
including the spacer for ku2 and
part of pBBR1MCS2-sgRNA 
backbone
BG12330
G AATTCG TCG ATG CG G TG AGGTTTTAGAGCTAGAAATAGCAAGTT
A AAATAAGGCTAGTC 
FW to com bine with BG11182
for am plifying the sgRNA
including the spacer for ku2 and
part of hCas9 gene
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BG12347 GATGGTCAAGCACGGTCGGG 
FW for upp flanking site 1
am plification, including
overhang for BG12348 and point
m utation for the start ATG
codon
BG12348 CCCGACCGTGCTTGACCATC 
RV for upp flanking site 1
am plification, including
overhang for BG12347 and point
m utation for the start ATG
codon
BG12908 TAATG G TCAAG CATG G TCG GAACCAGCGATCCCGTCCG 
RV to com bine with BG11886 
for am plifying the sgRNA
including the spacer 4 for Δupp
and part of pBBR1MCS2-sgRNA 
backbone
BG12907
CCG ACCATG CTTG ACCATTAGTTTTAGAGCTAGAAATAGCAAGTT
A AAATAAGGCTAGTC 
FW to com bine with BG11182
for am plifying the sgRNA
BG11869 ttacaatttccattcgccattcaggcTTTCCACGTCTTCGCCGG 
FW for 500 bp amplification of 
the second homology region of 
upp.  
BG11871 TAAGGGAAACCCCGCTTTACAGAG 
RV for 500/1000 bp 
amplification of the second 
homology region of upp. It 
contains overhangs with 
BG11866 
BG11868 taatagcgaagaggcccgcacCGCATCTGGGCCTCTCCAA 
RV for 1000 bp amplification of 
the first homology region of upp.  
BG11870 ttacaatttccattcgccattcaggcTGTCTCTAGCGGAGGAATGCGT 
FW for 1000 bp amplification of 
the second homology region of 
upp.  
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BG12363 tgatgatgaGGATCCATCCGCTGGATTATGCCGAG 
FW for ligD flanking site 2 
amplification, including 
overhangs with flanking site 1 
BG12366 taatagcgaagaggcccgcacGCCTCGATATCCTCGACGAG 
RV for ligD flankins site 2 
amplification, with overhang for 
the backbone 
BG12365 ttacaatttccattcgccattcaggcCCGGAGACAAGGACAGTCTCC 
FW for ligD flanking site 2 
amplification, including 
overhangs with the plasmid 
backbone 
BG12364 CGGATGGATCCtcatcatcaTTGCACGACGAAGGACAGGC 
RV for ligD flanking site 2 
amplification, including 
overhangs with the flanking site 
1 
BG12340 GGAGGCTGCATGTTTTTGCAAACCAGCGATCCCGTCCG 
RV to combine with BG11886 
for amplifying the sgRNA 
including the spacer for ligD and 
part of pBBR1MCS2-sgRNA 
backbone 
BG12325 
TGCAAAAACATGCAGCCTCCGTTTTAGAGCTAGAAATAGCAAGTT
A AAATAAGGCTAGTC 
FW to combine with BG11182 
for amplifying the sgRNA 
including the spacer for ligD and 
part of hCas9 gene 
BG12360 tgatgatgaGGATCCCGGACCATCGACATCGACTG 
FW for ku1 flanking site 2 
amplification, including 
overhangs with flanking site 1 
BG12359 taatagcgaagaggcccgcacAGCCCTTGCCCTCGATGC 
RV for ku1 flankins site 2 
amplification, with overhang for 
the backbone 
BG12361 ttacaatttccattcgccattcaggcCCCACGAGGTCGAGGATTATG 
FW for ku1 flanking site 2 
amplification, including 
overhangs with the plasmid 
backbone 
BG12362 GTCCGGGATCCtcatcatcaGTTCAGCGTACGGAAGCGCAC 
RV for ku1 flanking site 2 
amplification, including 
overhangs with the flanking site 
1 
4111
BG11869 ttacaatttccattcgccattcaggcTTTCCACGTCTTCGCCGG
FW for 500 bp am plification of
the second hom ology region of
upp.
BG11871 TAAGGGAAACCCCGCTTTACAGAG
RV for 500/1000 bp
am plification of the second
hom ology region ofupp. It
contains overhangs with
BG11866
BG11868 taatagcgaagaggcccgcacCGCATCTGGGCCTCTCCAA
RV for 1000 bp am plification of
the first hom ology region ofupp.
BG11870 ttacaatttccattcgccattcaggcTGTCTCTAGCGGAGGAATGCGT
FW for 1000 bp am plification of
the second hom ology region of
upp.
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BG12363 tgatgatgaGGATCCATCCGCTGGATTATGCCGAG
FW for ligD flanking site 2
am plification, including
overhangs with flanking site 1
BG12366 taatagcgaagaggcccgcacGCCTCGATATCCTCGACGAG
RV for ligD flankins site 2
am plification, with overhang for
the backbone
BG12365 ttacaatttccattcgccattcaggcCCGGAGACAAGGACAGTCTCC
FW for ligD flanking site 2
am plification, including
overhangs with the plasm id
backbone
BG12364 CG G ATG G ATCCtcatcatcaTTGCACGACGAAGGACAGGC 
RV for ligD flanking site 2
am plification, including
overhangs with the flanking site
1 
BG12340 G G AG G CTG CATG TTTTTG CAA CCAGCGATCCCGTCCG 
RV to com bine with BG11886 
for am plifying the sgRNA
including the spacer for ligD and
part of pBBR1MCS2-sgRNA 
backbone
BG12325
TG CAAAAACATG CAG CCTCCGTTTTAGAGCTAGAAATAGCAAGTT
A AAATAAGGCTAGTC 
FW to com bine with BG11182
for am plifying the sgRNA
including the spacer for ligD and
part of hCas9 gene
BG12360 tgatgatgaGGATCCCGGACCATCGACATCGACTG
FW for ku1 flanking site 2
am plification, including
overhangs with flanking site 1
BG12359 taatagcgaagaggcccgcacAGCCCTTGCCCTCGATGC
RV for ku1 flankins site 2
am plification, with overhang for
the backbone
BG12361 ttacaatttccattcgccattcaggcCCCACGAGGTCGAGGATTATG
FW for ku1 flanking site 2
am plification, including
overhangs with the plasm id
backbone
BG12362 G TCCG G G ATCCtcatcatcaGTTCAGCGTACGGAAGCGCAC 
RV for ku1 flanking site 2
am plification, including
overhangs with the flanking site
1 
BG12336 GGTGAAGGGCTATCCCCGCAAACCAGCGATCCCGTCCG 
RV to combine with BG11886 
for amplifying the sgRNA 
including the spacer for ku1 and 
part of pBBR1MCS2-sgRNA 
backbone 
BG12333 
TGCGGGGATAGCCCTTCACCGTTTTAGAGCTAGAAATAGCAAGTT
A AAATAAGGCTAGTC 
FW to combine with BG11182 
for amplifying the sgRNA 
including the spacer for ku1 and 
part of hCas9 gene 
BG12357 tgatgatgaGGATCCGTTCCCGACAGCGACAAGTG 
FW for ku2 flanking site 2 
amplification, including 
overhangs with flanking site 1 
BG12356 taatagcgaagaggcccgcacATGAGATCGGACGGCTCCCG 
RV for ku2 flankins site 2 
amplification, with overhang for 
the backbone 
BG12355 ttacaatttccattcgccattcaggcGATGGCGGAATGATCGAGGC 
FW for ku2 flanking site 2 
amplification, including 
overhangs with the plasmid 
backbone 
BG12358 GGAACGGATCCtcatcatcaGAAACTCACCCGGTCCGAGG 
RV for ku2 flanking site 2 
amplification, including 
overhangs with the flanking site 
1 
BG12339 CTCACCGCATCGACGAATTCAACCAGCGATCCCGTCCG 
RV to combine with BG11886 
for amplifying the sgRNA 
including the spacer for ku2 and 
part of pBBR1MCS2-sgRNA 
backbone 
BG12330 
GAATTCGTCGATGCGGTGAGGTTTTAGAGCTAGAAATAGCAAGTT 
AAAATAAGGCTAGTC 
FW to combine with BG11182 
for amplifying the sgRNA 
including the spacer for ku2 and 
part of hCas9 gene 
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BG12347 GATGGTCAAGCACGGTCGGG 
FW for upp flanking site 1 
amplification, including 
overhang for BG12348 and point 
mutation for the start ATG 
codon 
BG12348 CCCGACCGTGCTTGACCATC 
RV for upp flanking site 1 
amplification, including 
overhang for BG12347 and point 
mutation for the start ATG 
codon 
BG12908 TAATGGTCAAGCATGGTCGGAACCAGCGATCCCGTCCG 
RV to combine with BG11886 
for amplifying the sgRNA 
including the spacer 4 for Δupp 
and part of pBBR1MCS2-sgRNA 
backbone 
BG12907 
CCGACCATGCTTGACCATTAGTTTTAGAGCTAGAAATAGCAAGTT
A AAATAAGGCTAGTC 
FW to combine with BG11182 
for amplifying the sgRNA 
Efficient Cas9-based genome editing of Rhodobacter sphaeroides
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including the spacer 4 for Δupp 
and part of hCas9 gene 
BG12910 TTAAGGGAAACCCCGCTTTAAACCAGCGATCCCGTCCG 
RV to combine with BG11886 
for amplifying the sgRNA 
including the spacer 5 for Δupp 
and part of pBBR1MCS2-sgRNA 
backbone 
BG12909 
TAAAGCGGGGTTTCCCTTAAGTTTTAGAGCTAGAAATAGCAAGTTA
A AATAAGGCTAGTC 
FW to combine with BG11182 
for amplifying the sgRNA 
including the spacer 5 for Δupp 
and part of hCas9 gene 
se
qu
en
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ng
 
BG12037 GGCCGAAGGGCTGCATC for Δupp sequencing 
BG12038 CATGGCAACGATCCCACCTT for Δupp sequencing 
BG12367 TTCTTGTCTTGTGACTGTCG for ΔligD sequencing 
BG12368 TAGACCAGACGGCTCTTTTC for ΔligD sequencing 
BG12369 CGGTATTTCTCGGGCGAGTG for Δku2 sequencing 
BG12370 AGGAGACCCTGCTCGAACTG for Δku2 sequencing 
BG12371 TCATGGATCTGGGCGTGCATC for Δku1 sequencing 
BG12372 CCTCGGACCGGGTGAGTTTC for Δku1 sequencing 
Table S3. List of spacers used for targeting Rhodobacter sphaeroides’ genomic DNA 
Spacer 
name 
Sequence PAM 
Targeted 
gene 
NT --- 
sp1 CGG upp 
sp2 GGG upp 
sp3 TGG upp 
sp4 AGG Δupp 
sp5 TGG Δupp 
ligD CGG ligD 
ku1 TGG ku1 
ku2 
AGGAGGGACGTTGCGACAAG 
CACCTTCGCATAATATTGCA 
ATCGATCTCCTGAAGGAGAA 
CGGCGTCTGGATCGTCGTCG 
CCGACCATGCTTGACCATTA 
TAAAGCGGGGTTTCCCTTAA 
TGCAAAAACATGCAGCCTCC  
TGCGGGGATAGCCCTTCACC 
GAATTCGTCGATGCGGTGAG CGG ku2 
4113
including the spacer 4 for Δupp 
and part of hCas9 gene
BG12910 TTAAG G G AAACCCCG CTTTAACCAGCGATCCCGTCCG 
RV to com bine with BG11886 
for am plifying the sgRNA
including the spacer 5 for Δupp
and part of pBBR1MCS2-sgRNA 
backbone
BG12909
TAAAG CG G G G TTTCCCTTAAGTTTTAGAGCTAGAAATAGCAAGTTA
A AATAAGGCTAGTC 
FW to com bine with BG11182
for am plifying the sgRNA
including the spacer 5 for Δupp
and part of hCas9 gene
se
qu
en
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ng
BG12037 GGCCGAAGGGCTGCATC for Δupp sequencing
BG12038 CATGGCAACGATCCCACCTT for Δupp sequencing
BG12367 TTCTTGTCTTGTGACTGTCG for ΔligD sequencing
BG12368 TAGACCAGACGGCTCTTTTC for ΔligD sequencing
BG12369 CGGTATTTCTCGGGCGAGTG for Δku2 sequencing
BG12370 AGGAGACCCTGCTCGAACTG for Δku2 sequencing
BG12371 TCATGGATCTGGGCGTGCATC for Δku1 sequencing
BG12372 CCTCGGACCGGGTGAGTTTC for Δku1 sequencing
Table S3. List of spacers used for targeting Rhodobacter sphaeroides’ genom ic DNA
Spacer 
name
Sequence PAM
Targeted
gene
NT AGGAGGGACGTTGCGACAAG ---
sp1 CACCTTCGCATAATATTGCA CGG upp
sp2 ATCGATCTCCTGAAGGAGAA GGG upp
sp3 CGGCGTCTGGATCGTCGTCG TGG upp
sp4 CCGACCATGCTTGACCATTA AGG Δupp
sp5 TAAAGCGGGGTTTCCCTTAA TGG Δupp
ligD TGCAAAAACATGCAGCCTCC CGG ligD
ku1 TGCGGGGATAGCCCTTCACC TGG ku1 
ku2 GAATTCGTCGATGCGGTGAG CGG ku2
Table S4. List of bacteria and NCBI accession numbers of the proteins used for generating Ku and LigD 
phylogenetic trees 
LigD 
Species Accession # 
Sequenced genome (Isobionics) 
WP_101340727.1 
WP_107663713.1 
WP_088200687.1 
WP_009208938.1 
ALB18079.1 
ADR60141.1 
AFP41860.1 
Rhodobacter sphaeroides 
Rhodobacter azotoformans 
Cereibacter changlensis 
Sinorhizobium meliloti 
Aurantimonas manganoxydans 
Mycobacterium tuberculosis 
Pseudomonas putida 
Mycolicibacterium smegmatis 
Rhizobium leguminosarum 
Pseudomonas aeruginosa 
Nitrospirillum amazonense 
Rhodobacter johrii 
Rhizobium lusitanum 
Mycobacterium tuberculosis 
Bacillus cereus 
Rhizobium tropici 
Bacillus subtilis 
AUW40742.1 
BAR68071.1 
ASG25270.1 
RAZ83231.1 
SCB45385.1 
AJF02293.1 
AUZ26128.1 
RAX41073.1 
AQZ90234.1 
Ku 1 
Species Accession # 
Sequenced genome (Isobionics) 
Sequenced genome (Isobionics) 
WP_101341724 
PTE23121 
WP_107662491 
WP_047555545 
WP_028734704.1 
KZO53158.1 
KXN95658.1 
WP_108223209.1 
Rhodobacter sphaeroides Ku1 
Rhodobacter sphaeroides Ku2 
Rhodobacter azotoformans 
Cereibacter changlensis  
Cereibacter changlensis  
Rhizobium leguminosarum 
Rhizobium leguminosarum 
Pseudomonas putida 
Mycobacterium tuberculosis 
Rhodobacter johrii 
Rhodobacter azotoformans 
Rhizobium lusitanum 
Nitrospirillum amazonense 
Agrobacterium tumefaciens 
Mycobacterium haemophilum 
Cereibacter changlensis 
WP_101340822.1 
WP_092574817.1 
WP_004274142.1 
WP_025591969.1 
WP_047314295.1 
WP_107662492.1 
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strain and spacers dilution
# 
conjugants
# 
screened
colonies
# 
survivals
(5FU)
# NH EJ 
mutants
% NH EJ
efficiency *
wt-sp1 100x 17 15 0 0 0
wt-sp2 100x 60 60 3 3 5
ΔligD-sp1 1x 1726 179 0 0 0
ΔligD-sp2 1x 2004 195 0 0 0
Δku1-sp1 100x 81 65 3 1 1.54
Δku1-sp2 1000x 658 81 5 4 4.94
Δku2-sp1 10x 155 65 4 2 3.08
Δku2-sp2 100x 839 100 21 20 20
Δku1-2-sp1 10x 120 106 3 0 0
Δku1-2-sp2 100x 568 130 8 7 5.38
* The efficiencies were determ ined as ratio of the num ber of sequenced NHEJ m utants to the num ber of colonies
screened for 5FU toxicity.
Table S8. Description of the type of indels registered for the m utants obtained from the pBBR_cas9_sp1/2 in the
NHEJ KO strains (ΔligD, Δku1, Δku2, Δku1-2). 
strain colony mutation
wt-sp2
wt-sp2c24 1bp substitution
wt-sp2c32 1bp substitution
wt-sp2c49 1bp substitution
Δku1-sp1 k1-sp1c23 1bp insertion
Δku1-sp2
k1-sp2c19 1bp substitution
k1-sp2c49 6bp repeat insertion
k1-sp2c55 1bp substitution
k1-sp2c77 1bp substitution
Δku1-2-sp2
k12-sp2c50 6bp repeat insertion
k12-sp2c53 1bp substitution
k12-sp2c57 1bp substitution
k12-sp2c76 1bp substitution
k12-sp2c81 1bp substitution
k12-
sp2c106 6bp repeat insertion
k12-
sp2c108 1bp deletion
Δku2-sp1
k2'-sp1c6 1bp insertion
k2'-sp1c36 1bp insertion
Δku2-sp2
k2'-sp2c2
k2'-sp2c9
1bp substitution
9bp deletion
k2'-sp2c11 1bp substitution
k2'-sp2c12 1bp substitution
k2'-sp2c15 6bp repeat insertion
k2'-sp2c34 9bp deletion
k2'-sp2c37 1bp substitution
k2'-sp2c39 1bp substitution
k2'-sp2c40 1bp substitution
k2'-sp2c43 6bp repeat insertion
k2'-sp2c49 1bp substitution
k2'-sp2c51 6bp repeat insertion
k2'-sp2c66 1bp substitution
k2'-sp2c67 1bp substitution
k2'-sp2c69 6bp repeat insertion
k2'-sp2c74 55bp deletion
k2'-sp2c79 1bp substitution
k2'-sp2c95 6bp repeat insertion
k2'-sp2c96 1bp substitution
k2'-sp2c98 9bp deletion
strain colony mutation
RAX38214.1 
AKR33785.1 
Rhizobium tropici 
Bacillus thuringiensis 
Bacillus cereus PGV94828.1 
Ku  2
Species Accession # 
WP_069332344.1 
CRF99327.1 
OBQ66756.1 
BAR68056.1 
Rhodobacter johrii 
Streptococcus pneumoniae 
Mesorhizobium loti 
Pseudomonas aeruginosa 
Mycolicibacterium smegmatis YP_889815.1 
Table S5. NHEJ in R. sphaeroides conjugated with pBBR_Cas9_sp1 and pBBR_Cas9_sp2. 
Plasmid 
CFUs (100x 
dilution) 
5FU-screening: edited 
colonies/streaked colonies 
% NHEJ 
efficiency * 
pBBR_Cas9_sp1 113 3/40 7.5 
pBBR_Cas9_sp2 89 6/85 7.1 
* The percentage of NHEJ efficiency has been determined by restreak of conjugants strains on 5FU and 
subsequent sequencing of the protospacer locus. All the survival colonies on the 5FU plates showed indels in the 
protospacer region.
Table S6. Efficiency of the knock-outs generated via HR-CRISPR/Cas9 counter-selection for the NHEJ genes 
ligD, ku1 and ku2 
Plasmid used Mutated colonies/colonies screened 
Mutation 
efficiency (%) 
pBBR_Cas9_ΔligD 
(spacer1) 
1/7 14% 
pBBR_Cas9_Δku1 
(spacer3) 
1/9 11% 
pBBR_Cas9_Δku2 
(spacer3) 
6/20 30% 
Table S7. Comparison of the NHEJ efficiencies in the different NHEJ KO strains conjugated with 
pBBR_cas9_sp1/2 targeting upp.  
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Rhizobium tropici RAX38214.1
Bacillus thuringiensis AKR33785.1
Bacillus cereus PGV94828.1
K u  2
Species Accession #
Rhodobacter johrii WP_069332344.1
Streptococcus pneumoniae CRF99327.1
Mesorhizobium loti OBQ66756.1
Pseudomonas aeruginosa BAR68056.1
Mycolicibacterium smegmatis YP_889815.1
Table S5. NHEJ in R. sphaeroides conjugated with pBBR_Cas9_sp1 and pBBR_Cas9_sp2.
Plasmid
CFUs (100x
dilution)
5FU-screening: edited
colonies/streaked colonies
% NH EJ
efficiency *
pBBR_Cas9_sp1 113 3/40 7.5
pBBR_Cas9_sp2 89 6/85 7.1
* The percentage of NHEJ efficiency has been determ ined by restreakof conjugants strains on 5FU and
subsequent sequencing of the protospacer locus. All the survival colonies on the 5FU plates showed indels in the
protospacer region.
Table S6. Efficiency of the knock-outs generated via HR-CRISPR/Cas9 counter-selection for the NHEJ genes
ligD, ku1 and ku2
Plasmid used Mutated colonies/colonies screened
Mutation 
efficiency (%)
pBBR_Cas9_ΔligD
(spacer1)
1/7 14%
pBBR_Cas9_Δku1 
(spacer3)
1/9 11%
pBBR_Cas9_Δku2 
(spacer3)
6/20 30%
Table S7. Com parison of the NHEJ efficiencies in the different NHEJ KO strains conjugated with
pBBR_cas9_sp1/2 targeting upp. 
strain and spacers dilution 
# 
conjugants 
# 
screened 
colonies 
# 
survivals 
(5FU) 
# NHEJ 
mutants 
% NHEJ 
efficiency * 
wt-sp1 100x 17 15 0 0 0 
wt-sp2 100x 60 60 3 3 5 
ΔligD-sp1 1x 1726 179 0 0 0 
ΔligD-sp2 1x 2004 195 0 0 0 
Δku1-sp1 100x 81 65 3 1 1.54 
Δku1-sp2 1000x 658 81 5 4 4.94 
Δku2-sp1 10x 155 65 4 2 3.08 
Δku2-sp2 100x 839 100 21 20 20 
Δku1-2-sp1 10x 120 106 3 0 0 
Δku1-2-sp2 100x 568 130 8 7 5.38 
* The efficiencies were determ ined as ratio of the num ber of sequenced NHEJ m utants to the num ber of colonies
screened for 5FU toxicity.
Table S8. Description of the type of indels registered for the m utants obtained from the pBBR_cas9_sp1/2 in the 
NHEJ KO strains (ΔligD, Δku1, Δku2, Δku1-2).  
strain colony mutation 
wt-sp2 
wt-sp2c24 1bp substitution 
wt-sp2c32 1bp substitution 
wt-sp2c49 1bp substitution 
Δku1-sp1 k1-sp1c23 1bp insertion 
Δku1-sp2 
k1-sp2c19 1bp substitution 
k1-sp2c49 6bp repeat insertion 
k1-sp2c55 1bp substitution 
k1-sp2c77 1bp substitution 
Δku1-2-sp2 
k12-sp2c50 6bp repeat insertion 
k12-sp2c53 1bp substitution 
k12-sp2c57 1bp substitution 
k12-sp2c76 1bp substitution 
k12-sp2c81 1bp substitution 
k12-
sp2c106 6bp repeat insertion 
k12-
sp2c108 1bp deletion 
Δku2-sp1 
k2'-sp1c6 1bp insertion 
k2'-sp1c36 1bp insertion 
Δku2-sp2 
k2'-sp2c2 
k2'-sp2c9 
1bp substitution 
9bp deletion 
k2'-sp2c11 1bp substitution 
k2'-sp2c12 1bp substitution 
k2'-sp2c15 6bp repeat insertion 
k2'-sp2c34 9bp deletion 
k2'-sp2c37 1bp substitution 
k2'-sp2c39 1bp substitution 
k2'-sp2c40 1bp substitution 
k2'-sp2c43 6bp repeat insertion 
k2'-sp2c49 1bp substitution 
k2'-sp2c51 6bp repeat insertion 
k2'-sp2c66 1bp substitution 
k2'-sp2c67 1bp substitution 
k2'-sp2c69 6bp repeat insertion 
k2'-sp2c74 55bp deletion 
k2'-sp2c79 1bp substitution 
k2'-sp2c95 6bp repeat insertion 
k2'-sp2c96 1bp substitution 
k2'-sp2c98 9bp deletion 
strain colony mutation 
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ABSTRACT 
CRISPR-Cas9 based genome engineering tools have revolutionized fundamental research 
and biotechnological exploitation of both eukaryotes and prokaryotes. However, the 
mesophilic nature of the established Cas9 systems does not allow for applications that 
require enhanced stability, including engineering at elevated temperatures. Here, we 
identify and characterize ThermoCas9 from the thermophilic bacterium Geobacillus 
thermodenitrificans T12. We show that ThermoCas9 is active in vitro between 20°C 
and 70°C, a temperature range much broader than that of currently used Cas9 
orthologues. Additionally, we demonstrate that ThermoCas9 activity at elevated 
temperatures is strongly associated with the structure of the employed sgRNA. 
Subsequently, we develop ThermoCas9-based engineering tools for gene deletion 
and transcriptional silencing at 55°C in Bacillus smithii and for gene deletion at 
37°C in Pseudomonas putida. Altogether, our findings provide fundamental insights into a 
thermophilic CRISPR-Cas family member and establish the first Cas9-based bacterial 
genome editing and silencing tool with a broad temperature range. 
KEYWORDS  
CRISPR/Cas9, thermoCas9, Bacillus smithii, Pseudomonas putida, thermophiles, genome 
editing, genome silencing  
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ABSTRACT 
CRISPR-Cas9 based genome engineering tools have revolutionized fundamental research 
and biotechnological exploitation of both eukaryotes and prokaryotes. However, the 
mesophilic nature of the established Cas9 systems does not allow for applications that 
require enhanced stability, including engineering at elevated temperatures. Here, we 
identify and characterize ThermoCas9from the thermophilic bacterium Geobacillus 
thermodenitrificans T12. We show that ThermoCas9 is active in vitro between 20°C and 70°
C, a temperature range much broader than that of currently used Cas9 orthologues. 
Additionally, we demonstrate that ThermoCas9 activity at elevated temperatures is 
strongly associated with the structure of the employed sgRNA. Subsequently, we develop 
ThermoCas9-based engineering tools for gene deletion and transcriptional silencing at 55°
C in Bacillus smithii and for gene deletion at 37°C in Pseudomonas putida. 
Altogether, our findings provide fundamental insights into a thermophilic CRISPR-Cas 
family member and establish the first Cas9-based bacterial genome editing and silencing 
tool with a broad temperature range. 
K EYWO RDS  
CRISPR/Cas9, thermoCas9, Bacillus smithii, Pseudomonas putida, thermophiles, 
genome editing, genome silencing  
INTRODUCTION 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and the 
CRISPR-associated (Cas) proteins provide adaptive and heritable immunity in 
prokaryotes against invading genetic elements1–4. CRISPR-Cas systems are subdivided into 
two classes (1 and 2) and six types (I-VI), depending on their complexity and signature 
proteins5. Class 2 systems, including type-II CRISPR-Cas9 and type V CRISPR-Cas12a 
(previously called CRISPR- Cpf1) have recently been exploited as genome engineering tools 
for both eukaryotes6–10 and prokaryotes11–13. These systems are among the simplest CRISPR-
Cas systems known as they introduce targeted double stranded DNA breaks (DSBs) based on 
a ribonucleoprotein (RNP) complex formed by a single Cas endonuclease and an RNA guide.  
The guide of Cas9 consists of a crRNA (CRISPR RNA):tracrRNA 
(trans-activating-CRISPR-RNA) duplex. For engineering purposes, the 
crRNA:tracrRNA duplex has been simplified by generating a chimeric, single guide 
RNA (sgRNA) to guide Cas9 upon co-expression14. In addition, cleavage of the 
target DNA requires a protospacer adjacent motif (PAM): a 3-8 nucleotide (nt) long 
sequence located next to the targeted protospacer that is highly variable between 
different Cas9 proteins15–17. Cas9 endonucleases contain two catalytic domains, 
denoted as RuvC and HNH. Substituting catalytic residues in one of these domains 
results in Cas9 nickase variants, and in both domains in an inactive variant18-20. The 
inactive or dead Cas9 (dCas9) has been instrumental as an efficient gene 
silencing system and for modulating the expression of essential genes11,21,22.
To date, Streptococcus pyogenes Cas9 (SpCas9) is the best characterized 
and most widely employed Cas9 for genome engineering. Although a few other 
type-II systems have been exploited for bacterial genome engineering purposes, none of 
them is derived from a thermophilic organism23. Characterization of such CRISPR-Cas 
systems would be interesting to gain fundamental insights as well as to develop novel 
applications.  
Although basic genetic tools are available for a number of 
thermophiles24–27, the efficiency of these tools is still too low to enable full exploration 
and exploitation of this interesting group of organisms. Based on our finding that 
SpCas9 is not active in vivo at or above 42°C, we have previously developed a SpCas9-
based engineering tool for facultative thermophiles, combining homologous 
recombination at elevated temperatures and SpCas9-based counter-selection at moderate 
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temperatures28. However, a Cas9-based editing and silencing tool for obligate thermophiles 
is not yet available a s SpCas9 is not active at elevatedtemperatures28,29, and to date no 
thermophilic Cas9 has been adapted for such purpose. Here, we describe the 
characterization of ThermoCas9, an RNA-guided DNA-endonuclease from the CRISPR-
Cas type-IIc system of the thermophilic bacterium Geobacillus thermodenitrificans 
T1230. We show that ThermoCas9 is active in vitro between 20 and 70°C and demonstrate 
the effect of the sgRNA-structure on its thermostability. We apply ThermoCas9 for in 
vivo genome editing and silencing of the industrially important thermophile Bacillus 
smithii ET 13831 at 55°C, creating the first Cas9-based genome engineering tool 
readily applicable to thermophiles. In addition, we apply ThermoCas9 for in vivo genome 
editing of the mesophile Pseudomonas putida KT2440, for which to date no CRISPR-
Cas9-based editing tool had been described32,33, confirming the wide temperature range 
and broad applicability of this novel Cas9 system. 
RESULTS 
THERMOCAS9 IDENTIFICATION AND PURIFICATION 
We recently isolated and sequenced Geobacillus thermodenitrificans strain T12, a Gram 
positive, moderately thermophilic bacterium with an optimal growth temperature at 65°C30. 
Contrary to previous claims that type II CRISPR-Cas systems are not present in thermophilic 
bacteria34, the sequencing results revealed the existence of a type-IIC CRISPR-Cas system in 
the genome of G. thermodenitrificans T12 (Figure 1A)35. The Cas9 endonuclease of 
this system (ThermoCas9) was predicted to be relatively small (1082 amino acids) 
compared to other Cas9 orthologues, such as SpCas9 (1368 amino acids). The size 
difference is mostly due to a truncated REC lobe, as has been demonstrated for other 
small Cas9 orthologues36. Furthermore, ThermoCas9 was expected to be active at 
least around the temperature optimum of G. thermodenitrificans T1230. Using the 
ThermoCas9 sequence as query, we performed BLAST-P searches in the NCBI/non-
redundant protein sequences dataset, and found a number of highly identical Cas9 
orthologues (87-99% identity at amino acid level, Supplementary Table 1), mostly within 
the Geobacillus genus, supporting the idea that ThermoCas9 is part of a highly 
conserved defense system of thermophilic bacteria (Figure 1B). These characteristics 
suggested it may be a potential candidate for exploitation as a genome editing and 
silencing tool for thermophilic microorganisms, and for conditions at which enhanced 
protein robustness is required.  
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Figure 1. The Geobacillus thermodenitrificans T12 type-IIC CRISPR-Cas locus encoding ThermoCas9. 
a) Schematic representation of the genomic locus encoding ThermoCas9. The domain architecture of
ThermoCas9 based on sequence comparison, with predicted active sites residues highlighted in magenta. A
homology model of ThermoCas9 generated using Phyre 2 58 is shown, with different colours for the domains.
b) Phylogenetic tree of Cas9 orthologues highly identical to ThermoCas9. Evolutionary analysis was
conducted in MEGA759. c) SDS-PAGE of ThermoCas9 after purification by metal-affinity chromatography
and gel filtration. The migration of the obtained single band is consistent with the theoretical apo-ThermoCas9
molecular weight of 126 kDa.
10  1
spacer (29-31nt)  direct 
repeat (36nt)
CRISPR array
tracrRNA ThermoCas9 Cas1 Cas2
Geobacillus thermodenitricans T12
We initially performed in silico prediction of the crRNA and tracrRNA modules of 
the G. thermodenitrificans T12 CRISPR-Cas system using a previously described 
approach11,36. Based on this prediction, a 190 nt sgRNA chimera was designed by linking the 
predicted full-size crRNA (30 nt long spacer followed by 36 nt long repeat) and tracrRNA 
(36 nt long anti-repeat followed by a 88 nt sequence with three predicted hairpin structures). 
ThermoCas9 was heterologously expressed in E. coli and purified to homogeneity. 
Hypothesizing that the loading of the sgRNA to the ThermoCas9 would stabilize the protein, 
we incubated purified apo-ThermoCas9 and ThermoCas9 loaded with in vitro transcribed 
sgRNA at 60°C and 65°C, for 15 and 30 min. SDS-PAGE analysis showed that the purified 
ThermoCas9 denatures at 65°C but not at 60°C, while the denaturation temperature of 
ThermoCas9-sgRNA complex is above 65°C (Figure 1C). The demonstrated thermostability 
of ThermoCas9 implied its potential as a thermo-tolerant CRISPR-Cas9 genome editing tool, 
and encouraged us to analyze some relevant molecular features in more detail.
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THERMOCAS9 PAM DETERMINATION
The first step towards the characterization of ThermoCas9 was the in silico prediction of its 
PAM preferences for successful cleavage of a DNA target. We used the 10 spacers of the G. 
thermodenitrificans T12 CRISPR locus to search for potential protospacers in viral and 
plasmid sequences using CRISPRtarget37. As only two hits were obtained with phage genomes 
(Supplementary Fig. 1A), it was decided to proceed with an in vitro PAM determination 
approach. The predicted sgRNA sequence was generated by in vitro transcription, including a 
spacer that should allow for ThermoCas9-based targeting of linear dsDNA substrates with a 
matching protospacer. The protospacer was flanked at its 3’-end by randomized 7-base pair 
(bp) sequences. After performing ThermoCas9-based cleavage assays at 55°C, the cleaved 
sequences of the library (together with a non-targeted library sample as control) were separated 
from uncleaved sequences, by gel electrophoresis, and analyzed by deep-sequencing in order to 
identify the ThermoCas9 PAM preference (Figure 2A). The sequencing results revealed that 
ThermoCas9 introduces double stranded DNA breaks that, in analogy with the mesophilic 
Cas9 variants, are located mostly between the 3rd and the 4th PAM proximal nucleotides, at 
the 3’ end of the protospacer. Moreover, the cleaved sequences revealed that ThermoCas9 
recognizes a 5’-NNNNCNR-3’ PAM, with subtle preference for cytosine at the 1st, 3rd, 4th 
and 6th PAM positions (Figure 2B). Recent studies have revealed the importance of the 8th 
PAM position for target recognition of some Type IIC Cas9 orthologues17,38. For this purpose, 
and taking into account the results from the in silico ThermoCas9 PAM prediction 
(Supplementary Fig. 1), we performed additional PAM determination assays. This revealed 
optimal targeting efficiency in the presence of an adenine at the 8th PAM position (Figure 2C). 
Interestingly, despite the limited number of hits, the aforementioned in silico PAM prediction 
(Supplementary Fig. 1B) also suggested the significance of a cytosine at the 5th and an adenine 
at the 8th PAM positions. To further clarify the ambiguity of the PAM at the 6 th and 7th PAM 
positions, we generated a set of 16 different target DNA fragments in which the matching 
protospacer was flanked by 5’-CCCCCNNA-3’PAMs. Cleavage assays of these fragments 
(each with a unique combination of the 6th and 7th nucleotide) were performed in which the 
different components (ThermoCas9, sgRNA guide, dsDNA target) were pre-heated separately 
at different temperatures (20, 30, 37, 45, 55 and 60°C) for 10 min before combining and 
incubating them for 1 hour at the corresponding assay temperature.
Figure 2. ThermoCas9 PAM analysis. a) Schematic illustrating the in vitro cleavage assay for discovering 
the position and identity (5′-NNNNNNN-3’) of the protospacer adjacent motif (PAM). Magenta triangles 
indicate the cleavage position. b) Sequence logo of the consensus 7nt long PAM of ThermoCas9, obtained by 
comparative analysis of the ThermoCas9-based cleavage of target libraries. Letter height at each position is 
measured by information content. c) Extension of the PAM identity to the 8th position by in vitro cleavage 
assay. Four linearized plasmid targets, each containing a distinct 5′-CCCCCCAN-3 PAM, were incubated with 
ThermoCas9 and sgRNAat 55˚C for 1 hour, then analysed by agarose gel electrophoresis. d) In vitro cleavage 
assays for DNA targets with different PAMs at 30˚C and 55˚C. Sixteen linearized plasmid targets, each 
containing one distinct 5’-CCCCCNNA-3’ PAM, were incubated with ThermoCas9 and sgRNA, then 
analysed for cleavage efficiency by agarose gel electrophoresis. See also Supplementary Fig. 2. Supplementary 
Fig. 9 shows the uncropped gel images. 
(5th to 8th PAM positions) 5’-CNAA-3’ and 5’-CMCA-3’, whereas the least digested 
targets contained a 5’-CAKA-3’ PAM. At 30°C, only cleavage of the DNA substrates with 
the optimal PAM sequences (5th to 8th PAM positions) 5’-CNAA-3’ and 5’-CMCA-3’ was 
observed (Figure 2D). Lastly, at 20°C only the DNA substrates with (5th to 8th PAM 
positions) 5’-CVAA-3’ and 5’-CCCA-3’ PAM sequences were targeted (Supplementary 
Fig. 2), making these sequences the most preferred PAMs. Our findings demonstrate that at
its lower temperature limit, ThermoCas9 only cleaves fragments with a preferred PAM. 
This characteristic could be exploited during in vivo editing processes, for example to avoid 
off-target effects.  
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TH ERMO CAS9 PAM DETERMINATIO N 
The first step towards the characterization of ThermoCas9 was t he in silico prediction of its 
PAM preferences for successful cleavage of a DNA target. We used the 10 spacers of the G. 
thermodenitrificans T12 CRISPR locus to search for potential protospacers in viral and 
plasmid sequences using CRISPRtarget37. As only two hits were obtained with phage 
genomes (Supplementary Fig. 1A), it was decided to proceed with an in vitro PAM 
determination approach. The predicted sgRNA sequence was generated by in vitro 
transcription, including aspacer that should allow for ThermoCas9-based targeting of linear 
dsDNA substrates with a matching protospacer. The protospacer was flanked at its 3’-end 
by randomized 7-base pair (bp) sequences. After performing ThermoCas9-based cleavage 
assays at 55°C, the cleaved sequences of the library (together with a non-targeted library 
sample as control) were separated from uncleaved sequences, by gel electrophoresis, and 
analyzed by deep-sequencing in order to identify the Thermo Cas9 PAM preference (Figure 
2A). The sequencing results revealed that ThermoCas9 introduces double stranded DNA 
breaks that, in analogy with the mesophilic Cas9 variants, are located mostly between the 3rd
and the 4th PAM proximal nucleotides, at the 3’ end of the protospacer. Moreover, the 
cleaved sequences revealed that ThermoCas9 recognizes a 5’-NNNNCNR-3’ PAM, with 
subtle preference for cytosine at the 1st, 3rd, 4th and 6th PAM positions (Figure 2B). Recent 
studies have revealed the importance of the 8th PAM position for target recognition of some 
Type IIC Cas9 orthologues17,38. For this purpose, and taking into account the results from 
the in silico ThermoCas9 PAM prediction (Supplementary Fig. 1), we performed additional 
PAM determination assays. This revealed optimal targeting efficiency in the presence of an 
adenine at the 8th PAM position (Figure 2C). Interestingly, despite the limited number of hits, 
the aforementioned in silico PAM prediction (Supplementary Fig. 1B) also suggested the 
significance of a cytosine at the 5th and an adenine at the 8th PAM positions. To further clarify 
the ambiguity of the PAM at the 6 th and 7th PAM positions, we generated a set of 16 different 
target DNA fragments in which the matching protospacer was flanked by 5’-
CCCCCNNA-3’PAMs. Cleavage assays of these fragments (each with a unique combination 
of the 6th and 7th nucleotide) were performed in which the different components 
(ThermoCas9, sgRNA guide, dsDNA target) were pre-heated separately at different 
temperatures (20, 30, 37, 45, 55 and 60°C) for 10 min before combining and incubating 
them for 1 hour at the corresponding assay temperature. When the assays were performed 
at temperatures between 37°C and 60°C, all the different DNA substrates were cleaved 
(Figure 2D, S3). However, the most digested target fragments consisted of PAM sequences 
Figure 2. ThermoCas9 PAM analysis. a) Schematic illustrating the in vitro cleavage assay for discovering 
the position and identity (5′-NNNNNNN-3’) of the protospacer adjacent motif (PAM). Magenta triangles 
indicate the cleavage position. b) Sequence logo of the consensus 7nt long PAM of ThermoCas9, obtained by 
comparative analysis of the ThermoCas9-based cleavage of target libraries. Letter height at each position is 
measured by information content. c) Extension of the PAM identity to the 8th position by in vitro cleavage 
assay. Four linearized plasmid targets, each containing a distinct 5′ -CCCCCCAN-3 PAM, were incubated with 
ThermoCas9 and sgRNA at 55˚C for 1 hour, then analysed by agarose gel electrophoresis. d) In vitro cleavage 
assays for DNA targets with different PAMs at 30˚C and 55˚C. Sixteen linearized plasmid targets, each 
containing one distinct 5’-CCCCCNNA-3’ PAM, were incubated with ThermoCas9 and sgRNA, then 
analysed for cleavage efficiency by agarose gel electrophoresis. See also Supplementary Fig. 2. Supplementary 
Fig. 9 shows the uncropped gel images. 
When the assays were performed at temperatures between 37°C and 60°C, all the 
different DNA substrates were cleaved (Figure 2D, S3). However, the most digested target 
fragments consisted of PAM sequences (5th to 8th PAM positions) 5’-CNAA-3’ and 5’-
CMCA-3’, whereas the least digested targets contained a 5’-CAKA-3’ PAM. At 30°C, only 
cleavage of the DNA substrates with the optimal PAM sequences (5th to 8th PAM positions) 
5’-CNAA-3’ and 5’-CMCA-3’ was observed (Figure 2D). Lastly, at 20°C only the DNA 
substrates with (5th to 8th PAM positions) 5’-CVAA-3’ and 5’-CCCA-3’ PAM sequences 
were targeted (Supplementary Fig. 2), making these sequences the most preferred PAMs. Our 
findings demonstrate that at its lower temperature limit, ThermoCas9 only cleaves fragments 
with a preferred PAM. This characteristic could be exploited during in vivo editing processes,
for example to avoid off-target effects.  
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METAL ION DEPENDENCY
Previously characterized, mesophilic Cas9 endonucleases employ divalent cations to catalyze 
the generation of DSBs in target DNA14,39. To determine the ion dependency of ThermoCas9 
cleavage activity, plasmid cleavage assays were performed in the presence of one of the 
following divalent cations: Mg2+, Ca2+, Mn2+, Fe2+, Co2+, Ni2+, and Zn2+; an assay with the 
cation-chelating agent EDTA was included as negative control. As expected, target dsDNA 
was cleaved in the presence of divalent cations and remained intact in the presence of EDTA 
(Supplementary Fig. 5A). The DNA cleavage activity of ThermoCas9 was the highest when 
Mg2+ and Mn2+ was added to the reaction consistent with other Cas9 variants14,20,40. 
Addition of Fe2+, Co2+, Ni2+, or Zn2+ ions also mediated cleavage. Ca2+ only supported 
plasmid nicking, suggesting that with this cation only one of the endonuclease domains is 
functional.
THERMOSTABILITY AND TRUNCATIONS
The predicted tracrRNA consists of the anti-repeat region followed by three hairpin structures 
(Figure 3A). Using the tracrRNA along with the crRNA to form a sgRNA chimera resulted in 
successful guided cleavage of the DNA substrate. It was observed that a 41-nt long deletion 
of the spacer distal end of the full-length repeat-anti-repeat hairpin (Figure 3A), most likely 
better resembling the dual guide’s native state, had little to no effect on the DNA cleavage 
efficiency. The effect of further truncation of the predicted hairpins (Figure 3A) on the 
cleavage efficiency of ThermoCas9 was evaluated by performing a cleavage time-series in 
which all the components (sgRNA, ThermoCas9, substrate DNA) were pre-heated separately 
at different temperatures (37-65°C) for 1, 2 and 5 min before combining and incubating them 
for 1 hour at various assay temperatures (37-65°C). The number of predicted stem-loops of 
the tracrRNA scaffold seemed to play a crucial role in DNA cleavage; when all three loops 
were present, the cleavage efficiency was the highest at all tested temperatures, whereas the 
efficiency decreased upon removal of the 3’ hairpin (Figure 3B). Moreover, the cleavage 
efficiency drastically dropped upon removal of both the middle and the 3’ hairpins 
(Supplementary Fig. 4). Whereas pre-heating ThermoCas9 at 65°C for 1 or 2 min resulted in 
detectable cleavage, the cleavage activity was abolished after 5 min incubation. The 
thermostability assay showed that sgRNA variants without the 3‘stem-loop result in 
decreased stability of the ThermoCas9 protein at 65°C, indicating that a full length tracrRNA 
is required for optimal ThermoCas9-based DNA cleavage at elevated temperatures. 
Additionally, we also varied the lengths of the spacer sequence (from 25 to 18 nt) and found 
that spacer lengths of 23, 21, 20 and 19 cleaved the targets with the highest efficiency. The
Figure 3. ThermoCas9 temperature range and effect of sgRNA-binding. a) Schematic representation of the 
sgRNA and a matching target DNA. The target DNA, the PAM and the crRNA are shown in grey, blue and 
green, respectively. The site where the crRNA is linked with the tracrRNA is shown in purple. The dark blue 
and light blue boxes indicate the predicted three and two loops of the tracrRNA, respectively. The 41-nt 
truncation of the repeat-antirepeat region and the three loops of the sgRNA are indicated by the magen ta dotted 
line and magenta triangles, respectively. b) The importan ce of the predicted three stem-loops of the tracrRNA 
scaffold was tested by transcribing truncated variants of the sgRNA and evaluating their ability to guide 
ThermoCas9 to cleave target DNA at various temperatures. Average values of three replicates are shown, with 
error bars representing S.D.. The blots of one of the replicates are shown in Supplementary Fig. 10. c) The 
importance of the length of the spacer was tested by transcribing truncated variants of the initial spacer in the 
sgRNA and evaluating their ability to guide ThermoCas9 to cleave target DNA at 55°C. Average values of 
three replicates are shown, with error bars representing S.D.. The blots of one of the replicates are shown in 
Supplementary Fig. 11. d) To identify the maximum temperature, endonuclease activity of 
ThermoCas9:sgRNA RNP complex was assayed after incubation at 60˚C, 65˚C and 70˚C for 5 or 10 min. The 
pre-heated DNA substrate was added and the reaction was incubated for 1 hour at the corresponding 
temperature. e) Comparison of active temperature range of Thermo Cas9 and SpCas9 by activity assays 
conducted after 5 min of incubation at the indicated temperature. The pre-heated DNA substrate was added and 
the reaction was incubated for 1 hour at the same temperature. 
cleaved the targets with the highest efficiency. The cleavage efficiency drops significantly 
when a spacer of 18 nt is used (Figure 3C). In vivo, the ThermoCas9:sgRNA RNP complex 
is probably formed within minutes. Together with the above findings, this motivated us to 
evaluate the activity and thermostability of the RNP. Pre-assembled RNP complex was 
heated at 60, 65 and 70°C for 5 and 10 min before adding pre-heated DNA and subsequent 
incubation for 1 hour at 60, 65 and 70°C. Strikingly, we observed that the ThermoCas9 RNP 
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METAL IO N DEPENDENCY
Previously characterized, mesop hilic Cas9 endonucleases employ divalent cations to catalyze 
the generation of DSBs in target DNA14,39. To determine the ion dependency of ThermoCas9 
cleavage activity, plasmid cleavage assays were performed in the presence of one of the 
following divalent cations: Mg2+, Ca2+, Mn2+, Fe2+, Co2+, Ni2+, and Zn2+; an assay with the 
cation-chelating agent EDTA was included as negative control. As expected, target dsDNA 
was cleaved in the presence of divalent cations and remained intact in the presence of EDTA 
(Supplementary Fig. 5A). The DNA cleavage activity of ThermoCas9 was the highest when 
Mg2+ and Mn2+ was added to the reaction consistent with other Cas9 variants14,20,40. Addition 
of Fe2+, Co2+, Ni2+, or Zn2+ ions also mediated cleavage. Ca2+ only supported plasmid 
nicking, suggesting that with this cation only one of the endonuclease domains is functional.  
TH ERMO STABILITY AND TRUNCATIO NS
The predicted tracrRNA consists of the anti-repeat region followed by three hairpin 
structures (Figure 3A). Using the tracrRNA along with the crRNA to form a sgRNA 
chimera resulted in successful guided cleavage of the DNA substrate. It was observed that 
a 41-nt long deletion of the spacer distal end of the full-length repeat-anti-repeat hairpin 
(Figure 3A), most likely better resembling the dual guide’s native state, had little to no 
effect on the DNA cleavage efficiency. The effect of further truncation of the predicted 
hairpins (Figure 3A) on the cleavage efficiency of ThermoCas9 was evaluated by 
performing a cleavage time-series in which all the components (sgRNA, 
ThermoCas9, substrate DNA) were pre-heated separately at different temperatures 
(37-65°C) for 1, 2 and 5 min before combining and incubating them for 1 hour at 
various assay temperatures (37-65°C). The number of predicted stem-loops of the 
tracrRNA scaffold seemed to play a crucial role in DNA cleavage; when all three 
loops were present, the cleavage efficiency was the highest at all tested temperatures, 
whereas the efficiency decreased upon removal of the 3’ hairpin (Figure 3B). 
Moreover, the cleavage efficiency drastically dropped upon removal of both the middle 
and the 3’ hairpins (Supplementary Fig. 4). Whereas pre-heating ThermoCas9 at 65°C for 
1 or 2 min resulted in detectable cleavage, the cleavage activity was abolished after 5 
min incubation. The thermostability assay showed that sgRNA variants without the 
3‘stem-loop result in decreased stability of the ThermoCas9 protein at 65°C, 
indicating that a full length tracrRNA is required for optimal ThermoCas9-based DNA 
cleavage at elevated temperatures. Additionally, we also varied the lengths of the 
spacer sequence (from 25 to 18 nt) and found that spacer lengths of 23, 21, 20 and 19 
Figure 3. ThermoCas9 temperature range and effect of sgRNA-binding. a) Schematic representation of the 
sgRNA and a matching target DNA. The target DNA, the PAM and the crRNA are shown in grey, blue and 
green, respectively. The site where the crRNA is linked with the tracrRNA is shown in purple. The dark blue and 
light blue boxes indicate the predicted three and two loops of the tracrRNA, respectively. The 41-nt 
truncation of the repeat-antirepeat region and the three loops of the sgRNA are indicated by the magenta dotted 
line and magenta triangles, respectively. b) The importance of the predicted three stem -loops of the tracrRNA 
scaffold was tested by transcribing truncated variants of the sgRNA and evaluating their ability to guide 
ThermoCas9 to cleave target DNA at various temperatures. Average values of three replicates are shown, with 
error bars representing S.D.. The blots of one of the replicates are shown in Supplementary Fig. 10. c) The 
importance of the length of the spacer was tested by transcribing truncated variants of the initial spacer in the 
sgRNA and evaluating their ability to guide ThermoCas9 to cleave target DNA at 55°C. Average values of 
three replicates are shown, with error bars representing S.D.. The blots of one of the replicates are shown in 
Supplementary Fig. 11. d) To identify the maximum temperature, endonuclease activity of 
ThermoCas9:sgRNA RNP complex was assayed a fter incubation at 60˚C, 65˚C and 70˚C for 5 or 10 min. The 
pre-heated DNA substrate was added and the reaction was incubated for 1 hour at the corresponding 
temperature. e) Comparison of active temperature range of ThermoCas9 and SpCas9 by activity assays 
conducted after 5 min of incubation at the indicated temperature. The pre-heated DNA substrate was added and 
the reaction was incubated for 1 hour at the same temperature. 
cleavage efficiency drops significantly when a spacer of 18 nt is used (Figure 3C). In vivo, 
the ThermoCas9:sgRNA RNP complex is probably formed within minutes. Together with the 
above findings, this motivated us to evaluate the activity and thermostability of the RNP. Pre-
assembled RNP complex was heated at 60, 65 and 70°C for 5 and 10 min before adding pre-
heated DNA and subsequent incubation for 1 hour at 60, 65 and 70°C. Strikingly, we 
observed that the ThermoCas9 RNP was active up to 70°C, in spite of its pre-heating for 5 
min at 70°C (Figure 3D). This finding confirmed our assumption that the ThermoCas9 stabili-
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ty strongly correlates with the association of an appropriate sgRNA guide.
Proteins of thermophilic origin generally retain activity at lower temperatures. 
Hence, we set out to compare the ThermoCas9 temperature range to that of the Streptococcus 
pyogenes Cas9 (SpCas9). Both Cas9 homologues were subjected to in vitro activity assays 
between 20 and 65°C. Both proteins were incubated for 5 min at the corresponding assay 
temperature prior to the addition of the sgRNA and the target DNA molecules. In agreement 
with previousanalysis28,29, the mesophilic SpCas9 was active only between 25 and 44°C 
(Figure 3E); above this temperature SpCas9 activity rapidly decreased to undetectable levels. 
In contrast, ThermoCas9 cleavage activity could be detected between 25 and 65°C (Figure 3). 
This indicates the potential to use ThermoCas9 as a genome editing tool for both thermophilic 
and mesophilic organisms.  
Based on previous reports that certain type-IIC systems were efficient single 
stranded DNA cutters41,40, we tested the activity of ThermoCas9 on ssDNA substrates. 
However, no cleavage was observed, indicating that ThermoCas9 is a dsDNA nuclease 
(Supplementary Fig. 5B).
SPACER-PROTOSPACER MISMATCH TOLERANCE
The predicted tracrRNA consists The targeting specificity and spacer-protospacer mismatch 
tolerance of a Cas9 endonuclease provide vital information for the development of the Cas9 
into a genome engineering tool. To investigate the targeting specificity of ThermoCas9 
towards a selected protospacer, we constructed a target plasmid library by introducing either 
single- or multiple-mismatches to the previously employed protospacer (Figure 4a). Each 
member of the plasmid library, and its PCR-linearized derivative, was separately used as 
substrate for in vitro ThermoCas9 cleavage assays in three independent experiments, both  at 
37 and 55°C.   
The ThermoCas9:sgRNA activity on linear dsDNA targets was abolished at 37°C for 
most of the single-mismatch targets (Figure 4b). Noteworthy exceptions were the targets with 
single-mismatches  at the PAM proximal position 2 and PAM distal position 20, which 
allowed for weak cleavage (Figure 4b). At 55°C, the cleavage efficiency for single-mismatch 
linear targets was higher than at 37°C, however it was strongly hampered for most of the 
tested targets,  especially for single-mismatches at the PAM proximal positions 4, 5 and 10 
(Figure 4c). On the contrary, single-mismatches at positions 1, 2 and 20 were the most 
tolerated for cleavage (Figure 4c).  
In complete contrast to the linear targets with single-mismatches, all the 
corresponding plasmid targets were cleaved by the ThermoCas9:sgRNA complex at 37°C, re-
In complete contrast to the linear targets with single-mismatches, all the corresponding 
plasmid targets were cleaved by the ThermoCas9:sgRNA complex at 37°C, regardless the 
position of the mismatch, with preference for the targets with single-mismatches at the PAM 
proximal positions 2, 6 to 10, 15 and 20 (Figure 4b). At 55°C, a similar trend was observed, 
with elevated cleavage rates (Figure 4c). Remarkably, the ThermoCas9:sgRNA activity was 
impeded for both linear and plasmid targets with multiple-mismatches as there was no 
detectable cleavage for most of these targets at the tested temperatures (Figure 4b, 4c). 
Notable exception was the target with a double mismatch at positions 19 and 20 which was 
cleaved at both tested temperatures but more prominently at 55°C  (Figure 4b, 4c). 
Figure 4. Protospacer targeting Specificity of ThermoCas9. a) Scheme of the generated mismatch 
protospacers library, employed for evaluating the ThermoCas9:sgRNA targeting specificity in vitro. The 
mismatch spacer-protospacer positions are shown in red, the PAM in light blue with the 5th to 8th positions 
underlined. b) Graphical representation of the ThermoCas9:sgRNA cleavage efficiency over linear or 
plasmid targets with different mismatches at 37°C. The percentage of cleavage was calculated based on 
integrated band intensities after gel electrophoresis. Average values from three biological replicates are shown, 
with error bars representing S.D.. Average values of three replicates are shown, with error bars representing 
S.D. The blots of one of the replicates are shown in Supplementary Fig. 12. c) Graphical representation of the 
ThermoCas9:sgRNA cleavage efficiency over linear or plasmid targets with different mismatches at 55°C. The 
percentage of cleavage was calculated based on integrated band intensities after gel electrophoresis. Average 
values from three biological replicates are shown, with error bars representing S.D.. Average values of three 
replicates are shown, with error bars representing S.D. 
TH ERMO CAS9-BASED G ENE DELETIO N IN TH E TH ERMO PH ILE B. SMITHII
We set out to develop a ThermoCas9-based genome editing tool for thermophilic bacteria. 
This group of bacteria is of great interest both from a fundamental as well as from an 
applied perspective. For biotechnological applications, their thermophilic nature results in for 
examp leless cooling costs, higher reaction rates and less contamination risk compared to 
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was active up to 70°C, in spite of its pre-heating for 5 min at 70°C (Figure 3D). This finding 
confirmed our assumption that the ThermoCas9 stability strongly correlates with the 
association of an appropriate sgRNA guide.
Proteins of thermoph ilic origin generally retain activity at lower temper atures. Hence, 
we set out to compare the ThermoCas9 temper ature range to that of the Streptococcus 
pyogenes Cas9 (SpCas9). Both Cas9 homologues were subjected to in vitro activity assays 
between 20 and 65°C. Both proteins were incubated for 5 min at the corresponding assay 
temperature prior to the addition of the sgRNA and the target DNA molecules. In agreement 
with previousanalysis28,29, the mesophilic SpCas9 was active only between 25 and 44°C 
(Figure 3E); above this temperature SpCas9 activity rapidly decreased to undetectable 
levels. In contrast, ThermoCas9 cleavage activity could be detected between 25 and 65°C 
(Figure 3). This indicates the potential to use ThermoCas9 as a genome editing tool for both 
thermophilic and mesophilic organisms.  
Based on previous reports that certain type-IIC systems were efficient single stranded 
DNA cutters41,40, we tested the activity of ThermoCas9 on ssDNA substrates. However, no 
cleavage was observed, indicating that ThermoCas9 is a dsDNA nuclease (Supplementary 
Fig. 5B). 
SPACER-PRO TO SPACER MISMATCH TO LERANCE 
The predicted tracrRNA consists The targeting specificity and spacer-protospacer 
mismatch tolerance of a Cas9 endonuclease provide vital information for the development 
of the Cas9 into a genome engineering tool. To investigate the targeting specificity of 
ThermoCas9 towards a selected protospacer, we constructed a target plasmid library by 
introducing either single- or multiple-mismatches to the previously employed protospacer 
(Figure 4a). Each member of the plasmid library, and its PCR-linearized derivative, was 
separately used as substrate for in vitro ThermoCas9 cleavage assays in three independent 
experiments, both  at 37 and 55°C.   
The ThermoCas9:sgRNA activity on linear dsDNA targets was abolished at 37°C 
for most of the single-mismatch targets (Figure 4b). Noteworthy exceptions were the targets 
with single-mismatches at the PAM proximal position 2 and PAM distal position 20, 
which allowed for weak cleavage (Figure 4b). At 55°C, the cleavage efficiency for single-
mismatch linear targets was higher than at 37°C, however it was strongly hampered for most 
of the tested targets, especially for single-mismatches at the PAM proximal positions 4, 5 
and 10 (Figure 4c). On the contrary, single-mismatches at positions 1, 2 and 20 were the 
most tolerated for cleavage (Figure 4c).  
gardless the  position of the mismatch, with preference for the targets with single-mismatches 
at the PAM proximal positions 2, 6 to 10, 15 and 20 (Figure 4b). At 55°C, a similar trend was 
observed, with elevated cleavage rates (Figure 4c). Remarkably, the ThermoCas9:sgRNA 
activity was impeded for both linear and plasmid targets with multiple-mismatches as there 
was no detectable cleavage for most of these targets at the tested temperatures (Figure 4b, 4c). 
Notable exception was the target with a double mismatch at positions 19 and 20 which was 
cleaved at both tested temperatures but more prominently at 55° C  (Figure 4b, 4c). 
Figure  4. Protospacer targeting Specificity of ThermoCas9. a) Scheme of the generated 
mismatch protospacers library, employed for evaluating the ThermoCas9:sgRNA targeting specificity in vitro. 
The mismatch spacer-protospacer positions are shown in red, the PAM in light blue with the 5th to 8th positions 
underlined. b) Graphical representation of the ThermoCas9:sgRNA cleavage efficiency over linear or plasmid 
targets with different mismatches at 37°C. The percentage of cleavage was calculated based on integrated band 
intensities after gel electrophoresis. Average values from three biological replicates are shown, with error bars 
representing S.D.. Average values of three replicates are shown, with error bars representing S.D. The blots of 
one of the replicates are shown in Supplementary Fig. 12. c) Graphical representation of the 
ThermoCas9:sgRNA cleavage efficiency over linear or plasmid targets with different mismatches at 
55°C. The percentage of cleavage was calculated based on integrated band intensities after gel 
electrophoresis. Average values from three biological replicates are shown, with error bars representing 
S.D.. Average values of three replicates are shown, with error bars representing S.D.
THERMO CAS9-BASED GENE DELETION IN THE THERMOPHILE B. SMITHII
We set out to develop a ThermoCas9-based genome editing tool for thermophilic bacteria. 
This group of bacteria is of great interest both from a fundamental as well as from an applied 
perspective. For biotechnological applications, their thermophilic nature results in for 
example less cooling costs, higher reaction rates and less contamination risk compared to the 
widely used mesophilic industrial work horses such as E. coli24,25,42,43. Here, we show a proof
128
Chapter 5
of principle study on the use of ThermoCas9 as genome editing tool for thermophiles, 
employing Bacillus smithii ET 138 cultured at 55°C. Its wide substrate utilization range, 
thermophilic and facultative anaerobic nature, combined with its genetic amenability 
make this an organism with high potential as platform organism for the production 
of green chemicals in a biorefinery24,28,31,44. In order to use a minimum of genetic parts, we 
followed a single plasmid approach. We constructed a set of pNW33n-based 
pThermoCas9 plasmids containing the thermocas9 gene under the control of the native 
xylA promoter (PxylA), a homologous recombination template for repairing Cas9-
induced double stranded DNA breaks within a gene of interest, and a sgRNA expressing 
module under control of the constitutive pta promoter (Ppta) from Bacillus coagulans (Figure 
5A).  
The first goal was the deletion of the full length pyrF gene from the genome of B. 
smithii ET 138. The pNW33n-derived plasmids pThermoCas9_bsΔpyrF1 and 
pThermoCas9_bsΔpyrF2 were used for expression of different ThermoCas9 guides with 
spacers targeting different sites of the pyrF gene, while a third plasmid (pThermoCas9_ctrl) 
contained a random non-targeting spacer in the sgRNA expressing module. Transformation of 
B. smithii ET 138 competent cells at 55°C with the control plasmids pNW33n (no guide) and
pThermoCas9_ ctrl resulted in the formation of ~200 colonies each. Out of 10 screened
pThermoCas9_ ctrl colonies, none contained the ΔpyrF genotype, confirming findings from
previous studies that, in the absence of appropriate counter-selection, homologous
recombination in B. smithii ET 138 is not sufficient to obtain clean mutants28,44. In contrast,
transformation with the pThermoCas9_bsΔpyrF1 and pThermoCas9_bsΔpyrF2 plasmids
resulted in 20 and 0 colonies respectively. Out of the ten pThermoCas9_ΔpyrF1 colonies
screened, one was a clean ΔpyrF mutant whereas the rest had a mixed wild type/ΔpyrF
genotype (Figure 5B), proving the applicability of the system, as the designed homology
directed repair of the targeted pyrF gene was successful. Contrary to eukaryotes, most
prokaryotes including B. smithii do not possess a functional NHEJ system, and hence DSBs
induced by Cas9 have been shown to be lethal in the absence of a functional HR system and/or
of an appropriate HR template11,28. Hence, Cas9 functions as stringent counter-selection
system to kill cells that have not performed the desired HR prior to Cas9 cleavage11,28,45. The
combination of lack of NHEJ and low HR-frequencies found in most prokaryotes provides the
basis for the power of Cas9-based editing but also creates the need for tight control of Cas9
activity11,28,45. As the promoter we use here for thermocas9-expression is not sufficiently
controllable and HR is inefficient in B. smithii28,44, the low number (pyrF1) or even complete
sufficiently controllable and HR is inefficient in B. smithii28,44, the low number (pyrF1) or 
even complete lack (pyrF2) of colonies we observed here in the presence of an HR template 
confirms the high in vivo activity of ThermoCas9 at 55°C. In the SpCas9-based counter-
selection system we previously developed for B. smithii, the activity of Cas9 was very tightly 
controlled by the growth temperature rather than by gene expression. This allowed for 
extended time for the cells to perform HR prior to Cas9 counter-selection, resulting in a 
higher pyrF deletion efficiency28.We anticipate that the use of a tightly controlled 
promoter will increase efficiencies of the ThermoCas9-system. 
Figure 5. ThermoCas9-based genome engineering in thermophiles. a) Schematic overview of the basic 
pThermoCas9_Δgene-of-interest (goi) construct. The thermocas9 gene was introduced either to the pNW33n (B. 
smithii) or to the pEMG (P. putida) vector. Homologous recombination flanks were introduced upstream 
thermocas9 and encompassed the 1kb (B.smithii) or 0.5kb (P. putida ) upstream and and downstream regions of 
the gene of interest (goi) in the targeted genome. A sgRNA-expressing module was introduced downstream the 
thermocas9 gene. As the origin of replication (ori), replication protein (rep), antibiotic resistance marker (AB) 
and possible accesory elements (AE) are backbone specific, they are represented with dotted outline. b) Agarose 
gel electrophoresis showing the resulting products from genome-specific PCR on ten colonies from the 
ThermoCas9-based pyrF deletion process from the genome of B. smithii ET 138. All ten colonies contained the 
ΔpyrF genotype and one colony was a clean ΔpyrF mutant, lacking the wild type product. Supplementary Fig. 
13 shows the uncropped gel image. c) Schematic overview of the basic pThermoCas9i_goi construct. Aiming 
for the expression of a catalytically inactive ThermoCas9 (ThermodCas9: D8A, H582A mutant), the 
corresponding mutations were introduced to create the thermodcas9 gene. The thermodcas9 gene was 
introduced to the pNW33n vector. A sgRNA-expressing module was introduced downstream thethermodcas9.
d) Graphical representation of the production, growth and RT-qPCR results from theldhL silencing experimen t 
using ThermodCas9. The graphs represent the lactate production, optical density at 600nm and percentage of 
ldhL transcription in the repressed cultures compared to the control cultures. Average values from three 
biological replicates are shown, with error bars representing S.D. 
sufficiently controllable and HR is inefficient in B. smithii28,44, the low number (pyrF1) or 
even complete lack (pyrF2) of colonies we observed here in the presence of an HR template 
confirms the high in vivo activity of ThermoCas9 at 55°C. In the SpCas9-based counter-
selection system we previously developed for B. smithii, the activity of Cas9 was very tightly 
controlled by the growth temperature rather than by gene expression. This allowed for 
extended time for the cells to perform HR prior to Cas9 counter-selection, resulting in a 
higher pyrF deletion efficiency28.We anticipate that the use of a tightly controlled 
promoter will increase efficiencies of the ThermoCas9-system. 
Figure 5. ThermoCas9-based genome engineering in thermophiles. a) Schematic overview of the basic 
pThermoCas9_Δgene-of-interest (goi) construct. The thermocas9 gene was introduced either to the pNW33n (B. 
smithii) or to the pEMG (P. putida) vector. Homologous recombination flanks were introduced upstream 
thermocas9 and encompassed the 1kb (B.smithii) or 0.5kb (P. putida ) upstream and and downstream regions of 
the gene of interest (goi) in the targeted genome. A sgRNA-expressing module was introduced downstream the 
thermocas9 gene. As the origin of replication (ori), replication protein (rep), antibiotic resistance marker (AB) 
and possible accesory elements (AE) are backb ne specific, they are represented with dotted outline. b) Agarose 
gel electrophoresis showi g the resulting pr ducts from genom -specific PCR on ten colonies from the 
ThermoCas9-based pyrF dele ion process from the geno e of B. s ithii ET 138. All ten colonies contained the 
ΔpyrF genotyp  and one colony was a clean ΔpyrF mutant, lacking the wild type product. Suppleme tary Fig. 
13 shows the uncropped gel image. c) Schematic overview of the basic pThermoCas9i_goi construct. Aiming 
for the expressi n of a cat lytically inactive ThermoCas9 (ThermodCas9: D8A, H582A mutant), the 
corresponding mutations were introduced to create the thermodcas9 gene. The thermodcas9 gene was 
introduced to the pNW33n vector. A sgRNA-expressing module was introduced downstrea thethermodcas9.
d) Graphical representation of the production, growth and RT-qPCR results from theldhL silencing experimen t 
using ThermodCas9. The graphs represent the lactate production, optical density at 600nm and percentage of 
ldhL transcription in the repressed cultures compared to the control cultures. Average values from three 
biological replicates are shown, with error bars representing S.D. 
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the widely used mesophilic industrial work horses such as E. coli24,25,42,43. Here, we show a 
proof of principle study on the use of ThermoCas9 as genome editing tool for thermophiles, 
employing Bacillus smithii ET 138 cultured at 55°C. Its wide substrate utilization range, 
thermophilic and facultative anaerobic nature, combined with its genetic amenability make 
this an organism with high potential as platform organism for the production of green 
chemicals in a biorefinery24,28,31,44. In order to use a minimum of genetic parts, we followed a 
single plasmid approach. We constructed a set of pNW33n-based pThermoCas9 
plasmids containing the thermocas9 gene under the control of the native xylA
promoter (PxylA), a homologous recombin ation template for repairing Cas9-induced double 
stranded DNA breaks within a gene of interest, and a sgRNA expressing module under 
control of the constitutive pta promoter (Ppta) from Bacillus coagulans  (Figure 5A).  
The first goal was the deletion of the full length pyrF gene from the genome of B. 
smithii ET 138. The pNW33n-derived plasmids pThermoCas9_bsΔpyrF1 
and pThermoCas9_bsΔpyrF2 were used for expression of different ThermoCas9 guides 
with spacers targeting different sites of the pyrF gene, while a third plasmid 
(pThermoCas9_ctrl) contained a random non-targeting spacer in the sgRNA expressing 
module. Transformation of B. smithii ET 138 competent cells at 55°C with the control 
plasmids pNW33n (no guide) and pThermoCas9_ ctrl resulted in the formation of ~200 
colonies each. Out of 10 screened pThermoCas9_ ctrl colonies, none contained the 
ΔpyrF genotype, confirming findings from previous studies that, in the absence of 
appropriate counter-selection, homologous recombination in B. smithii ET 138 is not 
sufficient to obtain clean mutants28,44. In contrast, transformation with the 
pThermoCas9_bsΔpyrF1 and pThermoCas9_bsΔpyrF2 plasmids resulted in 20 and 0 
colonies respectively. Out of the ten pThermoCas9_ΔpyrF1 coloniesscreened, one was a 
clean ΔpyrF mutant whereas the rest had a mixed wild type/ΔpyrF genotype (Figure 
5B), proving the applicability of the system, as the designed homologydirected repair 
of the targeted pyrF gene was successful. Contrary to eukaryotes, most prokaryotes 
including B. smithii do not possess a functional NHEJ system, and hence DSBs induced by 
Cas9 have been shown to be lethal in the absence of a functional HR system and/or of an 
appropriate HR template11,28. Hence, Cas9 functions as stringent counter-selection system to 
kill cells that have not performed the desired HR prior to Cas9 cleavage11,28,45. The 
combination of lack of NHEJ and low HR-frequencies found in most prokaryotes provides 
the basis for the power of Cas9-based editing but also creates the need for tight control of 
Cas9 activity11,28,45. As the promoter we use here for thermocas9-expression is not 
lack (pyrF2) of colonies we observed here in the presence of an HR template confirms the 
high in vivo activity of ThermoCas9 at 55°C. In the SpCas9-based counter-selection system 
we previously developed for B. smithii, the activity of SpCas9 was tightly 
controlled by the growth temperature rather than by gene expression. This 
allowed for extended time for the cells to perform HR prior to Cas9 counter-selection, 
resulting in a higher pyrF deletion efficiency28. We anticipate that the use of a tightly 
controlled promoter will increase efficiencies of the ThermoCas9-system.  
Figure 5. ThermoCas9-based genome engineering in thermophiles. a) Schematic overview of the basic 
pThermoCas9_Δgene-of-interest (goi) construct. The thermocas9 gene was introduced either to the pNW33n (B. 
smithii) or to the pEMG (P. putida) vector. Homologous recombination flanks were introduced upstream 
thermocas9 and encompassed the 1kb (B.smithii) or 0.5kb (P. putida ) upstream and and downstream regions of 
the gene of interest (goi) in the targeted genome. A sgRNA-expressing module was introduced downstream the 
thermocas9 gene. As the origin of replication (ori), replication protein (rep), antibiotic resistance marker (AB) 
and possible accesory elements (AE) are backbone specific, they are represented with dotted outline. b) Agarose 
gel electrophoresis showing the resulting products from genome-specific PCR on ten colonies from the 
ThermoCas9-based pyrF deletion process from the genome of B. smithii ET 138. All ten colonies contained the 
ΔpyrF genotype and one colony was a clean ΔpyrF mutant, lacking the wild type product. Supplementary Fig. 
13 shows the uncropped gel image. c) Schematic overview of the basic pThermoCas9i_goi construct. Aiming 
for the expression of a catalytically inactive ThermoCas9 (ThermodCas9: D8A, H582A mutant), the 
corresponding mutations were introduced to create the thermodcas9 gene. The thermodcas9 gene was 
introduced to the pNW33n vector. A sgRNA-expressing module was introduced downstream thethermodcas9.
d) Graphical representation of the production, growth and RT-qPCR results from theldhL silencing experimen t 
using ThermodCas9. The graphs represent the lactate production, optical density at 600nm and percentage of 
ldhL transcription in the repressed cultures compared to the control cultures. Average values from three 
biological replicates are shown, with error bars representing S.D. 
sufficiently controllable and HR is inefficient in B. smithii28,44, the low number (pyrF1) or 
even complete lack (pyrF2) of colonies we observed here in the presence of an HR template 
confirms the high in vivo activity of ThermoCas9 at 55°C. In the SpCas9-based counter-
selection system we previously developed for B. smithii, the activity of Cas9 was very tightly 
controlled by the growth temperature rather than by gene expression. This allowed for 
extended time for the cells to perform HR prior to Cas9 counter-selection, resulting in a 
higher pyrF deletion efficiency28.We anticipate that the use of a tightly controlled 
promoter will increase efficiencies of the ThermoCas9-system. 
Figure 5. ThermoCas9-based genome engineering in thermophiles. a) Schematic overview of the basic 
pThermoCas9_Δgene-of-interest (goi) construct. The thermocas9 gene was introduced either to the pNW33n (B. 
smithii) or to the pEMG (P. putida) vector. Homologous recombination flanks were introduced upstream 
thermocas9 and encompassed the 1kb (B.smithii) or 0.5kb (P. putida) upstream and and downstream regions of  
the gene of interest (goi) in the targeted genome. A sgRNA-expressing module was introduced downstream the 
thermocas9 gene. As the origin of replication (ori), replication protein (rep), antibiotic resistance marker (AB) 
and possible accesory elements (AE) are backbone specific, they are represented with dotted outline. b) Agarose 
gel electrophoresis showing the resulting products from genome-specific PCR on ten colonies from the 
ThermoCas9-based pyrF deletion process from the genome ofB. smithii ET 138. All ten colonies contained the 
ΔpyrF genotype and one colony was a clean ΔpyrF mutant, lacking the wild type product. Supplementary Fig.  
13 shows the uncropped gel image. c) Schematic overview of the basic pThermoCas9i_goi construct. Aiming 
for the expression of a catalytically inactive ThermoCas9 (ThermodCas9: D8A, H582A mutant), the 
corresponding mutations were introduced to create the thermodcas9 gene. The thermodcas9 gene was
intr duced to the pNW33n vector. A sgRNA-expressing module was introduced downstream the thermodcas9.
d) Graphical representation of the production, growt  and RT-qPCR r sults from the ldhL silencing experimen t 
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biological replicat s re shown, with error bars representing S.D. 
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sequence, ThermodCas9 was heterologously produced, purified and used for an in vitro 
cleavage assay with the same DNA target as used in the aforementioned ThermoCas9 assays; 
no cleavage was observed confirming the catalytic inactivation of the nuclease. 
Towards the development of a ThermodCas9-based CRISPRi tool, we aimed for 
the transcriptional silencing of the highly expressed ldhL gene from the genome of B. smithii 
ET 138. We constructed the pNW33n-based vectors pThermoCas9i_ldhL and 
pThermoCas9i_ctrl. Both vectors contained the thermodCas9 gene under the control of PxylL
promoter and a sgRNA expressing module under the control of the constitutive Ppta
promoter (Figure 5C). The pThermoCas9i_ldhL plasmid contained a spacer for targeti ng
the non-template DNA strand at the 5’ end of the 138 ldhL gene in B. smithii ET 138 
(Supplementary Fig. 7). The position and targeted strand selection were based on previous
studies18,48, aiming for the efficient down-regulation of the ldhL gene. The 
pThermoCas9i_ctrl plasmid contained a random non-targeting spacer in the sgRNA-
expressing module. The constructs were used to transform B. smithii ET 138 competent cells
at 55°C followed by plating on LB2 agar plates, resulting in equal amounts of colonies. Tw o
out of the approximately 700 colonies per construct were selected for culturing under 
microaerobic lactate-producing conditions for 24 hours44. The growth of the 
pThermoCas9i_ldhL cultures was 50% less than the growth of the pThermoCas9i_ctrl
cultures (Figure 5D). We have previously shown that deletion of the ldhL gene leads to 
severe growth retardation in B. smithii ET 138 due to a lack of Ldh-based NAD+-
regenerating capacity under micro-aerobic conditions44. Thus, the observed decrease in 
growth is likely caused by the transcriptional inhibition of the ldhL gene and subsequent 
redox imbalance due to loss of NAD+-regenerating capacity. Indeed, HPLC analysis 
revealed 40% reduction in lactate production of the ldhL silenced cultures, and RT-qPCR 
analysis showed that the transcription levels of the ldhL gene were significantly reduced 
in the pThermoCas9i_ldhL cultures compared to the pThermoCas9i_ctrl cultures (Figure 
5D).
DISCUSSIO N 
Most CRISPR-Cas applications are based on RNA-guided DNA interference by Class 
2 CRISPR-Cas proteins, such as Cas9 and Cas12a6–13. Prior to this work, there were only a 
few examples of Class 1 CRISPR-Cas systems present in thermophilic bacteria and 
archaea5,49, which have been used for genome editing of thermophiles34. As a result, the 
application of CRISPR-Cas technologies was mainly restricted to temperatures below 
42°C, due to the mesophilic nature of the employed Cas-endonucleases28,29. Hence, this has 
THERMOCAS9-BASED GENE DELETION IN THE MESOPHILE P. PUTIDA
To broaden the applicability of the ThermoCas9-based genome editing tool and to evaluate 
whether our in vitro results could be confirmed in vivo, we next evaluated its activity in the 
mesophilic Gram-negative bacterium P. putida KT2440. This soil bacterium is well-known for 
its unusual metabolism and biodegradation capacities, especially of aromatic compounds. 
Recently, interest in this organism has further increased due to its potential as platform host 
for biotechnology purposes using metabolic engineering46,47. However, to date no CRISPR-
Cas9-based editing system has been reported for P. putida whereas such a system would 
greatly increase engineering efficiencies and enhance further study and use of this 
organism32,33. Once more, we followed a single plasmid approach and combined homologous 
recombination and ThermoCas9-based counter-selection. We constructed the pEMG-based 
pThermoCas9_ppΔpyrF plasmid containing the thermocas9 gene under the control of the 3-
methylbenzoate-inducible Pm-promoter, a homologous recombination template for deletion of 
the pyrF gene and a sgRNA expressing module under the control of the constitutive P3 
promoter. After transformation of P. putida KT2440 cells and PCR confirmation of plasmid 
integration, a colony was inoculated in selective liquid medium for overnight culturing at 37°
C. The overnight culture was used for inoculation of selective medium and ThermoCas9 
expression was induced with 3-methylbenzoate. Subsequently, dilutions were plated on non-
selective medium, supplemented with 3-methylbenzoate. For comparison, we performed a 
parallel experiment without inducing ThermoCas9 expression with 3-methylbenzoate. The 
process resulted in 76 colonies for the induced culture and 52 colonies for the non-induced 
control culture. For the induced culture, 38 colonies (50%) had a clean deletion genotype and 
6 colonies had mixed wild-type/deletion genotype. On the contrary, only 1 colony (2%) of the 
non-induced culture had the deletion genotype and there were no colonies with mixed wild-
type/deletion genotype retrieved (Supplementary Fig. 6). These results show that ThermoCas9 
can be used as an efficient counter-selection tool in the mesophile P. putida KT2440 when 
grown at 37°C. THERMOCAS9-BASED GENE SILENCING
An efficient thermoactive transcriptional silencing CRISPRi tool is currently not available. 
Such a system could greatly facilitate metabolic studies of thermophiles. A catalytically dead 
variant of ThermoCas9 could serve this purpose by steadily binding to DNA elements without 
introducing dsDNA breaks. To this end, we identified the RuvC and HNH catalytic domains 
of ThermoCas9 and introduced the corresponding D8A and H582A mutations for creating a 
dead (d) ThermoCas9. After confirmation of the designed sequence, ThermodCas9 was hete-
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TH ERMO CAS9-BASED G ENE DELETIO N IN TH E MESO PH ILEP. PUTIDA
To broaden the applicability of the ThermoCas9-based genome editing tool and to evaluate 
whether our in vitro results could be confirmed in vivo, we next evaluated its activity in the 
mesophilic Gram-negative bacterium P. putida KT2440. This soil bacterium is well-
knownfor its unusual metabolism and biodegradation capacities, especially of aromatic 
compounds. Recently, interest in this organism has further increased due to its potential as 
platform host for biotechnology purposes using metabolic engineering46,47. However, to date 
no CRISPR-Cas9-based editing system has been reported for P. putida whereas such a 
system would greatly increase engineering efficiencies and enhance further study and use of 
this organism32,33. Once more, we followed a single plasmid approach and combined 
homologous recombination and ThermoCas9-based counter-selection. We constructed the 
pEMG-based pThermoCas9_ppΔpyrF plasmid containing the thermocas9 gene under the 
control of the 3-methylbenzoate-inducible Pm-promoter, a homologous recombination 
template for deletion of the pyrF gene and a sgRNA expressing module under the control of 
the constitutive P3 promoter. After transformation of P. putida KT2440 cells and PCR 
confirmation of plasmid integration, a colony was inoculated in selective liquid medium for 
overnight culturing at 37°C. The overnight culture was used for inoculation of selective 
medium and ThermoCas9 expression was induced with 3-methylbenzoate. Subsequently, 
dilutions were plated on non-selective medium, supplemented with3-methylbenzoate. For 
comparison, we performed a parallel experiment without inducing ThermoCas9 expression 
with 3-methylbenzoate. The process resulted in 76 colonies for the induced culture and 52 
colonies for the non-induced control culture. For the induced culture, 38 colonies (50%) had 
a clean deletion genotype and 6 colonies had mixed wild-type/deletion genotype. On the 
contrary, only 1 colony (2%) of the non-induced culture had the deletion genotype and there 
were no colonies with mixed wild-type/deletion genotype retrieved (Supplementary Fig. 6). 
These results show that ThermoCas9 can be used as an efficient counter-selection tool in the 
mesophile P. putida KT2440 when grown at 37°C. 
TH ERMO CAS9-BASED G ENE SILENCING
An efficient thermoactive transcriptional silencing CRISPRi tool is currently not 
available. Such a system could greatly facilitate metabo lic studies of thermophiles. A 
catalytically dead variant of ThermoCas9 could serve this purpose by steadily binding to 
DNA elements without introducing dsDNA breaks. To this end, we identified the RuvC and 
HNH catalytic domains of ThermoCas9 and introduced the corresponding D8A and H582A 
mutations for creating a dead (d) ThermoCas9. After confirmation of the designed 
rologously produced, purified and used for an in vitro cleavage assay with the same DNA 
target as used in the aforementioned ThermoCas9 assays; no cleavage was observed 
confirming the catalytic inactivation of the nuclease. Towards the development of a 
ThermodCas9-based CRISPRi tool, we aimed for the transcriptional silencing of the highly 
expressed ldhL gene from the genome of B. smithii ET 138. We constructed the pNW33n-
based vectors pThermoCas9i_ldhL and pThermoCas9i_ctrl. Both vectors contained the 
thermodCas9 gene under the control of PxylL promoter and a sgRNA expressing module 
under the control of the constitutive Ppta promoter (Figure 5C). The pThermoCas9i_ldhL 
plasmid contained a spacer for targeting the non-template DNA strand at the 5’ end of the 138 
ldhL gene in B. smithii ET 138 (Supplementary Fig. 7). The position and targeted strand 
selection were based on previous studies18,48, aiming for the efficient down-regulation of the 
ldhL gene. The pThermoCas9i_ctrl plasmid contained a random non-targeting spacer in the 
sgRNA-expressing module. The constructs were used to transform B. smithii ET 138 
competent cells at 55°C followed by plating on LB2 agar plates, resulting in equal amounts of 
colonies. Two out of the approximately 700 colonies per construct were selected for culturing 
under microaerobic lactate-producing conditions for 24 hours44. The growth of the 
pThermoCas9i_ldhL cultures was 50% less than the growth of the pThermoCas9i_ctrl 
cultures (Figure 5D). We have previously shown that deletion of the ldhL gene leads to severe 
growth retardation in B. smithii ET 138 due to a lack of LdhL-based NAD+-regenerating 
capacity under micro-aerobic conditions44. Thus, the observed decrease in growth is likely 
caused by the transcriptional inhibition of the ldhL gene and subsequent redox imbalance due 
to loss of NAD+-regenerating capacity. Indeed, HPLC analysis revealed 40% reduction in 
lactate production of the ldhL silenced cultures, and RT-qPCR analysis showed that the 
transcription levels of the ldhL gene were significantly reduced in the pThermoCas9i_ldhL 
cultures compared to the pThermoCas9i_ctrl cultures (Figure 5D).
DISCUSSION
Most CRISPR-Cas applications are based on RNA-guided DNA interference by Class 2 
CRISPR-Cas proteins, such as Cas9 and Cas12a6–13. Prior to this work, there were only a few 
examples of Class 1 CRISPR-Cas systems present in thermophilic bacteria and archaea5,49, 
which have been used for genome editing of thermophiles34. As a result, the application of 
CRISPR-Cas technologies was mainly restricted to temperatures below 42°C, due to the 
mesophilic nature of the employed Cas-endonucleases28,29. Hence, this has excluded 
application of these technologies in obligate thermophiles and in experimental approaches 
that require elevated temperatures and/or improved protein stability.
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In the present study, we have characterized ThermoCas9, a Cas9 orthologue from the 
thermophilic bacterium G. thermodenitrificans T12 that has been isolated from compost30. 
Data mining revealed additional Cas9 orthologues in the genomes of other  thermophiles, 
which were nearly identical to ThermoCas9, showing that CRISPR-Cas type II systems do 
exist in thermophiles, at least in some branches of the Bacillus and Geobacillus genera. We 
showed that ThermoCas9 is active in vitro in a wide temperature range of 20-70°C, which is 
much broader than the 25–44°C range of its mesophilic orthologue SpCas9. The extended 
activity and stability of ThermoCas9 allows for its application in molecular biology 
techniques that require DNA manipulation at temperatures of 20-70°C, as well as its 
exploitation in harsh environments that require robust enzymatic activity. Furthermore, we 
identified several factors that are important for conferring the thermostability of ThermoCas9. 
Firstly, we showed that the PAM preferences of ThermoCas9 are very strict for activity in the 
lower part of the temperature range (≤ 30°C), whereas more variety in the PAM is allowed for 
activity at the moderate to optimal temperatures (37-60°C). Secondly, we showed that 
ThermoCas9 activity and thermostability strongly depends on the association with an 
appropriate sgRNA guide. This stabilization of the multi-domain Cas9 protein is most likely 
the result of a major conformational change from an open/flexible state to a rather compact 
state, as described for SpCas9 upon guide binding50. Additionally, we showed that the 
ThermoCas9 activity on linear DNA targets is very sensitive to spacer-protospacer 
mismatches. At 55°C, cleavage is affected of all linear fragments with single mismatches 
ranging from position 1 (PAM proximal) to position 20 (PAM distal). Interestingly, positions 
4, 5 and 10 are most important, whereas base pairing at position 2 appears less important. The 
same cleavage pattern is observed with plasmid targets. The elevated cleavage efficiencies of 
these targets suggest that the negatively supercoiled configuration of the used plasmids 
improves the target accessibility, as has been described before for the E. coli Type I-E 
CRISPR-Cas system51. Interestingly, despite overall lower activities, similar trends are 
observed in the case of cleavage assays of both linear fragments and plasmids with single 
mismatches at 37°C. The analysis of multiple mismatches reveals that the ThermoCas9 
nuclease is extremely sensitive to four or more mismatches at the PAM distal end: at both 
temperatures cleavage is completely abolished of all tested targets. Even with two 
mismatches at positions 19-20, a severe drop of cleavage efficiency is observed. These results 
indicate a lower in vitro spacer-protospacer mismatch tolerancei of ThermoCas9 compared 
to SpCas952and highlight its potential as a genome editing tool for eukaryotic cells 
with enhanced target specificity. Elucidation of the ThermoCas9 crystal structure is required 
results indicate a lower in vitro spacer-protospacer mismatch tolerance of ThermoCas9 
compared to SpCas952and highlight its potential as a genome editing tool for eukaryotic 
cells with enhanced target specificity. Elucidation of the ThermoCas9 crystal structure is 
required to gain insight on the molecular basis of the ThermoCa s9 cleavage mechanism.    
Based on the here described characterization of the novel ThermoCas9, we 
successfully developed genome engineering tools for strictly thermophilic prokaryotes. 
We showed that ThermoCas9 is active in vivo at 55°C and 37°C, and we adapted the 
current Cas9-based engineering technologies for the thermophile B. smithii ET 138 and 
the mesophile P. putida KT2440. Due to the wide temperature range of ThermoCas9, it is 
anticipated that the simple, effective and single plasmid-based ThermoCas9 approach will 
be suitable for a wide range of thermophilic and mesophilic microorganisms that can grow 
at temperatures from 37°C up to 70°C. This complements the existing mesophilic 
technologies, allowing their use for a large group of organisms for which these efficient 
tools were thus far unavailable.
Screening natural resources for novel enzymes with desired traits is 
unquestionably valuable. Previous studies have suggested that the adaptation of a mesophilic 
Cas9 orthologue to higher temperatures, with directed evolution and protein engineering, 
would be the best approach towards the construction of a thermophilic Cas9 protein34. 
Instead, we identified a clade of Cas9 in some thermophilic bacteria, and transformed 
one of these thermostable ThermoCas9 variants into a powerful genome engineering 
tool for both thermophilic and mesophilic organisms. With this study, we further 
stretched the potential of the Cas9-based genome editing technologies and open new 
possibilities for using Cas9 technologies in novel applications under harsh conditions or 
requiring activity over a wide temperature range. 
METH O DS 
BACTERIAL STRAINS AND G RO WTH CO NDITIO NS 
The moderate thermophile B. smithii ET 138 ΔsigF ΔhsdR28 was used for the gene editing 
and silencing experiments using ThermoCas9. It was grown in LB2 medium44 at 55°C. 
For plates, 30 g of agar (Difco) per liter of medium was used in all experiments. If 
needed chloramphenicol was added at the concentration of 7 μg mL-1. For microaerobic 
lactate-producing conditions, B. smithii strains were grown in 25 mL TVMY medium44 in 
a 50 mL Greiner tube for 24 h at 55°C and 120 rpm after transfer from an overnight 
culture44. For protein expression, E. coli Rosetta (DE3) was grown in LB medium in 
flasks at 37°C in a shaker incubator at 120 rpm until an OD600 nm of 0.5 was reached after 
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excluded application of these technologies in obligate thermophiles and in experimental 
approaches that require elevated temperatures and/or improved protein stability.  
In the present study, we have characterized ThermoCas9, a Cas9 orthologue from
the thermophilic bacterium G. thermodenitrificans T12 that has been isolated from
compost30. Data mining revealed additional Cas9 orthologues in the genomes of other
thermophiles, which were nearly identical to ThermoCas9, showing that CRISPR-Cas 
type II systems do exist in thermophiles, at least in some branches of the Bacillus and 
Geobacillus genera. We showed that ThermoCas9 is active in vitro in a wide temperature
range of 20-70°C, which is much broader than the 25–44°C range of its mesophilic 
orthologue SpCas9. The extended activity and stability of ThermoCas9 allows for its
application in molecular biology techniques that require DNA manipulation at 
temper atures of 20-70°C, as well as its exploitation in harsh environments that require
robust enzymatic activity. Furthermore, we identified several factors that are important for 
conferring the thermostability of ThermoCas9. Firstly, we showed that the PAM 
preferences of ThermoCas9 are very strict for activity in the lower part of the 
temperature range (≤ 30°C), whereas more variety in the PAM is allowed for activity at 
the moderate to optimal temperatures (37-60°C). Secondly, we showed that ThermoCas9 
activity and thermostability strongly depends on the association with an appropriate sgRNA
guide. This stabilization of the multi-domain Cas9 protein is most likely the result 
of a major conformational change from an open/flexible state toa rather compact state, as 
described for SpCas9 upon guide binding50. Additionally, we showed that the ThermoCas 9
activity on linear DNA targets is very sensitive to spacer-protospacer mismatches. At 55°C, 
cleavage is affected of all linear fragments with single mismatches ranging from position 
1 (PAM proximal) to position 20 (PAM distal). Interestingly, positions 4, 5 and 10 are most
important, whereas base pairing at position 2 appears less important. The same cleavage 
pattern is observed with plasmid targets. The elevated cleavage efficiencies of these 
targets suggest that the negatively supercoiled configuration of the used plasmids
improves the target accessibility, as has been described before for the E. coli Type I-E 
CRISPR-Cas system51. Interestingly, despite overall lower activities, similar trends are 
observed in the case of cleavage assays of both linear fragments and plasmids with single
mismatches at 37°C. The analysis of multiple mismatches reveals that the ThermoCas 9
nuclease is extremely sensitive to four or more mismatches at the PAM distal end: at both 
temperatures cleavage is completely abolished of all tested targets. Even with two 
mismatches at positions 19-20, a severe drop of cleavage efficiency is observed. These 
togain insight on the molecular basis of the ThermoCas9 cleavage mechanism.    
Based on the here described characterization of the novel ThermoCas9, we 
successfully developed genome engineering tools for strictly thermophilic prokaryotes. 
We showed that ThermoCas9 is active in vivo at 55°C and 37°C, and we adapted the 
current Cas9-based engineering technologies for the thermophile B. smithii ET 138 and the 
mesophile P. putida KT2440. Due to the wide temperature range of ThermoCas9, it 
is anticipated that the simple, effective and single plasmid-based ThermoCas9 approach 
will be suitable for a wide range of thermophilic and mesophilic microorganisms that can 
grow at temperatures from 37°C up to 70°C. This complements the existing 
mesophilic technologies, allowing their use for a large group of organisms for which 
these efficient tools were thus far unavailable.  
Screening natural resources for novel enzymes with desired traits is 
unquestionably valuable. Previous studies have suggested that the adaptation of a mesophilic 
Cas9 orthologue to higher temperatures, with directed evolution and protein engineering, 
would be the best approach towards the construction of a thermophilic Cas9 protein34. 
Instead, we identified a clade of Cas9 in some thermophilic bacteria, and transformed 
one of these thermostable ThermoCas9 variants into a powerful genome engineering 
tool for both thermophilic and mesophilic organisms. With this study, we further 
stretched the potential of the Cas9-based genome editing technologies and open new 
possibilities for using Cas9 technologies in novel applications under harsh conditions or 
requiring activity over a wide temperature range. 
METHODS 
BACTERIAL STRAINS AND GROWTH CONDITIONS 
The moderate thermophile B. smithii ET 138 ΔsigF ΔhsdR28 was used for the gene 
editing and silencing experiments using ThermoCas9. It was grown at 55°C in LB2 
medium44 . For plates, 30 g of agar (Difco) per liter of medium was used in all experiments. If 
needed chloramphenicol was added at the concentration of 7 μg*mL-1. For microaerobic 
lactate-producing conditions, B. smithii strains were grown in 25 mL TVMY medium44 in a 
50 mL Greiner tube for 24 h at 55°C and 120 rpm after transfer from an overnight culture.44. 
For protein expression, E. coli Rosetta (DE3) was grown in LB medium in flasks at 37°C in a 
shaker incubator at 120 rpm until an OD600 nm of 0.5 was reached after the temperature was 
switched to 16°C. After 30 min, expression was induced by addition of isopropyl-1-thio-β-D-
gal-actopyranoside (IPTG) to a final concentration of 0.5 mM, a fter which incubation was co
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ntinued at 16°C. For cloning PAM constructs for 6th and 7th, and 8th positions, DH5-alpha 
competent E. coli (NEB) was transformed according to the manual provided by the 
manufacturer and grown overnight on LB agar plates at 37°C. For cloning degenerate 7-nt 
long PAM library, electro-competent DH10B E. coli cells were transformed according to 
standard procedures53 and grown on LB agar plates at 37°C overnight. E. coli DH5α λpir 
(Invitrogen) was used for P. putida plasmid construction using the transformation procedure 
described by Ausubel et al.54. For all E. coli strains, if required chloramphenicol was used in 
concentrations of 25 m g L-1 and kanamycin in 50 m*g*L-1. P. putida KT2440 (DSM 6125) 
strains were cultured at 37°C in LB medium unless stated otherwise. If required, kanamycin 
was added in concentrations of 50 mg*L-1 and 3-methylbenzoate in a concentration of 3 mM.
THERMOCAS9 EXPRESSION AND PURIFICATION 
ThermoCas9 was PCR-amplified from the genome of G. thermodenitrificans T12, then 
cloned and heterologously expressed in E. coli Rosetta (DE3) and purified using FPLC by a 
combination of Ni2+-affinity, ion exchange and gel filtration chromatographic steps. The 
gene sequence was inserted into plasmid pML-1B (obtained from the UC Berkeley 
MacroLab, Addgene#29653) by ligation-independent cloning using oligonucleotides 
(Supplementary Table 2) to generate a protein expression construct encoding the ThermoCas9 
polypeptide sequence (residues 1-1082) fused with an N-terminal tag comprising a 
hexahistidine sequence and a Tobacco Etch Virus (TEV) protease cleavage site. To express 
the catalytically inactive ThermoCas9 protein (ThermodCas9), the D8A and H582A point 
mutations were inserted using PCR and verified by DNA sequencing. 
The proteins were expressed in E. coli Rosetta 2 (DE3) strain. Cultures were grown 
to an OD600nm of 0.5-0.6. Expression was induced by the addition of IPTG to a 
final concentration of 0.5 mM and incubation was continued at 16°C overnight. 
Cells were harvested by centrifugation and the cell pellet was resuspended in 20 mL of 
Lysis Buffer (50 mM sodium phosphate pH 8, 500 mM NaCl, 1 mM DTT, 10 mM 
imidazole) supplemented with protease inhibitors (Roche cOmplete, EDTA-free) and 
lysozyme. Once homogenized, cells were lysed by sonication (Sonoplus, Bandelin) 
using a using an ultrasonic MS72 microtip probe (Bandelin), for 5-8 minutes 
consisting of 2s pulse and 2.5s pause at 30%amplitude and then centrifuged at 16,000xg 
for 1 hour at 4°C to remove insoluble material. The clarified lysate was filtered 
through 0.22 micron filters (Mdi membrane technologies) and applied to a nickel column 
(Histrap HP, GE Lifesciences), washed and then eluted with 250 mM imidazole. Fractions 
and applied to a nickel column (Histrap HP, GE Lifesciences), washed and then eluted with 
250 mM imidazole. Fractions containing ThermoCas9 were pooled and dialyzed overnight 
into the dialysis buffer (250 mM KCl, 20 mM HEPES/KOH, and 1 mM DTT, pH 8). After 
dialysis, sample was diluted 1:1 in 10 mM HEPES/KOH pH 8, and loaded on a heparin FF 
column pre-equilibrated in IEX-A buffer (150 mM KCl, 20 mM HEPES/KOH pH 8). 
Column was washed with IEX-A and then eluted with a gradient of IEX-C (2M KCl, 20 
mM HEPES/KOH pH 8). The sample was concentrated to 700 μL prior to loading on a gel 
filtration column (HiLoad 16/600 Superdex 200) via FPLC (AKTA Pure). Fractions from 
gel filtration were analysed by SDS-PAGE; fractions containing ThermoCas9 were pooled 
and concentrated to 200 μL (50 mM sodium phosphate pH 8, 2 mM DTT, 5% glycerol, 
500 mM NaCl) and either used directly for biochemical assays or frozen at -80°C for 
storage.
IN VITRO SYNTH ESIS OF SG RNA 
The sgRNA module was designed by fusing the predicted crRNA and tracrRNA 
sequences with a 5'-GAAA-3' linker. The sgRNA-expressing DNA sequence was put 
under the transcriptional control of the T7 promoter. It was synthesized (Baseclear, 
Leiden, The Netherlands) and provided in the pUC57 backbone. All sgRNAs used in 
the biochemical reactions were synthesized using the HiScribe™ T7 High Yield RNA 
Synthesis Kit (NEB). PCR fragments coding for sgRNAs, with the T7 sequence on the 
5’ end, were utilized as templates for in vitro transcription reaction. T7 transcription was 
performed for 4 hours. The sgRNAs were run and excised from urea-PAGE gels and purified 
using ethanol precipitation.
IN VITRO CLEAVAG E ASSAY 
In vitro cleavage assays were performed with purified recombinant 
ThermoCas9. ThermoCas9 protein, the in vitro transcribed sgRNA and the DNA substrates 
(generated using PCR amplification using primers described in Supplementary Table 
2) were incubated separately (unless otherwise indicated) at the stated temperature for 
10 min, followed by combining the components together and incubating them at the various 
assay temperatures in a cleavage buffer (100 mM sodium phosphate buffer (pH=7), 500 mM 
NaCl, 25 mM MgCl2, 25 (V/V%) glycerol, 5 mM dithiothreitol (DTT)) for 1 hour. Each 
cleavage reaction contained 160 nM of ThermoCas9 protein, 4 nM of substrate DNA, and 
150 nM of synthetized sgRNA. Reactions were stopped by adding 6x loading dye (NEB) 
and run on 1.5% agarose gels. Gels were stained with SYBR safe DNA stain (Life 
Technologies) and imaged with a Gel DocTM EZ gel imaging system (Bio-rad). 
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the temperature was switched to 16°C. After 30 min, expression was induced by addition of 
isopropyl-1-thio-β-D-gal-actopyranoside (IPTG) to a final concentration of 0.5 mM, 
after which incubation was continued at 16°C. For cloning PAM constructs for 6th and 7th, 
and 8th positions, DH5-alpha competent E. coli (NEB) was transformed according t o
the manual provided by the manufacturer and grown overnight on LB agar plates at 37°C. 
For cloning degenerate 7-nt long PAM library, electro-competent DH10B E. coli cells were 
transformed according to standard procedures 53 and grown on LB agar plates at 37°C 
overnight. E. coli DH5α λpir (Invitrogen) was used for P. putida plasmid construction
using the transformation procedure described by Ausubel et al.54. For all E. coli
strains, if required chloramphenicol was used in concentrations of 25 mg L-1 and
kanamycin in 50 mg L-1. P. putida KT2440 (DSM 6125) strains were cultured at 37°C in 
LB medium unless stated otherwise. If required, kanamycin was added in concentrations of 
50 mg L-1 and 3-methylbenzoate in a concentration of 3 mM.  
THERMO CAS9 EXPRESSIO N AND PURIFICATIO N 
ThermoCas9 was PCR-amplified from the genome ofG. thermodenitrificans T12, 
then cloned and heterologously expressed in E. coli Rosetta (DE3) and purified using 
FPLC by a combination of Ni2+-affinity, ion exchange and gel filtration chromatographic
steps. The gene sequence was inserted into plasmid pML-1B (obtained from the UC
Berkeley MacroLab, Addgene #29653) by ligation-independent cloning using 
oligonucleotides (Supplementary Table 2) to generate a protein expression construct
encoding the ThermoCas9 polypeptide sequence (residues 1-1082) fused with an N-terminal
tag comprising a hexahistidine sequence and a Tobacco Etch Virus (TEV) protease cleavage 
site. To express the catalytically inactive ThermoCas9 protein (ThermodCas9), the D8A and 
H582A point mutations were inserted using PCR and verified by D NA sequencing.
The proteins were expressed in E. coli Rosetta 2 (DE3) strain. Cultures were grown to an 
OD600nm of 0.5-0.6. Expression was induced by the addition of IPTG to a final concentration 
of 0.5 mM and incubation was continued at 16°C overnight. Cells were harveste d
by centrifugation and the cell pellet was resuspended in 20 mL of Lysis Buffer (50 mM
sodium phosphate pH 8, 500 mM NaCl, 1 mM DTT, 10 mM imidazole) supplemented with 
protease inhibitors (Roche cOmplete, EDTA-free) and lysozyme. Once homogenized, cells 
were lysed by sonication (Sonoplus, Bandelin) using a using an ultrasonic MS72 
microtip probe (Bandelin), for 5-8 minutes consisting of 2s pulse and 2.5s pause at 30%
amplitude and then centrifuged at 16,000g for 1 hour at 4°C to remove insoluble
material. The clarified lysate was filtered through 0.22 micron filters (Mdi membrane 
technologies) 
containing ThermoCas9 were pooled and dialyzed overnight into the dialysis buffer (250 mM 
KCl, 20 mM HEPES/KOH, and 1 mM DTT, pH 8). After dialysis, sample was diluted 1:1 in 
10 mM HEPES/KOH pH 8, and loaded on a heparin FF column pre-equilibrated in IEX-A 
buffer (150 mM KCl, 20 mM HEPES/KOH pH 8). Column was washed with IEX-A and then 
eluted with a gradient of IEX-C (2M KCl, 20 mM HEPES/KOH pH 8). The sample was 
concentrated to 700 μL prior to loading on a gel filtration column (HiLoad 16/600 Superdex 
200) via FPLC (AKTA Pure). Fractions from gel filtration were analysed by SDS-PAGE; 
fractions containing ThermoCas9 were pooled and concentrated to 200 μL (50 mM sodium 
phosphate pH 8, 2 mM DTT, 5% glycerol, 500 mM NaCl) and either used directly for 
biochemical assays or frozen at -80°C for storage.
IN VITRO SYNTHESIS OF SGRNA
The sgRNA module was designed by fusing the predicted crRNA and tracrRNA 
sequences with a 5'-GAAA-3' linker. The sgRNA-expressing DNA sequence was put 
under the transcriptional control of the T7 promoter. It was synthesized (Baseclear, 
Leiden, The Netherlands) and provided in the pUC57 backbone. All sgRNAs used 
in the biochemical reactions were synthesized using the HiScribe™ T7 High Yield 
RNA Synthesis Kit (NEB). PCR fragments coding for sgRNAs, with the T7 sequence 
on the 5’ end, were utilized as templates for in vitro transcription reaction. T7 
transcription was performed for 4 hours. The sgRNAs were run and excised from urea-
PAGE gels and purified using ethanol precipitation.
IN VITRO CLEAVAGE ASSAY
In vitro cleavage assays were performed with purified recombinant ThermoCas9. 
ThermoCas9 protein, the in vitro transcribed sgRNA and the DNA substrates (generated 
using PCR amplification using primers described in Supplementary Table 2) 
were incubated separately (unless otherwise indicated) at the stated temperature for 10 
min, followed by combining the components together and incu bating them at the various 
assay temperatures in a cleavage buffer (100 mM sodium phosphate buffer (pH=7), 500 mM 
NaCl, 25 mM MgCl2, 25 (V/V%) glycerol, 5 mM dithiothreitol (DTT)) for 1 hour. Each 
cleavage reaction contained 160 nM of ThermoCas9 protein, 4 nM of substrate DNA, and 
150 nM of synthetized sgRNA. Reactions were stopped by adding 6x loading dye (NEB) 
and run on 1.5% agarose gels. Gels were stained with SYBR safe DNA stain (Life 
Technologies) and imaged with a Gel DocTM EZ gel imaging system (Bio-rad).
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B. SMITH IIAND P. PUTIDA EDITING AND SILENCING CO NSTRUCTS
All the primers and plasmids used for plasmid construction were designed with
appropriate overhangs for performing NEBuilder HiFi DNA assembly (NEB), and they 
are listed in Supplementary Table 2 and 3 respectively. The fragments for assembling the 
plasmids were obtained through PCR with Q5 Polymerase (NEB) or Phusion Flash High-
Fidelity PCR Master Mix (ThermoFisher Scientific), the PCR products were subjected to 1% 
agarose gel electrophoresis and they were purified using Zymogen gel DNA recovery kit 
(Zymo Research). The assembled plasmids were transformed to chemically competent E. coli 
DH5α cells (NEB), or to E. coli DH5α λpir (Invitrogen) in the case of P. putida constructs, 
the latter to facilitate direct vector integration. Single colonies were inoculated in LB medium, 
plasmid mater ial was isolated using the GeneJet plasmid minip rep kit (ThermoFisher 
Scientific) and sequence verified (GATC-biotech) and 1μg of each construct was 
transformed to B. smithii ET 138 electro-competent cells44. The MasterPure™ Gram 
Positive DNA Purification Kit (Epicentre) was used for genomic DNA isolation from B. 
smithii and P. putida liquid cultures. For the construction of the 
pThermoCas9_ctrl, pThermoCas9_bsΔpyrF1 and pThermoCas9_bsΔpyrF2 vectors, the 
pNW33n backbone together with the ΔpyrF homologous recombination flanks were PCR 
amplified from the pWUR_Cas9sp1_hr vector28 (BG8191and BG8192). The native PxylA
promoter was PCR amplified from the genome of B. smithii ET 138 (BG8194 and BG8195). 
The thermocas9 gene was PCR amplified from the genome ofG. thermodenitrificans T12 
(BG8196 and BG8197). The Ppta promoter was PCR amplified from the pWUR_Cas9sp1_hr 
vector 28 (BG8198 and BG8261_2/BG8263_nc2/ BG8317_3). The spacers followed by the 
sgRNA scaffold were PCR amplified from the pUC57_T7t12sgRNA vector (BG8266_2/
BG8268_nc2/8320_3 and BG8210). 
A four-fragment assembly was designed and executed for the construction of 
the pThermoCas9i_ldhL vectors. Initially, targeted point mutations were introduced to the 
codons of the thermocas9 catalytic residues (mutations D8A and H582A), through a two-
step PCR approach using pThermoCas9_ctrl as template. During the first PCR step 
(BG9075, BG9076), the desired mutations were introduced at the ends of the produced 
PCR fragment and during the second step (BG9091, BG9092) the produced fragment was 
employed as PCR template for the introduction of appropriate assembly-overhangs. The part 
of the thermocas9 downstream the second mutation along with the ldhL silencing 
spacer was PCR amplified using pThermoCas9_ctrl as template (BG9077 and BG9267). 
The sgRNA scaffold together with the pNW33n backbone was PCR amplified using 
LIBRARY CONSTRUCTION FOR IN VITRO PAM SCREEN
For the construction of the PAM library, a 122-bp long DNA fragment, 
containing the protospacer and a 7-bp long degenerate sequence at its 3’-end, 
was constructed by primer annealing and Klenow fragment (exo-) (NEB) based 
extension. The PAM-library fragment and the pNW33n vector were digested by 
BspHI and BamHI (NEB) and the n ligated (T4 ligase, NEB). The ligation 
mixture was transformed into electro-competent E. coli DH10B cells and plasmids 
were isolated from liquid cultures. For the 7nt-long PAM determination process, the 
plasmid library was linearized by SapI (NEB) and used as the target. For the rest of 
the assays the DNA substrates were linearized by PCR amplification.
PAM SCREENING ASSAY
The PAM screening of thermoCas9 was performed using in vitro cleavage assays, which 
consisted of (per reaction): 160 nM of ThermoCas9, 150 nM in vitro transcribe d sgRNA, 4 
nM of DNA target, 4 μl of cleavage buffer (100 mM sodium phosphate buffer pH 7.5, 500 
mM NaCl, 5 mM DTT, 25% glycerol) and MQ water up to 20 μl final reacti on volume. The 
PAM containing cleavage fragments from the 55°C reactions were gel purified, ligated with 
Illumina sequencing adaptors and sent for Illumina HiSeq 2500 sequencing (Baseclear). 
Equimolar amount of non-ThermoCas9 treated PAM library was subjected to the same 
process and sent for Illumina HiSeq 2500 sequencing as a reference. HiSeq reads with perfect 
sequence match to the reference sequence were selected for further analysis. From the selected 
reads, those present more than 1000 times in the ThermoCas9 treated library and at least 10 
times more in the ThermoCas9 treated library compared to the control library were employed 
for WebLogo analysis 55.
LIBRARY CONSTRUCTION FOR IN VITRO MISMATCH TOLERANCE SCREEN 
For the construction of the spacer-protospacer mismatch target library, twenty pairs of 40-nt 
long complementary ssDNA fragments, containing the mismatch-protospacers, were annealed. 
The annealing products were designed to have overhangs compatible for their directional 
ligation (T4 ligase, NEB) into the pNW33n backbone, upon BspHI and BamHI (NEB) 
digestion of the vector. The ligation mixtures were transformed into chemically competent E. 
coli DH5α cells (NEB), plasmids were isolated from liquid cultures and verified by 
sequencing. Both plasmids and PCR linearized DNA substrates were employed for the 
mismatch-tolerance assays.
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LIBRARY CO NSTRUCTIO N FOR IN VITRO PAM SCREEN 
For the construction of the PAM library, a 122-bp long DNA fragment, containi ng
the protospacer and a 7-bp long degenerate sequence at its 3’-end, was constructed by 
primer annealing and Klenow fragment (exo-) (NEB) based extension. The PAM-library 
fragment and the pNW33n vector were digested by BspHI and BamHI (NEB) and the n
ligated (T4 ligase, NEB). The ligation mixture was transformed into electro-competent E. 
coli DH10B cells and plasmids were isolated from liquid cultures. For the 7nt-long PAM
determination process, the plasmid library was linearized by SapI (NEB) and used as the 
target. For the rest of the assays the DNA substrates were linearized by PCR amplification.  
PAM SCREENING ASSAY 
The PAM screening of thermoCas9 was performed using in vitro cleavage assays, 
which consisted of (per reaction): 160 nM of ThermoCas9, 150 nM in vitro transcribe d
sgRNA, 4 nM of DNA target, 4 μl of cleavage buffer (100 mM sodium phosphate buffer 
pH 7.5, 500 mM NaCl, 5 mM DTT, 25% glycerol) and MQ water up to 20 μl final reacti on
volume. The PAM containing cleavage fragments from the 55°C reactions were gel purified, 
ligated with Illumina sequencing adaptors and sent for Illumina HiSeq 2500 sequencing 
(Baseclear). Equimolar amount of non-ThermoCas9 treated PAM library was subjected to 
the same process and sent for Illumina HiSeq 2500 sequencing as a reference. HiSeq reads 
with perfect sequence match to the reference sequence were selected for further analysis. 
From the selected reads, those present more than 1000 times in the ThermoCas9 treated 
library and at least 10 times more in the ThermoCas9 treated library compared to the control 
library were employed for WebLogo analysis 55. 
LIBRARY CO NSTRUCTIO N FOR IN VITRO MISMATCH TO LERANCE SCREEN 
For the construction of the spacer-protospacer mismatch target library, twenty pairs of 
40-nt long complementary ssDNA fragments, containing the mismatch-protospacers,
were annealed. The annealing products were designed to have overhangs compatible for
their directional ligation (T4 ligase, NEB) into the pNW33n backbone, upon BspHI and
BamHI (NEB) digestion of the vector. The ligation mixtures were transformed into
chemically competent E. coli DH5α cells (NEB), plasmids were isolated from liquid cultures
and verified by sequencing. Both plasmids and PCR linearized DNA substrates were
employed for the mismatch-tolerance assays.
B. SMITHII AND P. PUTIDA EDITING AND SILENCING CONSTRUCTS
All the primers and plasmids used for plasmid construction were designed with appropriate
overhangs for performing NEBuilder HiFi DNA assembly (NEB), and they are listed in
Supplementary Table 2 and 3 respectively. The fragments for assembling the plasmids were
obtained through PCR with Q5 Polymerase (NEB) or Phusion Flash High-Fidelity PCR
Master Mix (ThermoFisher Scientific), the PCR products were subjected to 1% agarose gel
electrophoresis and they were purified using Zymogen gel DNA recovery kit (Zymo
Research). The assembled plasmids were transformed to chemically competent E. coli DH5α
cells (NEB), or to E. coli DH5α λpir (Invitrogen) in the case of P. putida constructs, the latter
to facilitate direct vector integration. Single colonies were inoculated in LB medium, plasmid
material was isolated using the GeneJet plasmid miniprep kit (ThermoFisher Scientific) and
sequence verified (GATC-biotech) and 1μg of each construct was transformed to B. smithii
ET 138 electro-competent cells44. The MasterPure™ Gram Positive DNA Purification Kit
(Epicentre) was used for genomic DNA isolation from B. smithii and P. putida liquid cultures.
For the construction of the pThermoCas9_ctrl, pThermoCas9_bsΔpyrF1 and
pThermoCas9_bsΔpyrF2 vectors, the pNW33n backbone together with the ΔpyrF
homologous recombination flanks were PCR amplified from the pWUR_Cas9sp1_hr vector28
(BG8191and BG8192). The native PxylA promoter was PCR amplified from the genome of B.
smithii ET 138 (BG8194 and BG8195). The thermocas9 gene was PCR amplified from the
genome of G. thermodenitrificans T12 (BG8196 and BG8197). The Ppta promoter was PCR
amplified from the pWUR_Cas9sp1_hr vector 28 (BG8198 and BG8261_2/BG8263_nc2/
BG8317_3). The spacers followed by the sgRNA scaffold were PCR amplified from the
pUC57_T7t12sgRNA vector (BG8266_2/BG8268_nc2/8320_3 and BG8210).
A four-fragment assembly was designed and executed for the construction of the 
pThermoCas9i_ldhL vectors. Initially, targeted point mutations were introduced to the codons 
of the thermocas9 catalytic residues (mutations D8A and H582A), through a two-step PCR 
approach using pThermoCas9_ctrl as template. During the first PCR step (BG9075, BG9076), 
the desired mutations were introduced at the ends of the produced PCR fragment and during 
the second step (BG9091, BG9092) the produced fragment was employed as PCR template 
for the introduction of appropriate assembly-overhangs. The part of the thermocas9 
downstream the second mutation along with the ldhL silencing spacer was PCR amplified 
using pThermoCas9_ctrl as template (BG9077 and BG9267). The sgRNA scaffold together 
with the pNW33n backbone was PCR amplified using pThermoCas9_ctrl as template and the
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BG9263 and BG9088. The promoter together with the part of the thermocas9 upstream 
the first mutation was PCR amplified using pThermoCas9_ctrl as template (BG9089, 
BG9090).
A two-fragment assembly was designed and executed for the construction of 
pThermoCas9i_ctrl vector. The spacer sequence in the pThermoCas9i_ldhL vector was 
replaced with a random sequence containing BaeI restriction sites at both ends. The sgRNA 
scaffold together with the pNW33n backbone was PCR amplified using pThermoCas9_ctrl as 
template (BG9548, BG9601). The other half of the construct consisting of thermodcas9 and 
promoter was amplified using pThermoCas9i_ldhL as template (BG9600, BG9549). 
A five-fragment assembly was designed and executed for the construction of the P. 
putida KT2440 vector pThermoCas9_ppΔpyrF. The replicon from the suicide vector pEMG 
was PCR amplified (BG2365, BG2366). The flanking regions of pyrF were amplified from 
KT2440 genomic DNA (BG2367, BG2368 for the 576-bp upstream flank, and BG2369, 
BG2370 for the 540-bp downstream flank). The flanks were fused in an overlap extension 
PCR using primers BG2367 and BG2370 making use of the overlaps of primers BG2368 and 
BG2369. The sgRNA was amplified from the pThermoCas9_ctrl plasmid (BG2371, 
BG2372). The constitutive P3 promoter was amplified from pSW_I-SceI (BG2373, BG2374). 
This promoter fragment was fused to the sgRNA fragment in an overlap extension PCR using 
primers BG2372 and BG2373 making use of the overlaps of primers BG2371 and BG2374. 
ThermoCas9 was amplified from the pThermoCas9_ctrl plasmid (BG2375, BG2376). The 
inducible Pm-XylS system, to be used for 3-methylbenzoate induction of ThermoCas9 was 
amplified from pSW_I -SceI (BG2377, BG2378).
EDITING PROTOCOL FOR P. PUTIDA
Transformation of the plasmid to P. putida was performed according to Choi et al.56. After 
transformation and selection of integrants, overnight cultures were inoculated. 10 μl of 
overnight culture was used for inoculation of 3 ml fresh selective medium and after 2 hours of 
growth at 37°C ThermoCas9 was induced with 3-methylbenzoate. After an additional 6h, 
dilutions of the culture were plated on non-selective medium supplemented with 3-
methylbenzoate. For the control culture the addition of 3-methylbenzoate was omitted  in all 
the steps. Confirmation of plasmid integration in the chromosome was done by colony 
PCR with primers BG2381 and BG2135. Confirmation of pyrF deletion was done by colony 
PCR with primers BG2381 and BG2382.
RNA ISO LATIO N 
RNA isolation was performed by the phenol extraction based on a previously described 
protocol 57. Overnight 10 mL cultures were centrifuged at 4°C and 4816g for 15 min and 
immediately used for RNA isolation. After removal of the medium, cells were suspended in 
0.5 mL of ice-cold TE buffer (pH 8.0) and kept on ice. All samples were divided into two 2 
mL screw-capped tubes containing 0.5 g of zirconium beads, 30 μL of 10% SDS, 30 μL of 3 
M sodium acetate (pH 5.2), and 500 μL of Roti-Phenol (pH 4.5−5.0, Carl Roth GmbH). Cells 
were disrupted using a FastPrep-24 apparatus (MP Biomedicals) at 5500 rpm for 45 s and 
centrifuged at 4°C and 9400g for 5 min. 400 μL of the water phase from each tube was 
transferred to a new tube, to which 400 μL of chloroform−isoamyl alcohol (Carl Roth 
GmbH) was added, after which samples were centrifuged at 4 °C and 18 400g for 3 min. 
300 μL of the aqueous phase was transferred to a new tube and mixed with 300 μL of the 
lysis buffer from the high pure RNA isolation kit (Roche). Subsequently, the rest of the 
procedure from this kit was performed according to the manufacturer’s protocol, except for 
the DNase incubation step, which was performed for 45 min. The concentration and integrity 
of cDNA was determined using Nanodrop-1000 Integrity and concentration of the isolated 
RNA was checked on a NanoDrop 1000.  
Q UANTIFICATIO N O F MRNA BY RT-Q PCR 
First-strand cDNA synthesis was performed for the isolated RNA using SuperScriptTM 
III Reverse Transcriptase (Invitrogen) according to manufacturer’s protocol. qPCR was 
performed using the PerfeCTa SYBR Green Supermix for iQ from Quanta Biosciences. 40 
ng of each cDNA library was used as the template for qPCR. Two sets of primers were 
used; BG9665:BG9666 amplifying a 150-nt long region of the ldhL gene and 
BG9889:BG9890 amplifying a 150-nt long sequence of the rpoD (RNA polymerase sigma 
factor) gene which was used as the control for the qPCR. The qPCR was run on a Bio-Rad 
C1000 Thermal Cycler. 
H PLC 
A high-pressure liquid chromatography (HPLC) system ICS-5000 was used for lactate 
quantification. The system was operated with Aminex HPX 87H column from Bio-Rad 
Laboratories and equipped with a UV1000 detector operating on 210 nm and a RI-150 40°C 
refractive index detector. The mobile phase consisted of 0.16 N H2SO4 and the column was 
operated at 0.8 mL min-1. All samples were diluted 4:1 with 10 mM DMSO in 0.01 N H2SO4.   
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pThermoCas9_ctrl as template (BG9263 and BG9088). The promoter together with the part 
of the thermocas9 upstream the first mutationwas PCR amplified using pThermoCas9_ctrl 
as template (BG9089, BG9090)
A two-fragment assembly was designed and executed for the construction 
of pThermoCas9i_ctrl vector. The spacer sequence in the pThermoCas9i_ldhL vector 
was replaced with a random sequence containing BaeI restriction sites at both ends. The 
sgRNA scaffold together with the pNW33n backbone was PCR amplified using 
pThermoCas9_ctrl as template (BG9548, BG9601). The other half of the construct 
consisting of thermodcas9 and promoter was amplified using pThermoCas9i_ldhL as 
template (BG9600, BG9549). 
A five-fragment assembly was designed and executed for the construction of the P. 
putida KT2440 vector pThermoCas9_ppΔpyrF. The replicon from the suicide vector pEMG 
was PCR amplified (BG2365, BG2366). The flanking regions of pyrF were amplified from 
KT2440 genomic DNA (BG2367, BG2368 for the 576-bp upstream flank, and BG2369, 
BG2370 for the 540-bp downstream flank). The flanks were fused in an overlap extension PCR 
using prim ers BG2367 and BG2370 making use of the overlaps of primers BG2368 and 
BG2369. The sgRNA was amplified from the pThermoCas9_ctrl plasmid (BG2371, 
BG2372). The constitutive P3 promoter was amplified from pSW_I-SceI (BG2373, 
BG2374). This promoter fragment was fused to the sgRNA fragment in an overlap 
extension PCR using primers BG2372 and BG2373 making use of the overlaps of primers 
BG2371 and BG2374. ThermoCas9 was amplified from the pThermoCas9_ctrl plasmid 
(BG2375, BG2376). The inducible Pm-XylS system, to be used for 3-methylbenzoate
induction of ThermoCas9 was amplified from pSW_I-SceI (BG2377, BG2378).  
EDITING PRO TO CO L FO R P. PUTIDA
Transformat ion of the plasm id to P. putida was performed according to Choi et al.56. After 
transformation and selection of integrants, overnight cultures were inoculated. 10 μl of 
overnight culture was used for inoculation of 3 ml fresh selective medium and after 2 hours 
of growth at 37°C ThermoCas9 was induced with 3-methylbenzoate. After an additional 
6h, dilutions of the culture were plated on non-selective mediu m supplemented with 
3-methylbenzoate. For the control culture the addition of 3-methylbenzoate was omitted in 
all the steps. Confirmation of plasmid integration in the P. putida chromosome was done by 
colony PCR with primers BG2381 and BG2135. Confirmation of pyrF deletion was done 
by colony PCR with primers BG2381 and BG2382. 
BG9263 and BG9088. The promoter together with the part of the thermocas9 upstream 
the first mutation was PCR amplified using pThermoCas9_ctrl as template (BG9089, 
BG9090) 
A two-fragment assembly was designed and executed for the 
construction of pThermoCas9i_ctrl vector. The spacer sequence in the 
pThermoCas9i_ldhL vector was replaced with a random sequence containing BaeI 
restriction sites at both ends. The sgRNA scaffold together with the pNW33n backbone 
was PCR amplified using pThermoCas9_ctrl as template (BG9548, BG9601). The other 
half of the construct consisting of thermodcas9 and promoter was amplified using 
pThermoCas9i_ldhL as template (BG9600, BG9549). 
A five-fragment assembly was designed and executed for the construction of the P. 
putida KT2440 vector pThermoCas9_ppΔpyrF. The replicon from the suicide vector pEMG 
was PCR amplified (BG2365, BG2366). The flanking regions of pyrF were amplified from 
KT2440 genomic DNA (BG2367, BG2368 for the 576-bp upstream flank, and BG2369, 
BG2370 for the 540-bp downstream flank). The flanks were fused in an overlap extension 
PCR using primers BG2367 and BG2370 making use of the overlaps of primers BG2368 and 
BG2369. The sgRNA was amplified from the pThermoCas9_ctrl plasmid (BG2371, 
BG2372). The constitutive P3 promoter was amplified from pSW_I-SceI (BG2373, BG2374). 
This promoter fragment was fused to the sgRNA fragment in an overlap extension PCR using 
primers BG2372 and BG2373 making use of the overlaps of primers BG2371 and BG2374. 
ThermoCas9 was amplified from the pThermoCas9_ctrl plasmid (BG2375, BG2376). The 
inducible Pm-XylS system, to be used for 3-methylbenzoate induction of ThermoCas9 was 
amplified from pSW_I -SceI (BG2377, BG2378).
EDITING PROTOCOL FOR P. PUTIDA
Transformation of the plasmid to P. putida was performed according to Choi et al.56. After 
transformation and selection of integrants, overnight cultures were inoculated. 10 μl of 
overnight culture was used for inoculation of 3 ml fresh selective medium and after 2 hours of 
growth at 37°C ThermoCas9 was induced with 3-methylbenzoate. After an additional 6h, 
dilutions of the culture were plated on non-selective medium supplemented with 3-
methylbenzoate. For the control culture the addition of 3-methylbenzoate was omitted in all 
the steps. Confirmation of plasmid integration in the P. putida chromosome was done 
by colony PCR with primers BG2381 and BG2135. Confirmation of pyrF deletion was done 
by colony PCR with primers BG2381 and BG2382.
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Plasmids expressing ThermoCas9 or ThermodCas9, together with the corresponding sgRNA  
are available on Addgene (#100981 & #100982). 
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Characterizing a thermostable Cas9 for bacterial genome editing and silencing
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SUPPLEMENTARY FIG URES 
A. 
B. Supplementary Fig. 2 | ThermoCas9 PAM discovery. In vitro cleavage assays for DNA targets with 
different PAMs at 20˚C, 37˚C, 45˚C and 60˚C. Seven (20˚C) or sixteen (37˚C, 45˚C, 60˚C) linearized plasmid 
targets, each containing a distinct 5’-CCCCCNNA-3’ PAM, were incubated with ThermoCas9 and sgRNA, 
then analysed by agarose gel electrophoresis. 
Supplementary Fig. 3 | Activity of ThermoCas9 at a wide temperature range using sgRNA containing 
one stem-loop. The importance of the predicted three stem loops of the tracrRNA scaffold was 
tested by transcribing truncated variations of the sgRNA and evaluating their ability to guide ThermoCas9 
to cleave target DNA at various temperatures. Shown above is the effect of one stem-loop on the activity of 
ThermoCas9 at various temperatures. Average values from at least two biological replicates are shown, with 
error bars representing S.D. 
Supplementary Fig. 1 | In silico PAM determination results. 
(A) The two hits obtained with phage genomes using CRISPRtarget7.
(B) Sequence logo of the consensus 7-nt long PAM of ThermoCas9, obtained by in silico PAM analysis. Letter
height at each position is measured by information content8.
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each containing a distinct 5’-CCCCCNNA-3’ PAM, were incubated with ThermoCas9 and sgRNA, then 
analysed by agarose gel electrophoresis. 
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error bars representing S.D. 
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Supplementary Fig. 5 | Colony PCR of P. putida ThermoCas9-based pyrF deletion. 
Capillary gel electrophoresis showing the resulting products from genome-specific PCR on the obtained colonies 
from the Th ermoCas9-based pyrF deletion process from the genome of Pseudomonas putida. The 1854 bp band 
and the 1112 bp band corresponds to the pyrF and ΔpyrF genotype, respectively. 
Supplementary Fig. 6 | Spacer selection for the ldhL silencing experiment. 
Schematic representation of the spacer (sgRNA)-protospacer annealing during the ldhL silencing process; the 
selected protospacer resides on the non- template strand and 39nt downstream the start codon of the ldhL gene. 
The PAM sequence is shown in bold. 
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ABSTRACT 
CRISPR-Cas9 technologies have enabled unprecedented efficient genome editing and 
transcriptional regulation in prokaryotes, allowing for their accelerated exploration and 
exploitation. However, tight control of Cas9 expression requires either multi-step approaches, 
or synthetic  fusions of Cas9 and specific sensor proteins that respond to  external stimuli. 
Here we harness the function of a small anti-CRISPR protein from Neisseria meningitidis 
(AcrIIC1Nme) as natural and direct "on/off-switch" of two thermo-tolerant Cas9 orthologues, 
from Geobacillus thermodenitrificans T12 (ThermoCas9) and Geobacillus 
stearothermophilus (GeoCas9). We demonstrate that both ThermoCas9 and GeoCas9 are in 
vivo active at 37°C and can be used for introducing dsDNA breaks in E. coli, in a  tunable 
and spacer-dependent manner. In addition, we show that AcrIIC1Nme traps in vivo these Cas9 
endonucleases in a DNA-bound, catalytically inactive state, robustly inhibiting targeting and 
resulting in a transcriptional silencing that is comparable to their catalytically "dead" variants 
(Thermo-dCas9 and Geo-dCas9). Moreover, we describe a single-vector, tightly controllable 
and highly efficient Cas9/AcrIIC1Nme-based tool for silencing in bacteria. Altogether,  an 
anti-CRISPR protein has been used to control Cas9-based genome editing and transcriptional 
regulation. 
KEYWORDS 
ThermoCas9, GeoCas9, antiCRISPR, bacteria, genome engineering 
INTRO DUCTIO N
The development of genetic engineering tools has been instrumental for fundamental and 
applied (micro)biology. Initially, a range of seminal discoveries (restriction enzymes, ligases, 
polymerases) and pivotal technological advances (Sanger sequencing, PCR) spurre d
recombinant DNA technologies, thereby setting the stage for the establishment of a basic 
toolkit for precise genetic manipulation (deletion, insertion, substitution) and metabolic 
engineering1. In case of bacteria, efficient genome engineering traditionally hinges on the
endogenous homologous recombination (HR) system and homologous recombination 
templates combined with counter-selection systems (pyrF-system, lacZ-system, tdk-hpt
system) or additional recombinase-based systems (Cre-lox system and FLP-FRT system)2-5. 
However, these methods are laborious, time-consuming, require available selectable markers
and the latter two leave genomic scars that could trigger undesirable chromosomal 
rearrangements. Alternatively, endogenous or viral recombineering methods (Rac prophage-
RecET system, phage λ-Red system) have been applied in few bacteria, though providing 
low engineering efficiencies5,6. In addition, group II intron retrotransposition (ClosTron 
system, TargeTron system) has been employed for limited number of bacterial species, albeit 
often leading to unstable insertions and polar effects5,7-9. Moreover, the mentioned tools are
generally suboptimal for editing the genome of non-model microorganisms with low
transformation and recombination efficiencies. Hence, the need for user-friendly, high-
throughput and broad-range genome engineering tools remained. 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) and CRISPR-
associated (Cas) genes are prokaryotic immune systems that have recently been repurposed 
as a next-generation, genome engineering toolset. CRISPR-Cas technology has
unprecedentedly given the means for streamlined genome editing and stringent
transcriptional control for model and non-model industrial workhorses10-12. CRISPR-Cas 
applications have also spanned across the detection/tracking/typing and epidemiology of
spoilage and pathogenic strains, vaccination of fermentative bacteria against phage threats or
undesirable plasmid uptake as well as the development of smart antibiotics and probiotics 
with improved metabolism and resistance in the gut11,13,14. The integration of the cutting-
edge CRISPR-Cas molecular scissors into the current molecular biology scheme has 
undeniably provided the impetus for a rapid, and cost-effective manipulation of industrially 
attractive organisms. 
The popularity of the CRISPR-Cas toolbox originates from its impressive 
efficiency and simplicity. This versatile genome editing tool relies on only two elements :
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ABSTRACT 
CRISPR-Cas9 technologies have enabled unprecedented efficient genome editing 
and transcriptional regulation in prokaryotes, allowing for their accelerated exploration 
and exploitation. However, tight control of Cas9 expression requires either multi-step 
approaches, or synthetic fusions of Cas9 and specific sensor proteins that respond to external 
stimuli. Here we harness the function of a small anti-CRISPR protein from
Neisseria meningitidis (AcrIIC1Nme) as natural and direct "on/off-switch" of two thermo-
tolerant Cas9 orthologues, from Geobacillus thermodenitrificans T12 (ThermoCas9) a nd
Geobacillus stearothermophilus (GeoCas9). We demonstrate that both ThermoCas9 and 
GeoCas9 are in vivo active at 37°C and can be used for introducing dsDNA breaks in E. 
coli, in a tunable and spacer-dependent manner. In addition, we show that AcrIIC1Nme traps 
in vivo these Cas9 endonucleases in a DNA-bound, catalytically inactive state, robustly 
inhibiting targeting and resulting in a transcriptional silencing that is comparable to their 
catalytically "dead" variants (Thermo-dCas9 and Geo-dCas9). Moreover, we describe a 
single-vector, tightly controllable and highly efficient Cas9/AcrIIC1Nme-based tool for 
silencing in bacteria. Altogether, an anti-CRISPR protein has been used to control Cas9-
based genome editing and transcriptional regulation. 
K EYWO RDS 
ThermoCas9, GeoCas9, antiCRISPR, bacteria, genome engineering 
INTRODUCTION
The development of genetic engineering tools has been instrumental for fundamental and 
applied (micro)biology. Initially, a range of seminal discoveries (restriction enzymes, ligases, 
polymerases) and pivotal technological advances (Sanger sequencing, PCR) spurred 
recombinant DNA technologies, thereby setting the stage for the establishment of a basic 
toolkit for precise genetic manipulation (deletion, insertion, substitution) and metabolic 
engineering1. In case of bacteria, efficient genome engineering traditionally hinges on the 
endogenous homologous recombination (HR) system and homologous recombination 
templates combined with counter-selection systems (pyrF-system, lacZ-system, tdk-hpt 
system) or additional recombinase-based systems (Cre-lox system and FLP-FRT system)2-5. 
However, these methods are laborious, time-consuming, require available selectable markers 
and the latter two leave genomic scars that could trigger undesirable chromosomal 
rearrangements. Alternatively, endogenous or viral recombineering methods (Rac prophage-
RecET system, phage λ-Red system) have been applied in few bacteria, though providing low 
engineering efficiencies5,6. In addition, group II intron retrotransposition (ClosTron system, 
TargeTron system) has been employed for limited number of bacterial species, albeit often 
leading to unstable insertions and polar effects5,7-9. Moreover, the mentioned tools are 
generally suboptimal for editing the genome of non-model microorganisms with low 
transformation and recombination efficiencies. Hence, the need for user-friendly, high-
throughput and broad-range genome engineering tools remained. 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) and CRISPR-
associated (Cas) genes are prokaryotic immune systems that have recently been repurposed as 
a next-generation, genome engineering toolset. CRISPR-Cas technology has unprecedentedly 
given the means for streamlined genome editing and stringent transcriptional control 
for model and non-model industrial workhorses10-12. CRISPR-Cas applications have also 
spanned across the detection/tracking/typing and epidemiology of spoilage and 
pathogenic strains, vaccination of fermentative bacteria against phage threats or 
undesirable plasmid uptake as well as the development of smart antibiotics and probiotics 
with improved metabolism and resistance in the gut11,13,14. The integration of the 
cutting-edge CRISPR-Cas molecular scissors into the current molecular biology scheme has 
undeniably provided the impetus for a rapid, and cost-effective manipulation of 
industrially attractive organisms. The popularity of the CRISPR-Cas toolbox 
originates from its impressive efficiency and simplicity. This versatile genome editing tool 
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relies on only two elements: (i) a Cas endonuclease (usually from the type II-A CRISPR-
Cas system of Streptococcus pyogenes strain SF370, SpyCas9)10-12, and (ii) a 
programmable single-guide RNA (sgRNA) molecule15. The sgRNA guides the Cas9 
nuclease to introduce double-stranded DNA breaks (DSDBs) to a desired DNA sequence 
(protospacer), which is complementary to the exchangeable 5'-end of the sgRNA (spacer)16 
and flanked downstream by a 3-8nt long conserved motif (protospacer adjacent motif, 
PAM)17,18. Unlike eukaryotes, Cas9-mediated DSDBs are lethal for most prokaryotes in 
the absence of a rescuing template, due to the lack or the conditional expression of 
an efficient Non-Homologous End Joining (NHEJ) repair mechanism19-22. Leveraging 
this lethality, recent genetic engineering methods interlace Cas9 technology with HR or 
recombineering systems, providing a chromosome/plasmid-borne  or ss/ds-DNA editing 
template, respectively10,23,24. The Cas9 endonuclease either triggers cellular repair 
mechanisms, usually resulting in escape mutants and mixed wild type-mutant genotypes25-27, 
or serves as a stringent counter-selection system that allows HR to occur before the Cas9-
mediated targeting, though often requiring multiple-plasmid strategies  or strictly controlled 
promoters28-31. Due to the absence of well-characterized inducible promoters in non-model 
organisms32, Cas9-based targeting often acts as an extended recombination inducer, leading to 
lower survival rates and editing efficiencies. As such, there is a tangible need for tight control 
of the Cas9-expression through alternative strategies, as has been recently demonstrated via 
temperature-based activation of SpyCas9 in a moderate thermophile33, and through the 
development of synthetic Cas9 variants regulated by drugs, light or other external stimuli34-42.
Intriguingly, several small (50 - 150 amino acids) proteins naturally 
neutralizing CRISPR-Cas systems were recently identified in prokaryotic viruses and 
mobile genetic elements43-50, launching the now rapidly expanding anti-CRISPR field. Out of 
the currently thirty-seven identified anti-CRISPR proteins, ten have been characterized 
and shown to exhibit direct interactions with a Cas protein/complex, abolishing DNA 
cleavage, and thus holding tremendous promise as natural "off-switches". Specifically, 
most anti-CRISPRs hinder DNA-binding (complete "off-switch") by association with 
the Cascade (AcrID1, AcrIF1, AcrIF2, AcrIF4, AcrIF10)48,51-55, by masking of the PAM-
interacting domain of Cas9 (AcrIIA2, AcrIIA4)56-59 or by forcing dimerization of the Cas9 
(AcrIIC3)46,60. Such proteins have been successfully applied to limit off-target 
editing46,57,61, control leaky CRISPR interference (CRISPRi)46, and optimize CRISPR-
based imaging46 in human cells as well as to inactivate a gene drive in budding yeast62, and 
to hamper CRISPRi in E. coli61. Particularly, two anti-CRISPR proteins, AcrIF3 and AcrIIC1
their ability to impede DNA cleavage but still permit DNA binding (incomplete "off-
switch"), thereby switching Cas proteins from the catalytically active (targeting) to the 
catalytically inactive (silencing) state. AcrIF3 hampers the recruitment of the Cas 3
endonuclease to the DNA-associated Cascade51,63 in type I CRISPR-Cas systems. AcrIIC1
binds to the HNH nuclease domain in certain type II-C Cas9 systems, obstructing the 
cleavage of the target DNA strand, thereby restricting conformational changes 
necessary for the cleavage of the non-target strand by the RuvC domain60. In this way, 
AcrIIC1 traps Cas9 in a DNA-bound, catalytically inactive state, resulting in 
transcriptional silencing of a target gene. The robust inhibition of Cas9 
endonucleases from Neisseria meningitidis (NmeCas9), Campylobacter jejuni (CjeCas9) 
and Geobacillus stearothermophilus (GeoCas9) both in vitro and in mammalian 
cells46,60 by AcrIIC1 from N. meningitidis (AcrIIC1Nme) has attracted attention for its 
potential to become an appealing, broad-range and natural CRISPR/CRISPRi-regulator. 
However, AcrIIC1Nme has never been employed for bacterial genome engineering. 
In this study, we report that the Cas9 orthologues from Geobacillus 
thermodenitrificans (ThermoCas9) and Geobacillus stearothermophilus (GeoCas9) , which 
are functional at wide-temperature range, both efficiently introduce lethal DSDBs in the 
E. coli genome. We demonstrate that the AcrIIC1Nme robustly inhibits the nuclease activity
of both ThermoCas9 and GeoCas9 in vivo and can be used to silence a chromosomally-
integrated gfp gene in E. coli in a tunable manner. The gene silencing efficiencies of the
ThermoCas9/GeoCas9: AcrIIC1Nme complexes is subsequently compared to that of their
catalytically inactive ("dead") counterparts (Geo-dCas9, Thermo-dCas9). Following on these
advances, we develop a one-plasmid based, tuneable silencing system. This sets further
directions for the development of a tightly controllable antiCRISPR-based toolkit for
sequential silencing and editing in E. coli and other industrially relevant non-model
organisms. This strategy is expected not only to prolong the HR phase and thus improve
the editing efficiencies in a wide range of microorganisms, butalso circumvent the need of
time-consuming construction of distinct plasmid variants for editi ng and silencing.
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(i) a Cas endonuclease (usually from the type II-A CRISPR-Cas system of Streptococcus 
pyogenes strain SF370, SpyCas9)10-12, and (ii) a programmable single-guide RNA (sgRNA) 
molecule15. The sgRNA guides the Cas9 nuclease to introduce double-stranded DNA breaks 
(DSDBs) to a desired DNA sequence (protospacer), which is complementary to the 
exchangeable 5'-end of the sgRNA (spacer)16 and flanked downstream by a 3-8nt long 
conserved motif (protospacer adjacent motif, PAM)17,18. Unlike eukaryotes, Cas9-mediated 
DSDBs are lethal for most prokaryotes in the absence of a rescuing template, due to the lack 
or the conditional expression of an efficient Non-Homologous End Joining (NHEJ) repair 
mechanism19-22. Leveraging this lethality, recent genetic engineering methods interlace Cas9 
technology with HR or recombineering systems, providing a chromosome/plasmid-borne or 
ss/ds-DNA editing template, respectively10,23,24. The Cas9 endonuclease either triggers 
cellular repair mechanisms, usually resulting in escape mutants and mixed wild type-mutant 
genotypes25-27, or serves as a stringent counter-selection system that allows HR to occur 
before the Cas9-mediated targeting, though often requiring multiple-plasmid strategies or 
strictly controlled promoters28-31. Due to the absence of well-characterized inducible 
promoters in non-model organisms32, Cas9-based targeting often acts as an extended 
recombination inducer, leading to lower survival rates and editing efficiencies. As such, there 
is a tangible need for tight control of the Cas9-expression through alternative strategies, as 
has been recently demonstrated via temperature-based activation of SpyCas9 in a moderate 
thermophile33, and through the development of synthetic Cas9 variants regulated by drugs, 
light or other external stimuli34-42. 
Intriguingly, several small (50 - 150 amino acids) proteins naturally neutralizing 
CRISPR-Cas systems were recently identified in prokaryotic viruses and mobile genetic 
elements43-50, launching the now rapidly expanding anti-CRISPR field. Out of the currently 
thirty-seven identified anti-CRISPR proteins, ten have been characterized and shown to 
exhibit direct interactions with a Cas protein/complex, abolishing DNA cleavage, and thus 
holding tremendous promise as natural "off-switches". Specifically, most anti-CRISPRs 
hinder DNA-binding (complete "off-switch") by association with the Cascade (AcrID1, 
AcrIF1, AcrIF2, AcrIF4, AcrIF10)48,51-55, by masking of the PAM-interacting domain of 
Cas9 (AcrIIA2, AcrIIA4)56-59 or by forcing dimerization of the Cas9 (AcrIIC3)46,60. Such 
proteins have been successfully applied to limit off-target editing46,57,61, control leaky 
CRISPR interference (CRISPRi)46, and optimize CRISPR-based imaging46 in human cells as 
well as to inactivate a gene drive in budding yeast62, and to hamper CRISPRi in E. coli61. 
Particularly, two anti-CRISPR proteins, AcrIF3 and AcrIIC1, have attracted interest, due to 
have attracted interest, due to their ability to impede DNA cleavage but still permit 
DNA binding (incomplete "off -switch"), thereby switching Cas proteins from 
the catalytically active (targeting) to the catalytically inactive (silencing) state. 
AcrIF3 hampers the recruitment of the Cas 3 endonuclease to the DNA-associated 
Cascade51,63 in type I CRISPR-Cas systems.  AcrIIC1 binds to the HNH nuclease domain in 
certain type II-C Cas9 systems, obstructing the cleavage of the target DNA strand, thereby 
restricting conformational changes necessary for the cleavage of the non-target strand by the 
RuvC domain60. In this way, AcrIIC1 traps Cas9 in a DNA-bound, catalytically inactive 
state, resulting in transcriptional silencing of a target gene. The robust inhibition 
of Cas9 endonucleases from Neisseria meningitidis (NmeCas9), Campylobacter 
jejuni (CjeCas9) and Geobacillus stearothermophilus (GeoCas9) both 
in vitro and in mammalian cells46,60 by AcrIIC1 from N. meningitidis (AcrIIC1Nme) 
has attracted attention for its potential to become an appealing, broad-range and natural 
CRISPR/CRISPRi-regulator. However, AcrIIC1Nme has never been employed for 
bacterial genome engineering. 
In this study, we report that the Cas9 orthologues from Geobacillus 
thermodenitrificans (ThermoCas9) and Geobacillus stearothermophilus (GeoCas9), 
which are functional at wide-temperature range, both efficiently introduce lethal DSDBs  in 
the E. coli genome. We demonstrate that the AcrIIC1Nme robustly inhibits the 
nuclease activity of both ThermoCas9 and GeoCas9 in vivo and can be used to 
silence a chromosomally-integrated gfp gene in E. coli in a tunable manner. 
The gene silencing efficiencies of the ThermoCas9/GeoCas9:AcrIIC1Nme complexes is 
subsequently compared to that of their catalytically inactive ("dead") counterparts (Geo-dCas9, 
Thermo-dCas9). Following on these advances, we develop a one-plasmid based, tuneable 
silencing system. This sets further directions for the development of a tightly controllable 
antiCRISPR-based toolkit for sequential silencing and editing in E. coli and other industrially 
relevant non-model organisms. This strategy is expected not only to prolong the HR phase and 
thus improve the editing efficiencies in a wide range of microorganisms, but also circumvent 
the need of time-consuming construction of distinct plasmid variants for editing and silencing.
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to protospacers with 5’-NNNNCACA-3’ as PAM and the remaining spacer (spacer 3) was
corresponding to a protospacer with 5’-NNNNCCAA-3’ as PAM. Both PAM sequences 
have been proven to allow ThermoCas9 targeting in vitro64, while they have not been tested  
for GeoCas9. This cloning process resulted in the construction of the pTCas9_sp1/2/3/scr and 
pGCas9_sp1/2/3/scr series of plasmids (Fig. 1; Sup. Table S2). The pACYC184 plasmid and 
the ThermoCas9 and GeoCas9 plasmids containing the non-targeting, scrambled spacer were 
used as transformation controls. After transformation of the whole series of plasmids to E.
coli DH10B_gfp cells, the ThermoCas9 plasmid bearing the spacer that corresponds to a 
protospacer with the optimal PAM for ThermoCas9 (spacer 3) resulted in at least 4 orders of 
magnitude reduction in the transformation efficiency compared to the control plasmid, even 
when ThermoCas9 was not induced (Fig. 1b; Sup. Fig. 2a). Moreover, the transformation of 
the ThermoCas9 plasmid harboring spacer 1 that corresponds to a protospacer with a 
suboptimal PAM for ThermoCas9-mediated targeting, resulted in transformation efficiency 
levels similar to the controls in the absence of ThermoCas9 induction, whereas at maximum 
ThermoCas9 induction there was complete loss of transformation efficiency. Notably, no 
ThermoCas9 activity was observed for the plasmid with spacer 2, even at the highest 
ThermoCas9 induction. Intriguingly, even though spacer 1 and 2 target closely locate d
protospacers that have the same PAM, the targeting efficiencies were completely different. 
This phenomenon suggests that ThermoCas9 cleavage activity depends not only on the PAM
or the location of a protospacer within the genome but also on the spacer sequence. 
Regarding GeoCas9 targeting efficiency, the plasmids carrying spacers 1 and 2 resulted i n
transformation efficiencies similar to the controls in absence of GeoCas9 induction, whilst 
high GeoCas9 induction resulted in at least 3 orders of magnitude drop in the transformation 
efficiency (Fig. 1c; Sup. Fig. 2b). However, the GeoCas9 plasmid with the spacer 3 cause d
less than 1 order of magnitude decrease in the transformation efficiency in all GeoCas9 
induction conditions, suggesting that GeoCas9 activity was very limited when this spacer, or
this PAM, was employed. Altogether, these findings demonstrate that both ThermoCas9 and 
GeoCas9 are actively targeting the E. coli DH10B_gfp genome, in a spacer-dependent
manner. Nonetheless, stricter control of their cleavage activity would substantially benefit
future genome engineering applications to reach optimal efficiencies.
RESULTS 
THERMOCAS9 AND GEOCAS9 ARE ACTIVE IN E. COLI
Recently, we characterized in vitro the thermo-tolerant and thermo-active ThermoCas9 
endonuclease from the type II-C CRISPR-Cas system of the thermophilic Geobacillus 
thermodenitrificans T12 strain64. We further employed ThermoCas9 to develop the first Cas9-
based genome editing and silencing tools for thermophilic bacteria, readily applicable to 
mesophilic bacteria too64. ThermoCas9 and its catalytically inactive mutant Thermo-dCas9 
were applied for gene deletion and transcriptional silencing, respectively, in Bacillus smithii 
ET138 (55°C) as well as for gene deletion in Pseudomonas putida KT2440 (37°C)64. 
Concurrently, the closely related GeoCas9 orthologue (88% amino acid identity to 
ThermoCas9) from the type II-C CRISPR-Cas system of another thermophilic species, 
Geobacillus stearothermophilus, was characterized in vitro and employed for in vitro DNA 
targeting in human plasma65, for gene disruption in mammalian cells65 and for in vivo 
targeting of viral DNA during E. coli infection60. The wide-temperature activity range (20-70°
C in vitro), the recalcitrance and the relatively small sizes of ThermoCas9 and GeoCas9 (Sup. 
Fig. S1a) could serve as basis for the development of various genome engineering 
applications in a broad range of model and non-model bacteria.
In this study, we started by determining the in vivo DNA targeting 
efficiency of ThermoCas9 and GeoCas9 at 37°C. For this purpose, we employed the 
previously constructed E. coli DH10B_gfp strain that harbors a genome-integrated 
gfp gene under the transcriptional control of the constitutive lacUV5 promoter 
(PlacUV5) (Creutzburg et al., in preparation). The cas9 (thermocas9 or geocas9) genes were 
cloned separately into the low copy number plasmid pACYC184, under the transcriptional 
control of the IPTG-inducible tet promoter (Ptet combined with lac operator, Ptet-lac). In the 
same plasmids, we  cloned the lacI gene, under the transcriptional control of the constitutive 
lacI promoter (PlacI), and a sgRNA-expressing module under the transcriptional control of 
the synthetic, constitutive promoter PJ23119, lacking a ribosomal binding site (RBS) (Fig. 1; 
Sup. Fig. S1b). Four spacers were introduced separately into the 5’-end of the sgRNA 
expressing module of the plasmids. Three of the spacers were targeting either a protospacer 
on the non-coding strand close to the start codon of the gfp gene in the genome of the E. coli 
DH10B_gfp strain or protospacers in the promoter region of the same gene (Fig. 1a), and the 
fourth spacer was scrambled, not targeting any region in the genome of the E. coli 
DH10B_gfp strain (Sup. Table S1). Two of the spacers (spacers 1 and 2) were corresponding
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RESULTS 
TH ERMO CAS9 AND G EO CAS9 ARE ACTIVEIN E. COLI
Recently, we characterized in vitro the thermo-tolerant and thermo-active 
ThermoCas9 endonuclease from the type II-C CRISPR-Cas system of the 
thermophilic Geobacillus thermodenitrificans T12 strain64. We further employe d
ThermoCas9 to develop the first Cas9-based genome editing and silencing tools for 
thermophilic bacteria, readily applicable to mesophilic bacteria too64. ThermoCas9 and 
its catalytically inactive mutant Thermo-dCas9 were applied for gene deletion and 
transcriptional silencing, respectively, in Bacillus smithii ET138 (55°C) as well as for 
gene deletion in Pseudomonas putida KT2440 (37°C)64. Concurrently, the closely 
related GeoCas9 orthologue (88% amino acid identity to ThermoCas9) from the 
type II-C CRISPR-Cas system of another thermophilic species, Geobacillus 
stearothermophilus , was characterized in vitro and employed for in vitro DNA targeting in 
human plasma65, for gene disruption in mammalian cells65 and for in vivo targeting of viral 
DNA during E. coli infection60. The wide-temperature activity range (20-70°C in vitro), the 
recalcitrance and the relatively small sizes of ThermoCas9 and GeoCas9 (Sup. Fig. S1a) 
could serve as basis for the development of various genome engineering applications in a 
broad range of model and non-model bacteria. 
In this study, we started by determining the in vivo DNA targeting efficiency 
of ThermoCas9 and GeoCas9 at 37°C. For this purpose, we employed the previousl y
constructed E. coli DH10B_gfp strain that harbors a genome-integrated gfp gene under the 
transcriptional control of the constitutive lacUV5 promoter (PlacUV5) (Creutzburg et al., in 
preparation). The cas9 (thermocas9 or geocas9) genes were cloned separately into the low 
copy number plasmid pACYC184, under the transcriptional control of the IPTG-inducible tet
promoter (Ptet combined with lac operator, Ptet-lac). In the same plasmids, we cloned 
the lacI gene, under the transcriptional control of the constitutive lacI promoter (PlacI), and 
a sgRNA-expressing module under the transcriptional control of the synthetic, 
constitutive promoter PJ23119, lacking a ribosomal binding site (RBS) (Fig. 1; Sup. Fig. 
S1b). Four spacers were introduced separately into the 5’-end of the sgRNA expressing 
module of the plasmids. Three of the spacers were targeting either a protospacer on the 
non-coding strand close to the start codon of the gfp gene in the genome of the E. coli
DH10B_gfp strain or protospacers in the promoter region of the same gene (Fig. 1a), and 
the fourth spacer was scrambled, not targeting any region in the genome of the E. coli
DH10B_gfp strain (Sup. Table S1). Two of the spacers (spacers 1 and 2) were corresponding 
to protospacers with 5’-NNNNCACA-3’ as PAM and the remaining spacer (spacer 3) was 
corresponding to a protospacer with 5’-NNNNCCAA-3’ as PAM. Both PAM sequences have 
been proven to allow ThermoCas9 targeting in vitro64, while they have not been tested for 
GeoCas9. This cloning process resulted in the construction of the pTCas9_sp1/2/3/scr and 
pGCas9_sp1/2/3/scr series of plasmids (Fig. 1; Sup. Table S2). The pACYC184 plasmid and 
the ThermoCas9 and GeoCas9 plasmids containing the non-targeting, scrambled spacer were 
used as transformation controls. After transformation of the whole series of plasmids to E. 
coli DH10B_gfp cells, the ThermoCas9 plasmid bearing the spacer that corresponds to a 
protospacer with the optimal PAM for ThermoCas9 (spacer 3) resulted in at least 4 orders of 
magnitude reduction in the transformation efficiency compared to the control plasmid, even 
when ThermoCas9 was not induced (Fig. 1b; Sup. Fig. 2a). Moreover, the transformation of 
the ThermoCas9 plasmid harboring spacer 1 that corresponds to a protospacer with a 
suboptimal PAM for ThermoCas9-mediated targeting, resulted in transformation efficiency 
levels similar to the controls in the absence of ThermoCas9 induction, whereas at maximum 
ThermoCas9 induction there was complete loss of transformation efficiency. Notably, no 
ThermoCas9 activity was observed for the plasmid with spacer 2, even at the highest 
ThermoCas9 induction. Intriguingly, even though spacer 1 and 2 target closely located 
protospacers that have the same PAM, the targeting efficiencies were completely different. 
This phenomenon suggests that ThermoCas9 cleavage activity depends not only on the PAM 
or the location of a protospacer within the genome but also on the spacer sequence. Regarding 
GeoCas9 targeting efficiency, the plasmids carrying spacers 1 and 2 resulted in 
transformation efficiencies similar to the controls in absence of GeoCas9 induction, whilst 
high GeoCas9 induction resulted in at least 3 orders of magnitude drop in the transformation 
efficiency (Fig. 1c; Sup. Fig. 2b). However, the GeoCas9 plasmid with the spacer 3 cause d 
less than 1 order of magnitude decrease in the transformation efficiency in all GeoCas9 
induction conditions, suggesting that GeoCas9 activity was very limited when this spacer, or 
this PAM, was employed. Altogether, these findings demonstrate that both ThermoCas9 and 
GeoCas9 are actively targeting the E. coli DH10B_gfp genome, in a spacer-dependent 
manner. Nonetheless, stricter control of their cleavage activity would substantially benefit 
future genome engineering applications to reach optimal efficiencies.
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Figure 1 | ThermoCas9- and G eoCas9-based targeting in E. coli DH 10B_gfp. a) Schematic illustration of the 
strategy for ThermoCas9- and GeoCas9-based targeting in E. coli DH10B_gfp. The pCas9 plasmid was used for 
the expression of the ThermoCas9/GeoCas9 nuclease and its respective sgRNA to target and cleave specific sites 
on the genome of E. coli DH10B_gfp. b) Results of the ThermoCas9-based targeting assays in E. coli DH10B_gfp 
cells employing the pTCas9 plasmid series. c) Results of the GeoCas9-based targeting assays in E. coli 
DH10B_gfp cells employing the pGCas9 plasmid series. 
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ACRIIC1NME INH IBITS TH ERMO CAS9 AND G EO CAS9 ACTIVITY IN E. COLI
(DUAL-VECTO R SYSTEM)
Recently, various anti-CRISPR systems, encoded by viral genomes and mobile 
genetic elements, were demonstrated to block the targeting activity of CRISPR-Cas 
systems. The exploitation of anti-CRISPR proteins for regulating the activity of Cas9 
endonucleases during genome engineering applications has the potential to increase the 
efficiency of these systems. The AcrIIC1 from Neisseria meningitidis (AcrIIC1Nme) has 
displayed robust inhibition of GeoCas9-mediated genome editing in human cells60, albeit 
not yet in prokaryotes. Specifically, in vitro studies showed that AcrIIC1Nme binds to the 
active site of the HNH nuclease domain (D587, H588), trapping GeoCas9 in a DNA-bound 
but catalytically inactive state60. The crystal structure of the GeoCas9 HNH-AcrIIC1Nme
complex showed that AcrIIC1Nme additionally binds to five charged residues around the 
active site (T549, H551, D598, K603, N616), potentially ensuring the high stability of this 
inter-protein interaction60. Some of these five charged residuesare conserved among diverse 
type II-C Cas9 orthologues, while others are species-specific. These findings prompte d
us to align and compare the HNH domains of GeoCas9 and ThermoCas9. We 
observed that all the crucial residues for the association of the ThermoCas9 HNH domai n
with AcrIIC1Nme were identical to the GeoCas9 HNH domain, except for the histidine at 
position 551(H551) that was substituted with the non-charged leucine in the 
ThermoCas9HNH domain (Sup. Fig. S3). These data suggested that not only GeoCas9 but 
also ThermoCas9 cleavage activity canbe sufficiently blocked  by AcrIIC1Nme.  
To evaluate the in vivo efficiency of AcrIIC1Nme to block the GeoCas9 and 
ThermoCas9 activities, we repeated the ThermoCas9- and GeoCas9- targeting assays 
employing an AcrIIC1Nme-expressing E. coli DH10B_gfp strain. The employed E. coli 
DH10B_gfp strain was already transformed with the AcrIIC1Nme-encoding pAcr plasmid, 
resulting in the E. coli DH10B_gfp(pAcr) strain (Fig. 2a). The pAcr was constructed by 
cloning the E. coli codon optimized acrIIC1 Nme gene in the high copy number pUC 19
backbone plasmid under the transcriptional control of the L-rhamnose-inducible promoter 
(Prha) (Fig. 2a). This tactic was expected to allow for high expression of AcrIIC1Nme, 
and thus sufficient inhibition of ThermoCas9 and GeoCas9 activity upon transformati on
of the E. coli DH10B_gfp(pAcr) cells with the most effectively targeting plasmids
pTCas9_sp3 and pGCas9 sp1 and 2 (Fig. 2a), as well as the pTCas9L551H_sp3 plasmi d
that is similar to the pTCas9_sp3 plasmid but encompasses the thermoCas9L551H gene 
that codes for the ThermoCas9L551H variant, which harbours the L551H substitution 
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Figure 1 | ThermoCas9- and G eoCas9-based targeting in E. coli DH 10B_gfp. a) Schematic illustration of the 
strategy for Therm oCas9- and GeoCas9-based targeting in E. coli DH10B_gfp. The pCas9 plasm id was used for
the expression of the Therm oCas9/GeoCas9 nuclease and its respective sgRNA to target and cleave specific sites
on the genom e ofE. coli DH10B_gfp. b) Results of the Therm oCas9-based targeting assays in E. coli DH10B_gfp
cells em ploying the pTCas9 plasm id series. c) Results of the GeoCas9-based targeting assays in E. coli DH10B_gfp
cells em ploying the pGCas9 plasm idseries.
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ACRIIC1NME INHIBITS THERMOCAS9 AND GEOCAS9 ACTIVITY IN E. COLI  
(DUAL-VECTOR SYSTEM)
Recently, various anti-CRISPR systems, encoded by viral genomes and mobile genetic 
elements, were demonstrated to block the targeting activity of CRISPR-Cas systems. The 
exploitation of anti-CRISPR proteins for regulating the activity of Cas9 endonucleases during 
genome engineering applications has the potential to increase the efficiency of these systems. 
The AcrIIC1 from Neisseria meningitidis (AcrIIC1Nme) has displayed robust inhibition of 
GeoCas9-mediated genome editing in human cells60, albeit not yet in prokaryotes. 
Specifically, in vitro studies showed that AcrIIC1Nme binds to the active site of the HNH 
nuclease domain (D587, H588), trapping GeoCas9 in a DNA-bound but catalytically inactive 
state60. The crystal structure of the GeoCas9 HNH-AcrIIC1Nme complex showed that 
AcrIIC1Nme additionally binds to five charged residues around the active site (T549, H551, 
D598, K603, N616), potentially ensuring the high stability of this inter-protein interaction60. 
Some of these five charged residues are conserved among diverse type II-C Cas9 orthologues, 
while others are species-specific. These findings prompted us to align and compare the HNH 
domains of GeoCas9 and ThermoCas9. We observed that all the crucial residues for the 
association of the ThermoCas9 HNH domain with AcrIIC1Nme were identical to the GeoCas9 
HNH domain, except for the histidine at position 551(H551) that was substituted with the 
non-charged leucine in the ThermoCas9HNH domain (Sup. Fig. S3). These data suggested 
that not only GeoCas9 but also ThermoCas9 cleavage activity can be sufficiently blocked  by 
AcrIIC1Nme.  
To evaluate the in vivo efficiency of AcrIIC1Nme to block the GeoCas9 and 
ThermoCas9 activities, we repeated the ThermoCas9- and GeoCas9- targeting assays 
employing an AcrIIC1Nme-expressing E. coli DH10B_gfp strain.  The employed E. coli 
DH10B_gfp strain was already transformed with the AcrIIC1Nme-encoding pAcr plasmid, 
resulting in the E. coli DH10B_gfp(pAcr) strain (Fig. 2a). The pAcr was constructed by 
cloning the E. coli codon optimized acrIIC1Nme gene in the high copy number 
pUC19 backbone plasmid under the transcriptional control of the L-rhamnose-inducible 
promoter (Prha) (Fig. 2a). This tactic was expected to allow for high expression of AcrIIC1Nme, 
and thus sufficient inhibition of ThermoCas9 and GeoCas9 activity upon transformation of 
the E. coli DH10B_gfp(pAcr) cells with the most effectively targeting plasmids 
pTCas9_sp3 and pGCas9 sp1 and 2 (Fig. 2a), as well as the pTCas9L551H_sp3 plasmid 
that is similar to the pTCas9_sp3 plasmid but encompasses the thermoCas9L551H gene 
that codes for the ThermoCas9L551H variant, which harbors the L551H substitution (Sup. -
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Fig. S4a). Assays were conducted with and without L-rhamnose supplementation (Sup. 
Fig. S4a). Strikingly, complete abolishment of the ThermoCas9, ThermoCas9L551H 
and GeoCas9 activity was observed in all cases even without L-rhamnose-based induction of 
the AcrIIC1Nme expression (Fig. 2b,c; Sup. Fig. S4a,b; Sup. Fig. S5a,b), most probably 
due to leaky AcrIIC1Nme expression at adequate levels for targeting inhibition. 
Moreover, the presence of the hydrophobic leucine at the 551 position of the 
ThermoCas9 sequence, instead of the positively charged histidine that is present in 
the GeoCas9 sequence, apparently did not inhibit the binding of the AcrIIC1Nme to 
levels that could reduce the ThermoCas9 inhibition in the current system. To sum 
up, in the described dual-vector system AcrIIC1Nme presented robust inhibition of 
the ThermoCas9-, ThermoCas9L551H- and GeoCas9-based targeting in E. coli DH10B_gfp 
cells, in a non-tunable manner.
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TH E TH ERMO CAS9/G EO CAS9:ACRIIC1NME CO MPLEXES MEDIATE G ENE
SILENCING  IN E. COLI
In this part of the study, we set off to verify the hypothesis that in vivo binding of 
AcrIIC1Nme to the HNH domain of ThermoCas9, and GeoCas9 transforms the enzymes into a 
DNA-bound but catalytically inactive form, with similar activity to the 
catalytically inactive ThermoCas9D8A,H582A (Thermo-dCas9) and GeoCas9D8A,H582A
(Geo-dCas9) variants. For this purpose, we repeated the transformations of the
E. coli DH10B_gfp(pAcr) strain with the pTCas9_sp3 and pGCas9_sp1 and 2
plasmids. We simultaneously constructed variations of the same plasmid s containing the
thermo-dcas9 and geo-dCas9 genes instead of the active variants and transformed them to
E. coli DH10B_gfp. We then used the transformation mixtures to inoculate media
with a variety of IPTG concentrations, aiming to achieve different induction levels of
ThermoCas9, GeoCas9, Thermo-dCas9 and Geo-dCas9 expression (Fig. 4), and we
executed flow cytometry-based fluorescence loss assays. The E. coli 
DH10B(pUC19, pACYC184) and E. coli DH10B(pACYC184) strains were employed as 
the no-fluorescence control strains of the assays, while the E. coli
DH10B_gfp(pUC19, pACYC184), E. coli DH10B_gfp(pACYC184), E. coli
DH10B_gfp(pAcr, pTCas9_spscr), E. coli DH10B_gfp(pAcr, pTCas9L551H_spscr),
E. coli DH10B_gfp(pAcr, pGCas9_spscr), E. coli DH10B_gfp(pT-dCas9_spscr), and
E. coli DH10B_gfp(pG-dCas9_spscr) strains were used as the fluorescence control strains.
The results of the flow cytometry-based fluorescence loss assays revealed the 
transcriptional silencing effect of the ThermoCas9-AcrIIC1Nme complexes. The fluorescence 
intensity of the E. coli DH10B_gfp_AcrIIC1Nme cells transformed with the pTCas9_sp3 
plasmid, under non-induced conditions, was ~77% less than the detected fluorescence 
intensity for the E. coli DH10B_gfp(pAcr, pTCas9_spscr) control strain (Fig. 3a; Sup. Fig. 
6a). When ThermoCas9 expression was induced with 1 - 50 μM IPTG, a gradual decrease of 
the GFP signal was observed, while IPTG concentrations ≥ 50 μM resulted in complete loss 
of fluorescence. Similar results were obtained when the E. coli DH10B_gfp(pAcr) cells 
were transformed with the pTCas9L551H_sp3 plasmid, suggesting that the stability of the 
ThermoCas9-AcrIIC1Nme comp lex is not significantly impaired by the lack of a positively 
charged amino-acid at the residue-position 551 of the protein. In comparison, after 
transformation of E. coli DH10B_gfp cells with the pT-dCas9_sp3 plasmid under non-
induced conditions, absolute fluorescence loss was observed (Fig. 3b; Sup. Fig. 8a). Hence, 
the ThermoCas9-AcrIIC1Nme, and the ThermoCas9L551H-AcrIIC1Nme complexes mediate d
Figure 2 | AcrIIC1Nme-mediated inhibition of ThermoCas9- and GeoCas9-based targeting in E. 
coli DH10B_gfp (dual-vector system). a) Schematic illustration of the dual-vector strategy for AcrIIC1Nme-
mediated inhibition of ThermoCas9- and GeoCas9-based targeting in E. coli DH10B_gfp. The pCas9 plasmid 
was used for the expression of the ThermoCas9/GeoCas9 nuclease and its respective sgRNA to target and cleave 
specific sites on the genome of E. coli DH10B_gfp (either at the genome-integrated gfp gene or its promoter, 
PlacUV5). The Cas9-inhibitor AcrIIC1Nme was expressed from the pAcr plasmid in the same strain. b) Results 
of the AcrIIC1Nme-mediated inhibition assay of ThermoCas9-based targeting. c) Results of the AcrIIC1Nme-
mediated inhibition assay of GeoCas9-based targeting.
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(Sup. Fig. S4a). Assays were conducted with and without L-rhamnose supplementation (Sup. 
Fig. S4a). Strikingly, complete abolishment of the ThermoCas9, ThermoCas9L551H and 
GeoCas9 activity was observed in all cases even without L-rhamnose-based induction of the 
AcrIIC1Nme expression (Fig. 2b,c; Sup. Fig. S4a,b; Sup. Fig. S5a,b), most probably due to 
leaky AcrIIC1Nme expression at adequate levels for targeting inhibition. Moreover, the 
presence of the hydrophobic leucine at the 551 position of the ThermoCas9 sequence, 
instead of the positively charged histidine that is present in the GeoCas9 sequence, 
apparently did not inhibit the binding of the AcrIIC1Nme to levels that could reduce the 
ThermoCas9 inhibition in the current system. To sum up, in the described dual-vector
system AcrIIC1Nme presented robust inhibition of the ThermoCas9-, ThermoCas9L551H- 
and GeoCas9-based targeting in E. coli DH10B_gfp cells, in a non-tunable manner.
Figure 2 | AcrIIC1Nme-mediated inhibition of ThermoCas9- and G eoCas9-based 
targeting in E. coli DH 10B_gfp (dual-vector system). a) Schematic illustration of the dual-
vector strategy for AcrIIC1Nme-mediated inhibition of ThermoCas9- and GeoCas9-based 
targeting in E. coli DH10B_gfp. The pCas9 plasmid was used forthe expression of the ThermoCas9/
GeoCas9 nuclease and its respective sgRNA to target and cleave specific sites on the genome of E. coli
DH10B_gfp (either at the genome-integrated gfp gene or its promoter, PlacUV5). The Cas9-inhibitor 
AcrIIC1Nme was expressed from the pAcr plasmid in the same strain. b) Results of the 
AcrIIC1Nme-mediated inhibition assay of ThermoCas9-based targeting. c) Results of the AcrIIC1Nme-
mediated inhibition assay of GeoCas9-based targeting.
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THE THERMOCAS9/GEOCAS9:ACRIIC1NME COMPLEXES MEDIATE GENE 
SILENCING IN E. COLI
In this part of the study, we set off to verify the hypothesis that in vivo binding of AcrIIC1Nme 
to the HNH domain of ThermoCas9, and GeoCas9 transforms the enzymes into a DNA-
bound but catalytically inactive form, with similar activity to the catalytically inactive 
ThermoCas9D8A,H582A (Thermo-dCas9) and GeoCas9D8A,H582A (Geo-dCas9) variants. For this 
purpose, we repeated the transformations of the E. coli DH10B_gfp(pAcr) strain with the 
pTCas9_sp3 and pGCas9_sp1 and 2 plasmids. We simultaneously constructed variations of 
the same plasmids containing the thermo-dcas9 and geo-dCas9 genes instead of the active 
variants and transformed them to E. coli DH10B_gfp. We then used the transformation 
mixtures to inoculate media with a variety of IPTG concentrations, aiming to achieve 
different induction levels of ThermoCas9, GeoCas9, Thermo-dCas9 and Geo-dCas9 
expression (Fig. 4), and we executed flow cytometry-based fluorescence loss assays. The E. 
coli DH10B(pUC19, pACYC184) and E. coli DH10B(pACYC184) strains were employed as 
the no-fluorescence control strains of the assays, while the E. coli DH10B_gfp(pUC19, 
pACYC184), E. coli DH10B_i(pACYC184), E. coli DH10B_gfp(pAcr, pTCas9_spscr), E. 
coli DH10B_gfp(pAcr, pTCas9L551H_spscr), E. coli DH10B_gfp(pAcr, pGCas9_spscr), E. 
coli DH10B_gfp(pT-dCas9_spscr), and E. coli DH10B_gfp(pG-dCas9_spscr) strains were 
used as the fluorescence control strains.
The results of the flow cytometry-based fluorescence loss assays revealed the 
transcriptional silencing effect of the ThermoCas9-AcrIIC1Nme complexes. The fluorescence 
intensity of the E. coli DH10B_gfp_AcrIIC1Nme cells transformed with the pTCas9_sp3 
plasmid, under non-induced conditions, was ~77% less than the detected fluorescence 
intensity for the E. coli DH10B_gfp(pAcr, pTCas9_spscr) control strain (Fig. 3a; Sup. Fig. 
6a). When ThermoCas9 expression was induced with 1 - 50 μM IPTG, a gradual decrease of 
the GFP signal was observed, while IPTG concentrations ≥ 50 μM resulted in complete loss 
of fluorescence. Similar results were obtained when the E. coli DH10B_gfp(pAcr) cells were 
transformed with the pTCas9L551H_sp3 plasmid, suggesting that the stability of the 
ThermoCas9-AcrIIC1Nme complex is not significantly impaired by the lack of a positively 
charged amino-acid at the residue-position 551 of the protein. In comparison, after 
transformation of E. coli DH10B_gfp cells with the pT-dCas9_sp3 plasmid under non-
induced conditions, absolute fluorescence loss was observed (Fig. 3b; Sup. Fig. 8a). Hence, 
the ThermoCas9-AcrIIC1Nme, and the ThermoCas9L551H-AcrIIC1Nme complexes mediated sile-
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previously described flow cytometry-based fluorescence loss assays (Sup. Fig. S9), 
indicating the uniform effect of the tool to all the cells. Furthermore, we repeated the
described fluorescence loss assays employing a spectrophotometer-based approach obtaining
similar outcomes (Sup. Fig. S10; S11; S12). 
Figure 3 | Comparison of the ThermoCas9/G eoCas9:AcrIIC1Nme-based and the Thermo-dCas9/G eo-dCas9-
based silencing in E. coli DH 10B_gfp (flow cytometry-based fluorescence loss assays). a) 
Thermo Cas9:AcrIIC1Nme-mediated silencing/fluorescence downregulation assays in E. coli DH10B_gfp
cells harbouring either the pTCas9_sp3 or the pTCas9_scr vectors. b) ThermodCas9-mediated silencing/
fluorescence downregulation assays in E. coli DH10B_gfp cells harbouring either the pT-dCas9_sp3 or the 
pT-dCas9_scr vectors. c) GeoCas9:AcrIIC1Nme-mediated silencing/fluorescence downregulation assays in E. coli
DH10B_gfp cells harbouring either the pGCas9_sp1 or the pGCas9_sp2 or the pGCas9_scr vectors. b) 
GeodCas9-mediated silencing/fluorescence downregulation assays in E. coli DH10B_gfp cells harbouring either 
the pG-dCas9_sp1 or the pG-dCas9_sp2 or the pT-dCas9_scr vectors. The E. coli DH10B_gfp and the E. 
coli DH10B strains carrying the empty pACYC184 vector were used as the positive - fluorescence- 
control (PC) and the negative -no-fluorescence- control (NC) respectively for all the above described assays.
TH ERMO CAS9/G EO CAS9-ACRIIC1NME-BASED TARG ETING AND TARG ETING
INH IBITIO N IN E. COLI (SING LE-VECTO R SYSTEM) 
To simplify our system by minimizing the number of employed plasmids, we designed 
and developed a single-plasmid system for ThermoCas9/GeoCas9-AcrCII1Nme-mediated 
targeting and targeting inhibition in E. coli. To this end, we added the E. coli codon-optimized 
acrIIC1 Nme gene under the transcriptional control of the L-rhamnose-inducible promoter 
(Prha) to the previously used pTCas9_sp1/2/3/scr and pGCas9_sp1/2/3/scr. We repeated the 
ThermoCas9- and GeoCas9- targeting assays in the E. coli DH10B_gfp strain using the 
pAcr_TCas9_sp1, pAcr_TCas9_sp1/2/3/scr, and pAcr_GCas9_sp1/2/3/scr constructs 
(Fig. 4a). The pAcr_TCas9_spscr, pAcr_GCas9_spscr, and the pACYC184 plasmids were 
used as negative controls. 
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ncing of the gfp gene with the same efficiency as Thermo-dCas9 at higher induction levels, 
while at lower induction levels there was a narrow window of gradual repression.  
The results of the flow cytometry-based fluorescence loss assays based on the 
GeoCas9-related constructs revealed more tunable transcriptional silencing effects compared 
to the ThermoCas9-related constructs. After transformation of E. coli DH10B_gfp(pAcr) cells 
with the pGCas9_sp1 and 2 plasmids separately and in absence of IPTG-based GeoCas9 
expressional induction, the detected fluorescence intensity was reduced by ~21% (spacer 1) 
and ~29% (spacer 2) compared to the detected fluorescence intensity for the E. coli 
DH10B_gfp(pAcr, pGCas9_spscr) control strain (Fig. 3c; Sup. Fig. 7a). When GeoCas9 
expression was induced with 1 - 50 μM IPTG, a steady reduction of the fluorescence intensity 
was observed by ~84% (spacer 1) and ~68% (spacer 2) of the fluorescence intensity obtained 
by E. coli DH10B_gfp(pAcr, pGCas9_spscr) at 50 μM IPTG induction. No further 
fluorescence loss was observed at >50μM IPTG induction concentrations. In comparison, 
after transformation of E. coli DH10B_gfp with the pG-dCas9_sp1 and 2, separately and in 
absence of induction of Geo-dCas9 expression, the fluorescence intensity was decreased by 
~27% (spacer 1) and ~45% (spacer 2) compared to the fluorescence intensity detected in the 
E. coli DH10B_gfp(pG-dCas9_spscr) control strain (Fig. 3d; Sup. Fig. 8b). When the Geo-
dCas9 expression was induced with 1 - 50 μM IPTG, a progressive reduction of the
fluorescence intensity was observed, being reduced by ~89%(spacer 1) and ~91% (spacer 2)
of the fluorescence intensity obtained by the E. coli DH10B_gfp(pG-dCas9_spscr) control
strain at 50 μM IPTG induction. No further fluorescence loss was observed at >50μM IPTG
induction concentrations. Therefore, the GeoCas9-AcrIIC1Nme complex mediated silencing of
the gfp gene with efficiency similar to Geo-dCas9 for the spacer 1. However, regarding spacer
2, Geo-dCas9-based silencing resulted in 20% higher loss of fluorescence intensity compared
to the GeoCas9-AcrIIC1Nme complex-based silencing. Therefore, the silencing efficiencies of
the GeoCas9-AcrIIC1Nme complex and the Geo-dCas9 were proved to be spacer-dependent
but still relatively comparable.
In addition, we repeated the flow cytometry-based fluorescence loss assays for the 
E. coli DH10B_gfp(pAcr) strain transformed with the pTCas9_sp3, pTCas9L551H_sp3, and
pGCas9_sp1 and 2 plasmids, this time inducing the expression of AcrIIC1Nme via L-rhamnose
supplementation. Notably, no substantial difference was observed in the results of these
assays compared to the assays without L-rhamnose supplementation (Sup. Fig. S6b; Sup. Fig.
S7b). Moreover, single cell populations were always observed for all the previously described
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silencing of the gfp gene with the same efficiency as Thermo-dCas9 at higher induction 
levels, while at lower induction levels there was a narrow window of gradual repression.  
The results of the flow cytometry-based fluorescence loss assays based on the 
GeoCas9-related constructs revealed more tunable transcriptional silencing effects compare d
to the ThermoCas9-related constructs. After transformation of E. coli DH10B_gfp(pAcr) 
cells with the pGCas9_sp1 and 2 plasmids separately and in absence of IPTG-based 
GeoCas9 expressional induction, the detected fluorescence intensity was reduced by ~21% 
(spacer 1) and ~29% (spacer 2) compared to the detected fluorescence intensity for the 
E. coli DH10B_gfp(pAcr, pGCas9_spscr) control strain (Fig. 3c; Sup. Fig. 7a). When
GeoCas9 expression was induced with 1 - 50 μM IPTG, a steady reduction of the
fluorescence intensity was observed by ~84% (spacer 1) and ~68% (spacer 2) of the
fluorescence intensity obtained by E. coli DH10B_gfp(pAcr, pGCas9_spscr) at 50 μM IPTG
induction. No further fluorescence loss was observed at >50μM IPTG induction
concentrations. In comparison, after transformation of E. coli DH10B_gfp with the pG-
dCas9_sp1 and 2, separately and in absence of induction of Geo-dCas9 expression, the
fluorescence intensity was decreased by ~27% (spacer 1) and ~45% (spacer 2) compared to
the fluorescence intensity detected in the E. coli DH10B_gfp(pG-dCas9_spscr) control strain
(Fig. 3d; Sup. Fig. 8b). When the Geo-dCas9 expressionwas induced with 1 - 50 μM IPTG, a
progressive reduction of the fluorescence intensity was observed, being reduced by ~89%
(spacer 1) and ~91% (spacer 2) of the fluorescence intensity obtained by the E. coli
DH10B_gfp(pG-dCas9_spscr) control strain at 50 μM IPTG induction. No further
fluorescence loss was observed at >50μM IPTG induction concentrations. Therefore, the
GeoCas9-AcrIIC1Nme complex mediated silencing of thegfp gene with efficiency similar to
Geo-dCas9 for the spacer 1. However, regarding spacer 2, Geo-dCas9-based silencing
resulted in 20% higher loss of fluorescence intensity compared to the GeoCas9-AcrIIC1Nme
complex-based silencing. Therefore, the silencing efficiencies of the GeoCas9-AcrIIC1Nme
complex and the Geo-dCas9 were proved to be spacer-dependent but still relatively
comparable.
In addition, we repeated the flow cytometry-based fluorescence loss assays for the 
E. coli DH10B_gfp(pAcr) strain transformed with the pTCas9_sp3, pTCas9L551H_sp3,
and pGCas9_sp1 and 2 plasmids, this time inducing the expression of AcrIIC1Nme via L-
rhamnose supplementation. Notably, no substantial difference was observed in the results of
these assays compared to the assays without L-rhamnose supplementation (Sup. Fig. S6b;
Sup. Fig. S7b). Moreover, single cell populations were always observed for all the
flow cytometry-based fluorescence loss assays (Sup. Fig. S9), indicating the uniform effect 
of the tool to all the cells. Furthermore, we repeated the described fluorescence loss assays 
employing a spectrophotometer-based approach obtaining similar outcomes (Sup. Fig. S10; 
S11; S12). 
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Figure 3 | Comparison of the ThermoCas9/GeoCas9:AcrIIC1Nme-based and the Thermo-dCas9/Geo-
dCas9-based silencing in E. coli DH10B_gfp (flow cytometry-based fluorescence loss 
assays). a) ThermoCas9:AcrIIC1Nme-mediated silencing/fluorescence downregulation assays in E. coli 
DH10B_gfp cells harbouring either the pTCas9_sp3 or the pTCas9_scr vectors. b) ThermodCas9-mediated 
silencing/fluorescence downregulation assays in E. coli DH10B_gfp cells harbouring either the pT-
dCas9_sp3 or the pT-dCas9_scr vectors. c) GeoCas9:AcrIIC1Nme-mediated silencing/fluorescence downregulation 
assays in E. coli DH10B_gfp cells harbouring either the pGCas9_sp1 or the pGCas9_sp2 or the 
pGCas9_scr vectors. b) GeodCas9-mediated silencing/fluorescence downregulation assays in E. coli DH10B_gfp 
cells harbouring either the pG-dCas9_sp1 or the pG-dCas9_sp2 or the pT-dCas9_scr vectors. The E. coli 
DH10B_gfp and the E. coli DH10B strains carrying the empty pACYC184 vector were used as the 
positive - fluorescence- control (PC) and the negative -no-fluorescence- control (NC) respectively for all the 
above described assays.
THERMOCAS9/GEOCAS9-ACRIIC1NME-BASED TARGETING AND TARGETING 
INHIBITION IN E. COLI (SINGLE-VECTOR SYSTEM)
To  simplify our system by minimizing the number of employed plasmids,  we  designed and 
developed a single-plasmid system for ThermoCas9/GeoCas9-AcrCII1Nme-mediated targeting 
and targeting inhibition in E. coli. To this end, we added the E. coli codon-optimized 
acrIIC1Nme gene under the transcriptional control of the L-rhamnose-inducible promoter 
(Prha) to the previously used pTCas9_sp1/2/3/scr and pGCas9_sp1/2/3/scr. We repeated the 
ThermoCas9- and GeoCas9- targeting assays in the E. coli DH10B_gfp strain using the 
pAcr_TCas9_sp1, pAcr_TCas9_sp1/2/3/scr, and pAcr_GCas9_sp1/2/3/scr constructs 
(Fig. 4a). 
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Figure 4 | AcrIIC1Nme-mediated inhibition of ThermoCas9- and G eoCas9-based targeting in E. coli 
DH 10B_gfp (single-vector system). a) Schematic illustration of the single-vector strategy for AcrIIC1Nme-mediated 
inhibition ofThermoCas9- and GeoCas9-based targeting in E. coli DH10B_gfp. The pAcrCas9 plasmid was used for 
the expression of the ThermoCas9/GeoCas9 endonuclease guided by the sgRNA to target and cleave specific sites on 
the genome of E. coli DH10B_gfp. The Cas9-inhibitor, AcrIIC1Nme, was additionally expressed from the same 
plasmid. b) Results of the ThermoCas9:AcrIIC1Nme-based targeting-inhibition assays. c) Results of the 
GeoCas9:AcrIIC1Nme-based targeting-inhibition assays. The results for the assays that the AcrIIC1Nme expression was 
induced with rhamnose supplementation are depicted with dotted bars.
The pAcr_TCas9_spscr, pAcr_GCas9_spscr, and the pACYC184 plasmids were used as 
negative controls. To assess the efficiency of the ThermoCas9 targeting inhibition using the 
single plasmid system, experiments similar to the targeting assays were conducted. Initially 
the experiments were conducted without L-rhamnose supplementation and hence without 
induction of the AcrIIC1Nme expression (Fig. 4b; Sup. Fig. 13a). The transformation efficiency 
of the E. coli DH10B_gfp cells was reduced by an order of magnitude when transformed with 
the pAcr_TCas9_sp3 plasmid without IPTG-based ThermoCas9 induction. However, when 
the expression of ThermoCas9 was induced by supplementing 100 μM IPTG, the 
transformation efficiency was null. The transformation efficiencies of the cells transformed 
with the pAcr_TCas9_sp1 and pAcr_TCas9_spscr plasmid, in the absence of ThermoCas9 
induction, were similar. A progressive reduction and an absolute loss of the transformation 
efficiency was observed when cells transformed with the pAcr_TCas9_sp1 plasmid were 
supplemented with 100 μM and 1000 μM IPTG respectively. On the contrary, no suppleme-
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a plasmid upon supplementation with 1000 μM IPTG. Subsequently, the whole set of
experiments was repeated by supplementing the culture medium with 0.2% (w/v) L-
rhamnose for induction of the AcrIIC1Nme expression (Fig. 4b; Sup. Fig. 13a). The 
transformation efficiency of the cells transformed with the pAcr_TCas9_sp3 plasmi d 
increased, when compared to the corresponding experiments without L-rhamnose
supplementation, by one order of magnitude in the absence of IPTG supplementation and by 
three orders of magnitude with 100 μM IPTG supplementation (Fig. 5c). Interestingly, there 
was no loss of transformation efficiency for the cells transformed with pAcr_TCas9_sp1 and 
supplemented with L-rhamnose, even when 1000 μM of IPTG was used for the ThermoCas9 
induction. 
We proceeded with the assessment of the GeoCas9-based targeting inhibition
efficiency using the single plasmid system. The transformation efficiencies of E. coli 
DH10B_gfp cells with the pAcr_GCas9_sp1 and 2 plasmids exhibited similar efficiencies a s 
the transformation efficiencies of the cells transformed with the pAcr_GCas9_spscr 
(negative control) in the absence of the GeoCas9 induction (Fig. 4c; Sup. Fig. 13b). On the 
contrary, when using 100 μM and 1000 μM of IPTG for induction of the GeoCas9 
expression, the transformation efficiencies dropped ~2 orders of magnitude (Fig. 5d). When 
we repeated these experiments by supplementing the culture medium with 0.2% (w/v) L-
rhamnose, for induction of the AcrIIC1Nme expression, the transformation efficiencies of the
cells transformed with pAcr_GCas9_sp1 and 2 were similar to the control levels (Fig. 4c ; 
Sup. Fig. 13b). These findings imply that it is possible to achieve ThermoCas9/GeoCas9-
AcrIIC1Nme- mediated targeting and targeting inhibition in a spacer-dependent and tuneable
manner using a single plasmid system. 
DISCUSSIO N
In this study, we demonstrate that the thermostable ThermoCas9 and GeoCas9 
endonucleases are highly active in vivo at 37°C and introduce lethal DSDBs to the E. 
coli genome in a spacer-dependent manner. Moreover, the developed Cas9 systems had 
tuneable targeting efficiencies, as the general trend for efficiently targeted spacers was 
that upon ascending ThermoCas9 and GeoCas9 expression levels, the E. coli 
transformation efficiencies were proportionally descending. We also report that the 
AcrIIC1Nme protein efficiently hinders the DNA targeting activity of ThermoCas9 and 
GeoCas9, trapping them in a DNA-bound and catalytically inactive condition. It 
was also shown that the ThermoCas9/GeoCas9-AcrIIC1Nme complexes can efficiently 
knock-down the in vivo and the silencing effect was proved to be spacer-dependent, tuneable
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Figure 4 | AcrIIC1Nme-mediated inhibition of ThermoCas9- and G eoCas9-based targeting in E. 
coli DH 10B_gfp (single-vector system). a) Schematic illustration of the single-vector strategy for AcrIIC1Nme-
mediated inhibition ofThermoCas9- and GeoCas9-based targeting in E. coli DH10B_gfp. The pAcrCas9 plasmid 
was used for the expression of the ThermoCas9/GeoCas9 endonuclease guided by the sgRNA to target and cleave 
specific sites on the genome of E. coli DH10B_gfp. The Cas9-inhibitor, AcrIIC1Nme, was additionally expressed from 
the same plasmid. b) Results of the ThermoCas9:AcrIIC1Nme-based targeting-inhibition assays. c)
Results of the GeoCas9:AcrIIC1Nme-based targeting-inhibition assays. The results for the assays that the 
AcrIIC1Nme expression was induced with rhamnose supplementation are depicted with dotted bars.
To assess the efficiency of the ThermoCas9 targeting inhibition using the single plasmid 
system, experiments similar to the targeting assays were conducted. Initially the experiments 
were conducted without L-rhamnose supplementation and hence without induction of the 
AcrIIC1Nme expression (Fig. 4b; Sup. Fig. 13a). The transformation efficiency of the E. coli 
DH10B_gfp cells was reduced by an order of magnitude when transformed with the 
pAcr_TCas9_sp3 plasmid without IPTG-based ThermoCas9 induction. However, when the 
expression of ThermoCas9 was induced by supplementing 100 μM IPTG, the transformation 
efficiency was null. The transformation efficiencies of the cells transformed with the 
pAcr_TCas9_sp1 and pAcr_TCas9_spscr plasmid, in the absence of ThermoCas9 induction, 
were similar. A progressive reduction and an absolute loss of the transformation 
efficiency was observed when cells transformed with the pAcr_TCas9_sp1 plasmid were 
supplemented with 100 μM and 1000 μM IPTG respectively. On the contrary, no loss of 
transformation efficiency was detected for the cells transforme d with the pAcr_TCas9_sp2
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ntation with 1000 μM IPTG. Subsequently, the whole set of experiments was repeated by 
supplementing the culture medium with 0.2% (w/v) L-rhamnose for induction of the 
AcrIIC1Nme expression  (Fig. 4b; Sup. Fig. 13a). The transformation efficiency of the cells 
transformed with the pAcr_TCas9_sp3 plasmi d increased, when compared to the 
corresponding experiments without L-rhamnose supplementation, by one order of magnitude 
in the absence of IPTG supplementation and by three orders of magnitude with 100 μM IPTG 
supplementation (Fig. 5c). Interestingly, there was no loss of transformation efficiency for the 
cells transformed with pAcr_TCas9_sp1 and supplemented with L-rhamnose, even when 1000 
μM of IPTG was used for the ThermoCas9 induction. 
We proceeded with the assessment of the GeoCas9-based targeting inhibition 
efficiency using the single plasmid system. The transformation efficiencies of E. coli 
DH10B_gfp cells with the pAcr_GCas9_sp1 and 2 plasmids exhibited similar  efficiencies as 
the transformation efficiencies of the cells transformed with the pAcr_GCas9_spscr (negative 
control) in the absence of the GeoCas9 induction (Fig. 4c; Sup. Fig. 13b). On the contrary, 
when using 100 μM and 1000 μM of IPTG for induction of the GeoCas9 expression, the 
transformation efficiencies dropped ~2 orders of magnitude (Fig. 5d). When we repeated 
these experiments by supplementing the culture medium with 0.2% (w/v) L-rhamnose, for 
induction of the AcrIIC1Nme expression, the transformation efficiencies of the cells 
transformed with pAcr_GCas9_sp1 and 2 were similar to the control levels (Fig. 4c ; Sup. 
Fig. 13b). These findings imply that it is possible to achieve ThermoCas9/GeoCas9-
AcrIIC1Nme- mediated targeting and targeting inhibition in a spacer-dependent and tuneable 
manner using a single plasmid system. 
DISCUSSION
In this study, we demonstrate that the thermostable ThermoCas9 and GeoCas9 
endonucleases are highly active in vivo at 37°C and introduce lethal DSDBs 
to the E. coli genome in a spacer-dependent manner. Moreover, the developed Cas9 
systems had tuneable targeting efficiencies, as the general trend for efficiently targeted 
spacers was that upon ascending ThermoCas9 and GeoCas9 expression  the levels E. coli 
transformation efficiencies were proportionally descending. We also report that the 
AcrIIC1Nme protein efficiently hinders the DNA targeting activity of ThermoCas9 and 
GeoCas9, trapping them in a DNA-bound and catalytically inactive condition. It was 
also shown that the ThermoCas9/GeoCas9-AcrIIC1Nme complexes can efficiently knock-
down the in vivo and the silencing effect was proved to be spacer-dependent, tuneable and
174
Chapter 6
comparable to the silencing effect of the catalytically inactive ("dead") variants Thermo-
dCas9 and Geo-dCas9, for the same targets. Finally, we created a single-vector-based, 
highly efficient Cas9/AcrIIC1Nme-based approach for tuneable bacterial genome 
targeting and targeting inhibition, and we envision to further explore the potential of this tool 
by developing a tightly controllable sequential bacterial silencing and editing tool. 
The vast majority of the currently developed Cas9-based bacterial genome editing 
tools are based on the introduction of the desired modifications in a genome via double cross 
over events of plasmid-borne homologous recombination (HR) templates, followed by Cas9-
based counter-selection of the non-mutated cells10-12. The limitation of this approach, for the 
majority of microorganisms, is that the Cas9-based introduction of lethal DSDBs  often 
precedents the incorporation of the desired modifications in a genome, resulting in the 
dramatic reduction of the surviving mutants number. This can be attributed either to the lack 
of tightly controlled promoter systems for the microorganisms or to low native HR 
efficiencies. A solution employed for bacteria with more than 1 plasmid in their genetic 
toolbox follows a two-step approach. The cells are initially transformed with a plasmid that 
carries the HR flanks, then cells that have incorporated the plasmid via a single cross over 
(SCO) event are selected and retransformed with a second plasmid that carries the cas9 gene 
and is responsible for the elimination of the non-mutated cells. In this context, a highly 
controllable and generally applicable Cas9 expression system would be valuable for the 
development of an “all-in-one plasmid” system, without simultaneously compromising the 
tool’s efficiency. For this purpose, we aim to create a system for which the thermocas9 or 
geocas9 gene, the acrIIC1Nme gene and the HR flanks that carry the desired modifications will 
be introduced into the same plasmid. In this system, the thermocas9 or geocas9 gene can be 
set under the transcriptional control of a constitutive, species-specific promoter, while a 
ribozyme with induced self-splicing capacity can be inserted into the selected cas9 gene, 
disrupting its coding sequence. The probable expressional leakiness of the ThermoCas9 or 
GeoCas9 expression in the absence of the splicing inducer, which can still be enough to 
efficiently introduce lethal DSDBs, will be counteracted by AcrIIC1Nme, the gene of which 
will also be under the transcriptional control of a constitutive promoter. This system will 
allow for efficient introduction of the desired modifications into the genome via HR of the 
plasmid-borne HR template. Subsequently, the splicing-inducer supplementation will result in 
the maturation of mRNAs, leading to ThermoCas9/GeoCas9 expression levels that prevail 
over the antiCRISPR-mediated inhibition, allowing the endonuclease to act as a stringent cou-
mRNAs, leading to ThermoCas9/GeoCas9 expression levels that 
prevail over the antiCRISPR-mediated inhibition, allowing the endonuclease to
act as a stringent counter-selection system. We plan to establish the proof of 
principle approach in E. coli. 
Harnessing the flexibility of the here described antiCRISPR-
based technology, this system may be further programmed for base-editing 
purposes that enable gene inactivation in prokaryotes, without the need of repair 
templates or sacrifice of the transformation efficiency. Inspired by the creation 
of premature stop codons in the genome of E. coli66,67, Brucella 
melitensis67, Staphylococcus aureus 68, Corynebacterium glutamicum69, 
and several Pseudomonas species70 employing a fusion of catalytically
inactivated or nickase SpyCas9 and cytidine deaminase (PmCDA1; APOBEC1) that 
converts cytosine (C) to uracil (U) at spacer-targeted sites without DSDBs, 
active Thermo-Cas9/GeoCas9-AcrIIC1Nme may be applied instead of the 
catalytically deficient SpyCas9 variants to broaden the spectrum of DNA
targets (different PAMs) and reduce the off-target effects (stringent PAM recognition 
at 37°C). As such, a ThermoCas9/GeoCas9-cytidine deaminase fusion can be
generated and trapped by AcrIIC1Nme in a Cas9-catalytically inactive state on 
the DNA target, allowing the generation of premature stop codons. As an added value, 
our system will not require ancillary proteins, as in previous studies, to enhance the 
base editing efficiency at screenable levels, as upon induction of the ThermoCas9/
GeoCas9 expression at levels that surpass the AcrIIC1Nme counter-acting function, 
counter-selection in favour of the mutated cells can take efficiently place. Taking an 
even larger flight in the burgeoning field of genetic tool development, this 
antiCRISPR-based system may be further customized for a broad-range of 
microorganisms for multiplexed and sequential editing, silencing, gene inactivation or 
even base-editing in promoter sequences and small RNA-coding regions.
The demand for tightly controlled and precise CRISPR-based genome 
editing and regulation tools is higher than ever. The pace and scale at which 
novel CRISPR-Cas endonucleases are characterized, engineered and exploited as 
advanced molecular scissors is exponentially increasing. Newly discovered
antiCRISPR proteins may serve as powerful natural "off-switches" of these 
nucleases, essentially diminishing the Achilles’ heel of the CRISPR-Cas systems 
and launching the prokaryotic genome engineering field. The development 
of an exchangeable genome editing and regulation tool, universally
applicable to academically and industrially relevant bacteria, is now closer 
than ever before. 
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and comparable to the silencing effect of the catalytically inactive ("dead") 
variants Thermo-dCas9 and Geo-dCas9, for the same targets. Finally, we created 
a single-vector-based, highly efficient Cas9/AcrIIC1Nme-based approach for 
tuneable bacterial genome targeting and targeting inhibition, and we envision to
further explore the potential of this tool by developing a tightly controllable sequential 
bacterial silencing and editing tool. 
The vast majority of the currently developed Cas9-based bacterial genome 
editing tools are based on the introduction of the desired modifications in a 
genome via double cross over events of plasmid-borne homologous recombination 
(HR) templates, followed by Cas9-based counter-selection of the non-mutated cells10-12. 
The limitation of this approach, for the majority of microorganisms, is that the Cas9-
based introduction of lethal DSDBs often precedents the incorporation of the 
desired modifications in a genome, resulting in the dramatic reduction of the 
surviving mutants number. This can be attributed either to the lack of tightly 
controlled promoter systems for the microorganisms or to low native HR efficiencies. 
A solution employed for bacteria with more than 1 plasmid in their genetic toolbox 
follows a two-step approach. The cells are initially transformed with a plasmid that 
carries the HR flanks, then cells that have incorporated the plasmid via a single 
cross over (SCO) event are selected and retransformed with a second plasmid that 
carries the cas9 gene and is responsible for the elimination of the non-mutated cells. 
In this context, a highly controllable and generally applicable Cas9 expression 
system would be valuable for the development of an “all-in-one plasmid” system, 
without simultaneously compromising the tool’s efficiency. For this purpose, we 
aim to create a system for which the thermocas9 or geocas9 gene, the acrIIC1 Nme
gene and the HR flanks that carry the desired modifications will be introduced
into the same plasmid. In this system, the thermocas9 or geocas9 gene can be set 
under the transcriptional control of a constitutive, species-specific promoter, while a 
ribozyme with induced self-splicing capacity can be inserted into the selected cas9 
gene, disrupting its coding sequence. The probable expressional leakiness of the 
ThermoCas9 or GeoCas9 expression in the absence of the splicing inducer, which
can still be enough to efficiently introduce lethal DSDBs, will be counteracted by 
AcrIIC1Nme, the gene of which will also be under the transcriptional control of a 
constitutive promoter. This system will allow for efficient introduction of the desired 
modifications into the genome via HR of the plasmid-borne HR template. Subsequently, the 
splicing-inducer supplementation will result in the maturati on of thethermocas9 and geocas9
nter-selection system. We plan to establish the proof of principle approach in E. coli. 
Harnessing the flexibility of the here described antiCRISPR-based technology, 
this system may be further programmed for base-editing purposes that enable gene 
inactivation in prokaryotes, without the need of repair templates or sacrifice of the 
transformation efficiency. Inspired by the creation of premature stop codons in the 
genome of E. coli66,67, Brucella melitensis67, Staphylococcus aureus68, Corynebacterium 
glutamicum69 and several Pseudomonas species70, employing a fusion of catalytically 
inactivated or nickase SpyCas9 and cytidine deaminase (PmCDA1; APOBEC1) that converts 
cytosine (C) to uracil (U) at spacer-targeted sites without DSDBs, active Thermo-Cas9/
GeoCas9-AcrIIC1Nme may be applied instead of the catalytically deficient SpyCas9 variants 
to broaden the spectrum of DNA targets (different PAMs) and reduce the off-target effects 
(stringent PAM recognition at 37°C). As such, a ThermoCas9/GeoCas9-cytidine deaminase 
fusion can be generated and trapped by AcrIIC1Nme in a Cas9-catalytically inactive state on 
the DNA target, allowing the generation of premature stop codons. As an added value, our 
system will not require ancillary proteins, as in previous studies,  to enhance the base editing 
efficiency at screenable levels, as upon induction of the ThermoCas9/GeoCas9 expression at 
levels that surpass the AcrIIC1Nme counter-acting function, counter-selection in favor of the 
mutated cells can take efficiently place. Taking an even larger flight in the burgeoning field of 
genetic tool development, this antiCRISPR-based system may be further customized for a 
broad-range of microorganisms for multiplexed and sequential editing, silencing, gene 
inactivation or even base-editing in promoter sequences and small RNA-coding regions.
The demand for tightly controlled and precise CRISPR-based genome editing and 
regulation tools is higher than ever. The pace and scale at which novel CRISPR-Cas 
endonucleases are characterized, engineered and exploited as advanced molecular scissors is 
exponentially increasing. Newly discovered antiCRISPR proteins may serve as powerful 
natural "off-switches" of these nucleases, essentially diminishing the Achilles’ heel of the 
CRISPR-Cas systems and launching the prokaryotic genome engineering field. The 
development of an exchangeable genome editing and regulation tool, universally applicable to 
academically and industrially relevant bacteria, is now closer than ever before. 
176
Chapter 6
biological triplicates and used for calculating the transformation efficiencies. Similar 
approach was used to assess the targeting efficiency for the GeoCas9 variants. The plasmids 
pGCas9_sp1, pGCas9_sp2, pGCas9_sp3, pGCas9_spscr were used for assessing the 
targeting efficiency by GeoCas9 following the same approach as described above. 
INH IBITIO N ASSAYS (DUAL-VECTO R SYSTEM)
L-rhamnose was added during the preparation of the chemically competent E. coli
DH10B_gfp cells to ensure the induction of the expression of the AcrIIC1Nme. To inhibit
targeting of the bacterial genomic DNA using the dual-vector system, E. coli DH10B_gfp
cells(pAcr) were transformed71 with equal amounts (5 ng) of plasmids expressing a spacer
that targets the start of the gfp gene along with an either wild-type ThermoCas9
(pTCas9_sp3) or the mutant ThermoCas9L551H (pTCas9L551H_sp3). As controls, 5 ng of non-
targeting plasmids (pTCas9_spscr, pTCas9L551H_spscr) and the empty vectors (pACYC184,
pUC19) were used. In the cases, where the inducers were used (IPTG, L-rhamnose), they
were supplemented in the recovery medium after the heat-shock. Transformed cells were
grown on LB agar supplemented with ampicillin (100 μg/ml), chloramphenicol (15 μg/mL),
different IPTG concentrations (0 - 1000 μM), and L-rhamnose (0 or 0.2%) for 17 h at 37°C.
Colony forming units (CFUs) were counted after plating undiluted biological triplicates and
used for calculating the transformation efficiencies. Similar approach as above was used to
assess the target inhibition efficiency for the GeoCas9 variants using the pGCas9_sp1,
pGCas9_sp2, pGCas9_sp3, pGCas9_spscr plasmids.
SPECTRO PH O TO METRY-BASED FLUO RESCENCE LO SS ASSAYS
To quantify the fluorescence loss, E. coli DH10B_gfp cells harbouring an AcrIIC1Nme-
expressing plasmid (pAcr) were transformed71 with equal amounts (5 ng) of plasmids
expressing a spacer that targets the start of the gfp gene and either wild-type ThermoCas9
(pTCas9_sp3) or the mutant ThermoCas9L551H (pTCas9L551H_sp 3). As positive control, 5 ng
of the empty vectors (pACYC184, pUC19) were used, while as negative controls 5 ng of the
non-targeting plasmids (pTCas9_spscr, pTCas9L551H_spscr) and commercial E. coli DH10B
cells (NEB) electroporated with 100 ng of empty vectors (pACYC184, pUC19), were used.
Post-transformation, 2 μl of recovered cells were cultured in 198 μl M9TG containing
ampicillin (100 μg/ml) and chloramphenicol (15 μg/mL) in a Masterblock® 96-well deep
microplate (Greiner Bio-One) for 22 h at 37°C with vigorous shaking (900 rpm). The second
day, 2 μl of the overnight cultures were diluted in 198 μl M9TG containing the same
antibiotics, and 2 μl of these were re-diluted in 198 μl M9TG with the antibiotics along with
the appropriate concentrations of IPTG (0 - 1000 μM) and L-rham nose (0 or 0.2%) in a
METHODS 
BACTERIAL STRAINS AND GROWTH CONDITIONS
Bacterial strains used in this study are listed in Sup. Table S3. All E. coli strains were 
cultured in Luria-Bertani broth (LB) or on LB agar plates, supplemented with 
chloramphenicol (15 μg/ml), and/or ampicillin (100 μg/ml). L-rhamnose (0.2%), and/or 
IPTG (0 - 1000 μM) were additionally used for inducing the expression of the anti-
CRISPR and ThermoCas9/GeoCas9, respectively. For the fluorescence loss and flow 
cytometry assays, M9TG (11.28 g 1X M9 salts, 10 g tryptone, 5 g glycerol) medium was 
used instead of LB.
CONSTRUCTION OF PLASMIDS
Plasmids, primers/oligonucleotides, and Cas9/anti-CRISPR genes used in this study are 
presented in Supplementary Table S2, S4, and S5, respectively. The plasmids were 
constructed using the NEBuilder HiFi DNA Assembly Cloning Kit (NEB). The fragments 
for assembling the plasmids were obtained through PCR with Q5® High-Fidelity 2X 
Master Mix (NEB). The PCR products were run on a 0.8 % agarose gel and were 
subsequently purified using Zymogen gel DNA recovery kit (Zymo Research). The 
assembled plasmids were transformed to chemically competent E. coli DH5α cells71 and 
plated on LB agar containing chloramphenicol (15 μg/ml) or ampicillin (100 μg/ml)  and 
grown overnight at 37 ˚C  The next day, single colonies were inoculated in LB medium, 
grown overnight at 37 ˚C and the plasmids were isolated using the GeneJet plasmid 
Miniprep kit (ThermoFisher Scientific). All the constructs were verified using Sanger 
sequencing (Macrogen). Description of the assembled fragments used for the construction 
of each plasmid is detailed in Supplementary Table S2. For annealing of oligos to create 
dsDNA used in the plasmid assembly, 4 μl oligonucleotide pairs (100 μM each) were 
mixed in Milli-Q water to a final volume of 100 μl, heated at 95°C for 5 min, and slowly 
cooled to room temperature.
TARGETING ASSAYS
To target bacterial DNA, chemically competent E. coli DH10B cells71 harbouring a 
genome-integrated gfp gene under the transcriptional control of PlacUV5 (E. coli 
DH10B_gfp) were transformed71 with equal amounts (3 ng) of  the different plasmids. 
These variants include the plasmid expressing ThermoCas9 and a spacer targeting 
the -10 sequence of PlacUV5 (pTCas9_sp1), the region immediately after the -10 
sequence (pTCas9_sp2) or the start of the gfp gene (pTCas9_sp3). As controls, 3 ng of a 
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METH O DS 
BACTERIAL STRAINS AND G RO WTH CO NDITIO NS
Bacterial strains used in this study are listed in Sup. Table S3. All E. coli strains were 
cultured in Luria-Bertani broth (LB) or on LB agar plates, supplemented with
chloramphenicol (15 μg/ml) , and/or ampicillin (100 μg/ml).L-rhamnose (0.2%), and/or IPTG 
(0 - 1000 μM) were additionally used for inducing the expression of the anti-CRISPR and 
ThermoCas9/GeoCas9, respectively. For the fluorescence loss and flow cytometry assays, 
M9TG (11.28 g 1X M9 salts, 10 g tryptone, 5 g glycerol) medium  was used instead of LB. 
CO NSTRUCTIO N OF PLASMIDS
Plasmids, primers/oligonucleotides, and Cas9/anti-CRISPR genes used in this study are 
presented in Supplementary Table S2, S4, and S5, respectively. The plasmids were 
constructed using the NEBuilder HiFi DNA Assembly Cloning Kit (NEB). The fragments 
for assembling the plasmids were obtained through PCR with Q5® High-Fidelity 2X Master 
Mix (NEB). The PCR products were run on a 0.8 % agarose gel and were subsequently 
purified using Zymogen gel DNA recovery kit (Zymo Research). The assembled plasmids 
were transformed to chemically competentE. coli DH5α cells71 and plated on LB agar 
containing chloramphenicol (15 μg/ml) or ampicillin (100 μg/ml) and grown overnight at 37 
˚C The next day, single colonies were inoculated in LB medium, grown overnight at 37 ˚C 
and the plasmids were isolated using the GeneJet plasmid Miniprep kit (ThermoFisher 
Scientific). All the constructs were verified using Sanger sequencing (Macrogen). 
Description of the assembled fragments used for the construction of each plasmid is detailed 
in Supplementary Table S2. For annealing of oligos to create dsDNA used in the plasmid 
assembly, 4 μl oligonucleotide pairs (100 μM each) were mixed in Milli-Q water to a final 
volume of 100 μl, heated at 95°C for 5 min, and slowly cooled t o room temperature. 
TARG ETING ASSAYS
To target bacterial DNA, chemically competentE. coli DH10B cells71 harbouring a genome-
integrated gfp gene under the transcriptional control of PlacUV5 (E. coli DH10B_gfp) were 
transformed71 with equal amounts (3 ng) of the different plasmids. These variants include the 
plasmid expressing ThermoCas9 and a spacer targeting the -10 sequence of PlacUV5
(pTCas9_sp1), the region immediately after the -10 sequence (pTCas9_sp2) or the start of the 
gfp gene (pTCas9_sp3). As controls, 3 ng of a non-targeting plasmid (pTCas9_spscr) and the 
empty vector (pACYC184) were used. Transformed cells were cultured on LB agar 
supplemented with chloramphenicol (15 μg/mL) and different IPTG concentrations (0 - 1000
μM) for 17 h at 37°C. Colony forming units (CFUs) were counte d after plating undiluted
non-targeting plasmid (pTCas9_spscr) and the empty vector (pACYC184) were used. 
Transformed cells were cultured on LB agar supplemented with chloramphenicol (15 μg/
mL) and different IPTG concentrations (0 - 1000 μM) for 17 h at 37°C. Colony forming 
units (CFUs) were counted after plating undilutedbiological triplicates and used for 
calculating the transformation efficiencies. Similar approach was used to assess the 
targeting efficiency for the GeoCas9 variants. The plasmids pGCas9_sp1, pGCas9_sp2, 
pGCas9_sp3, pGCas9_spscr were used for assessing the targeting efficiency by GeoCas9 
following the same approach as described above.
INHIBITION ASSAYS (DUAL-VECTOR SYSTEM)
L-rhamnose was added during the preparation of the chemically competent E. coli
DH10B_gfp cells to ensure the induction of the expression of the AcrIIC1Nme. To inhibit
targeting of the bacterial genomic DNA using the dual-vector system, E. coli DH10B_gfp
cells(pAcr) were transformed71 with equal amounts (5 ng) of plasmids expressing a spacer
that targets the start of the gfp gene along with an either wild-type ThermoCas9
(pTCas9_sp3) or the mutant ThermoCas9L551H (pTCas9L551H_sp3). As controls, 5 ng of
non-targeting plasmids (pTCas9_spscr, pTCas9L551H_spscr) and the empty vectors
(pACYC184, pUC19) were used. In the cases, where the inducers were used (IPTG, L-
rhamnose), they were supplemented in the recovery medium after the heat-shock.
Transformed cells were grown on LB agar supplemented with ampicillin (100 μg/ml),
chloramphenicol (15 μg/mL), different IPTG concentrations (0 - 1000 μM), and L-
rhamnose (0 or 0.2%) for 17 h at 37°C. Colony forming units (CFUs) were counted after
plating undiluted biological triplicates and used for calculating the transformation
efficiencies. Similar approach as above was used to assess the target inhibition efficiency
for the GeoCas9 variants using the pGCas9_sp1, pGCas9_sp2,
pGCas9_sp3, pGCas9_spscr plasmids.
SPECTROPHOTOMETRY-BASED FLUORESCENCE LOSS ASSAYS
To quantify the fluorescence loss, E. coli DH10B_gfp cells harbouring an
AcrIIC1Nme-expressing plasmid (pAcr) were transformed71 with equal amounts (5 ng)
of plasmids expressing a spacer that targets the start of the gfp gene and either wild-type
ThermoCas9 (pTCas9_sp3) or the mutant ThermoCas9L551H (pTCas9L551H_sp 3). As
positive control, 5 ng of the empty vectors (pACYC184, pUC19) were used, while as
negative controls 5 ng of the non-targeting plasmids (pTCas9_spscr, pTCas9L551H_spscr)
and commercial E. coli DH10B cells (NEB) electroporated with 100 ng of empty vectors
178
Chapter 6
FLO W CYTO METRY-BASED FLUO RESCENCE LO SS ASSAYS
To verify the levels of fluorescence loss and investigate the presence of sub-populations in all 
samples, the same protocol as the fluorescence loss assayswas followed, with the only 
difference that on the third day 2 μl of overnight cultures were diluted in 998 μl 1X PBS in a 
Masterblock® 96-well deep microplate (Greiner Bio-One). The fluorescence signal and the 
presence of subpopulations were examined using the Attune NxT Flow Cytometer device 
(Thermo Fisher Scientific) (GFP intensity 405-512/25 of 30,000 single cells per sample). 
INH IBITIO N ASSAYS (SING LE-VECTO R SYSTEM)
To inhibit targeting of the genomic DNA using the single-vector system, E. coli DH10B_gfp
cells were transformed71 with equal amounts (5 ng) of plasmids expressing AcrIIC1Nme, 
ThermoCas9, and a spacer that targets the -10 sequence of PlacUV5 (pAcr_TCas9_sp1), the 
region immed iately after the-10 sequence (pAcr_TCas9_sp2) or the start of the gfp gene 
(pAcr_TCas9_sp3). As controls, 5 ng of a non-targeting plasmid (pAcr_TCas9_spscr) and 
the empty vector (pACYC184) were used. Transformed cells were grown on LB agar 
supplemented with chloramphenicol (15 μg/mL), different IPTG concentrations (0 - 1000 
μM), and L-rhamnose (0 or 0.2%) for 17 h at 37°C. In the cases, where inducers were used 
(IPTG, L-rhamnose), they were supplemented in the recovery media after transformation. 
CFUs were counted after plating undiluted biological triplicates, and used for calculating the 
transformation efficiencies. The single plasmids, pAcr_GCas9_sp1, pAcr_GCas9_sp2, 
pAcr_GCas9_sp3, pAcr_GCas9_spscr were used for assessing the inhibition by GeoCas9 
following the same approach as described above. 
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(pACYC184, pUC19),were used. Post-transformation, 2 μl of recovered cells were cultured 
in 198 μl M9TG containing ampicillin (100 μg/ml) and chloramphenicol (15 μg/mL) in a 
Masterblock®  96-well deep microplate (Greiner Bio-One) for 22 h at 37°C with vigorous 
shaking (900 rpm). The second day, 2 μl of the overnight cultures were diluted in 198 μl 
M9TG containing the same antibiotics, and 2 μl of these were re-diluted in 198 μl M9TG 
with the antibiotics along with the appropriate concentrations of IPTG (0 - 1000 μM) and L-
rhamnose (0 or 0.2%) in aMasterblock® 96-well deep microplate (Greiner Bio-One), and 
incubated for 22 h at 37°C with vigorous shaking (900 rpm). The third day, 40 μl of 
overnight cultures were diluted i n 160 μl 1X PBS (8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4 
2H2O, 0.24 g KH2PO4; pH=6.8) in a Greiner CELLSTAR® 96-well plate (Greiner Bio-One), 
and 100 μl of these dilutions were transferred 96-well clear bottom black microplate 
(CorningTM). The OD600s and the fluorescence signal (GFP:395,508) were measured with a 
SynergyMx Monochromator-Based Multi-Mode Microplate reader (BioTek). Similar 
approach as above was used to assess the target inhibition efficiency for the GeoCas9 
variants using the pGCas9_sp1, pGCas9_sp2, pGCas9_sp3, pGCas9_spscr plasmids. 
For the comparison of the silencing of the GFP using the Thermo/GeoCas9:AcrIINme 
to that of the dead variants, E. coli DH10B_gfp cells were heat-transformed71 with equal 
amounts (3 ng) of the different plasmids. These variants include the plasmid expressing 
Thermo_dCas9 and a spacer targeting the -10 sequence of PlacUV5 (pT-dCas9_sp1), the 
region immediately after the -10 sequence (pT-dCas9_sp2) or the start of the gfp gene (pT-
dCas9_sp3). As a positive control, 3 ng of empty vector (pACYC184) was used while as 
negative controls 3 ng of the non-targeting plasmid (pT-dCas9_spscr) and commercial E. 
coli DH10B cells (NEB) harbouring the empty vector (pACYC184) were used. Post-
transformation, 2 μl of the recovered cells were cultured in 198 μl M9TG containi ng 
chloramphenicol (15 μg/mL) in a Masterblock® 96-well deep microplate (Greiner Bio-One) 
for 22 h at 37°C with vigorous shaking (900 rpm). The second day, 2 μl of overnight cultures 
were diluted in 198 μl M9TG containing the same antibiotic, and 2 μl of these were re-
diluted in 198 μl M9TG with antibiotic and IPTG (0 - 1000 μM) in a Masterblock® 96-well 
deep micro-plate (Greiner Bio-One), and incubated for 22 h at 37°C with vigorous shaking 
(900 rpm). The third day, 40 μl of overnight cultures were diluted in 160 μl 1X PBS in a 
Greiner CELLSTAR® 96-well plate (Greiner Bio-One), and 100 μl of these dilutions were 
transferred 96-well clear bottom black microplate (CorningTM). The OD600s and the 
fluorescence signal (GFP:395,508) of the cultures were measured with a SynergyM 
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Masterblock® 96-well deep microplate (Greiner Bio-One), and incubated for 22 h at 37°C
with vigorous shaking (900 rpm). The third day, 40 μl of overnight cultures were diluted i n
160 μl 1X PBS (8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4 2H2O, 0.24 g KH2PO4; pH=6.8) in a 
Greiner CELLSTAR® 96-well plate (Greiner Bio-One), and 100 μl of these dilutions were 
transferred 96-well clear bottom black microplate (CorningTM). The OD600s and the 
fluorescence signal (GFP:395,508) were measured with a SynergyMx Monochromator-
Based Multi-Mode Microplate reader (BioTek). Similar approach as above was used t o
assess the target inhibition efficiency for the GeoCas9 variants using the pGCas9_sp1, 
pGCas9_sp2, pGCas9_sp3, pGCas9_spscr plasmids. 
For the comparison of the silencing of the GFP using the Thermo/GeoCas9:AcrIINme
to that of the dead variants, E. coli DH10B_gfp cells were heat-transformed71 with equal 
amounts (3 ng) of the different plasmids. These variants include the plasmid expressing 
Thermo_dCas9 and a spacer targeting the -10 sequence of PlacUV5 (pT-dCas9_sp1), the 
region immediately after the -10 sequence (pT-dCas9_sp2) or the start of the gfp gene (pT-
dCas9_sp3). As a positive control, 3 ng of empty vector (pACYC184) was used while as
negative controls 3 ng of the non-targeting plasmid (pT-dCas9_spscr) and commercial E. 
coli DH10B cells (NEB) harbouring the empty vector (pACYC184) were used. Post-
transformation, 2 μl of the recovered cells were cultured in 198 μl M9TG containi ng
chloramphenicol (15 μg/mL) in a Masterblock® 96-well deep microplate (Greiner Bio-One) 
for 22 h at 37°C with vigorous shaking (900 rpm). The second day, 2 μl of overnight
cultures were diluted in 198 μl M9TG containing the same antibiotic, and 2 μl of these were
re-diluted in 198 μl M9TG with antibiotic and IPTG (0 - 1000 μM) in a Masterblock® 96-
well deep micro-plate (Greiner Bio-One), and incubated for 22 h at 37°C with vigorous
shaking (900 rpm). The third day, 40 μl of overnight cultures were diluted in 160 μl 1X PBS
in a Greiner CELLSTAR® 96-well plate (Greiner Bio-One), and 100 μl of these dilutions 
were transferred 96-well clear bottom black microplate (CorningTM). The OD600s and the 
fluorescence signal (GFP:395,508) of the cultures were measured with a SynergyM x
Monochromator-Based Multi-Mode Micro-plate reader (BioTek). The plasmids, 
pGeodCas9_sp1, pGeodCas9_sp2, pGeodCas9_sp3, pGeodCas9_spscr were used for 
assessing the fluorescence loss by Geo_dCas9 following the same approach as describe d
above. 
x Monochromator-Based Multi-Mode Micro-plate reader (BioTek). The plasmid 
pGeodCas9_sp1, pGeodCas9_sp2, pGeodCas9_sp3, pGeodCas9_spscr were used for 
assessing the fluorescence loss by Geo_dCas9 following the previously described approach. 
FLOW CYTOMETRY-BASED FLUORESCENCE LOSS ASSAYS
To verify the levels of fluorescence loss and investigate the presence of sub-populations in all 
samples, the same protocol as the fluorescence loss assays was followed, with the only 
difference that on the third day 2 μl of overnight cultures were diluted in 998 μl 1X PBS in a 
Masterblock® 96-well deep microplate (Greiner Bio-One). The fluorescence signal and the 
presence of subpopulations were examined using the Attune NxT Flow Cytometer device 
(Thermo Fisher Scientific) (GFP intensity 405-512/25 of 30,000 single cells per sample). 
INHIBITION ASSAYS (SINGLE-VECTOR SYSTEM)
To inhibit targeting of the genomic DNA using the single-vector system, E. coli DH10B_gfp 
cells were transformed71 with equal amounts (5 ng) of plasmids expressing AcrIIC1Nme, 
ThermoCas9, and a spacer that targets the -10 sequence of PlacUV5 (pAcr_TCas9_sp1), the 
region immediately after the -10 sequence (pAcr_TCas9_sp2) or the start of the gfp gene 
(pAcr_TCas9_sp3). As controls, 5 ng of a non-targeting plasmid (pAcr_TCas9_spscr) and the 
empty vector (pACYC184) were used. Transformed cells were grown on LB agar 
supplemented with chloramphenicol (15 μg/mL), different IPTG concentrations (0 - 1000 
μM), and L-rhamnose (0 or 0.2%) for 17 h at 37°C. In the cases, where inducers were used 
(IPTG, L-rhamnose), they were supplemented in the recovery media after transformation. 
CFUs were counted after plating undiluted biological triplicates, and used for calculating the 
transformation efficiencies. The single plasmids, pAcr_GCas9_sp1, pAcr_GCas9_sp2, 
pAcr_GCas9_sp3, pAcr_GCas9_spscr were used for assessing the inhibition by GeoCas9 
following the same approach as described above. 
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Sup. Fig. S1 | Comparison of the domain architecture and the sgRNA modules of ThermoCas9 
and GeoCas9. a. Schematic illustration of the domain architecture of SpyCas9 (green), ThermoCas9 (dark 
orange), and GeoCas9 (light orange). The active site residues are indicated with asterisks. b. Sequence 
alignment of the sgRNA modules of ThermoCas9 and GeoCas9, used in previous studies for in vivo 
experiments62,63. Dark green colour indicates identical nucleotides, while light green colour represents non-
identical regions. 
a. 
b.
a.
b.
Sup. Fig. S2 | Comparison of ThermoCas9- and G eoCas9-based targeting in E. coli DH 10B_gfp. a. 
Complete data for ThermoCas9-based targeting in E. coli DH10B_gfp including the whole range of IPTG 
concentrations used for the induction of the ThermoCas9 expression. b. Complete data for GeoCas9-based 
targeting in E. coli DH10B_gfp including the whole range of IPTG concentrations used for the induction of the 
GeoCas9 expression.
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Supplementary Figures S1-S13
Sup. Fig. S1 | Comparison of the domain architecture and the sgRNA modules of ThermoCas9 
and G eoCas9. a. Schematic illustration of the domain architecture of SpyCas9 (green), ThermoCas9 (dark 
orange), and GeoCas9 (light orange). The active site residues are indicated with asterisks. b. Sequence 
alignment of the sgRNA modules of ThermoCas9 and GeoCas9, used in previous studies for in vivo
experiments62,63. Dark green colour indicates identical nucleotides, while light green colour represents non-
identical regions.
a.
b.
a. 
b. 
Sup. Fig. S2 | Comparison of ThermoCas9- and GeoCas9-based targeting in E. coli DH 10B_gfp. a. 
Complete data for ThermoCas9-based targeting in E. coli DH10B_gfp including the whole range of IPTG 
concentrations used for the induction of the ThermoCas9 expression. b. Complete data for GeoCas9-based 
targeting in E. coli DH10B_gfp including the whole range of IPTG concentrations used for the induction of the 
GeoCas9 expression. 
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Sup. Fig. S3 | Amino acid sequence alignment of the HNH domain of ThermoCas9 and GeoCas9. Dark 
orange colour indicates identical amino acid, while light orange colour represents non-identical residues. 
Asterisks indicate catalytic residues, and, specifically, green asterisks represent catalytic residues that interact 
with AcrIIC1Nme. Arrows indicate surrounding residues possibly involved in the stabilization of the association 
of AcrIIC1Nme with the GeoCas9 protein. The alignment was performed using ClustalO (default settings) and 
the results were visualized via Jalview. 
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Sup. Fig. S3 | Amino acid sequence alignment of the H NH domain of ThermoCas9 and G eoCas9. Dark 
orange colour indicates identical amino acid, while light orange colour represents non-identical residues. 
Asterisks indicate catalytic residues, and, specifically, green asterisks represent catalytic residues that 
interact with AcrIIC1Nme. Arrows indicate surrounding residues possibly involved in the stabilization of 
the association of AcrIIC1Nme with the GeoCas9 protein. The alignment was performed using ClustalO 
(default settings) and the results were visualized via Jalview.
a. 
b. 
Sup. Fig. S4 | AcrIIC1Nme-mediated inhibition of ThermoCas9 and ThermoCas9L551H in E. coli DH 
10B_gfp (dual-vector system). a. Complete data for inhibition of ThermoCas9 and ThermoCas9L551H cleavage 
activity, when the expression of AcrIIC1Nme is not induced (no supplementation of L-rhamnose). b. Complete 
data for inhibition of ThermoCas9 and ThermoCas9L551H cleavage activity, when the expression of AcrIIC1Nme 
is induced (supplementation of 0.2% L-rhamnose). 
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a. 
b. 
Sup. Fig. S5 | AcrIIC1Nme-mediated inhibition of GeoCas9 in E. coli DH10B_gfp (dual-vector system). 
a. Complete data for inhibition of GeoCas9 cleavage activity, when the expression of AcrIIC1Nme is not induced 
(no supplementation of L-rhamnose). b. Complete data for inhibition of GeoCas9 cleavage activity,
when the expression of AcrIIC1Nme is induced (supplementation of 0.2% L-rhamnose).
Sup. Fig. S6 | ThermoCas9/ThermoCas9L551H:AcrIIC1Nme-based silencing in E. coli DH 10B_gfp
(flow cytometry-based fluorescence loss assays). a. Complete data for ThermoCas9/ThermoCas9L551H–
mediated silencing, when the expression of AcrIIC1Nme is not induced (no supplementation of L-rhamnose). b.
Complete data for ThermoCas9/Th ermoCas9L551H–mediated silencing, when the expression of AcrIIC1Nme
is induced (supplementation of 0.2% L-rhamnose).
a.
b.
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a.
b.
Sup. Fig. S5 | AcrIIC1Nme-mediated inhibition of G eoCas9 in E. coli DH 10B_gfp (dual-vector system). 
a. Complete data for inhibition of GeoCas9 cleavage activity, when the expression of AcrIIC1Nme is not induced
(no supplementation of L-rhamnose). b. Complete data for inhibition of GeoCas9 cleavage activity,
when the expression of AcrIIC1Nme is induced (supplementation of 0.2% L-rhamnose).
Sup. Fig. S6 | ThermoCas9/ThermoCas9L551H:AcrIIC1Nme-based silencing in E. coli DH10B_gfp (flow 
cytometry-based fluorescence loss assays). a. Complete data for Thermo Cas9/ThermoCas9L551H–mediated 
silencing, when the expression of AcrIIC1Nme is not induced (no supplementation of L-rhamnose). b. Complete 
data for ThermoCas9/Th ermoCas9L551H–mediated silencing, when the expression of AcrIIC1Nme is induced 
(supplementation of 0.2% L-rhamnose). 
a. 
b.
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Sup. Fig. S7 | GeoCas9:AcrIIC1Nme-based silencing in E. coli DH10B_gfp (flow cytometry-based 
fluorescence loss assays). a. Complete data for GeoCas9-m ediated silencing, when the expression of 
AcrIIC1Nme is not induced (no supplementation of L-rhamnose). b. Complete data for GeoCas9-m ediated 
silencing, when the expression of AcrIIC1Nme is induced (supplementation of 0.2% L-rhamnose). 
a. 
b.
Sup. Fig. S8 | Thermo-dCas9 and G eo-dCas9-based silencing in E. coli DH 10B_gfp (flow cytometry-based 
fluorescence loss assays). a. Complete data for Thermo-dCas9-mediated silencing in E. coli DH10B_gfp. 
b. Complete data for Geo-dCas9-mediated silencing in E. coli DH10B_gfp.
b.
a.
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Sup. Fig. S7 | G eoCas9:AcrIIC1Nme-based silencing in E. coli DH 10B_gfp (flow cytometry-
based fluorescence loss assays). a. Complete data for GeoCas9-m ediated silencing, when the expression of 
AcrIIC1Nme is not induced (no supplementation of L-rhamnose). b. Complete data for GeoCas9-m ediated 
silencing, when the expression of AcrIIC1Nme is induced (supplementation  of 0.2% L-rhamnose).
a.
b.
Sup. Fig. S8 | Thermo-dCas9 and Geo-dCas9-based silencing in E. coli DH10B_gfp (flow cytometry-based 
fluorescence loss assays). a. Complete data for Thermo-dCas9-mediated silencing in E. coli DH10B_gfp. b. 
Complete data for Geo-dCas9-mediated silencing in E. coli DH10B_gfp.
b. 
a.
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Sup. Fig. S9 | GFP intensity (405-512/25) curves indicate single populations in all tested samples (flow 
cytometry-based fluorescence loss assays). Different colours of the peaks indicate different IPTG 
concentrations for the induction of the expression of GeoCas9, ThermoCas9, and ThermoCas9L551H. All graphs 
are representative of biological triplicates.  
Sup. Fig. S10 | ThermoCas9/ThermoCas9L551H:AcrIIC1Nme-based silencing in E. coli
DH 10B_gfp (spectrophotometry-based fluorescence loss assays). a. Complete data for ThermoCas9/
ThermoCas9L551H–mediated silencing, when the expression of AcrIIC1Nme is not induced (no 
supplementation of L-rhamnose). b. Complete data for ThermoCas9/ThermoCas9L551H–mediated silencing, 
when the expression of AcrIIC1Nme is induced (supplementation of 0.2% L-rhamnose).
a.
b.
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Sup. Fig. S9 | G FP intensity (405-512/25) curves indicate single populations in all tested samples 
(flow cytometry-based fluorescence loss assays). Different colours of the peaks indicate different IPTG 
concentrations for the induction of the expression of GeoCas9, ThermoCas9, and ThermoCas9L551H. All graphs 
are representative of biological triplicates. 
Sup. Fig. S10 | ThermoCas9/ThermoCas9L551H:AcrIIC1Nme-based silencing in E. coli DH 10B_gfp 
(spectrophotometry-based fluorescence loss assays). a. Complete data for ThermoCas9/ThermoCas9L551H–
mediated silencing, when the expression of AcrIIC1Nme is not induced (no supplementation of L-rhamnose). 
b. Complete data for ThermoCas9/ThermoCas9L551H–mediated silencing, when the expression of AcrIIC1Nme is
induced (supplementation of 0.2% L-rhamnose).
a. 
b.
a. 
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Sup. Fig. S11 | GeoCas9:AcrIIC1Nme-based silencing in E. coli DH10B_gfp (spectrophotometry-based 
fluorescence loss assays). a. Complete data for GeoCas9-mediated silencing, when the expression of 
AcrIIC1Nme is not induced (no supplementation of L-rhamnose). b. Complete data for GeoCas9-mediated 
silencing, when the expression of AcrIIC1Nme is induced (supplementation of 0.2% L-rhamnose). 
b.
a.
Sup. Fig. S12 | Thermo-dCas9 and G eo-dCas9-based silencing in E. coli DH 10B_gfp (spectrophotometry-
based fluorescence loss assays). a. Complete data for Thermo-dCas9-mediated silencing in E. coli
DH10B_gfp. b. Complete data for Geo-dCas9-mediated silencing in E. coli DH10B_gfp.
b.
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Sup. Fig. S11 | G eoCas9:AcrIIC1Nme-based silencing in E. coli DH 10B_gfp (spectrophotometry-
based fluorescence loss assays). a. Complete data for GeoCas9-mediated silencing, when the expression of 
AcrIIC1Nme is not induced (no supplementation of L-rhamnose). b. Complete data for GeoCas9-mediated 
silencing, when the expression of AcrIIC1Nme is induced (supplementation of 0.2% L-rhamnose).
a.
b.
a. 
Sup. Fig. S12 | Thermo-dCas9 and G eo-dCas9-based silencing in E. coli DH10B_gfp (spectrophotometry-
based fluorescence loss assays). a. Complete data for Thermo-dCas9-mediated silencing in E. coli 
DH10B_gfp. b. Complete data for Geo-dCas9-mediated silencing in E. coli DH10B_gfp.
b.
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Sup. Fig. S13 | AcrIIC1Nme-mediated inhibition of ThermoCas9, ThermoCas9L551H, and GeoCas9 in E. coli 
DH10B_gfp (single-vector system). a. Complete data for inhibition of ThermoCas9 and ThermoCas9L551H 
cleavage activity, when the expression of AcrIIC1Nme is either not induced (no supplementation of L-
rhamnose) or induced (supplementation of 0.2% L-rhamnose). b. Complete data for inhibition of GeoCas9 
cleavage activity, when the expression of AcrIIC1Nme is either not induced (no supplementation of L-
rhamnose) or induced (supplementation of 0.2% L-rhamnose). 
a. 
b.
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DH 10B_gfp (single-vector system). a. Complete data for inhibition of ThermoCas9 and 
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Supplementary Table 1: Spacers used in this study for ThermoCas9, ThermoCas9L551H , and GeoCas 9
Spacer 
ID 
Target 
strand 
Targeting location in 
PlacUV5 (5' -> 3') 
 PAM (5' -> 3') Sequence (23 nt) (5’ -> 3’) 
1 + 16 - 38 (PlacUV5) NNNNCACA TCCGGCTCGTATAATGTGTGGGG 
2 - 60 - 38 (PlacUV5) NNNNCACA TAGAGGGAAACCGTTGTGGTCTC 
3 - 82 - 60 (gfp gene) NNNNCCAA AGAATTTATGCCCATTCACATCC 
scr X X X CTAGATCCGCAGTAACCCCATGG 
Supplementary 
Table 2: Plasmids 
used in this study 
Plasmid ID Cloning 
strategy 
Description of fragments Function Reference 
pACYC184 - - Negative control in targeting 
assays, inhibition assays, 
spectrophotometry- and flow 
cytometry-based 
fluorescence loss assays 
Lab stock 
pUC19 - - Negative control in targeting 
assays, inhibition assays, 
spectrophotometry- and flow 
cytometry-based 
fluorescence loss assays. 
PCR template for 
pAcrIIC1Nm e 
Lab stock 
pET_MBP_Geo_st - - PCR template for 
pGCas9_sp1, pGCas9_sp2, 
pGCas9_sp3, pGCas9_spscr 
[63] 
pPtet_Acr_Prha_ 
TCas9 
- - PCR template for 
pGCas9_sp1, pGCas9_sp2, 
pGCas9_sp3, pGCas9_spscr, 
pTCas9_sp1, pTCas9_sp2, 
pTCas9_sp3, pTCas9_spscr 
Lab stock 
pPtet_Acr_Prha_ 
TCas9L551H 
- - PCR template for 
pTCas9L551H_sp3, 
pTCas9L551H_spscr 
Lab stock 
pPrha_TCas9 _sp1 - - PCR template for 
pGCas9_sp1 
Lab stock 
pPrha_TCas9 _sp2 - - PCR template for 
pGCas9_sp2 
Lab stock 
pPrha_TCas9 _sp3 - - PCR template for 
pGCas9_sp3 
Lab stock 
pPrha_TCas9 _spscr - - PCR template for 
pGCas9_spscr 
Lab stock 
pPrha_GCas9 _sp1 - - PCR template for pAcr Lab stock 
pMK-RQ-
_Acr_coK12_coT12 
- - PCR template for pAcr Lab stock 
pThermoCas9i - - PCR template for pT-
dCas9_sp1, pT-dCas9_sp2, 
pT-dCas9_sp3, and pT-
dCas9_spscr 
[62] 
pGCas9_sp1 Gibson 
assem bly 
Fragm ent 1: geoCas9 gene from 
pET_MBP_Geo_st amplified with 
primers BG13307 and BG13310   
GeoCas9 and sgRNA 
(spacer 1) targeting the 
genome-integrated PlacUV5
This study 
Fragm ent 2: 5' UTR, lac operator,
Ptet, PlacI, and lacI gene from
pPtet_Acr_Prha_ TCas9 am plified
with prim ers BG13311 and
BG13312
targeting assays, inhibition
assays (dual-vector system ),  
spectophotom etry- and flow
cytom etry-based
fluorescence loss assays.
Moreover, PCR tem plate for
pTCas9_sp1, pG-dCas9_sp1,
and pAcr_GCas9_sp1.
Fragm ent 3: term inator, sgRNA 1, 
term inator, backbone, and term inator
from pPrha_TCas9 _sp1 am plified 
with prim ers BG13313 and
BG13309
pGCas9_sp2 Gibson 
assem bly
Fragm ent 1: geoCas9 gene from
pET_MBP_Geo_st am plified with 
prim ers BG13307 and BG13310
GeoCas9 and sgRNA (spacer
2) targeting the genom e-
integrated PlacUV5 in
targeting assays, inhibition
assays (dual-vector system ),
spectophotom etry- and flow
cytom etry-based
fluorescence loss assays.
Moreover, PCR tem plate for
pTCas9_sp2, pG-dCas9_sp2,
and pAcr_GCas9_sp2.
This study
Fragm ent 2: 5' UTR, lac operator,
Ptet, PlacI, and lacI gene from
pPtet_Acr_Prha_ TCas9 am plified
with prim ers BG13311 and
BG13312
Fragm ent 3: term inator, sgRNA 2, 
term inator, backbone, and term inator
from pPrha_TCas9 _sp2 am plified 
with prim ers BG13313 and
BG13309
pGCas9_sp3 Gibson 
assem bly
Fragm ent 1:geoCas9 gene from
pET_MBP_Geo_st am plified with 
prim ers BG13307 and BG13310
GeoCas9 and sgRNA (spacer
3) targeting the genom e-
integrated PlacUV5 in
targeting assays, inhibition
assays (dual-vector system ),
spectophotom etry- and flow
cytom etry-based
fluorescence loss assays.
Moreover, PCR tem plate for
pTCas9_sp3,
pTCas9L551H_sp3, pG-
dCas9_sp3, and
pAcr_GCas9_sp3.
This study
Fragm ent 2: 5' UTR, lac operator,
Ptet, PlacI, and lacI gene from
pPtet_Acr_Prha_ TCas9 am plified
with prim ers BG13311 and
BG13312
Fragm ent 3: term inator, sgRNA 3, 
term inator, backbone, and term inator
from pPrha_TCas9 _sp3 am plified 
with prim ers BG13313 and
BG13309
pGCas9_spscr Gibson 
assem bly
Fragm ent 1:geoCas9 gene from
pET_MBP_Geo_st am plified with 
prim ers BG13307and BG13310
GeoCas9 and sgRNA (spacer
scr) non-targeting the 
genom e-integrated PlacUV5
in targeting assays, inhibition
assays (dual-vector system ),
spectophotom etry- and flow
cytom etry-based
fluorescence loss assays.
Moreover, PCR tem plate for
pTCas9_spscr, 
pTCas9L551H_spscr, pG-
dCas9_spscr, and 
pAcr_GCas9_spscr.
This study
Fragm ent 2: 5' UTR, lac operator,
Ptet, PlacI, and lacI gene from
pPtet_Acr_Prha_ TCas9 am plified
with prim ers BG13311 and
BG13312
Fragm ent 3: term inator, sgRNA scr, 
term inator,backbone, and term inator
from pPrha_TCas9 _spscr am plified 
with prim ers BG13313 and
BG13309
pTCas9_sp1 Gibson 
assem bly
Fragm ent 1: 5'UTR, lac operator,
Ptet, PlacI, lacI gene, term inator,
sgRNA 1, term inator, backbone, and 
term inator from pGCas9_sp1 
amplified with prim ers BG13459 and 
BG13460
Therm oCas9 and sgRNA
(spacer 1) targeting the 
genom e-integrated PlacUV5
in targeting assays, inhibition
assays (dual-vector system ),
spectophotom etry- and flow
cytom etry-based
fluorescence loss assays.
PCR tem plate for pT-
dCas9_sp1, and 
pAcr_TCas9_sp1.
This study
Fragm ent 2:thermoCas9 gene from
pPtet_Acr_Prha_ TCas9 am plified
with prim ers BG13461 and
BG13462
pTCas9_sp2 Gibson 
assem bly
Fragm ent 1: 5'UTR, lac operator,
Ptet, PlacI, lacI gene, term inator,
sgRNA 2, term inator, backbone, and 
term inator from pGCas9_sp2 
am plified with prim ers BG13459 and 
BG13460
Therm oCas9 and sgRNA
(spacer 2) targeting the 
genom e-integrated PlacUV5
in targeting assays, inhibition
assays (dual-vector system ),
spectophotom etry- and flow
This study
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Supplementary Table 1: Spacers used in this study for ThermoCas9, ThermoCas9L551H , and G eoCas9
Spacer 
ID
Target
strand
Targeting location in PlacUV5
(5' -> 3')
PAM (5' -> 3') Sequence (23 nt) (5’ -> 3’)
1 + 16 - 38 (PlacUV5) NNNNCACA TCCGGCTCGTATAATGTGTGGGG
2 - 60 - 38 (PlacUV5) NNNNCACA TAGAGGGAAACCGTTGTGGTCTC
3 - 82 - 60 (gfp gene) NNNNCCAA AGAATTTATGCCCATTCACATCC
scr X X X CTAGATCCGCAGTAACCCCATGG
Supplementary
Table 2: Plasmids
used in this study
Plasmid ID Cloning
strategy
Description of fragments Function Reference
pACYC184 - - Negative control in targeting
assays, inhibition assays,
spectrophotom etry- and flow
cytom etry-based
fluorescence loss assays
Lab stock
pUC19 - - Negative control in targeting
assays, inhibition assays,
spectrophotom etry- and flow
cytom etry-based
fluorescence loss assays.
PCR tem plate for
pAcrIIC1Nm e
Lab stock
pET_MBP_Geo_st - - PCR tem plate for
pGCas9_sp1, pGCas9_sp2,
pGCas9_sp3, pGCas9_spscr
[63]
pPtet_Acr_Prha_ 
TCas9
- - PCR tem plate for 
pGCas9_sp1, pGCas9_sp2,
pGCas9_sp3, pGCas9_spscr,
pTCas9_sp1, pTCas9_sp2,
pTCas9_sp3, pTCas9_spscr
Lab stock
pPtet_Acr_Prha_ 
TCas9L551H
- - PCR tem plate for
pTCas9L551H_sp3,
pTCas9L551H_spscr
Lab stock
pPrha_TCas9 _sp1 - - PCR tem plate for
pGCas9_sp1
Lab stock
pPrha_TCas9 _sp2 - - PCR tem plate for
pGCas9_sp2
Lab stock
pPrha_TCas9 _sp3 - - PCR tem plate for
pGCas9_sp3
Lab stock
pPrha_TCas9 _spscr - - PCR tem plate for
pGCas9_spscr
Lab stock
pPrha_GCas9 _sp1 - - PCR tem plate for pAcr Lab stock
pMK-RQ-
_Acr_coK12_coT12
- - PCR tem plate for pAcr Lab stock
pTherm oCas9i - - PCR tem plate for pT-
dCas9_sp1, pT-dCas9_sp2,
pT-dCas9_sp3, and pT-
dCas9_spscr
[62]
pGCas9_sp1 Gibson 
assem bly
Fragm ent 1:geoCas9 gene from
pET_MBP_Geo_st am plified with 
prim ers BG13307and BG13310 
GeoCas9 and sgRNA (spacer
1) targeting the genom e-
integrated PlacUV5 in
This study
Fragment 2: 5' UTR, lac operator, 
Ptet, PlacI, and lacI gene from 
pPtet_Acr_Prha_ TCas9 amplified 
with primers BG13311 and 
BG13312 
targeting assays, inhibition 
assays (dual-vector system),  
spectophotometry- and flow 
cytometry-based 
fluorescence loss assays. 
Moreover, PCR template for 
pTCas9_sp1, pG-dCas9_sp1, 
and pAcr_GCas9_sp1. 
Fragment 3: terminator, sgRNA 1, 
terminator, backbone, and terminator 
from pPrha_TCas9 _sp1 amplified 
with primers BG13313 and 
BG13309 
pGCas9_sp2 Gibson 
assembly 
Fragment 1: geoCas9 gene from 
pET_MBP_Geo_st amplified with 
primers BG13307 and BG13310 
GeoCas9 and sgRNA (spacer 
2) targeting the genome-
integrated PlacUV5 in
targeting assays, inhibition
assays (dual-vector system),
spectophotometry- and flow
cytometry-based
fluorescence loss assays.
Moreover, PCR template for
pTCas9_sp2, pG-dCas9_sp2,
and pAcr_GCas9_sp2.
This study 
Fragment 2: 5' UTR, lac operator, 
Ptet, PlacI, and lacI gene from 
pPtet_Acr_Prha_ TCas9 amplified 
with primers BG13311 and 
BG13312 
Fragment 3: terminator, sgRNA 2, 
terminator, backbone, and terminator 
from pPrha_TCas9 _sp2 amplified 
with primers BG13313 and 
BG13309 
pGCas9_sp3 Gibson 
assembly 
Fragment 1: geoCas9 gene from 
pET_MBP_Geo_st amplified with 
primers BG13307 and BG13310 
GeoCas9 and sgRNA (spacer 
3) targeting the genome-
integrated PlacUV5 in
targeting assays, inhibition
assays (dual-vector system),
spectophotometry- and flow
cytometry-based
fluorescence loss assays.
Moreover, PCR template for
pTCas9_sp3,
pTCas9L551H_sp3, pG-
dCas9_sp3, and
pAcr_GCas9_sp3.
This study 
Fragment 2: 5' UTR, lac operator, 
Ptet, PlacI, and lacI gene from 
pPtet_Acr_Prha_ TCas9 amplified 
with primers BG13311 and 
BG13312 
Fragment 3: terminator, sgRNA 3, 
terminator, backbone, and terminator 
from pPrha_TCas9 _sp3 amplified 
with primers BG13313 and 
BG13309 
pGCas9_spscr Gibson 
assembly 
Fragment 1: geoCas9 gene from 
pET_MBP_Geo_st amplified with 
primers BG13307 and BG13310 
GeoCas9 and sgRNA (spacer 
scr) non-targeting the 
genome-integrated PlacUV5 
in targeting assays, inhibition 
assays (dual-vector system), 
spectophotometry- and flow 
cytometry-based 
fluorescence loss assays. 
Moreover, PCR template for 
pTCas9_spscr, 
pTCas9L551H_spscr, pG-
dCas9_spscr, and 
pAcr_GCas9_spscr. 
This study 
Fragment 2: 5' UTR, lac operator, 
Ptet, PlacI, and lacI gene from 
pPtet_Acr_Prha_ TCas9 amplified 
with primers BG13311 and 
BG13312 
Fragment 3: terminator, sgRNA scr, 
terminator, backbone, and terminator 
from pPrha_TCas9 _spscr amplified 
with primers BG13313 and 
BG13309 
pTCas9_sp1 Gibson 
assembly 
Fragment 1: 5'UTR, lac operator, 
Ptet, PlacI, lacI gene, terminator, 
sgRNA 1, terminator, backbone, and 
terminator from pGCas9_sp1 
amplified with primers BG13459 and 
BG13460 
ThermoCas9 and sgRNA 
(spacer 1) targeting the 
genome-integrated PlacUV5 
in targeting assays, inhibition 
assays (dual-vector system), 
spectophotometry- and flow 
cytometry-based 
fluorescence loss assays. 
PCR template for pT-
dCas9_sp1, and 
pAcr_TCas9_sp1. 
This study 
Fragment 2: thermoCas9 gene from 
pPtet_Acr_Prha_ TCas9 amplified 
with primers BG13461 and 
BG13462 
pTCas9_sp2 Gibson 
assembly 
Fragment 1: 5'UTR, lac operator, 
Ptet, PlacI, lacI gene, terminator, 
sgRNA 2, terminator, backbone, and 
terminator from pGCas9_sp2 
amplified with primers BG13459 and 
BG13460 
ThermoCas9 and sgRNA 
(spacer 2) targeting the 
genome-integrated PlacUV5 
in targeting assays, inhibition 
assays (dual-vector system), 
spectophotometry- and flow 
This study 
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Fragm ent 2:Geo-dCas9 gene, 5' 
UTR, lac operator, Ptet, PlacI, lacI
gene, term inator, sgRNA 1, 
term inator, backbone, and term inator
from pGCas9_sp1 am plified with 
prim ers BG13682 and BG13683
in spectophotom etry- and 
flow cytom etry-based
fluorescence loss assays.
pG-dCas9_sp2 Gibson 
assem bly
Fragm ent 1:Geo-dCas9 gene from
pGCas9_sp2 am plified with prim ers
BG13680 and BG13681
Geo-dCas9 and sgRNA
(spacer 2) targeting the 
genom e-integrated PlacUV5
in spectophotom etry- and 
flow cytom etry-based
fluorescence loss assays.
This study
Fragm ent 2:Geo-dCas9 gene, 5' 
UTR, lac operator, Ptet, PlacI, lacI
gene, term inator, sgRNA 2, 
term inator, backbone, and term inator
from pGCas9_sp1 am plified with 
prim ers BG13682 and BG13683
pG-dCas9_sp3 Gibson 
assem bly
Fragm ent 1:Geo-dCas9 gene from
pGCas9_sp3 am plified with prim ers
BG13680 and BG13681
Geo-dCas9 and sgRNA
(spacer 3) targeting the 
genom e-integrated PlacUV5
in spectophotom etry- and 
flow cytom etry-based
fluorescence loss assays.
This study
Fragm ent 2:Geo-dCas9 gene, 5' 
UTR, lac operator, Ptet, PlacI, lacI
gene, term inator, sgRNA 3, 
term inator, backbone, and term inator
from pGCas9_sp1 am plified with 
prim ers BG13682 and BG13683
pG-dCas9_spscr Gibson 
assem bly
Fragm ent 1:Geo-dCas9 gene from
pGCas9_spscr am plified with 
prim ers BG13680 and BG13681
Geo-dCas9 and sgRNA
(spacer scr) targeting the 
genom e-integrated PlacUV5
in spectophotom etry- and 
flow cytom etry-based
fluorescence loss assays.
This study
Fragm ent 2:Geo-dCas9 gene, 5' 
UTR, lac operator, Ptet, PlacI, lacI
gene, term inator, sgRNA scr, 
term inator, backbone, and term inator
from pGCas9_sp1 am plified with 
prim ers BG13682 and BG13683
pT-dCas9_sp1 Gibson 
assem bly
Fragm ent 1:Thermo-dCas9 gene 
from pTherm oCas9i am plified with 
prim ers BG12625 and BG13684
Thermo-dCas9 and sgRNA
(spacer 1) targeting the 
genom e-integrated PlacUV5
in spectophotom etry- and 
flow cytom etry-based
fluorescence loss assays.
This study
Fragm ent 2:  5' UTR, lac operator, 
Ptet, PlacI, lacI gene, term inator,
sgRNA 1, term inator, backbone, and 
term inator from pTCas9_sp1
am plified with prim ers BG13311 and 
BG13685
pT-dCas9_sp2 Gibson 
assem bly
Fragm ent 1:Thermo-dCas9 gene 
from pTherm oCas9i am plified with 
prim ers BG12625 and BG13684
Thermo-dCas9 and sgRNA
(spacer 2) targeting the 
genom e-integrated PlacUV5
in spectophotom etry- and 
flow cytom etry-based
fluorescence loss assays.
This study
Fragm ent 2:  5' UTR, lac operator, 
Ptet, PlacI, lacI gene, term inator,
sgRNA 2, term inator, backbone, and 
term inator from pTCas9_sp2
am plified with prim ers BG13311 and 
BG13685
pT-dCas9_sp3 Gibson 
assem bly
Fragm ent 1:Thermo-dCas9 gene 
from pTherm oCas9i am plified with 
prim ers BG12625 and BG13684
Thermo-dCas9 and sgRNA
(spacer 3) targeting the 
genom e-integrated PlacUV5
in spectophotom etry- and 
flow cytom etry-based 
fluorescence loss assays.
This study
Fragm ent 2:  5' UTR, lac operator, 
Ptet, PlacI, lacI gene, term inator,
sgRNA 3, term inator, backbone, and 
term inator from pTCas9_sp3
am plified with prim ers BG13311 and 
BG13685
pT-dCas9_spscr Gibson 
assem bly
Fragm ent 1: Thermo-dCas9 gene 
from pTherm oCas9i am plified with 
prim ers BG12625 and BG13684
Thermo-dCas9 and sgRNA
(spacer scr) targeting the 
genom e-integrated PlacUV5
This study
Fragment 2: thermoCas9 gene from 
pPtet_Acr_Prha_ TCas9 amplified 
with primers BG13461 and 
BG13462 
cytometry-based 
fluorescence loss assays. 
PCR template for pT-
dCas9_sp2, and 
pAcr_TCas9_sp2. 
pTCas9_sp3 Gibson 
assembly 
Fragment 1: 5'UTR, lac operator, 
Ptet, PlacI, lacI gene, terminator, 
sgRNA 3, terminator, backbone, and 
terminator from pGCas9_sp3 
amplified with primers BG13459 and 
BG13460 
ThermoCas9 and sgRNA 
(spacer 3) targeting the 
genome-integrated PlacUV5 
in targeting assays, inhibition 
assays (dual-vector system), 
spectophotometry- and flow 
cytometry-based 
fluorescence loss assays. 
PCR template for pT-
dCas9_sp3, and 
pAcr_TCas9_sp3. 
This study 
Fragment 2: thermoCas9 gene from 
pPtet_Acr_Prha_ TCas9 amplified 
with primers BG13461 and 
BG13462 
pTCas9_spscr Gibson 
assembly 
Fragment 1: 5'UTR, lac operator, 
Ptet, PlacI, lacI gene, terminator, 
sgRNA scr, terminator, backbone, 
and terminator from pGCas9_spscr 
amplified with primers BG13459 and 
BG13460 
ThermoCas9 and sgRNA 
(spacer scr) non-targeting the 
genome-integrated PlacUV5 
in targeting assays, inhibition 
assays (dual-vector system), 
spectophotometry- and flow 
cytometry-based 
fluorescence loss assays. 
PCR template for pT-
dCas9_spscr, and 
pAcr_TCas9_spscr. 
This study 
Fragment 2: thermoCas9 gene from 
pPtet_Acr_Prha_ TCas9 amplified 
with primers BG13461 and 
BG13462 
pAcr Gibson 
assembly 
Fragment 1: Prha, and 5'UTR from 
pPrha_GCas9_sp1 amplified with 
primers BG13427 and BG13428 
AcrIIC1Nme inhibiting 
ThermoCas9, 
ThermoCas9L551H or 
GeoCas9 in inhibition assays 
(dual-vector system), 
spectophotometry- and flow 
cytometry-based 
fluorescence loss assays. 
PCR template for 
pAcr_TCas9_sp1, 
pAcr_TCas9_sp2, 
pAcr_TCas9_sp3, 
pAcr_TCas9_spscr, 
pAcr_GCas9_sp1, 
pAcr_GCas9_sp2, 
pAcr_GCas9_sp3, and 
pAcr_GCas9_spscr. 
This study 
Fragment 2: AcrIIC1Nme from pMK-
RQ-_Acr_coK12_coT12 amplified 
with primers BG13429 and 
BG13430 
Fragment 3: T7 terminator from 
annealed oligonucleotides BG13431 
and BG13432 
Fragment 4: pUC19 amplified with 
primers BG13433 and BG13434 
pTCas9L511H_sp3 Gibson 
assembly 
Fragment 1: 5' UTR, lac operator, 
Ptet, PlacI, lacI gene, terminator, 
sgRNA 3, terminator, backbone, and 
terminator from pGCas9_sp3 
amplified with primers BG13459 and 
BG13460 
ThermoCas9L551H and 
sgRNA (spacer 3) targeting 
the genome-integrated 
PlacUV5 in inhibition assays 
(dual-vector system), 
spectophotometry- and flow 
cytometry-based 
fluorescence loss assays. 
This study 
Fragment 2: thermoCas9L551H gene 
from pPtet_Acr_Prha_ TCas9L551H 
amplified with primers BG13461 and 
BG13462 
pTCas9L511H_spscr Gibson 
assembly 
Fragment 1: 5' UTR, lac operator, 
Ptet, PlacI, lacI gene, terminator, 
sgRNA scr, terminator, backbone, 
and terminator from pGCas9_spscr 
amplified with primers BG13459 and 
BG13460 
ThermoCas9L551H and 
sgRNA (spacer scr) non-
targeting the genome-
integrated PlacUV5 in 
inhibition assays (dual-vector 
system), spectophotometry- 
and flow cytometry-based 
fluorescence loss assays. 
This study 
Fragment 2: thermoCas9L551H gene 
from pPtet_Acr_Prha_ TCas9L551H 
amplified with primers BG13461 and 
BG13462 
pG-dCas9_sp1 Gibson 
assembly 
Fragment 1: Geo-dCas9 gene from 
pGCas9_sp1 amplified with primers 
BG13680 and BG13681 
Geo-dCas9 and sgRNA 
(spacer 1) targeting the 
genome-integrated PlacUV5 
This study 
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Fragm ent 2:thermoCas9 gene from
pPtet_Acr_Prha_ TCas9 am plified
with prim ers BG13461 and
BG13462
cytom etry-based
fluorescence loss assays.
PCR tem plate for pT-
dCas9_sp2, and 
pAcr_TCas9_sp2.
pTCas9_sp3 Gibson 
assem bly
Fragm ent 1: 5'UTR, lac operator,
Ptet, PlacI, lacI gene, term inator,
sgRNA 3, term inator, backbone, and 
term inator from pGCas9_sp3 
am plified with prim ers BG13459 and 
BG13460
Therm oCas9 and sgRNA
(spacer 3) targeting the 
genom e-integrated PlacUV5
in targeting assays, inhibition 
assays (dual-vector system ),
spectophotom etry- and flow
cytom etry-based
fluorescence loss assays.
PCR tem plate for pT-
dCas9_sp3, and 
pAcr_TCas9_sp3.
This study
Fragm ent 2:thermoCas9 gene from
pPtet_Acr_Prha_ TCas9 am plified
with prim ers BG13461 and
BG13462
pTCas9_spscr Gibson 
assem bly
Fragm ent 1: 5'UTR, lac operator,
Ptet, PlacI, lacI gene, term inator,
sgRNA scr, term inator, backbone, 
and term inator from pGCas9_spscr
am plified with prim ers BG13459 and 
BG13460
Therm oCas9 and sgRNA
(spacer scr) non-targeting the 
genom e-integrated PlacUV5
in targeting assays, inhibition
assays (dual-vector system ),
spectophotom etry- and flow
cytom etry-based
fluorescence loss assays.
PCR tem plate for pT-
dCas9_spscr, and 
pAcr_TCas9_spscr.
This study
Fragm ent 2:thermoCas9 gene from
pPtet_Acr_Prha_ TCas9 am plified
with prim ers BG13461 and
BG13462
pAcr Gibson 
assem bly
Fragm ent 1: Prha, and 5'UTR from
pPrha_GCas9_sp1 am plified with
prim ers BG13427 and BG13428
AcrIIC1Nm e inhibiting
Therm oCas9,
Therm oCas9L551H or
GeoCas9 in inhibition assays
(dual-vector system ),
spectophotom etry- and flow
cytom etry-based
fluorescence loss assays.
PCR tem plate for
pAcr_TCas9_sp1,
pAcr_TCas9_sp2,
pAcr_TCas9_sp3,
pAcr_TCas9_spscr,
pAcr_GCas9_sp1,
pAcr_GCas9_sp2,
pAcr_GCas9_sp3, and 
pAcr_GCas9_spscr.
This study
Fragm ent 2: AcrIIC1Nm e from
pMK-RQ-_Acr_coK12_coT12 
am plified with prim ers BG13429 and 
BG13430
Fragm ent 3: T7 term inator from
annealed oligonucleotides BG13431 
and BG13432
Fragm ent 4: pUC19 am plified with 
prim ers BG13433 and BG13434
pTCas9L511H_sp3 Gibson 
assem bly
Fragm ent 1: 5' UTR, lac operator,
Ptet, PlacI, lacI gene, term inator,
sgRNA 3, term inator, backbone, and 
term inator from pGCas9_sp3 
am plified with prim ers BG13459 and 
BG13460
Therm oCas9L551H and 
sgRNA (spacer 3) targeting
the genom e-integrated
PlacUV5 in inhibition assays
(dual-vector system ),
spectophotom etry- and flow
cytom etry-based
fluorescence loss assays.
This study
Fragm ent 2:thermoCas9L551H gene 
from pPtet_Acr_Prha_ TCas9L551H
am plified with prim ersBG13461 and 
BG13462
pTCas9L511H_spscr Gibson 
assem bly
Fragm ent 1: 5' UTR, lac operator,
Ptet, PlacI, lacI gene, term inator,
sgRNA scr, term inator, backbone, 
and term inator from pGCas9_spscr
am plified with prim ers BG13459 and 
BG13460
Therm oCas9L551H and 
sgRNA (spacer scr) non-
targeting the genom e-
integrated PlacUV5 in
inhibition assays (dual-vector
system ), spectophotom etry- 
and flow cytom etry-based
fluorescence loss assays.
This study
Fragm ent 2:thermoCas9L551H gene 
from pPtet_Acr_Prha_ TCas9L551H
amplified with prim ers BG13461 and 
BG13462
pG-dCas9_sp1 Gibson 
assem bly
Fragm ent 1:Geo-dCas9 gene from
pGCas9_sp1 am plified with prim ers
BG13680 and BG13681
Geo-dCas9 and sgRNA
(spacer 1) targeting the 
genom e-integrated PlacUV5
This study
Fragment 2: Geo-dCas9 gene, 5' 
UTR, lac operator, Ptet, PlacI, lacI 
gene, terminator, sgRNA 1, 
terminator, backbone, and terminator 
from pGCas9_sp1 amplified with 
primers BG13682 and BG13683 
in spectophotometry- and 
flow cytometry-based 
fluorescence loss assays. 
pG-dCas9_sp2 Gibson 
assembly 
Fragment 1: Geo-dCas9 gene from 
pGCas9_sp2 amplified with primers 
BG13680 and BG13681 
Geo-dCas9 and sgRNA 
(spacer 2) targeting the 
genome-integrated PlacUV5 
in spectophotometry- and 
flow cytometry-based 
fluorescence loss assays. 
This study 
Fragment 2: Geo-dCas9 gene, 5' 
UTR, lac operator, Ptet, PlacI, lacI 
gene, terminator, sgRNA 2, 
terminator, backbone, and terminator 
from pGCas9_sp1 amplified with 
primers BG13682 and BG13683 
pG-dCas9_sp3 Gibson 
assembly 
Fragment 1: Geo-dCas9 gene from 
pGCas9_sp3 amplified with primers 
BG13680 and BG13681 
Geo-dCas9 and sgRNA 
(spacer 3) targeting the 
genome-integrated PlacUV5 
in spectophotometry- and 
flow cytometry-based 
fluorescence loss assays. 
This study 
Fragment 2: Geo-dCas9 gene, 5' 
UTR, lac operator, Ptet, PlacI, lacI 
gene, terminator, sgRNA 3, 
terminator, backbone, and terminator 
from pGCas9_sp1 amplified with 
primers BG13682 and BG13683 
pG-dCas9_spscr Gibson 
assembly 
Fragment 1: Geo-dCas9 gene from 
pGCas9_spscr amplified with 
primers BG13680 and BG13681 
Geo-dCas9 and sgRNA 
(spacer scr) targeting the 
genome-integrated PlacUV5 
in spectophotometry- and 
flow cytometry-based 
fluorescence loss assays. 
This study 
Fragment 2: Geo-dCas9 gene, 5' 
UTR, lac operator, Ptet, PlacI, lacI 
gene, terminator, sgRNA scr, 
terminator, backbone, and terminator 
from pGCas9_sp1 amplified with 
primers BG13682 and BG13683 
pT-dCas9_sp1 Gibson 
assembly 
Fragment 1: Thermo-dCas9 gene 
from pThermoCas9i amplified with 
primers BG12625 and BG13684 
Thermo-dCas9 and sgRNA 
(spacer 1) targeting the 
genome-integrated PlacUV5 
in spectophotometry- and 
flow cytometry-based 
fluorescence loss assays. 
This study 
Fragment 2:  5' UTR, lac operator, 
Ptet, PlacI, lacI gene, terminator, 
sgRNA 1, terminator, backbone, and 
terminator from pTCas9_sp1 
amplified with primers BG13311 and 
BG13685 
pT-dCas9_sp2 Gibson 
assembly 
Fragment 1: Thermo-dCas9 gene 
from pThermoCas9i amplified with 
primers BG12625 and BG13684 
Thermo-dCas9 and sgRNA 
(spacer 2) targeting the 
genome-integrated PlacUV5 
in spectophotometry- and 
flow cytometry-based 
fluorescence loss assays. 
This study 
Fragment 2:  5' UTR, lac operator, 
Ptet, PlacI, lacI gene, terminator, 
sgRNA 2, terminator, backbone, and 
terminator from pTCas9_sp2 
amplified with primers BG13311 and 
BG13685 
pT-dCas9_sp3 Gibson 
assembly 
Fragment 1: Thermo-dCas9 gene 
from pThermoCas9i amplified with 
primers BG12625 and BG13684 
Thermo-dCas9 and sgRNA 
(spacer 3) targeting the 
genome-integrated PlacUV5 
in spectophotometry- and 
flow cytometry-based 
fluorescence loss assays. 
This study 
Fragment 2:  5' UTR, lac operator, 
Ptet, PlacI, lacI gene, terminator, 
sgRNA 3, terminator, backbone, and 
terminator from pTCas9_sp3 
amplified with primers BG13311 and 
BG13685 
pT-dCas9_spscr Gibson 
assembly 
Fragment 1: Thermo-dCas9 gene 
from pThermoCas9i amplified with 
primers BG12625 and BG13684 
Thermo-dCas9 and sgRNA 
(spacer scr) targeting the 
genome-integrated PlacUV5 
This study 
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with prim ers BG12705 and
BG14002
Fragm ent 3: PartlylacI gene,
term inator, PJ23119, sgRNA 1, 
term inator, and backbone from
pTCas9_sp1 am plified with prim ers
BG12722 and BG14003
pAcr_TCas9_sp2 Gibson 
assem bly
Fragm ent 1: Prha, and AcrIIC1Nm e 
from pAcr am plified with prim ers
BG14000 and BG14001
Therm oCas9 and sgRNA
(spacer 2) targeting the 
genom e-integrated PlacUV5
and AcrIIC1Nm e inhibiting
GeoCas9, in inhibition assays
(single-vector system ).
This study
Fragm ent 2: Term inator,
Therm oCas9, 5' UTR, lac operator, 
Ptet, backbone, PlacI, and partly lacI
gene from pTCas9_sp2 am plified 
with prim ers BG12705 and
BG14002
Fragm ent 3: PartlylacI gene,
term inator, PJ23119, sgRNA 2, 
term inator, and backbone from
pTCas9_sp2 am plified with prim ers
BG12722 and BG14003
pAcr_TCas9_sp3 Gibson 
assem bly
Fragm ent 1: Prha, and AcrIIC1Nm e 
from pAcr am plified with prim ers
BG14000 and BG14001
Therm oCas9 and sgRNA
(spacer 3) targeting the 
genom e-integrated PlacUV5
and AcrIIC1Nm e inhibiting
GeoCas9, in inhibition assays
(single-vector system ).
This study
Fragm ent 2: Term inator,
Therm oCas9, 5' UTR, lac operator, 
Ptet, backbone, PlacI, and partly lacI
gene from pTCas9_sp3 am plified 
with prim ers BG12705 and
BG14002
Fragm ent 3: PartlylacI gene,
term inator, PJ23119, sgRNA 3, 
term inator, and backbone from
pTCas9_sp3 am plified with prim ers
BG12722 and BG14003
pAcr_TCas9_spscr Gibson 
assem bly
Fragm ent 1: Prha, and AcrIIC1Nm e 
from pAcr am plified with prim ers
BG14000 and BG14001
Therm oCas9 and sgRNA
(spacer scr) targeting the 
genom e-integrated PlacUV5
and AcrIIC1Nm e inhibiting
GeoCas9, in inhibition assays
(single-vector system ).
This study
Fragm ent 2: Term inator,
Therm oCas9, 5' UTR, lac operator, 
Ptet, backbone, PlacI, and partly lacI
gene from pTCas9_spscr am plified 
with prim ers BG12705 and
BG14002
Fragm ent 3: PartlylacI gene,
term inator, PJ23119, sgRNA scr, 
term inator, and backbone from
pTCas9_spscr am plified with 
prim ers BG12722 and BG14003
Supplementary Table 3: Strains used in this study
Strain Description Plasmid Antibiotic
resistance
Reference
E. coli
DH5α
Wild-type - - Lab stock
E. coli
DH10Β
Wild-type - - Lab stock
E. coli
DH10Β
Prom oter lacUV5 andgfp gene integrated in the 
genom e
- - Lab stock
E. coli
DH10Β
Prom oter lacUV5 andgfp gene integrated in the 
genom e
pAcrIIC1Nm e Am picillin This study
Fragment 2:  5' UTR, lac operator, 
Ptet, PlacI, lacI gene, terminator, 
sgRNA scr, terminator, backbone, 
and terminator from pTCas9_spscr 
amplified with primers BG13311 and 
BG13685 
in spectophotometry- and 
flow cytometry-based 
fluorescence loss assays. 
pAcr_GCas9_sp1 Gibson 
assembly 
Fragment 1: Prha, and AcrIIC1Nme 
from pAcr amplified with primers 
BG14000 and BG14001 
GeoCas9 and sgRNA (spacer 
1) targeting the genome-
integrated PlacUV5 and 
AcrIIC1Nme inhibiting
GeoCas9, in inhibition assays
(single-vector system).
This study 
Fragment 2: Terminator, GeoCas9, 5' 
UTR, lac operator, Ptet, backbone, 
PlacI, and partly lacI gene from 
pGCas9_sp1 amplified with primers 
BG12705 and BG14002 
Fragment 3: Partly lacI gene, 
terminator, PJ23119, sgRNA 1, 
terminator, and backbone from 
pGCas9_sp1 amplified with primers 
BG12722 and BG14003 
pAcr_GCas9_sp2 Gibson 
assembly 
Fragment 1: Prha, and AcrIIC1Nme 
from pAcr amplified with primers 
BG14000 and BG14001 
GeoCas9 and sgRNA (spacer 
2) targeting the genome-
integrated PlacUV5 and 
AcrIIC1Nme inhibiting
GeoCas9, in inhibition assays
(single-vector system).
This study 
Fragment 2: Terminator, GeoCas9, 5' 
UTR, lac operator, Ptet, backbone, 
PlacI, and partly lacI gene from 
pGCas9_sp2 amplified with primers 
BG12705 and BG14002 
Fragment 3: Partly lacI gene, 
terminator, PJ23119, sgRNA 2, 
terminator, and backbone from 
pGCas9_sp2 amplified with primers 
BG12722 and BG14003 
pAcr_GCas9_sp3 Gibson 
assembly 
Fragment 1: Prha, and AcrIIC1Nme 
from pAcr amplified with primers 
BG14000 and BG14001 
GeoCas9 and sgRNA (spacer 
3) targeting the genome-
integrated PlacUV5 and 
AcrIIC1Nme inhibiting
GeoCas9, in inhibition assays
(single-vector system).
This study 
Fragment 2: Terminator, GeoCas9, 5' 
UTR, lac operator, Ptet, backbone, 
PlacI, and partly lacI gene from 
pGCas9_sp3 amplified with primers 
BG12705 and BG14002 
Fragment 3: Partly lacI gene, 
terminator, PJ23119, sgRNA 3, 
terminator, and backbone from 
pGCas9_sp3 amplified with primers 
BG12722 and BG14003 
pAcr_GCas9_spscr Gibson 
assembly 
Fragment 1: Prha, and AcrIIC1Nme 
from pAcr amplified with primers 
BG14000 and BG14001 
GeoCas9 and sgRNA (spacer 
scr) targeting the genome-
integrated PlacUV5 and 
AcrIIC1Nme inhibiting 
GeoCas9, in inhibition assays 
(single-vector system). 
This study 
Fragment 2: Terminator, GeoCas9, 5' 
UTR, lac operator, Ptet, backbone, 
PlacI, and partly lacI gene from 
pGCas9_spscr amplified with 
primers BG12705 and BG14002 
Fragment 3: Partly lacI gene, 
terminator, PJ23119, sgRNA scr, 
terminator, and backbone from 
pGCas9_spscr amplified with 
primers BG12722 and BG14003 
pAcr_TCas9_sp1 Gibson 
assembly 
Fragment 1: Prha, and AcrIIC1Nme 
from pAcr amplified with primers 
BG14000 and BG14001 
ThermoCas9 and sgRNA 
(spacer 1) targeting the 
genome-integrated PlacUV5 
and AcrIIC1Nme inhibiting 
GeoCas9, in inhibition assays 
(single-vector system). 
This study 
Fragment 2: Terminator, 
ThermoCas9, 5' UTR, lac operator, 
Ptet, backbone, PlacI, and partly lacI 
gene from pTCas9_sp1 amplified 
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Fragm ent 2:  5' UTR, lac operator, 
Ptet, PlacI, lacI gene, term inator,
sgRNA scr, term inator, backbone, 
and term inator from pTCas9_spscr
am plified with prim ers BG13311 and 
BG13685
in spectophotom etry- and 
flow cytom etry-based
fluorescence loss assays.
pAcr_GCas9_sp1 Gibson 
assem bly
Fragm ent 1: Prha, and AcrIIC1Nm e 
from pAcr amp lified with prim ers
BG14000 and BG14001
GeoCas9 and sgRNA (spacer
1) targeting the genom e-
integrated PlacUV5 and
AcrIIC1Nm e inhibiting
GeoCas9, in inhibition assays
(single-vector system ).
This study
Fragm ent 2: Term inator, GeoCas9, 5'
UTR, lac operator, Ptet, backbone,
PlacI, and partly lacI gene from
pGCas9_sp1 am plified with prim ers
BG12705 and BG14002
Fragm ent 3: PartlylacI gene,
term inator, PJ23119, sgRNA 1, 
term inator, and backbone from
pGCas9_sp1 am plified with prim ers
BG12722 and BG14003
pAcr_GCas9_sp2 Gibson 
assem bly
Fragm ent 1: Prha, and AcrIIC1Nm e 
from pAcr am plified with prim ers
BG14000 and BG14001
GeoCas9 and sgRNA (spacer
2) targeting the genom e-
integrated PlacUV5 and
AcrIIC1Nm e inhibiting
GeoCas9, in inhibition assays
(single-vector system ).
This study
Fragm ent 2: Term inator, GeoCas9, 5'
UTR, lac operator, Ptet, backbone,
PlacI, and partly lacI gene from
pGCas9_sp2 am plified with prim ers
BG12705 and BG14002
Fragm ent 3: PartlylacI gene,
term inator, PJ23119, sgRNA 2, 
term inator,and backbone from
pGCas9_sp2 am plified with prim ers
BG12722 and BG14003
pAcr_GCas9_sp3 Gibson 
assem bly
Fragm ent 1: Prha, and AcrIIC1Nm e 
from pAcr am plified with prim ers
BG14000 and BG14001
GeoCas9 and sgRNA (spacer
3) targeting the genom e-
integrated PlacUV5 and
AcrIIC1Nm e inhibiting
GeoCas9, in inhibition assays
(single-vector system ).
This study
Fragm ent 2: Term inator, GeoCas9, 5'
UTR, lac operator, Ptet, backbone,
PlacI, and partly lacI gene from
pGCas9_sp3 am plified with prim ers
BG12705 and BG14002
Fragm ent 3: PartlylacI gene,
term inator, PJ23119, sgRNA 3, 
term inator, and backbone from
pGCas9_sp3 am plified with prim ers
BG12722 and BG14003
pAcr_GCas9_spscr Gibson 
assem bly
Fragm ent 1: Prha, and AcrIIC1Nm e 
from pAcr am plified with prim ers
BG14000 and BG14001
GeoCas9 and sgRNA (spacer
scr) targeting the genom e-
integrated PlacUV5 and
AcrIIC1Nm e inhibiting
GeoCas9, in inhibition assays
(single-vector system ).
This study
Fragm ent 2: Term inator, GeoCas9, 5'
UTR, lac operator, Ptet, backbone,
PlacI, and partly lacI gene from
pGCas9_spscr am plified with 
prim ers BG12705 and BG14002
Fragm ent 3: PartlylacI gene,
term inator, PJ23119, sgRNA scr, 
term inator, and backbone from
pGCas9_spscr am plified with 
prim ers BG12722 and BG14003
pAcr_TCas9_sp1 Gibson 
assem bly
Fragm ent 1: Prha, and AcrIIC1Nm e 
from pAcr am plified with prim ers
BG14000 and BG14001
Therm oCas9 and sgRNA
(spacer 1) targeting the 
genom e-integrated PlacUV5
and AcrIIC1Nm e inhibiting
GeoCas9, in inhibition assays
(single-vector system ).
This study
Fragm ent 2: Term inator,
Therm oCas9, 5' UTR, lac operator, 
Ptet, backbone, PlacI, and partly lacI
gene from pTCas9_sp1 am plified 
with primers BG12705 and 
BG14002 
Fragment 3: Partly lacI gene, 
terminator, PJ23119, sgRNA 1, 
terminator, and backbone from 
pTCas9_sp1 amplified with primers 
BG12722 and BG14003 
pAcr_TCas9_sp2 Gibson 
assembly 
Fragment 1: Prha, and AcrIIC1Nme 
from pAcr amplified with primers 
BG14000 and BG14001 
ThermoCas9 and sgRNA 
(spacer 2) targeting the 
genome-integrated PlacUV5 
and AcrIIC1Nme inhibiting 
GeoCas9, in inhibition assays 
(single-vector system). 
This study 
Fragment 2: Terminator, 
ThermoCas9, 5' UTR, lac operator, 
Ptet, backbone, PlacI, and partly lacI 
gene from pTCas9_sp2 amplified 
with primers BG12705 and 
BG14002 
Fragment 3: Partly lacI gene, 
terminator, PJ23119, sgRNA 2, 
terminator, and backbone from 
pTCas9_sp2 amplified with primers 
BG12722 and BG14003 
pAcr_TCas9_sp3 Gibson 
assembly 
Fragment 1: Prha, and AcrIIC1Nme 
from pAcr amplified with primers 
BG14000 and BG14001 
ThermoCas9 and sgRNA 
(spacer 3) targeting the 
genome-integrated PlacUV5 
and AcrIIC1Nme inhibiting 
GeoCas9, in inhibition assays 
(single-vector system). 
This study 
Fragment 2: Terminator, 
ThermoCas9, 5' UTR, lac operator, 
Ptet, backbone, PlacI, and partly lacI 
gene from pTCas9_sp3 amplified 
with primers BG12705 and 
BG14002 
Fragment 3: Partly lacI gene, 
terminator, PJ23119, sgRNA 3, 
terminator, and backbone from 
pTCas9_sp3 amplified with primers 
BG12722 and BG14003 
pAcr_TCas9_spscr Gibson 
assembly 
Fragment 1: Prha, and AcrIIC1Nme 
from pAcr amplified with primers 
BG14000 and BG14001 
ThermoCas9 and sgRNA 
(spacer scr) targeting the 
genome-integrated PlacUV5 
and AcrIIC1Nme inhibiting 
GeoCas9, in inhibition assays 
(single-vector system). 
This study 
Fragment 2: Terminator, 
ThermoCas9, 5' UTR, lac operator, 
Ptet, backbone, PlacI, and partly lacI 
gene from pTCas9_spscr amplified 
with primers BG12705 and 
BG14002 
Fragment 3: Partly lacI gene, 
terminator, PJ23119, sgRNA scr, 
terminator, and backbone from 
pTCas9_spscr amplified with 
primers BG12722 and BG14003 
Supplementary Table 3: Strains used in this study 
Strain Description Plasmid Antibiotic 
resistance 
Reference 
E. coli
DH5α
Wild-type - - Lab stock 
E. coli
DH10Β
Wild-type - - Lab stock 
E. coli
DH10Β
Promoter lacUV5 and gfp gene integrated in the 
genome 
- - Lab stock 
E. coli
DH10Β
Promoter lacUV5 and gfp gene integrated in the 
genome 
pAcrIIC1Nme Ampicillin This study 
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BG12719 GTGCATGCAAGGAGATGG
*BG12705 GTCGACAGGATTAAACAAAAATGGCC
BG12706 GGTAGCTCAGAGAACCTTCG Sequencing of
pTCas9_sp1,
pTCas9_sp2,
pTCas9_sp3,
pTCas9_spscr,
pTCas9L551H_sp3,
pTCas9L551H_spscr,
pT-dCas9_sp1, pT-
dCas9_sp2, and pT-
dCas9_sp3, pT-
dCas9_spscr,
*pAcr_TCas9_sp1,
*pAcr_TCas9_sp2,
*pAcr_TCas9_sp3,
and
*pAcr_TCas9_spscr
BG12707 GTCGTATCGATGATTTTGATTGTTCG
BG12708 GCGTGAGATATAACGGGTATC
BG12709 GTAGACTTCGCCTTGTTCC
BG12710 GTTCCCATATTCGCGCTG
BG12712 ACGCGATGGATATGTTCTG
BG12713 CGAAGATTTAGGTGTCCGC
BG12714 CATACACATTCCAGTCCTTCACC
BG12715 CACCGGTCTCCATCCATATC
BG12716 CAACGCCGAGCGATATCG
BG12717 CCGTACTCTGAGTGGAAGG
BG12718 CAGTCGCGTACCGTCTTC
BG12719 GTGCATGCAAGGAGATGG
BG12721 CTGCGTTAGCAATTTAACTGTG
BG12722 GCAAACAGTCGTTGCTGATTG
BG12723 GTTAACCACCATCAAACAGG
*BG12705 GTCGACAGGATTAAACAAAAATGGCC
*BG14004 CAGTCGGGAAACCTGTCG
BG13437 CAATACGCAAACCGCCTC Sequencing of pAcr
BG13438 GAGACGGTCACAGCTTGTC
Supplementary Table 5: DNA sequences of Cas9 and anti-CRISPR genes used in this study
G ene DNA sequence (5'->3')
thermocas9 ATGAAGTATAAAATCGGTCTTGATATCGGCATTACGTCTATCGGTTGGGCTGTCATTAATTTGG
ACATTCCTCGCATCGAAGATTTAGGTGTCCGCATTTTTGACAGAGCGGAAAACCCGAAAACCG
GGGAGTCACTAGCTCTTCCACGTCGCCTCGCCCGCTCCGCCCGACGTCGTCTGCGGCGTCGCAA
ACATCGACTGGAGCGCATTCGCCGCCTGTTCGTCCGCGAAGGAATTTTAACGAAGGAAGAGCT
GAACAAGCTGTTTGAAAAAAAGCACGAAATCGACGTCTGGCAGCTTCGTGTTGAAGCACTGGA
TCGAAAACTAAATAACGATGAATTAGCCCGCATCCTTCTTCATCTGGCTAAACGGCGTGGATTT
AGATCCAACCGCAAGAGTGAGCGCACCAACAAAGAAAACAGTACGATGCTCAAACATATTGA
AGAAAACCAATCCATTCTTTCAAGTTACCGAACGGTTGCAGAAATGGTTGTCAAGGATCCGAA
ATTTTCCCTGCACAAGCGTAATAAAGAGGATAATTACACCAACACTGTTGCCCGCGACGATCTT
GAACGGGAAATCAAACTGATTTTCGCCAAACAGCGCGAATATGGGAACATCGTTTGCACAGAA
GCATTTGAACACGAGTATATTTCCATTTGGGCATCGCAACGCCCTTTTGCTTCTAAGGATGATA
TCGAGAAAAAAGTCGGTTTCTGTACGTTTGAGCCTAAAGAAAAACGCGCGCCAAAAGCAACAT
ACACATTCCAGTCCTTCACCGTCTGGGAACATATTAACAAACTTCGTCTTGTCTCCCCGGGAGG
CATCCGGGCACTAACCGATGATGAACGTCGTCTTATATACAAGCAAGCATTTCATAAAAATAA
AATCACCTTCCATGATGTTCGAACATTGCTTAACTTGCCTGACGACACCCGTTTTAAAGGTCTT
TTATATGACCGAAACACCACGCTGAAGGAAAATGAGAAAGTTCGCTTCCTTGAACTCGGCGCC
TATCATAAAATACGGAAAGCGATCGACAGCGTCTATGGCAAAGGAGCAGCAAAATCATTTCGT
CCGATTGATTTTGATACATTTGGCTACGCATTAACGATGTTTAAAGACGACACCGACATTCGCA
GTTACTTGCGAAACGAATACGAACAAAATGGAAAACGAATGGAAAATCTAGCGGATAAAGTC
TATGATGAAGAATTGATTGAAGAACTTTTAAACTTATCGTTTTCTAAGTTTGGTCATCTATCCCT
TAAAGCGCTTCGCAACATCCTTCCATATATGGAACAAGGCGAAGTCTACTCAACCGCTTGTGA
ACGAGCAGGATATACATTTACAGGGCCAAAGAAAAAACAGAAAACGGTATTGCTGCCGAACA
TTCCGCCGATCGCCAATCCGGTCGTCATGCGCGCACTGACACAGGCACGCAAAGTGGTCAATG
CCATTATCAAAAAGTACGGCTCACCGGTCTCCATCCATATCGAACTGGCCCGGGAACTATCAC
AATCCTTTGATGAACGACGTAAAATGCAGAAAGAACAGGAAGGAAACCGAAAGAAAAACGAA
ACTGCCATTCGCCAACTTGTTGAATATGGGCTGACGCTCAATCCAACTGGGCTTGACATTGTGA
AATTCAAACTATGGAGCGAACAAAACGGAAAATGTGCCTATTCACTCCAACCGATCGAAATCG
AGCGGTTGCTCGAACCAGGCTATACAGAAGTCGACCATGTGATTCCATACAGCCGAAGCTTGG
ACGATAGCTATACCAATAAAGTTCTTGTGTTGACAAAGGAGAACCGTGAAAAAGGAAACCGC
ACCCCAGCTGAATATTTAGGATTAGGCTCAGAACGTTGGCAACAGTTCGAGACGTTTGTCTTGA
CAAATAAGCAGTTTTCGAAAAAGAAGCGGGATCGACTCCTTCGGCTTCATTACGATGAAAACG
AAGAAAATGAGTTTAAAAATCGTAATCTAAATGATACCCGTTATATCTCACGCTTCTTGGCTAA
CTTTATTCGCGAACATCTCAAATTCGCCGACAGCGATGACAAACAAAAAGTATACACGGTCAA
CGGCCGTATTACCGCCCATTTACGCAGCCGTTGGAATTTTAACAAAAACCGGGAAGAATCGAA
TTTGCATCATGCCGTCGATGCTGCCATCGTCGCCTGCACAACGCCGAGCGATATCGCCCGAGTC
ACCGCCTTCTATCAACGGCGCGAACAAAACAAAGAACTGTCCAAAAAGACGGATCCGCAGTTT
CCGCAGCCTTGGCCGCACTTTGCTGATGAACTGCAGGCGCGTTTATCAAAAAATCCAAAGGAG
AGTATAAAAGCTCTCAATCTTGGAAATTATGATAACGAGAAACTCGAATCGTTGCAGCCGGTT
Supplementary Table 4: Primers/Oligonucleotides used in this study 
Primer/ 
Oligo ID 
Sequence (5' -> 3') Function 
T
ar
ge
ti
n
g,
 in
h
ib
it
io
n
 
BG13307 tcataagcaggccattttgtctgatTTAGTCACGAGTAGATTGCAGTG Construction of 
pGCas9_sp1, 
pGCas9_sp2, 
pGCas9_sp3, 
pGCas9_spscr 
BG13310 ttgctaacgcagtcaggcaccgtgtATGCGTTATAAGATTGGCCTGG 
BG13311 ACACGGTGCCTGACTG 
BG13312 tttttggtccatcagtcgattctgaTCACTGCCCGCTTTCC 
BG13313 TCAGAATCGACTGATGGACC 
BG13309 ATCAGACAAAATGGCCTGC 
BG13459 tatcaagaccgattttatacttcatACACGGTGCCTGACTG Construction of 
pTCas9_sp1, 
pTCas9_sp2, 
pTCas9_sp3, 
pTCas9_spscr 
BG13460 cggggaaactatccgtccgttataaATCAGACAAAATGGCCTGCTTATG 
BG13461 TTATAACGGACGGATAGTTTCCC 
BG13462 ATGAAGTATAAAATCGGTCTTGATATCGG 
In
h
ib
it
io
n
 (
d
u
al
-  v
ec
to
r 
ap
p
ro
ac
h
),
 
BG13427 aagcgggcagtgagcgcaacgcaatCACCACAATTCAGCAAATTGTG Construction of pAcr 
BG13428 ATGTATATCTCCTTCTTATAGTTAAACAAAATTATTTCTAG 
BG13429 ttaactataagaaggagatatacatATGAATAAAACATATAAAATCGGAAAAAATG
CGG 
BG13430 gctcagcggtggcggccgctctaggTCATAGTTCAACAAACTCCCAACATG 
BG13431 CCTAGAGCGGCCGCCACCGCTGAGCAATAACTAGCATAACCCCTTG
GGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG 
BG13432 CAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATGCT
AGTTATTGCTCAGCGGTGGCGGCCGCTCTAGG 
BG13433 taaacgggtcttgaggggttttttgTTAAGCCAGCCCCGAC 
BG13434 ATTGCGTTGCGCTCAC 
BG13459 tatcaagaccgattttatacttcatACACGGTGCCTGACTG Construction of 
pTCas9L551H_sp3 
pTCas9L551H_spscr 
BG13460 cggggaaactatccgtccgttataaATCAGACAAAATGGCCTGCTTATG 
BG13461 TTATAACGGACGGATAGTTTCCC 
BG13462 ATGAAGTATAAAATCGGTCTTGATATCGG 
Sp
ec
tr
op
ho
to
m
et
ry
 BG13680 gatcacaGCatctacttcaacgtaac Construction of 
pG-dCas9_sp1, 
pG-dCas9_sp2, 
pG-dCas9_sp3, 
pG-dCas9_spscr 
BG13681 gcctggccatcggtattac 
BG13682 gtaataccgatggccaggc 
BG13683 gttacgttgaagtagatGCtgtgatc 
BG12625 atcttattaatcagataaaatatttGTCGACAGGATTAAACAAAAATGGC Construction of 
pT-dCas9_sp1, 
pT-dCas9_sp2, 
pT-dCas9_sp3, 
pT-dCas9_spscr 
BG13684 ttgctaacgcagtcaggcaccgtgtATGAAGTATAAAATCGGTCTTGCTATCG 
BG13311 ACACGGTGCCTGACTG 
BG13685 aaatattttatctgattaataagatgatcttcttgagatcg 
In
h
ib
it
io
n
 a
ss
ay
s 
BG14000 atcttattaatcagataaaatatttCACCACAATTCAGCAAATTGTG Construction of 
pAcr_GCas9_sp1, 
pAcr_GCas9_sp2, 
pAcr_GCas9_sp3, 
pAcr_GCas9_spscr, 
pAcr_TCas9_sp1, 
pAcr_TCas9_sp2, 
pAcr_TCas9_sp3, 
pAcr_TCas9_spscr 
BG14001  gccatttttgtttaatcctgtcgacTCATAGTTCAACAAACTCCCAACATG 
BG12705 GTCGACAGGATTAAACAAAAATGGCC 
BG14002  CAATCAGCAACGACTGTTTGC 
BG12722 GCAAACAGTCGTTGCTGATTG 
BG14003  AAATATTTTATCTGATTAATAAGATGATCTTCTTGAGATCG 
S
eq
u
en
ci
n
g 
BG12706 GGTAGCTCAGAGAACCTTCG Sequencing of 
pGCas9_sp1, 
pGCas9_sp2, 
pGCas9_sp3, 
pGCas9_spscr,  
pG-dCas9_sp1, 
 pG-dCas9_sp2,  
pG-dCas9_sp3,  
pG-dCas9_spscr, 
*pAcr_GCas9_sp1,
*pAcr_GCas9_sp2,
*pAcr_GCas9_sp3,
*pAcr_GCas9_spscr
BG12712 ACGCGATGGATATGTTCTG 
BG13157 GCGAATTCGGCAACATGTC 
BG13158 CAGGGTGAAGTCTACTCCTC 
BG13159 GCTACATCAGCCGCTTCTTC 
BG13160 GTCTGCTGGAGCATAACAAC 
BG13161 GCACCCTGAAACGTTTCG 
BG13163 CGAAACGTGTAATCTTCGGTC 
BG13164 GGCCAGTTCCTTGTTCTG 
BG13165 CGGTTTTCATCCTGTTCC 
BG13166 CTGGAATGCTTGTTCATACAGC 
BG13167 CGCTCCAGACGGTGTTTAC 
BG12721 CTGCGTTAGCAATTTAACTGTG 
BG12722 GCAAACAGTCGTTGCTGATTG 
BG12723 GTTAACCACCATCAAACAGG 
BG12718 CAGTCGCGTACCGTCTTC 
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Primer/
O ligo ID
Sequence (5' -> 3') Function
T
ar
ge
ti
n
g,
in
h
ib
it
io
n
 (
d
u
al
- BG13307 tcataagcaggccattttgtctgatTTAGTCACGAGTAGATTGCAGTG Construction of
pGCas9_sp1,
pGCas9_sp2,
pGCas9_sp3,
pGCas9_spscr
BG13310 ttgctaacgcagtcaggcaccgtgtATGCGTTATAAGATTGGCCTGG
BG13311 ACACGGTGCCTGACTG
BG13312 tttttggtccatcagtcgattctgaTCACTGCCCGCTTTCC
BG13313 TCAGAATCGACTGATGGACC
BG13309 ATCAGACAAAATGGCCTGC
BG13459 tatcaagaccgattttatacttcatACACGGTGCCTGACTG Construction of
pTCas9_sp1,
pTCas9_sp2,
pTCas9_sp3,
pTCas9_spscr
BG13460 cggggaaactatccgtccgttataaATCAGACAAAATGGCCTGCTTATG
BG13461 TTATAACGGACGGATAGTTTCCC
BG13462 ATGAAGTATAAAATCGGTCTTGATATCGG
In
h
ib
it
io
n
 (
d
u
al
-v
ec
to
r 
ap
p
ro
ac
h
),
BG13427 aagcgggcagtgagcgcaacgcaatCACCACAATTCAGCAAATTGTG Construction of pAcr
BG13428 ATGTATATCTCCTTCTTATAGTTAAACAAAATTATTTCTAG
BG13429 ttaactataagaaggagatatacatATGAATAAAACATATAAAATCGGAAAAAATG
CGG
BG13430 gctcagcggtggcggccgctctaggTCATAGTTCAACAAACTCCCAACATG
BG13431 CCTAGAGCGGCCGCCACCGCTGAGCAATAACTAGCATAACCCCTTG
GGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG
BG13432 CAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATGCT
AGTTATTGCTCAGCGGTGGCGGCCGCTCTAGG
BG13433 taaacgggtcttgaggggttttttgTTAAGCCAGCCCCGAC
BG13434 ATTGCGTTGCGCTCAC
BG13459 tatcaagaccgattttatacttcatACACGGTGCCTGACTG Construction of
pTCas9L551H_sp3
pTCas9L551H_spscr
BG13460 cggggaaactatccgtccgttataaATCAGACAAAATGGCCTGCTTATG
BG13461 TTATAACGGACGGATAGTTTCCC
BG13462 ATGAAGTATAAAATCGGTCTTGATATCGG
S
p
ec
tr
op
h
ot
om
et
ry
- 
an
d BG13680 gatcacaGCatctacttcaacgtaac Construction of
pG-dCas9_sp1,
pG-dCas9_sp2,
pG-dCas9_sp3,
pG-dCas9_spscr
BG13681 gcctggccatcggtattac
BG13682 gtaataccgatggccaggc
BG13683 gttacgttgaagtagatGCtgtgatc
BG12625 atcttattaatcagataaaatatttGTCGACAGGATTAAACAAAAATGGC Construction of
pT-dCas9_sp1,
pT-dCas9_sp2,
pT-dCas9_sp3,
pT-dCas9_spscr
BG13684 ttgctaacgcagtcaggcaccgtgtATGAAGTATAAAATCGGTCTTGCTATCG
BG13311 ACACGGTGCCTGACTG
BG13685 aaatattttatctgattaataagatgatcttcttgagatcg
In
h
ib
it
io
n
as
sa
ys
 
BG14000 atcttattaatcagataaaatatttCACCACAATTCAGCAAATTGTG Construction of
pAcr_GCas9_sp1,
pAcr_GCas9_sp2,
pAcr_GCas9_sp3,
pAcr_GCas9_spscr,
pAcr_TCas9_sp1,
pAcr_TCas9_sp2,
pAcr_TCas9_sp3,
pAcr_TCas9_spscr
BG14001 gccatttttgtttaatcctgtcgacTCATAGTTCAACAAACTCCCAACATG
BG12705 GTCGACAGGATTAAACAAAAATGGCC
BG14002 CAATCAGCAACGACTGTTTGC
BG12722 GCAAACAGTCGTTGCTGATTG
BG14003 AAATATTTTATCTGATTAATAAGATGATCTTCTTGAGATCG
S
eq
u
en
ci
n
g
BG12706 GGTAGCTCAGAGAACCTTCG Sequencing of
pGCas9_sp1,
pGCas9_sp2,
pGCas9_sp3,
pGCas9_spscr,
pG-dCas9_sp1,
pG-dCas9_sp2,
pG-dCas9_sp3,
pG-dCas9_spscr,
*pAcr_GCas9_sp1,
*pAcr_GCas9_sp2,
*pAcr_GCas9_sp3,
*pAcr_GCas9_spscr
BG12712 ACGCGATGGATATGTTCTG
BG13157 GCGAATTCGGCAACATGTC
BG13158 CAGGGTGAAGTCTACTCCTC
BG13159 GCTACATCAGCCGCTTCTTC
BG13160 GTCTGCTGGAGCATAACAAC
BG13161 GCACCCTGAAACGTTTCG
BG13163 CGAAACGTGTAATCTTCGGTC
BG13164 GGCCAGTTCCTTGTTCTG
BG13165 CGGTTTTCATCCTGTTCC
BG13166 CTGGAATGCTTGTTCATACAGC
BG13167 CGCTCCAGACGGTGTTTAC
BG12721 CTGCGTTAGCAATTTAACTGTG
BG12722 GCAAACAGTCGTTGCTGATTG
BG12723 GTTAACCACCATCAAACAGG
BG12718 CAGTCGCGTACCGTCTTC
BG12719 GTGCATGCAAGGAGATGG 
*BG12705 GTCGACAGGATTAAACAAAAATGGCC 
BG12706 GGTAGCTCAGAGAACCTTCG Sequencing of 
pTCas9_sp1, 
pTCas9_sp2, 
pTCas9_sp3, 
pTCas9_spscr, 
pTCas9L551H_sp3, 
pTCas9L551H_spscr, 
pT-dCas9_sp1, pT-
dCas9_sp2, and pT-
dCas9_sp3, pT-
dCas9_spscr, 
*pAcr_TCas9_sp1,
*pAcr_TCas9_sp2,
*pAcr_TCas9_sp3,
and
*pAcr_TCas9_spscr
BG12707 GTCGTATCGATGATTTTGATTGTTCG 
BG12708 GCGTGAGATATAACGGGTATC 
BG12709 GTAGACTTCGCCTTGTTCC 
BG12710 GTTCCCATATTCGCGCTG 
BG12712 ACGCGATGGATATGTTCTG 
BG12713 CGAAGATTTAGGTGTCCGC 
BG12714 CATACACATTCCAGTCCTTCACC 
BG12715 CACCGGTCTCCATCCATATC 
BG12716 CAACGCCGAGCGATATCG 
BG12717 CCGTACTCTGAGTGGAAGG 
BG12718 CAGTCGCGTACCGTCTTC 
BG12719 GTGCATGCAAGGAGATGG 
BG12721 CTGCGTTAGCAATTTAACTGTG 
BG12722 GCAAACAGTCGTTGCTGATTG 
BG12723 GTTAACCACCATCAAACAGG 
*BG12705 GTCGACAGGATTAAACAAAAATGGCC 
*BG14004  CAGTCGGGAAACCTGTCG 
BG13437 CAATACGCAAACCGCCTC Sequencing of pAcr 
BG13438 GAGACGGTCACAGCTTGTC 
Supplementary Table 5: DNA sequences of Cas9 and anti-CRISPR genes used in this study 
Gene DNA sequence (5'->3') 
thermocas9 ATGAAGTATAAAATCGGTCTTGATATCGGCATTACGTCTATCGGTTGGGCTGTCATTAATTTGG
ACATTCCTCGCATCGAAGATTTAGGTGTCCGCATTTTTGACAGAGCGGAAAACCCGAAAACCG
GGGAGTCACTAGCTCTTCCACGTCGCCTCGCCCGCTCCGCCCGACGTCGTCTGCGGCGTCGCAA
ACATCGACTGGAGCGCATTCGCCGCCTGTTCGTCCGCGAAGGAATTTTAACGAAGGAAGAGCT
GAACAAGCTGTTTGAAAAAAAGCACGAAATCGACGTCTGGCAGCTTCGTGTTGAAGCACTGGA
TCGAAAACTAAATAACGATGAATTAGCCCGCATCCTTCTTCATCTGGCTAAACGGCGTGGATTT
AGATCCAACCGCAAGAGTGAGCGCACCAACAAAGAAAACAGTACGATGCTCAAACATATTGA
AGAAAACCAATCCATTCTTTCAAGTTACCGAACGGTTGCAGAAATGGTTGTCAAGGATCCGAA
ATTTTCCCTGCACAAGCGTAATAAAGAGGATAATTACACCAACACTGTTGCCCGCGACGATCTT
GAACGGGAAATCAAACTGATTTTCGCCAAACAGCGCGAATATGGGAACATCGTTTGCACAGAA
GCATTTGAACACGAGTATATTTCCATTTGGGCATCGCAACGCCCTTTTGCTTCTAAGGATGATA
TCGAGAAAAAAGTCGGTTTCTGTACGTTTGAGCCTAAAGAAAAACGCGCGCCAAAAGCAACAT
ACACATTCCAGTCCTTCACCGTCTGGGAACATATTAACAAACTTCGTCTTGTCTCCCCGGGAGG
CATCCGGGCACTAACCGATGATGAACGTCGTCTTATATACAAGCAAGCATTTCATAAAAATAA
AATCACCTTCCATGATGTTCGAACATTGCTTAACTTGCCTGACGACACCCGTTTTAAAGGTCTT
TTATATGACCGAAACACCACGCTGAAGGAAAATGAGAAAGTTCGCTTCCTTGAACTCGGCGCC
TATCATAAAATACGGAAAGCGATCGACAGCGTCTATGGCAAAGGAGCAGCAAAATCATTTCGT
CCGATTGATTTTGATACATTTGGCTACGCATTAACGATGTTTAAAGACGACACCGACATTCGCA
GTTACTTGCGAAACGAATACGAACAAAATGGAAAACGAATGGAAAATCTAGCGGATAAAGTC
TATGATGAAGAATTGATTGAAGAACTTTTAAACTTATCGTTTTCTAAGTTTGGTCATCTATCCCT
TAAAGCGCTTCGCAACATCCTTCCATATATGGAACAAGGCGAAGTCTACTCAACCGCTTGTGA
ACGAGCAGGATATACATTTACAGGGCCAAAGAAAAAACAGAAAACGGTATTGCTGCCGAACA
TTCCGCCGATCGCCAATCCGGTCGTCATGCGCGCACTGACACAGGCACGCAAAGTGGTCAATG
CCATTATCAAAAAGTACGGCTCACCGGTCTCCATCCATATCGAACTGGCCCGGGAACTATCAC
AATCCTTTGATGAACGACGTAAAATGCAGAAAGAACAGGAAGGAAACCGAAAGAAAAACGAA
ACTGCCATTCGCCAACTTGTTGAATATGGGCTGACGCTCAATCCAACTGGGCTTGACATTGTGA
AATTCAAACTATGGAGCGAACAAAACGGAAAATGTGCCTATTCACTCCAACCGATCGAAATCG
AGCGGTTGCTCGAACCAGGCTATACAGAAGTCGACCATGTGATTCCATACAGCCGAAGCTTGG
ACGATAGCTATACCAATAAAGTTCTTGTGTTGACAAAGGAGAACCGTGAAAAAGGAAACCGC
ACCCCAGCTGAATATTTAGGATTAGGCTCAGAACGTTGGCAACAGTTCGAGACGTTTGTCTTGA
CAAATAAGCAGTTTTCGAAAAAGAAGCGGGATCGACTCCTTCGGCTTCATTACGATGAAAACG
AAGAAAATGAGTTTAAAAATCGTAATCTAAATGATACCCGTTATATCTCACGCTTCTTGGCTAA
CTTTATTCGCGAACATCTCAAATTCGCCGACAGCGATGACAAACAAAAAGTATACACGGTCAA
CGGCCGTATTACCGCCCATTTACGCAGCCGTTGGAATTTTAACAAAAACCGGGAAGAATCGAA
TTTGCATCATGCCGTCGATGCTGCCATCGTCGCCTGCACAACGCCGAGCGATATCGCCCGAGTC
ACCGCCTTCTATCAACGGCGCGAACAAAACAAAGAACTGTCCAAAAAGACGGATCCGCAGTTT
CCGCAGCCTTGGCCGCACTTTGCTGATGAACTGCAGGCGCGTTTATCAAAAAATCCAAAGGAG
AGTATAAAAGCTCTCAATCTTGGAAATTATGATAACGAGAAACTCGAATCGTTGCAGCCGGTT
204
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acrIIC1Nme ATGAATAAAACATATAAAATCGGAAAAAATGCGGGATATGACGGCTGCGGGTTATGTTTAGCC
GCGATCTCAGAAAATGAAGCTATTAAAGTTAAGTATCTGCGCGATATCTGTCCAGACTATGAC
GGCGACGACAAAGCTGAGGACTGGCTGAGATGGGGAACGGATAGCCGCGTGAAAGCTGCGGC
TTTAGAAATGGAGCAATATGCTTATACGTCGGTTGGGATGGCGTCATGTTGGGAGTTTGTTGAA
CTATGA
TTTGTCTCCCGAATGCCGAAGCGGAGCATAACAGGAGCGGCTCATCAAGAAACATTGCGGCGT
TATATCGGCATCGACGAACGGAGCGGAAAAATACAGACGGTCGTCAAAAAGAAACTATCCGA
GATCCAACTGGATAAAACAGGTCATTTCCCAATGTACGGGAAAGAAAGCGATCCAAGGACAT
ATGAAGCCATTCGCCAACGGTTGCTTGAACATAACAATGACCCAAAAAAGGCGTTTCAAGAGC
CTCTGTATAAACCGAAGAAGAACGGAGAACTAGGTCCTATCATCCGAACAATCAAAATCATCG
ATACGACAAATCAAGTTATTCCGCTCAACGATGGCAAAACAGTCGCCTACAACAGCAACATCG
TGCGGGTCGACGTCTTTGAGAAAGATGGCAAATATTATTGTGTCCCTATCTATACAATAGATAT
GATGAAAGGGATCTTGCCAAACAAGGCGATCGAGCCGAACAAACCGTACTCTGAGTGGAAGG
AAATGACGGAGGACTATACATTCCGATTCAGTCTATACCCAAATGATCTTATCCGTATCGAATT
TCCCCGAGAAAAAACAATAAAGACTGCTGTGGGGGAAGAAATCAAAATTAAGGATCTGTTCG
CCTATTATCAAACCATCGACTCCTCCAATGGAGGGTTAAGTTTGGTTAGCCATGATAACAACTT
TTCGCTCCGCAGCATCGGTTCAAGAACCCTCAAACGATTCGAGAAATACCAAGTAGATGTGCT
AGGCAACATCTACAAAGTGAGAGGGGAAAAGAGAGTTGGGGTGGCGTCATCTTCTCATTCGAA
AGCCGGGGAAACTATCCGTCCGTTATAA 
geocas9 ATGCGTTATAAGATTGGCCTGGACATCGGTATTACCTCTGTTGGTTGGGCAGTCATGAACCTGG
ATATCCCTCGTATCGAAGATCTGGGCGTGCGCATTTTTGACCGTGCGGAGAACCCGCAGACCG
GTGAATCTCTGGCTCTGCCGCGTCGTCTGGCACGTAGCGCACGCCGCCGCCTGCGTCGTCGTAA
ACACCGTCTGGAGCGTATTCGTCGCCTGGTTATTCGTGAAGGCATCCTGACGAAAGAAGAACT
GGATAAACTGTTCGAAGAAAAACACGAGATCGACGTATGGCAGCTGCGTGTAGAAGCCCTGG
ACCGTAAGCTGAACAACGACGAACTGGCGCGTGTCCTGCTGCATCTGGCAAAGCGTCGTGGCT
TCAAATCTAACCGTAAATCTGAACGCTCCAATAAAGAGAACTCCACTATGCTGAAACATATTG
AGGAGAACCGTGCAATTCTGTCTAGCTACCGTACCGTGGGCGAAATGATTGTTAAAGACCCGA
AATTCGCACTGCATAAGCGTAACAAAGGCGAAAACTACACCAACACCATTGCACGCGATGACC
TGGAACGTGAAATCCGTCTGATTTTCTCCAAACAGCGCGAATTCGGCAACATGTCTTGCACCGA
AGAATTCGAAAACGAATATATTACCATTTGGGCATCTCAGCGTCCGGTGGCGTCTAAAGATGA
TATCGAAAAAAAAGTAGGCTTTTGTACTTTCGAACCGAAGGAAAAACGTGCGCCGAAAGCCAC
CTATACCTTCCAGTCTTTTATCGCGTGGGAACATATCAACAAACTGCGTCTGATTTCTCCGTCTG
GCGCCCGCGGCCTGACCGACGAAGAACGTCGTCTGCTGTATGAACAAGCATTCCAGAAAAACA
AAATTACCTACCACGATATTCGTACCCTGCTGCATCTGCCGGACGACACCTACTTCAAGGGCAT
CGTTTACGATCGCGGTGAATCTCGTAAGCAGAACGAAAACATTCGTTTCCTGGAACTGGATGC
ATACCACCAGATCCGTAAAGCTGTAGATAAAGTTTACGGCAAGGGTAAATCCAGCAGCTTCCT
GCCGATCGACTTTGATACCTTCGGTTACGCGCTGACCCTGTTTAAAGACGATGCGGATATCCAC
TCTTACCTGCGCAACGAGTACGAACAGAACGGCAAACGTATGCCTAACCTGGCTAACAAAGTT
TACGATAACGAGCTGATTGAAGAACTGCTGAACCTGTCCTTCACTAAATTCGGTCACCTGTCTC
TGAAAGCTCTGCGTTCCATCCTGCCGTATATGGAACAGGGTGAAGTCTACTCCTCCGCTTGTGA
ACGTGCAGGCTACACCTTCACCGGTCCGAAAAAGAAGCAAAAAACTATGCTGCTGCCGAACAT
CCCGCCGATTGCGAACCCTGTAGTAATGCGTGCACTGACCCAGGCGCGCAAAGTAGTCAACGC
GATCATCAAAAAGTACGGCAGCCCGGTTTCCATCCATATCGAACTGGCGCGCGACCTGAGCCA
GACTTTTGACGAGCGTCGTAAAACTAAAAAGGAACAGGATGAAAACCGTAAAAAAAACGAAA
CCGCGATCCGCCAGCTGATGGAATACGGTCTGACTCTGAACCCTACTGGTCACGATATTGTGA
AGTTCAAGCTGTGGTCTGAACAGAACGGTCGCTGTGCTTACTCTCTGCAGCCGATCGAGATCG
AACGTCTGCTGGAGCCAGGTTACGTTGAAGTAGATCATGTGATCCCGTACTCCCGCTCTCTGGA
TGATTCTTATACCAACAAAGTTCTGGTTCTGACTCGCGAAAACCGTGAGAAAGGCAACCGCAT
CCCAGCTGAATATCTGGGTGTTGGCACTGAGCGTTGGCAACAGTTCGAAACCTTCGTCCTGACC
AATAAACAGTTCTCTAAAAAGAAACGTGACCGTCTGCTGCGTCTGCACTACGATGAAAACGAA
GAGACTGAATTCAAAAACCGTAACCTGAACGATACTCGCTACATCAGCCGCTTCTTCGCAAAC
TTCATTCGTGAACACCTGAAATTTGCGGAATCCGACGATAAACAGAAAGTTTATACCGTAAAC
GGCCGTGTTACCGCCCACCTGCGTTCTCGCTGGGAGTTCAACAAGAACCGTGAGGAAAGCGAT
CTGCACCACGCTGTTGACGCCGTTATTGTGGCGTGCACCACCCCAAGCGATATCGCTAAGGTG
ACCGCATTCTACCAGCGTCGTGAGCAGAACAAGGAACTGGCCAAAAAAACCGAACCGCATTTT
CCGCAGCCGTGGCCGCACTTCGCGGACGAACTGCGTGCTCGTCTGTCCAAACATCCTAAAGAA
AGCATCAAAGCTCTGAACCTGGGTAACTACGATGACCAAAAACTGGAATCTCTGCAGCCGGTG
TTTGTCAGCCGTATGCCGAAACGTTCTGTTACTGGCGCTGCGCACCAGGAAACGCTGCGCCGTT
ACGTGGGCATCGACGAACGCTCCGGTAAAATCCAGACCGTAGTAAAAACCAAACTGTCCGAG
ATTAAACTGGATGCATCCGGCCACTTCCCAATGTACGGTAAAGAATCCGATCCACGCACTTAT
GAAGCCATCCGCCAGCGTCTGCTGGAGCATAACAACGACCCGAAAAAGGCATTCCAGGAGCC
TCTGTACAAACCGAAAAAAAACGGCGAACCGGGCCCGGTAATCCGTACTGTAAAAATTATCGA
CACGAAAAACCAGGTGATCCCTCTGAACGATGGTAAAACCGTGGCCTACAATTCCAACATCGT
TCGCGTGGACGTGTTCGAAAAAGATGGTAAATACTACTGTGTACCGGTGTATACCATGGACAT
CATGAAAGGCATTCTGCCGAACAAAGCGATTGAACCGAACAAGCCGTACTCTGAATGGAAAG
AAATGACCGAAGATTACACGTTTCGTTTCAGCCTGTATCCGAACGACCTGATCCGCATCGAACT
GCCGCGTGAAAAAACCGTTAAAACCGCTGCAGGCGAAGAAATTAACGTGAAAGACGTGTTCG
TTTACTATAAAACGATCGACTCCGCAAACGGCGGCCTGGAACTGATTTCTCACGACCACCGTTT
CTCTCTGCGTGGCGTTGGCTCTCGCACCCTGAAACGTTTCGAGAAATATCAAGTTGATGTTCTG
GGTAACATCTATAAAGTGCGTGGCGAGAAACGTGTCGGTCTGGCGTCCTCCGCACACAGCAAA
CCTGGCAAAACCATTCGTCCACTGCAATCTACTCGTGACTAA 
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TTTGTCTCCCGAATGCCGAAGCGGAGCATAACAGGAGCGGCTCATCAAGAAACATTGCGGCGT
TATATCGGCATCGACGAACGGAGCGGAAAAATACAGACGGTCGTCAAAAAGAAACTATCCGA
GATCCAACTGGATAAAACAGGTCATTTCCCAATGTACGGGAAAGAAAGCGATCCAAGGACAT
ATGAAGCCATTCGCCAACGGTTGCTTGAACATAACAATGACCCAAAAAAGGCGTTTCAAGAGC
CTCTGTATAAACCGAAGAAGAACGGAGAACTAGGTCCTATCATCCGAACAATCAAAATCATCG
ATACGACAAATCAAGTTATTCCGCTCAACGATGGCAAAACAGTCGCCTACAACAGCAACATCG
TGCGGGTCGACGTCTTTGAGAAAGATGGCAAATATTATTGTGTCCCTATCTATACAATAGATAT
GATGAAAGGGATCTTGCCAAACAAGGCGATCGAGCCGAACAAACCGTACTCTGAGTGGAAGG
AAATGACGGAGGACTATACATTCCGATTCAGTCTATACCCAAATGATCTTATCCGTATCGAATT
TCCCCGAGAAAAAACAATAAAGACTGCTGTGGGGGAAGAAATCAAAATTAAGGATCTGTTCG
CCTATTATCAAACCATCGACTCCTCCAATGGAGGGTTAAGTTTGGTTAGCCATGATAACAACTT
TTCGCTCCGCAGCATCGGTTCAAGAACCCTCAAACGATTCGAGAAATACCAAGTAGATGTGCT
AGGCAACATCTACAAAGTGAGAGGGGAAAAGAGAGTTGGGGTGGCGTCATCTTCTCATTCGAA
AGCCGGGGAAACTATCCGTCCGTTATAA
geocas9 ATGCGTTATAAGATTGGCCTGGACATCGGTATTACCTCTGTTGGTTGGGCAGTCATGAACCTGG
ATATCCCTCGTATCGAAGATCTGGGCGTGCGCATTTTTGACCGTGCGGAGAACCCGCAGACCG
GTGAATCTCTGGCTCTGCCGCGTCGTCTGGCACGTAGCGCACGCCGCCGCCTGCGTCGTCGTAA
ACACCGTCTGGAGCGTATTCGTCGCCTGGTTATTCGTGAAGGCATCCTGACGAAAGAAGAACT
GGATAAACTGTTCGAAGAAAAACACGAGATCGACGTATGGCAGCTGCGTGTAGAAGCCCTGG
ACCGTAAGCTGAACAACGACGAACTGGCGCGTGTCCTGCTGCATCTGGCAAAGCGTCGTGGCT
TCAAATCTAACCGTAAATCTGAACGCTCCAATAAAGAGAACTCCACTATGCTGAAACATATTG
AGGAGAACCGTGCAATTCTGTCTAGCTACCGTACCGTGGGCGAAATGATTGTTAAAGACCCGA
AATTCGCACTGCATAAGCGTAACAAAGGCGAAAACTACACCAACACCATTGCACGCGATGACC
TGGAACGTGAAATCCGTCTGATTTTCTCCAAACAGCGCGAATTCGGCAACATGTCTTGCACCGA
AGAATTCGAAAACGAATATATTACCATTTGGGCATCTCAGCGTCCGGTGGCGTCTAAAGATGA
TATCGAAAAAAAAGTAGGCTTTTGTACTTTCGAACCGAAGGAAAAACGTGCGCCGAAAGCCAC
CTATACCTTCCAGTCTTTTATCGCGTGGGAACATATCAACAAACTGCGTCTGATTTCTCCGTCTG
GCGCCCGCGGCCTGACCGACGAAGAACGTCGTCTGCTGTATGAACAAGCATTCCAGAAAAACA
AAATTACCTACCACGATATTCGTACCCTGCTGCATCTGCCGGACGACACCTACTTCAAGGGCAT
CGTTTACGATCGCGGTGAATCTCGTAAGCAGAACGAAAACATTCGTTTCCTGGAACTGGATGC
ATACCACCAGATCCGTAAAGCTGTAGATAAAGTTTACGGCAAGGGTAAATCCAGCAGCTTCCT
GCCGATCGACTTTGATACCTTCGGTTACGCGCTGACCCTGTTTAAAGACGATGCGGATATCCAC
TCTTACCTGCGCAACGAGTACGAACAGAACGGCAAACGTATGCCTAACCTGGCTAACAAAGTT
TACGATAACGAGCTGATTGAAGAACTGCTGAACCTGTCCTTCACTAAATTCGGTCACCTGTCTC
TGAAAGCTCTGCGTTCCATCCTGCCGTATATGGAACAGGGTGAAGTCTACTCCTCCGCTTGTGA
ACGTGCAGGCTACACCTTCACCGGTCCGAAAAAGAAGCAAAAAACTATGCTGCTGCCGAACAT
CCCGCCGATTGCGAACCCTGTAGTAATGCGTGCACTGACCCAGGCGCGCAAAGTAGTCAACGC
GATCATCAAAAAGTACGGCAGCCCGGTTTCCATCCATATCGAACTGGCGCGCGACCTGAGCCA
GACTTTTGACGAGCGTCGTAAAACTAAAAAGGAACAGGATGAAAACCGTAAAAAAAACGAAA
CCGCGATCCGCCAGCTGATGGAATACGGTCTGACTCTGAACCCTACTGGTCACGATATTGTGA
AGTTCAAGCTGTGGTCTGAACAGAACGGTCGCTGTGCTTACTCTCTGCAGCCGATCGAGATCG
AACGTCTGCTGGAGCCAGGTTACGTTGAAGTAGATCATGTGATCCCGTACTCCCGCTCTCTGGA
TGATTCTTATACCAACAAAGTTCTGGTTCTGACTCGCGAAAACCGTGAGAAAGGCAACCGCAT
CCCAGCTGAATATCTGGGTGTTGGCACTGAGCGTTGGCAACAGTTCGAAACCTTCGTCCTGACC
AATAAACAGTTCTCTAAAAAGAAACGTGACCGTCTGCTGCGTCTGCACTACGATGAAAACGAA
GAGACTGAATTCAAAAACCGTAACCTGAACGATACTCGCTACATCAGCCGCTTCTTCGCAAAC
TTCATTCGTGAACACCTGAAATTTGCGGAATCCGACGATAAACAGAAAGTTTATACCGTAAAC
GGCCGTGTTACCGCCCACCTGCGTTCTCGCTGGGAGTTCAACAAGAACCGTGAGGAAAGCGAT
CTGCACCACGCTGTTGACGCCGTTATTGTGGCGTGCACCACCCCAAGCGATATCGCTAAGGTG
ACCGCATTCTACCAGCGTCGTGAGCAGAACAAGGAACTGGCCAAAAAAACCGAACCGCATTTT
CCGCAGCCGTGGCCGCACTTCGCGGACGAACTGCGTGCTCGTCTGTCCAAACATCCTAAAGAA
AGCATCAAAGCTCTGAACCTGGGTAACTACGATGACCAAAAACTGGAATCTCTGCAGCCGGTG
TTTGTCAGCCGTATGCCGAAACGTTCTGTTACTGGCGCTGCGCACCAGGAAACGCTGCGCCGTT
ACGTGGGCATCGACGAACGCTCCGGTAAAATCCAGACCGTAGTAAAAACCAAACTGTCCGAG
ATTAAACTGGATGCATCCGGCCACTTCCCAATGTACGGTAAAGAATCCGATCCACGCACTTAT
GAAGCCATCCGCCAGCGTCTGCTGGAGCATAACAACGACCCGAAAAAGGCATTCCAGGAGCC
TCTGTACAAACCGAAAAAAAACGGCGAACCGGGCCCGGTAATCCGTACTGTAAAAATTATCGA
CACGAAAAACCAGGTGATCCCTCTGAACGATGGTAAAACCGTGGCCTACAATTCCAACATCGT
TCGCGTGGACGTGTTCGAAAAAGATGGTAAATACTACTGTGTACCGGTGTATACCATGGACAT
CATGAAAGGCATTCTGCCGAACAAAGCGATTGAACCGAACAAGCCGTACTCTGAATGGAAAG
AAATGACCGAAGATTACACGTTTCGTTTCAGCCTGTATCCGAACGACCTGATCCGCATCGAACT
GCCGCGTGAAAAAACCGTTAAAACCGCTGCAGGCGAAGAAATTAACGTGAAAGACGTGTTCG
TTTACTATAAAACGATCGACTCCGCAAACGGCGGCCTGGAACTGATTTCTCACGACCACCGTTT
CTCTCTGCGTGGCGTTGGCTCTCGCACCCTGAAACGTTTCGAGAAATATCAAGTTGATGTTCTG
GGTAACATCTATAAAGTGCGTGGCGAGAAACGTGTCGGTCTGGCGTCCTCCGCACACAGCAAA
CCTGGCAAAACCATTCGTCCACTGCAATCTACTCGTGACTAA
acrIIC1Nme ATGAATAAAACATATAAAATCGGAAAAAATGCGGGATATGACGGCTGCGGGTTATGTTTAGCC
GCGATCTCAGAAAATGAAGCTATTAAAGTTAAGTATCTGCGCGATATCTGTCCAGACTATGAC
GGCGACGACAAAGCTGAGGACTGGCTGAGATGGGGAACGGATAGCCGCGTGAAAGCTGCGGC
TTTAGAAATGGAGCAATATGCTTATACGTCGGTTGGGATGGCGTCATGTTGGGAGTTTGTTGAA
CTATGA 
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ABSTRACT 
High engineering efficiencies are required for industrial strain development. Due to its user-
friendliness and its stringency, CRISPR-Cas-based technologies have strongly increased 
genome engineering efficiencies in bacteria. This has enabled more rapid metabolic 
engineering of both the model host Escherichia coli and non-model organisms like 
Clostridia, Bacilli, Streptomycetes and cyanobacteria, opening new possibilities to use these 
organisms as improved cell factories. The discovery of novel Cas9-like systems from diverse 
microbial environments will extend the repertoire of applications and broaden the range of 
organisms in which it can be used to create novel production hosts. This review analyzes the 
current status of prokaryotic metabolic engineering towards the production of 
biotechnologically relevant products, based on the exploitation of different CRISPR-related 
DNA/RNA endonuclease variants.
KEYWORDS  
CRISPR/Cas, bacteria, metabolic engineering, genome editing, genome silencing 
INTRO DUCTIO N
The transition towards a bio-based economy demands the development 
of fermentation-based processes economically competitive with the currently 
employed unsustainable production processes1. Unfortunately, only very 
few natural organisms are suitable for their direct application in an industrial 
process. Therefore, efficient metabolic engineering via targeted genome engineering 
is required and the development and use of simple and high-throughput 
genome engineering tools generally applicable to many model and non-
model organisms is of great importance2. Most prokaryotes possess 
homology directed repair (HDR) systems, which have since long been 
exploited in a great variety of microorganisms for targeted chromosomal 
integrations of desired modifications3-5. In the HDR-based systems, plasmid-
borne homologous recombination templates, which often harbor selection markers 
for screening purposes, are introduced into the genome through double or 
sequential single crossover events. The HDR-based approach is based Cre-
lox or FLP-FRT systems, for excision of the markers from the genomes 
for recycling purposes. However, these systems leave genomic scars that 
could be the cause of unwanted chromosomal rearrangements6,7. 
Alternatively, for a small number of bacteria, markerless genomic modifications are 
possible via recombineering systems8. These systems are based on bacteriophage 
recombinases and ssDNA, dsDNA or plasmid-borne DNA fragments with 
sequence homology to the genomic target. However, due to the absence of 
marker-based selection, these systems mostly result in low mutation efficiencies8. 
The construction and screening of mutants in all these HDR-based approaches is 
time consuming, rendering these tools suboptimal for extensive metabolic 
engineering, particularly in non-model organisms with low transformability and 
recombination rates. 
A breakthrough moment in the molecular microbiology field was 
the discovery of bacterial adaptive immune systems that are based on genomic 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) - the 
memory of the systems - and CRISPR–associated (Cas) proteins9-11.The repurposing 
of the RNA-guided DNA endonuclease from the type IIa CRISPR-Cas system of 
Streptococcus pyogenes (spCas9) and of other Cas9 orthologues as genome editing 
tools brought an unprecedented revolution to the life sciences field2,12,13. The basis of 
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ABSTRACT 
High engineering efficiencies are required for industrial strain development. Due to 
its user-friendliness and its stringency, CRISPR-Cas-based technologies have 
strongly increased genome engineering efficiencies in bacteria. This has enabled more rapid 
metabolic engineering of both the model host Escherichia coli and non-model 
organisms like Clostridia, Bacilli, Streptomycetes and cyanobacteria, opening new 
possibilities to use these organisms as improved cell factories. The discovery of 
novel Cas9-like systems from diverse microbial environments will extend the repertoire 
of applications and broaden the range of organisms in which it can be used to create novel 
production hosts. This review analyzes the current status of prokaryotic metabolic 
engineering towards the production of biotechnologically relevant products, based on 
the exploitation of different CRISPR-related DNA/RNA endonuclease variants. 
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INTRO DUCTIO N
The transition towards a bio-based economy demands the development of 
fermentation-based processes economically competitive with the currently employed 
unsustainable production processes1. Unfortunately, only very few natural organisms are 
suitable for their direct application in an industrial process. Therefore, efficient metabolic 
engineering via targeted genome engineering is required and the development and use of  
simple and high-throughput genome engineering tools generally applicable to many model 
and non-model organisms is of great importance2. Most prokaryotes possess homology 
directed repair (HDR) systems, which have since long been exploited in a great variety of 
microorganisms for targeted chromosomal integrations of desired modifications3-5. In the 
HDR-based systems, plasmid-borne homologous recombination templates, which often harbor 
selection markers for screening purposes, are introduced into the genome through double or 
sequential single crossover events. The HDR-based approach is based Cre-lox or FLP-FRT 
systems, for excision of the markers from the genomes for recycling purposes. However, these 
systems leave genomic scars that could be the cause of unwanted chromosomal 
rearrangements6,7. Alternatively, for a small number of bacteria, markerless genomic 
modifications are possible via recombineering systems8. These systems are based on 
bacteriophage recombinases and ssDNA, dsDNA or plasmid-borne DNA fragments with 
sequence homology to the genomic target. However, due to the absence of marker-based 
selection, these systems mostly result in low mutation efficiencies8. The construction and  
screening of mutants in all these HDR-based approaches is time consuming, rendering these 
tools suboptimal for extensive metabolic engineering, particularly in non-model organisms 
with low transformability and recombination rates. 
A breakthrough moment in the molecular microbiology field was the discovery of 
bacterial adaptive immune systems that are based on genomic Clustered Regularly 
Interspaced Short Palindromic Repeats (CRISPRs) - the memory of the systems - and 
CRISPR–associated (Cas) proteins9-11.The repurposing of the RNA-guided DNA 
endonuclease from the type IIa CRISPR-Cas system of Streptococcus pyogenes (spCas9) and 
of other Cas9 orthologues as genome editing tools brought an unprecedented revolution to the 
life sciences field2,12,13. The basis of he Cas9 engineering tools is the simple way in which 
Cas9 nucleases can be guided to the desired DNA target, denoted as protospacer, by a 
CRISPR–RNA:trans-activating CRISPR RNA (crRNA:tracrRNA) hybrid complex. For this 
purpose, the 5’-end of the crRNA module, denoted as spacer, has to be complementary to the 
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selected protospacer14 and a specific short DNA motif, denoted as protospacer adjacent motif 
(PAM), has to be present at the 3’-end of the denoted as spacer, has to be complementary to 
the selected protospacer14 and a specific short DNA motif, denoted as protospacer adjacent 
motif (PAM), has to be present at the 3’-end of the selected protospacer15,16. For further 
simplification of the engineering processes, the crRNA:tracrRNA complex can be combined 
into a chimeric single guide RNA (sgRNA)17.   
CRISPR-Cas-based genome editing is now broadly used in a variety of 
organisms,including human cells, zebrafish, plants, yeast and bacteria18,19. The successful 
application of Cas9-based genome editing in eukaryotic cells is based on the error-prone 
correction of Cas9-induced double-strand DNA breaks (DSBs) by the efficient eukaryotic 
Non-Homologous End Joining (NHEJ) mechanism. Contrary to eukaryotes, most prokaryotes 
do not have an active NHEJ system3 and Cas9-induced DSBs cannot be repaired, resulting in 
cell death. Recent studies have shown that engineering efficiencies in prokaryotes were 
strongly increased (often up to 100%) upon combining the existing homologous 
recombination and recombineering systems with Cas9-targeting; the Cas9-induced DNA 
breaks served, simultaneously, as recombination inducers and counter-selection tools12,20,21. 
Moreover, catalytically inactive variants of Cas9 orthologues and variants fused with 
transcriptional activating factors have been developed and used for transcriptional regulation. 
Altogether, CRISPR-Cas9 orthologues and catalytically inactive mutants have accelerated the 
construction and screening of in silico designed strains, facilitating metabolic engineering of a 
wide range of bacterial species for industrial cell factory development (Figure 1). 
In this review, we summarize recent bacterial metabolic engineering studies that 
focused on the construction and improvement of microbial cell factories, making use of 
CRISPR-Cas-based technologies. Additionally, we explore newly developed CRISPR-Cas 
tools and argue on how their application could improve the currently available technologies. 
Finally, we discuss how screening diverse environments can lead to discovery of new Cas-
related variants to extend the repertoire of applications and create novel production hosts.   
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Figure 1. CRISPR-Cas9-based metabolic engineering of bacterial cell factories. Using Cas9 as 
counter-selection tool for traditional genome editing processes such as recombineering or plasmid-based 
homologous recombination has led to efficient metabolic engineering towards a wide range of products. 
Additionally, dCas9 can be used for CRISPRi to rapidly screen in silico predicted phenotypes prior to Cas9-
based engineering.  
BACTERIAL METABO LIC ENG INEERING AND CRISPR-CAS 
TECH NO LO G IES
Many chemicals such as terpenoids, alcohols, amino acids, organic acids and antibiotics 
have high commercial value in the pharmaceutical and nutritional industry, and as fuels and 
building block chemicals. Most of these compounds result from multi-step metabolic 
pathways and are often tightly regulated in their natural genomic context22, 23. Model 
organisms, like E. coli, have well-studied metabolisms, extensive and high-
throughput molecular toolboxes and detailed in silico metabolic models. Hence, the 
use of such organisms minimizes the number of required engineering steps and maximizes 
engineering efficiencies. Nevertheless, the demands for engineering work remain high 
before efficient production strains are constructed due to the complexity of the 
metabolic pathways for many commercially interesting products2. Moreover, model 
organisms are often suboptimal as production hosts and the use of alternative organisms 
could benefit the production of many valuable chemicals. Cas-based genome 
engineering and silencing tools have enabled and accelerated complex metabolic 
engineering and systems-level understanding of metabolic pathways in a wide 
range of organisms2,12,13,18 (Figure 1).  
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the Cas9 engineering tools is the simple way in which Cas9 nucleases can be guided to the 
desired DNA target, denoted as protospacer, by a CRISPR–RNA:trans-activating 
CRISPR RNA (crRNA:tracrRNA) hybrid complex. For this purpose, the 5’-end 
of the crRNA module, denoted as spacer, has to be complementary to the selected 
protospacer14 and a specific short DNA motif, denoted as protospacer adjacent motif 
(PAM), has to be present at the 3’-end of the denoted as spacer, has to be 
complementary to the selected protospacer14 and a specific short DNA motif, 
denoted as protospacer adjacent motif (PAM), has to be present at the 3’-end of the 
selected protospacer15,16. For further simplification of the engineering processes, the 
crRNA:tracrRNA complex can be combined into a chimeric single guide RNA 
(sgRNA)17.   
CRISPR-Cas-based genome editing is now broadly used in a variety 
of organisms,including human cells, zebrafish, plants, yeast and bacteria18,19. The 
successful application of Cas9-based genome editing in eukaryotic cells is based on 
the error-prone correction of Cas9-induced double-strand DNA breaks (DSBs) by the 
efficient eukaryotic Non-Homologous End Joining (NHEJ) mechanism. Contrary to 
eukaryotes, most prokaryotes do not have an active NHEJ system3 and Cas9-induced 
DSBs cannot be repaired, resulting in cell death. Recent studies have shown that 
engineering efficiencies in prokaryotes were strongly increased (often up to 100%) upon 
combining the existing homologous recombination and recombineering systems with 
Cas9-targeting; the Cas9-induced DNA breaks served, simultaneously, as recombination 
inducers and counter-selection tools12,20,21. Moreover, catalytically inactive variants of 
Cas9 orthologues and variants fused with transcriptional activating factors have 
been developed and used for transcriptional regulation. Altogether, CRISPR-Cas9 
orthologues and catalytically inactive mutants have accelerated the construction and 
screening of in silico designed strains, facilitating metabolic engineering of a wide range 
of bacterial species for industrial cell factory development (Figure 1) . 
In this review, we summarize recent bacterial metabolic engineering studies 
that focused on the construction and improvement of microbial cell factories, making 
use of CRISPR-Cas-based technologies. Additionally, we explore newly developed 
CRISPR-Cas tools and argue on how their application could improve the currently 
available technologies. Finally, we discuss how screening diverse environments can lead 
to discovery of new Cas-related variants to extend the repertoire of applications and create 
novel production hosts.   
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Figure 1. CRISPR-Cas9-based metabolic engineering of bacterial cell factories. Using Cas9 as 
counter-selection tool for traditional genome editing processes such as recombineering or plasmid-based 
homologous recombination has led to efficient metabolic engineering towards a wide range of products. 
Additionally, dCas9 can be used for CRISPRi to rapidly screen in silico predicted phenotypes prior to Cas9-
based engineering.  
BACTERIAL METABOLIC ENGINEERING AND CRISPR-CAS TECHNOLOGIES 
Many chemicals such as terpenoids, alcohols, amino acids, organic acids and antibiotics have 
high commercial value in the pharmaceutical and nutritional industry, and as fuels and 
building block chemicals. Most of these compounds result from multi-step metabolic 
pathways and are often tightly regulated in their natural genomic context22,23. Model 
organisms, like E. coli, have well-studied metabolisms, extensive and high-throughput 
molecular toolboxes and detailed in silico metabolic models. Hence, the use of such 
organisms minimizes the number of required engineering steps and maximizes engineering 
efficiencies. Nevertheless, the demands for engineering work remain high before efficient 
production strains are constructed due to the complexity of the metabolic pathways for 
many commercially interesting products2. Moreover, model organisms are often suboptimal 
as production hosts and the use of alternative organisms could benefit the production of 
many valuable chemicals. Cas-based genome engineering and silencing tools have enabled 
and accelerated complex metabolic engineering and systems-level understanding of 
metabolic pathways in a wide range of organisms2,12,13,18 (Figure 1).  
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Product Species Strategy Chromosomal 
modifications 
made using 
CRISPR-Cas-
editing 
Ref. 
Product 
pathway 
overexpress
ion 
Chromoso
mal 
deletions 
Chromoso
mal 
insertions 
Chromoso
mal 
substituti-
ons 
T
er
pe
no
id
s 
β-carotene Escherichia 
coli 
Heterolo- 
gous, 
chromoso
-mal 
Competing 
pathways 
Product 
pathway 
Promoters, 
RBSs 
Knock-in crtE-
crtB-crtI-crtY + 
knock-out ldhA, 
knock-in gps, 
combinatorial 
promoter/RBS 
replacement of 9 
MEP pathway 
genes, 
combinatorial 
overexpressions 
and deletions of 8 
central carbon 
metabolism genes, 
knock-in 2nd
copies of selected 
MEP and β-
carotene pathway 
genes 
[24]
Native, 
plasmid; 
Product 
pathway 
Knock-in almgs
under control of 
various regulatory 
parts (in  a  
β-carotene 
production strain) 
[36]
A
lc
oh
ol
s 
Isopropan
ol 
Escherichia 
coli 
Heterologous,
chromosomal
Product 
pathway 
RBSs Knock-in and 
RBS replacement of 
thl, atoDA, adc, 
adh 
[26]
n- Butanol
plasmid 
5’-UTR of 
competing 
pathway 
gene
Modification of 
gltA 5’-UTR for 
expression 
reduction
[27]
Clostridium 
saccharoper
-butylacetoni
cum
Competing 
pathways 
Knock-out pta, 
buk
[28]
Isopropan
ol-butanol-
ethanol 
Clostridium 
acetobutylicu
m
Heterologous
and native,
chromosomal 
Product 
pathway
Knock-in ctfAB, 
adc, adh
[29]
Heterologous,
chromosomal
Heterologous,
cluster (BGC) copies33,34. In C. glutamicum, the natural proline production was enhanced 
6.5-fold through a codon saturation mutagenesis approach to relieve product 
inhibition35. Noteworthy, this work was performed using the Cas12a (formerly Cpf1) 
RNA-guided endonuclease, making it the first application of a non-Cas9-based 
CRISPR-Cas/recombineering genome editing tool in bacteria for metabolic engineering 
purposes (Table 1).   
A
m
in
o
ac
id
s
L-proline Corynebacter
ium 
glutamicum
- Codons (to
relieve 
product
inhibition)
Codon saturation
m utagenesis γ-
glutamyl kinase
by CRISPR-Cpf1
[35]
γ-ami no-
butyric
acid
(GABA)
Heterolo-
gous,
plasm id
Transporter
s,
degradation 
pathway
Knock-out
Ncgl1221, gabT,
gabP and various
com binations
thereof
[31]
5-Ami no-
levulinic
acid
Escherichia
coli
Heterolo-
gous,
plasm id
Com peting
pathways
Prom oter,
codons (to
relieve 
product
inhibition)
coaA point
m utation
(R106A), serA
prom oter
replacem ent and
C-term inal
residues deletion,
knockout sucCD,
hemB
translational
downregulation
by start codon
substitution
[32]
Table 1. CRISPR-Cas-mediated metabolic engineering of bacteria for industrial products. 
CRISPR-CAS EDITING
Metabolic engineering strategies include plasmid-based expression or, preferably, 
chromosomal integration of heterologous metabolic pathways, and/or targeted genome editing 
and adaptive evolution for flux redistribution through native metabolic pathways (Table 1). In 
their pioneering work, Li et al.24 combined Cas9-induced targeted DSBs with ss or ds λ-RED 
recombineering for the introduction of a heterologous β-carotene biosynthetic pathway into the 
E. coli genome. They further substituted the promoters and ribosome binding sites (RBSs)
from the native MEP pathway genes to achieve different levels of overexpression of the
corresponding enzymes. Further engineering steps, including numerous deletions and
promoter/RBS substitutions of central carbon metabolism genes, improved pyruvate and
glyceraldehyde-3P supply and lead to the construction of a highly improved β-carotene
producing strain24. This extensive study was possible only due to the development of the Cas9-
based tools, revealing their great potential for efficient and diverse manipulation of genomic
DNA.
The Cas9-recombineering method was further exploited with the development of the 
CRISPR-enabled trackable genome engineering (CREATE) tool25. Application of this tool in 
E. coli cells allowed their simultaneous transformation with multiple libraries of plasmid-borne
recombination templates, each designed to introduce easily trackable mutations at different
genomic loci25. The CREATE tool was employed to introduce multiple RBS variations for
each of the genes in a genomically integrated isopropanol production pathway in E. coli,
leading to the time-efficient construction and testing of ~1000 strains. The isopropanol titer of
the best strain was 1.5-fold higher compared to the initial integration strain, but still lower
compared to the plasmid-based overexpression approach26. Cas9-based downregulation or
deletion of competing pathways in strains already overexpressing heterologous pathways
towards the desired product could further improve titers. This has been proven successful for
many compounds, including n-butanol in E. coli27 and Clostridium
saccharoperbutylacetonicum 28, isopropanol-butanol-ethanol in Clostridium acetobutylicum29,
succinic acid in Synechococcus elongatus30, γ-amino-butyric acid (GABA) in Corynebacterium
glutamicum31, and 5-aminolevulinic acid in E. coli32 (Table 1). However, the use of natural
producers can substantially reduce the complexity of engineering steps towards production
and tolerance build-up. The tolerance of Streptomyces species to antibiotics has been
exploited for the production of antibiotic and antitumor compounds simply by Cas9-
facilitated genomic integration of multiple biosynthetic gene cluster (BGC)
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CRISPR-CAS EDITING
Metabolic engineering strategies include plasmid-based expression or, preferably, 
chromosomal integration of heterologous metabolic pathways, and/or targeted genome 
editing and adaptive evolution for flux redistribution through native metabolic pathways 
(Table 1). In their pioneering work, Li et al.24 combined Cas9-induced targeted DSBs with 
ss or ds λ-RED recombineering forthe introduction of a heterologous β-carotene biosynthetic 
pathway into the E. coli genome. They further substituted the promoters and ribosome 
binding sites (RBSs) from the native MEP pathway genes to achieve different levels of 
overexpression of the corresponding enzymes. Further engineering steps, including 
numerous deletions and promoter/RBS substitutions of central carbon metabolism genes, 
improved pyruvate and glyceraldehyde-3P supply and lead to the construction of a highly 
improved β-carotene producing strain24. This extensive study was possible only due to the 
development of the Cas9-based tools, revealing their great potential for efficient and diverse 
manipulation of genomic DNA.
The Cas9-recombineering method was further exploited with the development of the 
CRISPR-enabled trackable genome engineering (CREATE) tool25. Application of this tool in 
E. coli cells allowed their simultaneous transformation with multiple libraries of plasmid-
borne recombination templates, each designed to introduce easily trackable mutations at
different genomic loci25. The CREATE tool was employed to introduce multiple RBS
variations for each of the genes in a genomically integrated isopropanol production pathway
in E. coli, leading to the time-efficient construction and testing of ~1000 strains. The
isopropanol titer of the best strain was 1.5-fold higher compared to the initial integration
strain, but still lower compared to the plasmid-based overexpression approach26.
Cas9-based downregulation or deletion of competing pathways in strains already
overexpressing heterologous pathways towards the desired product could further improve
titers. This has been proven successful for many compounds, including n-butanol in E. coli27
and Clostridium saccharoperbutylacetonicum 28, isopropanol-butanol-ethanol in Clostridium
acetobutylicum29, succinic acid in Synechococcus elongatus30, γ-amino-butyric acid (GABA)
in Corynebacterium glutamicum31, and 5-aminolevulinic acid in E. coli32 (Table 1).
However, the use of natural producers can substantially reduce the complexity of
engineering steps towards production and tolerance build-up. The tolerance of Streptomyces
species to antibiotics has been exploited for the production of antibiotic and antitumor
compounds simply by Cas9-facilitated genomic integ ration of multiple biosynthetic gene
copies33,34. In C. glutamicum, the natural proline production was enhanced 6.5-fold through aa 
codon saturation mutagenesis approach to relieve product inhibition35. Noteworthy, this work 
was performed using the Cas12a (formerly Cpf1) RNA-guided endonuclease, making it the 
first application of a non-Cas9-based CRISPR-Cas/recombineering genome editing tool in 
bacteria for metabolic engineering purposes (Table 1).   
Table 1. CRISPR-Cas-mediated metabolic engineering of bacteria for industrial products. 
Product Species Strategy Chromosomal 
modifications 
made using 
CRISPR-Cas-
editing 
Ref. 
Product 
pathway 
overexpress
ion 
Chromoso
mal 
deletions 
Chromoso
mal 
insertions 
Chromoso
mal  
substituti-
ons 
T
er
pe
no
id
s 
β-carotene Escherichia 
coli 
Heterolo- 
gous, 
chromoso
-mal 
Competing 
pathways 
Product 
pathway 
Promoters, 
RBSs 
Knock-in crtE-
crtB-crtI-crtY + 
knock-out ldhA, 
knock-in gps, 
combinatorial 
promoter/RBS 
replacement of 9 
MEP pathway 
genes, 
combinatorial 
overexpressions 
and deletions of 8 
central carbon 
metabolism genes, 
knock-in 2nd 
copies of selected 
MEP and β-
carotene pathway 
genes 
[24]
Native, 
plasmid; 
Product 
pathway 
Knock-in almgs 
under control of 
various regulatory 
aparts (in  
β-carotene 
production strain) 
[36]
A
lc
oh
ol
s 
Isopropan
ol 
Escherichia 
coli 
Heterologous,
chromosomal
Product 
pathway 
RBSs Knock-in and 
RBS replacement of 
thl, atoDA, adc, 
adh 
[26]
n- Butanol
plasmid 
5’-UTR of 
competing 
pathway 
gene 
Modification of 
gltA 5’-UTR for 
expression 
reduction 
[27]
Clostridium 
saccharoper
-butylacetoni
cum 
Competing 
pathways 
Knock-out pta, 
buk 
[28]
Isopropan
ol-butanol-
ethanol 
Clostridium 
acetobutylicu
m 
Heterologous
and native,
chromosomal 
Product 
pathway 
Knock-in ctfAB, 
adc, adh 
[29]
Heterologous,
chromosomal
Heterologous,
A
m
in
o 
ac
id
s 
L-proline Corynebacter
ium 
glutamicum 
- Codons (to 
relieve 
product 
inhibition) 
Codon saturation 
mutagenesis γ-
glutamyl kinase 
by CRISPR-Cpf1 
[35]
γ-amino-
butyric 
acid 
(GABA) 
Heterolo-
gous, 
plasmid 
Transporter
s, 
degradation 
pathway 
Knock-out 
Ncgl1221, gabT, 
gabP and various 
combinations 
thereof 
[31]
5-Amino-
levulinic
acid
Escherichia 
coli 
Heterolo-
gous, 
plasmid 
Competing 
pathways 
Promoter, 
codons (to 
relieve 
product 
inhibition) 
coaA point 
mutation 
(R106A), serA 
promoter 
replacement and 
C-terminal
residues deletion,
knockout sucCD,
hemB
translational
downregulation
by start codon
substitution
[32]
214
Chapter 7
employed for the expression of the Cas9 or the sgRNA module. This is crucial when 
targeting essential genes, competing pathways (which can also be biomass-
producing) or regulators for which a basal expression level is required (Figure 
2a,b,c,d). It can also be used as a quick alternative to the often 
laborious RBS/promoter-engineering to tune production pathway activity to either
modulate amounts and properties of the target product (Figure 2e)39,40 or 
prevent accumulation of toxic intermediates41 (Figure 2f). Although CRISPRi 
does not lead to the construction of stably genetically modified strains, it is a powerful
met hod for quick evaluation of the possible effects of genetic
modifications to the metabolism of a microorganism, allowing to design 
genome editing approaches and to gain insights into micro bial metabolisms (Figure 1, 
Table 2).  
Similar to CRISPR-Cas-based editing, model organisms such as E. coli
and C. glutamicum were the first organisms for which CRISPRi-based metabolic
engineering was applied (Table 2). A heterologous polyhydroxyalkanoate (PHA) 
biosynthesis pathway was introduced into E. coli for the production 
of poly(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)]42. The 4HB 
fraction of the polymer was enhanced via CRISPRi-based downregulation of
multiple TCA cycle genes aiming to increase the supply of the 4HB-
precursor succinate semialdehyde42 (Figure 2e). Subsequent works in E. coli and 
in the natural PHA-producer Halomonas focused on silencing cell morphology genes 
to increase the storage capacity of the cells for PHAs40,43 (Figure 2d), as well as 
biosynthetic pathway genes to control PHA content and chemical properties
such as molecular weight and polydispersity39,40 (Figure 2d). Cell morphol ogy
engineering, through CRISPRi-based repression of E. coli cell division and shape 
genes, combined with expression of a heterologous production pathway, was also 
used for the production of the phytochemical zeaxanthin44 (Table 2). Several other 
studies used CRISPRi-based repression of competing pathway or repressor genes for the 
enrichment of precursor pools (Figure 2a, c), aiming at the enhancement of the natural amino 
acid production by C. glutamicum45 and the E. coli-based heterologous production of various 
phytochemicals including naringenin46,47, resveratrol48, pinosylvin49, anthocyanin50, as 
well as medium chain fatty acids (MCFAs)51 and n-butanol52 (Table 2) Additionally, 
CRISPRi-based repression of essential genes was used to minimize carbon loss towards 
biomass formation. Notably, many of these studies employed multiplex silencing using an 
Table 1(cont). CRISPR-Cas-mediated metabolic engineering of bacteria for industrial  products. 
Finally, Cas9-based editing tools were successfully employed for membrane engineering 
purposes in E. coli. The β-carotene storage capacity of E. coli cell membranes was increased 
by chromosomal integration of heterologous membrane-bending protein genes using plasmid-
borne homologous recombination and Cas9-targeting36. Furthermore, the Cas9-
recombineering tool proved efficient for the enhancement of the E. coli lipid content by 
simultaneous chromosomal integration of a heterologous fatty acid regulatory transcription 
factor gene together with a delta9 desaturase and an acetyl-CoA carboxylase gene37 (Table 1). 
CRISPRi
Next to the integration or deletion of genes and pathways, an important metabolic 
engineering strategy is the fine-tuning of gene expression. Whereas in eukaryotic systems 
siRNA-techniques have since long enabled transcriptional control, for prokaryotes such 
silencing tools have only recently become available with the CRISPR interference (CRISPRi) 
tool, which is based on dCas9: the catalytically inactive variant of the Cas9 endonuclease38. 
This tool can be used for complete or partial expression; repression strength can be tuned by 
altering the position of the selected protospacer within the targeted gene (Figure 2), or the 
inducer concentration when an inducible promoter is employed for the expression of the Cas9 
or the sgRNA module. This is crucial when targeting essential genes, competing pathways 
(which can also be biomass-producing) or regulators for which a basal expression level is re-
O
rg
. a
ci
ds
 
Succinic 
acid 
Synechococc
us elongatus 
Native, 
chromoso-
mal 
Competing 
pathways 
Product 
pathway 
Knock-out glgc 
and knock-in 
gltA-ppc (under 
nitrogen 
starvation 
conditions) 
[30]
A
nt
ib
io
ti
cs
/a
nt
i-
tu
m
or
 
Pristinamy
cin I (PI) 
Streptomyces 
pristinaespira
lis 
Native, 
chromoso-
mal 
Repressor, 
competing 
pathway 
Product 
pathway 
Knock-out snaEI, 
snaE2 and papR3, 
knock-in PI 
biosynthetic gene 
cluster 
[33]
Pristinamy
cin II (PII) 
Native, 
chromoso-
mal 
Product 
pathway 
Knock-in of 
artificial 
bacteriophage 
attachment/integr
ation (attB) sites 
in which the 
biosynthetic 
pathway is 
subsequently 
inserted 
[34]
Chloram-
phenicol 
Streptomyces 
coelicolor 
Heterolo-
gous, 
chromoso-
mal 
Product 
pathway 
Anti-
tumor 
compound 
YM-
216391 
Heterolo-
gous, 
chromoso-
mal 
Product 
pathway 
L
ip
id
 
Fatty acids Escherichia 
coli 
Heterolo-
gous, 
chromoso-
mal 
Competing 
pathways 
Product 
pathway 
Knock-in fadR, 
delta9 and acc 
(deletions made 
previously) 
[37]
Product Species Strategy Chromosomal 
modifications 
made using 
CRISPR-Cas-
editing 
Ref. 
Product 
pathway 
overexpress
ion 
Chromoso
mal 
deletions 
Chromoso
mal 
insertions 
Chromoso
mal  
substituti-
ons 
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O
rg
.a
ci
ds
Succinic 
acid
Synechococc
us elongatus
Native,
chrom oso-
m al
Com peting
pathways
Product
pathway
Knock-out glgc
and knock-in 
gltA-ppc (under 
nitrogen 
starvation
conditions)
[30]
A
nt
ib
io
ti
cs
/a
nt
i-
tu
m
or
Pristinamy
cin I (PI)
Streptomyces
pristinaespira
lis
Native,
chrom oso-
m al
Repressor,
com peting
pathway
Product
pathway
Knock-out snaEI,
snaE2 and papR3, 
knock-in PI 
biosynthetic gene
cluster
[33]
Pristinamy
cin II (PII)
Native,
chrom oso-
m al
Product
pathway
Knock-in of
artificial 
bacteriophage 
attachm ent/integr
ation (attB) sites
in which the
biosynthetic
pathway is
subsequently
inserted
[34]
Chloram -
phenicol
Streptomyces
coelicolor
Heterolo-
gous,
chrom oso-
m al
Product
pathway
Anti-
tum or
com pound
YM-
216391
Heterolo-
gous,
chrom oso-
m al
Product
pathway
L
ip
id
Fatty acids Escherichia
coli
Heterolo-
gous,
chrom oso-
m al
Com peting
pathways
Product
pathway
Knock-in fadR,
delta9 and acc
(deletions m ade 
previously)
[37]
Product Species Strategy Chromosomal
modifications
made using
CRISPR-Cas-
editing
Ref.
Product
pathway
overexpress
ion
Chromoso
mal
deletions
Chromoso
mal
insertions
Chromoso
mal
substituti-
ons
Table 1(cont). CRISPR-Cas-mediated metabolic engineering of bacteria for industrial
products.
Finally, Cas9-based editing tools were successfully employed f or membrane engineering 
purposes in E. coli. The β-carotene storage capacity of E. coli cell membranes was increased 
by chromosomal integration of heterologous membrane-bending protein genes using 
plasmid-borne homologous recombination and Cas9-targeting36. Furthermore, the Cas9-
recombineering tool proved efficient for the enhancement of the E. coli lipid content by 
simultaneous chromosomal integration of a heterologous fatty acid regulatory transcription 
factor gene together with a delta9 desaturase and an acetyl-CoA carboxylase gene37 (Table 
1).  
CRISPRi 
Next to the integration or deletion of genes and pathways, an 
important metabolic engineering strategy the fine-tuning of gene is
expression. Whereas in eukaryotic siRNA-techniques have since systems
long enabled transcriptional control, for prokaryotes such silencing tools have only 
recently become available with the CRISPR interference (CRISPRi) tool, which is 
based on dCas9: the catalytically inactive variant of the Cas9 endonuclease38. This tool 
can be used for complete or partial expression; repression strength can be tuned by 
altering the position of the selected protospacer within the targeted gene 
(Figure 2), or the inducer concentration when an inducible promoter is 
quired (Figure 2a,b,c,d). It can also be used as a quick alternative to the often laborious 
RBS/promoter-engineering to tune production pathway activity to either modulate amounts 
and properties of the target product (Figure 2e)39,40 or prevent accumulation of toxic 
intermediates41 (Figure 2f). Although CRISPRi does not lead to the construction of stably 
genetically modified strains, it is a powerful method for quick evaluation of the possible 
effects of genetic modifications to the metabolism of a microorganism, allowing to design 
genome editing approaches and to gain insights into microbial metabolisms (Figure 1, Table 
2).  
Similar to CRISPR-Cas-based editing, model organisms such as E. coli and C. 
glutamicum were the first organisms for which CRISPRi-based metabolic engineering was 
applied (Table 2). A heterologous polyhydroxyalkanoate (PHA) biosynthesis pathway was 
introduced into E. coli for the production of poly(3-hydroxybutyrate-co-4-hydroxybutyrate) 
[P(3HB-co-4HB)]42. The 4HB fraction of the polymer was enhanced via CRISPRi-based 
downregulation of multiple TCA cycle genes aiming to increase the supply of the 4HB-
precursor succinate semialdehyde42 (Figure 2e). Subsequent works in E. coli and in the 
natural PHA-producer Halomonas focused on silencing cell morphology genes to increase 
the storage capacity of the cells for PHAs40,43 (Figure 2d), as well as biosynthetic pathway 
genes to control PHA content and chemical properties such as molecular weight and 
polydispersity39,40 (Figure 2d). Cell morphology engineering, through CRISPRi-based 
repression of E. coli cell division and shape genes, combined with expression of a 
heterologous production pathway, was also used for the production of the phytochemical 
zeaxanthin44 (Table 2). Several other studies used CRISPRi-based repression of competing 
pathway or repressor genes for the enrichment of precursor pools (Figure 2a, c), aiming at the 
enhancement of the natural amino acid production by C. glutamicum45 and the E. coli-based 
heterologous production of various phytochemicals including naringenin46,47, resveratrol48, 
pinosylvin49, anthocyanin50, as well as medium chain fatty acids (MCFAs)51 and n-butanol52 
(Table 2) Additionally, CRISPRi-based repression of essential genes was used to minimize 
carbon loss towards biomass formation. Notably, many of these studies employed multiplex 
silencing using an sgRNA approach, whereas Cress et al. used a dual RNA (crRNA/
tracrRNA) approach, developing a rapid CRISPR-array assembly method denoted as 
CRISPathBrick47. This tool could facilitate multiplex CRISPRi-based silencing in non-model 
organisms with limited toolboxes.
CRISPRi-based repression has already been used for metabolic engineering 
purposes in non-model organisms such as in Clostridium cellulovorans and Klebsiella pneu-
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Table 2. CRISPRi-based metabolic engineering of bacteria for industrial products. 1 See Figure 2 for a 
visualization of these strategies. Modifications other than CRISPRi are shown in brackets. 2 M: multiplexing. 
sgRNA approach, whereas Cress et al. used a dual RNA (crRNA/tracrRNA) approach, 
developing a rapid CRISPR-array assembly meth od denoted as CRISPathBrick47. This tool 
could facilitate multiplex CRISPRi-based silencing in non-model organisms with limited 
toolboxes.
CRISPRi-based repression has already been used for metabolic engineering purposes 
in non-model organisms such as in Clostridium cellulovorans and Klebsiella pneumoniae
for alcohol production54,55, Synechococcus elongatus for succinate production57 (Table 2), as 
well as in Clostridium acetobutylicum to relieve carbon catabolite repression for sugar co-
utilization59. The CRISPRi tool is particularly useful in cyanobacteria, in which genome 
editing is complicated and time consuming due to slow growth and multiple 
chromosome copies57,60. Furthermore, the ability to fine-tune expression levels using 
CRISPRi was exploited in Synechococcus sp., where repression of nitrogen assimilation 
gene glnA was shown to increase the pool of α-ketoglutarate58. A moderate increase of this 
metabolite enhanced glycolytic flux and lactate production, whereas a too large increase 
resulted in a decrease in protein production58. CRISPRi-based multiplex gene repression was 
established in Synechocystis sp.60 and subsequently used to determine optimal gene 
repression combinations for fatty alcohol production56 (Table 2). As in all studies using 
CRISPRi in cyanobacteria, dCas9 and sgRNAs were chromosomally integrated into the 
genome. This resulted in stable repression strains in the absence of selective pressure for 
single sgRNAs, but the use of repetitive promoter elements resulted in undesired 
recombination events when multiplexing was attempted56, highlighting the potential 
advantage of using a dual RNA approach. Finally, it was observed that a targeted gene with 
a very distant transcription start site (TSS) from the start codon could be efficiently repressed 
by CRISPRi only when employing multiple sgRNAs targeting within the gene or the 
preceding operon genes60. Hence, this study revealed that the efficient application of the 
CRISPRi tool is strongly connected with the precise identification of TSS for the targeted 
genes.  
FUTURE PERSPECTIVES
In prokaryotes, CRISPR-Cas based genome editing has strongly increased 
engineering efficiencies by adding a powerful counter-selection method to existing 
engineering systems or by enhancing recombination efficiencies through induction of 
cellular DNA repair mechanisms12,20. In model organism E. coli high-throughput tools 
such as crMAGE7 and CREATE25 made multiplex engineering possible upon combining 
the Cas9 and recombineering tools. It is expected that these high-throughput tools will be 
Product Species Product pathway 
overexpression 
method 
CRISPRi-based 
repression of:1 
Genes 
targeted by 
CRISPRi 
M 
2
Ref. 
P
ol
yh
yd
ro
xy
al
ka
no
at
es
 (
P
H
A
) 
P(3HB-co-4HB) 
with enhanced 
4HB content 
Escherichia coli Heterologous, 
plasmid 
Competing pathways sad/gadB, 
sucCD, 
sdhAB 
+ [42] 
Polyhydroxy-
butyrate (PHB) 
Heterologous, 
plasmid 
Cell morphology ftsZ, mreB - [43] 
PHB Heterologous, 
plasmid 
Product pathway phaC - [39] 
3-
hydroxybutyrate/ 
3-
hydroxyvalerate 
(PHBV) and 
PHB 
Halomonas sp. - Cell morphology 
Product pathway 
Competing pathways 
ftsZ, prpC, 
gltA 
- [40] 
Ph
yt
oc
he
m
ic
al
s 
Zeaxanthin Escherichia coli Heterologous, 
plasmid (+sensor 
for dynamic 
and control) 
chromosomal 
Cell morphology ftsZ, mreB, 
pbp, rodZ 
- [44] 
Naringenin Heterologous, 
plasmid 
Competing pathways eno, adhE, 
mdh, fabB, 
fabF, sucC, 
fumC 
+ [46] 
Naringenin Heterologous, 
plasmid 
fadR, fumC,
sucABCD, 
scpC 
Resveratrol Heterologous, 
plasmid 
Competing pathways fabD, fabH, 
fabB, fabF, 
fabI 
- [48] 
Pinosylvin Heterologous, 
plasmid 
Competing pathways eno, adhE, 
fabB, sucC, 
fumC, fabF 
+ [49] 
Anthocyanin Heterologous, 
plasmid 
Repressor of product 
pathway 
metJ - [50] 
Fa
tty
 a
ci
ds
 Medium chain 
fatty acids 
(MCFAs) 
Escherichia coli Heterologous and 
native, plasmid 
Competing pathways rdA, adhE, 
ldhA, poxB, 
pta 
- [51] 
T
er
pe
no
id
s 
(-)-α-bisabolol, 
isoprene, 
lycopene 
Escherichia coli Heterologous, 
plasmid 
Product pathway 
Competing pathway: 
biomass 
mvaK1, 
mvaE, ispA 
- [41] 
Mevalonate Heterologous, 
plasmid 
Competing pathway: 
biomass 
pyrF, oriC, 
dnaA 
- [53] 
A
m
in
o 
ac
id
s L-lysine, L-
glutamate
Corynebacterium 
glutamicum 
- Competing pathways pgi, pck, pyk - [45]
A
lc
oh
ol
s 
Acetone-
butanol-ethanol 
Clostridium 
cellulovorans & 
Clostridium 
beijerinckii 
Native, plasmid Competing pathways  
(as well as knock-out) 
putative 
hydrogenase 
in C. 
cellulovorans 
- [54] 
n-Butanol
Klebsiella 
pneumoniae 
Heterologous, 
plasmid 
Competing pathways ilvB, ilvI, 
metA, alaA 
- [55] 
Escherichia coli Heterologous, 
plasmid 
Competing pathways pta, frdA, 
ldhA, adhE 
+ [52] 
Fatty alcohols Synechocystis sp. Heterologous, 
plasmid 
Competing pathways plsX, aar, 
ado, plsC, 
lplat 
+ [56] 
O
rg
an
ic
 a
ci
ds
 
Succinate Synechococcus 
elongatus 
- Competing pathways 
(under nitrogen 
starvation conditions) 
glgc, sdhA, 
sdhB 
- [57] 
Lactate Synechococcus 
sp. 
- Competing pathway to 
accumulate activator 
metabolite 
glnA - [58] 
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Product Species Product pathway 
overexpression 
method 
CRISPRi-based 
repression of:1
G enes 
targeted by 
CRISPRi 
M 
2
Ref. 
P
ol
yh
yd
ro
xy
al
ka
no
at
es
(P
H
A
) 
P(3HB-co-4HB) 
with enhanced 
4HB content 
Escherichia coli Heterologous, 
plasmid 
Competing pathways sad/gadB, 
sucCD, 
sdhAB 
+ [42] 
Polyhydroxy-
butyrate (PHB) 
Heterologous, 
plasmid 
Cell morphology ftsZ, mreB - [43] 
PHB Heterologous, 
plasmid 
Product pathway phaC - [39] 
3-
hydroxybutyrate/ 
3-
hydroxyvalerate 
(PHBV) and 
PHB 
Halomonas sp. - Cell morphology 
Product pathway 
Competing pathways 
ftsZ, prpC, 
gltA 
- [40] 
Ph
yt
oc
he
m
ic
al
s 
Zeaxanthin Escherichia coli Heterologous, 
plasmid (+sensor 
for dynamic 
and control) 
chromosomal 
Cell morphology ftsZ, mreB, 
pbp, rodZ 
- [44] 
Naringenin Heterologous, 
plasmid 
Competing pathways eno, adhE, 
mdh, fabB, 
fabF, sucC, 
fumC 
+ [46] 
Naringenin Heterologous, 
plasmid 
fadR, fumC,
sucABCD, 
scpC 
Resveratrol Heterologous, 
plasmid 
Competing pathways fabD, fabH, 
fabB, fabF, 
fabI 
- [48] 
Pinosylvin Heterologous, 
plasmid 
Competing pathways eno, adhE, 
fabB, sucC, 
fumC, fabF
+ [49] 
Anthocyanin Heterologous, 
plasmid 
Repressor of product 
pathway 
metJ - [50] 
Fa
tty
ac
id
s 
Medium chain 
fatty acids 
(MCFAs) 
Escherichia coli Heterologous and 
native, plasmid 
Competing pathways rdA, adhE, 
ldhA, poxB, 
pta 
- [51] 
T
er
pe
no
id
s 
(-)-α-bisabolol, 
isoprene, 
lycopene 
Escherichia coli Heterologous, 
plasmid 
Product pathway 
Competing pathway: 
biomass 
mvaK1, 
mvaE, ispA 
- [41] 
Mevalonate Heterologous, 
plasmid 
Competing pathway: 
biomass 
pyrF, oriC, 
dnaA 
- [53] 
A
m
in
o
ac
id
s L-lysine, L-
glutamate
Corynebacterium 
glutamicum 
- Competing pathways pgi, pck, pyk - [45]
A
lc
oh
ol
s 
Acetone-
butanol-ethanol 
Clostridium 
cellulovorans &
Clostridium 
beijerinckii 
Native, plasmid Competing pathways  
(as well as knock-out) 
putative 
hydrogenase 
in C. 
cellulovorans 
- [54] 
n-Butanol
Klebsiella 
pneumoniae 
Heterologous, 
plasmid 
Competing pathways ilvB, ilvI, 
metA, alaA 
- [55] 
Escherichia coli Heterologous, 
plasmid 
Competing pathways pta, frdA, 
ldhA, adhE 
+ [52] 
Fatty alcohols Synechocystissp. Heterologous, 
plasmid 
Competing pathways plsX, aar, 
ado, plsC, 
lplat 
+ [56] 
O
rg
an
ic
 a
ci
ds
 
Succinate Synechococcus 
elongatus
- Competing pathways 
(under nitrogen 
starvation conditions) 
glgc, sdhA, 
sdhB 
- [57] 
Lactate Synechococcus 
sp. 
- Competing pathway to 
accumulate activator 
metabolite 
glnA - [58] 
Table 2. CRISPRi-based metabolic engineering of bacteria for industrial products. 1 See Figure 2 for a 
visualization of these strategies. Modifications other than CRISPRi are shown in brackets. 2 M: multiplexing. 
moniae for alcohol production54,55, Synechococcus elongatus for succinate production57 
(Table 2), as well as in Clostridium acetobutylicum to relieve carbon catabolite repression for 
sugar co-utilization59. The CRISPRi tool is particularly useful in cyanobacteria, in which 
genome editing is complicated and time consuming due to slow growth and multiple 
chromosome copies57,60. Furthermore, the ability to fine-tune expression levels using 
CRISPRi was exploited in Synechococcus sp., where repression of nitrogen assimilation gene 
glnA was shown to increase the pool of α-ketoglutarate58. A moderate increase of this 
metabolite enhanced glycolytic flux and lactate production, whereas a too large increase 
resulted in a decrease in protein production58. CRISPRi-based multiplex gene repression was 
established in Synechocystis sp.60 and subsequently used to determine optimal gene repression 
combinations for fatty alcohol production56 (Table 2). As in all studies using CRISPRi in 
cyanobacteria, dCas9 and sgRNAs were chromosomally integrated into the genome. This 
resulted in stable repression strains in the absence of selective pressure for single sgRNAs, 
but the use of repetitive promoter elements resulted in undesired recombination events when 
multiplexing was attempted56, highlighting the potential advantage of using a dual RNA 
approach. Finally, it was observed that a targeted gene with a very distant transcription start 
site (TSS) from the start codon could be efficiently repressed by CRISPRi only when 
employing multiple sgRNAs targeting within the gene or the preceding operon genes60. 
Hence, this study revealed that the efficient application of the CRISPRi tool is strongly 
connected with the precise identification of TSS for the targeted genes.  
FUTURE PERSPECTIVES
In prokaryotes, CRISPR-Cas based genome editing has strongly increased engineering 
efficiencies by adding a powerful counter-selection method to existing engineering systems or 
by enhancing recombination efficiencies through induction of cellular DNA repair 
mechanisms12,20. In model organism E. coli high-throughput tools such as crMAGE7 and 
CREATE25 made multiplex engineering possible upon combining the Cas9 and 
recombineering tools. It is expected that these high-throughput tools will be Further 
developed into automated pipelines for rapid industrial strain development, while the 
thorough exploitation of their potential requires the additional development of rapid and easy 
screening and read-out systems.CRISPR-Cas-based counter-selection tools have increased 
editing efficiencies in many non-model organisms. However, further improvement of these 
tools still strongly depends on the development of basics, such as well-characterized inducible 
promoters61. The tight control of the Cas9-expression would allow for efficient integration of
218
Figure 2. Overview of CRISPRi-based metabolic engineering strategies to increase production of the target 
product (P). Abbreviations: C: carbon source; I: intermediate metabolite; B: byproduct or biomass; P: 
target product; TI: toxic intermediate; R: repressor; M: morphology. See legend of Figure 1 for graphic legend. 
Arrows represent intracellular carbon flows and their thickness corresponds to the flow rate. Arrows with dashed 
outlines represent merged pathways. a) Repression of competing pathway that leads to byproduct or biomass 
formation with i) indicating dCas9 targeting the promoter region, resulting in stronger repression than in ii), where 
the coding region is targeted. b) Repression of competing pathway that leads to product consumption with i) 
indicating dCas9 targeting the promoter region, resulting in stronger repression than in ii), where the coding 
region is targeted.  c) Repression of the product pathway to change product com position or properties. d) 
Repression of the product pathway to prevent accumulation of toxic intermediates.  e) Repression of repressor of 
the target product pathway.   f) Repression of cell shape/morphology genes to increase cell size and storage 
capacity for the target product.
Further developed into automated pipelines for rapid industrial strain development, while 
the thorough exploitation of their potential requires the additional development of rapid and 
easy screening and read-out systems.CRISPR-Cas-based counter-selection 
tools have increased editing efficiencies in many non-model organisms. 
However, further improvement of these tools still strongly depends on the 
development of basics, such as well-characterized inducible promoters61. The tight 
control of the Cas9-expression would allow for efficient integration of an employed 
homologous recombination template prior to the counter-selection step. The use of 
intrinsic Cas9-properties, such as temperature-sensitivity, can substitute the requirement for 
inducible promoters in organisms that can grow under conditions outside the Cas9 activity 
range62.
The use of alternative Class 2 CRISPR systems will further extend the Cas-
based engineering toolbox. Recently, the Cpf1 (Cas12) RNA-guided DNA endonucleases 
from the type V CRISPR-Cas systems of Francisella novicida35 and Acidaminococcus 
sp.63 have been repurposed for bacterial genome editing and silencing. Cpf1 does 
not require a tracrRNA and can process its own precursor crRNA via its intrinsic RNAse 
activity. Hence, the use of Cpf1 for the development of a multiplex engineering tool can 
prevent the issues encountered when using Cas9 and multiple sgRNAs for multiplex 
engineering63. The use of a Cpf1-recombineering tool in C. glutamicum, for which 
only very low levels of Cas9 expression can be tolerated31,35,64, resulted in 
screenable editing efficiencies35, while a DNase-dead Cpf1 (ddCpf1) variant was 
recently employed for multiplex silencing in E. coli63. The newly discovered Class 
2 Type VI system Cas13 (C2c2) RNA-guided RNA-nuclease can be used for 
silencing via the degradation of transcripts, or for tracking of 
transcripts using fluorescent-coupled catalytically inactive variants65,66. The 
RNA-guided RNA endonuclease from the type VI CRISPR-Cas systems 
of Leptotrichia shahii and Leptotrichia wadei have already been successfully 
repurposed for RNA interference in E. coli66,67. Furthermore, the repurposing of 
native CRISPR-Cas systems for genome editing68, has been proved efficient and 
holds promise for organisms with low transformation efficiencies69. It is 
anticipated that the development of easy and rapid characterization techniques70-73 will 
accelerate the exploitation of novel CRISPR-Cas systems for the development of 
prokaryotic engineering tools. These tools will further expand the number of target sites, 
the range of easy-to-engineer organisms and they will increase the engineering speed by 
simultaneous usage of different Cas systems for genome editing and plasmid 
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Figure 2. O verview of CRISPRi-based metabolic engineering strategies to increase production of the target
product (P). Abbreviations: C: carbon source; I: interm ediate m etabolite; B: byproduct or biom ass; P: target
product; TI: toxic interm ediate; R: repressor; M: m orphology. See legend of Figure 1 for graphic legend. Arrows
represent intracellular carbon flows and their thickness corresponds to the flow rate. Arrows with dashed outlines
represent m erged pathways.a) Repression of com peting pathway that leads to byproduct or biom ass form ation 
with i) indicating dCas9 targeting the prom oter region, resulting in stronger repression than in ii), where the coding
region is targeted. b) Repression of com peting pathway that leads to product consum ption with i) indicating dCas9 
targeting the prom oter region, resulting in stronger repression than in ii), where the coding region is targeted. c)
Repression of the product pathway to change product com position or properties. d) Repression of the product
pathway to prevent accum ulation of toxic interm ediates.e) Repression of repressor of the target product pathway.
f) Repression of cell shape/m orphology genes to increase cell size and storage capacity for the target product.
an employed homologous recombination template prior to the counter-selection step. The use 
of intrinsic Cas9-properties, such as temperature-sensitivity, can substitute the requirement 
for inducible promoters in organisms that can grow under conditions outside the Cas9 activity 
range62.
The use of alternative Class 2 CRISPR systems will further extend the Cas-based 
engineering toolbox. Recently, the Cpf1 (Cas12) RNA-guided DNA endonucleases from the 
type V CRISPR-Cas systems of Francisella novicida35 and Acidaminococcus sp.63 have 
been repurposed for bacterial genome editing and silencing. Cpf1 does not require a 
tracrRNA and can process its own precursor crRNA via its intrinsic RNAse activity. Hence, 
the use of Cpf1 for the development of a multiplex engineering tool can prevent the issues 
encountered when using Cas9 and multiple sgRNAs for multiplex engineering63. The use of 
a Cpf1-recombineering tool in C. glutamicum, for which only very low levels of Cas9 
expression can be tolerated31,35,64, resulted in screenable editing efficiencies35, while a DNase-
dead Cpf1 (ddCpf1) variant was recently employed for multiplex silencing in E. coli63. The 
newly discovered Class 2 Type VI system Cas13 (C2c2) RNA-guided RNA-nuclease can be 
used for silencing via the degradation of transcripts, or for tracking of transcripts using 
fluorescent-coupled catalytically inactive variants65,66. The RNA-guided RNA 
endonuclease from the type VI CRISPR-Cas systems of Leptotrichia shahii and 
Leptotrichia wadei have already been successfully repurposed for RNA interference in E. 
coli66,67. Furthermore, the repurposing of native CRISPR-Cas systems for genome editing68, 
has been proved efficient and holds promise for organisms with low transformation 
efficiencies69.  It is anticipated that the development of easy and rapid characterization 
techniques70-73 will accelerate the exploitation of novel CRISPR-Cas systems for the 
development of prokaryotic engineering tools. These tools will further expand the number of 
target sites, the range of easy-to-engineer organisms and they will increase the engineering 
speed by simultaneous usage of different Cas systems for genome editing and plasmid 
curing65,74 similar to the recently developed EXIT-circuit approach that combines Cas9-base 
d editing and I-SceI-based plasmid curing75.  
Screening natural resources for novel CRISPR-Cas systems will further expand the 
applications and range of organisms and environments in which CRISPR-Cas-based editing 
can be applied76-78. A recent example of this approach was the identification of a 
thermostable Cas9-orthologue in the genome of a Geobacillus thermodenitrificans strain 
isolated from a compost sample, which was further characterized and employed to establish 
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the first Cas9-based engineering tool for thermophilic bacteria79. The robustness of thermo-
stable Cas9-based tools can be further exploited for applications in extreme environments, as 
was recently shown for another thermostable Cas9-orthologue with prolonged life time in 
blood plasma80. The discovery of novel Cas nucleases with different properties, such as 
tolerance to alkaline or acidic pH and high saline concentrations, would be possible by 
screening selected environmental samples and metagenomic libraries. The characterization 
of these nucleases could lead to the development of engineering tools with wide 
applicability to biotechnologically relevant but currently unexploited extremophilic 
organisms.  
CONCLUSIONS 
Altogether, the developments in CRISPR-Cas-based bacterial genome engineering and 
increase insight into metabolism on a systems level and enable more rapid strain 
engineering, which is crucial for the development of a bio-based economy using microbial 
cell factories. Rapid current developments and future applications, which will further expand 
the range of organisms and applications of CRISPR-Cas-based editing for metabolic 
engineering, consist of fine-tuning of the tools, their adaptation to different hosts, their 
extension into combinations with other active components such as proteases, markers or 
activators, as well as the discovery and development of novel Cas-like systems.  
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curing65,74 similar to the recently developed EXIT-circuit approach that combines Cas9-base d
editing and I-SceI-based plasmid curing75. 
Screening natural resources for novel CRISPR-Cas systems will further expand the 
applications and range of organisms and environments in which CRISPR-Cas-based editing 
can be applied76-78. A recent example of this approach was theidentification of a 
thermostable Cas9-orthologue in the genome of a Geobacillus thermodenitrificans 
strain isolated from a compost sample, which was further characterized and 
employed to establish the first Cas9-based engineering tool for thermophilic bacteria79. The 
robustness of thermostable Cas9-based tools can be further exploited for applications in 
extreme environments, as was recently shown for another thermostable Cas9-orthologue with 
prolonged life time in blood plasma80. The discovery of novel Cas nucleases with different 
properties, such as tolerance to alkaline or acidic pH and high saline concentrations, would 
be possible by screening selected environmental samples and metagenomic libraries. The
characterization of these nucleases could lead to the development of engineering tools with 
wide applicability to biotechnologically relevant but currently unexploited extremophilic 
organisms.  
CO NCLUSIO NS 
Altogether, the developments in CRISPR-Cas-based bacterial genome engineering and 
increase insight into metabolism on a systems level and enable more rapid strain 
engineering, which is crucial for the development of a bio-based economy using 
microbial cell factories. Rapid current developments and future applications, which will 
further expand the range of organisms and applications of CRISPR-Cas-based editing for 
metabolic engineering, consist of fine-tuning of the tools, their adaptation to different 
hosts, their extension into combinations with other active components such as proteases, 
markers or activators, as well as the discovery and development of novel Cas-like 
systems.  
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INTRO DUCTIO N 
A bio-based economy aims towards the substitution of non-renewable energy and 
chemical resources by renewable biomass-based substrates for microbial 
fermentations in biorefineries1,2. Examples of valuable microbial products that 
can replace oil-based chemicals are dicarboxylic acids such as succinate and 
malate, which can be used in pharmaceuticals and cosmetics and as building blocks 
for bio-plastics. The development of microbial workhorses, that produce compounds of 
interest at high yields and titers, is based on the thorough understanding of their 
metabolism and on high-throughput metabolic engineering approaches with efficient 
genome engineering tools. Hence, till recently, only a handful of microbes, such as E. 
coli and S. cerevisiae, could serve as production platform organisms. Nonetheless, the 
recent development of generally applicable and efficient CRISPR-Cas genome 
engineering tools for a wide variety of bacteria can accelerate studies on their metabolism 
and unlock their biotechnological potential3,4. 
The use of moderately thermophilic instead of mesophilic bacteria in 
biorefineries presents several advantages, such as reduced cooling costs, elimination of 
contamination risks from mesophilic contaminants and reduced requirements for 
thermoactive saccharolytic enzymes5. The development of the thermotolerant 
ThermoCas9-based genome editing and silencing tools, applicable at temperatures at 
least up to 55°C, can facilitate the metabolic exploration and biotechnological exploitation 
of a wide range of thermophilic bacteria. Bacillus smithii ET 138 was the first thermophilic 
bacterium edited with the ThermoCas9-based tool6 and it was selected for its genetic 
accessibility, wide growth temperature range, tolerance to pH fluctuations, ability to grow 
anaerobically and its interesting metabolism7. Bosma et al. previously demonstrated 
that B. smithii ET 138 mainly produces L-lactate under oxygen-limited and acetate 
under oxygen-rich culturing conditions8. Lactate production from pyruvate is 
catalysed by L-lactate dehydrogenase (LdhL), which in parallel oxidizes an NADH 
molecule into NAD+. Deleting the ldhL gene from theB. smithii ET 138 genome9 resulted in 
the complete elimination of L-lactate production under every tested condition. It also 
led to severe growth reduction under oxygen-limited conditions, most likely due to the 
lack of an alternative efficient NAD+-regenerating pathway8. Growth under aerobic 
conditions is not hampered by the ldhL deletion, with acetate being the main product 
under these conditions8. However, it is unknown how B. smithii produces acetate. None of the 
three currently sequenced B. smithii genomes, incl. ET 138, encompasses any phospho-
ABSTRACT 
Modern society highly resides on fossil fuel resources for energy and chemicals. The study 
and exploitation of non-model microbial production platforms, along with the currently 
model microorganisms like Escherichia coli and Saccharomyces cerevisiae, will accelerate 
the transition to an economy that promotes the environmental friendly production of green 
chemicals and fuels by microbial fermentation of renewable biomass. Bacillus smithii ET 138 
is a recently isolated bacterial strain with great potential as a biorefinery-based production 
platform. Amongst its other features, it is able to grow in a wide temperature range, it is 
genetically accessible, able to grow and produce organic acids under oxygen rich and limited 
conditions and tolerates low pH environments. In this study, we employed our SpCas9- based 
genome editing tool to substitute the native NAD+-dependent glyceraldehyde-3P 
dehydrogenase (gapA) gene, in the genome of the previously constructed lactate 
dehydrogenase deletion mutant B. smithii ET 138 ΔldhL (TKO) strain, by the NADP+-
dependent gapC gene from Clostridium acetobutylicum ATCC 824. This substitution aimed 
to relieve the NAD+ deficiency of the TKO strain under oxygen-limited conditions, due to 
the deletion of its main NAD+ regenerative pathway, and resulted in  moderate enhancement 
of its growth. We further employed the recently developed ThermoCas9-based genome 
editing tool to study the non-canonical acetate production pathway of B. smithii ET 138, by 
deleting the acetyl-CoA synthetase (acs) and acetyl-CoA hydrolase (ach) genes. Both 
deletions did not affect the acetate production of the mutant strains. Moreover, we cultured B. 
smithii ET 138 under controlled conditions at a wide temperature range aiming to reveal 
differences in growth, production and protein content. Finally, we engineered a B. smithii ET 
138 strain that shows enhanced production of dicarboxylic acids and reduced production of 
acetate. This study underlined the interesting features of the B. smithii ET 138 metabolism 
and its potential to become a green chemicals production host, paving the way for further 
engineering and culturing studies. 
KEYWORDS  
CRISPR/Cas9, Bacillus smithii, thermophiles, metabolic engineering, temperature shift
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ABSTRACT 
Modern society highly resides on fossil fuel resources for energy and chemicals. The study 
and exploitation of non-model microbial production platforms, along with the currently 
model microorganisms like Escherichia coli and Saccharomyces cerevisiae, will accelerate 
the transition to an economy that promotes the environmental friendly production of green 
chemicals and fuels by microbial fermentation of renewable biomass. Bacillus smithii ET 138 
is a recently isolated bacterial strain with great potential as a biorefinery-based production 
platform. Amongst its other features, it is able to grow in a wide temperature range, it is 
genetically accessible, able to grow and produce organic acids under oxygen rich and limited 
conditions and tolerates low pH environments. In this study, we employed our SpCas9- based 
genome editing tool to substitute the native NAD+-dependent glyceraldehyde-3P 
dehydrogenase (gapA) gene, in the genome of the previously constructed lactate 
dehydrogenase deletion mutant B. smithii ET 138 ΔldhL (TKO) strain, by the NADP+-
dependent gapC gene from Clostridium acetobutylicum ATCC 824. This substitution aimed 
to relieve the NAD+ deficiency of the TKO strain under oxygen-limited conditions, due to the 
deletion of its main NAD+ regenerative pathway, and resulted in moderate enhancement of 
its growth. We further employed the recently developed ThermoCas9-based genome editing 
tool to study the non-canonical acetate production pathway of B. smithii ET 138, by deleting 
the acetyl-CoA synthetase (acs) and acetyl-CoA hydrolase (ach) genes. Both deletions did 
not affect the acetate production of the mutant strains. Moreover, we cultured B. smithii ET 
138 under controlled conditions at a wide temperature range aiming to reveal differences in 
growth, production and protein content. Finally, we engineered a B. smithii ET 138 strain that 
shows enhanced production of dicarboxylic acids and reduced production of acetate. This 
study underlined the interesting features of the B. smithii ET 138 metabolism and its potential 
to become a green chemicals production host, paving the way for further engineering and 
culturing studies. 
K EYWO RDS  
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INTRODUCTION
A bio-based economy aims towards the substitution of non-renewable energy and 
chemical resources by renewable biomass-based substrates for microbial fermentations in 
biorefineries1,2. Examples of valuable microbial products that can replace oil-based chemicals 
are dicarboxylic acids such as succinate and malate, which can be used in pharmaceuticals 
and cosmetics and as building blocks for bio-plastics. The development of microbial 
workhorses, that produce compounds of interest at high yields and titers, is based on the 
thorough understanding of their metabolism and on high-throughput metabolic engineering 
approaches with efficient genome engineering tools. Hence, till recently, only a handful of 
microbes, such as Escherichia coli and Saccharomyces cerevisiae, could serve as production 
platform organisms. Nonetheless, the recent development of generally applicable and 
efficient CRISPR-Cas genome engineering tools for a wide variety of bacteria can accelerate 
studies on their metabolism and unlock their biotechnological potential3,4. 
The use of moderately thermophilic instead of mesophilic bacteria in biorefineries 
presents several advantages, such as reduced cooling costs, elimination of contamination risks 
from mesophilic contaminants and reduced requirements for thermoactive saccharolytic 
enzymes5. The development of the thermotolerant ThermoCas9-based genome editing and 
silencing tools, applicable at temperatures at least up to 55°C, can facilitate the metabolic 
exploration and biotechnological exploitation of a wide range of thermophilic bacteria. 
Bacillus smithii ET 138 was the first thermophilic bacterium edited with the ThermoCas9-
based tool6 and it was selected for its genetic accessibility, wide growth temperature range, 
tolerance to pH fluctuations, ability to grow anaerobically and its interesting metabolism7. 
Bosma et al. previously demonstrated that B. smithii ET 138 mainly produces L-lactate under 
oxygen-limited and acetate under oxygen-rich culturing conditions8. Lactate production from 
pyruvate is catalyzed by L-lactate dehydrogenase (LdhL), which in parallel oxidizes an 
NADH molecule into NAD+. Deleting the ldhL gene from the B. smithii ET 138 genome9 
resulted in the complete elimination of L-lactate production under every tested condition. It 
also led to severe growth reduction under oxygen-limited conditions, most likely due to the 
lack of an alternative efficient NAD+-regenerating pathway8. Growth under aerobic 
conditions is not hampered by the ldhL deletion, with acetate being the main product under 
these conditions8. However, it is unknown how B. smithii produces acetate. None of the three 
currently sequenced B. smithii genomes, incl. ET  138, encompasses any 
phosphotransacetylase (pta) and acetate kinase (ack), or pyruvate oxidase (pox) genes, which 
constitute the common acetate production pathways in bacteria10.
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Figure 1. Schematic representation of the central glucose metabolism of B. smithii ET 138 along 
with candidate acetate production pathways and the bacillithiol production pathway. Coloured boxes 
indicate: red rectangular: upper glycolysis; orange rectangular: lower glycolysis; brown rectangular: 
pentose phosphate pathway; grey rectangular: methylglyoxal pathway; green eclipse: reactions connected to 
pyruvate metabolism; purple triangle: reactions examined in this study that could be responsible for the acetate 
production; blue circle: tricarboxylic acid (TCA) cycle; dashed square: bacillithiol production pathway. Blue 
arrows indicate reactions catalyzed by enzymes of which the EC-number was identified via domainome 
analysis while dashed arrows indicate reactions catalyzed by enzymes which have not been identified in 
the B. smithii ET 138 genome. Intermediates or producs denoted in bold and underlined have been discussed 
in this study. Enzymes underlined have been engineered and/or discussed in this study. Abbreviations: PTS: 
phosphotransferase system; GK: glucokinase; PGI: glucose-6-phosphate isomerase; G6PDH: glucose-6-
phosphate dehydrogenase; 6PGDH: 6-phosphogluconate dehydrogenase; RPI: phosphopentose isomerase; 
RPE: phosphopentose epimerase; TKL: transketolase; TAL: transaldolase; FBP: fructose bisphosphatase; 
PFK: phosphofructokinase; FBA: fructose bis-phosphate aldolase; TPI: triosephosphate isomerase; GAP: 
glyceraldehyde 3-phosphate dehydrogenase; PGK: phosphoglycerate kinase; PGM: phosphoglycerate mutase; 
ENO: enolase; MGS: methylglyoxal synthase; MGR: methylglyoxal reductase; LADH: lactaldehyde 
dehydrogenase; GLXA: glyoxalase A; GLXB: glyoxalase B; PCK: phosphoenol pyruvate carboxykinase; PPC: 
phosphoenol pyruvate carboxylase; PYK: pyruvate kinase; PYC: pyruvate carboxylase; CS: citrate 
synthase; ACN: aconitase; ICL: isocitrate lyase; MS: malate synthase; ICD: isocitrate dehydrogenase; OOR: 
2-oxoglutarate reductase; ODH: 2-oxoglutrate dehydrogenase; SCS: succinyl-CoA synthetase; SDH: 
succinate dehydrogenase; FH: fumarate hydratase; ME: malic enzyme; MDH: malate dehydrogenase; 
MQO: malate:qu inone oxidoreductase; ALS: acetolactate synthase; LDHL: L-lactate dehydrogenase; 
PDHC: pyruvate dehydrogenase complex; ACDH: acetyl-CoA dehydrogenase; ALDH: acetaldehyde 
dehydrogenase; ACS: acetyl-CoA synthetase; ACH: acety-CoA hydratase; BSHA: L-malate 
glucosyltransferase; BSHB: maly l-N-acetyl-D-glucosamine N-acetyl hydrolase; BSHC: bacillithiol synthase. 
Altogether, to plan further metabolic engineering steps and enable the development 
of B. smithii into a platform organism it is crucial to 1) reconstitute the growth of B. smithii 
ET 138 ΔldhL under oxygen-limited conditions, and 2) identify the alternative acetate 
production pathway employed by B. smithii ET 138. In this study, we aimed to achieve 
this by 1) substituting the native NAD+-dependent glyceraldehyde 3P-dehydrogenase 
(gapA) gene for the NADP+-dependent glyceraldehyde 3P-dehydrogenase (i) from 
Clostridium acetobutylicum ATCC 824 and 2) deleting the genes of corresponding 
enzymes that could catalyse acetate-producing reactions, namely acetyl-CoA hydrolase 
(ach) and acetyl-CoA synthetase (acs). We performed culturing experiments with the 
constructed mutant strains to evaluate the effect of the deletions on B. smithii ET 138 
metabolism. To further improve our understanding of B. smithii metabolic pathways and 
fluxes, and optimize culture conditions, we additionally explored differences in growth, 
product profiles and proteome at temperatures between 37 and 55°C, between which the 
acetate and dicarboxylic acid production patterns showed striking differences. Finally, we 
engineered a strain with reduced carbon flux towards acetate and enhanced flux towards 
dicarboxylic acids under the optimized culturing conditions.
RESULTS & DISCUSSION
RECONSTITUTING B. SMITHII ET 138 ΔLDHL GROWTH UNDER OXYGEN-
LIMITED CONDITIONS
Background knowledge
Lactate is the main fermentation product of B. smithii as the conversion of pyruvate to L-
lactate via L-lactate dehydrogenase (LdhL) is the main NAD+-regenerative route under 
oxygen-limited culturing conditions8. Earlier studies strongly suggested that the growth 
reduction of B. smithii ET 138 ΔldhL compared to the wild type under oxygen-limited 
conditions is the result of NAD+-deficiency8. This hypothesis was supported by partial 
reconstitution of the B. smithii ET 138 ΔldhL growth under oxygen-limited conditions via 
plasmid-based expression of the NAD+- and D-lactate producing- D-lactate dehydrogenase 
(LdhA) from Lactobacillus delbrueckii subsp. bulgaricus8. Metabolomics data on B. smithii 
ET 138 ΔldhL fermentations revealed the intracellular accumulation of glyceraldehyde-3P 
(G3P), an upper glycolytic intermediate which is normally metabolised into 1,3-bisP-glycerate 
(1,3bPG) by the NAD+-dependent glyceraldehyde 3P-dehydrogenase gene (gapA) or the 
NADP+-dependent glyceraldehyde 3P-dehydrogenase gene (gapB)8 (Fig. 1).
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transacetylase (pta) and acetate kinase (ack), or pyruvate oxidase (pox) genes, which 
constitute the common acetate production pathways in bacteria10.
Altogether, to plan further metabolic engineering steps and enable the development of 
B. smithii into a platform organism it is crucial to 1) reconstitute the growth of B. smithii ET
138 ΔldhL under oxygen-limited conditions, and 2) identify the alternative acetate production
pathway employed by B. smithii ET 138. In this study, we aimed to achieve this by 1)
substituting the native NAD+-dependent glyceraldehyde 3P-dehydrogenase (gapA) gene for
the NADP+-dependent glyceraldehyde 3P-dehydrogenase (gapC) from Clostridium
acetobutylicum ATCC 824 and 2) deleting the genes of corresponding enzymes that could
catalyse acetate-producing reactions, namely acetyl-CoA hydrolase (ach) and acetyl-CoA
synthetase (acs). We performed culturing experiments with the constructed mutant strains to
evaluate the effect of the deletions on B. smithii ET 138 metabolism. To further improve our
understanding of B. smithii metabolic pathways and fluxes, and optimize culture conditions,
we additionally explored differences in growth, product profiles and proteome at
temperatures between 37 and 55°C, between which the acetate and dicarboxylic acid
production patterns showed striking differences. Finally, we engineered a strain with reduced
carbon flux towards acetate and enhanced flux towards dicarboxylic acids under the
optimized culturing conditions.
RESULTS & DISCUSSIO N
RECO NSTITUTINGB. SMITHII ET 138 ΔLDHL GRO WTH UNDER O XYG EN-
LIMITED CO NDITIO NS
Background knowledge 
Lactate is the main fermentation product of B. smithii as the conversion of pyruvate to 
L-lactate via L-lactate dehydrogenase (LdhL) is the main NAD+-regenerative route under
oxygen-limited culturing conditions8. Earlier studies strongly suggested that the growth
reduction of B. smithii ET 138 ΔldhL compared to the wild type under oxygen-limited
conditions is the result of NAD+-deficiency8. This hypothesis was supported by partial
reconstitution of the B. smithii ET 138 ΔldhL growth under oxygen-limited conditions via
plasmid-based expression of the NAD+- and D-lactate producing- D-lactate dehydrogenase
(LdhA) from Lactobacillus delbrueckii subsp. bulgaricus 8. Metabolomics data on B. smithii
ET 138 ΔldhL fermentations revealed the intracellular accumulation of glyceraldehyde-3P
(G3P), an upper glycolytic intermediate which is normally metabolised into 1,3-bisP-
glycerate (1,3bPG) by the NAD+-dependent glyceraldehyde 3P-dehydrogenase gene (gapA)
or the NADP+-dependent glyceraldehyde 3P-dehydrogenase gene (gapB)8 (Fig. 1).
Figure 1. Schematic representation of the central glucose metabolism of B. smithii ET 138 along with 
candidate acetate production pathways and the bacillithiol production pathway. Coloured boxes indicate: 
red rectangular: upper glycolysis; orange rectangular: lower glycolysis; brown rectangular: pentose phosphate 
pathway; grey rectangular: methylglyoxal pathway; green eclipse: reactions connected to pyruvate metabolism; 
purple triangle: reactions examined in this study that could be responsible for the acetate production; blue circle: 
tricarboxylic acid (TCA) cycle; dashed square: bacillithiol production pathway. Blue arrows indicate reactions 
catalyzed by enzymes of which the EC-number was identified via domainome analysis while dashed arrows 
indicate reactions catalyzed by enzymes which have not been identified in the B. smithii ET 138 genome. 
Intermediates or producs denoted in bold and underlined have been discussed in this study. Enzymes underlined 
have been engineered and/or discussed in this study. Abbreviations: PTS: phosphotransferase system; GK: 
glucokinase; PGI: glucose-6-phosphate isomerase; G6PDH: glucose-6-phosphate dehydrogenase; 6PGDH: 6-
phosphogluconate dehydrogenase; RPI: phosphopentose isomerase; RPE: phosphopentose epimerase; TKL: 
transketolase; TAL: transaldolase; FBP: fructose bisphosphatase; PFK: phosphofructokinase; FBA: fructose bis-
phosphate aldolase; TPI: triosephosphate isomerase; GAP: glyceraldehyde 3-phosphate dehydrogenase; PGK: 
phosphoglycerate kinase; PGM: phosphoglycerate mutase; ENO: enolase; MGS: methylglyoxal synthase; MGR: 
methylglyoxal reductase; LADH: lactaldehyde dehydrogenase; GLXA: glyoxalase A; GLXB: glyoxalase B; 
PCK: phosphoenol pyruvate carboxykinase; PPC: phosphoenol pyruvate carboxylase; PYK: pyruvate kinase; 
PYC: pyruvate carboxylase; CS: citrate synthase; ACN: aconitase; ICL: isocitrate lyase; MS: malate synthase; 
ICD: isocitrate dehydrogenase; OOR: 2-oxoglutarate reductase; ODH: 2-oxoglutrate dehydrogenase; SCS: 
succinyl-CoA synthetase; SDH: succinate dehydrogenase; FH: fumarate hydratase; ME: malic enzyme; MDH: 
malate dehydrogenase; MQO: malate:qu inone oxidoreductase; ALS: acetolactate synthase; LDHL: L-lactate 
dehydrogenase; PDHC: pyruvate dehydrogenase complex; ACDH: acetyl-CoA dehydrogenase; ALDH: 
acetaldehyde dehydrogenase; ACS: acetyl-CoA synthetase; ACH: acety-CoA hydratase; BSHA: L-malate 
glucosyltransferase; BSHB: malyl-N-acetyl-D-glucosamine N-acetyl hydrolase; BSHC: bacillithiol synthase.
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Figure 2. A) Schematic overview of the pSpCas9_ ΔgapA::gapC based editing process. The spcas9 gene 
was cloned into the pNW33n vector under the control of PxynA promoter, followed by the sgRNA-expressing 
module encompassing a spacer targeting the gapA gene within the genome of B. smithii ET 138. The sgRNA 
module is under the transcriptional control of the Ppta from B. coagulans . The 1kb upstream and 1kb 
downstream genomic region of the gapA gene are cloned in the pSpCas9_ ΔgapA::gapC vector upstream of the 
spcas9 and interspaced by the gapC gene from Clostridium acetobutylicum ATCC 824. After a first single 
crossover event, the vector is integrated into the genome. A second crossover event will either result in a wild 
type revertant genome, which is recognised and targeted by the spCas9:sgRNA ribonucleoprotein (RNP), or a 
genome with the desired insertion. The RNP-induced lethal double stranded DNA breaks eliminate the wild 
type cells and allow the rapid and easy screening of the mutant cells. B) Gel-electrophoresis of the PCR and 
restriction analysis products from cTKO B. smithii ET 138 strains. Genomic DNA was extracted from 10
cTKO cultures grown at 50˚C, and 4 kb fragments from the gapC genomic regions were PCR amplified 
using genome specific primers. The PCR products were digested with EcoRI, giving fragments of 315 bp, 
809 bp and 2931 bp for the wild-type genotype and 809 bp, 1202 bp and 2041 bp for the mutated 
genotype.Genomic DNA from the wild-type strain was used as negative control. RD: Restriction digested 
product, PCR: PCR product. C) Growth and production profile of DKO, TKO and cTKO strains under micro-
aerobic conditions. Samples were taken after 24 h of growth in 25 mL TVMY medium in 50 mL Greiner 
tubes at 50˚C. Data represent means of 3 replicates and error bars indicate standard deviations. Significant 
differences with the control strains were determined by Student’s t test; *, P <0.05. 
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Transcriptomics data on the same B. smithii ET 138 ΔldhL fermentations showed the expected 
transcriptional upregulation of the gapA and gapB genes, as well as the upregulation of the 
triosphosphate isomerase (tpiA) gene compared to the wild type control fermentations. The 
tpiA upregulation suggests that B. smithii ET 138 ΔldhL either purposely promotes the 
isomerisation of the formed dihydroxyacetone-phosphate (DHAP) into G3P, in its attempt to 
enhance the “stuck” lower glycolysis, or it tries to channel the accumulating G3P towards the 
methylglyoxal pathway, with D/L-lactate as final product, via its isomerization to DHAP (Fig. 
1). Nonetheless, the transcriptomics data did not reveal any transcriptional upregulation of the 
methylglyoxal synthase (mgs) gene and the HPLC analysis of the B. smithii ET 138 ΔldhL 
fermentation products did not show lactate accumulation, supporting the former scenario.  
RECONSTITUTING B. SMITHII ET 138 ΔLDHL GROWTH UNDER OXYGEN-
LIMITED CONDITIONS
Strain development via genetic engineering
The aim of this  study was to overcome the metabolic bottleneck of the NAD+-deficiency, 
that results in intracellular G3P accumulation in B. smithii ET 138 ΔldhL fermentations, and 
further expand the variety of B. smithii ET 138 fermentation products. We decided to 
substitute the NAD+-dependent gapA gene in the genome of B. smithii ET 138 with the 
NADP+-dependent gapC gene from Clostridium acetobutylicum ATCC 824. This substitution 
would result in the elimination of any NAD+-dependent reaction in glycolysis, relieving the 
NAD+-deficiency in B. smithii ET 138 ΔldhL fermentations and allowing us to evaluate if the 
NADP+-availability is high enough to reconstitute growth and glucose consumption. 
Moreover, it was previously shown that the gapA to gapC substitution is an effective method 
for changing cofactor availability and redirecting metabolic pathways11.
We used the B. smithii ΔsigF_ΔldhL_ΔhsdR mutant strain12, from now onwards denoted as 
TKO (Triple Knock-Out), as platform organism for the gapA substitution by gapC. Next to 
the inability to produce lactate, the TKO strain has also lost the ability to sporulate, and it does 
not encompass any active restriction/modification system that could hamper plasmid-based 
genome engineering experiments. The previously developed plasmid-based homologous 
recombination (HR)-SpCas9 counter selection system12 was employed for the substitution of 
the gapA by the gapC gene in the B. smithii ET 138 genome (Fig. 2a). After in silico 
analysis13 and confirmation that the that the codon usage landscape of gapC gene in its native 
genomic context would be comparable to the codon usage landscape in B. smithii, 
we proceeded with immediate PCR amplification of the gapC from the C. acetobutylicum ge-
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Transcriptomics data on the same B. smithii ET 138 ΔldhL fermentations showed the 
expected transcriptional upregulation of the gapA and gapB genes, as well as the 
upregulation of the triosphosphate isomerase (tpiA) gene compared to the wild type control 
fermentations.The tpiA upregulation suggests that B. smithii ET 138 ΔldhL either purposely 
promotes the isomerisation of the formed dihydroxyacetone-phosphate (DHAP) into G3P, in 
its attempt to enhance the “stuck” lower glycolysis, or it tries to channel the accumulating 
G3P towards the methylglyoxal pathway, with D/L-lactate as final product, via its 
isomerization to DHAP (Fig. 1). Nonetheless, the transcriptomics data did not reveal any 
transcriptional upregulation of the methylglyoxal synthase (mgs) gene and the HPLC analysis 
of the B. smithii ET 138 ΔldhL fermentation products did not show lactate accumulation, 
supporting the former scenario.  
RECO NSTITUTING B. SMITHII ET 138 ΔLDHL G RO WTH UNDER O XYG EN-
LIMITED CO NDITIO NS
Strain development via genetic engineering
The aim of this study was to overcome the metabolic bottleneck of the NAD+-deficiency, 
that results in intracellular G3P accumulation in B. smithii ET 138 ΔldhL fermentations, and 
further expand the variety of B. smithii ET 138 fermentation products. We decided to 
substitute the NAD+-dependent gapA gene in the genome of B. smithii ET 138 with the 
NADP+-dependent gapC gene from Clostridium acetobutylicum ATCC 824. This 
substitution would result in the elimination of any NAD+-dependent reaction in glycolysis, 
relieving the NAD+-deficiency in B. smithii ET 138 ΔldhL fermentations and allowing us to 
evaluate if the NADP+-availability is high enough to reconstitute growth and glucose 
consumption. Moreover, it was previously shown that the gapA to gapC substitution is an 
effective method for changing cofactor availability and redirecting metabolic pathways11.
We used the B. smithii ΔsigF_ΔldhL_ΔhsdR mutant strain12, from now onwards 
denoted as TKO (Triple Knock-Out), as platform organism for the gapA substitution by 
gapC. Next to the inability to produce lactate, the TKO strain has also lost the ability to 
sporulate, and it does not encompass any active restriction/modification system that could 
hamper plasmid-based genome engineering experiments. The previously developed plasmid-
based homologous recombination (HR)-SpCas9 counter selection system12 was employed for 
the substitution of the gapA by the gapC gene in the B. smithii ET 138 genome (Fig. 2a). 
After in silico analysis13 and confirmation that the that the codon usage landscape of gapC
gene in its native genomic context would be comparable to the codon usage landscape in B. 
smithii, we proceeded with immediate PCR amplification of the gapC from the 
Figure 2. A) Schematic overview of the pSpCas9_ ΔgapA::gapC based editing process. The spcas9 gene was 
cloned into the pNW33n vector under the control of PxynA promoter, followed by the sgRNA-expressing 
module encompassing a spacer targeting the gapA gene within the genome of B. smithii ET 138. The sgRNA 
module is under the transcriptional control of the Ppta from B. coagulans . The 1kb upstream and 1kb 
downstream genomic region of the gapA gene are cloned in the pSpCas9_ ΔgapA::gapC vector upstream of the 
spcas9 and interspaced by the gapC gene from Clostridium acetobutylicum ATCC 824. After a first single 
crossover event, the vector is integrated into the genome. A second crossover event will either result in a wild type 
revertant genome, which is recognised and targeted by the spCas9:sgRNA ribonucleoprotein (RNP), or a genome 
with the desired insertion. The RNP-induced lethal double stranded DNA breaks eliminate the wild type cells 
and allow the rapid and easy screening of the mutant cells. B) Gel-electrophoresis of the PCR and restriction 
analysis products from cTKO B. smithii ET 138 strains. Genomic DNA was extracted from 10 cTKO 
cultures grown at 50˚C, and 4 kb fragments from the gapC genomic regions were PCR amplified using 
genome specific primers. The PCR products were digested with EcoRI, giving fragments of 315 bp, 809 bp and 
2931 bp for the wild-type genotype and 809 bp, 1202 bp and 2041 bp for the mutated genotype.Genomic DNA 
from the wild-type strain was used as negative control. RD: Restriction digested product, PCR: PCR product. C) 
Growth and production profile of DKO, TKO and cTKO strains under micro-aerobic conditions. Samples were 
taken after 24 h of growth in 25 mL TVMY medium in 50 mL Greiner tubes at 50˚C. Data represent means of 3 
replicates and error bars indicate standard deviations. Significant differences with the control strains were 
determined by Student’s t test; *, P <0.05. 
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affects the metabolism by changing the redox cofactors availability, increasing the glucose
consumption and channeling carbon towards the methyglyoxal pathway. 
As described in the background knowledge part, the major metabolic bottleneck of 
ΔldhL cultures under oxygen-limited conditions is the NAD+-dependent conversion of G3P 
to 1,3bPG by GapA. Here we show that the substitution of gapA by the NADP+-dependent 
gapC in the cTKO genome relieves -to some extend- upper glycolysis from this bottleneck 
step and allows for higher glucose consumption and better growth of the cTKO cultures, 
compared to the TKO cultures. In line with this observation, it was previously reported for E. 
coli that the gapA to gapC substitution significantly enhanced the flux through the glycolytic 
pathway, whereas the flux through the Pentose Phosphate (PP) pathway was strongly 
reduced11, as this important pathway for biomass production heavily relies on NADP+. 
Hence, the incomplete growth restoration of the TKO cultures, compared to the DKO 
cultures, could be attributed to reduced flux through the PP pathway.  
The cTKO cultures produce substantial amounts of lactate that most probably 
originates from the methylglyoxal pathway, considering the background deletion of the L-
lactate dehydrogenase gene from the cTKO genome as well as the lack of a D-lactate 
dehydrogenase gene from the B. smithii ET 138 genome10. As previously mentioned, there 
was no indication of a transcriptionally active methylglyoxal pathway in the B. smithii ET 
138 ΔldhL fermentations, while surprisingly the cTKO fermentations in this study indicate 
activation of this pathway. While this remains to be experimentally proven, a possible 
explanation is the cofactor coupling of the NADP+-consuming GapC to the NADP+-
producing methylglyoxal reductase (MgR) (Fig. 1): the conversion of methylglyoxal to L-
lactaldehyde via MGR is accompanied by the production of NADP+, which can be further 
used by GapC during glycolysis. Notably, the conversion of the toxic L-lactaldehyde to L-
lactate requires an NAD+ molecule15, probably creating another NAD+-deficiency issue. This 
might explain that the observed lactate production in the cTKO fermentations was higher 
than the TKO fermentations but much lower compared to the theoretical maximum of 2 
lactate molecules produced per glucose molecule consumed. Moreover, the accumulation of 
toxic methylglyoxal could also negatively affect the growth of the cTKO cultures, unless it is 
further converted into D-lactate in a process that requires bacillithiol as cofactor (Fig. 1).  
Lastly, Martinez et al.11 demonstrated for the E. coli ΔgapA::gapC strain that the flux 
through the lower TCA cycle was decreased, as the conversion of isocitrate to oxoglutarate is 
an NADP+-dependent process. This allowed for enhanced acetyl-CoA conversion into
nome. Moreover, the 1 kb upstream (US) and downstream (DS) genomic regions of the gapA 
were PCR amplified from the B. smithii genome and all three fragments were cloned into the 
pSpCas9 vector, creating the pSpCas9_ ΔgapA::gapC vector (  Fig. 2a). Moreover, the 
cloning was designed in such way that the gapC gene would be flanked by the US and DS 
regions as the gapA is flanked in the B. smithii genome. The spacer introduced into the 
sgRNA expressing module of the pSpCas9_ ΔgapA::gapC vector was designed to lead 
SpCas9 to introduce double stranded DNA breaks (DSB) in gapA upon incubation of the cells 
at 37°C, facilitating the selection of HR-based mutated cells over the wild-type cells (Fig. 2a). 
After transformation of TKO with the pSpCas9_ΔgapA::gapC vector and subsequent HR and 
Cas9-counter-selection, 28 randomly selected colonies were PCR-screened for clean gapA to 
gapC substitutions with genome-specific primers. To discriminate between gapA and gapC 
that generate PCR products of similar sizes, each PCR amplification product was subjected to 
restriction digestion with EcoRI. Out of the 28 PCR products, 27 had the restriction pattern 
corresponding to the clean mutant genotype (Fig. 2b). T  he gapA to gapC genotype of 10 
mutant colonies was confirmed via sequencing of the corresponding PCR-amplified 
fragments. Finally, plasmid curing was successfully performed by non-selective subculturing, 
resulting in  the TKO _ΔgapA::gapC mutant strain, from now onwards denoted as cTKO.
RECONSTITUTING B. SMITHII ET 138 ΔLDHL GROWTH UNDER OXYGEN-
LIMITED CONDITIONS
Phenotypic characterization of the gapA to gapC substitution strain
The effect of the chromosomal gapA to gapC replacement on growth and organic acids 
production was assessed by culturing the B. smithii cTKO, TKO and ΔsigF_ΔhsdR (from here 
onwards denoted as DKO) strains under oxygen-limited conditions (25 ml TVMY medium 
supplemented with 10 g/l glucose in 50 ml falcon tubes) for 24 h at 50°C. The culturing 
temperature was set at the optimal growth temperature of C. acetobutylicum ATCC 824, from 
which the gapC originates14 and which is within the optimal growth temperature range of B. 
smithii7. Under the tested conditions, the growth of the cTKO cultures was enhanced 
compared to the TKO cultures, but they still did not reach the growth levels of the DKO 
cultures (Fig. 2c). The glucose consumption of the cTKO cultures was 41% higher compared 
to the TKO cultures (Fig. 2c). The higher cTKO glucose consumption was accompanied by a 
dramatic increase in lactate production, a moderate increase in acetate production and 
a minor increase in pyruvate production compared to the TKO cultures. These results indicate 
8233
Exploring and enhancing the potential of B. smithii ET 138 as a green chemicals production platform organism
C. acetobutylicum genome. Moreover, the 1 kb upstream (US) and downstream (DS)
genomic regions of the gapA were PCR amplified from theB. smithii genome and all three
fragments werecloned into the pSpCas9 vector, creating the pSpCas9_ ΔgapA::gapC vector
(Fig. 2a). Moreover, the cloning was designed in such way that the gapC gene would be
flanked by the US and DS regions as the gapA is flanked in the B. smithii genome. The
spacer introduced into the sgRNA expressing module of the pSpCas9_ ΔgapA::gapC vector
was designed to lead SpCas9 to introduce double stranded DNA breaks (DSB) in gapA upon
incubation of the cells at 37°C, facilitating the selection of HR-based mutated cells over the
wild-type cells (Fig. 2a). After transformation of TKO with the pSpCas9_ΔgapA::gapC
vector and subsequent HR and Cas9-counter-selection, 28 randomly selected colonies were
PCR-screened for clean gapA to gapC substitutions with genome-specific primers. To
discriminate betweengapA and gapC that generate PCR products of similar sizes, each PCR
amplification product was subjected to restriction digestion with EcoRI. Out of the 28 PCR
products, 27 had the restriction pattern corresponding to the clean mutant genotype (Fig. 2b).
The gapA to gapC genotype of 10 mutant colonies was confirmed via sequencing of the
corresponding PCR-amplified fragments. Finally, plasmid curing was successfully
performed by non-selective subculturing, resulting in the TKO_ΔgapA::gapC mutant strain,
from now onwards denoted as cTKO.
RECO NSTITUTINGB. SMITHII ET 138 ΔLDHL G RO WTH UNDER O XYG EN-
LIMITED CO NDITIO NS
Phenotypic characterization of the gapA to gapC substitution strain 
The effect of the chromosomal gapA to gapC replacement on growth and organic acids 
production was assessed by culturing the B. smithii cTKO, TKO and ΔsigF_ΔhsdR (from 
here onwards denoted as DKO) strains under oxygen-limited conditions (25 ml TVMY 
medium supplemented with 10 g/l glucose in 50 ml falcon tubes) for 24 h at 50°C. The 
culturing temperature wasset at the optimal growth temperature ofC. acetobutylicum ATCC 
824, from which the gapC originates14 and which is within the optimal growth temperature 
range of B. smithii7. Under the tested conditions, the growth of the cTKO cultures was 
enhanced compared to the TKO cultures, but they still did not reach the growth levels of the 
DKO cultures (Fig. 2c). The glucose consumption of the cTKO cultures was 41% higher 
compared to the TKO cultures (Fig. 2c). The higher cTKO glucose consumption was 
accompanied by a dramatic increase inlactate production, a moderate increase in acetate 
production and a minor increase in pyruvate production compared to the TKO cultures. 
These results indicate that the NADP+-based G3P conversion to 1,3bPG in the cTKO strain 
that the NADP+-based G3P conversion to 1,3bPG in the cTKO strain affects the metabolism 
by changing the redox cofactors availability, increasing the glucose consumption and 
channeling carbon towards the methyglyoxal pathway. 
As described in the background knowledge part, the major metabolic bottleneck of 
ΔldhL cultures under oxygen-limited conditions is the NAD+-dependent conversion of G3P to 
1,3bPG by GapA. Here we show that the substitution of gapA by the NADP+-dependent gapC 
in the cTKO genome relieves -to some extend- upper glycolysis from this bottleneck step and 
allows for higher glucose consumption and better growth of the cTKO cultures, compared to 
the TKO cultures. In line with this observation, it was previously reported for E. coli that the 
gapA to gapC substitution significantly enhanced the flux through the glycolytic pathway, 
whereas the flux through the Pentose Phosphate (PP) pathway was strongly reduced11, as this 
important pathway for biomass production heavily relies on NADP+. Hence, the incomplete 
growth restoration of the TKO cultures, compared to the DKO cultures, could be attributed to 
reduced flux through the PP pathway.  
The cTKO cultures produce substantial amounts of lactate that most probably 
originates from the methylglyoxal pathway, considering the background deletion of the L-
lactate dehydrogenase gene from the cTKO genome as well as the lack of a D-lactate 
dehydrogenase gene from the B. smithii ET 138 genome10. As previously mentioned, there 
was no indication of a transcriptionally active methylglyoxal pathway in the B. smithii ET 138 
ΔldhL fermentations, while surprisingly the cTKO fermentations in this study indicate 
activation of this pathway. While this remains to be experimentally proven, a possible 
explanation is the cofactor coupling of the NADP+-consuming GapC to the NADP+-
producing methylglyoxal reductase (MgR) (Fig. 1): the conversion of methylglyoxal to L-
lactaldehyde via MGR is accompanied by the production of NADP+, which can be further 
used by GapC during glycolysis. Notably, the conversion of the toxic L-lactaldehyde to L-
lactate requires an NAD+ molecule15, probably creating another NAD+-deficiency issue. This 
might explain that the observed lactate production in the cTKO fermentations was higher than 
the TKO fermentations but much lower compared to the theoretical maximum of 2 lactate 
molecules produced per glucose molecule consumed. Moreover, the accumulation of toxic 
methylglyoxal could also negatively affect the growth of the cTKO cultures, unless it is 
further converted into D-lactate in a process that requires bacillithiol as cofactor (Fig. 1).  
Lastly, Martinez et al.11 demonstrated for the E. coli ΔgapA::gapC strain that the 
flux through the lower TCA cycle was decreased, as the conversion of isocitrate to 
oxoglutarate is an NADP+-dependent process. This allowed for enhanced acetyl-CoA 
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genes. Acetyl-CoA hydrolase (AcH) catalyses the hydrolysis of acetyl-CoA into acetate and 
CoA (Fig. 1), and it was previously found to be highly transcribed in B. smithii ET 138 
cultures under aerobic but not under oxygen-limited conditions (unpublished data). Acetytl-
CoA synthetase (AcS) catalyses the ATP-dependent reversible activation of acetate into 
acetyl-CoA (Fig. 1). Although the reaction favours the acetyl-CoA formation, the Gibbs free 
energy (ΔG°’) of the acetate formation is -4.5 kJ/mol, hence thermodynamically feasible. 
Additionally, it was recently demonstrated that the AMP- and acetyl-CoA-forming ACS 
from Syntrophus aciditrophicus catalyses the production of acetate and ATP when the AMP-
to-ATP ratio is high19. 
       For the ach and acs deletions, we again used the TKO strain as platform strain, but this 
time we employed our previously developed homologous recombination (HR) - 
ThermoCas9-based counter selection system (Fig. 3a). The genomicregions 1 kb upstream of 
the start codon and 1 kb downstream of the stop codon of each target gene were PCR 
amplified and each pair was cloned as a fused 2kb long HR fragment into the editing vectors. 
For each deletion, we evaluated 4 different spacers, creating two 4-member libraries of 
editing vectors (pThermoCas9_Δach_ sp1/2/3/4 and pThermoCas9_Δacs_sp1/2/3/4). TKO 
was transformed with the two editing libraries, yielding similar numbers of colonies, on 
which we performed genome-specific colony PCR. Out of the 9 colonies from the Δach
editing library, only 2 (both from the transformation with the pThermoCas9_Δach_sp1 
vector) gave a colony PCR amplification product that corresponded to the expected Δach 
deletion size. However, both colonies appeared to be a mixture of wild-type and Δach cells 
(Fig. S1a). Therefore, we employed them both as the starting material for a sequential re-
streaking process on LB2_7Cm plates until we obtained clean Δach mutant colonies, from 
now onwards denoted as QKO_Δach (Quadruple Knock-Out ach). On the contrary, 6 out of 
the 9 colonies transformed with the Δacs editing library (all 6 originating from the 
transformations with the pThermoCas9_Δacs_sp1/2/3 vectors) gave a single PCR 
amplification product corresponding to the expected Δacs deletion size (Fig. S1b), indicating 
that all 6 are clean Δacs mutants, from now onwards denoted as QKO_Δacs (Quadruple 
Knock-Out acs). Finally, plasmid curing was successfully performed by non-selective 
subculturing for both mutant strains, and a last round of genome specific PCR on genomic 
DNA isolated from four plasmid cured cultures per mutant confirmed the desired deletions 
(Fig. 3b). 
conversion into acetate. Accordingly, the observed increase in acetate production from the 
cTKO fermentations (Fig. 2C) might be the result of lower acetyl-CoA incorporation into the 
TCA cycle (Fig. 1).
Altogether, the substitution of gapA by gapC in the TKO genome had a positive 
impact on the growth and glucose consumption of the TKO strain under oxygen-limited 
conditions, it redirected flux towards the methylglyoxal pathway, but likely introduced a 
NADP(H) redox imbalance or a methylglyoxal toxicity problem. Further metabolomics studies 
would be needed to confirm this, showing either lack of PP pathway intermediates or 
methylglyoxal accumulation. On the metabolic engineering aspect, the cTKO is a NADPH-
producing strain that could serve as platform for metabolic engineering studies aiming at 
NADPH-dependent synthesis production pathways. Additionally, as it was recently 
demonstrated for E. coli, deletion of the tpiA gene from the cTKO genome could increase the 
flux towards the methylglyoxal pathway16, while a limited number of additional and simple 
engineering steps could further result in simultaneous cofactor regeneration and production of 
biotechnologically interesting compounds, such as 1,2-propenediol or 1-propanol17. 
Alternatively, a study on B. smithii methylgyoxal synthase (mgsA) deletion mutants would be 
of great interest if aiming to direct the total consumed carbon towards lower glycolysis and 
induce the production of for example TCA cycle intermediates. Additionally, methylglyoxal 
has been shown to enhance catabolite repression in E. coli; acknowledging the differences 
between the catabolite repression system of Gram positive and Gram negative bacteria, it 
would be of great interest to study if the ΔmgsA deletion in combination with the deactivation 
of the phosphotransferase system could facilitate sugar co-metabolism in B. smithii ET 13818. 
Finally, the observed increase in acetate production for the cTKO fermentations stresses the 
major importance of identifying the acetate production pathway in B. smithii ET 138 for 
further engineering steps.
GENETIC BACKGROUND INVESTIGATION OF B. SMITHII ET 138 ACETATE 
PRODUCTION PATHWAY
Deletion of ach and acs
Acetate is the main product of B. smithii ET 138 under aerobic conditions, and the main 
by-product under microaerobic conditions7. In this part of our study, we attempted 
to reveal the B. smithii ET 138 genes responsible for the acetate production, since 
the canonical pathways based on the phosphotransacetylase (pta) - acetyl-CoA kinase 
(ack) or the pyruvate oxidase (pox) genes are not present in the B. smithii ET 138 
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acetate. Accordingly, the observed increase in acetate production from the cTKO fermentations 
(Fig. 2C) might be the result of lower acetyl-CoA incorporation into the TCA cycle (Fig. 1).  
Altogether, the substitution of gapA by gapC in the TKO genome had a positive 
impact on the growth and glucose consumption of the TKO strain under oxygen-limited 
conditions, it redirected flux towards the methylglyoxal pathway, but likely introduced a 
NADP(H) redox imbalance or a methylglyoxal toxicity problem. Further metabolomics 
studies would be needed to confirm this, showing either lack of PP pathway intermediates or 
methylglyoxal accumulation. On the metabolic engineering aspect, the cTKO is a NADPH-
producing strain that could serve as platform for metabolic engineering studies aimin g at 
NADPH-dependent synthesis production pathways. Additionally, as it was recently 
demonstrated for E. coli, deletion of the tpiA gene from the cTKO genome could increase 
the flux towards the methylglyoxal pathway16, while a limited number of additional and 
simple engineering steps could further result in simultaneous cofactor regeneration and 
production of biotechnologically interesting compounds, such as 1,2-propenediol or 1-
propanol17. Alternatively, a study on B. smithii methylgyoxal synthase (mgsA) deletion 
mutants would be of great interest if aiming to direct the total consumed carbon towards 
lower glycolysis and induce the production of for example TCA cycle intermediates. 
Additionally, methylglyoxal has been shown to enhance catabolite repression in E. coli; 
acknowledging the differences between the catabolite repression system of Gram positive and 
Gram negative bacteria, it would be of great interest to study if the ΔmgsA deletion in 
combination with the deactivation of the phosphotransferase system could facilitate sugar co-
metabolism in B. smithii ET 13818. Finally, the observed increase in acetate production for 
the cTKO fermentations stresses the major importanceof identifying the acetate production 
pathway in B. smithii ET 138 for further engineering steps.
G ENETIC BACK G RO UND INVESTIG ATIO N O FB. SMITHII ET 138 ACETATE 
PRO DUCTIO N PATH WAY
Deletion of ach and acs
Acetate is the main product of B. smithii ET 138 under aerobic conditions, and the main 
by-product under microaerobic conditions7. In this part of our study, we attempted 
to reveal the B. smithii ET 138 genes responsible for the acetate production, since 
the canonical pathways based on the phosphotransacetylase (pta) - acetyl-CoA kinase
(ack) or the pyruvate oxidase (pox) genes are not present in the B. smithii ET 138 
genome. We reasoned to proceed by deleting two of the theoreticaly most probable 
candidate genes: the acetyl-CoA hydrolase (ach) and acetyl-CoA synthetase (acs)
genome. We reasoned to proceed by deleting two of the theoretically most probable candidate 
genes: the acetyl-CoA hydrolase (ach) and acetyl-CoA synthetase (acs) genes. Acetyl-CoA 
hydrolase (AcH) catalyses the hydrolysis of acetyl-CoA into acetate and CoA (Fig. 1), and it 
was previously found to be highly transcribed in B. smithii ET 138 cultures under aerobic but 
not under oxygen-limited conditions (unpublished data). Acetytl-CoA synthetase (AcS) 
catalyses the ATP-dependent reversible activation of acetate into acetyl-CoA (Fig. 1). 
Although the reaction favours the acetyl-CoA formation, the Gibbs free energy (ΔG°’) of the 
acetate formation is -4.5 kJ/mol, hence thermodynamically feasible. Additionally, it was 
recently demonstrated that the AMP- and acetyl-CoA-forming ACS from Syntrophus 
aciditrophicus  catalyses the production of acetate and ATP when the AMP-to-ATP ratio 
is high19. 
  For the ach and acs deletions, we again used the TKO strain as platform strain, but this 
time we employed our previously developed homologous recombination (HR) - ThermoCas9-
based counter selection system (Fig. 3a). The genomic regions 1 kb upstream of the start 
codon and 1 kb downstream of the stop codon of each target gene were PCR amplified and 
each pair was cloned as a fused 2kb long HR fragment into the editing vectors. For each 
deletion, we evaluated 4 different spacers, creating two 4-member libraries of editing vectors 
(pThermoCas9_Δach_ sp1/2/3/4 and pThermoCas9_Δacs_sp1/2/3/4). TKO was transformed 
with the two editing libraries, yielding similar numbers of colonies, on which we performed 
genome-specific colony PCR. Out of the 9 colonies from the Δach editing library, only 2 
(both from the transformation with the pThermoCas9_Δach_sp1 vector) gave a colony PCR 
amplification product that corresponded to the expected Δach deletion size. However, both 
colonies appeared to be a mixture of wild-type and Δach cells (Fig. S1a). Therefore, we 
employed them both as the starting material for a sequential re-streaking process on 
LB2_7Cm plates until we obtained clean Δach mutant colonies, from now onwards denoted 
as QKO_Δach (Quadruple Knock-Out ach). On the contrary, 6 out of the 9 colonies 
transformed with the Δacs editing library (all 6 originating from the transformations with the 
pThermoCas9_Δacs_sp1/2/3 vectors) gave a single PCR amplification product corresponding 
to the expected Δacs deletion size (Fig. S1b), indicating that all 6 are clean Δacs mutants, 
from now onwards denoted as QKO_Δacs (Quadruple Knock-Out acs). Finally, plasmid 
curing was successfully performed by non-selective subculturing for both mutant strains, and 
a last round of genome specific PCR on genomic DNA isolated from four plasmid cured 
cultures per mutant confirmed the desired deletions (Fig. 3b). 
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G ENETIC BACK G RO UND INVESTIG ATIO N O F B. SMITHII ET 138 ACETATE 
PRO DUCTIO N PATH WAY
Phenotypic characterization of the Δach and Δacs strains
The constructed QKO_Δach and QKO_Δacs strains were cultured under aerobic/acetate-
producing conditions: in 50ml falcon tubes containing 10 mL TVMY medium supplemented 
with 10 g/L glucose as carbon source. The DKO and the TKO strains were used as controls. 
The growth and glucose consumption of the DKO, TKO, QKO_Δach and QKO_Δacs were 
comparable (Fig. 3c).Both QKO strains produced substantially higher amounts of acetate 
compared to the DKO control and comparable amounts to the TKO control, indicating that 
the ach and acs genes in the genome of B. smithii are not key elements of the acetate 
production pathway(s).  
To see if the ach and acs genes are involved in acetate assimilation we looked at 
growth on acetate. Activation of acetate into acetyl-CoA is required for its further 
assimilation. Ιt was previously reported that the growth of Saccharomyces cerevisiae20 and 
Neurospora crassa 21 Δach mutant strains was not affected when glucose was used as the 
carbon source, while it was strongly inhibited when acetate was used as the carbon source. It 
has been shown that in S. cerevisiae acetyl-CoA hydrolase has a role in regulating the acetyl-
CoA concentration, in order to prevent protein autoacetylation phenomena and generation of 
toxic metabolites22. In line with these studies, we decided to further investigate the ach and 
acs role in acetate metabolism.
The TKO, QKO_Δach and QKO_Δacs strains were cultured as previously but in 
TVMY medium with 5 g/L ammonium acetate instead of glucose as the carbon source (Fig. 
3d). The QKO_Δach growth, but not acetate consumption, was severely affected, only 
reaching a final OD600 of 0.5, while surprisingly the QKO_Δacs growth and acetate 
consumption was comparable to the TKO strain. The deletion of the ach gene in the 
QKO_Δach strain in combination with the observed unaffected acetate consumption, when 
ammonium acetate was used as the carbon source, potentially led to toxic intracellular 
accumulation of acetyl-CoA that could have significantly affected the growth of the 
QKO_Δach cultures compared to the control cultures. Contrary to expectations, the 
QKO_Δacs strain grew well in the medium with acetate as the carbon source. It was 
previously demonstrated for other microorganisms that disruption of the acs gene leads to 
very poor or even no growth on acetate23,24. As there is only one predicted acs homolog in 
the B. smithii ET 138 genome, the fact that QKO_Δacs can grow on acetate indicates the 
existence of an alternative enzyme that overtakes the acetyl-CoA synthetase activity. 
To date, only three enzymes have been shown to demonstrate acetate activation activity:
Figure 3. A) Schematic overview of the pThermoCas9_ Δach_sp or pThermoCas9_ Δacs_sp - based editing 
process. The thermoCas9 gene was cloned into the pNW33n vector under the control of PxynA promoter, 
followed by the sgRNA-expressing module encompassing a spacer targeting the acs or ach gene within the 
genome of B. smithii ET 138. The sgRNA module is under the transcriptional control of the Ppta from B. 
coagulans. The 1kb upstream and 1kb downstream genomic regions of the ach or the acs genes are cloned as 
fused fragments in either the pThermoCas9_ Δach_sp or the pThermoCas9_ Δacs_sp vectors respectively, 
upstream of the thermocas9 gene. After a first single crossover event, the vectors are integrated into the genome. 
A second crossover event will either result in wild type revertant genomes, which is recognised and targeted by 
the spCas9:sgRNA ribonucleoprotein (RNP), or genomes with the desired deletions. The RNP-induced lethal 
double stranded DNA breaks eliminate the wild type cells and allow the rapid and easy screening of the mutant 
cells. B) Gel-electrophoresis of genome specific PCR products from plasmid cured QKO_Δach and QKO_Δacs 
strains. Δach genotype is 2442 bp while the expected size for the wild-type genotype is 3963 bp. The expected 
size for the PCR fragments of the Δacs genotype is 2494 bp while the expected size for the wild-type genotype is 
4207 bp. C) Growth and production profile of the DKO, TKO, QKO_Δach and QKO_Δacs  strains, after 24 
hours of culturing in 50 mL Greiner tubes containing 10 mL TVMY medium supplemented with 10 g/L glucose. 
Data shown are average of triplicates. D) Growth and acetate consumption profile of the TKO, QKO_Δach and 
QKO_Δacs  strains, after 24 hours of culturing in 50 mL Greiner tubes containing 10 mL TVMY medium 
supplemented with 5 g/L ammonium acetate. Data shown are average of triplicates.  
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Figure 3. A) Schem atic overview of the pTherm oCas9_ Δach_sp or pTherm oCas9_ Δacs_sp - based editing 
process. The thermoCas9 gene was cloned into the pNW33n vector under the control of PxynA prom oter, followed
by the sgRNA-expressing m odule encom passing a spacer targeting the acs or ach gene within the genom e ofB. 
smithii ET 138. The sgRNA m odule is under the transcriptional control of the Ppta fromB. coagulans. The 1kb 
upstream and 1kb downstream genom ic regions of theach or the acs genes are cloned as fused fragm ents in either
the pTherm oCas9_ Δach_sp or the pTherm oCas9_ Δacs_sp vectors respectively, upstream of thethermocas9 gene. 
After a first single crossover event, the vectors are integrated into the genom e. A second crossover event will either
result in wild type revertant genom es, which is recognised and targeted by the spCas9:sgRNA ribonucleoprotein 
(RNP), or genom es with the desired deletions. The RNP-induced lethal double stranded DNA breaks elim inate the
wild type cells and allow the rapid and easy screening of the m utant cells. B) Gel-electrophoresis of genom e
specific PCR products from plasmid cured QKO_ach and QKO_acs strains. Final screening of the QKO_Δach
and QKO_Δacs strains using isolated genom ic DNA as PCR tem plate and genom e specific prim ers. Δach genotype
is 2442 bp while the expected size for the wild-type genotype is 3963 bp. The expected size for the PCR fragm ents
of the Δacs genotype is 2494 bp while the expected size for the wild-type genotype is 4207 bp. C) Growth and
production profile of the DKO, TKO, QKO_Δach and QKO_Δacs  strains, after 24 hours of culturing in 50 m L
Greiner tubes containing 10 m L TVMY m edium supplem ented with 10 g/L glucose. Data shown are average of
triplicates. D) Growth and acetate consum ption profile of the TKO, QKO_Δach and QKO_Δacs strains, after 24
hours of culturing in 50 m L Greiner tubes containing 10 m L TVMY m edium supplem ented with 5 g/L am m onium
acetate. Data shown are average of triplicates.
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GENETIC BACKGROUND INVESTIGATION OF B. SMITHII ET 138 ACETATE 
PRODUCTION PATHWAY
Phenotypic characterization of the Δach and Δacs strains
The constructed QKO_Δach and QKO_Δacs strains were cultured under aerobic/acetate-
producing conditions: in 50ml falcon tubes containing 10 mL TVMY medium supplemented 
with 10 g/L glucose as carbon source. The DKO and the TKO strains were used as controls. 
The growth and glucose consumption of the DKO, TKO, QKO_Δach and QKO_Δacs were 
comparable (Fig. 3c).Both QKO strains produced substantially higher amounts of acetate 
compared to the DKO control and comparable amounts to the TKO control, indicating that 
the ach and acs genes in the genome of B. smithii are not key elements of the acetate 
production pathway(s).  
To see if the ach and acs genes are involved in acetate assimilation we looked at 
growth on acetate. Activation of acetate into acetyl-CoA is required for its further 
assimilation. Ιt was previously reported that the growth of Saccharomyces cerevisiae20 and 
Neurospora crassa21 Δach mutant strains was not affected when glucose was used as the 
carbon source, while it was strongly inhibited when acetate was used as the carbon source. It 
has been shown that in S. cerevisiae acetyl-CoA hydrolase has a role in regulating the acetyl-
CoA concentration, in order to prevent protein autoacetylation phenomena and generation of 
toxic metabolites22. In line with these studies, we decided to further investigate the ach and 
acs role in acetate metabolism.
The TKO, QKO_Δach and QKO_Δacs strains were cultured as previously but in 
TVMY medium with 5 g/L ammonium acetate instead of glucose as the carbon source (Fig. 
3d). The QKO_Δach growth, but not acetate consumption, was severely affected, only 
reaching a final OD600 of 0.5, while surprisingly the QKO_Δacs growth and acetate 
consumption was comparable to the TKO strain. The deletion of the ach gene in the 
QKO_Δach strain in combination with the observed unaffected acetate consumption, when 
ammonium acetate was used as the carbon source, potentially led to toxic intracellular 
accumulation of acetyl-CoA that could have significantly affected the growth of the 
QKO_Δach cultures compared to the control cultures. Contrary to expectations, the 
QKO_Δacs strain grew well in the medium with acetate as the carbon source. It was 
previously demonstrated for other microorganisms that disruption of the acs gene leads to 
very poor or even no growth on acetate23,24. As there is only one predicted acs homolog in the 
B. smithii ET 138 genome, the fact that QKO_Δacs can grow on acetate indicates the
existence of an alternative enzyme that overtakes the acetyl-CoA synthetase activity.
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To date, only three enzymes have been shown to demonstrate acetate activation activity: 
the phosphotransacetylase-acetate kinase, propionyl-CoA synthetase and propionate 
kinase25-29. However, none of the corresponding genes are found in the genome of ET 138. 
Therefore, the pathway responsible for acetate activation in ET 138 remains to be elucidated. 
Investigating the culturing temperature influence on the production profile of ET 138 
The above results clearly indicate a lack of understanding of the metabolic pathways 
and fluxes in B. smithii ET 138. They also show strong differences in metabolism under 
different culturing conditions. Hence, we hypothesized that we could exploit these 
differences, shedding light on B. smithii ET 138 pathways and fluxes: since the 
acetate production pathway could not be identified via the gene deletions process, we 
aimed to discover and study high- and low-acetate producing culturing conditions. Not 
only does B. smithii ET 138 produce acetate under aerobic culturing conditions whereas 
lactate is its main product under oxygen-limited conditions, but also preliminary 
culturing experiments at different temperatures showed striking differences in product 
profiles. In this part of our study, we decided to explore how culturing temperature 
affects B. smithii ET 138 growth and organic acids production pattern under aerobic 
culturing conditions, with special focus on acetate and dicarboxylic acids.
The DKO strain was cultured at 37°C, 45°C, 50°C and 55°C in 1 L 
fermenters containing 500 mL TVMY liquid medium supplemented with 30 g/L 
glucose, under controlled pH and DO conditions (pH 6.5 and 10% DO). All the cultures 
were inoculated with precultures grown at the corresponding temperature, except for the 
37°C culture for which the 45°C precultures were used due to the extremely long lag 
phase of the 37°C precultures. The maximum growth for the DKO 45°C, 50°C and 55°C 
cultures was observed 10 hours post-inoculation. Surprisingly, the 50°C cultures showed 
the highest growth, with maximum OD600 value at 5.35, and the 55°C cultures the 
lowest, with maximum OD600 value at 3.8 (Fig. 4a). The 37°C cultures showed an 
extended lag phase, as after 10 hours the growth of the DKO 37°C culture reached 
an OD600 value 1.20. The growth delay at 37°C could be attributed to the non-optimal 
growth temperature as well as to the use of precultures grown at 45°C. Despite the long 
lag phase, the 37°C cultures reached maximum OD600 value higher than the 45°C and 
55°C cultures, but still lower compared to the 50°C cultures (Fig. 4a). The cell growth 
rate, the productivity and the glucose consumption rate are tightly interconnected in 
every bacterial culture. Here we observed that glucose consumption was increasing at hi-
temperatures (Fig. 4b). The DKO 55°C cultures consumed almost the entireamount of
provided glucose between 24-48 hours of culturing, while the glucose consumption of the
50°C cultures was slightly lower. Since the final growth of the 55°C cultures was lower 
compared to the rest of the cultures, a relatively larger part of the consumed glucose was
channelled towards products. After 10 hours of culturing, the 55°C cultures consume d
43mM of glucose and produced 0.9 mol of acetate for every mol of consumed glucose (Fig. 
4c). After 48 hours of culturing, however, the glucose consumption was more than triple (142 
mM), there was no additional growth, and for every mol of consumed glucose there was still 
0.9 mol of acetate produced together with 0.05 mo l of succinate (Fig. 4c, 4d). This indicates a 
clear uncoupling of growth and production for the DKO cultures at 55°C, while the produced 
acetate is most likely the result of overflow metabo lism. For the 50°C cultures the uncoupling 
of growth and production was also apparent but less pronounced. Interestingly, after 48 hours 
of culturing there was only 0.3 mol of acetate produced per mol of consumed glucose, while
the succinate yield on glucose was double compared to the 55°C cultures (Fig. 4c, 4d). 
Additionally, after 48 hours the final glucose consumption of the 45°C and 37°C cultures was
60% and 70%, respectively, which is lower compar ed to the glucose consumption of the 55°
C cultures and they produced negligible amounts of organic acids (Fig. 4a, 4b, 4c, 4d). 
Finally, except for acetate and succinate, there were no other organic acids produced at all 
tested temperatures. 
A
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Figure 4. Culturing of DKO at 37°C, 45°C, 50°C and 55°C in 1 L fermenters containing 
500 mL TVMY liquid medium supplemented with 30g/L glucose, under controlled pH and 
DO conditions (pH 6.5 and 10% DO). Sampling points at 10, 24 and 48 hours post 
inoculation. A) Cell growth (OD600), B) Glucose consumption, C) Acetate production, D) 
Succinate production. The data shown here are average of duplicates for the 37°C and 45°C 
cultures, triplicates for the 50°C and 55°C cultures, with error bars depicting the standard 
deviations.
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4c). After 48 hours of culturing, however, the glucose consumption was more than triple (142 
mM), there was no additional growth, and for every mol of consumed glucose there was still 
0.9 mol of acetate produced together with 0.05 mo l of succinate (Fig. 4c, 4d). This indicates a 
clear uncoupling of growth and production for the DKO cultures at 55°C, while the produced 
acetate is most likely the result of overflow metabo lism. For the 50°C cultures the uncoupling 
of growth and production was also apparent but less pronounced. Interestingly, after 48 hours 
of culturing there was only 0.3 mol of acetate produced per mol of consumed glucose, while
the succinate yield on glucose was double compared to the 55°C cultures (Fig. 4c, 4d). 
Additionally, after 48 hours the final glucose consumption of the 45°C and 37°C cultures was
60% and 70%, respectively, which is lower compar ed to the glucose consumption of the 55°
C cultures and they produced negligible amounts of organic acids (Fig. 4a, 4b, 4c, 4d). 
Finally, except for acetate and succinate, there were no other organic acids produced at all 
tested temperatures. 
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Figure 4. Culturing of DKO at 37°C, 45°C, 50°C and 55°C in 1 L fermenters containing 
500 mL TVMY liquid medium supplemented with 30g/L glucose, under controlled pH and 
DO conditions (pH 6.5 and 10% DO). Sampling points at 10, 24 and 48 hours post 
inoculation. A) Cell growth (OD600), B) Glucose consumption, C) Acetate production, D) 
Succinate production. The data shown here are average of duplicates for the 37°C and 45°C 
cultures, triplicates for the 50°C and 55°C cultures, with error bars depicting the standard 
deviations.
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the phosphotransacetylase-acetate kinase, propionyl-CoA synthetase and propionate 
kinase25-29. However, none of the corresponding genes are found in the genome of B.
smithii ET 138. Therefore, the pathway responsible for acetate activation in 
ET 138 remains to be elucidated.
Investigating the culturing temperature influence on the production profile of ET 138  
The above results clearly indicate a lack of understanding of the metabolic pathways and 
fluxes in B. smithii ET 138. They also show strong differences in metabolism under different 
culturing conditions. Hence, we hypothesized that we could exploit these differences, 
shedding light on B. smithii ET 138 pathways and fluxes: since the acetate production 
pathway could not be identified via the gene deletions process, we aimed to discover and 
study high- and low-acetate producing culturing conditions. Not only does B. smithii ET 138 
produce acetate under aerobic culturing conditions whereas lactate is its main product under 
oxygen-limited conditions, butalso prelimin ary culturing experiments at different 
temper atures showed striking differences inproduct profiles. In this part of our study, we 
decided to explore how culturing temperature affects B. smithii ET 138 growth and organic 
acids production pattern under aerobic culturing conditions, with special focus on acetate and 
dicarboxylic acids.
The DKO strain was cultured at 37°C, 45°C, 50°C and 55°C in 1 
L fermenters containing 500 mL TVMY liquid medium supplemented with 30 g/L 
glucose, under controlled pH and DO conditions (pH 6.5 and 10% DO). All the 
cultures were inoculated with precultures grown at the corresponding temperature, except 
for the 37°C culture for which the 45°C precultures were used due to the extremely 
long lag phase of the 37°C precultures. The maximum growth for the DKO45°C, 
50°C and 55°C cultures was observed 10 hours post-inoculation. Surprisingly, the 50°C 
cultures showed the highest growth, with maximum OD600 value at 5.35, and the 55°C 
cultures the lowest, with maximum OD600 value at 3.8 (Fig. 4a). The 37°C cultures showed 
an extended lag phase, as after 10 hours the growth of the DKO 37°C culture reached an 
OD600 value 1.20. The growth delay at 37°C could be attributed to the non-optimal growth 
temperature as well as to the use of precultures grown at 45°C. Despite the long lag 
phase, the 37°C cultures reached maximum OD600 value higher than the 45°C and 55°C 
cultures, but still lower compared to the 50°C cultures (Fig. 4a). The cell growth rate, 
the productivity and the glucose consumption rate are tightly interconnected in every 
bacterial culture. Here we observed that glucose consumption wa s increasing at higher 
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Figure 4. Culturing of DKO at 37°C, 45°C, 50°C and 55°C in 1 L fermenters containing 
500 mL TVMY liquid medium supplemented with 30g/L glucose, under controlled pH and 
DO conditions (pH 6.5 and 10% DO). Sampling points at 10, 24 and 48 hours post 
inoculation. A) Cell growth (OD600), B) Glucose consumption, C) Acetate production, D) 
Succinate production. The data shown here are average of duplicates for the 37°C and 45°C 
cultures, triplicates for the 50°C and 55°C cultures, with error bars depicting the standard 
deviations.
temperatures (Fig. 4b). The DKO 55°C cultures consumed almost the entireamount of
provided glucose between 24-48 hours of culturing, while the glucose consumption of the
50°C cultures was slightly lower. Since the final growth of the 55°C cultures was lower 
compared to the rest of the cultures, a relatively larger part of the consumed glucose was
channelled towards products. After 10 hours of culturing, the 55°C cultures consume d
43mM of glucose and produced 0.9 mol of acetate for every mol of consumed glucose (Fig. 
4c). After 48 hours of culturing, however, the glucose consumption was more than triple (142 
mM), there was no additional growth, and for every mol of consumed glucose there was still 
0.9 mol of acetate produced together with 0.05 mo l of succinate (Fig. 4c, 4d). This indicates a 
clear uncoupling of growth and production for the DKO cultures at 55°C, while the produced 
acetate is most likely the result of overflow metabo lism. For the 50°C cultures the uncoupling 
of growth and production was also apparent but less pronounced. Interestingly, after 48 hours 
of culturing there was only 0.3 mol of acetate produced per mol of consumed glucose, while
the succinate yield on glucose was double compared to the 55°C cultures (Fig. 4c, 4d). 
Additionally, after 48 hours the final glucose consumption of the 45°C and 37°C cultures was
60% and 70%, respectively, which is lower compar ed to the glucose consumption of the 55°
C cultures and they produced negligible amounts of organic acids (Fig. 4a, 4b, 4c, 4d). 
Finally, except for acetate and succinate, there were no other organic acids produced at all 
tested temperatures. 
A
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Figure 4. Culturing of DKO at 37°C, 45°C, 50°C and 55°C in 1 L fermenters containing 500 mL 
TVMY liquid medium supplemented with 30g/L glucose, under controlled pH and DO inoculation. 
conditions A) (pH Cell 6.5 growth and 10% (OD600), DO). B) Glucose Sampling points consumption, at 10, C) 
24 Acetate and 48 production, hours post D) Succinate production. The data shown here are average of 
duplic es for the 37°C and 45°C  cultures, triplicates for th 50°C and 55°C cultures, with error bars depicting 
the standard deviations 
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gher temperatures (Fig. 4b). The DKO 55°C cultures consumed almost the entire amount of 
provided glucose between 24-48 hours of cultur ing, while the glucose consumption of the 
50°C cultures was slightly lower. Since the final growth of the 55°C cultures was lower 
compared to the rest of the cultures, a relatively larger part of the consumed glucose was 
channeled towards products. After 10 hours of culturing, the 55°C cultures consumed 43 mM 
of glucose and produced 0.9 mol of acetate for every mol of consumed glucose (Fig. 4c). 
After 48 hours of culturing, however, the glucose consumption was more than triple (142 
mM), there was no additional growth, and for every mol of consumed glucose there was still 
0.9 mol of acetate produced together with 0.05 mol of succinate (Fig. 4c, 4d). This indicates a 
clear uncoupling of growth and production for the DKO cultures at 55°C, while the produced 
acetate is most likely the result of overflow metabolism. For the 50°C cultures the uncoupling 
of growth and production was also apparent but less pronounced. Interestingly, after 48 hours 
of culturing there was only 0.3 mol of acetate produced per mol of consumed glucose, while 
the succinate yield on glucose was double compared to the 55°C cultures (Fig. 4c, 4d). 
Additionally, after 48 hours the final glucose consumption of the 45°C and 37°C cultures was 
60% and 70%, respectively, which is lower c mpared t  the glucos consumption of the 55°C 
cultures and they produc  negligible mounts of organic acids (Fig. 4 , 4b, 4c, 4d). Fin lly, 
except for ace at  and succinate, there were no other organic acids produced at all tested 
temperatures. 
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peroxide. Thiol peroxidases, that require thiols as cofactors35, are responsible for the 
intracellular elimination of the highly reactive peroxide molecules, providing an 
explanation for the upregulation of the bacillithiol biosynthesis in B. smithii ET 
138 cultures. Previously acquired transcriptomics data on B. smithii ET 138 
cultures at 55°C8 showed that transcription of the thiol peroxidase and the 
acetolactate synthase genes is enhanced under oxygen-rich compared to oxygen-
limited conditions. Moreover, the comparative proteomics analysis data show a 4-
fold higher expression of the thiol peroxidase in the 55°C culture compared to 37°C 
culture. However, the same analysis also showed that the production of the acetolactate 
synthase at the 37°C culture is higher chanccompared es thato t thethe des55°C cribed 
aculture, cetate prreducing oductithe on scenario is the most  probable. 
In an alternative scenario, the acetate production in 55°C B. smithii ET 138 cultures 
can be connected with a metabolic “jamming” due to the rapid glucose consumption rate. As 
the TCA cycle reaches its maximum capacity, the acetyl-CoA can no longer be incorporated 
to the cycle thus accumulates inside the cells. Then, the excess acetyl-CoA can be further 
converted into acetaldehyde by the acetaldehyde dehydrogenase (AcdH) (Fig. 1). As 
acetaldehyde is a highly reactive and toxic compound, which either needs a compound as 
bacillithiol to be counteracted or has to be converted into something less toxic such as 
acetate, via for instance an aldehyde dehydrogenase (AldH) (Fig. 1). Nonetheless, the 
comparative proteomics analysis data though show that aldehyde dehydrogenases are 
significantly more abundant in the 37°C B. smithii ET 138 culture compared to the 55°C 
culture. Alternatively, it has been suggested that the autooxidation of acetaldehyde to 
peracetic acid is possible, followed by the subsequent reaction of the peracetic acid with 
acetaldehyde to form a peroxide. The peroxide can be further decompose to acetic acid and 
acetic anhydride36. Moreover, the peroxides formation might explain the upregulation of 
bacillithiol synthesis. 
Finally, the comparative proteomics analysis data revealed the overexpression of the 
aminomethyltransferase protein (the “T-protein” of the glycine cleavage system) at the 55°C 
culture, which can be triggered only under high glycine concentration conditions. This is an 
interesting observation, as the proteomics data also suggest nitrogen-deprivation at the 55°C 
culture, indicated by the over production of the nitrogen regulatory protein PII37. Thus, we 
expect that glycine is abundant at the 55°C culture despite the nitrogen-limitation. Hence 
there is a possible connection between glycine and acetate accumulation. L-threonine 
aldolase is an enzyme that catalyses the degradation of threonine, to form glycine and 
COMPARATIVE PROTEOMICS ANALYSIS BETWEEN ACETATE-PRODUCING 
AND NON-PRODUCING CONDITIONS AT 37°C AND 55°C 
Our culturing experiments at different temperatures showed that the main B. smithii ET 138 
product at 50°C and 55°C under aerobic conditions is acetate. On the contrary, there 
was no acetate production detected at the 37°C and 45°C B. smithii ET 138 cultures. Since 
the B. smithii ET 138 acetate production pathway still remains to be elucidated, we 
decided to follow a comparative proteomics analysis approach using two of the above 
described DKO cultures. Samples were taken from the 37°C and 55°C DKO cultures, 24 
hours post inoculation, and the total soluble protein (SP) fraction was prepared from the 
corresponding cell-free extracts. The two samples were selected due to the significant 
difference detected in acetate production (0.07 mM of acetate at 37°C, 80 mM of acetate at 
55°C) (Fig. 4c). The prepared SP fractions were processed by SDS-PAGE, in-gel 
digestion, µColumns-purification and LC-MS detection analysis. The comparative 
proteomics analysis revealed that there were 74 and 46 proteins more than 100-fold 
upregulated at 37°C and 55°C, respectively (Supp. Figure 3, Supp. table 1). From the proteins 
found to be significantly upregulated at 55°C, tw o are known to have direct or indirect 
connection with formation of acetate: the acetyl-CoA synthetase and the bacillithiol synthase. 
As in this study we already demonstrated that deletion of acetyl-CoA synthetase does 
not eliminate the acetate formation in B. smithii ET 138 cultures, we focused on the 
possible connection between the bacilithiol and acetate production processes.
Bacillithiol is the major low molecular weight thiol in bacilli and related firmicutes, 
and it plays an important role in cell physiology by maintaining the reducing cytoplasmic 
environment and by protecting cysteine residues from oxidation30,31. Moreover, it provides 
resistance to aldehydes and ketones, amongst which is the toxic methylglyoxal32. We earlier 
hypothesized that methylglyoxal could be an abundant intracellular intermediate in the cTKO 
fermentations at 55°C. Notably, these fermentations showed enhanced acetate production 
compared to the TKO control fermentations. Along the bacillithiol production process, 
acetate is formed as by-product (Fig. 1). Nonetheless, it has been demonstrated that the 
intracellular concentration of bacillithiol in other Bacilli does not usually exceed the level of 
100 μM30, hence it cannot justify the observed acetate production. Another possible reason 
for the triggering of the bacilithiol production at higher temperature cultures is the 
simultaneous  production of acetolactate. Acetolactate synthases (AcS) are responsible for the 
conversion of pyruvate to acetolactate (Fig. 1). Some acetolactate synthases though, such as 
the ones from E. coli33 and S. typhimurium, perform34 oxygenase side reactions 
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CO MPARATIVE PRO TEO MICS ANALYSIS BETWEEN ACETATE-PRO DUCING
AND NO N-PRO DUCING CO NDITIO NS AT 37°C AND 55°C 
Our culturing experiments at different temperatures showed that the main B. smithii 
ET 138 product at 50°C and 55°C under aerobic conditions is acetate. On the contrary, there 
was no acetate production detected at the 37°C and 45°C B. smithii ET 138 cultures. Since the 
B. smithii ET 138 acetate production pathway still remains to be elucidated, we decided to
follow a comparative proteomics analysis approach using two of the above described DKO
cultures. Samples were taken from the 37°C and 55°C DKO cultures, 24 hours post 
inoculation, and the total soluble protein (SP) fraction was prepared from the correspondi ng
cell-free extracts. The two samples were selected due to the significant difference detected in
acetate production (0.07 mM of acetate at 37°C, 80 mM of acetate at 55°C) (Fig. 4c). The 
prepared SP fractions were processed by SDS-PAGE, in-gel digestion, µColumns-purificati on
and LC-MS detection analysis. The comparative proteomics analysis revealed that there were
74 and 46 proteins more than 100-fold upregulated at 37°C and 55°C, respectively (Supp. 
Figure 3, Supp. table 1). From the proteins found to be significantly upregulated at 55°C, tw o
are known to have direct or indirect connection with formation of acetate: the acetyl-CoA
synthetase and the bacillithiol synthase. As in this study we already demonstrated that
deletion of acetyl-CoA synthetase does not eliminate the acetate formation in B. smithii ET
138 cultures, we focused on the possible connection between the bacilithiol and acetate
production processes.
Bacillithiol is the major low molecular weight thiol in bacilli and related firmicutes, 
and it plays an important role in cell physiology by maintaining the reducing cytoplasmic 
environment and by protecting cysteine residues from oxidation30,31. Moreover, it provides 
resistance to aldehydes and ketones, amongst which is the toxic methylglyoxal32. We earlier 
hypothesized that methylglyoxal could be an abundant intracellular intermediate in the cTKO
fermentations at 55°C. Notably, these fermentations showed enhanced acetate production 
compared to the TKO control fermentations. Along the bacillithiol production process, acetate 
is formed as by-product (Fig. 1). Nonetheless, it has been demonstrated that the intracellular 
concentration of bacillithiol in other Bacilli does not usually exceed the level of 100 μM30, 
hence it cannot justify the observed acetate production. Another possible reason for the 
triggering of the bacilithiol production at higher temperature cultures is the simultaneous  
production of acetolactate. Acetolactate synthases (AcS) are responsible for the conversion of 
pyruvate to acetolactate (Fig. 1). Some acetolactate synthases though, such as the ones from
E. coli33 and S. typhimurium, perform34 oxygenase side reactions producing peracetate and
producing peracetate and peroxide. Thiol peroxidases, that require thiols as 
cofactors35, are responsible for the intra-cellular elimination of the highly reactive 
peroxide molecules, providing an explanation for the upregulation of the bacillithiol 
biosynthesis in B. smithii ET 138 cultures. Previously acquired transcriptomics data 
on B. smithii ET 138 cultures at 55°C8 showed that transcription of the thiol 
peroxidase and the acetolactate synthase genes is enhanced under oxygen-rich 
compared to oxygen-limited conditions. Moreover, the comparative proteomics analysis 
data show a 4-fold higher expression of the thiol peroxidase in the 55°C 
culture compared to 37°C culture. However, the same analysis also showed that the 
production of the acetolactate synthase at the 37°C culture is higher compared to the 55°C 
culture, reducing the chances that the described acetate production scenario is the most 
probable. 
In an alternative scenario, the acetate production in 55°C B. smithii ET 138 cultures 
can be connected with a metabolic “jamming” due to the rapid glucose consumption rate. As 
the TCA cycle reaches its maximum capacity, the acetyl-CoA can no longer 
be incorporated to the cycle thus accumulates inside the cells. Then, the excess acetyl-
CoA can be further converted into acetaldehyde by the acetaldehyde 
dehydrogenase (AcdH) (Fig. 1). As acetaldehyde is a highly reactive and toxic 
compound, which either needs a compound as bacillithiol to be counteracted or has to 
be converted into something less toxic such as acetate, via for instance an 
aldehyde dehydrogenase (AldH) (Fig. 1). Nonetheless, the comparative proteomics 
analysis data though show that aldehyde dehydrogenases are significantly more 
abundant in the 37°C B. smithii ET 138 culture compared to the 55°C culture. 
Alternatively, it has been suggested that the autooxidation of acetaldehyde to 
peracetic acid is possible, followed by the subsequent reaction of the peracetic 
acid with acetaldehyde to form a peroxide. The peroxide can be further decompose to 
acetic acid and acetic anhydride36. Moreover, the peroxides formation might explain 
the upregulation of bacillithiol synthesis. 
Finally, the comparative proteomics analysis data revealed the overexpression of the 
aminomethyltransferase protein (the “T-protein” of the glycine cleavage system) at the 
55°C culture, which can be triggered only under high glycine concentration conditions. 
This is an interesting observation, as the proteomics data also suggest nitrogen-
deprivation at the 55°C culture, indicated by the over production of the nitrogen 
regulatory protein PII37. Thus, we expect that glycine is abundant at the 55°C 
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an “enhanced” upper part of the reductive TCA cycle. Hence, we transformed the TKO strain 
with the pNW_PM vector that was constructed by employing the pNW33n E. coli-
Bacilli shuttle vector as backbone and cloning the B. smithii ET 138 native pyruvate 
carboxylase (pyc) and the malate dehydrogenase (mdh) genes, as an operon, under the 
transcriptional ntrol of the strong Ppta (phosphate acetyltransferase) promoter.
(phosphate acetyltransferase) prom oter. 
Figure 5. Aerobic cultures of the TKO and TKO:pNW_PM strains. Growth, glucose consumption and 
product profiles of the strains cultured in 500 mL TVMY supplemented with 30 g/L glucose at 50°C, under 
controlled pH and DO conditions (pH 6.5 and 10% DO). The data shown are average of triplicates with error 
bars depicting the standard deviations. 
We cultured the TKO and TKO:pNW_PM strains in 1 L fermenters containing 500 mL 
TVMY liquid medium supplemented with 30g/L glucose, under controlled pH and 
DO conditions (pH 6.5 and 10% DO) at 50°C for 122h. Growth and glucose uptake rates of 
both strains were similar (Fig. 5a, 5b), however each strain produced different amounts of 
organic acids (Fig. 5c, 5d, 5e, 5f). TKO produced acetate and succinate to similar levels as 
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culture despite the nitrogen-limitation. Hence there is a possible connection between glycine 
and acetate accumulation. L-threonine aldolase is an enzyme that catalyses the degradation of 
threonine acetaldehyde. As has been discussed, acetaldehyde can be converted to acetate. 
However, there is no predicted threonine aldolase gene in the genome of B smithii ET 138. 
Even though we did not yet manage to elucidate the B. smithii ET 138 
acetate production pathway, it is more than clear that follow-up experiments 
as well as further examination of the already acquired proteomics data is a 
priority for future work. Till date, a  limited number of comparative 
proteomics studies have been performed in thermophiles, and especially in 
facultative thermophiles, on cultures incubated at significantly differing 
temperatures. Such studies could shed light on for example thermo-adaptation, 
of which little is currently known. In a recent study, Bacillus licheniformis was 
cultured at 42°C, 50°C and 60°C and the reported quantitative proteomics 
results indicated the overexpression at high temperatures of chaperones 
involved in facilitating correct protein folding, and of enzymes involved 
in the production of cell wall components, as well as growth inducing 
and stress response factors, as part of the amino acid and fatty acid 
metabolism38. Interestingly, the comparative proteomics data for B. smithii ET 138 
present a similar trend in the type of overexpressed enzymes at 55°C, supporting 
the possible existence of a thermo-adaptation enzymatic machinery in moderate 
thermophilic bacteria. Furthermore, taking into account that the acetate production 
is apparently crucial for the B. smithii ET 138 metabolism, it would not be 
surprising if the acetate production enzymatic machinery is constantly expressed 
in the cells, aiming to allow for rapid adjustment to fluctuating environments 
based on allosteric regulations. In that case, the comparative proteomics 
approach is of little use and further construction and phenotypic characterization 
of additional B. smithii ET 138 mutants should be considered.
ENGINEERING AND CULTURING OF B. SMITHII ET 138 STRAINS TOWARDS 
PRODUCTION OF DICARBOXYLIC ACIDS
The previously described culturing experiments showed that DKO culturing under aerobic 
conditions at 50°C gives the best succinate to acetate production ratio. In this part of our 
study, we aimed to improve the dicarboxylic acids production and reduce the carbon loss in 
acetate production, without affecting  the  B. smithii ET 138 growth. 
242
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acetaldehyde. As has been discussed, acetaldehyde can be converted to acetate. However, 
there is no predicted threonine aldolase gene in the genome of  B smithii ET 138.   
Even though we did not yet manage to elucidate the B. smithii ET 138 acetate 
production pathway, it is more than clear that follow-up experiments as well as further 
examination of the already acquired proteomics data isa priority for future work. Till date, 
a limited number of comparative proteomics studies have been performed in 
thermophiles, and especially in facultative thermophiles, on cultures incubated at 
significantly differing temperatures. Such studies could shed light on for example thermo-
adaptation, of which little is currently known. In a recent study, Bacillus licheniformis was 
cultured at 42°C, 50°C and 60°C and the reported quantitative proteomics results indicated 
the overexpression at high temperatures of chaperones involved in facilitating correct protein 
folding, and of enzymes involved in the production of cell wall components, as well as 
growth inducing and stress response factors, as part of the amino acid and fatty acid 
metabolism38. Interestingly, the comparative proteomics data for B. smithii ET 138 
present a similar trend in the type of overexpressed enzymes at 55°C, supporting the 
possible existence of a thermo-adaptation enzymatic machinery in moderate thermophilic 
bacteria. Furthermore, taking into account that the acetate production is apparently crucial for 
the B. smithii ET 138 metabolism, it would not be surprizing if the acetate production 
enzymatic machinery is constantly expressed in the cells, aiming to allow for rapid 
adjustment to fluctuating environments based on allosteric regulations. In that case, the 
comparative proteomics approach is of little use and further construction and phenotypic 
characterization of additional B. smithii ET 138 mutants should be considered.
ENG INEERING AND CULTURING B. SMITHII ET 138 STRAINS TO WARDS 
PRO DUCTIO N O F DICARBO XYLIC ACIDS
The previously described culturing experiments showed that DKO culturing under aerobic 
conditions at 50°C gives the best succinate to acetate production ratio. In this part of our 
study, we aimed to improve the dicarboxylic acids production and reduce the carbon loss in 
acetate production, without affecting the B. smithii ET 138 gr owth. 
In large scale fermenters, even if they operate under oxygen-controlled conditions, 
the formation of oxygen-limited “pockets” is frequent. In these pockets, B. smithii ET 138 
would metabolise the provided substrate into L-lactate. In order to entirely avoid carbon 
losses towards L-lactate, we decided to evaluate the production performance of the TKO 
strain, instead of the DKO, under oxygen-rich conditions. Moreover, since we are interested 
in the production of dicarboxylic acids, we reasoned to test the performance of a strain with 
In large scale fermenters, even if they operate under oxygen-controlled conditions, the 
formation of oxygen-limited “pockets” is frequent. In these pockets, B. smithii ET 138 would 
metabolise the provided substrate into L-lactate. In order to entirely avoid carbon losses 
towards L-lactate, we decided to evaluate the production performance of the TKO strain, 
instead of the DKO, under oxygen-rich conditions. Moreover, since we are interested in  the
(phosphate acetyltransferase) prom oter. 
Figure 5. Aerobic cultures of the TKO and TKO:pNW_PM strains. Growth, glucose consumption and 
product profiles of the strains cultured in 500 mL TVMY supplemented with 30 g/L glucose at 50°C, under 
controlled pH and DO conditions (pH 6.5 and 10% DO). The data shown are average of triplicates with error 
bars depicting the standard deviations. 
production of dicarboxylic acids, we reasoned to test the performance of a strain with 
an “enhanced” upper part of the reductive TCA cycle. Hence, we transformed the 
TKO strain with the pNW_PM vector that was constructed by employing the pNW33n 
E. coli-Bacilli shuttle vector as backbone and cloning the B. smithii ET 138 native py-
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Chapter 8
CO NCLUSIO NS 
Aiming to exploit the potential of nature towards the development of an sustainable economy, 
special attention should be paid on studying the metabolism of non-model microorganisms. 
This work underlined the very interesting differentiations in B. smithii, metabolism at 
different temperatures, as well as the great potential in improving its production 
profile towards dicarboxylic acids. The experimental work was based on our previously 
developed SpCas9- and ThermoCas9-based genome editing tools for gene deletions and 
substitutions, as well as culturing under controlled temperature and pH conditions and 
comparative proteomics analysis of selected samples. We achieved 1) the partial 
reconstitution of the B. smithii ET 138 ΔldhL growth under oxygen-limited conditions and 
we simultaneously constructed a NADPH-producing strain for future expansion of the B. 
smithii product variety, 2) the elimination of a number of metabolic pathways candidates for 
the still unknown acetate production pathway of B. smithii, and 3) the revealing of strains 
and culturing conditions that favour the production of dicarboxylic acids on top of other 
by-products. Finally, the existence of efficient genome engineering tools and of a 
mutants collection that could be further tested under diverse conditions, strongly 
facilitates further fundamental and metabolic engineering studies of B. smithii.
MATERIALS AND METH O DS 
BACTERIAL STRAINS AND G RO WTH CO NDITIO NS 
Strains constructed and used in this study are listed in Table 1. 
Strain Relevant genotype Reference
E. coli DH 5α Cloning host for all the plasm id constructions NEB
B. smithii ET
138 strains:
DKO ΔsigF ΔhsdR [12]
TKO ΔsigF ΔhsdR ΔldhL [12]
TKO:pNW_PM ΔsigF ΔhsdR ΔldhL:
pNW_PM
This study
cTKO ΔsigF ΔhsdR ΔgapA::gapC This study
QKO_Δach ΔsigF ΔhsdR ΔldhL Δach This study
QKO_Δacs ΔsigF ΔhsdR ΔldhL Δacs This study
Table 1. Strains used in this study 
ruvate carboxylase (pyc) and the malate dehydrogenase (mdh) genes, as an operon, under the 
transcriptional control of the strong Ppta (phosphate acetyltransferase) promoter.
We cultured the TKO and TKO:pNW_PM strains in 1 L fermenters containing 500 
mL TVMY liquid medium supplemented with 30g/L glucose, under controlled pH and DO 
conditions (pH 6.5 and 10% DO) at 50°C for 122h. Growth and glucose uptake rates of both 
strains were similar (Fig. 5a, 5b), however each strain produced different amounts of organic 
acids (Fig. 5c, 5d, 5e, 5f). TKO produced acetate and succinate tosimilar levels as previously 
reported for DKO under the same culturing conditions, with succinate production though 
being slightly enhanced (Fig. 5c, 5d). Surprisingly, TKO produced low amounts of malate and 
fumarate, becoming the first B. smithii ET 138 strain to produce these compounds (Fig. 5e, 5f). 
TKO:pNW_PM also produced acetate, succinate, malate and fumarate (Fig. 5c, 5d, 5e, 5f). 
However, the TKO:pNW_PM acetate production was significantly reduced compared to the 
DKO and TKO strains; only 21 mM of acetate produced after 122 hours of fermentation (Fig. 
5c). At the same time point, TKO:pNW_PM produced 20 mM of succinate with a yield of 
0.14 mol succinate/mol glucose (Fig. 5d). This is the highest reported succinate yield by a B. 
smithii ET 138 strain, nonetheless it is still far lower than the theoretical maximum yield of 
1.7 mol succinate/mol glucose39. Moreover, TKO:pNW_PM produced similar amounts of 
malate compared to the TKO strain, while it produced 3 times higher amounts of fumarate 
after 48 hours (Fig. 5e, 5f). Apparently, the pyc and mdh overexpression enhanced the 
reductive part of the TCA cycle, with fumarate being its final product due to the lack of a 
fumarate reductase in the genome of B. smithii ET 138. A large part of the produced fumarate 
appeared to be consumed during the remaining course of the culturing process (Fig. 5f).
The TKO:pNW_PM strain developed in this experiment shows the same growth 
profile as the DKO and TKO strains under oxygen-rich conditions, while its acetate production 
yield is reduced and its dicarboxylic acids production yield is enhanced. Therefore, the 
TKO:pNW_PM strain should become the platform strain for further metabolic engineering 
experiments, especially those focusing on the identification of the acetate production pathway. 
It has been demonstrated that the deletion of the succinate dehydrogenase (sdhA), the isocitrate 
dehydrogenase (icd) and the isocitrate lyase repressor (iclR) genes in E. coli resulted in the 
construction of an efficient succinate-producing strain under oxygen-rich conditions47. We 
previously attempted to delete the genes for the different subunits of the succinate 
dehydrogenase complex without success. This was not surprising as the lack of a 
fumarate reductase gene from the B. smithii ET 138 genome makes the succinate dehydro
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previously reported for DKO under the same culturing conditions, with succinate production 
though being slightly enhanced (Fig. 5c, 5d). Surprisingly, TKO produced low amounts 
of malate and fumarate, becoming the first B. smithii ET 138 strain to produce these 
compounds (Fig. 5e, 5f). TKO:pNW_PM also produced acetate, succinate, malate and 
fumarate (Fig. 5c, 5d, 5e, 5f). However, the TKO:pNW_PM acetate production was 
significantly reduced compared to the DKO and TKO strains; only 21 mM of acetate 
produced after 122 hours of fermentation (Fig. 5c). At the same time point, TKO:pNW_PM 
produced 20 mM of succinate with a yield of 0.14 mol succinate/mol glucose (Fig. 5d). This 
is the highest reported succinate yield by a B. smithii ET 138 strain, nonetheless it is still 
far lower than the theoretical maximum yield of 1.7 mol succinate/mol glucose39. 
Moreover, TKO:pNW_PM produced similar amounts of malate compared to the TKO 
strain, while it produced 3 times higher amounts of fumarate after 48 hours (Fig. 5e, 
5f). Apparently, the pyc and mdh overexpression enhanced the reductive part of the 
TCA cycle, with fumarate being its final product due to the lack of a fumarate reductase 
in the genome of B. smithii ET 138. A large part of the produced fumarate 
appeared to be consumed during the remaining course of the culturing process (Fig. 
5f).   
The TKO:pNW_PM strain developed in this experiment shows the same growth 
profile as the DKO and TKO strains under oxygen-rich conditions, while its acetate 
production yield is reduced and its dicarboxylic acids production yield is 
enhanced. Therefore, the TKO:pNW_PM strain should become the platform strain 
for further metabolic engineering experiments, especially those focusing on the 
identification of the acetate production pathway. It has been demonstrated that the 
deletion of the succinate dehydrogenase (sdhA), the isocitrate dehydrogenase (icd) and 
the isocitrate lyase repressor (iclR) genes in E. coli resulted in the construction of an 
efficient succinate-producing strain under oxygen-rich conditions[47]. We previously 
attempted to delete the genes for the different subunits of the succinate 
dehydrogenase complex without success. This was not surprising as the lack of a 
fumarate reductase gene from the B. smithii ET 138 genome makes the succinate 
dehydrogenase complex indispensable. The deletion of the icd and iclR genes though, 
along with overexpression of the native pyc and mdh genes, may increase the carbon 
flux into the glyoxylate shunt and hence increase the production of malate and 
fumarate. 
genase complex indispensable. The deletion of the icd and iclR genes though, along with 
overexpression of the native pyc and mdh genes, may increase the carbon flux into the 
glyoxylate shunt and hence increase the production of malate and fumarate. 
CONCLUSIONS 
Aiming to exploit the potential of nature towards the development of an sustainable economy, 
special attention should be paid on studying the metabolism of non-model microorganisms. 
This work underlined the very interesting differentiations in B. smithii, metabolism at different 
temperatures, as well as the great potential in improving its production profile towards 
dicarboxylic acids. The experimental work was based on our previously developed SpCas9- 
and ThermoCas9-based genome editing tools for gene deletions and substitutions, as well as 
culturing under controlled temperature and pH conditions and comparative proteomics 
analysis of selected samples. We achieved 1) the partial reconstitution of the B. smithii ET 
138 ΔldhL growth under oxygen-limited conditions and we simultaneously constructed a 
NADPH-producing strain for future expansion of the B. smithii product variety, 2) the 
elimination of a number of metabolic pathways candidates for the still unknown acetate 
production pathway of B. smithii, and 3) the revealing of strains and culturing conditions that 
favour the production of dicarboxylic acids on top of other by-products. Finally, the existence 
of efficient genome engineering tools and of a mutants collection that could be further tested 
under diverse conditions, strongly facilitates further fundamental and metabolic engineering 
studies of B. smithii.
MATERIALS AND METHODS
BACTERIAL STRAINS AND GROWTH CONDITIONS 
Strains constructed and used in this study are listed in Table 1. 
Table 1. Strains used in this study 
Strain Relevant genotype Reference 
E. coli DH5α Cloning host for all the plasmid constructions NEB 
B. smithii ET 138 strains:
DKO ΔsigF ΔhsdR [12] 
TKO ΔsigF ΔhsdR ΔldhL [12] 
TKO:pNW_PM ΔsigF ΔhsdR ΔldhL: pNW_PM This study 
cTKO ΔsigF ΔhsdR ΔgapA::gapC This study 
QKO_Δach ΔsigF ΔhsdR ΔldhL Δach This study 
QKO_Δacs ΔsigF ΔhsdR ΔldhL Δacs This study 
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The construction of the cTKO strain was based on the pSpCas9_ ΔgapA::gapC 
editing vector. Competent TKO cells were prepared and transformed with the pSpCas9_ 
ΔgapA::gapC vector. The transformation reaction was plated on LB2 selection plate 
supplemented with 7 μg/ml chloramphenicol (LB2_7Cam) at 55°C. Three of the formed 
colonies were used for inoculation of 10ml TVMY liquid medium supplemented with 7 μg/
ml chloramphenicol (TVMY_7Cam) and the cultures were incubated at 55°C for 8hours. 
100 μl from each culture were used for inoculation of fresh 10 ml TVMY_7Cam liquid 
media and the cultures were incubated at 45°C, 150rpm for 8hours. These first two 
incubation steps constitute the homologous recombination phase of the process. The 
incubation step was repeated once more with incubation temperature set at 37°C. This last 
incubation step constitutes the counter selection phase of the process. 100 μl from each 
culture were plated on TVMY_7Cam agar plates and after 24 h randomly selected colonies 
were PCR screened for clean gapA to gapC substitutions with genome specific primers 
(Supp. table 5) and the PCR fragments were subjected to restriction digestion with the EcoRI 
restriction enzyme (NEB). The PCR and digestion products were subjected to 1% agarose 
gel electrophoresis and the PCR products with a digestion pattern that corresponds to the 
desired substitution were purified using Zymogen gel DNA recovery kit (Zymo Research) 
and sequence verified (Macrogen, Inc). 
The construction of the QKO_Δach and QKO_Δacs strains was based on the 
pThermoCas9_ Δach_sp1-4 and pThermoCas9_ Δacs_sp1-4 editing vectors. Competent 
TKO cells were prepared and transformed with the pThermoCas9_ Δach_sp1-4 and 
pThermoCas9_ Δacs_sp1-4 vectors. The transformation reactions were plated on 
LB2_7Cam plates and incubated at 55°C. Randomly selected colonies were PCR screened 
for Δach and Δacs genotypes with genome specific primers (Supp. table 5) and the PCR 
products were subjected to 1% agarose gel electrophoresis. The PCR products with size that 
corresponds to the desired deletion were purified using Zymogen gel DNA recovery kit 
(Zymo Research) and sequence verified (Macrogen, Inc).
PLASMID CURING
For the plasmid curing processes, colonies that contained the desired genotypes were 
inoculated in 10 mL LB2 medium in 50 mL Greiner tubes. The cultures were incubated at 
50-55˚C, and every 24 hours 100 µL of culture were re-inoculated in fresh media. After 5 days, 
200 µL of 10-4 culture dilutions were plated on LB2 agar plates. After overnight incubation 
at 50-55˚C, single colonies were streaked on LB2 and LB2_7Cam plates. Subsequently, 
colonies growingonly in the LB2 plates were subjected to cPCR with Spcas9- and 
Thermocas9-specific primer s (Supp. table 6). The PCR products were subjected to 1% 
E. coli DH5α chemically competent cells (NEB) were employed as cloning hosts and 
routinely cultured in LB medium at 37°C and 200 rpm. LB agar plates were prepared by 
adding 15 g of agar (Difco) per liter of LB medium. When required, chloramphenicol was 
added up to 25 µg/mL final concentration. All B. smithii strains were routinely cultured at 55°
C and 150rpm,unless stated otherwise, in TVMY or LB2 medium. The media were prepared 
as described previously9 and the corresponding agar plates were prepared by adding 30 g of 
agar (Difco) per liter of medium. Electro-competent B. smithii cells were prepared and 
transformed with plasmid DNA as previously described7. For the B. smithii ET 138 culturing 
experiments in tubes, 10 ml TVMY medium cultures were inoculated with the desired cells 
from the corresponding glycerol stocks and cultured overnight in 50 mL Greiner tubes. After 
overnight growth, 100 μL of each pre-culture was transferred to 10 mL fresh TVMY medium 
-in 50 mL Greiner tube- for experiments under oxygen-rich conditions and 250 μL of each 
pre-culture was transferred to 25 mL fresh TVMY medium -in 50 mL Greiner tube- for 
experiments under oxygen-limited conditions. When required, chloramphenicol was added up 
to 7 µg/ mL final concentration.
PLASMID CONSTRUCTION AND B. SMITHII EDITING
All the plasmids constructed and/or used in this study are listed in Supp. table 2 together with 
the primer numbers and the templates used for the construction process. The primers were 
designed with appropriate overhangs for NEBuilder HiFi DNA assembly (NEB) and their 
sequences are listed in Supp. table 3. The fragments for assembling the plasmids were 
obtained through PCR with Q5 Polymerase (NEB), the PCR products were subjected to 1%
agarose gel electrophoresis and they were purified using Zymogen gel DNA recovery kit 
(Zymo Research). The assembled plasmids were transformed to chemically competent E. coli 
DH5α cells (NEB), according to the manufacturer’s protocol. Upon overnight incubation of 
the transformation mixture on LB agar plates supplemented with antibiotic, single colonies 
were inoculated in LB medium supplemented antibiotic. Upon overnight incubation, plasmid 
material was isolated from each culture using the GeneJet plasmid miniprep kit (Thermo 
Fisher Scientific). Each plasmid was sequence verified (Macrogen, Inc) employing primers 
listed in Supp. table 4 and 1 μg from each verified construct was transformed into the desired 
B. smithii ET 138 strain. The MasterPure Gram Positive DNA Purification Kit (Epicentre) was 
used for genomic DNA isolation from B. smithii cultures, while the Phire Plant Direct PCR kit 
(Thermo Scientific) was used for colony PCR on B. smithii ET 138 colonies, according to the 
manufacturers’ protocols.
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E. coli DH5α chemically competent cells (NEB) were employed as cloning hosts and
routinely cultured in LB medium at 37°C and 200 rpm. LB agar plates were prepared by
adding 15 g of agar (Difco) per liter of LB medium. When required, chloramphenicol was
added up to 25 µg/mL final concentration. All B. smithii strains were routinely cultured at 55°
C and 150rpm,unless stated otherwise, in TVMY or LB2 medium. The media were prepared
as described previously9 and the corresponding agar plates were prepared by adding 30 g of
agar (Difco) per liter of medium. Electro-competent B. smithii cells were prepared and
transformed with plasmid DNA as previously described7. For the B. smithii ET 138 culturing
experiments in tubes, 10 ml TVMY medium cultures were inoculated with the desired cells
from the corresponding glycerol stocks and cultured overnight in 50 mL Greiner tubes. After
overnight growth, 100 μL of each pre-culture was transferred to 10 mL fresh TVMY medium
-in 50 mL Greiner tube- for experiments under oxygen-rich conditions and 250 μL of each
pre-culture was transferred to 25 mL fresh TVMY medium -in 50 mL Greiner tube- for
experiments under oxygen-limited conditions. When required, chloramphenicol was added up
to 7 µg/ mL final concentration.
PLASMID CO NSTRUCTIO N ANDB. SMITHII EDITING
All the plasmids constructed and/or used in this study are listed in Supp. table 2 together with
the primer numbers and the templates used for the construction process. The primers were
designed with appropriate overhangs for NEBuilder HiFi DNA assembly (NEB) and their
sequences are listed in Supp. table 3. The fragments for assembling the plasmids were
obtained through PCR with Q5 Polymerase (NEB), the PCR products were subjected to 1%
agarose gel electrophoresis and they were purified using Zymogen gel DNA recovery kit
(Zymo Research). The assembled plasmids were transformed to chemically competent E. coli
DH5α cells (NEB), according to the manufacturer’s protocol. Upon overnight incubation of
the transformation mixture on LB agar plates supplemented with antibiotic, single colonies
were inoculated in LB medium supplemented antibiotic. Upon overnight incubation, plasmid
material was isolated from each culture using the GeneJet plasmid minip rep kit (Thermo
Fisher Scientific). Each plasmid was sequence verified (Macrogen, Inc) employing primers
listed in Supp. table 4 and 1 μg from each verified construct was transformed into the desired
B. smithii ET 138 strain. The MasterPure Gram Positive DNA Purification Kit (Epicentre)
was used for genomic DNA isolation from B. smithii cultures, while the Phire Plant Direct
PCR kit (Thermo Scientific) was used for colony PCR on B. smithii ET 138 colonies,
according to the manufacturers’ protocols.
The construction of the cTKO strain was based on the pSpCas9_ ΔgapA::gapC editing 
vector. Competent TKO cells were prepared and transformed with the pSpCas9_ 
ΔgapA::gapC vector. The transformation reaction was plated on LB2 selection plate 
supplemented with 7 μg/ml chloramphenicol (LB2_7Cam) at 55°C. Three of the formed 
colonies were used for inoculation of 10ml TVMY liquid medium supplemented with 7 μg/
ml chloramphenicol (TVMY_7Cam) and the cultures were incubated at 55°C for 8 hours. 
100 μl from each culture were used for inoculation of fresh 10 ml TVMY_7Cam liquid 
media and the cultures were incubated at 45°C, 150rpm for 8hours. These first two 
incubation steps constitute the homologous recombination phase of the process. The 
incubation step was repeated once more with incubation temperature set at 37°C. This last 
incubation step constitutes the counter selection phase of the process. 100 μl from each 
culture were plated on TVMY_7Cam agar plates and after 24 h randomly selected colonies 
were PCR screened for clean gapA to gapC substitutions with genome specific primers 
(Supp. table 5) and the PCR fragments were subjected to restriction digestion with the EcoRI 
restriction enzyme (NEB). The PCR and digestion products were subjected to 1% agarose gel 
electrophoresis and the PCR products with a digestion pattern that corresponds to the desired 
substitution were purified using Zymogen gel DNA recovery kit (Zymo Research) and 
sequence verified (Macrogen, Inc). 
The construction of the QKO_Δach and QKO_Δacs strains was based on the 
pThermoCas9_ Δach_sp1-4 and pThermoCas9_ Δacs_sp1-4 editing vectors. Competent TKO 
cells were prepared and transformed with the pThermoCas9_ Δach_sp1-4 and 
pThermoCas9_ Δacs_sp1-4  vectors. The transformation reactions were plated on 
LB2_7Cam plates and incubated at 55°C. Randomly selected colonies were PCR screened 
for Δach and Δacs genotypes with genome specific primers (Supp. table 5) and the PCR 
products were subjected to 1% agarose gel electrophoresis. The PCR products with size that 
corresponds to the desired deletion were purified using Zymogen gel DNA recovery kit 
(Zymo Research) and sequence verified (Macrogen, Inc).
PLASMID CURING
For the plasmid curing processes, colonies that contained the desired genotypes were 
inoculated in 10 mL LB2 medium in 50 mL Greiner tubes. The cultures were incubated at 
55˚C, and every 24 hours 100 µL of culture were re-inoculated in fresh media. After 5 days, 
200 µL of 10-4 culture dilutions were plated on LB2 agar plates. After overnight incubation at 
50-55˚C, single colonies were streaked on LB2 and LB2_7Cam plates. Subsequently, colo-
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was calculated by assuming a half-life time of 100 h at 55˚C40. Concentration of 
chloramphenicol ata given time point can be determined based on the equation: C(t)= C0 × 
0.5100. Antifoam was added to the bioreactor s in case of foam formation.
PRO TEO MICS 
CELL-FREE EXTRACT (CFE) PREPARATIO N
Selected culture samples were sent for proteomics analysis. The samples were collected 
from fermenters and pelleted by centrifugation at >14000 rpm, 4°C and for 15 minutes. 
The cell pellets were further washed via resuspension in 500 µL ice-cold sterile 
phosphate buffer solution pH7 (PBS,. The resuspended pellets were then centrifuged, the 
supernatants were discarded and the washing step was repeated. Cell pellets from the second 
washing step were resuspended in 500 µL of 100 mM Tris-HCl buffer pH 7.6 containing 50 
mM DTT. 250 µL of each resuspension mixture were stored at -20°C for further use, while 
the rest 250 µL were transferred into a sterile bead-beating tube supplemented with sterile 
beads. The cells were then disrupted by bead beating at 6000 rpm for 40 seconds, using 
the Percellys24 Homogenizer (Bertin Instruments). The lysis mixtures were centrifuged 
at >14000 rpm and 4°C for 10 minutes. The supernatants, which werethe cell free extracts 
(CFE), were transferred to 2.0 mL low binding protein tubes and used for further analysis. 
The total protein content of the CFEs was determined using Roti®-Nanoquant (Roth), 
according to manufacturer’s protocol.  
SDS-PAG E 
In a clean 1.5 mL low binding protein tube, the CFE samples were mixed with 4x sample 
loading buffer (Bio-Rad) containing 10% β-mercaptoethanol. The mixtures were incubated 
at 95°C for 10 minutes, then briefly centrifuged. 50 µL of each mixture were loaded in the 
wells of a 1 mm Mini-PROTEAN® TGXTM Precast Gel (Bio-Rad). The gel was subjected to 
electrophoresis (25 mA, 30 min) for protein separation using the PowerPacTM HC HigH-
Current Power Supply (Bio-Rad) unit. At the end of the run, the gel was rinsed with miliQ 
water and incubated overnight in excess Commassie Blue stain with gentle shaking. 
Subsequently the gel was rinsed several times with miliQ water, until no trace of Commassie 
Blue stain could be observed. During the whole procedure it was important to keep the gel 
covered to prevent keratin contamination. The gel could then be directly used for the in-gel 
digestion step or stored at 4°C until further use. 
IN-G EL DIG ESTIO N
The previously described sds-page gel was incubated overnight at RT in 25 mL of 50 
mM NH4HCO3 and 10 mM DTT pH 8 solution. Following the incubation, the gel was 
nies growing only in the LB2 plates were subjected to cPCR with spcas9- and thermocas9-
specific primers (Supp. table 6). The PCR products were subjected to 1% agarose 
gel electrophoresis,  and colonies that resulted in cPCR without product were considered 
cured from plasmid. Cured colonies were further cultured in LB2 and LB2_7Cam media to 
further confirm the absence of the plasmid.
ANALYTICAL METHODS
B. smithii cell growth was monitored by measuring the optical density at 600 nm (OD600)
using a UV-1800 UV-VIS spectrophotometer (Shimadzu). Acidification of the cultures in the
tube culturing experiments was determined by measuring the pH using a ProLine benchtop
pH meter (ProSense B.V.). Extracellular concentrations of glucose and fermentation products
were determined using the high pressure liquid chromatography (HPLC) system ICS-5000
(Thermo Scientific). The system was equipped with an Aminex HPX 87H column (Bio-Rad
Laboratories), a UV1000 detector operating at 210 nm and a RI-150 refraction index detector
at 40°C. The mobile phase consisted of 0.016 N H2SO4, and the column was operated at a
flow rate of 0.8 mL/min at 80°C. For the preparation of the HPLC samples, 1 mL culture
samples were removed at the desired time point from each culturing experiment and they
were centrifuged for 10 min at room temperature (RT) at 13,000 rpm. The resulting
supernatant was stored at -20˚C or diluted 4:1 with 10 mM DMSO in 0.04 N H2SO4 (internal
standard) and directly used for HPLC analysis.
CULTURING IN BIOREACTORS
The culturing in bioreactors experiments were conducted in glass reactors of 1L working 
volume (Eppendorf) operated via the DASGIP® software. The bioreactors contained 500 mL 
of modified TVMY medium (TVMY without MOPS and supplemented with 30 g/L glucose), 
as well as antibiotic when required. The temperature was controlled to remain at the desired 
levels and the pH was controlled to maintain at 6.5 via addition of 3 M KOH. The precultures 
for the bioreactor culturing experiments were prepared upon inoculation of 10 mL TVMY 
medium in 50 mL Greiner tubes, supplemented with antibiotic when required, with cells from 
the glycerol stocks. After overnight culturing at the selected temperatures 100μl from the 
precultures were transferred to 20 mL fresh TVMY medium in 50 mL Greiner tubes to an 
initial OD600 of 0.08. Upon reaching an OD600 of 0.5-0.7 (exponential growth phase), the 
cultures were used as starting material for the inoculation of the bioreactors to an initial OD600 
of approximately 0.015. Samples of about 2 mL were taken at several time points, OD600 was 
measured to monitor cell growth and glucose and fermentation products were quantified by
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Agarose gel electrophoresis, and colonies that resulted in cPCR without product 
were considered cured from plasmid. Cured colonies were further cultured in LB2 and 
LB2_7Cam media to further confirm the ab sence of the plasmid.
ANALYTICAL METH O DS
B. smithii cell growth was monitored by measuring the optical density at 600 nm (OD600) 
using a UV-1800 UV-VIS spectrophotometer (Shimadzu). Acidification of the cultures in 
the tube culturing experiments was determined by measuring the pH using a ProLine 
benchtop pH meter (ProSense B.V.). Extracellular concentrations of glucose and 
fermentation products were determined using the high pressure liquid chromatography 
(HPLC) system ICS-5000 (Thermo Scientific). The system was equipped with an Aminex 
HPX 87H column (Bio-Rad Laboratories), a UV1000 detector operating at 210 nm and a 
RI-150 refraction index detector at 40°C. The mobile phase consisted of 0.016 N H2SO4, and 
the column was operated at a flow rate of 0.8 mL/min at 80°C. For the preparation of the 
HPLC samples, 1 mL culture samples were removed at the desired time point from each 
culturing experiment and they were centrifuged for 10 min at room temperature (RT) at 
13,000 rpm. The resulting supernatant was stored at -20˚C or diluted 4:1 with 10 mM 
DMSO in 0.04 N H2SO4 (internal standard) and directly used for HPLC analysis.
CULTURING IN BIO REACTO RS
The culturing in bioreactors experiments were conducted in glass reactors of 1L working 
volume (Eppendorf) operated via the DASGIP® software. The bioreactors contained 500 mL 
of modified TVMY medium (TVMY without MOPS and supplemented with 30 g/L 
glucose), as well as antibiotic when required. The temperature was controlled to remain at 
the desired levels and the pH was controlled to maintain at 6.5 via addition of 3 M KOH. 
The precultures for the bioreactor culturing experiments were prepared upon inoculation of 
10 mL TVMY medium in 50 mL Greiner tubes, supplemented with antibiotic when 
required, with cells from the glycerol stocks. After overnight culturing at the selected 
temperatures 100μl from the precultures were transferred to 20 mL fresh TVMY medium 
in 50 mL Greiner tubes to an initial OD600 of 0.08. Upon reaching an OD600 of 0.5-0.7 
(exponential growth phase), the cultures were used as starting mater ial for the inoculation 
of the bioreactors to an initial OD600 of approximately 0.015. Samples of about 2 mL 
were taken at several time points, OD600 was measured to monitor cell growth and glucose 
and fermentation products were quantified by HPLC. Furthermore, when required, 
chloramphenicol was added to the bioreactors every 24 h in order to maintain the 
chloramphenicol concentration above 6 µg/mL. Chemical degradation of chloramphenicol 
HPLC. Furthermore, when required, chloramphenicol was added to the bioreactors every 24 
h in order to maintain the chloramphenicol concentration above 6 µg/mL. Chemical 
degradation of chloramphenicolwas calculated by assuming a half-life time of 100 h at 
55˚C40. Concentration of chloramphenicol at a given time point can be determined based on 
the equation: C(t) = C0 × 0.5100. Antifoam was added to the bioreactors in case of foaming.
PROTEOMICS 
CELL-FREE EXTRACT (CFE PREPARATION)
Selected culture samples were sent for proteomics analysis. The samples were collected from 
fermenters and pelleted by centrifugation at >14000 rpm, 4°C and for 15 minutes. The cell 
pellets were further washed via resuspension in 500 µL ice-cold sterile phosphate buffer 
solution pH7 (PBS,. The resuspended pellets were then centrifuged, the supernatants were 
discarded and the washing step was repeated. Cell pellets from the second washing step were 
resuspended in 500 µL of 100 mM Tris-HCl buffer pH 7.6 containing 50 mM DTT. 250 µL 
of each resuspension mixture were stored at -20°C for further use, while the rest 250 µL were 
transferred into a sterile bead-beating tube supplemented with sterile beads. The cells were 
then disrupted by bead beating at 6000 rpm for 40 seconds, using the Percellys24 
Homogenizer (Bertin Instruments). The lysis mixtures were centrifuged at >14000 rpm and 
4°C for 10 minutes. The supernatants, which were the cell free extracts (CFE), were 
transferred to 2.0 mL low binding protein tubes and used for further analysis. The total 
protein content of the CFEs was determined using Roti®-Nanoquant (Roth), according to 
manufacturer’s protocol.
SDS-PAGE 
In a clean 1.5 mL low binding protein tube, the CFE samples were mixed with 4x sample 
loading buffer (Bio-Rad) containing 10% β-mercaptoethanol. The mixtures were incubated at 
95°C for 10 minutes, then briefly centrifuged. 50 µL of each mixture were loaded in the 
wells of a 1 mm Mini-PROTEAN® TGXTM Precast Gel (Bio-Rad). The gel was subjected 
to electrophoresis (25 mA, 30 min) for protein separation using the PowerPacTM HC HigH-
Current Power Supply (Bio-Rad) unit. At the end of the run, the gel was rinsed with miliQ 
water and incubated overnight in excess Commassie Blue stain with gentle shaking. 
Subsequently the gel was rinsed several times with miliQ water , until no trace of Commassie 
Blue stain could be observed. During the whole procedure it was important to keep the gel 
covered to prevent keratin contamination. The gel could then be directly used for the in-gel 
digestion step or stored at 4°C until further use.
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IN-GEL DIGESTION
The previously described sds-page gel was incubated overnight at RT in 25 mL of 50 mM 
NH4HCO3 and 10 mM DTT pH 8 solution. Following the incubation, the gel was rinsed with 
miliQ water and washed with 25 mL of a solution containing 22,5 mL dH2O, 2.5 mL 1M Tris 
pH 8 and 20 mM iodoacetamide pH 8. Using a scalpel, the sample from each well was 
divided into 5 small fractions. Each gel fraction was again cut into smaller pieces then 
transferred to a clean 0.5 mL low protein low binding tube. Fresh 50 µL trypsin solution was 
added to each tube, followed by overnight incubation at RT. The following day, the pH of 
each mixture was adjusted to between 2 and 4, with the addition of 10% trifluoroacetic acid 
(TFA).
µCOLUMNS PREPARATION
The trypsinated samples were cleaned, using µColumns, for the liquid chromatography-mass 
spectrometry (LC-MS) analysis step. For the µColumns preparation, a small piece of C18 
Empore disk (frit) was transferred to a 200 µl tip, then 200 µl methanol were added to the tip. 
50% slurry LichroprepC18 column material in methanol was also prepared, and 4 µl of this 
mixture was added to the tip containing the frit and the methanol. The content of the μ-
Column was then eluted either by hand, with a 10 mL plastic syringe, or with vacuum 
manifold. The µColumns washing step was repeated with 100 µl of methanol. Subsequently 
the µColumns were eluted with 100 µl of 1ml/L HCOOH in dH2O. The samples after the in-
gel digestion were added to the μ-Columns and the μ-Columns were washed with 100 µl of 
1ml/L HCOOH and transferred to clean 0.5 mL low binding tubes. The peptides were 
manually eluted from the μ-Columns upon addition of 50 µl of a solution containing 50% 
Acetonitrile and 50% 1ml/L HCOOH in water. The samples were then concentrated via 
incubation at 45°C for at least 2 hours, until the final volume was < 20 µl. Finally, the 
samples were adjusted to final volume of 50 µL and then sonicat ed for 5 seconds.
STATISTICAL ANALYSIS
Statistical significances of growth, glucose consumption and acids production differences 
between genetically engineered and control strains were evaluated by performing the two-
sided Student’s t-test. The values were presented as the mean ± standard error of 2 or 3 
replicates. A P value <0.05 was considered to be statistically significant. 
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rinsed with miliQ water and washed with 25 mL of a solution containing 22,5 mL dH2O, 2.5 
mL 1M Tris pH 8 and 20 mM iodoacetamide pH 8. Using a scalpel, the sample from 
each well was divided into 5 small fractions. Each gel fraction was again cut into 
smaller pieces then transferred to a clean 0.5 mL low protein low binding tube. Fresh 50 µL 
trypsin solution was added to each tube, followed by overnight incubation at RT. The 
following day, the pH of each mixture was adjusted to between 2 and 4, with the addition 
of 10% trifluoroacetic acid (TFA).  
µCO LUMNS PREPARATIO N
The trypsinated samples were cleaned, using µColumns, for the liquid chromatography-mass 
spectrometry (LC-MS) analysis step. For the µColumns preparation, a small piece of C18 
Empore disk (frit) was transferred to a 200 µl tip, then 200 µl methanol were added to the 
tip. 50% slurry LichroprepC18 column material in methanol was also prepared, and 4 µl of 
this mixture wasadded to the tip containing the frit and the methanol. The content of the μ-
Column was then eluted either by hand, with a 10 mL plastic syringe, or with vacuum 
manifold. The µColumns washing step was repeated with 100 µl of methanol. Subsequently 
the µColumns were eluted with 100 µl of 1ml/L HCOOH in dH2O. The samples after the in-
gel digestion were added to the μ-Columns and the μ-Columns were washed with 100 µl of 
1ml/L HCOOH and transferred to clean 0.5 mL low binding tubes. The peptides were 
manually eluted from the μ-Columns upon addition of 50 µl of a solution containing 50% 
Acetonitrile and 50% 1ml/L HCOOH in water. The samples were then concentrated via 
incubation at 45°C for at least 2 hours, until the final volume was < 20 µl. Finally, the 
samples were adjusted to final volume of 50 µL and then sonicat ed for 5 seconds. 
STATISTICAL ANALYSIS
Statistical significances of growth, glucose consumption and acids production 
differences between genetically engineered and control strains were evaluated by performing 
the two-sided Student’s t-test. The values were presented as the mean ± standard error of 2 or 
3 replicates. A P value <0.05 was considered to be statistically significant. 
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Supplementary tables
Supp. table 1. List of B. smithii ET 138 proteins significantly m ore abundant either at 37°C or 55°C, as extracted
from the proteom ics data analysis. The Log protein values correspond to the logarithm ic protein abundance ratio
between 37°C and 55°C. Only proteins with Log ratio ≥ 2 or ≤-2 are listed.
Name
Log 
Protein Protein IDs
hydantoinase b/oxoprolinase 4.04 138update_0816
peptidase u32 3.98 138update_2403;A0A0H4P5Y9
hydantoinase/oxoprolinase 3.72 138update_0815
sm cs flexible hinge 3.64 138update_1453;A0A0H4NZ49
stage ii sporulation protein e 3.60 138update_0073;A0A0H4PC65
Hypothetical protein 3.55 138update_0268;A0A0H4NZU7
Alcohol dehydrogenase 3.43 A0A0H4NZ36;138update_0586
Aspartokinase 3.37 A0A0H4NW59;138update_0280
Methionine synthase II 3.25 A0A0H4PLN6;138update_3312
phosphom ethylpyrim idine synthase 3.24 138update_1819
Arginine decarboxylase 3.04 A0A0H4NXQ8;138update_0035
Foldase protein PrsA
3.02
A0A0H4NWW6;138update_0938;
A0A0H4P7C4;138update_2819
cobalam in-independent m ethionine synthase 3.01 138update_3306;A0A0H4P7W7
transcription sporulation two-com ponent dna-binding
phosphorylation sensory regulation
2.92
138update_2251;A0A0H4PIL5
Acetolactate synthase 2.88 A0A0H4NXP3;138update_0905
RNA polym erase sigm a factor 2.88 A0A0H4P1D5;138update_1403
Uncharacterized protein Bsub YpbR 2.84 A0A0H4P126;138update_2067
Quinolinate synthase 2.80 138update_2451;A0A0H4P651
Glycine cleavage system H protein 2.79 A0A0H4P618;138update_2797
O-succinylhom oserine sulfhydrylase 2.75 A0A0H4NZ30;138update_1687
Hypothetical protein 2.74 138update_0572
Anthranilate phosphoribosyltransferase 2.74 A0A0H4P0M6;138update_1929
Glyoxalase fam ily protein 2.73 A0A0H4P295;138update_1223
Dihydrolipoam ide acetyltransferase com ponent of
pyruvate dehydrogenase com plex
2.72
138update_0537;A0A0H4P0K7
Acyl-coenzym e A synthetases/AMP-fattyacid ligases
YtcI-like
2.72
A0A0H4PJK4;138update_2600
Carbon starvation protein 2.72 A0A0H4P4G6;138update_3136
Acetoin dehydrogenase E1 com ponent beta-subunit 2.69 A0A0H4PDK4;138update_0536
Uncharacterized protein 2.62 A0A0H4P8J6;138update_3191
acetyl-coa carboxylase carboxyl transferase beta subunit 2.61 138update_2575;A0A0H4P591
 Supplementary Figures 
Supp. Figure 1. Gel-electrophoresis of genome specific colony PCR products from B. smithii ET 138 colonies 
formed upon transformation with pThermo_Δach_sp1 and pThermo_Δacs_sp1/2/3 editing vectors. The Δach 
genotype corresponds to 2442 bp while the wild-type genotype corresponds to 3963 bp. The expected size for the 
PCR fragments of the Δacs genotype is 2494 bp while the expected size for the wild-type genotype fragments is 
4207 bp. 
Supp. Figure 2. . Gel-electrophoresis of plasmid specific PCR products on DNA isolated from B. smithii ET 138 
cultures. The QKO_Δach and QKO_Δacs cultures were inoculated by colonies that resulted from the -described 
in this study- plasmid curing processes, while the TKO negative control culture was inoculated by a glycerol 
stock of already plasmid cured cells. The pThermo_Δach_sp1 vector was employed as positive control. 
Supp. Figure 3. Graphical representation of the comparative proteomics data analysis. The graph depicts the 
logarithmic protein abundance ratio between proteins isolated from B. smithii ET 138 (strain DKO) cultures at 
37°C and 55°C. The blue dots correspond to proteins with logarithmic abundance (37/55) ratio ≤2 and ≥-2 
(insignificant difference between 37°C and 55°C), the orange dots correspond to proteins with logarithmic 
abundance (37/55) ratio ≥2 and ≤-2 (significant difference between 37°C and 55°C) and the grey dots correspond 
to contaminants. The proteins with the highest abundance at 37°C and 55°C are noted. 
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Supplementary Figures
Supp. Figure 1. Gel-electrophoresis of genom e specificcolony PCR products from B. smithii ET 138 colonies
form ed upon transform ation with pTherm o_Δach_sp1 and pTherm o_Δacs_sp1/2/3 editing vectors. The Δach
genotype corresponds to 2442 bp while the wild-type genotype corresponds to 3963 bp. The expected size for the
PCR fragm ents of the Δacs genotype is 2494 bp while the expected size for the wild-type genotype fragm ents is
4207 bp.
Supp. Figure 2. . Gel-electrophoresis of plasm id specificPCR products on DNA isolated from B. smithii ET 138 
cultures. The QKO_Δach and QKO_Δacs cultures were inoculated by colonies that resulted from the -described
in this study- plasm id curing processes, while the TKO negative control culture was inoculated by a glycerol stock
of already plasm id cured cells. The pTherm o_Δach_sp1 vector was em ployed as positive control.
Supp. Figure 3. Graphical representation of the com parative proteom ics data analysis. The graph depicts the 
logarithm ic protein abundance ratio between proteins isolated from B. smithii ET 138 (strain DKO) cultures at
37°C and 55°C. The blue dots correspond to proteins with logarithm ic abundance (37/55) ratio ≤2 and ≥-2 
(insignificant difference between 37°C and 55°C), the orange dots correspond to proteins with logarithm ic
abundance (37/55) ratio ≥2 and ≤-2 (significant difference between 37°C and 55°C) and the grey dots correspond 
to contam inants. The proteins with the highest abundance at 37°C and 55°C are noted.
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Supplementary tables 
Supp. table 1. List of B. smithii ET 138 proteins significantly more abundant either at 37°C or 55°C, as extracted 
from the proteomics data analysis. The Log protein values correspond to the logarithmic protein abundance ratio 
between 37°C and 55°C. Only proteins with Log ratio ≥ 2 or ≤-2 are listed. 
Name 
Log 
Protein Protein IDs 
hydantoinase b/oxoprolinase 4.04 138update_0816 
peptidase u32 3.98 138update_2403;A0A0H4P5Y9 
hydantoinase/oxoprolinase 3.72 138update_0815 
sm cs flexible hinge 3.64 138update_1453;A0A0H4NZ49 
stage ii sporulation protein e 3.60 138update_0073;A0A0H4PC65 
Hypothetical protein 3.55 138update_0268;A0A0H4NZU7 
Alcohol dehydrogenase 3.43 A0A0H4NZ36;138update_0586 
Aspartokinase 3.37 A0A0H4NW59;138update_0280 
Methionine synthase II 3.25 A0A0H4PLN6;138update_3312 
phosphom ethylpyrim idine synthase 3.24 138update_1819 
Arginine decarboxylase 3.04 A0A0H4NXQ8;138update_0035 
Foldase protein PrsA 
3.02 
A0A0H4NWW6;138update_0938; 
A0A0H4P7C4;138update_2819 
cobalam in-independent m ethionine synthase 3.01 138update_3306;A0A0H4P7W7 
transcription sporulation two-com ponent dna-binding 
phosphorylation sensory regulation 
2.92 
138update_2251;A0A0H4PIL5 
Acetolactate synthase 2.88 A0A0H4NXP3;138update_0905 
RNA polym erase sigm a factor 2.88 A0A0H4P1D5;138update_1403 
Uncharacterized protein Bsub YpbR 2.84 A0A0H4P126;138update_2067 
 Quinolinate synthase 2.80 138update_2451;A0A0H4P651 
Glycine cleavage system  H protein 2.79 A0A0H4P618;138update_2797 
O-succinylhom oserine sulfhydrylase 2.75 A0A0H4NZ30;138update_1687 
Hypothetical protein 2.74 138update_0572 
Anthranilate phosphoribosyltransferase 2.74 A0A0H4P0M6;138update_1929 
Glyoxalase fam ily protein 2.73 A0A0H4P295;138update_1223 
Dihydrolipoam ide acetyltransferase com ponent of 
pyruvate dehydrogenase com plex 
2.72 
138update_0537;A0A0H4P0K7 
Acyl-coenzym e A synthetases/AMP-fattyacid ligases 
YtcI-like  
2.72 
A0A0H4PJK4;138update_2600 
Carbon starvation protein 2.72 A0A0H4P4G6;138update_3136 
Acetoin dehydrogenase E1 com ponent beta-subunit 2.69 A0A0H4PDK4;138update_0536 
Uncharacterized protein 2.62 A0A0H4P8J6;138update_3191 
acetyl-coa carboxylase carboxyl transferase beta subunit 2.61 138update_2575;A0A0H4P591 
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Name 
Log 
Protein Protein IDs 
glycosyl transferases group 1 2.61 138update_2685 
Diam inopim elate decarboxylase 2.57 A0A0H4P3Z2;138update_2183 
Hydrolase HAD superfam ilyin cluster with DUF1447 2.55 A0A0H4P0N3;138update_1185 
Two-com ponent sensor histidine kinase 2.52 A0A0H4NXN7;138update_1281 
Transcriptional regulatorTetR fam ily 2.51 A0A0H4PF47;138update_1171 
Aspartokinase 2.47 A0A0H4P324;138update_1901 
Glycine oxidase ThiO 2.46 A0A0H4P0S2;138update_0628 
saicar synthetase signature 2.44 138update_3029;A0A0H4PKT0 
peptidase 2.44 138update_2826;A0A0H4P3F6 
phosphorylase pyridoxal-phosphate attachm ent site 2.44 138update_2684;A0A0H4P5S9 
s-adenosyl-l-m ethionine-dependent m ethyltransferase 2.44 138update_2966 
 tRNA uridine 5-carboxym ethylam inom ethyl m odification
enzyme  MnmG 
2.38 
A0A0H4PLT1;138update_3376 
phospholipase/carboxylesterase/thioesterase 2.37 138update_1670 
protein secy signature 2.35 138update_0145;A0A0H4NVM4 
Anti-sigm a F factor antagonist 2.33 A0A0H4P0N1;138update_2189 
Hypothetical protein 2.32 138update_2622;A0A0H4P5F1 
six-hairpin glycosidase 2.28 138update_1941;A0A0H4P0N7 
 Stage V sporulation protein AF SpoVAF 2.25 A0A0H4P0M9;138update_2184 
5,10-m ethylenetetrahydrofolate reductase 2.25 A0A0H4PDZ0;138update_0688 
Succinyl-CoA:3-ketoacid-coenzym e A transferase 2.25 A0A0H4P1B5;138update_0819 
Hydroxym ethylpyrim idine phosphate kinase 2.24 A0A0H4P1M7;138update_2214 
asparagine synthase 2.24 138update_2659;A0A0H4P5Q5 
Hypothetical protein 2.24 138update_2873;A0A0H4P2S3 
ribosom al protein s6 signature 2.22 138update_3365;A0A0H4P559 
Pili retraction protein pilT 2.21 A0A0H4NVH5;138update_0099 
Glycosyltransferase 2.20 A0A0H4P127;138update_2319 
fatty acid synthase 2.19 138update_1682;A0A0H4NZT6 
Thiazole synthase 2.19 A0A0H4NW37;138update_0626 
sporulation stage 0  protein 2.18 138update_2031;A0A0H4P3G9 
Glycogen synthase 2.13 A0A0H4P2B5 
Single-stranded-DNA-specific exonuclease RecJ 2.13 A0A0H4P625;138update_2432 
Methylthioribulose-1-phosphate dehydratase 2.11 A0A0H4P6Z1;138update_3051 
dehydrogenase  e1 com ponent 2.10 138update_0535;A0A0H4NVY3 
Hypothetical protein 2.10 138update_1655 
 Diami nopim elate epim erase 2.10 A0A0H4P0V6;138update_2014 
heat shock protein 2.08 138update_0080;A0A0H4NXT5 
Name
Log 
Protein Protein IDs
Aldehyde dehydrogenase 2.08 A0A0H4P418;138update_1744
S1 RNA binding dom ain 2.06 A0A0H4P2L5;138update_2823
forma te--tetrahydrofolate ligase signature 2.04 138update_2058;A0A0H4P086
Carbamo yl-phosphate synthase sm all chain 2.02 A0A0H4NZ11;138update_1420
Aspartokinase 2.02 A0A0H4P533;138update_2533
Chrom osom e plasm id partitioning protein ParB Stage 0
sporulation protein 
2.02
138update_3372;A0A0H4P950
Succinyl-CoA:3-ketoacid-coenzym e A transferase subunit
A 
2.02
A0A0H4PEB5;138update_0818
am inotransferase class iv 2.00 138update_0658
Cell shape-determ ining protein MreC 2.00 A0A0H4PJ66;138update_2469
denosylm ethionine-8-ami no-7-oxononanoate
am inotransferase 
-2.01
138update_2229;A0A0H4P1N9
Xanthine dehydrogenaseFAD binding subunit -2.03 A0A0H4P4N2;138update_1967
Phosphopentom utase -2.06 A0A0H4P1I3;138update_2192
Sialic acid utilization regulatorRpiR fam ily -2.07 A0A0H4P453;138update_2220
1-deoxy-D-xylulose 5-phosphate reductoisom erase -2.10 A0A0H4PG46;138update_1514
Sulfur carrier protein adenylyltransferase ThiF -2.10 A0A0H4NZ78;138update_0625
Transition state regulatory protein AbrB -2.12 A0A0H4NXR4;138update_0045
pyridine nucleotide-disulphide oxidoreductase class-ii -2.13 138update_2152;A0A0H4P1C5
Am ino acid ABC transporter -2.15 A0A0H4P671;138update_2838
Im idazoleglycerol-phosphate dehydratase -2.19 A0A0H4NWL9;138update_0474
Acetyl-coenzym e A synthetase -2.20 A0A0H4P214
Am inom ethyltransferase -2.24 A0A0H4P4C1;138update_2285
Flagellar M-ring protein -2.24 A0A0H4PG15;138update_1480
Coenzym e A biosynthesis bifunctional protein CoaBC -2.24 138update_1432;A0A0H4NY73
ClpB protein -2.25 A0A0H4P2H3;138update_1287
30S ribosom al protein -2.26 A0A0H4NZ53;138update_1458
l-lactate perm ease -2.31 138update_3342;A0A0H4P803
DNA polym erase X fam ily -2.32 A0A0H4P6E3;138update_2542
transform ing protein p21 ras signature -2.34 138update_3377;A0A0H4P955
Ribosom e-binding ATPase YchF -2.38 A0A0H4P4C3;138update_3366
Am ino acid perm ease -2.39 A0A0H4P3T5;138update_2921
Transcriptional repressor NrdR -2.43 A0A0H4P6J0;138update_2559
RND m ultidrug efflux transporterAcriflavin resistance 
protein
-2.48
A0A0H4P8E8
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Name
Log 
Protein Protein IDs
glycosyl transferases group 1 2.61 138update_2685
Diam inopim elate decarboxylase 2.57 A0A0H4P3Z2;138update_2183
Hydrolase HAD superfam ilyin cluster with DUF1447 2.55 A0A0H4P0N3;138update_1185
Two-com ponent sensor histidine kinase 2.52 A0A0H4NXN7;138update_1281
Transcriptional regulatorTetR fam ily 2.51 A0A0H4PF47;138update_1171
Aspartokinase 2.47 A0A0H4P324;138update_1901
Glycine oxidase ThiO 2.46 A0A0H4P0S2;138update_0628
saicar synthetase signature 2.44 138update_3029;A0A0H4PKT0
peptidase 2.44 138update_2826;A0A0H4P3F6
phosphorylase pyridoxal-phosphate attachm ent site 2.44 138update_2684;A0A0H4P5S9
s-adenosyl-l-m ethionine-dependent m ethyltransferase 2.44 138update_2966
tRNA uridine 5-carboxym ethylam inom ethyl m odification
enzyme MnmG
2.38
A0A0H4PLT1;138update_3376
phospholipase/carboxylesterase/thioesterase 2.37 138update_1670
protein secy signature 2.35 138update_0145;A0A0H4NVM4
Anti-sigm a F factor antagonist 2.33 A0A0H4P0N1;138update_2189
Hypothetical protein 2.32 138update_2622;A0A0H4P5F1
six-hairpin glycosidase 2.28 138update_1941;A0A0H4P0N7
Stage V sporulation protein AF SpoVAF 2.25 A0A0H4P0M9;138update_2184
5,10-m ethylenetetrahydrofolate reductase 2.25 A0A0H4PDZ0;138update_0688
Succinyl-CoA:3-ketoacid-coenzym e A transferase 2.25 A0A0H4P1B5;138update_0819
Hydroxym ethylpyrim idine phosphate kinase 2.24 A0A0H4P1M7;138update_2214
asparagine synthase 2.24 138update_2659;A0A0H4P5Q5
Hypothetical protein 2.24 138update_2873;A0A0H4P2S3
ribosom al protein s6 signature 2.22 138update_3365;A0A0H4P559
Pili retraction protein pilT 2.21 A0A0H4NVH5;138update_0099
Glycosyltransferase 2.20 A0A0H4P127;138update_2319
fatty acid synthase 2.19 138update_1682;A0A0H4NZT6
Thiazole synthase 2.19 A0A0H4NW37;138update_0626
sporulation stage 0 protein 2.18 138update_2031;A0A0H4P3G9
Glycogen synthase 2.13 A0A0H4P2B5
Single-stranded-DNA-specific exonuclease RecJ 2.13 A0A0H4P625;138update_2432
Methylthioribulose-1-phosphate dehydratase 2.11 A0A0H4P6Z1;138update_3051
dehydrogenase e1 com ponent 2.10 138update_0535;A0A0H4NVY3
Hypothetical protein 2.10 138update_1655
Diami nopim elate epim erase 2.10 A0A0H4P0V6;138update_2014
heat shock protein 2.08 138update_0080;A0A0H4NXT5
Name 
Log 
Protein Protein IDs 
Aldehyde dehydrogenase 2.08 A0A0H4P418;138update_1744 
S1 RNA binding dom ain 2.06 A0A0H4P2L5;138update_2823 
forma te--tetrahydrofolate ligase signature 2.04 138update_2058;A0A0H4P086 
Carbamo yl-phosphate synthase sm all chain 2.02 A0A0H4NZ11;138update_1420 
Aspartokinase 2.02 A0A0H4P533;138update_2533 
 Chrom osom e plasm id partitioning protein ParB Stage 0 
sporulation protein  
2.02 
138update_3372;A0A0H4P950 
Succinyl-CoA:3-ketoacid-coenzym e A transferase subunit 
A 
2.02 
A0A0H4PEB5;138update_0818 
aminotransferase class iv 2.00 138update_0658 
Cell shape-determ ining protein MreC 2.00 A0A0H4PJ66;138update_2469 
denosylm ethionine-8-ami no-7-oxononanoate 
am inotransferase 
-2.01
138update_2229;A0A0H4P1N9 
Xanthine dehydrogenaseFAD binding subunit -2.03 A0A0H4P4N2;138update_1967 
Phosphopentom utase -2.06 A0A0H4P1I3;138update_2192 
Sialic acid utilization regulatorRpiR fam ily -2.07 A0A0H4P453;138update_2220 
1-deoxy-D-xylulose 5-phosphate reductoisom erase -2.10 A0A0H4PG46;138update_1514 
Sulfur carrier protein adenylyltransferase ThiF -2.10 A0A0H4NZ78;138update_0625 
Transition state regulatory protein AbrB -2.12 A0A0H4NXR4;138update_0045 
pyridine nucleotide-disulphide oxidoreductase class-ii -2.13 138update_2152;A0A0H4P1C5 
Am ino acid ABC transporter -2.15 A0A0H4P671;138update_2838 
Imidazoleglycerol-phosphate dehydratase -2.19 A0A0H4NWL9;138update_0474 
Acetyl-coenzym e A synthetase -2.20 A0A0H4P214 
Am inom ethyltransferase -2.24 A0A0H4P4C1;138update_2285 
Flagellar M-ring protein -2.24 A0A0H4PG15;138update_1480 
Coenzym e A biosynthesis bifunctional protein CoaBC -2.24 138update_1432;A0A0H4NY73 
ClpB protein -2.25 A0A0H4P2H3;138update_1287 
30S ribosom al protein -2.26 A0A0H4NZ53;138update_1458 
l-lactate perm ease -2.31 138update_3342;A0A0H4P803 
DNA polym erase X fam ily -2.32 A0A0H4P6E3;138update_2542 
transform ing protein p21 ras signature -2.34 138update_3377;A0A0H4P955 
Ribosom e-binding ATPase YchF -2.38 A0A0H4P4C3;138update_3366 
Am ino acid perm ease -2.39 A0A0H4P3T5;138update_2921 
Transcriptional repressor NrdR -2.43 A0A0H4P6J0;138update_2559 
RND multidrug efflux transporter Acriflavin 
resistance protein  
-2.48
A0A0H4P8E8 
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Name 
Log 
Protein Protein IDs 
Nucleotide-binding protein -2.48 A0A0H4NWM5;138update_0482 
90kda heat shock protein signature -2.49 138update_1706 
PTS system N-acetylglucosam ine-specific IIC com ponent -2.49 A0A0H4P0C5;138update_0458 
Cell division topological determ inant MinJ -2.51 A0A0H4NYT1;138update_0447 
Flagellar hook-associated protein 2 -2.54 A0A0H4NWH0;138update_0423 
Two-com ponent response regulator SA14-24 -2.60 A0A0H4P812;138update_3353 
Cell wall lytic activity -2.65 A0A0H4NYP2;138update_0396 
DNA repair protein RecN -2.67 A0A0H4P1R5;138update_2253 
Niacin transporter NiaP -2.74 A0A0H4P615 
Uncharacterized protein -2.86 A0A0H4PCL1;138update_0210 
Am m onium  transporter -2.96 A0A0H4P8F1;138update_3143 
 Acyl carrier protein -2.97 A0A0H4PFY0;138update_1451 
Uncharacterized protein -3.00 A0A0H4P2G9;138update_2772 
sulfatase -3.08 138update_3296;A0A0H4P7V3 
nitrile hydratase alpha /thiocyanate hydrolase gam m a -3.16 138update_1625 
nitrile hydratase beta subunit -3.28 138update_1624 
Hypothetical protein -3.30 138update_0518 
bacillithiol biosynthesis bshc -3.30 A0A0H4NZF9;138update_0188 
bacillithiol biosynthesis; Putative cysteine ligase -3.50 138update_1387;A0A0H4PFR9 
Alcohol dehydrogenase -3.58 A0A0H4P012;138update_0356 
Hypothetical protein -4.20 138update_3172 
nitrogen regulatory protein pii -4.66 138update_3142;A0A0H4PL50 
Supp. table 2. List of plasm ids constructed and/or used during this study, together with the prim er num bers and 
the PCR tem plates em ployed for their construction via Gibson assem bly. 
pTherm oCas9_Δach_sp1
Therm oCas9_ach_sp1 pTherm oCas9_ctrl[6]
BG11773
BG11774
ach_sp1_pNW33n backbone pTherm oCas9_ctrl[6]
BG11775
BG11776
ach Upstream region B. smithii ET138 genom e
BG11777
BG11778
ach Downstream region B. smithii ET138 genom e
BG11779
BG11780
pTherm oCas9_Δach_sp2
Therm oCas9_ach_sp2 pTherm oCas9_ctrl[6]
BG11773
BG11782
ach_sp2_pNW33n backbone pTherm oCas9_ctrl[6]
BG11781
BG11775
ach Upstream region B. smithii ET138 genom e
BG11777
BG11778
ach Downstream region B. smithii ET138 genom e
BG11779
BG11780
pTherm oCas9_Δach_sp3
Therm oCas9_ach_sp3 pTherm oCas9_ctrl[6]
BG11773
BG11784
ach_sp3_pNW33n backbone pTherm oCas9_ctrl[6]
BG11783
BG11775
ach Upstream region B. smithii ET138 genom e
BG11777
BG11778
ach Downstream region B. smithii ET138 genom e
BG11779
BG11780
pTherm oCas9_Δach_sp4
Therm oCas9_ach_sp4 pTherm oCas9_ctrl[6]
BG11773
BG11786
ach_sp4_pNW33n backbone pTherm oCas9_ctrl [6]
BG11785
BG11775
ach Upstream region B. smithii ET138 genom e
BG11777
BG11778
ach Downstream region B. smithii ET138 genom e
BG11779
BG11780
pTherm oCas9_Δach_sp1
Therm oCas9_acs_sp1 pTherm oCas9_ctrl [6]
BG11773
BG11796
acs_sp1_pNW33n backbone pTherm oCas9_ctrl[6]
BG11795
BG11775
acs Upstream region B. smithii ET138 genom e
BG11797
BG11798
acs Downstream region B. smithii ET138 genom e BG11799
BG11800
Plasmid 
Fragment for Gibson 
assembly 
PCR Template Primer No. 
pSpCas9_ ΔgapA::gapC 
gapA spacer_ pnw33N 
backbone 
pNW_spCas9 [12] 
BG9870 
BG9871 
gapA Upstream region B. smithii ET138 genome
BG9872 
BG9873 
gapC C. acetobutylicum genome
BG9874 
BG9875 
gapA Downstream region B. smithii ET138 genome
BG9876 
BG9877 
SpCas9_gapA spacer pNW_spCas9[12] 
BG9878 
BG9879 
8257
Exploring and enhancing the potential of B. smithii ET 138 as a green chemicals production platform organism
Name
Log 
Protein Protein IDs
Nucleotide-binding protein -2.48 A0A0H4NWM5;138update_0482
90kda heat shock protein signature -2.49 138update_1706
PTS system N-acetylglucosam ine-specific IIC com ponent -2.49 A0A0H4P0C5;138update_0458
Cell division topological determ inant MinJ -2.51 A0A0H4NYT1;138update_0447
Flagellar hook-associated protein 2 -2.54 A0A0H4NWH0;138update_0423
Two-com ponent response regulator SA14-24 -2.60 A0A0H4P812;138update_3353
Cell wall lytic activity -2.65 A0A0H4NYP2;138update_0396
DNA repair protein RecN -2.67 A0A0H4P1R5;138update_2253
Niacin transporter NiaP -2.74 A0A0H4P615
Uncharacterized protein -2.86 A0A0H4PCL1;138update_0210
Am m onium transporter -2.96 A0A0H4P8F1;138update_3143
Acyl carrier protein -2.97 A0A0H4PFY0;138update_1451
Uncharacterized protein -3.00 A0A0H4P2G9;138update_2772
sulfatase -3.08 138update_3296;A0A0H4P7V3
nitrile hydratase alpha /thiocyanate hydrolase gam m a -3.16 138update_1625
nitrile hydratase beta subunit -3.28 138update_1624
Hypothetical protein -3.30 138update_0518
bacillithiol biosynthesis bshc -3.30 A0A0H4NZF9;138update_0188
bacillithiol biosynthesis; Putative cysteine ligase -3.50 138update_1387;A0A0H4PFR9
Alcohol dehydrogenase -3.58 A0A0H4P012;138update_0356
Hypothetical protein -4.20 138update_3172
nitrogen regulatory protein pii -4.66 138update_3142;A0A0H4PL50
Supp. table 2. List of plasm ids constructed and/or used during this study, together with the prim er num bers and 
the PCR tem plates em ployed for their construction via Gibson assem bly.
Plasmid
Fragment for G ibson
assembly
PCR Template Primer No.
pSpCas9_ ΔgapA::gapC
gapA spacer_ pnw33N
backbone
pNW_spCas9 [12]
BG9870
BG9871
gapA Upstream region B. smithii ET138 genom e
BG9872
BG9873
gapC C. acetobutylicum genom e
BG9874
BG9875
gapA Downstream region B. smithii ET138 genom e
BG9876
BG9877
SpCas9_gapA spacer pNW_spCas9[12]
BG9878
BG9879
pThermoCas9_Δach_sp1 
ThermoCas9_ach_sp1 pThermoCas9_ctrl [6] 
BG11773 
BG11774 
ach_sp1_pNW33n backbone pThermoCas9_ctrl [6] 
BG11775 
BG11776 
ach Upstream region B. smithii ET138 genome
BG11777 
BG11778 
ach Downstream region B. smithii ET138 genome
BG11779 
BG11780 
pThermoCas9_Δach_sp2 
ThermoCas9_ach_sp2 pThermoCas9_ctrl [6] 
BG11773 
BG11782 
ach_sp2_pNW33n backbone pThermoCas9_ctrl[6] 
BG11781 
BG11775 
ach Upstream region B. smithii ET138 genome
BG11777 
BG11778 
ach Downstream region B. smithii ET138 genome
BG11779 
BG11780 
pThermoCas9_Δach_sp3 
ThermoCas9_ach_sp3 pThermoCas9_ctrl [6] 
BG11773 
BG11784 
ach_sp3_pNW33n backbone pThermoCas9_ctrl [6] 
BG11783 
BG11775 
ach Upstream region B. smithii ET138 genome
BG11777 
BG11778 
ach Downstream region B. smithii ET138 genome
BG11779 
BG11780 
pThermoCas9_Δach_sp4 
ThermoCas9_ach_sp4 pThermoCas9_ctrl [6] 
BG11773 
BG11786 
ach_sp4_pNW33n backbone pThermoCas9_ctrl [6] 
BG11785 
BG11775 
ach Upstream region B. smithii ET138 genome
BG11777 
BG11778 
ach Downstream region B. smithii ET138 genome
BG11779 
BG11780 
pThermoCas9_Δach_sp1 
ThermoCas9_acs_sp1 pThermoCas9_ctrl [6] 
BG11773 
BG11796 
acs_sp1_pNW33n backbone pThermoCas9_ctrl [6] 
BG11795 
BG11775 
acs Upstream region B. smithii ET138 genome
BG11797 
BG11798 
acs Downstream region B. smithii ET138 genome BG11799 
BG11800 
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BG9874 ATGGCAAAGATAGCTATTAATGGTTTTG
BG9875 AATTTCCAATATTCTTCAGTTTATACTATTTTGCTATTTTTGCAAAGTAAGC
BG9876 TATAAACTGAAGAATATTGGAAATTG
BG9877 attatcctcagctcactagcgccatATGTCTAAAGCTTCCCAATC
BG9878 ATGGCGCTAGTGAGCTG
BG9879 CGGTATGATGACAACCGTTCGTATAACGGTATCCATTTTAAGAATAATCC
BG11773 GAACATCCTCTTTCTTAGTTTG
BG11774 aacagcggtctcttcatccggcgGTATAACGGTATCCATTTTAAGAAT
BG11775 cgccggatgaagagaccgctgttGTCATAGTTCCCCTGAGATTATCG
BG11776 TCATGACCAAAATCCCTTAACGTG
BG11777 cacgttaagggattttggtcatgaGTAAACGTTCTTTTAAGCACGGAATC
BG11778 CAAAAATCCCCCCTTTGATTGTT
BG11779 aacaatcaaaggggggatttttgTAATTTTAAACTCCCGTTTCCAGACG
BG11780 caaactaagaaagaggatgttcATCGTGCAGATTATGATTACTCTGTC
BG11781 ctattcaatcagggatcggatccGTCATAGTTCCCCTGAGATTATCG
BG11782 ggatccgatccctgattgaatagGTATAACGGTATCCATTTTAAGAAT
BG11783 tccggatcaagaggaatgccgatGTCATAGTTCCCCTGAGATTATCG
BG11784 atcggcattcctcttgatccggaGTATAACGGTATCCATTTTAAGAAT
BG11785 cgtcttgaagaacttcagaatatGTCATAGTTCCCCTGAGATTATCG
BG11786 atattctgaagttcttcaagacgGTATAACGGTATCCATTTTAAGAAT
BG11795 aagatgagacacatatcgactttGTCATAGTTCCCCTGAGATTATCG
BG11796 aaagtcgatatgtgtctcatcttGTATAACGGTATCCATTTTAAGAAT
pThermoCas9_Δach_sp2 
ThermoCas9_acs_sp2 pThermoCas9_ctrl [6] 
BG11773 
BG11802 
acs_sp2_pNW33n backbone pThermoCas9_ctrl [6] 
BG11801 
BG11775 
acs Upstream region B. smithii ET138 genome
BG11797 
BG11798 
acs Downstream region B. smithii ET138 genome
BG11799 
BG11800 
pThermoCas9_Δach_sp3 
ThermoCas9_acs_sp3 pThermoCas9_ctrl [6] 
BG11773 
BG11804 
acs_sp3_pNW33n backbone pThermoCas9_ctrl [6] 
BG11803 
BG11775 
acs Upstream region B. smithii ET138 genome
BG11797 
BG11798 
acs Downstream region B. smithii ET138 genome
BG11799 
BG11800 
pThermoCas9_Δach_sp4 
ThermoCas9_acs_sp4 pThermoCas9_ctrl [6] 
BG11773 
BG11806 
acs_sp4_pNW33n backbone pThermoCas9_ctrl 
BG11805 
BG11775 
acs Upstream region B. smithii ET138 genome
BG11797 
BG11798 
acs Downstream region B. smithii ET138 genome
BG11799 
BG11800 
pNW_PM [8] 
Supp. table 3. Sequences of the primers used for the plasmid construction processes. 
Primer No. Sequence 
BG9870 GAACGGTTGTCATCATACCGGTTTTAGAGCTAGAAATAGCAAG 
BG9871 TCATGACCAAAATCCCTTAAC 
BG9872 tcacgttaagggattttggtcatgaGTACCAGACCTGCTGCAAATC 
BG9873 AACCATTAATAGCTATCTTTGCCATTTTAAAAATTCCTCCTTCATAG 
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pTherm oCas9_Δach_sp2
Therm oCas9_acs_sp2 pTherm oCas9_ctrl[6]
BG11773
BG11802
acs_sp2_pNW33n backbone pTherm oCas9_ctrl[6]
BG11801
BG11775
acs Upstream region B. smithii ET138 genom e
BG11797
BG11798
acs Downstream region B. smithii ET138 genom e
BG11799
BG11800
pTherm oCas9_Δach_sp3
Therm oCas9_acs_sp3 pTherm oCas9_ctrl[6]
BG11773
BG11804
acs_sp3_pNW33n backbone pTherm oCas9_ctrl [6]
BG11803
BG11775
acs Upstream region B. smithii ET138 genom e
BG11797
BG11798
acs Downstream region B. smithii ET138 genom e
BG11799
BG11800
pTherm oCas9_Δach_sp4
Therm oCas9_acs_sp4 pTherm oCas9_ctrl [6]
BG11773
BG11806
acs_sp4_pNW33n backbone pTherm oCas9_ctrl
BG11805
BG11775
acs Upstream region B. smithii ET138 genom e
BG11797
BG11798
acs Downstream region B. smithii ET138 genom e
BG11799
BG11800
pNW_PM [8]
Supp. table 3. Sequences of the prim ers used for the plasm id construction processes.
Primer No. Sequence
BG9870 GAACGGTTGTCATCATACCGGTTTTAGAGCTAGAAATAGCAAG
BG9871 TCATGACCAAAATCCCTTAAC
BG9872 tcacgttaagggattttggtcatgaGTACCAGACCTGCTGCAAATC
BG9873 AACCATTAATAGCTATCTTTGCCATTTTAAAAATTCCTCCTTCATAG
Primer No. Sequence 
BG9874 ATGGCAAAGATAGCTATTAATGGTTTTG 
BG9875 AATTTCCAATATTCTTCAGTTTATACTATTTTGCTATTTTTGCAAAGTAAGC 
BG9876 TATAAACTGAAGAATATTGGAAATTG 
BG9877 attatcctcagctcactagcgccatATGTCTAAAGCTTCCCAATC 
BG9878 ATGGCGCTAGTGAGCTG 
BG9879 CGGTATGATGACAACCGTTCGTATAACGGTATCCATTTTAAGAATAATCC 
BG11773 GAACATCCTCTTTCTTAGTTTG 
BG11774 aacagcggtctcttcatccggcgGTATAACGGTATCCATTTTAAGAAT 
BG11775 cgccggatgaagagaccgctgttGTCATAGTTCCCCTGAGATTATCG 
BG11776 TCATGACCAAAATCCCTTAACGTG 
BG11777 cacgttaagggattttggtcatgaGTAAACGTTCTTTTAAGCACGGAATC 
BG11778 CAAAAATCCCCCCTTTGATTGTT 
BG11779 aacaatcaaaggggggatttttgTAATTTTAAACTCCCGTTTCCAGACG 
BG11780 caaactaagaaagaggatgttcATCGTGCAGATTATGATTACTCTGTC 
BG11781 ctattcaatcagggatcggatccGTCATAGTTCCCCTGAGATTATCG 
BG11782 ggatccgatccctgattgaatagGTATAACGGTATCCATTTTAAGAAT 
BG11783 tccggatcaagaggaatgccgatGTCATAGTTCCCCTGAGATTATCG 
BG11784 atcggcattcctcttgatccggaGTATAACGGTATCCATTTTAAGAAT 
BG11785 cgtcttgaagaacttcagaatatGTCATAGTTCCCCTGAGATTATCG 
BG11786 atattctgaagttcttcaagacgGTATAACGGTATCCATTTTAAGAAT 
BG11795 aagatgagacacatatcgactttGTCATAGTTCCCCTGAGATTATCG 
BG11796 aaagtcgatatgtgtctcatcttGTATAACGGTATCCATTTTAAGAAT 
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BG11797 cacgttaagggattttggtcatgaCGATGTATTTTCCATAATCACGCAAG 
BG11798 tagttcgaaatcgttgtttcattgtc 
BG11799 gacaatgaaacaacgatttcgaactaCATTTGACCGATTCCCCCTTTC 
BG11800 caaactaagaaagaggatgttcTGAAGTGCATCTCGAATTGAAGC 
BG11801 tattcggaccttggttaatgggaGTCATAGTTCCCCTGAGATTATCG 
BG11802 tcccattaaccaaggtccgaataGTATAACGGTATCCATTTTAAGAAT 
BG11803 cacaatcacgttggatgctcccaGTCATAGTTCCCCTGAGATTATCG 
BG11804 tgggagcatccaacgtgattgtgGTATAACGGTATCCATTTTAAGAAT 
BG11805 tgtgtctcatcttcttgaatatcGTCATAGTTCCCCTGAGATTATCG 
BG11806 gatattcaagaagatgagacacaGTATAACGGTATCCATTTTAAGAAT 
Supp. table 4. List of primers used in this study for sequence verification of the employed editing plasmids. 
Sequencing target 
Primer 
No 
Sequence 
pSpCas9_ΔgapA::gapC 
BG8478 TATTTACGTTGACGAATCTTG 
BG9216 AGGGCTCGCCTTTGGGAAG 
BG9874 ATGGCAAAGATAGCTATTAATGGTTTTG 
BG9875 
AATTTCCAATATTCTTCAGTTTATACTATTTTGCTATTTT
TGCAAAGTAAGC 
BG8487 GTATTTCCCAGAACCTTGAAC 
BG8472 GGAAATACAGACCGCCACAG 
Commo n for 
pTherm oCas9_Δach_sp1-4 
& 
pTherm oCas9_Δacs_sp1-4 
BG3664 AGGGCTCGCCTTTGGGAAG 
BG6769 CAATCCAACTGGGCTTGAC 
BG6840 TTGCAGAAATGGTTGTCAAG 
BG6841 CAAGAACTTTATTGGTATAG 
BG11773 GAACATCCTCTTTCTTAGTTTG 
Commo n for 
pTherm oCas9_Δach_sp1-4 
BG11778 CAAAAATCCCCCCTTTGATTGTT 
BG11779 aacaatcaaaggggggatttttgTAATTTTAAACTCCCGTTTCCAGACG 
BG11780 caaactaagaaagaggatgttcATCGTGCAGATTATGATTACTCTGTC 
pTherm oCas9_Δach_sp1 BG11774
aacagcggtctcttcatccggcgGTATAACGGTATCCATTTTAAGAA
T 
pTherm oCas9_Δach_sp2 BG11782
ggatccgatccctgattgaatagGTATAACGGTATCCATTTTAAGAA
T 
pTherm oCas9_Δach_sp3 BG11784 atcggcattcctcttgatccggaGTATAACGGTATCCATTTTAAGAAT
pTherm oCas9_Δach_sp4 BG11786 atattctgaagttcttcaagacgGTATAACGGTATCCATTTTAAGAAT
Commo n for
pTherm oCas9_Δacs_sp1-4
BG11798 tagttcgaaatcgttgtttcattgtc
BG11799 gacaatgaaacaacgatttcgaactaCATTTGACCGATTCCCCCTTTC
BG11800 caaactaagaaagaggatgttcTGAAGTGCATCTCGAATTGAAGC
pTherm oCas9_Δacs_sp1 BG11796 aaagtcgatatgtgtctcatcttGTATAACGGTATCCATTTTAAGAAT
pTherm oCas9_Δacs_sp2 BG11802
tcccattaaccaaggtccgaataGTATAACGGTATCCATTTTAAGAA
T 
pTherm oCas9_Δacs_sp3 BG11804
tgggagcatccaacgtgattgtgGTATAACGGTATCCATTTTAAGAA
T 
pTherm oCas9_Δacs_sp4 BG11806
gatattcaagaagatgagacacaGTATAACGGTATCCATTTTAAGAA
T 
Supp. table 5. List of prim ers used in this study for gene deletion or substitution PCR checks.
Sequencing target Primer No Sequence
ΔgapA::gapC m utant
confirm ation
BG10051 TTCACTAACGCCGTACCTG
BG10052 CTTCACGATATTTTTTGCTTGTTTC
Δach m utant confirm ation
BG11834 GTATCCAGCATCCTTATGGC
BG11835 TGCTACAGCAATGCTACTG
BG12128 GTCAGCCAAACGTACGCTAG
BG12129 CGGAGTAACAAAAGCGTATTTGGC
Δacs m utant confirm ation
BG11836 TCGTTAAACCATACGCTTTTGC
BG11837 GTTTGCCGTCTTGGACAATG
BG12130 GGCTTTTCCACGATTCATTTGTC
BG12131 CCCGAGCGATGATAATTCTTCC 
Supp. table 6. List of plasm id specific prim ers used in this study for plasm id curing PCR checks. 
Sequencing target
Primer 
No
Sequence
Spcas9 gene
BG8473 ATCTCATTGCTTTGTCATTG
BG8485 CCTTTATCGACAACTTCTTC
Thermocas9 gene
BG8196 ATGAAGTATAAAATCGGTCTTG
BG8197 TAACGGACGGATAGTTTC
8261
Exploring and enhancing the potential of B. smithii ET 138 as a green chemicals production platform organism
Primer No. Sequence
BG11797 cacgttaagggattttggtcatgaCGATGTATTTTCCATAATCACGCAAG
BG11798 tagttcgaaatcgttgtttcattgtc
BG11799 gacaatgaaacaacgatttcgaactaCATTTGACCGATTCCCCCTTTC
BG11800 caaactaagaaagaggatgttcTGAAGTGCATCTCGAATTGAAGC
BG11801 tattcggaccttggttaatgggaGTCATAGTTCCCCTGAGATTATCG
BG11802 tcccattaaccaaggtccgaataGTATAACGGTATCCATTTTAAGAAT
BG11803 cacaatcacgttggatgctcccaGTCATAGTTCCCCTGAGATTATCG
BG11804 tgggagcatccaacgtgattgtgGTATAACGGTATCCATTTTAAGAAT
BG11805 tgtgtctcatcttcttgaatatcGTCATAGTTCCCCTGAGATTATCG
BG11806 gatattcaagaagatgagacacaGTATAACGGTATCCATTTTAAGAAT
Supp. table 4. List of primers used in this study for sequence verification of the em ployed editing plasm ids.
Sequencing target
Primer 
No
Sequence
pSpCas9_ΔgapA::gapC
BG8478 TATTTACGTTGACGAATCTTG
BG9216 AGGGCTCGCCTTTGGGAAG
BG9874 ATGGCAAAGATAGCTATTAATGGTTTTG
BG9875
AATTTCCAATATTCTTCAGTTTATACTATTTTGCTATTTT
TGCAAAGTAAGC
BG8487 GTATTTCCCAGAACCTTGAAC
BG8472 GGAAATACAGACCGCCACAG
Commo n for
pTherm oCas9_Δach_sp1-4 
& 
pTherm oCas9_Δacs_sp1-4
BG3664 AGGGCTCGCCTTTGGGAAG 
BG6769 CAATCCAACTGGGCTTGAC
BG6840 TTGCAGAAATGGTTGTCAAG
BG6841 CAAGAACTTTATTGGTATAG
BG11773 GAACATCCTCTTTCTTAGTTTG
Commo n for
pTherm oCas9_Δach_sp1-4
BG11778 CAAAAATCCCCCCTTTGATTGTT
BG11779
aacaatcaaaggggggatttttgTAATTTTAAACTCCCGTTTCCAGAC
G 
BG11780
caaactaagaaagaggatgttcATCGTGCAGATTATGATTACTCTGT
C 
pTherm oCas9_Δach_sp1 BG11774 aacagcggtctcttcatccggcgGTATAACGGTATCCATTTTAAGAAT 
pTherm oCas9_Δach_sp2 BG11782 ggatccgatccctgattgaatagGTATAACGGTATCCATTTTAAGAAT 
pTherm oCas9_Δach_sp3 BG11784 atcggcattcctcttgatccggaGTATAACGGTATCCATTTTAAGAAT 
pTherm oCas9_Δach_sp4 BG11786 atattctgaagttcttcaagacgGTATAACGGTATCCATTTTAAGAAT 
Common for 
pThermoCas9_Δacs_sp1-4 
BG11798 tagttcgaaatcgttgtttcattgtc 
BG11799 gacaatgaaacaacgatttcgaactaCATTTGACCGATTCCCCCTTTC 
BG11800 caaactaagaaagaggatgttcTGAAGTGCATCTCGAATTGAAGC 
pTherm oCas9_Δacs_sp1 BG11796 aaagtcgatatgtgtctcatcttGTATAACGGTATCCATTTTAAGAAT 
pTherm oCas9_Δacs_sp2 BG11802 tcccattaaccaaggtccgaataGTATAACGGTATCCATTTTAAGAAT 
pTherm oCas9_Δacs_sp3 BG11804 tgggagcatccaacgtgattgtgGTATAACGGTATCCATTTTAAGAAT 
pTherm oCas9_Δacs_sp4 BG11806 gatattcaagaagatgagacacaGTATAACGGTATCCATTTTAAGAAT 
Supp. table 5. List of prim ers used in this study for gene deletion or substitution PCR checks. 
Sequencing target Primer No Sequence 
ΔgapA::gapC m utant 
confirm ation 
BG10051 TTCACTAACGCCGTACCTG 
BG10052 CTTCACGATATTTTTTGCTTGTTTC 
Δach m utant confirm ation 
BG11834 GTATCCAGCATCCTTATGGC 
BG11835 TGCTACAGCAATGCTACTG 
BG12128 GTCAGCCAAACGTACGCTAG 
BG12129 CGGAGTAACAAAAGCGTATTTGGC 
Δacs m utant confirm ation 
BG11836 TCGTTAAACCATACGCTTTTGC 
BG11837 GTTTGCCGTCTTGGACAATG 
BG12130 GGCTTTTCCACGATTCATTTGTC 
BG12131 CCCGAGCGATGATAATTCTTCC 
Supp. table 6. List of plasm id specific prim ers used in this study for plasm id curing PCR checks. 
Sequencing target 
Primer 
No 
Sequence 
Spcas9 gene 
BG8473 ATCTCATTGCTTTGTCATTG 
BG8485 CCTTTATCGACAACTTCTTC 
Thermocas9 gene 
BG8196 ATGAAGTATAAAATCGGTCTTG 
BG8197 TAACGGACGGATAGTTTC 
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Chapter 3 describes the development of the first SpCas9-based genome editing tool for a 
moderate thermophilic bacterium, namely Bacillus smithii ET 138. It is demonstrated that 
SpCas9 is in vivo inactive at temperatures above 42 °C and the wide growth temperature 
range of B. smithii ET 138 is employed for controllable induction of SpCas9 expression at 
temper atures below the 42°C threshold. Plasmid-bor ne editing templates are employed for 
homologous recombination (HR)-based introduction of the desired modifications to the 
genome of B. smitiii ET 138 at 45–55 °C. Transfer of the cultures to 37 °C induces the 
expression of active spCas9 from the same plasmid that carries the HR-templates. 
Subsequently, spCas9-based introduces lethal double-stranded DNA breaks to the non-edited 
cells, acting as a counter-selection mechanism. The developed method resulted in rapid 
and highly efficient genome editing applications on the B. smithii ET 138 genome, 
including the deletion of the pyrF (Orotidine 5'-phosphate decarboxylase) gene, knockout 
-via premature stop codons insertion- of the hsdR ( Type I restriction enzyme R Protein) 
gene and insertion of the ldhL (L-lactate dehydrogenase) gene back in the genome of a B. 
smithii ET 138 ΔldhL mutant strain.  
The development of a spCas9-based genome editing tool for the biotechnologically relevant 
α-proteobacterium Rhodobacter sphaeroides is described in chapter 4. A highly 
efficient SpCas9-based targeting system is established for R. sphaeroides and it is 
subsequently combined with HR from plasmid-borne templates for gene deletions, 
insertions, as well as for single nucleotide substitution with high efficiencies. 
Additionally, this study further investigates the unique NHEJ mechanism of R. 
sphaeroides , that is comprised of one LigD and two Ku homologs. The SpCas9-based 
targeting system is combined with the native R. sphaeroides NHEJ system resulting 
in indel formations with efficiencies of up to 20%. Moreover, it is demonstrated the 
activity of the R. sphaeroides NHEJ mechanism is based on the LigD and not on the 
predicted Ku homologs, strongly suggesting the existence of an unprecedented bacterial 
NHEJ system.  
The first aim of chapter 5 is to describe the characterization of the Cas9 orthologue from the 
type II-C CRISPR-Cas system of the thermophilic bacterium Geobacillus 
thermodenitrificans T12 ThermoCas9. It is demonstrated that ThermoCas9 is in vitro active 
between 20 and 70 °C, has strict PAM-preference at the lower temperatures range, does not 
tolerate extensive spacer-protospacer mismatches, the structure of its sgRNA 
influences its activity at elevated temp eratures and it cleaves more efficientlysuper-
THESIS SUMMARY
The global demand on chemicals and fuels is exponentially increasing. At the same time, the 
excessive exploitation of fossil-based resources for the coverage of this demand has a high 
environmental impact, motivating the production of green chemicals and biofuels from 
renewable resources. As described in chapter 1, the biotechnological potential of microbes 
for the production of food, beverages and –to a lesser extent- chemicals have been exploited 
throughout the human history. The last decades, the emerge of synthetic biology tools as well 
as of efficient, cost- and time-effective genome engineering tools, allowed the conduction of 
high-throughput microbial metabolic engineering studies that lead to the development of 
microbial platforms with high production capacities for green chemicals and biofuels. The 
genome engineering tools that brought a real revolution to the field of metabolic engineering 
are based predominantly on the RNA-guided DNA-endonuclease of the type II-A CRISPR-
Cas adaptive immune system of Streptococcus pyogenes, namely SpCas9. This thesis mainly 
focused on the development of genetic tools and novel CRISPR-Cas9-based and 
antiCRISPR-based genome engineering tools for model and non-model mesophilic and 
thermophilic bacteria. Consequently, some of these tools were further employed for studying 
the metabolism and the biotechnological potential of the moderate thermophilic bacterium 
Bacillus smithii ET 138. 
Chapter 2 reviews the first generation of CRISPR-Cas-based engineering tools, which is 
extensively used till date for genome editing as well as transcriptional silencing of both 
model and non-model prokaryotes. In this generation of editing tools, Cas9 endonucleases 
(more frequently the one originating from the type II-A CRISPR-Cas system of S. pyogenes, 
namely SpCas9) are combined either with plasmid-borne homologous recombination 
templates or recombineering systems (for the case of model organisms with already 
developed such systems), or more rarely with non-homologous end joining (NHEJ) systems, 
for gene deletions, gene insertions or nucleotide substitutions. Moreover, this chapter reviews 
the first generation of CRISPR-Cas transcriptional downregulation applications that 
employed either the catalytically inactive (“dead”) SpdCas9 variant or a native type I 
CRISPR-Cas system lacking the Cas3 nuclease component. Additionally, it is underlined the 
importance of characterizing novel CRISPR-Cas systems, aiming to increase the engineering 
throughput and develop CRISPR-Cas applications for a wider variety of bacteria. Finally, a 
short overview of the in silico, in vitro and  in vivo PAM identification approaches is 
provided. 
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temperatures below the 42°C threshold. Plasmid-borne editing templates are employed for 
homologous recombination (HR)-based introduction of the desired modifications to the 
genome of B. smitiii ET 138 at 45–55 °C. Transfer of the cultures to 37 °C induces the 
expression of active spCas9 from the same plasmid that carries the HR-templates. 
Subsequently, spCas9-based introduces lethal double-stranded DNA breaks to the non-edited 
cells, acting as a counter-selection mechanism. The developed method resulted in rapid and 
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SpCas9-based targeting system is established for R. sphaeroides and it is subsequently 
combined with HR from plasmid-borne templates for gene deletions, insertions, as well as for 
single nucleotide substitution with high efficiencies. Additionally, this study further 
investigates the unique NHEJ mechanism of R. sphaeroides, that is comprised of one LigD 
and two Ku homologs. The SpCas9-based targeting system is combined with the native R. 
sphaeroides NHEJ system resulting in indel formations with efficiencies of up to 20%. 
Moreover, it is demonstrated the activity of the R. sphaeroides NHEJ mechanism is based on 
the LigD and not on the predicted Ku homologs, strongly suggesting the existence of an 
unprecedented bacterial NHEJ system.  
The first aim of chapter 5 is to describe the characterization of the Cas9 orthologue from the 
type IIc CRISPR-Cas system of the thermophilic bacterium Geobacillus thermodenitrificans 
T12 ThermoCas9. It is demonstrated that ThermoCas9 is in vitro active between 20-70 °C, 
has strict PAM-preference at the lower temperatures range, does not tolerate extensive 
spacer-protospacer mismatches, the structure of its sgRNA influences its activity at elevated 
temperatures and it cleaves more efficiently supercoiled-plasmid DNA compared to linear 
DNA. The in vitro characterization data are further employed for the development of Thermo
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gene by the NADP+-dependent gapC gene from Clostridium acetobutylicum ATCC 824. 
The substitution was performed in the genome of the B. smithii ET 138 ΔldhL strain, it 
aimed to relieve its NAD+ deficiency under oxygen-limited culturing conditions, and it 
resulted in moderate growth enhancement. The ThermoCas9-based genome editing tool was 
employed for the deletion of the acetyl-CoA synthetase (acs) and acetyl-CoA hydrolase (ach) 
genes, aiming to reveal the non-canonical acetate production pathway of B. smithii ET 138. 
Nonetheless, none of these deletions affected the acetate production. Moreover, B. smithii
ET 138 was cultured under oxygen rich conditions, at a wide temperatures (between 37°C 
and 55°C), aiming to investigate the influence of the growth temperature on its production 
profile. Strikingly, acetate production was completely abolished when culturing at 37°C, 
while it was maximum at 55°C. Comparative proteomics between cultures grown at these 
two temperatures did not provide clear information about the acetate production pathway. 
Finally, a B. smithii ET 138 strain, transformed with a plasmid overexpressing the native 
pyruvate carboxylase (pyc) and the malate dehydrogenase(mdh) genes, was cultured at 50°C 
and produced the highest reported amounts of dicarboxylic acids while keeping low the 
acetate production levels.
Cas9-based engineering tools for gene deletion (pyrF) and transcriptional silencing 
(ldhL) at 55 °C in B. smithii ET 138 and for gene deletion (pyrF) at 37 °C in 
Pseudomonas putida. This is one of the first reports that provides fundamental insights into 
a thermophilic CRISPR-Cas family member and the first report that establishes Cas9-based 
bacterial genome engineering at temperatures above 42°C. 
The potential to harness the activity of an antiCRISPR proteins for genome engineering 
purposes is examined in Chapter 6 of this thesis. The antiCRISPR protein from Neisseria 
meningitidis (AcrIIC1Nme) is employed as "on/off-switch" of the thermo-active Cas9 
orthologues from Geobacillus thermodenitrificans T12 (ThermoCas9) and 
Geobacillus stearothermophilus (GeoCas9). Initially it is demonstrated that both 
ThermoCas9 and GeoCas9 can introduce lethal dsDNA breaks in E. coli at 37°C in a 
tunable and spacer-dependent manner. Consequently it is demonstrated that AcrIIC1Nme 
traps both tested Cas9 orthologues in a DNA-bound, catalytically inactive state. The Cas9/
AcrIIC1Nme complexes can promote a transcriptional silencing effect with efficiency 
comparable to the catalytically "dead" Thermo-dCas9 and Geo-dCas9 variants. Finally, this 
chapter describes the construction of the first reported single-vector, tightly controllable and 
highly efficient Cas9/AcrIIC1Nme-based tool for coupled silencing and targeting in bacteria 
that could be further employed for genome editing and transcriptional regulation of 
academically and industrially relevant bacteria. 
The number of metabolic engineering studies on model and non-model prokaryotes, towards 
the production of green chemicals and biofuels, that make use of CRISPR-Cas-based 
engineering technologies are exponentially increasing the last years. Chapter 7 reviews these 
studies and justifies that the characterisation of novel CRISPR-Cas systems from diverse 
environments is crucial for the extension of CRISPR-Cas-based engineering applications to 
previously unexploited non-model organisms that inhabit harsh environments (extreme 
temperatures, pH, salt concentrations etc.) but have great biotechnological potential. 
The work performed during this thesis on studying the metabolism of B. smithii ET 138, as 
well as on enhancing its production capacity in dicarboxylic acids, is presented in Chapter 8. 
The SpCas9- based genome editing tool, which was described in chapter 3, was employed for 
the substitution of the native NAD+-dependent glyceraldehyde-3P dehydrogenase (gapA) 
gene by the NADP+-dependent gapC gene from Clostridium acetobutylicum ATCC 824. The 
substitution was performed in the genome of the B. smithii ET 138 ΔldhL strain, it aimed to
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stearothermophilus (GeoCas9). Initially it is demonstrated that both ThermoCas9 and 
GeoCas9 can introduce lethal dsDNA breaks in E. coli at 37°C in a tunable and spacer-
dependent manner. Consequently it is demonstrated that AcrIIC1Nme traps both tested Cas9 
orthologues in a DNA-bound, catalytically inactive state. The Cas9/AcrIIC1Nme complexes 
can promote a transcriptional silencing effect with efficiency compar able to the catalytically 
"dead" Thermo-dCas9 and Geo-dCas9 variants. Finally, this chapter describes the 
construction of the first reported single-vector, tightly controllable and highly efficient 
Cas9/AcrIIC1Nm e-based tool for coupled silencing and targeting in bacteria that could be 
further employed for genome editing and transcriptional regulation of academically and 
industrially relevant bacteria. 
The number of metabolic engineering studies on model and non-model prokaryotes, 
towards the production of green chemicals and biofuels, that make use of CRISPR-
Cas-based engineering technologies are exponentially increasing the last years. Chapter 7
reviews these studies and justifies that the characterisation of novel CRISPR-Cas 
systems from diverseenvironments is crucial for the extension of CRISPR-Cas-based 
engineering applications to previously unexploited non-model organisms that inhabit 
harsh environments (extreme temperatures, pH, salt concentrations etc.) but have great 
biotechnological potential. 
The work performed during this thesis on studying the metabolism of B. smithii ET 138, as 
well as on enhancing its production capacity in dicarboxylic acids, is presented in Chapter 
8. The SpCas9- based genome editing tool, which was described in chapter 3, was employed
for the substitution of the native NAD+-dependent glyceraldehyde-3P dehydrogenase (gapA)
relieve its NAD+ deficiency under oxygen-limited culturing conditions, and it resulted in 
moderate growth enhancement. The ThermoCas9-based genome editing tool was employed 
for the deletion of the acetyl-CoA synthetase (acs) and acetyl-CoA hydrolase (ach) genes, 
aiming to reveal the non-canonical acetate production pathway of B. smithii ET 138. 
Nonetheless, none of these deletions affected the acetate production.  Moreover, B. 
smithii ET 138 was cultured under oxygen rich conditions, at a wide temperatures 
(between 37°C and 55°C), aiming to investigate the influence of the growth temperature 
on its production profile. Strikingly, acetate production was completely abolished 
when culturing at 37°C, while it was maximum at 55°C. Comparative proteomics between 
cultures grown at these two temperatures did not provide clear information about the acetate 
production pathway. Finally, a B. smithii ET 138 strain, transformed with a plasmid 
overexpressing the native pyruvate carboxylase (pyc) and the malate dehydrogenase 
(mdh) genes, was cultured at 50°C and produced the highest reported amounts of 
dicarboxylic acids while keeping low the acetate production levels.
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to possess an active DNA-uptake machinery9,10. During conjugation, DNA (usually in 
the form of a conjugative plasmid) is transferred from a “donor” to a “recipient” cells via 
pili-mediated direct contact11. This process is commonly employed by bacteria in nature for 
genetic information exchange, resulting in the spread of features, like stress tolerance12, 
antibiotic resistance13,14, proteolytic activity and carbohydrate utilization systems15, 
between bacterial strains. Moreover, all conjugative plasmids code for the enzymatic 
machinery responsible for the conjugation and some encode anti-restriction proteins 
to circumvent the cellular R/M systems16. Conjugative plasmids have been 
extensively used for heterologous expression and genome engineering purposes, 
including Rhodobacter sphaeroides as described in Chapter 4 of this thesis. 
Nonetheless, conjugation is a process restricted to conditions compatible with the 
donor strain, and host factors influencing conjugation are still poorly understood17. 
The microorganisms used during the course of this thesis were genetically accessible 
via previously established protocols; Pseudomonas putida KT2440[18] and Bacillus smithii 
ET 1387 are electro-transformable strains, while Rhodobacter sphaeroides ATC 3505319 is 
genetically accessible via conjugation. In this thesis, the work to improve transformation 
efficiencies was limited to B. smithii ET 138. In chapter 3 the hsdR gene, which codes for 
the only restriction enzyme expressed in B. smithii ET 138, was deleted from the genome of 
the sporulation-deficient B. smithii ET 138 ΔsigF strain. The resulting B. smithii ET 138 
ΔsigF ΔhsdR strain was extensively used in this thesis and even though the hsdR deletion 
did not improve the previously reported maximum transformation efficiency (in CFU/μgof 
transforming DNA) fora B. smithii ET 138 strain, the B. smithii ET 138 ΔsigF ΔhsdR strain 
was efficiently transformable with any pNW33n-based and pG2K-based construct of size up 
to -at least- 12.5 kb, without sequence limitations that were an obstacle prior to removal of 
the hsdR. This result facilitated the rapid and efficient realization of genome engineering
experiment, which was not possible for the wild type B. smithii ET 138 strain.
2) G ENETIC TO O LBO XES
Since 1973, when the first transformation of E. coli with a plasmid vector took place20, a
wide variety of genetic tools has been developed for bacterial engineering, aiming to
facilitate both fundamental research and metabolic engineering for strain development
purposes. Amongst these tools belong: i) replicating or integrative vectors, employed for
single genes and/or pathway expression and genome engineering purposes, ii)
constitutive or inducible promoters, employed for the continuous or controlled
transcription of associated genes, iii)
General Discussion 
The exploitation of the biotechnological potential of non-model microorganisms could 
accelerate the transition to a green economy. This potential resides in the natural ability of 
microbes to produce valuable molecules1,2, to tolerate harsh production conditions3, to 
communicate with other microbes4 and/or consume specific carbon sources5. The extent of 
metabolic engineering experiments on non-model microorganisms is restricted by their 
underdeveloped molecular/synthetic biology and genome engineering toolboxes, especially 
when compared to model microorganisms. The predominant bottlenecks that hamper 
metabolic engineering of non-model organisms are:  
1. the low genetic accessibility (transformation efficiency) of the vast majority of
the microorganisms
2. the lack of extensive genetic toolboxes*
3. the inefficient and time-consuming genome editing and transcriptional silencing tools*
4. the limited understanding of their metabolism
*Note that even though the genetic engineering tools are, by definition, included in the genetic toolbox of an organism, 
here it was decided that the independent analysis of the engineering tools would facilitate the flow of this discussion.
In the course of this thesis, this set of bottlenecks has been evaluated and 
addressed in experiments aiming to overcome them and to metabolically engineer B. smithii 
ET 138. This last chapter aims to further reflect on these bottlenecks and the results obtained 
regarding them, as well as to discuss several additional experiments and place the data in a 
broader context. 
1) GENETIC ACCESSIBILITY
The first step in bacterial genome engineering processes is to evaluate its genetic accessibility
by establishing a protocol for efficient introduction of exogenous DNA (generally in the form
of a plasmid). This is commonly achieved either via transformation or via conjugation. During
transformation, DNA is transferred from the extracellular space through the cell envelop either
through induced disruption by electrical or chemical means, or via the native DNA-uptake
systems (natural competence)6. Nonetheless, the process to establish a reliable transformation
protocol for a microorganism is strain-specific, labor-intensive and commonly based on a trial-
and-error approach7,8. Moreover, the existence of efficient restriction and modification (R/M)
systems in the majority of the microorganisms may severely reduce transformation
efficiencies, as also observed in Chapter 3 of this thesis. As for transformation approaches that
are based on natural competence, these are restricted to the low number of bacterial strains de-
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G eneral Discussion
The exploitation of the biotechnological potential of non-model microorganisms 
could accelerate the transition to a green economy. This potential resides in the natural 
ability of microbes to produce valuable molecules1,2, to tolerate harsh production 
conditions3, to communicate with other microbes4 and/or consume specific carbon 
sources5. The extent of metabolic engineering experiments on non-model 
microorganisms is restricted by their underdeveloped molecular/synthetic biology and 
genome engineering toolboxes, especially when compared to model microorganisms. The 
predominant bottlenecks that hamper metabolic engineering of non-model organisms are:  
1. the low genetic accessibility (transformation efficiency) of the vast majority of 
the microorganisms
2. the lack of extensive genetic toolboxes*
3. the inefficient and time-consuming genome editing and transcriptional silencing tools*
4. the limited understanding of their metabolism
*Note that even though the genetic engineering tools are, by definition, included in the genetic toolbox of an organism, 
here it was decided that the independent analysis of the engineering tools would facilitate the flow of this discussion.
In the course of this thesis, this set of bottlenecks has been evaluated and addressed 
in experiments aiming to overcome them and to metabolically engineerB. smithii ET 138. 
This last chapter aims to further reflect on these bottlenecks and the results obtained 
regarding them, as well as to discuss several additional experimen ts and place the data in a 
broader context. 
1) G ENETIC ACCESSIBILITY
The first step in bacterial genome engineering processes is to evaluate its genetic 
accessibility by establishing a protocol for efficient introduction of exogenous DNA 
(generally in the form of a plasmid). This is commonly achieved either via transformation or 
via conjugation. During transformation, DNA is transferred from the extracellular space 
through the cell envelop either through induced disruption by electrical or chemical 
means, or via the native DNA-uptake systems (natural competence)6. Nonetheless, the 
process to establish a reliable transformation protocol for a microorganism is strain-
specific, labor-intensive and commonly based on a trial-and-error approach7,8. Moreover, 
the existence of efficient restriction and modification (R/M) systems in the majority of 
the microorganisms may severely reduce transformation efficiencies, as also observed in 
Chapter 3 of this thesis. As for transformation approaches that are based on natural 
competence, these are restricted to the low number of bacterial strains demonstrated to
monstrated to possess an active DNA-uptake machinery9,10. During conjugation, 
DNA (usually in the form of a conjugative plasmid) is transferred from a “donor” to a 
“recipient” cells via pili-mediated direct contact11. This process is commonly employed 
by bacteria in nature for genetic information exchange, resulting in the spread of 
features, like stress tolerance12, antibiotic resistance13,14, proteolytic activity and 
carbohydrate utilization systems15, between bacterial strains. Moreover, all 
conjugative plasmids code for the enzymatic machinery responsible for the 
conjugation and some encode anti-restriction proteins to circumvent the cellular R/
M systems16. Conjugative plasmids have been extensively used for heterologous 
expression and genome engineering purposes, including Rhodobacter sphaeroides  as 
described in Chapter 4 of this thesis. Nonetheless, conjugation is a process restricted to 
conditions compatible with the donor strain, and host factors influencing conjugation 
are still poorly understood17. 
The microorganisms used during the course of this thesis were genetically 
accessible via previously established protocols; Pseudomonas putida KT244018 and Bacillus 
smithii ET 1387 are electro-transformable strains, while Rhodobacter sphaeroides ATC 
3505319 is genetically accessible via conjugation. In this thesis, the work to improve 
transformation efficiencies was limited to B. smithii ET 138. In chapter 3 the hsdR gene, 
which codes for the only restriction enzyme expressed in B. smithii ET 138, was deleted 
from the genome of the sporulation-deficient B. smithii ET 138 ΔsigF strain. The resulting B. 
smithii ET 138 ΔsigF ΔhsdR strain was extensively used in this thesis and even though the 
hsdR deletion did not improve the previously reported maximum transformation efficiency 
(in CFU/μg of transforming DNA) for a B. smithii ET 138 strain, the B. smithii ET 138 
ΔsigF ΔhsdR strain was efficiently transformable with any pNW33n-based and pG2K-based 
construct of size up to -at least- 12.5 kb, without sequence limitations that were an obstacle 
prior to removal of the hsdR. This result facilitated the rapid and efficient realization of 
genome engineering experiment, which was not possible for the wild type B. smithii ET 138.
2) GENETIC TOOLBOXES
Since 1973, when the first transformation of E. coli with a plasmid vector took place20, a wide
variety of genetic tools has been developed for bacterial engineering, aiming to facilitate both
fundamental research and metabolic engineering for strain development purposes. Amongst
these tools belong: i) replicating or integrative vectors, employed for single genes and/or
pathway expression and genome engineering purposes, ii) constitutive or inducible
promoters, employed for the continuous or controlled transcription of associated genes,
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have comparable sizes. Moreover, the co-transformation of B. smithii ET 138 ΔhsdR with 
pNW33n and pG2K was possible, with reduced efficiency (101 CFU/ μg of plasmid DNA). 
The inefficient expression of the RepBST1 protein by the pG1C and pG1K vectors was the 
most probable reason for the unsuccessful transformation of B. smithii ET 138 ΔhsdR with 
these vectors. Hence, testing alternative promoters and RBSs for the RepBST1 expression 
may further increase the number of vectors in the genetic tool box of B. smithii ET 138. 
A different approach for the introduction of additional plasmids into the genetic 
toolbox of an organism is the use of the origins of replication (ori) and of the replication 
proteins genes (rep) from the native plasmids of closely related species. In the case of B. 
smithii ET 138, the ori and rep from native plasmids of Bacillus coagulans , Bacillus 
licheniformis or other close relatives could be evaluated as backbones for the 
construction, and subsequent test transformation to B. smithii ET 138, of a “new” 
plasmid with the addition of the previously mentioned thermostable 
chloramphenicol acetyltransferase or kanamycin nucleotidyltransferase genes.   
PRO MO TERS 
The development of inducible or repressible promoters, as well as of promoter libraries 
that cover a wide range of transcriptional strengths is of great importance for an efficient 
genetic toolbox of an organism. Aiming to identify xylose- or glucose-inducible promoters 
present in the B. smithii ET 138 genome, transcriptomics analysis was performed on total 
RNA samples isolated from B. smithii ET 138 cultures grown in LB2 rich medium up to the 
early exponential phase (3 hours at 55°C) in the absence or presence of a carbon source 
(glucose or xylose). The comparative data analysis led to the selection of the 
bidirectional PxylA promoter for experimental evaluation of its inducibility.  
The PxylA promoter controls the transcription of the xylose isomerase (xylA) 
and transcriptional repressor (xylA) genes and the acquired transcriptomics data revealed 
that it is transcriptionally active only in the presence of xylose. Previous studies on 
other Gram-positive bacteria23,24 showed that there are two regulation systems 
that control the transcription of PxylA (Fig. 1a). The first system is based on the 
XylR transcriptional regulator; in the absence of xylose, XylR binds to the PxylA promoter 
and hinders the binding of the RNA polymerase, while in the presence of xylose the 
XylR is subjected to a conformational change and abolishes the ability to bind the PxylA, 
hence allowing for the xylA transcription and the further catabolism of xylose. The second 
regulation system is based on the presence of a catabolite-responsive element (CRE-box) in 
the PxylA;   the catabolic control protein A (CcpA) binds to the CRE-box when glucose is 
fold through a codon saturation mutagenesis approach to relieve product inhibition35. 
Noteworthy, this work was performed using the Cas12a (formerly Cpf1) RNA-guided 
endonuclease, making it the first application of a non-Cas9-based CRISPR-Cas/
recombineering genome editing tool in bacteria for metabolic engineering purposes (Table
1).   
Table 1. CRISPR-Cas-mediated metabolic engineering of bacteria for industrial products. 
iii) riboswitches, which upon binding to a suitable ligand molecule act as on/ off
transcriptional/ translational switches or result in mRNA maturation, iv) ribosome binding
sites (RBS), responsible for the translational efficiency of the associated genes, v)
transcriptional terminators, responsible for the dislodging of the RNA polymerase from the
mRNA transcript, and vi) reporter genes, such as genes that code for either antibiotic
resistance (selection marker) and fluorescence proteins (phenotypic marker); the latter allow
for measuring the activity of the previously mentioned regulatory elements. The modularity
of the described genetic tools/parts set the basis for the development of the synthetic biology
field that focuses on the building of artificial biological systems for research and engineering
purposes. Part of the work performed during this thesis aiming to transform B. smithii ET
138 into a synthetic biology chassis, by extending its genetic toolbox with vectors and
promoters, is described in chapters 2 and 3. Further details will be discussed below.
VECTORS 
Prior to this thesis, pNW33n was the only available B. smithii ET 138 vector for genome 
engineering and protein expression purposes21. pNW33n is an E. coli–Bacillus/Geobacillus 
sp. shuttle vector, comprised of the repB gene, which codes for a rolling circle replication 
initiator protein, the ColE1 E. coli origin of replication and the cat gene, which codes for a 
thermostable chloramphenicol acetyltransferase confering resistance to chloramphenicol. 
The further expansion of the B. smithii ET 138 toolbox with additional vectors was assigned 
as a high priority task. 
During this thesis, the transformation efficiency of B. smithii ET 138 with the 
recently developed E. coli – Bacillus/Geobacillus sp. shuttle vectors pG1C, pG1K and pG2K 
was evaluated22. The three tested vectors were selected due to their proven transformability 
into the Gram-positive thermophile Parageobacillus thermoglucosidasius22. All three vectors 
contained the ColE1 origin of replication. Both pG1C and pG1K code for the RepBST1 
replication protein, while pG2K codes for the RepB replication protein (the same as 
pNW33n). Moreover, the pG1K and pG2K code for a thermostable kanamycin 
nucleotidyltransferase, and pG1C codes for a thermostable chloramphenicol acetyltransferase 
(the same as pNW33n). The restriction- and sporulation-deficient B. smithii ET 138 ΔsigF 
ΔhsdR strain was employed for the transformation experiments and only pG2K was 
transformable into this strain. The transformation efficiency achieved with the pG2K vector 
was comparable to the transformation efficiency achieved with pNW33n (105 CFU/ μg of 
plasmid DNA), as was expected since the two vectors share the same replication protein and 
have comparable sizes. Moreover, the co-transformation of B. smithii ET 138 ΔhsdR with the
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riboswitches, which upon binding to a suitable ligand molecule act as on/
off transcriptional/translational switches or result in mR NA maturation, iv) ribosome 
binding sites (RBS), responsible for the translational efficiency of the associated genes, v) 
transcriptional terminators, responsible for the dislodging of the RNA polymerase from the 
mRNA transcript, and vi) reporter genes, such as genes that code for either antibiotic 
resistance (selection marker) and fluorescence proteins (phenotypic marker); the latter allow 
for measuring the activity of the previously mentioned regulatory elements. The modularity 
of the described genetic tools/parts set the basis for the development of the synthetic biology 
field that focuses on the building of artificial biological systems for research and engineering 
purposes. Part of the work performed during this thesis aiming to transform B. smithii ET 
138 into a synthetic biology chassis, by extending its genetic toolbox with vectors and 
promoters, is described in chapters 2 and 3. Further details on this work will be discussed 
below. 
VECTO RS 
Prior to this thesis, pNW33n was the only available B. smithii ET 138 vector for 
genome engineering and protein expression purposes21. pNW33n is an E. coli – Bacillus/
Geobacillus sp. shuttle vector, comprised of the repB gene, which codes for a rolling 
circle replication initiator protein, the ColE1 E. coli origin of replication and the cat gene, 
which codes for a thermostable chloramphenicol acetyltransferase confering resistance to 
chloramphenicol. Thefurther expansion of the B. smithii ET 138 toolbox with additional 
vectors was assigned as a high priority task. 
During this thesis, the transformation efficiency of B. smithii ET 138 with the 
recently developed E. coli – Bacillus/Geobacillus sp. shuttle vectors pG1C, pG1K and 
pG2K was evaluated22. The three tested vectors were selected due to their proven 
transformability into the Gram-positive thermophile Parageobacillus thermoglucosidasius22. 
All three vectors contained the ColE1 origin of replication. Both pG1C and pG1K code for 
the RepBST1 replication protein, while pG2K codes for the RepB replication protein (the 
same as pNW33n). Moreover, the pG1K and pG2K code for a thermostable kanamycin 
nucleotidyltransferase, and pG1C codes for a thermostable chloramphenicol acetyltransferase 
(the same as pNW33n). The restriction- and sporulation-deficient B. smithii ET 138 ΔsigF
ΔhsdR strain was employ ed for the transformation experiments and only pG2K was 
transformable into this strain. The transformation efficiency achieved with the pG2K vector 
was comparable to the transformation efficiency achieved with pNW33n (105 CFU/ μg of 
plasmid DNA), as was expected since the two vectors share the same replication protein and 
fold through a codon saturation mutagenesis approach to relieve product inhibition35. 
Noteworthy, this work was performed using the Cas12a (formerly Cpf1) RNA-guided 
endonuclease, making it the first application of a non-Cas9-based CRISPR-Cas/
recombineering genome editing tool in bacteria for metabolic engineering purposes (Table
1).   
Table 1. CRISPR-Cas-mediated metabolic engineering of bacteria for industrial products. 
 pNW33n and pG2K  was possible, with reduced efficiency (101 CFU/ μg of plasmid DNA). 
The inefficient expression of the RepBST1 protein by the pG1C and pG1K vectors was the 
most probable reason for the unsuccessful transformation of B. smithii ET 138 ΔhsdR with 
these vectors. Hence, testing alternative promoters and RBSs for the RepBST1 expression 
may further increase the number of vectors in the genetic toolbox of B. smithii ET 138. 
A different approach for the introduction of additional plasmids into the genetic 
toolbox of an organism is the use of the origins of replication (ori) and of the replication 
proteins genes (rep) from the native plasmids of closely related species. In the case of B. 
smithii ET 138, the ori and rep from native plasmids of Bacillus coagulans, Bacillus 
licheniformis or other close relatives could be evaluated as backbones for the construction, 
and subsequent test transformation to B. smithii ET 138, of a “new” plasmid with the 
addition of the previously mentioned thermostable chloramphenicol acetyltransferase or 
kanamycin nucleotidyltransferase genes.   
PROMOTERS 
The development of inducible or repressible promoters, as well as of promoter libraries that 
cover a wide range of transcriptional strengths is of great importance for an efficient genetic 
toolbox of an organism. Aiming to identify xylose- or glucose-inducible promoters present in 
the B. smithii ET 138 genome, transcriptomics analysis was performed on total RNA samples 
isolated from B. smithii ET 138 cultures grown in LB2 rich medium up to the early 
exponential phase (3 hours at 55°C) in the absence or presence of a carbon source (glucose or 
xylose). The comparative data analysis led to the selection of the bidirectional PxylA promoter 
for experimental evaluation of its inducibility.  
The PxylA promoter controls the transcription of the xylose isomerase (xylA) and 
transcriptional repressor (xylR) genes and the acquired transcriptomics data revealed that it is 
transcriptionally active only in the presence of xylose. Previous studies on other Gram-
positive bacteria23,24 showed that there are two regulation systems that control the 
transcription of PxylA (Fig. 1a). The first system is based on the XylR transcriptional 
regulator; in the absence of xylose, XylR binds to the PxylA promoter and hinders the 
binding of the RNA polymerase, while in the presence of xylose the XylR is subjected 
to a conformational change and abolishes the ability to bind the PxylA, hence allowing 
for the xylA transcription and the further catabolism of xylose. The second regulation system 
is based on the presence of a catabolite-responsive element (CRE-box) in the PxylA; the 
catabolic control protein A (CcpA) binds to the CRE-box when glucose is present, blocking 
transcription from PxylA in both directions. Based on previous reports for general CRE-box 
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 Figure 1a. Schematic representation of the PxylA promoter, as located within the B. smithii ET 138 genome, and 
of the 2 systems responsible for the control of its transcriptional repression. b.  B. UV exposed samples 
of B. smithii ET 138:: pNW_sfGFP cultures grown overnight in LB2 rich or TVMY poor 
media supplemented with different concentrations of glucose for repression of the PxylA promoter that 
controls the transcription of the sfgfp gene.
sequences25,26 an almost palindromic, CRE-box like sequence was identified 34bp 
upstream of the xylA gene within the PxylA region. The construction of a plasmid-
borne xylose inducible system for transcriptional regulation in B. smithii ET 138 
would require the cloning of the PxylA promoter in the pNW33n backbone together with 
the xylR gene, both right upstream of the gene-of-interest. Since the CRE-box based mode of 
regulation does not require the presence of XylR, it was decided to evaluate the efficiency of 
a plasmid-borne glucose repressible system for transcriptional regulation of a gene-of-
interest. For this purpose, the thermostable sfgfp gene27 was employed as the reporter gene 
and cloned in the pNW33n backbone under the transcriptional control of PxylA, resulting in 
the pNW_sfGFP plasmid. B. smithii ET 138:: pNW_sfGFP precultures grown overnight in 
LB2 rich or TVMY poor media (10 ml in 50 ml falcon tubes, 55°C, 150 rpm) were employed 
for inoculation of LB2 and TVMY cultures respectively, supplemented with 0 to 1%(w/v) 
glucose (10 ml in 50 ml falcon tubes, 55°C, 150 rpm). Regardless the employed glucose 
concentration, the optical density (OD600) of the cultures from each medium was comparable 
after overnight growth. Moreover, analysis of culture samples (with cell densities normalized 
based on the OD600 measurements) under UV light showed that glucose concentrations of 
0.25% and above result in almost complete elimination of fluorescence (Fig. 1b).
The PxylA was employed in Chapters 4 and 8 of this thesis for tuning down the 
transcription of the thermocas9 and thermodcas9 genes. Nonetheless, the use of glucose 
during the ThermoCas9-based editing and silencing experiments did not affect the efficiency  
a b 
CRE
Pxyl
xylR xylA
CcpA
XylR
xylose
are further employed for the development of ThermoCas9-b ased engineering tools for gene 
deletion (pyrF) and transcriptional silencing (ldhL) at 55 °C in Bacillus smithii ET 138 and 
for gene deletion (pyrF) at 37 °C in Pseudomonas putida. This is one of the first reports that 
provides fundamental insights into a thermophilic CRISPR-Cas family member and the first 
report that establishes Cas9-based bacterial genome editing and silencing at temperatures 
above 42°C. 
The potential to harness the activity of an antiCRISPR proteins for genome engineering 
purposes is examined in Chapter 6 of this thesis. The antiCRISPR protein from Neisseria 
meningitidis (AcrIIC1Nme) is employed as "on/off-switch" of the thermo-activ e Cas9 
orthologues from Geobacillus thermodenitrificans T12 (ThermoCas9) and Geobacillus 
stearothermophilus (GeoCas9). Initially it is demonstrated that both ThermoCas9 and 
GeoCas9 can introduce lethal dsDNA breaks in E. coli at 37°C in a tunable and spacer-
dependent manner. Consequently it is demonstrated that AcrIIC1Nme traps both tested Cas9 
orthologues in a DNA-bound, catalytically inactive state. The Cas9/AcrIIC1Nme complexes 
can promote a transcriptional silencing effect with efficiency comparable to the catalytically 
"dead" Thermo-dCas9 and Geo-dCas9 variants. Finally, this chapter describes the 
construction of the first reported single-vector, tightly controllable and highly efficient 
Cas9/AcrIIC1Nm e-based tool for coupled silencing and targeting in bacteria that could be 
further employed for genome editing and transcriptional regulation of academically and 
The PxylA was employed in Chapters 4 and 8 of this thesis for tuning down the transcription 
of the thermocas9 and thermodcas9 genes. Nonetheless, the use of glucose during the 
ThermoCas9-based editing and silencing experiments did not affect the efficiency of 
the tools, indicating that the PxylA promoter is not tightly repressible. An attempt to 
obtain a more tightly controlled, xylose inducible and glucose repressible transcription 
system, could be to clone the xylR gene upstream of the PxylA / gene-of-interest. 
Along the same line with the previously presented strategy, transcriptomics analysis on 
cultures grown under different environmental stimuli, such as higher or lower nitrogen 
concentrations, in the presence of high metal concentrations etc., could reveal 
other inducible or repressible promoters, as well as promoters of different strengths, present 
in the B. smithii ET 138 genome. These promoters could be further tested with reporter 
genes and added to the B. smithii ET 138 genetic toolbox. Additionally, a well-
characterized B. smithii ET 138 promoter could be used for the construction of a 
promoter library, by randomizing the sequence between the -10, -35 promoter regions. 
This approach would eliminate the need for extensive characterization of many different 
promoters and at the same time could result ina number of closely related promoters 
with a wide range of transcriptional strengths.   
3) G ENO ME ENG INEERING  TO O LS
For many model and most non-model prokaryotes, the execution or throughput of metabolic
engineering and systems biology experiments is hindered by the lack of efficient genome
engineering tools. From 2013 onwards it has been demonstrated that fora wide variety of
prokaryotes the activity of the Cas9 endonuclease from the type II−A CRISPR−Cas system
of Streptococcus pyogenes (SpCas9) can be combined with homologous recomb ination and
recombineering (recombination-mediated genome engineering) approaches for the
development of easy to design, efficient and precise genome editing tools, as was reviewed
in chapters 2 and 7 of this thesis. Moreover, it was recently demonstrated that the editing
efficiencies of these tools can significantly and unpredictably vary amongst the same
genomic targets28, justifying the usefulness of developing different SpCas9-based editing
tools. Additionally, many single effectors from other type II CRISPR-Cas systems, usually
of comparable or smaller size than SpCas9, have been characterized29-33 and tested in
genome engineering applications29,31,32 aiming to achieve higher efficiencies, to avoid
encountered SpCas9 toxicity issues, to increase targeting specificities and to extend the
number of available targets in a genome (via recognitionof alternative protospacer-adjacent
motifs (PAMs)).
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Figure 1a. Schematic representation of the PxylA promoter, as located within the B. smithii ET 138 genome, and 
of the 2 systems responsible for the control of its transcriptional repression. b. B. UV exposed samples of 
B. smithii ET 138:: pNW_sfGFP cultures grown overnight in LB2 rich or TVMY poor media 
supplemented with different concentrations of glucose for repression of the PxylA promoter that controls the 
transcription of the sfgfp gene. 
present, blocking transcription from PxylA in both directions. Based on previous 
reports for general CRE-box sequences25,26 an almost palindromic, CRE-box like 
sequence was identified 34bp upstream of the xylA gene within the PxylA region. The 
construction of a plasmid-borne xylose inducible system for transcriptional regulation in 
B. smithii ET 138 would require the cloning of the PxylA promoter in the pNW33n 
backbone together with the xylRgene, both right upstream of the gene-of-interest. Since 
the CRE-box based mode of regulation does not require the presence of XylR, it was 
decided to evaluate the efficiency of a plasmid-borne glucose repressible system 
for transcriptional regulation of a gene-of-interest. For this purpose, the 
thermostable sfgfp gene27 was employed as the reporter gene and cloned in the 
pNW33n backbone under the transcriptional control of PxylA, resulting in the 
pNW_sfGFP plasmid. B. smithii ET 138:: pNW_sfGFP precultures grown overnight 
in LB2 rich or TVMY poor media (10 ml in 50 ml falcon tubes, 55°C, 150 rpm) were 
employed for inoculation of LB2 and TVMY cultures respectively, 
supplemented with 0 to 1%(w/v) glucose (10 ml in 50 ml falcon tubes, 55°C, 150 
rpm). 
Regardless the employed glucose concentration, the optical density (OD600) of the 
cultures from each medium was comparable after overnight growth. Moreover, analysis 
of culture samples (with cell densities normalized based on the OD600 measurements) 
under UV light showed that glucose concentrations of 0.25% and above result in 
almost complete elimination of fluorescence (Fig. 1b).  
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are further employed for the development of ThermoCas9-b ased engineering tools for gene 
deletion (pyrF) and transcriptional silencing (ldhL) at 55 °C in Bacillus smithii ET 138 and 
for gene deletion (pyrF) at 37 °C in Pseudomonas putida. This is one of the first reports that 
provides fundamental insights into a thermophilic CRISPR-Cas family member and the first 
report that establishes Cas9-based bacterial genome editing and silencing at temperatures 
above 42°C. 
The potential to harness the activity of an antiCRISPR proteins for genome engineering 
purposes is examined in Chapter 6 of this thesis. The antiCRISPR protein from Neisseria 
meningitidis (AcrIIC1Nme) is employed as "on/off-switch" of the thermo-activ e Cas9 
orthologues from Geobacillus thermodenitrificans T12 (ThermoCas9) and Geobacillus 
stearothermophilus (GeoCas9). Initially it is demonstrated that both ThermoCas9 and 
GeoCas9 can introduce lethal dsDNA breaks in E. coli at 37°C in a tunable and spacer-
dependent manner. Consequently it is demonstrated that AcrIIC1Nme traps both tested Cas9 
orthologues in a DNA-bound, catalytically inactive state. The Cas9/AcrIIC1Nme complexes 
can promote a transcriptional silencing effect with efficiency comparable to the catalytically 
"dead" Thermo-dCas9 and Geo-dCas9 variants. Finally, this chapter describes the 
construction of the first reported single-vector, tightly controllable and highly efficient 
Cas9/AcrIIC1Nm e-based tool for coupled silencing and targeting in bacteria that could be 
further employed for genome editing and transcriptional regulation of academically and 
of the tools, indicating that the PxylA promoter is not tightly repressible. An 
attempt to obtain a more tightly controlled, xylose inducible and glucose 
repressible transcription system, could be to clone the xylR gene upstream of 
the PxylA / gene-of-interest. Along the same line with the previously presented strategy, 
transcriptomics analysis on cultures grown under different environmental stimuli, such as 
higher or lower nitrogen concentrations, in the presence of high metal concentrations etc., 
could reveal other inducible or repressible promoters, as well as promoters of different 
strengths, present in the B. smithii ET 138 genome. These promoters could be further tested 
with reporter genes and added to the B. smithii ET 138  genetic toolbox. Additionally, a well-
characterized B. smithii ET 138 promoter could be used for the construction of a promoter 
library, by randomizing the sequence between the -10, -35 promoter regions. This approach 
would eliminate the need for extensive characterization of many different promoters and at 
the same time could result in a number of closely related promoters with a wide range of 
transcriptional strengths.   
3) GENOME ENGINEERING TOOLS
For many model and most non-model prokaryotes, the execution or throughput of metabolic
engineering and systems biology experiments is hindered by the lack of efficient genome
engineering tools. From 2013 onwards it has been demonstrated that for a wide variety of
prokaryotes the activity of the Cas9 endonuclease from the type II−A CRISPR−Cas system of
Streptococcus pyogenes (SpCas9) can be combined with homologous recombination and
recombineering (recombination-mediated genome engineering)  approaches for the
development of easy to design, efficient and precise genome editing tools, as was reviewed in
chapters 2 and 7 of this thesis. Moreover, it was recently demonstrated that the editing
efficiencies of these tools can significantly and unpredictably vary amongst the same genomic
targets28, justifying the usefulness of developing different SpCas9-based editing tools.
Additionally, many single effectors from other type II CRISPR-Cas systems, usually of
comparable or smaller size than SpCas9, have been characterized29-33 and tested in genome
engineering applications29,31,32 aiming to achieve higher efficiencies, to avoid encountered
SpCas9 toxicity issues, to increase targeting specificities and to extend the number of
available targets in a genome (via recognition of alternative protospacer-adjacent motifs
(PAMs)).
The characterization of ThermoCas9, a thermotolerant Cas9 homologue that is 
smaller and has higher in vitro targeting specificity than SpCas9, has resulted in the develop-
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Figure 2. Schematic representation of the type I-A and type I-B CRISPR/Cas systems within the B. smithii ET 
138 genome. The two systems are interspaced by a single CRISPR array and each repeat of the array is 
depicted as a purple rectangular.  
For the in vivo PAM determination, four spacers from the native B. smithii ET 
138 CRISPR array (spacers 2, 12, 22 and 30 starting from the predicted leader sequence) 
were selected and cloned into the pNW33n vector in order to serve as protospacers 
in the transformation assays. Each protospacer was flanked at its 5′-end by a randomized 3-
bp long sequence, which served as the PAM library. Wild-type B. smithii ET 138 
cells were transformed with each plasmid library. Notably, the transformation efficiency 
of the cells with the library containing spacer 12 was three orders of magnitude lower com-
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m6A modification of the 5’-CAGNNNNNNTGT-3’ motif throughout the genome, and this 
motif was also present in the tested spacer 12. It was hypothesized that the described 
modification is most probably related to the R/M system of B. smithii ET 138 discussed 
above. Transformation of the spacer 12 plasmid library to sporulation- and restriction- 
deficient B. smithii ET 138 ΔsigF ΔhsdR strain reconstituted the transformation efficiency to 
control levels, confirming the hypothesis. Hence the observed drop in the transformation 
efficiency could not be attributed to targeting by the native CRISPR-Cas systems.  
The transformation efficiency of wild type B. smithii ET 138 cells with the 
libraries containing spacers 2, 22 and 30 was comparable to the efficiency upon 
transformation with the pNW33n control. Plasmid material was isolated from all the 
surviving colonies and was analyzed by deep sequencing together with samples from 
the same plasmid libraries prior transformation to B. smithii ET 138. The comparison of 
the sequencing results showed no statistically relevant differences between the members 
of the plasmid libraries pre- and post- transformation. These results indicated that either the 
type I-B CRISPR-Cas system of B. smithii ET 138 is not efficiently expressed, under the 
tested conditions, or that the activity of the missing Cas6 of the system is not 
complemented by the Cas6 of the neighboring type I-A system. The existence of an 
antiCRISPR system that counteracts the activity of the CRISPR-Cas system is also a 
possibility that requires further in silico and in vivo studies.    
TESTING AACAS12B AS A CO UNTER SELECTIO N TO O L IN B. SMITHII ET 138 
Chapters 2 and 3 describe the SpCas9- and ThermoCas9-based tools developed during this 
PhD project. One of the main objectives of this project was to further expand the CRISPR-
Cas-based genome engineering toolbox for thermophilic bacteria. Previous studies have 
demonstrated that the Cas12b endonuclease from the type V−B CRISPR−Cas system of the 
thermophilic bacteriumAlicyclobacillus acidoterrestris (AaCas12b) is active in vitro at 37°C 
and 50°C, as well as in vivo at 37°C in E. coli33. AaCas12b requires a crRNA-tracrRNA 
duplex for targeting, while the spacer sequence resides at the 3’-end of the crRNA and the 
PAM sequence (5’-TTN-3’) that it recognizes resides at the 5’-end of the protospacer and is 
quite distinct to the PAM sequences of the currently characterized thermoactive Cas9 
proteins. Moreover, it was shown that single nucleotide mismatches between the spacer of 
the employed sgRNA and the corresponding protospacer target hindered the AaCas12b in 
vitro activity, suggesting the potential of AaCas12b for reduced in vivo off−target cleavage 
events. These facts motivated the development of a AaCas12b-based genome engineering 
toolbox for thermophilic bacteria.  
ment of ThermoCas9-based engineering tools for thermophilic and mesophilic bacteria, as 
described in chapters 4 and 6 of this thesis. Additionally, the potential of two more CRISPR-
Cas systems, or the effector components thereof, to efficiently target and engineer the 
genome of B. smithii ET 138 was examined. Further details on these works are discussed 
below.   
CHARACTERIZING THE B. SMITHII ET 138 TYPE I-B CRISPR-CAS SYSTEM
There are a few examples of bacterial genome engineering tools designed to take advantage 
of native CRISPR-Cas systems34-36, reducing the size of the employed plasmids and 
the requirements in genetic parts. B. smithii ET 138 contains one type I-B 
CRISPR-Cas adaptive immune system in its genome that lacks the cas6 gene 
and which is followed by a CRISPR array of 32 spacers and a truncated type 
I-A CRISPR-Cas system that encompasses a cas6 gene (Fig. 2). Transcriptomics
data extracted from B. smithii ET 138 cultures grown under different aeration
conditions, in different media and with different carbon sources suggested that
the genes of the CRISPR-Cas I-B system are actively transcribed, especially at
the late exponential phase of growth (data not shown). This finding motivated
the further evaluation of the in vivo DNA targeting efficiency of the system,
which would also indicate the use of the Cas6 component from the neighboring
type I-A system. In silico mining for the preferred PAM sequences of the
system, using a previously established approach reviewed in chapter 237,38, did not
result in a convincing prediction. Hence, it was decided to proceed with an
in vivo PAM determination approach.
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The characterization of ThermoCas9, a thermotolerant Cas9 homologue that is 
smaller and has higher in vitro targeting specificity than SpCas9, has resulted in the 
development of ThermoCas9-based engineering tools for thermophilic and mesophilic 
bacteria, as described in chapters 4 and 6 of this thesis. Additionally, the potential of two 
more CRISPR-Cas systems, or the effector components thereof, to efficiently target and 
engineer the genome of B. smithii ET 138 was examined. Further details on these works will 
be discussed below.   
CH ARACTERIZING TH E B. SMITHII ET 138 TYPE I-B CRISPR-CAS SYSTEM 
There are a few examples of bacterial genome engineering tools designed to 
take advantage of native CRISPR-Cas systems34-36, reducing the size of the employed 
plasmids and the requirements in genetic parts. B. smithii ET 138 contains one type I-B 
CRISPR-Cas adaptive immune system in its genome that lacks the cas6 gene and which 
is followed by a CRISPR array of 32 spacers and a truncated type I-A CRISPR-Cas system 
that encompasses a cas6 gene (Fig. 2). Transcriptomics data extracted from B. smithii ET 
138 cultures grown under different aeration conditions, in different media and with 
different carbon sources suggested that the genes of the CRISPR-Cas I-B system are 
actively transcribed, especially at the late exponential phase of growth (data not shown). 
This finding motivated the further evaluation of the in vivo DNA targeting efficiency of the 
system, which would also indicate the use of the Cas6 component from the neighboring 
type I-A system. In silico mining for the preferred PAM sequences of the system, using 
a previously established approach reviewed in chapter 237,38, did not result in a 
convincing prediction. Hence, it was decided to proceed with an in vivo PAM 
determination approach.  
Figure 2. Schematic representation of thetype I-A and type I-B CRISPR/Cas systems within the B. smithii ET 
138 genome. The 2 systems are interspaced by a single CRISPR array and each repeat of the array is depicted 
as a purple rectangular.  
For the in vivo PAM determination, four spacers from the native B. smithii ET 138 
CRISPR array (spacers 2, 12, 22 and 30 starting from the predicted leader sequence) 
were selected and cloned into the pNW33n vector in order to serve as protospacers 
in the transformation assays. Each protospacer was flanked at its 5′-end by a randomized 3-
bp long sequence, which served as the PAM library. Wild-type B. smithii ET 138 cells were 
transformed with each plasmid library. Notably, the transformation efficiency of the cells 
with the library containing spacer 12 was 3 orders of magnitude lower compared to the 
pNW33n control. The methylation analysis of the B. smithii ET 138 genome revealed the 
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pared to the pNW33n control. The methylation analysis of the B. smithii ET 138 genome 
revealed the  m6A modification of the 5’-CAGNNNNNNTGT-3’ motif throughout the 
genome, and this motif was also present in the tested spacer 12. It was hypothesized that the 
described modification is most probably related to the R/M system of B. smithii ET 138 
discussed above. Transformation of the spacer 12 plasmid library to sporulation- and 
restriction- deficient B. smithii ET 138 ΔsigF ΔhsdR strain reconstituted the transformation 
efficiency to control levels, confirming the hypothesis. Hence the observed drop in the 
transformation efficiency could not be attributed to targeting by the native CRISPR-Cas 
systems.  
The transformation efficiency of wild type B. smithii ET 138 cells with the libraries 
containing spacers 2, 22 and 30 was comparable to the efficiency upon transformation with 
the pNW33n control. Plasmid material was isolated from all the surviving colonies and was 
analyzed by deep sequencing together with samples from the same plasmid libraries prior 
transformation to B. smithii ET 138. The comparison of the sequencing results showed no 
statistically relevant differences between the members of the plasmid libraries pre- and post- 
transformation. These results indicated that either the type I-B CRISPR-Cas system of B. 
smithii ET 138 is not efficiently expressed, under the tested conditions, or that the activity of 
the missing Cas6 of the system is not complemented by the Cas6 of the neighboring type I-A 
system. The existence of an antiCRISPR system that counteracts the activity of the CRISPR-
Cas system is also a possibility that requires further in silico and in vivo studies.
TESTING AACAS12B AS A COUNTER SELECTION TOOL IN B. SMITHII ET 138 
Chapters 2 and 3 describe the SpCas9- and ThermoCas9-based tools developed during this 
PhD project. One of the main objectives of this project was to further expand the CRISPR-
Cas-based genome engineering toolbox for thermophilic bacteria. Previous studies have 
demonstrated that the Cas12b endonuclease from the type V−B CRISPR−Cas system of the 
thermophilic bacterium Alicyclobacillus acidoterrestris (AaCas12b) is active in vitro at 37°C 
and 50°C, as well as in vivo at 37°C in E. coli33. AaCas12b requires a crRNA-tracrRNA 
duplex for targeting, while the spacer sequence resides at the 3’-end of the crRNA and the 
PAM sequence (5’-TTN-3’) that it recognizes resides at the 5’-end of the protospacer and is 
quite distinct to the PAM sequences of the currently characterized thermoactive Cas9 
proteins. Moreover, it was shown that single nucleotide mismatches between the spacer of the 
employed sgRNA and the corresponding protospacer target hindered the AaCas12b in vitro
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TH ERMO CAS9 TARG ETING EFFICIENCY IN G . TH ERMO DENITRIFICANS T12
There is only a limited number of studies that make use of endogenous type II CRIPSR-Cas 
systems for bacterial genome editing purposes39. The in vitro characterization of the 
ThermoCas9 endonuclease from the type II−C CRISPR−Cas system of Geobacillus 
thermodenitrificans T12 strain was presented in chapter 3 of this thesis. The native in vivo
efficiency of this system was further investigated, aiming to assess if it can be employed for 
the development of a “self-editing” system in G. thermodenitrificans T12. A minimal 
CRISPR array composed of the native leader and a repeat−spacer−repeat (RSR) sequence 
was cloned into the pNW33n E. coli-Bacilli/Geobacilli shuttle vector. The non-targeting 
control spacer was further substituted by spacers targeting different regions of the ldhL gene 
within the genome of G. thermodenitrificans T12, creating a library of 4 constructs (3 
targeting and 1 non-targeting control). The constructs were separately transformed into G. 
thermodenitrificans T12 competent cells at 55°C, but no significant difference was observed 
in the transformation efficiencies between the cells transformed with the targeting and the 
non−targeting constructs. This result could be attributed to the weak transcription levels of 
the thermocas9 gene that were detected by RT-PCR, whereas there was no detectable 
transcription for the predicted tracrRNA module.
A new plasmid library was constructed aiming to circumvent the null/weak/
conditional transcription of the native tracrRNA module. The previously employed spacers 
were separately cloned at the 5’-end of the ThermoCas9 sgRNA expression module in the 
pNW33n vector. Each sgRNA module was placed under the transcriptional control of four 
different promoters, previously shown to be functional in G. thermodenitrificans T1240; the 
Ppta from B. coagulans , the PrplS from P. thermoglucosidasius, the native PuppT12 and the Ppta
from P. thermoglucosidasius. Again, there was no significant difference observed in the 
transformation efficiencies between the cells transformed with the targeting and the non
−targeting sgRNA expressing constructs, regardless the employed promoter. The described
results indicate that either the native ThermoCas9 expression is not high enough to facilitate
efficient targeting, or that there is an antiCRIPSR system within the genome of G.
thermodenitrificans T12, which counteracts the activity of the native type II-C CRISPR-Cas
system. Further in silico and in vivo studies are required in order to elucidate the existence of
such an antiCRISPR system.
activity, suggesting the potential of AaCas12b for reduced in vivo off−target cleavage events. 
These facts motivated the development of a AaCas12b-based genome engineering toolbox 
for thermophilic bacteria.  
The first step in this toolbox development process was the evaluation of the in vivo 
targeting activity of AaCas12b at 50°C (the optimal growth temperature of A. 
acidoterrestris) in B. smithii ET 138. As the codon usage landscapes of B. smithii ET 138 
and A. acidoterrestris are comparable, the native aacas12b gene was cloned into 
the pNW33n vector under the transcriptional control of the PxylA promoter, which 
was previously employed for the thermocas9 transcription. The native A. 
acidoterrestris tracrRNA transcriptional module as well as the corresponding CRISPR 
array were also cloned into the same plasmid. Four spacers (three targeting and 
one non-targeting control) were each individually introduced into the array creating 
a library of four plasmids with a single-spacer CRISPR array (leader-repeat-
spacer-repeat) each. The plasmids were transformed to B. smithii ET 138 cells and 
the number of obtained CFUs upon transformation with the targeting constructs 
was compared to the number of obtained CFUs upon transformation with the control 
construct. The experiments were performed in biological duplicates and the 
transcription of the tracrRNA module and the aacas12b gene was confirmed via 
specific PCR amplifications using as template the constructed cDNA library from 
B. smithii ET 138 cultures transformed with the control plasmid. The transformation
efficiency of B. smithii ET 138 was reduced by 1 order of magnitude only for one the
targeting constructs, when compared to the control transformation efficiency. In
attempt to improve the AaCas12b targeting efficiency, a similar plasmid-based in
vivo interference assay was performed employing the same spacers incorporated at
the 3’-end of sgRNA expressing modules, instead of crRNA:tracrRNA
duplexes, as previously described in literature for AaCas12b in vitro targeting assays.
However, this approach reduced the AaCas12b targeting efficiency even further.
The optimal AaCas12b targeting efficiency achieved during this experiment was 
comparable to the previously described results for in vivo AaCas12b−mediated targeting in 
E. coli at 37°C. The AaCas12b targeting efficiency might be improved by the use of different
promoters with characterized transcriptional start sites, which could be used for and enhance
the crRNA or sgRNA transcription. Nonetheless, the AaCas12b targeting efficiency in the
currently designed system was much lower than the ThermoCas9 targeting efficiency, and
way below the required efficiency levels for the development of an efficient tool.
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The first step in this toolbox development process was the evaluation of thein vivo targeting 
activity of AaCas12b at 50°C (the optimal growth temperature ofA. acidoterrestris) in B. 
smithii ET 138. As the codon usage landscapes of B. smithii ET 138 and A. acidoterrestris 
are comparable, the native aacas12b gene was cloned into the pNW33n vector 
under the transcriptional control of the PxylA promoter, which was previously employed 
for the thermocas9 transcription. The native A. acidoterrestris tracrRNA 
transcriptional module as well as the corresponding CRISPR array were also 
cloned into the same plasmid. Four spacers (three targeting and one non-
targeting control) were each individually introduced into the array creating a 
library of four plasmids with a single-spacer CRISPR array (leader-repeat-spacer-
repeat) each. The plasmids were transformed tosmithii ET 138 cells and the 
number of obtained CFUs upon transformation with the targeting constructs was 
compared to the number of obtained CFUs upon transformation with the 
control construct. The experiments were performed in biological duplicates and 
the transcription of the tracrRNA module and the aacas12b gene was 
confirmed via specific PCR amplifications using as template the constructed 
cDNA library from B. smithii ET 138 cultures transformed with the 
control plasmid. The transformation efficiency of B. smithii ET 138 was reduced 
by 1 order of magnitude only for one the targeting constructs, when compared to 
the control transformation efficiency. In attempt to improve the AaCas12b targeting 
efficiency, a similar plasmid-based in vivo interference assay was performed 
employing the same spacers incorporated at the 3’-end of sgRNA expressing modules, 
instead of crRNA:tracrRNA duplexes, as previously described in literature for
AaCas12b in vitro targeting assays. However, this approach reduced the 
AaCas12b targeting efficiency even further.
The optimal AaCas12b targeting efficiency achieved during this experiment was 
comparable to the previously described results for in vivo AaCas12b−mediated targeting in 
E. coli at 37°C (REF). The AaCas12b targeting efficiency might be improved by the use of
different promoters with characterized transcriptional start sites, which could be used for and
enhance the crRNA or sgRNA transcription. Nonetheless, the AaCas12b targeting efficiency
in the currently designed system was much lower than the ThermoCas9 targeting efficiency,
and way below the required efficiency levels for the development of an efficient genome
editing tool.
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THERMOCAS9 TARGETING EFFICIENCY IN G. THERMODENITRIFICANS T12
There is only a limited number of studies that make use of endogenous type II CRIPSR-Cas 
systems for bacterial genome editing purposes39. The in vitro characterization of the 
ThermoCas9 endonuclease from the type II−C CRISPR−Cas system of Geobacillus 
thermodenitrificans T12 strain was presented in chapter 3 of this thesis. The native in vivo 
efficiency of this system was further investigated, aiming to assess if it can be employed for 
the development of a “self-editing” system in G. thermodenitrificans T12. A minimal 
CRISPR array composed of the native leader and a repeat−spacer−repeat (RSR) sequence 
was cloned into the pNW33n E. coli-Bacilli/Geobacilli shuttle vector. The non-targeting 
control spacer was further substituted by spacers targeting different regions of the ldhL gene 
within the genome of G. thermodenitrificans T12, creating a library of 4 constructs (3 
targeting and 1 non-targeting control). The constructs were separately transformed into G. 
thermodenitrificans T12 competent cells at 55°C, but no significant difference was observed 
in the transformation efficiencies between the cells transformed with the targeting and the 
non−targeting constructs. This result could be attributed to the weak transcription levels of 
the thermocas9 gene that were detected by RT-PCR, whereas there was no detectable 
transcription for the predicted tracrRNA module.
A new plasmid library was constructed aiming to circumvent the null/weak/
conditional transcription of the native tracrRNA module. The previously employed spacers 
were separately cloned at the 5’-end of the ThermoCas9 sgRNA expression module in the 
pNW33n vector. Each sgRNA module was placed under the transcriptional control of four 
different promoters, previously shown to be functional in G. thermodenitrificans T1240; the 
Ppta  from B. coagulans, the PrplS from P. thermoglucosidasius, the native PuppT12 and the Ppta 
from P. thermoglucosidasius. Again, there was no significant difference observed in the 
transformation efficiencies between the cells transformed with the targeting and the non− 
targeting sgRNA expressing constructs, regardless the employed promoter. The described 
results indicate that either the native ThermoCas9 expression is not high enough to facilitate 
efficient targeting, or that there is  an antiCRIPSR system within the genome of G. 
thermodenitrificans T12, which counteracts the activity of the native type II-C CRISPR-Cas 
system. Further in silico and in vivo studies are required in order to elucidate the existence of 
such an antiCRISPR system.
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an editing window of 350 nucleotides at millions-fold greater rates than the wild type 
mutation rates52.The use of these tools in bacteria allows either the introduction of 
predictable mutations, usually converting the codon of an amino-acid into a stop 
codon, or the construction of extensive mutant libraries, eliminating the need for 
homologous recombination templates carrying the desired mutations.
The CRISPR-Cas based revolution on bacterial genome engineering is 
only in its dawn. The possibilities that open up with the use of CRISPR-Cas 
RNA-guided DNA-endonucleases are unlimited and it is generally accepted that the 
development of new advanced genome engineering applications and synthetic 
biology tools will only accelerate. Metabolic engineering studies on model and non-model 
bacteria will benefit from this revolution and the transition to a green economy will 
hopefully soon turn from a dream into reality.  
4) UNDERSTANDING B. SMITHII ET 138 METABO LISM
FO R ENG INEERING  PURPO SES
Chapter 7 of this thesis reviewed many important metabolic engineering studies on model
and non-model prokaryotes that were engineered by CRISPR-Cas based genome engineering
tools towards the production of green chemicals and biofuels. Chapter 8 of this
thesis described the metabolic engineering steps employed to transform B. smithii ET 138
into a production platform of dicarboxylic acids, using the novel tools developed in this
thesis. Next to genetic tool development as described above, a major bottleneck in
using non-model organisms is the lack of understanding on their metabolisms, which
usually present significant differences compared to the metabolisms of well-studied model
organisms such as E. coli and B. subtilis. The limited knowledge and understanding on the
metabolism of B. smithii ET 138 became apparent in the work presented in Chapter 8, as
well as in several additional experiments that will be described and placed into further
perspective in the final part of this chapter.
TH E MYSTERY O F TH E B. SMITHII ET 138 ACETATE PRO DUCTIO N PATH WAY 
As discussed in chapter 8, B. smithii ET 138 does not contain the genes of a canonical 
acetate production pathway, even though acetate is the main product under oxygen-rich 
culturing conditions. The work already performed and discussed in this thesis attempting to 
reveal the B. smithii ET 138 acetate production pathway includes the construction of acetyl-
CoA synthase and aldehyde dehydrogenase deletion mutants. The mutants were cultured 
under acetate- producing conditions and the results showed that none of these genes is 
culture despite the nitrogen-limitation. Hence, there isa possible connection between glycine 
and acetate accumulation. L-threonine aldolase is an enzyme that catalyzes the degradation of 
threonine to form glycine and acetaldehyde, which can further be converted to acetate via an 
DEVELOPING THE 2ND GENERATION OF CRISPR-CAS BASED ENGINEERING 
TOOLS: PERSPECTIVES
Undoubtedly, the currently developed and employed CRISPR-Cas-based tools for bacterial 
genome engineering, predominantly of model bacteria such as E. coli, have unprecedentedly 
boosted the field of metabolic engineering both for fundamental and systems biology studies 
as well as for the production of green chemicals and biofuels. As reviewed in chapters 2 and 
7, the plasmid-borne homologous recombination-Cas9 based counter-selection tool and the 
transcriptional silencing tool based on the catalytically inactivate dCas9 are the basic 
CRISPR-Cas applications for bacterial genome engineering and  have been successfully 
adapted for few non-model bacteria. In model bacteria, such as E. coli41, P. putida42 and 
Corynebacterium glutamicum43, the activity of CRISPR-Cas effectors has been combined 
with recombineering systems, which are phage derived enzymatic systems employed for the 
introduction of linear (ss- or ds-) DNA fragments into a genome of interest44. These 
fragments carry the desired mutations and the use of the CRISPR-Cas effectors as inducers of 
the recombination efficiencies and/or as counter-selection systems against the unedited 
genomes has substantially facilitated the selection of the mutated strains. Additionally, the 
CRISPR-Cas effectors have been combined with native or heterologous non-homologous end 
joining systems45-48, as also presented in chapter 5, facilitating the construction of strain 
libraries with random indel mutations at the Cas-targeted sequences. Due to the simple 
designing basis of these combined systems, their adaptation for use in non-model bacteria can 
substantially enhance the throughput of their metabolic studies and possibly allow for 
multiplex genome editing.
The on-going development of a new generation of bacterial CRISPR-Cas based 
tools, such as base editors and EvolvR, as well as the exploitation of antiCRISPR systems, as 
proposed in chapter 6, promises to enhance engineering efficiencies and throughput, 
accelerating metabolic engineering studies for both model and non-model bacteria. As base 
editors are termed the fusions of nicking or catalytically inactive CRISPR-Cas effectors to 
DNA-deaminase enzymes, mainly cytidine deaminases (convert cytidine to thymidine) and 
adenosine deaminases (convert adenine to guanine), that introduce specific mutations within a 
certain window of the targeted protospacer49-51. Additionally, the fusion of the nicking Cas9 
variant (nCas9) with a nick-translating, error-prone DNA polymerase resulted in the 
development of the EvolvR system that can diversify any nucleotide within an editing 
window of 350 nucleotides at millions-fold greater rates than the wild type mutation rates52.
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DEVELO PING TH E 2ND G ENERATIO N O F CRISPR-CAS BASED ENG INEERING
TO O LS: PERSPECTIVES
Undoubtedly, the currently developed and employed CRISPR-Cas-based tools for bacterial 
genome engineering, predominantly of model bacteria such as E. coli, have unprecedentedly 
boosted the field of metabolic engineering both for fundamental and systems biology studies 
as well as for the production of green chemicals and biofuels. As reviewed in chapters 2 and 
7, the plasmid-borne homologous recombination-Cas9 based counter-selection tool and the 
transcriptional silencing tool based on the catalytically inactivate dCas9 are the 
basic CRISPR-Cas applications for bacterial genome engineering and have been 
successfully adapted for few non-model bacteria. In model bacteria, such as E. coli41, 
P. putida42 and Corynebacterium glutamicum43, the activity of CRISPR-Cas effectors
has been combined with recombineering systems, which are phage derived enzymatic
systems employed for the introduction of linear (ss- or ds-) DNA fragments into a
genome of interest44. These fragments carry the desired mutations and the use of
the CRISPR-Cas effectors as inducers of the recombination efficiencies and/or as
counter-selection systems against the unedited genomes has substantially facilitated
the selection of the mutated strains. Additionally, the CRISPR-Cas effectors have
been combined with native or heterologous non-homologous end joining systems45-48,
as also presented in chapter 5, facilitating the construction of strain libraries with
random indel mutations at the Cas-targeted sequences. Due to the simple designing basis of
these combined systems, their adaptation for use in non-model bacteria can substantially
enhance the throughput of their metabolic studies and possibly allow for multiplex
genome editing.
The on-going development of a new generation of bacterial CRISPR-Cas 
based tools, such as base editors and EvolvR, as well as the exploitation of 
antiCRISPR systems, as proposed in chapter 6, promises to enhance engineering 
efficiencies and throughput, accelerating metabolic engineering studies for both 
model and non-model bacteria. As base editors are termed the fusions of nicking 
or catalytically inactive CRISPR-Cas effectors to DNA-deaminase enzymes, mainly 
cytidine deaminases (convert cytidine to thymidine) and adenosine deaminases 
(convert adenine to guanine), that introduce specific mutations within a certain 
window of the targeted protospacer49-51. Additionally, the fusion of the nicking Cas9 
variant (nCas9) with a nick-translating, error-prone DNA polymerase resulted 
in the development of the EvolvR system that can diversify any nucleotide within 
culture despite the nitrogen-limitation. Hence, there isa possible connection between glycine 
and acetate accumulation. L-threonine aldolase is an enzyme that catalyzes the degradation of 
threonine to form glycine and acetaldehyde, which can further be converted to acetate via an 
Thesis summary and general discussion
The use of these tools in bacteria allows either the introduction of predictable 
mutations, usually converting the codon of an amino-acid into a stop codon, or the 
construction of extensive mutant libraries, eliminating the need for homologous 
recombination templates carrying the desired mutations.
The CRISPR-Cas based revolution on bacterial genome engineering is only in its 
dawn. The possibilities that open up with the use of CRISPR-Cas RNA-guided DNA-
endonucleases are unlimited and it is generally accepted that the development of new 
advanced genome engineering applications and synthetic biology tools will only accelerate. 
Metabolic engineering studies on model and non-model bacteria will benefit from this 
revolution and the transition to a green economy will hopefully soon turn from a dream into 
reality.  
4) UNDERSTANDING B. SMITHII ET 138 METABOLISM FOR ENGINEERING
PURPOSES
Chapter 7 of this thesis reviewed many important metabolic engineering studies on model
and non-model prokaryotes that were engineered by CRISPR-Cas based genome engineering
tools towards the production of green chemicals and biofuels. Chapter 8 of this thesis
described the metabolic engineering steps employed to transform B. smithii ET 138 into a
production platform of dicarboxylic acids, using the novel tools developed in this thesis. Next
to genetic tool development as described above, a major bottleneck in using non-model
organisms is the lack of understanding on their metabolisms, which usually present
significant differences compared to the metabolisms of well-studied model organisms such as
E. coli and B. subtilis. The limited knowledge and understanding on the metabolism of B.
smithii ET 138 became apparent in the work presented in Chapter 8, as well as in several
additional experiments that will be described and placed into further perspective in the final
part of this chapter.
THE MYSTERY OF THE B. SMITHII ET 138 ACETATE PRODUCTION 
PATHWAY 
As discussed in chapter 8, B. smithii ET 138 does not contain the genes of a canonical 
acetate production pathway, even though acetate is the main product under oxygen-
rich culturing conditions. The work already performed and discussed in this thesis 
attempting to reveal the B. smithii ET 138 acetate production pathway includes the 
construction of acetyl-CoA synthase and aldehyde dehydrogenase deletion mutants. The 
mutants were cultured under acetate- producing conditions and the results showed that 
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none of these genes is crucial for the acetate production. Moreover, comparative proteomics 
analysis data presented in chapter 8 revealed the overproduction of the 
aminomethyltransferase protein (the “T-protein” of the glycine cleavage system) in the 55°C 
culture, which can be triggered only under high glycine concentration conditions53. This is an 
interesting observation, as the proteomics data also suggest nitrogen-deprivation for the 55°C 
culture, indicated by the overproduction of the nitrogen regulatory protein PII54. Thus, we 
expect that glycine is abundant in the 55°C acetaldehyde dehydrogenase. However, the 
experimental verification of the hypothesis is hindered by the lack of predicted threonine 
aldolase genes in the B. smithii ET 138 genome.
Figure 3a. Representation of the L-cysteine biosynthetic pathway. b. Effect of L-cysteine supplementation on B. 
smithii ET 138 growth and production profile. The cultures were grown in 10 ml TVMY 
medium supplemented with 10 g/L glucose and different concentrations of L-cysteine (0.01 g/l, 0.05 g/l, 
0.1 g/l). Experiments were done in 50 ml Greiner tubes and harvested after 24 hours of culturing. Data 
shown were average of triplicates.
Another pathway that results in the production of acetate as by-product is the L-
cysteine biosynthesis pathway (Fig. 3a), which is responsible for the conversion of L-serine to 
L-cysteine. The first reaction of this pathway is catalyzed by serine acetyltransferase, which
transfers the acetyl-group of an acetyl-CoA molecule to L-serine, converting it to O-acetyl- L-
serine. The second reaction is catalysed by cysteine synthase that converts O-acetyl- L-serine
into L-cysteine and acetate in the presence of H2S. Since there is no extracellular cysteine
accumulation observed in the acetate-producing B. smithii ET 138 cultures, the described
pathway could not be the main acetate producing pathway. Nonetheless, its contribution to the
acetate production by B. smithii ET 138 was investigated by culturing the B. smithii ET 138
ΔsigF-ΔhsdR strain in TVMY liquid medium supplemented with 10 g/l glucose, at 55°C, 150
rpm and in volumes previously shown to promote acetate production (10 ml medium in 50 ml
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Greiner tubes). Moreover, the cultures were supplemented with either different L-cysteine 
concentrations (0.08-0.8mM), though low enough to avoid high levels of medium reduction, 
or different Na2SO4 concentrations (1.8-18mM). The hypothesis was that increasing 
Na2SO4 concentrations would increase the H2S availability, enhancing the L-cysteine and 
acetate production, whereas increasing L-cysteine supplementation would reduce the 
requirement for L-cysteine production leading to simultaneous decrement in acetate. 24 
hours post inoculation,the optical density of the cultures at 600nm was measured, as 
indication of the growth, and samples from the culture supernatants were collected for HPLC 
analysis and determination of the type and amount of produced acids (Fig. 3b). It was 
observed that increasing L-cysteine concentrations negatively affected the growth of the B. 
smithii ET 138 ΔsigF-ΔhsdR cultures. This could be attributed to reduced oxygen availability 
caused by L-cysteine supplementation (even though the employed concentrations were low 
enough) or by the L-cysteine reaction with dihydroxyacetone phosphate (DHAP) and 
pyruvate, which forms thiohemiketal compounds55. This reaction reduces the amount of 
available pyruvate either for lactate formation, which is the main NAD+-regeneration 
pathway in B. smithii ET 138 under oxygen limited conditions, or for introduction to the 
TCA cycle. Moreover, it has been shown that cysteine inhibits leucine, isoleucine, threonine, 
valine and RNA biosynthesis56. Notably, no statistically relevant effect on glucose 
consumption, as well as on the lactate and acetate production was observed for increasing L-
cysteine supplementation. This result could be attributed to the low employed cysteine  
concentrations, compared to the glucose concentration, which most probably could not 
thermodynamically block the conversion of serine to cysteine via the examined pathway. 
Additionally, it was observed that Na2SO4 supplementation does not influence the acetate 
production, regardless the employed concentration (data not shown). Finally, from the 
acquired data it was not possible to determine the contribution of the L-cysteine biosynthesis 
pathway to the total B. smithii ET 138 acetate production. The transcriptional silencing of the 
L-cysteine biosynthesis pathway genes with the use of the ThermodCas9 tool could provide 
more insights in the future. 
Acetolactate synthases (ALS) are involved in the conversion of pyruvate to 
branched-chain amino acids. They are evolutionary connected with pyruvate 
decarboxylases57, which catalyse the conversion of pyruvate to acetaldehyde, but also 
present extensive sequence homology with pyruvate oxidases (POX), a class of enzymes 
responsible for the conversion of pyruvate to acetate or acetyl-phosphate58. Notably, the 
ALS large subunit from B. smithii ET 138 shows 28% identity to the POX from 
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crucial for the acetate production. Moreover, comparative proteomics analysis data presented 
in chapter 8 revealed the overproduction of the aminomethyltransferase protein (the “T-
protein” of the glycine cleavage system) in the 55°C culture, which can be triggered only 
under high glycine concentration conditions53. This is an interesting observation, as the 
proteomics data also suggest nitrogen-deprivation for the 55°C culture, indicated by the 
overproduction of the nitrogen regulatory protein PII54. Thus, we expect that glycine is 
abundant in the 55°C acetaldehyde dehydrogenase. However, the experimental 
verification of the hypothesis is hindered by the lack of predicted threonine aldolase genes 
in the genome of B. smithii ET 138.
Figure 3a. Representation of the L-cysteine biosynthetic pathway. b. Effect of L-cysteine supplementation on B. 
smithii ET 138 growth and production profile. The cultures were grown in 10 ml TVMY 
medium supplementedwith 10 g/L glucose and different concentrations of L-cysteine (0.01 g/l, 0.05 g/l, 
0.1 g/l). Experiments were done in 50 ml Greiner tubes and harvested after 24 hours of culturing. Data 
shown were average of triplicates.
Another pathway that results in the production of acetate as by-product is the L-cysteine
biosynthesis pathway (Fig. 3a), which is responsible for the conversion of L-serine to L-
cysteine. The first reaction of this pathway is catalyzed by serine acetyltransferase, which 
transfers the acetyl-group of an acetyl-CoA molecule to L-serine, converting it to O-acetyl- L-
serine. The second reaction is catalysed by cysteine synthase that converts O-acetyl- L-serine 
into L-cysteine and acetate in the presence of H2S. Since there is no extracellular cysteine
accumulation observed in the acetate-producing B. smithii ET 138 cultures, the described 
pathway could not be the main acetate producing pathway. Nonetheless, its contribution to the 
acetate production by B. smithii ET 138 was investigated by culturing the B. smithii ET 138 
ΔsigF-ΔhsdR strain in TVMY liquid medium supplemented with 10 g/l glucose, at 55°C, 150 
rpm and in volumes previously shown to promote acetate producti on (10 ml medium in 50 ml 
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Thesis summary and general discussion
Greiner tubes). Moreover, the cultures were supplemented with either different L-cysteine 
concentrations (0.08-0.8mM), though low enough to avoid high levels of medium reduction, 
or different Na2SO4 concentrations (1.8-18mM). The hypothesis was that increasing 
Na2SO4 concentrations would increase the H2S availability, enhancing the L-cysteine and 
acetate production, whereas increasing L-cysteine supplementation would reduce the 
requirement for L-cysteine production leading to simultaneous decrement in acetate. 24 hours 
post inoculation,the optical density of the cultures at 600nm was measured, as indication of 
the growth, and samples from the culture supernatants were collected for HPLC analysis and 
determination of the type and amount of produced acids (Fig. 3b). It was observed that 
increasing L-cysteine concentrations negatively affected the growth of the B. smithii ET 138 
ΔsigF-ΔhsdR cultures. This could be attributed to reduced oxygen availability caused by L-
cysteine supplementation (even though the employed concentrations were low enough) or by 
the L-cysteine reaction with dihydroxyacetone phosphate (DHAP) and pyruvate, which forms 
thiohemiketal compounds55. This reaction reduces the amount of available pyruvate either for 
lactate formation, which is the main NAD+-regeneration pathway in B. smithii ET 138 under 
oxygen limited conditions, or for introduction to the TCA cycle. Moreover, it has been shown 
that cysteine inhibits leucine, isoleucine, threonine, valine and RNA biosynthesis56. Notably, 
no statistically relevant effect on glucose consumption, as well as on the lactate and acetate 
production was observed for increasing L-cysteine supplementation. This result could be 
attributed to the low employed cysteine  concentrations, compared to the glucose 
concentration, which most probably could not thermodynamically block the conversion of 
serine to cysteine via the examined pathway. Additionally, it was observed that Na2SO4 
supplementation does not influence the acetate production, regardless the employed 
concentration (data not shown). Finally, from the acquired data it was not possible to 
determine the contribution of the L-cysteine biosynthesis pathway to the total B. smithii ET 
138 acetate production. The transcriptional silencing of the L-cysteine biosynthesis pathway 
genes with the use of the ThermodCas9 tool could provide more insights in the future.
Acetolactate synthases (ALS) are involved in the conversion of pyruvate 
to branched-chain amino acids. They are evolutionary connected with 
pyruvate decarboxylases57, which catalyse the conversion of pyruvate to acetaldehyde, 
but also present extensive sequence homology with pyruvate oxidases (POX), a class of 
enzymes responsible for the conversion of pyruvate to acetate or acetyl-phosphate58. 
Notably, the ALS large subunit from B. smithii ET 138 shows 28% identity to the POX from 
Lactobacillus plantarum, which converts pyruvate to acetyl-P59,60. Additionally, previous stu-
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MALIC ENZYME DELETIO N
Previous studies on the metabolism of the B. smithii ET 138 ΔldhL strain (lactate 
dehydrogenase-deletion mutant), under oxygen limited conditions, have indicated the 
existence of a futile cycle between pyruvate, oxaloacetate and malate via the catalytic 
activities of pyruvate carboxylase (pyc), malate dehydrogenase (mdh) and malic enzyme 
(mae)68. It was hypothesized that deletion of the me gene from the B. smithii ET 138 genome 
would disrupt this cycle, resulting either in the accumulation of either malate, orfumarate or 
other TCA cycle intermediates. Multiple attempts to delete a 400 bp long region from the me 
gene, including the start codon, employing the developed Cas9-based genome editing tools, 
did not work out as anticipated. The processes resulted in the construction of B. smithii ET 
138 strains that contained the knock-out remnant of the me gene in the native chromosomal 
position but also in a variation of the Cas9-based editing vector that carried the wild type mae
gene in-between the employed homologous recombination flanks. Moreover, it was 
hypothesized that the vector was steadily integrated into the B. smithii ET 138 genome, or 
present as free plasmid in a very low number of copies, since the developed strains were 
showing resistance to the employed antibiotic after a few rounds of culturing in mediu m 
without antibiotic. Whole genome sequencing of the constructed strains could shed light on 
the genomic re-arrangements. Nonetheless, the failure to delete the mae gene from the genome 
of B. smithii ET 138 suggests that it is essential for viability. Hence, the use of the 
ThermodCas9-based CRISPRi technology for different levels of transcriptional silencing of 
the mae gene could facilitate the identification of the minimal required expression level of the 
enzyme and the study of the corresponding effects on the production pattern of B. smithii ET 
138. Furthermore, these results indicate the importance of knockout and silencing studies in 
non-model organisms to improve understanding of their metabolism, as they reveal 
unexpected differences with related species. For example, in B. subtilis, deletion of any of its 4 
predicted malic enzymes did not have any effect on growth on glucose but only on growth on 
malate69. This is in contrast with the findings of our study in B. smithii, where the deletion of 
the predicted malic enzymes is already problematic, even though its pyruvate node 
metabolism is rather similar tothat of B. subtilis, which in turn shows striking differences from 
E. coli70.
PH O SPH O ENO LPYRUVATE CARBO XYK INASE O VEREXPRESSIO N
Aiming to improve the B. smithii ET 138 succinate production, it is essential to properly 
control the phosphoenolpyruvate (PEP)-pyruvate-oxaloacetate (OAA) node since it fuels 
the TCA cycle, enables gluconeogenesis, and replenishes TCA cycle intermediates70,71. The
Lactobacillus plantarum, which converts pyruvate to acetyl-P59,60. Additionally, previous 
studies have demonstrated that some acetolactate synthases, such as the ones from E. coli61 
and S. typhimurium62 have an oxygenase catalytic centre that results in the production of 
peracetate and peroxide62. Thiol peroxidase can eliminate the highly reactive peroxide and 
the analysis of the comparative proteomics data presented in chapter 8 showed 4-fold higher 
thiol peroxidase expression for the 55°C B. smithii ET 138 culture, producing acetate, 
compared to the 37°C culture, producing no acetate. Moreover, previously acquired 
transcriptomic data from B. smithii ET 138 cultures grown at 55°C show that thiol 
peroxidase and acetolactate synthase are generally more expressed under oxygen-rich than 
oxygen-limited conditions. However, the comparative proteomics data show that acetolactate 
synthase is more abundant in the 37°C culture. Evaluation of a B. smithii ET 138 Δals 
mutant strain or als knock-down strain, employing the developed ThermoCas9-based editing 
and silencing tools, could shed light on the influence of acetolactate synthase on the cell 
growth and production pattern.
SUCCINATE DEHYDROGENASE DELETION
The highest succinate production levels by B. smithii ET 138 were achieved under oxygen-
rich conditions. Hence, it was hypothesized that the oxidative TCA cycle or/and 
the glyoxylate shunt were responsible for the produced succinate. Under 
oxygen-rich conditions, succinate is further oxidized into fumarate via a reaction 
catalysed by the succinate dehydrogenase complex. Deletions of the succinate 
dehydrogenase genes in Corynebacterium glutamicum and Saccharomyces cerevisiae 
has resulted in succinate-producing strains when cultured under oxygen-rich 
conditions63-65. A similar engineering approach has been executed in the B. smithii ET 
138 metabolism, by deleting the genes encoding the different succinate dehydrogenase 
subunits using the developed Cas9-based editing tools. None of the attempted deletion 
trials was successful, strongly suggesting an essential role of the succinate dehydrogenase 
complex in B. smithii ET 138, at least under the tested conditions; this is in agreement 
with the absence of fumarate reductase genes in the B. smithii ET 138 genome. As 
previously performed for E. coli66 and Synechococcus elongatus67, the use of the 
ThermodCas9-based CRISPRi tool would allow for different levels of transcriptional 
silencing of the B. smithii ET 138 succinate dehydrogenase genes, in order to identify 
the minimal expression level of the succinate dehydrogenase complex required for 
growth, and to study the corresponding effects on the B. smithii ET 138 production pattern.
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Lactobacillus plantarum, which converts pyruvate to acetyl-P59,60. Additionally, previous 
studies have demonstrated that some acetolactate synthases, such as the ones from E. coli61 
and S. typhimurium62 have an oxygenase catalytic centre that results in the production of 
peracetate and peroxide62. Thiol peroxidase can eliminate the highly reactive peroxide and 
the analysis of the comparative proteomics data presented in chapter 8 showed 4-fold higher 
thiol peroxidase expression for the 55°C B. smithii ET 138 culture, producing acetate, 
compared to the 37°C culture, producing no acetate. Moreover, previously acquired 
transcriptomic data from B. smithii ET 138 cultures grown at 55°C show that thiol peroxidase 
and acetolactate synthase are generally more expressed under oxygen-rich than oxygen-
limited conditions. However, the comparative proteomics data show that acetolactate 
synthase is more abundant in the 37°C culture. Evaluation of a B. smithii ET 138 Δals mutant 
strain or als knock-down strain, employing the developed ThermoCas9-based editing and 
silencing tools, could shed light on the influence of acetolactate synthase on the cell growth 
and production pattern.
SUCCINATE DEH YDRO G ENASE DELETIO N
The highest succinate production levels by B. smithii ET 138 were achieved under 
oxygen-rich conditions. Hence, it was hypothesized that the oxidative TCA cycle or/and 
the glyoxylate shunt were responsible for the produced succinate. Under oxygen-rich 
conditions, succinate is further oxidized into fumarate via a reaction catalysed by 
the succinate dehydrogenase complex. Deletions of the succinate 
dehydrogenase genes in Corynebacterium glutamicum and Saccharomyces 
cerevisiae has resulted in succinate-producing strains when cultured under 
oxygen-rich conditions63-65. A similar engineering approach has been executed 
in the B. smithii ET 138 metabolism, by deleting the genes 
encoding the different succinate dehydrogenase subunits using the developed 
Cas9-based editing tools. None of the attempted deletion trials was successful, 
strongly suggesting an essential role of the succinate dehydrogenase complex in 
B. smithii ET 138, at least under the tested conditions; this is in agreement with 
the absence of fumarate reductase genes in the B. smithii ET 138 genome. As 
previously performed for E. coli66 and Synechococcus elongatus67, the use of 
the ThermodCas9-based CRISPRi tool would allow for different levels of transcriptional 
silencing of the B. smithii ET 138 succinate dehydrogenase genes, in order to 
identify the minimal expression level of the succinate dehydrogenase complex 
required for growth, and to study the corresponding effects on the production 
pattern of B. smithii ET 138.    
Thesis summary and general discussion
MALIC ENZYME DELETION
Previous studies on the metabolism of the B. smithii ET 138 ΔldhL strain (lactate 
dehydrogenase-deletion mutant), under oxygen limited conditions, have indicated the 
existence of a futile cycle between pyruvate, oxaloacetate and malate via the catalytic 
activities of pyruvate carboxylase (pyc), malate dehydrogenase (mdh) and malic enzyme 
(mae)68. It was hypothesized that deletion of the me gene from the B. smithii ET 138 
genome would disrupt this cycle, resulting either in the accumulation of either malate, 
or fumarate or other TCA cycle intermediates. Multiple attempts to delete a 400 bp 
long region from the me gene, including the start codon, employing the developed Cas9-
based genome editing tools, did not work out as anticipated. The processes resulted 
in the construction of B. smithii ET 138 strains that contained the knock-out remnant of 
the mae gene in the native chromosomal position but also in a variation of the Cas9-
based editing vector that carried the wild type mae gene in-between the 
employed homologous recombination flanks. Moreover, it was hypothesized that the 
vector was steadily integrated into the B. smithii ET 138 genome, or present as free 
plasmid in a very low number of copies, since the developed strains were showing 
resistance to the employed antibiotic after a few rounds of culturing in medium without 
antibiotic. Whole genome sequencing of the constructed strains could shed light on the 
genomic re-arrangements. Nonetheless, the failure to delete the mae gene from the genome 
of  B. smithii ET 138 suggests that it is essential for viability. Hence, the use of the 
ThermodCas9-based CRISPRi technology for different levels of transcriptional silencing of 
the mae gene could facilitate the identification of the minimal required expression level of 
the enzyme and the study of the corresponding effects on the production pattern of B. 
smithii ET 138. Furthermore, these results indicate the importance of knockout and silencing 
studies in non-model organisms to improve understanding of their metabolism, as they 
reveal unexpected differences with related species. For example, in B. subtilis, deletion of 
any of its 4 predicted malic enzymes did not have any effect on growth on glucose but 
only on growth on malate69. This is in contrast with the findings of our study in B. smithii, 
where the deletion of the predicted malic enzymes is already problematic, even though its 
pyruvate node metabolism is rather similar to that of B. subtilis, which in turn shows 
striking differences from E. coli70.
PHOSPHOENOLPYRUVATE CARBOXYKINASE OVEREXPRESSION
Aiming to improve the B. smithii ET 138 succinate production, it is essential 
to properly control the phosphoenolpyruvate (PEP)-pyruvate-oxaloacetate (OAA) 
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The first aim of this thesis was to develop and further extend the existing genetic and genome 
engineering toolboxes of thermophilic and mesophilic bacteria, while the work towards 
that aim was mainly focused on the moderate thermophile B. smithii ET 138 and the 
mesophiles R. sphaeroides and E. coli. The expansion of the available B. smithii ET 
138 and R. sphaeroides genetic toolboxes with vectors, promoters or other genetic elements 
was limited, as presented in chapters 3, 4, 5 and 9, while solutions were proposed for 
surpassing the identified bottlenecks in the tools development process in the near future. 
Nonetheless, the developed parts satisfactorily acted as the basis for the SpCas9- and 
ThermoCas9-based genome engineering tools presented in chapters 3, 4 and 5. This fact 
underlined the minimal requirements of these tools and suggested their high potential to 
be easily and efficiently adapted in other model and non-model
organisms. Furthermore, chapter 6 demonstrated the potential of the 
antiCRISPR protein AcrIIc to interact with the ThermoCas9 
endonuclease and form a ThermoCas9/antiCRISPR complex that in vivo in E. 
coli has similar activity as the catalytically inactive ThermodCas9 variant. This 
finding opens up the potential for the construction of a new generation of 
ThermoCas9-based genome engineering and synthetic biology tool. Finally, this 
chapter presented the targeting efficiencies of alternative CRISPR-Cas systems in B. 
smithii ET 138 and in G. thermodenitrificans T12, but none of them reached 
the desired efficiency levels for the development of genome 
engineering tools. Further studies on these systems, based on the proposed 
approaches, could either improve their targeting efficiencies or, in the cases of the 
native systems, could result in the identification of novel antiCRISPR systems. 
The second aim of this thesis was to shed light on the unknown 
acetate production pathway of the B. smithii ET 138, as well as to enhance its 
dicarboxylic acids production profile. Even though the genetic background of the acetate 
production pathway was not elucidated, as presented in chapters 8 and 9, some 
possibilities were eliminated and further candidate pathways were proposed for 
future examination. Additionally, metabolic engineering studies presented in the same 
chapters, resulted in a strain with enhanced production in dicarboxylic acids and 
elucidated the essentiality of enzymes, such as the succinate dehydrogenase complex and the 
malic enzyme. Finally, studies on B. smithii ET 138 cultures at 37°C and 55°C revealed 
great differences in production profiles and enzymatic content, and hence 
suggested a temperature-based shift in the B. smithii ET 138 metabolism.  
node since it fuels the TCA cycle, enables gluconeogenesis, and replenishes TCA 
cycle intermediates70,71. The B. smithii ET 138 PEP carboxykinase (PCK) 
catalyses the interconversion between OAA and PEP and is predicted to function in the 
gluconeogenic direction (unpublished data). We hypothesized that overexpression of 
native B. smithii ET 138 PCK could reverse its direction, as was previously shown for E. 
coli72, contributing to ATP-generation, increased carbon flux towards OAA, and increased 
CO2 fixation. Plasmid-based overexpression of the native pck gene in B. smithii ET 
138 cultures led to the formation of cell aggregates when put under the control of the 
strong PldhL promoter, while it did not have apparent effect on growth, production and 
substrate consumption when put under the control of the moderate Ppta promoter. In 
previous studies it was demonstrated that PCK overexpression in E. coli had positive 
effects on growth and succinate production when the medium was supplemented with 
NaHCO3 at concentrations greater than 10 g/L73. The supplementation of B. smithii ET 
138 cultures with 4 g/l NaHCO3 negatively affected the growth, suggesting the 
requirement for further fine–tuning of CO2 supplementation. Another possible 
engineering approach for increasing the intracellular PEP pool, hence forcing PCK 
function in the glycolytic direction, would be the knockout of the PEP-dependent 
phosphotransferase system (PTS), which is responsible for the glucose import to the cells, 
or the heterologous expression of a PCK known to function in the glycolytic direction, 
like the one from Clostridium thermocellum. Finally, it was reported in Bacillus subtilis 
that upon deletion of the pyruvate kinase (pyk) gene, the PCK operated in the reverse 
direction, converting PEP to OAA71; hence it would be of great interest to evaluate the 
effect of the pyk deletion from the B. smithii ET 138 genome on its metabolism.
CONCLUDING REMARKS
The fundamental studies on the metabolism of genetically accessible model 
and non-model microorganisms, as well as the development of accurate metabolic models 
that aim to facilitate the exploitation of their biotechnological potential, heavily 
relies on the development of extensive genetic toolboxes and time-efficient 
genome engineering tools. As reviewed in chapter 2, the first generation of 
CRISPR-Cas based bacterial genome engineering tools have facilitated and 
accelerated the studies on bacterial metabolisms, while a second upcoming 
generation of CRISPR-Cas tools will further enhance the throughput of these 
studies and will provide the potential for the development of novel applications. 
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B. smithii ET 138 PEP carboxykinase (PCK) catalyses the interconversion between OAA
and PEP and is predicted to function in the gluconeogenic direction (unpublished data).
We hypothesized that overexpression of native B. smithii ET 138 PCK could reverse its
direction, as was previously shown for E. coli72, contributing to ATP-generation, increased
carbon flux towards OAA, and increased CO2 fixation. Plasmid-based overexpression
of the native pck gene in B. smithii ET 138 cultures led to the formation of cell
aggregates when put under the control of the strong PldhL promoter, while it did
not have apparent effect on growth, production and substrate consumption when
put under the control of the moderate Ppta promoter. In previous studies it was
demonstrated that PCK overexpression in E. coli had positive effects on growth
and succinate production when the medium was supplemented with NaHCO3 at
concentrations greater than 10 g/L73. The supplementation of B. smithii ET 138
cultures with 4 g/l NaHCO3 negatively affected the growth, suggesting the
requirement for further fine–tuning of CO2 supplementation. Another possible
engineering approach for increasing the intracellular PEP pool, hence forcing PCK
function in the glycolytic direction, would be the knockout of the PEP-dependent
phosphotransferase system (PTS), which is responsible for the glucose import to the
cells, or the heterologous expression of a PCK known to function in the glycolytic
direction, like the one from Clostridium thermocellum. Finally, it was reported in
Bacillus subtilis that upon deletion of the pyruvate kinase (pyk) gene, the PCK
operated in the reverse direction, converting PEP to OAA71; hence it would be of great
interest to evaluate the effect of the pyk deletion from the B. smithii ET 138 genome on
its metabolism.
CO NCLUDING REMARK S
The fundamental studies on the metabolism of genetically accessible model and non-
model microorganisms, as well as the development of accurate metab olic models that aim to 
facilitate the exploitation of their biotechnological potential, heavily relies on the 
development of extensive genetic toolboxes and time-efficient genome engineering tools. 
As reviewed in chapter 2, the first generation of CRISPR-Cas based bacterial genome 
engineering tools have facilitated and accelerated the studies on bacterial metabolisms, 
while a second upcoming generation of CRISPR-Cas tools will further enhance the 
throughput of these studies and will provide the potential for the development of novel 
applications. Additionally, chapter 7 of this thesis reviewed the bacterial metabolic 
engineering studies that aimed for the development of green chemical- and biofuel-
production workhorses.   
Thesis summary and general discussion
Additionally, chapter 7 of this thesis reviewed the bacterial metabolic engineering studies 
that aimed for the development of green chemical- and biofuel-production workhorses.   
The first aim of this thesis was to develop and further extend the existing 
genetic and genome engineering toolboxes of thermophilic and mesophilic bacteria, 
while the work towards that aim was mainly focused on the moderate thermophile B. 
smithii ET 138 and the mesophiles R. sphaeroides and E. coli. The expansion of the 
available B. smithii ET 138 and R. sphaeroides genetic toolboxes with vectors, promoters or 
other genetic elements was limited, as presented in chapters 3, 4, 5 and 9, while solutions 
were proposed for surpassing the identified bottlenecks in the tools development process in 
the near future. Nonetheless, the developed parts satisfactorily acted as the basis for the 
SpCas9- and ThermoCas9-based genome engineering tools presented in chapters 3, 4 and 5.  
This fact underlined the minimal requirements of these tools and suggested their high 
potential to be easily and efficiently adapted in other model and non-model organisms. 
Furthermore, chapter 6 demonstrated the potential of the antiCRISPR protein AcrIIC1 to 
interact with the ThermoCas9 endonuclease and form a ThermoCas9/antiCRISPR complex 
that in vivo in E. coli has similar activity as the catalytically inactive ThermodCas9 
variant. This finding opens up the potential for the construction of a new generation of 
ThermoCas9-based genome engineering and synthetic biology tool. Finally, this chapter 
presented the targeting efficiencies of alternative CRISPR-Cas systems in B. smithii ET 
138 and in G. thermodenitrificans T12, but none of them reached the desired 
efficiency levels for the development of genome engineering tools. Further studies on 
these systems, based on the proposed approaches, could either improve their targeting 
efficiencies or, in the cases of the native systems, could result in the identification 
of novel antiCRISPR systems. 
The second aim of this thesis was to shed light on the unknown acetate production 
pathway of the B. smithii ET 138, as well as to enhance its dicarboxylic acids production 
profile. Even though the genetic background of the acetate production pathway was not 
elucidated, as presented in chapters 8 and 9, some possibilities were eliminated and further 
candidate pathways were proposed for future examination. Additionally, metabolic 
engineering studies presented in the same chapters, resulted in a strain with enhanced 
production in dicarboxylic acids and elucidated the essentiality of enzymes, such as the 
succinate dehydrogenase complex and the malic enzyme. Finally, studies on B. smithii ET 
138 cultures at 37°C and 55°C revealed great differences in production profiles and 
enzymatic content, and hence suggested a temperature-based shift in the B. smithii ET 138 
metabolism. 
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